data_2laz_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2laz _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 2.2 mt . . . . . 0 N--CA 1.453 -0.297 0 N-CA-C 109.789 -0.449 . . . . 15.0 109.789 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 237' ' ' PRO . . . . . 0.467 ' O ' ' HD2' ' A' ' 240' ' ' TYR . 14.0 Cg_exo -69.5 166.75 26.2 Favored 'Trans proline' 0 N--CA 1.458 -0.615 0 C-N-CA 121.793 1.662 . . . . 15.0 110.221 165.706 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -69.74 142.99 53.17 Favored 'General case' 0 C--N 1.303 -1.433 0 CA-C-N 114.863 -1.062 . . . . 15.0 111.521 -173.024 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 100.15 5.83 54.27 Favored Glycine 0 N--CA 1.449 -0.485 0 CA-C-N 115.361 -0.836 . . . . 15.0 113.785 178.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 240' ' ' TYR . . . . . 0.623 ' CD1' ' HB2' ' A' ' 254' ' ' HIS . 71.7 m-85 -108.19 116.31 31.72 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 117.636 0.718 . . . . 15.0 111.678 -179.698 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -90.37 113.82 25.79 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.048 -0.978 . . . . 15.0 109.595 174.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 242' ' ' GLN . . . . . 0.661 ' HG3' ' CE1' ' A' ' 252' ' ' PHE . 39.6 tt0 -91.09 103.42 16.12 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 109.523 -0.547 . . . . 15.0 109.523 -179.771 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 243' ' ' ARG . . . . . 0.427 HH11 ' HD2' ' A' ' 243' ' ' ARG . 8.5 mtp180 -109.25 149.87 28.78 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 122.07 0.938 . . . . 15.0 112.637 -176.168 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 244' ' ' THR . . . . . . . . . . . . . 10.2 p -124.72 96.8 5.02 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 113.54 -1.664 . . . . 15.0 109.41 -176.257 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 245' ' ' THR . . . . . 0.683 HG22 ' HB2' ' A' ' 247' ' ' GLN . 2.7 t -89.99 150.28 22.2 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 115.861 -0.609 . . . . 15.0 111.412 -174.71 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 9.7 m -52.06 -19.21 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.315 0 CA-C-N 115.713 -0.676 . . . . 15.0 112.04 175.075 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 247' ' ' GLN . . . . . 0.683 ' HB2' HG22 ' A' ' 245' ' ' THR . 0.2 OUTLIER -49.81 -26.8 4.28 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 115.98 -0.554 . . . . 15.0 110.873 170.239 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 93.17 19.36 36.29 Favored Glycine 0 C--O 1.229 -0.188 0 CA-C-N 115.837 -0.619 . . . . 15.0 112.289 177.041 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 249' ' ' GLN . . . . . 0.436 ' NE2' ' HH2' ' A' ' 262' ' ' TRP . 0.0 OUTLIER -135.41 144.39 46.5 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.01 0.433 . . . . 15.0 110.724 -174.605 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 19.4 m -89.94 142.39 12.99 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 115.444 -0.798 . . . . 15.0 109.677 176.406 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 6.1 p90 -148.18 142.68 26.43 Favored 'General case' 0 C--N 1.321 -0.646 0 C-N-CA 120.67 -0.412 . . . . 15.0 110.693 -179.38 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 252' ' ' PHE . . . . . 0.678 ' CE2' ' HA ' ' A' ' 264' ' ' ASP . 29.7 m-85 -98.15 119.57 37.02 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.842 -0.617 . . . . 15.0 111.869 -175.631 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 253' ' ' LEU . . . . . 0.594 HD12 ' CB ' ' B' ' 212' ' ' PRO . 2.8 mt -104.36 103.23 12.93 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 114.744 -1.116 . . . . 15.0 112.012 -177.579 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 254' ' ' HIS . . . . . 0.623 ' HB2' ' CD1' ' A' ' 240' ' ' TYR . 36.7 t-80 -113.26 89.95 3.22 Favored 'General case' 0 C--N 1.312 -1.036 0 N-CA-C 107.982 -1.118 . . . . 15.0 107.982 167.413 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 255' ' ' THR . . . . . 0.4 HG21 ' HA2' ' A' ' 258' ' ' GLY . 23.4 m -92.43 87.78 6.13 Favored 'General case' 0 N--CA 1.432 -1.355 0 C-N-CA 116.684 -2.006 . . . . 15.0 109.496 -179.328 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 64.1 tt0 -101.54 -53.43 2.99 Favored 'General case' 0 N--CA 1.439 -1.008 0 N-CA-C 106.199 -1.778 . . . . 15.0 106.199 150.592 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 257' ' ' THR . . . . . . . . . . . . . 82.6 p -96.83 -13.61 22.44 Favored 'General case' 0 CA--C 1.484 -1.561 0 CA-C-O 124.889 2.28 . . . . 15.0 111.733 -178.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 258' ' ' GLY . . . . . 0.4 ' HA2' HG21 ' A' ' 255' ' ' THR . . . 87.73 72.83 1.28 Allowed Glycine 1 C--N 1.241 -4.695 1 CA-C-N 108.174 -4.103 . . . . 15.0 112.703 -171.638 . . . . . . . . 4 3 . 1 . 001 nuclear orig core ' A' A ' 259' ' ' VAL . . . . . 0.482 ' O ' ' HA ' ' A' ' 253' ' ' LEU . 53.0 t -89.89 125.2 42.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 121.585 0.707 . . . . 15.0 112.361 176.182 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 3.3 p -132.34 101.93 5.55 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 114.091 -1.413 . . . . 15.0 107.706 167.129 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 12.3 t -132.15 150.24 52.2 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 121.188 0.518 . . . . 15.0 112.352 -169.563 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 262' ' ' TRP . . . . . 0.436 ' HH2' ' NE2' ' A' ' 249' ' ' GLN . 77.0 m95 -78.26 -25.57 46.85 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.11 -0.95 . . . . 15.0 111.202 176.877 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 263' ' ' HIS . . . . . . . . . . . . . 6.5 p80 -89.34 131.36 35.46 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.496 -0.481 . . . . 15.0 110.212 -175.022 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 264' ' ' ASP . . . . . 1.106 ' HB3' HG12 ' A' ' 267' ' ' ILE . 19.8 t0 -56.36 125.03 64.33 Favored Pre-proline 0 C--N 1.323 -0.565 0 N-CA-C 107.669 -1.234 . . . . 15.0 107.669 170.061 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 265' ' ' PRO . . . . . 0.541 ' HD3' ' CD2' ' A' ' 252' ' ' PHE . 11.5 Cg_exo -70.54 -14.72 33.87 Favored 'Trans proline' 0 C--N 1.323 -0.766 0 C-N-CA 121.751 1.634 . . . . 15.0 112.573 -175.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 266' ' ' ARG . . . . . 0.429 ' HD3' ' HD3' ' A' ' 237' ' ' PRO . 19.3 tpt180 -76.27 -11.99 60.0 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 115.443 -0.799 . . . . 15.0 108.956 173.223 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 267' ' ' ILE . . . . . 1.106 HG12 ' HB3' ' A' ' 264' ' ' ASP . 40.3 pt . . . . . 0 C--O 1.249 1.027 0 CA-C-N 115.017 -0.992 . . . . 15.0 111.448 178.618 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 210' ' ' SER . . . . . . . . . . . . . 20.3 m . . . . . 0 N--CA 1.477 0.885 0 CA-C-O 120.635 0.255 . . . . 15.0 111.279 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' B' B ' 211' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -133.14 119.61 15.7 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 120.502 0.191 . . . . 15.0 110.519 -179.116 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 212' ' ' PRO . . . . . 0.594 ' CB ' HD12 ' A' ' 253' ' ' LEU . 3.9 Cg_endo -89.7 160.0 5.21 Favored 'Trans proline' 0 N--CA 1.455 -0.79 0 C-N-CA 122.707 2.271 . . . . 15.0 111.524 173.904 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.443 -0.879 0 C-N-CA 120.338 -0.934 . . . . 15.0 112.241 -177.388 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 61.1 mt . . . . . 0 CA--C 1.518 -0.261 0 N-CA-C 109.507 -0.553 . . . . 15.0 109.507 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 237' ' ' PRO . . . . . 0.932 ' HD3' ' HD3' ' A' ' 266' ' ' ARG . 15.2 Cg_exo -69.47 171.16 14.64 Favored 'Trans proline' 0 CA--C 1.513 -0.57 0 C-N-CA 122.055 1.837 . . . . 15.0 110.92 165.927 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -69.68 133.32 47.4 Favored 'General case' 0 C--N 1.302 -1.492 0 CA-C-N 114.415 -1.266 . . . . 15.0 112.208 -173.248 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 100.16 28.83 7.06 Favored Glycine 0 C--N 1.334 0.434 0 CA-C-N 115.16 -0.927 . . . . 15.0 114.094 174.08 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 240' ' ' TYR . . . . . 0.7 ' CD1' ' HB2' ' A' ' 254' ' ' HIS . 65.0 m-85 -117.36 123.72 47.17 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 117.963 0.881 . . . . 15.0 111.468 177.864 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 241' ' ' GLU . . . . . 0.492 ' HG3' ' HB2' ' A' ' 253' ' ' LEU . 10.6 pt-20 -119.64 119.97 35.28 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.76 -0.654 . . . . 15.0 109.595 172.807 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -90.13 109.45 20.51 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 108.775 -0.824 . . . . 15.0 108.775 178.371 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 243' ' ' ARG . . . . . 0.457 ' HB2' ' CE1' ' A' ' 251' ' ' TYR . 31.3 mtt180 -95.87 149.97 20.95 Favored 'General case' 0 CA--C 1.51 -0.574 0 CA-C-O 122.025 0.917 . . . . 15.0 112.295 -175.218 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 244' ' ' THR . . . . . . . . . . . . . 4.9 p -111.61 97.46 6.75 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-N 113.498 -1.683 . . . . 15.0 110.553 -176.553 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 245' ' ' THR . . . . . 0.695 HG21 ' HB2' ' A' ' 247' ' ' GLN . 0.9 OUTLIER -90.7 150.6 21.58 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.187 -0.915 . . . . 15.0 110.302 177.846 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 25.3 t -50.62 -18.43 0.63 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.489 0 O-C-N 123.52 0.513 . . . . 15.0 110.959 176.335 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 247' ' ' GLN . . . . . 0.695 ' HB2' HG21 ' A' ' 245' ' ' THR . 77.9 mm-40 -50.83 -29.11 10.9 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 116.038 -0.528 . . . . 15.0 111.156 171.916 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 80.94 21.41 63.29 Favored Glycine 0 N--CA 1.452 -0.27 0 N-CA-C 111.624 -0.59 . . . . 15.0 111.624 -178.43 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 249' ' ' GLN . . . . . 0.57 HE21 ' HB3' ' A' ' 247' ' ' GLN . 10.4 mt-30 -121.32 143.96 48.9 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.726 -0.472 . . . . 15.0 109.726 -175.803 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 28.8 m -89.84 133.28 32.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 N-CA-C 109.582 -0.525 . . . . 15.0 109.582 176.601 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 251' ' ' TYR . . . . . 0.457 ' CE1' ' HB2' ' A' ' 243' ' ' ARG . 2.4 p90 -140.49 130.11 24.21 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.054 0.454 . . . . 15.0 110.141 -177.12 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 252' ' ' PHE . . . . . 0.625 ' CD2' ' HA ' ' A' ' 264' ' ' ASP . 34.9 m-85 -90.01 116.49 28.09 Favored 'General case' 0 CA--C 1.513 -0.474 0 CA-C-N 115.874 -0.603 . . . . 15.0 111.857 -173.405 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 253' ' ' LEU . . . . . 0.525 HD12 ' CB ' ' B' ' 212' ' ' PRO . 12.9 mt -98.59 126.76 44.27 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-N 114.816 -1.083 . . . . 15.0 111.233 175.677 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 254' ' ' HIS . . . . . 0.7 ' HB2' ' CD1' ' A' ' 240' ' ' TYR . 33.2 t-80 -133.87 89.78 2.62 Favored 'General case' 0 C--N 1.309 -1.183 0 N-CA-C 107.633 -1.247 . . . . 15.0 107.633 167.032 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 3.3 t -94.13 87.95 5.46 Favored 'General case' 0 N--CA 1.429 -1.491 0 C-N-CA 116.334 -2.147 . . . . 15.0 110.105 -179.732 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 60.0 tt0 -101.61 -54.94 2.63 Favored 'General case' 0 N--CA 1.436 -1.137 0 CA-C-N 112.946 -1.934 . . . . 15.0 105.921 151.02 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 257' ' ' THR . . . . . . . . . . . . . 71.6 p -100.04 -13.63 18.97 Favored 'General case' 0 CA--C 1.489 -1.4 0 CA-C-N 111.989 -2.369 . . . . 15.0 112.401 -179.756 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 89.38 71.42 1.26 Allowed Glycine 1 C--N 1.243 -4.622 0 CA-C-N 108.566 -3.924 . . . . 15.0 113.59 -173.15 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 259' ' ' VAL . . . . . 0.657 ' HB ' ' HB3' ' A' ' 254' ' ' HIS . 52.6 t -90.12 129.24 41.32 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 CA-C-O 121.324 0.583 . . . . 15.0 111.564 172.954 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 1.4 p -143.36 108.15 4.9 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 114.539 -1.209 . . . . 15.0 108.643 169.35 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 7.4 t -149.01 150.34 32.66 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.042 0.448 . . . . 15.0 111.685 -171.616 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 262' ' ' TRP . . . . . . . . . . . . . 89.8 m95 -66.89 -30.21 70.3 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.295 -0.866 . . . . 15.0 111.613 177.119 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 263' ' ' HIS . . . . . . . . . . . . . 3.1 p80 -83.85 133.34 34.75 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.55 -0.46 . . . . 15.0 110.607 -172.248 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 264' ' ' ASP . . . . . 0.874 ' HB3' HG12 ' A' ' 267' ' ' ILE . 9.5 t70 -56.9 129.87 78.44 Favored Pre-proline 0 C--N 1.323 -0.549 0 N-CA-C 108.535 -0.913 . . . . 15.0 108.535 172.766 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 265' ' ' PRO . . . . . 0.472 ' HD3' ' HA ' ' A' ' 264' ' ' ASP . 2.6 Cg_exo -76.33 -14.59 18.28 Favored 'Trans proline' 0 CA--C 1.511 -0.655 0 C-N-CA 122.297 1.998 . . . . 15.0 113.451 -174.524 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 266' ' ' ARG . . . . . 0.932 ' HD3' ' HD3' ' A' ' 237' ' ' PRO . 6.4 tpt180 -79.39 -8.72 59.3 Favored 'General case' 0 C--N 1.31 -1.149 0 CA-C-O 121.953 0.882 . . . . 15.0 108.78 175.635 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 267' ' ' ILE . . . . . 0.874 HG12 ' HB3' ' A' ' 264' ' ' ASP . 42.4 mm . . . . . 0 C--O 1.249 1.033 0 CA-C-N 113.997 -1.456 . . . . 15.0 109.809 178.755 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 210' ' ' SER . . . . . . . . . . . . . 12.5 p . . . . . 0 N--CA 1.476 0.873 0 CA-C-O 121.14 0.495 . . . . 15.0 110.74 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' B' B ' 211' ' ' ASP . . . . . 0.485 ' HA ' ' HD3' ' B' ' 212' ' ' PRO . 7.2 p-10 -150.3 135.38 9.86 Favored Pre-proline 0 C--N 1.325 -0.488 0 CA-C-N 115.945 -0.57 . . . . 15.0 110.672 -179.185 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 212' ' ' PRO . . . . . 0.525 ' CB ' HD12 ' A' ' 253' ' ' LEU . 1.4 Cg_endo -89.79 138.87 3.12 Favored 'Trans proline' 0 N--CA 1.458 -0.599 0 C-N-CA 123.529 2.819 . . . . 15.0 111.99 178.766 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.444 -0.816 0 C-N-CA 120.813 -0.708 . . . . 15.0 111.561 -179.101 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 236' ' ' LEU . . . . . 0.443 HD22 ' N ' ' A' ' 236' ' ' LEU . 0.2 OUTLIER . . . . . 0 CA--C 1.518 -0.261 0 N-CA-C 109.188 -0.671 . . . . 15.0 109.188 . . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 237' ' ' PRO . . . . . 0.628 ' HD3' ' HD3' ' A' ' 266' ' ' ARG . 12.9 Cg_exo -69.84 163.32 38.77 Favored 'Trans proline' 0 CA--C 1.514 -0.487 0 C-N-CA 122.022 1.815 . . . . 15.0 110.143 167.839 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -69.81 146.14 51.6 Favored 'General case' 0 C--N 1.305 -1.365 0 CA-C-N 115.45 -0.795 . . . . 15.0 111.611 -175.456 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 99.96 3.54 55.84 Favored Glycine 0 N--CA 1.449 -0.48 0 CA-C-N 115.353 -0.84 . . . . 15.0 113.896 178.218 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 240' ' ' TYR . . . . . 0.738 ' CD1' ' HB2' ' A' ' 254' ' ' HIS . 83.6 m-85 -107.12 123.73 48.67 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 117.45 0.625 . . . . 15.0 110.878 178.001 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -110.12 130.71 55.49 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 109.534 -0.543 . . . . 15.0 109.534 170.442 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 242' ' ' GLN . . . . . 0.47 ' HG3' ' CE1' ' A' ' 252' ' ' PHE . 18.9 tt0 -89.92 112.04 23.3 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.253 -0.647 . . . . 15.0 109.253 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 31.9 mtp85 -105.94 145.67 31.01 Favored 'General case' 0 CA--C 1.502 -0.893 0 CA-C-O 121.957 0.884 . . . . 15.0 112.665 -177.508 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 244' ' ' THR . . . . . . . . . . . . . 48.6 m -121.74 93.33 3.97 Favored 'General case' 0 C--N 1.309 -1.157 0 CA-C-N 113.412 -1.722 . . . . 15.0 109.86 -178.8 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 245' ' ' THR . . . . . 1.052 HG23 ' HG2' ' A' ' 247' ' ' GLN . 5.2 t -89.97 150.61 22.07 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.15 -0.932 . . . . 15.0 110.484 -178.567 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 34.1 t -44.2 -25.7 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 N-CA-C 113.596 0.962 . . . . 15.0 113.596 -175.305 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 247' ' ' GLN . . . . . 1.052 ' HG2' HG23 ' A' ' 245' ' ' THR . 3.4 pt20 -55.1 -18.72 5.9 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 111.579 0.214 . . . . 15.0 111.579 177.649 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 87.7 26.52 29.44 Favored Glycine 0 C--N 1.334 0.472 0 C-N-CA 121.356 -0.449 . . . . 15.0 112.721 175.254 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 249' ' ' GLN . . . . . 0.487 ' HB2' ' OE1' ' A' ' 247' ' ' GLN . 10.7 mt-30 -138.86 140.34 38.42 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.699 -0.482 . . . . 15.0 109.699 -177.62 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 20.5 m -90.04 141.93 13.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 116.397 -0.365 . . . . 15.0 110.652 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 18.4 p90 -142.21 140.06 32.21 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.468 -0.567 . . . . 15.0 109.468 -178.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 252' ' ' PHE . . . . . 0.737 ' CD2' ' HA ' ' A' ' 264' ' ' ASP . 42.4 m-85 -93.6 119.39 32.58 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.123 -0.49 . . . . 15.0 111.895 -174.708 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 253' ' ' LEU . . . . . 0.584 HD21 ' O ' ' A' ' 259' ' ' VAL . 4.1 mt -101.46 117.05 34.15 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-N 115.225 -0.898 . . . . 15.0 111.136 179.244 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 254' ' ' HIS . . . . . 0.738 ' HB2' ' CD1' ' A' ' 240' ' ' TYR . 34.2 t-80 -130.76 90.02 2.84 Favored 'General case' 0 CA--C 1.5 -0.943 0 N-CA-C 107.916 -1.142 . . . . 15.0 107.916 169.464 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 37.1 m -92.73 87.93 6.06 Favored 'General case' 0 N--CA 1.433 -1.293 0 C-N-CA 116.735 -1.986 . . . . 15.0 110.453 -178.802 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 7.8 tt0 -101.14 -52.2 3.33 Favored 'General case' 0 N--CA 1.443 -0.809 0 N-CA-C 106.041 -1.837 . . . . 15.0 106.041 149.447 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 257' ' ' THR . . . . . . . . . . . . . 73.3 p -97.89 -13.48 21.21 Favored 'General case' 0 CA--C 1.487 -1.452 0 CA-C-O 124.779 2.228 . . . . 15.0 111.727 -179.839 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 86.28 70.83 1.31 Allowed Glycine 1 C--N 1.24 -4.772 0 CA-C-N 108.483 -3.962 . . . . 15.0 113.14 -172.665 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 259' ' ' VAL . . . . . 0.584 ' O ' HD21 ' A' ' 253' ' ' LEU . 48.0 t -89.99 125.33 42.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 N-CA-C 112.637 0.606 . . . . 15.0 112.637 177.103 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -138.07 102.19 4.62 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 107.794 -1.188 . . . . 15.0 107.794 167.217 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 12.5 t -138.02 150.35 46.88 Favored 'General case' 0 C--N 1.317 -0.812 0 C-N-CA 120.533 -0.467 . . . . 15.0 112.208 -167.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 262' ' ' TRP . . . . . 0.403 ' HZ3' ' CB ' ' A' ' 249' ' ' GLN . 80.7 m95 -71.28 -33.26 69.59 Favored 'General case' 0 N--CA 1.455 -0.195 0 CA-C-N 115.391 -0.822 . . . . 15.0 111.719 178.912 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 263' ' ' HIS . . . . . . . . . . . . . 5.0 p80 -83.48 134.68 34.84 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.511 -0.476 . . . . 15.0 110.017 -175.245 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 264' ' ' ASP . . . . . 1.018 ' HB3' HG12 ' A' ' 267' ' ' ILE . 10.8 t70 -55.87 131.9 73.17 Favored Pre-proline 0 C--N 1.323 -0.549 0 N-CA-C 108.664 -0.865 . . . . 15.0 108.664 172.615 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 265' ' ' PRO . . . . . 0.493 ' HD3' ' CD2' ' A' ' 252' ' ' PHE . 72.0 Cg_endo -75.67 -14.76 19.62 Favored 'Trans proline' 0 CA--C 1.507 -0.842 0 C-N-CA 121.456 1.437 . . . . 15.0 113.464 -172.071 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 266' ' ' ARG . . . . . 0.628 ' HD3' ' HD3' ' A' ' 237' ' ' PRO . 8.6 tpt180 -81.51 -7.43 59.58 Favored 'General case' 0 C--N 1.306 -1.283 0 N-CA-C 108.168 -1.049 . . . . 15.0 108.168 175.227 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 267' ' ' ILE . . . . . 1.018 HG12 ' HB3' ' A' ' 264' ' ' ASP . 37.5 pt . . . . . 0 C--O 1.25 1.093 0 CA-C-N 114.002 -1.454 . . . . 15.0 110.85 175.691 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 210' ' ' SER . . . . . . . . . . . . . 10.3 p . . . . . 0 N--CA 1.475 0.808 0 CA-C-O 121.014 0.435 . . . . 15.0 110.555 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' B' B ' 211' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -90.16 118.08 68.56 Favored Pre-proline 0 C--N 1.325 -0.489 0 CA-C-O 121.174 0.512 . . . . 15.0 111.346 -175.284 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 212' ' ' PRO . . . . . 0.541 ' CB ' HD11 ' A' ' 253' ' ' LEU . 9.2 Cg_endo -89.93 146.06 4.58 Favored 'Trans proline' 0 N--CA 1.451 -0.974 0 C-N-CA 122.816 2.344 . . . . 15.0 111.157 172.46 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.439 -1.148 0 C-N-CA 120.099 -1.048 . . . . 15.0 111.702 -179.502 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 5.8 mt . . . . . 0 C--O 1.233 0.217 0 N-CA-C 109.676 -0.49 . . . . 15.0 109.676 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 237' ' ' PRO . . . . . 0.597 ' HD3' ' HD3' ' A' ' 266' ' ' ARG . 21.9 Cg_exo -69.37 161.16 46.97 Favored 'Trans proline' 0 C--O 1.235 0.333 0 C-N-CA 121.876 1.717 . . . . 15.0 110.398 164.466 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -69.65 150.39 47.06 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-N 115.496 -0.774 . . . . 15.0 110.914 -175.313 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 100.24 -15.13 59.32 Favored Glycine 0 N--CA 1.447 -0.625 0 CA-C-N 115.688 -0.687 . . . . 15.0 112.599 -177.729 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 240' ' ' TYR . . . . . 0.449 ' CD1' ' HG2' ' A' ' 265' ' ' PRO . 65.9 m-85 -94.61 116.42 28.75 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.142 0.496 . . . . 15.0 110.523 177.057 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -95.3 116.93 29.43 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 115.625 -0.716 . . . . 15.0 109.123 174.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -90.01 97.45 11.2 Favored 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 108.993 -0.743 . . . . 15.0 108.993 178.03 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 243' ' ' ARG . . . . . 0.429 HH11 ' HD2' ' A' ' 243' ' ' ARG . 11.9 mtp180 -100.42 149.54 23.55 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 115.298 -0.865 . . . . 15.0 111.478 -179.162 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 244' ' ' THR . . . . . . . . . . . . . 22.8 m -117.64 128.7 55.18 Favored 'General case' 0 C--N 1.309 -1.172 0 CA-C-N 114.08 -1.418 . . . . 15.0 108.718 -178.629 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 245' ' ' THR . . . . . 0.419 HG23 ' O ' ' A' ' 249' ' ' GLN . 8.3 t -115.28 150.44 36.21 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 116.277 -0.42 . . . . 15.0 111.03 -174.113 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 50.8 t -57.73 -15.78 4.87 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 CA-C-N 115.795 -0.639 . . . . 15.0 111.302 179.865 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 247' ' ' GLN . . . . . . . . . . . . . 8.8 mm100 -61.46 -20.82 63.57 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 121.093 0.473 . . . . 15.0 110.65 175.553 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 90.63 36.98 6.64 Favored Glycine 0 N--CA 1.452 -0.28 0 CA-C-N 115.559 -0.746 . . . . 15.0 112.003 178.546 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 249' ' ' GLN . . . . . 0.419 ' O ' HG23 ' A' ' 245' ' ' THR . 8.0 pt20 -148.02 139.62 23.75 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.873 0.368 . . . . 15.0 111.12 -175.524 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 15.9 m -89.95 135.58 25.92 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 N-CA-C 109.395 -0.595 . . . . 15.0 109.395 172.557 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -136.81 138.36 40.77 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-O 120.95 0.405 . . . . 15.0 110.123 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 252' ' ' PHE . . . . . 0.619 ' CD2' ' HA ' ' A' ' 264' ' ' ASP . 40.6 m-85 -89.99 118.2 29.37 Favored 'General case' 0 CA--C 1.512 -0.491 0 CA-C-O 121.229 0.537 . . . . 15.0 111.449 -173.419 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 253' ' ' LEU . . . . . 0.902 HD13 ' HB3' ' B' ' 212' ' ' PRO . 0.8 OUTLIER -110.26 106.77 16.29 Favored 'General case' 0 N--CA 1.446 -0.653 0 CA-C-N 114.714 -1.13 . . . . 15.0 111.885 -173.048 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 254' ' ' HIS . . . . . . . . . . . . . 26.8 t-80 -115.41 95.03 4.97 Favored 'General case' 0 C--N 1.312 -1.048 0 N-CA-C 108.298 -1.001 . . . . 15.0 108.298 170.104 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 26.3 m -94.08 88.02 5.51 Favored 'General case' 0 N--CA 1.43 -1.436 0 C-N-CA 116.985 -1.886 . . . . 15.0 110.459 -179.08 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 58.9 tt0 -101.12 -51.15 3.59 Favored 'General case' 0 N--CA 1.438 -1.033 0 N-CA-C 105.924 -1.88 . . . . 15.0 105.924 146.768 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 257' ' ' THR . . . . . . . . . . . . . 63.1 p -99.94 -13.69 19.02 Favored 'General case' 0 CA--C 1.484 -1.581 0 CA-C-O 124.735 2.207 . . . . 15.0 112.275 -178.062 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 83.09 76.18 1.14 Allowed Glycine 1 C--N 1.239 -4.851 0 CA-C-N 108.594 -3.912 . . . . 15.0 111.934 -170.225 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 259' ' ' VAL . . . . . 0.66 ' O ' ' HA ' ' A' ' 253' ' ' LEU . 54.8 t -89.35 124.47 42.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-O 121.478 0.656 . . . . 15.0 111.725 176.86 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 3.6 p -135.04 97.41 3.73 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 114.285 -1.325 . . . . 15.0 108.394 171.347 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 10.6 t -134.92 150.26 50.39 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.037 0.446 . . . . 15.0 112.018 -170.387 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 262' ' ' TRP . . . . . . . . . . . . . 42.3 m95 -72.15 -31.04 65.6 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.38 -0.827 . . . . 15.0 111.844 177.341 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 263' ' ' HIS . . . . . . . . . . . . . 5.2 p80 -80.15 130.74 35.45 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 120.196 -0.602 . . . . 15.0 110.155 -174.413 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 264' ' ' ASP . . . . . 1.133 ' HB3' HG12 ' A' ' 267' ' ' ILE . 13.8 t0 -63.12 127.44 90.93 Favored Pre-proline 0 C--N 1.321 -0.64 0 N-CA-C 107.77 -1.196 . . . . 15.0 107.77 171.169 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 265' ' ' PRO . . . . . 0.449 ' HG2' ' CD1' ' A' ' 240' ' ' TYR . 15.9 Cg_exo -69.09 -14.9 39.05 Favored 'Trans proline' 0 C--N 1.323 -0.799 0 C-N-CA 121.878 1.719 . . . . 15.0 113.087 -178.118 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 266' ' ' ARG . . . . . 0.597 ' HD3' ' HD3' ' A' ' 237' ' ' PRO . 4.5 tpt180 -80.83 -6.5 58.66 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-O 121.834 0.826 . . . . 15.0 109.156 175.031 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 267' ' ' ILE . . . . . 1.133 HG12 ' HB3' ' A' ' 264' ' ' ASP . 48.2 pt . . . . . 0 C--O 1.248 0.987 0 CA-C-N 114.299 -1.318 . . . . 15.0 111.689 177.735 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 210' ' ' SER . . . . . . . . . . . . . 9.5 m . . . . . 0 N--CA 1.479 0.988 0 CA-C-O 120.759 0.314 . . . . 15.0 110.72 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' B' B ' 211' ' ' ASP . . . . . 0.421 ' HA ' ' HD3' ' B' ' 212' ' ' PRO . 3.0 m-20 -89.85 119.53 69.41 Favored Pre-proline 0 C--O 1.233 0.185 0 CA-C-N 116.278 -0.419 . . . . 15.0 110.319 -173.243 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 212' ' ' PRO . . . . . 0.902 ' HB3' HD13 ' A' ' 253' ' ' LEU . 1.9 Cg_endo -90.0 149.14 4.77 Favored 'Trans proline' 0 N--CA 1.458 -0.586 0 C-N-CA 123.118 2.545 . . . . 15.0 112.234 177.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.68 0 C-N-CA 120.925 -0.655 . . . . 15.0 112.607 -179.647 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 236' ' ' LEU . . . . . 0.444 HD23 ' N ' ' A' ' 236' ' ' LEU . 1.1 mm? . . . . . 0 N--CA 1.453 -0.28 0 N-CA-C 109.765 -0.457 . . . . 15.0 109.765 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 237' ' ' PRO . . . . . 0.446 ' O ' ' HD2' ' A' ' 240' ' ' TYR . 16.2 Cg_exo -69.53 164.72 33.23 Favored 'Trans proline' 0 N--CA 1.459 -0.522 0 C-N-CA 121.801 1.667 . . . . 15.0 110.118 165.011 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -69.58 135.65 50.28 Favored 'General case' 0 C--N 1.303 -1.443 0 CA-C-N 115.053 -0.976 . . . . 15.0 111.361 -171.955 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 100.44 21.63 12.68 Favored Glycine 0 CA--C 1.521 0.431 0 CA-C-N 115.504 -0.771 . . . . 15.0 114.349 178.794 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 240' ' ' TYR . . . . . 0.724 ' CD1' ' HB2' ' A' ' 254' ' ' HIS . 73.7 m-85 -112.39 114.43 27.14 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 118.298 1.049 . . . . 15.0 110.798 175.307 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 37.5 mm-40 -98.2 119.44 36.86 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.686 -0.688 . . . . 15.0 109.216 175.341 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -89.93 107.52 19.16 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 108.032 -1.099 . . . . 15.0 108.032 175.909 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 6.3 mtp85 -97.25 132.38 43.06 Favored 'General case' 0 CA--C 1.496 -1.109 0 CA-C-O 122.451 1.119 . . . . 15.0 113.434 -172.774 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 244' ' ' THR . . . . . . . . . . . . . 1.3 m -100.66 89.92 4.07 Favored 'General case' 0 C--N 1.306 -1.314 0 CA-C-N 112.805 -1.998 . . . . 15.0 109.05 177.517 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 245' ' ' THR . . . . . 1.071 HG22 ' HG2' ' A' ' 247' ' ' GLN . 7.8 t -95.04 150.75 19.83 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 114.989 -1.005 . . . . 15.0 110.401 -176.653 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 61.1 t -39.69 -30.9 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 N-CA-C 113.901 1.075 . . . . 15.0 113.901 -174.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 247' ' ' GLN . . . . . 1.071 ' HG2' HG22 ' A' ' 245' ' ' THR . 3.8 pt20 -56.55 -21.14 24.34 Favored 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 111.838 0.31 . . . . 15.0 111.838 178.111 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 80.42 37.21 21.46 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 121.141 -0.552 . . . . 15.0 112.988 176.49 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 249' ' ' GLN . . . . . 0.487 ' HB2' ' OE1' ' A' ' 247' ' ' GLN . 34.3 mt-30 -135.71 149.98 49.4 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.678 -0.49 . . . . 15.0 109.678 179.633 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 15.5 m -89.83 128.23 41.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 120.934 0.397 . . . . 15.0 110.562 178.433 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 4.0 p90 -138.69 133.19 31.98 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.006 0.431 . . . . 15.0 109.883 -178.647 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 252' ' ' PHE . . . . . 0.686 ' CD2' ' HA ' ' A' ' 264' ' ' ASP . 36.0 m-85 -89.78 118.2 29.2 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.023 -0.535 . . . . 15.0 110.88 -175.007 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 253' ' ' LEU . . . . . 0.544 HD12 ' HB3' ' B' ' 212' ' ' PRO . 0.7 OUTLIER -111.1 119.33 38.62 Favored 'General case' 0 N--CA 1.447 -0.617 0 CA-C-N 115.09 -0.959 . . . . 15.0 110.398 -177.674 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 254' ' ' HIS . . . . . 0.724 ' HB2' ' CD1' ' A' ' 240' ' ' TYR . 9.1 t-80 -133.0 101.31 5.18 Favored 'General case' 0 CA--C 1.495 -1.14 0 N-CA-C 108.956 -0.757 . . . . 15.0 108.956 173.951 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 3.5 t -95.89 87.66 4.69 Favored 'General case' 0 N--CA 1.432 -1.333 0 C-N-CA 116.388 -2.125 . . . . 15.0 110.617 179.74 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 44.3 tt0 -101.35 -55.96 2.42 Favored 'General case' 0 N--CA 1.441 -0.906 0 N-CA-C 105.973 -1.862 . . . . 15.0 105.973 150.807 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 257' ' ' THR . . . . . . . . . . . . . 80.4 p -99.77 -13.72 19.15 Favored 'General case' 0 CA--C 1.489 -1.383 0 CA-C-N 111.893 -2.412 . . . . 15.0 112.047 -176.275 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 89.16 70.6 1.26 Allowed Glycine 1 C--N 1.242 -4.655 0 CA-C-N 108.537 -3.938 . . . . 15.0 112.903 -171.025 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 259' ' ' VAL . . . . . 0.504 ' HB ' ' HB3' ' A' ' 254' ' ' HIS . 54.6 t -90.05 127.38 42.66 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.31 0 CA-C-O 121.207 0.527 . . . . 15.0 112.251 176.861 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 2.3 p -145.68 102.15 3.64 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 114.672 -1.149 . . . . 15.0 108.416 169.686 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 5.5 t -145.48 150.12 35.9 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 115.868 -0.606 . . . . 15.0 111.781 -171.384 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 262' ' ' TRP . . . . . . . . . . . . . 90.2 m95 -71.52 -23.31 61.76 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.358 -0.837 . . . . 15.0 111.199 176.535 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 263' ' ' HIS . . . . . . . . . . . . . 1.9 p80 -87.88 132.07 34.34 Favored 'General case' 0 C--O 1.234 0.266 0 C-N-CA 120.231 -0.587 . . . . 15.0 110.524 -173.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 264' ' ' ASP . . . . . 0.773 ' HB3' HG12 ' A' ' 267' ' ' ILE . 9.2 t70 -51.82 130.92 38.19 Favored Pre-proline 0 C--N 1.326 -0.439 0 CA-C-N 115.359 -0.837 . . . . 15.0 109.574 175.332 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 265' ' ' PRO . . . . . 0.493 ' HD3' ' CD2' ' A' ' 252' ' ' PHE . 71.9 Cg_endo -78.11 -14.89 14.86 Favored 'Trans proline' 0 CA--C 1.514 -0.506 0 C-N-CA 122.384 2.056 . . . . 15.0 113.644 -173.964 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 266' ' ' ARG . . . . . 0.443 ' HD3' ' HD3' ' A' ' 237' ' ' PRO . 7.2 tpt180 -77.08 -8.24 57.12 Favored 'General case' 0 C--N 1.311 -1.074 0 N-CA-C 107.694 -1.224 . . . . 15.0 107.694 174.546 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 267' ' ' ILE . . . . . 0.773 HG12 ' HB3' ' A' ' 264' ' ' ASP . 28.4 mm . . . . . 0 C--O 1.248 0.976 0 CA-C-N 113.537 -1.665 . . . . 15.0 109.216 174.634 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 210' ' ' SER . . . . . . . . . . . . . 14.9 m . . . . . 0 N--CA 1.477 0.889 0 CA-C-O 120.84 0.352 . . . . 15.0 110.572 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' B' B ' 211' ' ' ASP . . . . . 0.433 ' HA ' ' HD3' ' B' ' 212' ' ' PRO . 11.8 m-20 -89.81 130.61 42.27 Favored Pre-proline 0 C--N 1.332 -0.175 0 CA-C-N 116.449 -0.341 . . . . 15.0 110.274 -177.511 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 212' ' ' PRO . . . . . 0.544 ' HB3' HD12 ' A' ' 253' ' ' LEU . 5.0 Cg_endo -90.04 151.37 4.8 Favored 'Trans proline' 0 N--CA 1.46 -0.46 0 C-N-CA 123.483 2.788 . . . . 15.0 113.179 -175.404 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.444 -0.796 0 CA-C-N 115.346 -0.843 . . . . 15.0 112.839 178.538 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 5.8 mt . . . . . 0 CA--C 1.517 -0.296 0 N-CA-C 108.948 -0.76 . . . . 15.0 108.948 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 237' ' ' PRO . . . . . 0.514 ' HD3' ' HD3' ' A' ' 266' ' ' ARG . 17.2 Cg_exo -69.31 156.96 63.01 Favored 'Trans proline' 0 N--CA 1.458 -0.563 0 C-N-CA 121.55 1.5 . . . . 15.0 109.636 162.842 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 4.6 mp0 -69.71 149.38 48.09 Favored 'General case' 0 C--N 1.31 -1.146 0 CA-C-O 121.341 0.591 . . . . 15.0 111.409 -173.325 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 100.19 -7.36 58.5 Favored Glycine 0 N--CA 1.446 -0.66 0 CA-C-N 115.173 -0.921 . . . . 15.0 113.722 179.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 240' ' ' TYR . . . . . 0.634 ' CD1' ' HB2' ' A' ' 254' ' ' HIS . 67.7 m-85 -91.03 113.13 25.31 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 117.535 0.667 . . . . 15.0 110.81 178.199 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 57.9 mm-40 -92.05 118.41 30.77 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 109.367 -0.605 . . . . 15.0 109.367 174.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 24.8 tm0? -89.94 107.75 19.3 Favored 'General case' 0 C--N 1.314 -0.963 0 N-CA-C 109.163 -0.68 . . . . 15.0 109.163 176.806 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 243' ' ' ARG . . . . . 0.408 ' HB2' ' CE1' ' A' ' 251' ' ' TYR . 17.3 mtp85 -103.47 150.03 24.27 Favored 'General case' 0 CA--C 1.512 -0.519 0 CA-C-O 122.116 0.96 . . . . 15.0 111.982 178.081 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 244' ' ' THR . . . . . . . . . . . . . 24.4 p -111.27 148.24 33.31 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-N 113.504 -1.68 . . . . 15.0 109.367 -179.064 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 245' ' ' THR . . . . . 0.452 ' OG1' ' HG2' ' A' ' 247' ' ' GLN . 6.0 t -145.26 150.11 36.09 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-O 120.641 0.258 . . . . 15.0 111.142 -175.186 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 7.7 p -50.87 -26.79 4.55 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.219 0 CA-C-N 115.541 -0.754 . . . . 15.0 111.256 177.748 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 247' ' ' GLN . . . . . 0.452 ' HG2' ' OG1' ' A' ' 245' ' ' THR . 6.8 mm-40 -53.75 -21.4 7.16 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 114.787 -1.097 . . . . 15.0 111.472 177.959 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 81.82 25.19 53.78 Favored Glycine 0 CA--C 1.509 -0.282 0 C-N-CA 121.255 -0.498 . . . . 15.0 111.871 178.146 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -130.47 138.37 50.24 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.759 -0.46 . . . . 15.0 109.759 -175.614 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 18.8 m -90.02 132.43 34.72 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 N-CA-C 109.354 -0.61 . . . . 15.0 109.354 175.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 251' ' ' TYR . . . . . 0.408 ' CE1' ' HB2' ' A' ' 243' ' ' ARG . 4.4 p90 -135.16 134.19 39.91 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.486 0.66 . . . . 15.0 111.325 -178.7 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 252' ' ' PHE . . . . . 0.725 ' CE2' ' HA ' ' A' ' 264' ' ' ASP . 37.8 m-85 -90.28 118.5 29.84 Favored 'General case' 0 CA--C 1.516 -0.335 0 CA-C-N 115.246 -0.888 . . . . 15.0 111.046 -176.654 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 253' ' ' LEU . . . . . 0.851 HD13 ' HB3' ' B' ' 212' ' ' PRO . 0.5 OUTLIER -109.9 99.21 8.37 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-N 114.942 -1.026 . . . . 15.0 111.205 -174.675 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 254' ' ' HIS . . . . . 0.634 ' HB2' ' CD1' ' A' ' 240' ' ' TYR . 36.9 t-80 -112.17 92.56 4.07 Favored 'General case' 0 CA--C 1.499 -1.018 0 N-CA-C 108.57 -0.9 . . . . 15.0 108.57 169.58 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 7.9 t -96.55 88.06 4.57 Favored 'General case' 0 N--CA 1.432 -1.331 0 C-N-CA 116.524 -2.07 . . . . 15.0 110.729 -179.076 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 49.1 tt0 -101.17 -50.39 3.8 Favored 'General case' 0 N--CA 1.441 -0.924 0 CA-C-N 113.127 -1.851 . . . . 15.0 106.42 151.601 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 257' ' ' THR . . . . . . . . . . . . . 68.7 p -97.99 -13.57 21.05 Favored 'General case' 0 CA--C 1.488 -1.431 0 CA-C-O 124.865 2.269 . . . . 15.0 111.681 -179.565 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 88.71 71.41 1.27 Allowed Glycine 1 C--N 1.241 -4.737 1 CA-C-N 108.224 -4.08 . . . . 15.0 113.109 -171.602 . . . . . . . . 3 2 . 1 . 006 nuclear orig core ' A' A ' 259' ' ' VAL . . . . . 0.556 ' O ' ' HA ' ' A' ' 253' ' ' LEU . 45.8 t -89.81 124.45 42.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 121.376 0.607 . . . . 15.0 111.911 174.962 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -136.94 92.36 2.72 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 114.541 -1.209 . . . . 15.0 108.018 167.763 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 5.0 t -129.27 150.23 50.73 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.705 -0.679 . . . . 15.0 111.966 -166.193 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 262' ' ' TRP . . . . . . . . . . . . . 85.5 m95 -71.61 -50.63 29.04 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.164 -0.926 . . . . 15.0 111.691 179.337 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 263' ' ' HIS . . . . . . . . . . . . . 5.4 p80 -66.49 134.48 52.53 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.912 -0.586 . . . . 15.0 110.629 -175.527 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 264' ' ' ASP . . . . . 1.052 ' HB3' HG12 ' A' ' 267' ' ' ILE . 37.8 t0 -54.29 124.14 45.55 Favored Pre-proline 0 C--O 1.218 -0.554 0 N-CA-C 107.408 -1.33 . . . . 15.0 107.408 167.217 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 265' ' ' PRO . . . . . 0.575 ' HD3' ' CD2' ' A' ' 252' ' ' PHE . 12.6 Cg_exo -69.03 -14.67 38.84 Favored 'Trans proline' 0 C--N 1.323 -0.794 0 C-N-CA 121.788 1.659 . . . . 15.0 112.617 -176.324 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 266' ' ' ARG . . . . . 0.514 ' HD3' ' HD3' ' A' ' 237' ' ' PRO . 5.8 tpt180 -78.28 -9.86 59.41 Favored 'General case' 0 N--CA 1.439 -0.998 0 CA-C-O 121.861 0.838 . . . . 15.0 109.136 173.143 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 267' ' ' ILE . . . . . 1.052 HG12 ' HB3' ' A' ' 264' ' ' ASP . 48.2 pt . . . . . 0 C--O 1.246 0.89 0 CA-C-O 117.543 -1.218 . . . . 15.0 110.875 176.779 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 210' ' ' SER . . . . . . . . . . . . . 16.6 p . . . . . 0 N--CA 1.481 1.125 0 CA-C-O 120.859 0.361 . . . . 15.0 110.735 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' B' B ' 211' ' ' ASP . . . . . 0.409 ' HA ' ' HD3' ' B' ' 212' ' ' PRO . 2.8 m-20 -89.97 115.27 63.55 Favored Pre-proline 0 C--N 1.331 -0.223 0 CA-C-N 116.4 -0.364 . . . . 15.0 110.799 -173.948 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 212' ' ' PRO . . . . . 0.851 ' HB3' HD13 ' A' ' 253' ' ' LEU . 2.6 Cg_endo -89.67 154.13 5.18 Favored 'Trans proline' 0 N--CA 1.456 -0.7 0 C-N-CA 122.752 2.301 . . . . 15.0 112.104 175.789 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.636 0 C-N-CA 120.554 -0.831 . . . . 15.0 112.296 179.43 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 236' ' ' LEU . . . . . 0.441 HD23 ' N ' ' A' ' 236' ' ' LEU . 1.2 mm? . . . . . 0 CA--C 1.514 -0.404 0 CA-C-O 121.03 0.443 . . . . 15.0 110.586 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 237' ' ' PRO . . . . . 0.57 ' HD3' ' HD3' ' A' ' 266' ' ' ARG . 21.9 Cg_exo -69.34 166.58 26.6 Favored 'Trans proline' 0 N--CA 1.46 -0.442 0 C-N-CA 122.257 1.971 . . . . 15.0 110.528 163.885 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 -69.92 147.23 50.49 Favored 'General case' 0 C--N 1.304 -1.391 0 CA-C-N 115.038 -0.983 . . . . 15.0 111.809 -176.382 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 100.25 0.93 55.8 Favored Glycine 0 CA--C 1.518 0.237 0 CA-C-N 115.348 -0.842 . . . . 15.0 113.34 179.736 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 240' ' ' TYR . . . . . 0.489 ' HD2' ' O ' ' A' ' 237' ' ' PRO . 56.5 m-85 -97.45 121.37 39.26 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.552 0.691 . . . . 15.0 111.574 -178.419 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 241' ' ' GLU . . . . . 0.695 ' HB2' ' HB2' ' A' ' 253' ' ' LEU . 7.6 mp0 -89.87 100.45 13.26 Favored 'General case' 0 N--CA 1.442 -0.833 0 CA-C-N 114.885 -1.052 . . . . 15.0 108.777 173.147 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 1.5 tm0? -89.94 113.99 25.73 Favored 'General case' 0 C--N 1.313 -1.006 0 N-CA-C 108.451 -0.944 . . . . 15.0 108.451 179.33 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 243' ' ' ARG . . . . . 0.481 ' CZ ' ' HG2' ' B' ' 212' ' ' PRO . 28.0 mtt180 -112.94 144.94 41.65 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-O 122.392 1.092 . . . . 15.0 111.926 179.511 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 244' ' ' THR . . . . . . . . . . . . . 15.8 m -120.29 92.14 3.7 Favored 'General case' 0 C--N 1.304 -1.373 0 CA-C-N 112.998 -1.91 . . . . 15.0 108.263 178.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 245' ' ' THR . . . . . 0.481 ' OG1' ' HG2' ' A' ' 247' ' ' GLN . 6.7 t -89.72 149.99 22.51 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 115.441 -0.799 . . . . 15.0 110.989 -171.882 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 23.0 t -55.2 -15.13 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 CA-C-N 115.816 -0.629 . . . . 15.0 111.349 -179.194 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 247' ' ' GLN . . . . . 0.481 ' HG2' ' OG1' ' A' ' 245' ' ' THR . 8.3 mm-40 -59.29 -15.27 14.9 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 115.895 -0.593 . . . . 15.0 111.128 176.413 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 89.51 37.4 7.02 Favored Glycine 0 C--N 1.333 0.407 0 C-N-CA 121.218 -0.515 . . . . 15.0 112.164 178.334 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -150.17 147.14 27.37 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.399 0.619 . . . . 15.0 111.515 -174.905 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 16.6 m -100.92 131.41 48.61 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.928 0 CA-C-N 114.561 -1.2 . . . . 15.0 108.386 169.189 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 2.7 p90 -137.28 137.93 39.52 Favored 'General case' 0 C--N 1.317 -0.811 0 C-N-CA 120.558 -0.457 . . . . 15.0 110.395 -175.149 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 252' ' ' PHE . . . . . 0.742 ' CD2' ' HA ' ' A' ' 264' ' ' ASP . 40.8 m-85 -95.75 110.95 23.02 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.569 0.7 . . . . 15.0 112.329 -172.824 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 253' ' ' LEU . . . . . 0.695 ' HB2' ' HB2' ' A' ' 241' ' ' GLU . 38.9 mt -93.0 144.69 25.0 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 114.241 -1.345 . . . . 15.0 109.848 172.176 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 254' ' ' HIS . . . . . 0.56 ' HB3' ' HB ' ' A' ' 259' ' ' VAL . 40.3 t-80 -143.53 89.77 2.1 Favored 'General case' 0 C--N 1.305 -1.343 0 N-CA-C 107.31 -1.367 . . . . 15.0 107.31 164.143 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 16.3 m -91.72 87.61 6.37 Favored 'General case' 0 N--CA 1.426 -1.632 0 C-N-CA 115.655 -2.418 . . . . 15.0 110.096 -178.307 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 8.1 tt0 -101.53 -53.59 2.95 Favored 'General case' 0 N--CA 1.435 -1.193 0 CA-C-N 112.793 -2.003 . . . . 15.0 105.82 145.753 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 257' ' ' THR . . . . . . . . . . . . . 71.8 p -100.2 -13.52 18.88 Favored 'General case' 0 CA--C 1.49 -1.357 0 CA-C-O 124.727 2.203 . . . . 15.0 112.56 -176.459 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 86.07 73.24 1.28 Allowed Glycine 1 C--N 1.241 -4.747 0 CA-C-N 108.461 -3.972 . . . . 15.0 113.04 -172.529 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 259' ' ' VAL . . . . . 0.583 ' O ' ' HA ' ' A' ' 253' ' ' LEU . 74.9 t -89.71 136.76 22.89 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 CA-C-O 120.923 0.392 . . . . 15.0 112.028 174.127 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 4.0 p -145.62 100.02 3.37 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 114.822 -1.081 . . . . 15.0 108.731 168.834 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 24.3 p -132.39 150.17 52.21 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 112.216 0.45 . . . . 15.0 112.216 -172.364 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 262' ' ' TRP . . . . . . . . . . . . . 71.1 m95 -72.87 -30.0 63.63 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.781 -0.645 . . . . 15.0 110.68 174.347 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 263' ' ' HIS . . . . . . . . . . . . . 3.3 p80 -77.89 129.31 35.21 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.967 0.413 . . . . 15.0 110.252 -177.666 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 264' ' ' ASP . . . . . 1.032 ' HB3' HG12 ' A' ' 267' ' ' ILE . 9.1 t0 -59.21 129.21 86.27 Favored Pre-proline 0 C--N 1.319 -0.734 0 N-CA-C 108.509 -0.923 . . . . 15.0 108.509 172.032 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 265' ' ' PRO . . . . . 0.519 ' HD3' ' CD2' ' A' ' 252' ' ' PHE . 4.4 Cg_exo -74.19 -14.65 23.18 Favored 'Trans proline' 0 CA--C 1.509 -0.729 0 C-N-CA 122.112 1.875 . . . . 15.0 113.228 -175.737 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 266' ' ' ARG . . . . . 0.57 ' HD3' ' HD3' ' A' ' 237' ' ' PRO . 2.1 tpp180 -77.41 -11.55 59.85 Favored 'General case' 0 C--N 1.31 -1.119 0 N-CA-C 108.055 -1.091 . . . . 15.0 108.055 172.978 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 267' ' ' ILE . . . . . 1.032 HG12 ' HB3' ' A' ' 264' ' ' ASP . 31.8 pt . . . . . 0 C--O 1.249 1.05 0 CA-C-N 114.551 -1.204 . . . . 15.0 111.0 176.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 210' ' ' SER . . . . . . . . . . . . . 63.0 p . . . . . 0 N--CA 1.479 1.002 0 CA-C-O 120.72 0.295 . . . . 15.0 110.841 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' B' B ' 211' ' ' ASP . . . . . 0.453 ' HA ' ' HD3' ' B' ' 212' ' ' PRO . 56.6 m-20 -104.49 120.62 49.94 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 120.894 0.378 . . . . 15.0 110.294 179.485 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 212' ' ' PRO . . . . . 0.566 ' CB ' HD12 ' A' ' 253' ' ' LEU . 3.4 Cg_exo -89.64 151.93 5.18 Favored 'Trans proline' 0 N--CA 1.461 -0.435 0 C-N-CA 123.88 3.054 . . . . 15.0 112.17 179.885 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.443 -0.888 0 C-N-CA 120.74 -0.743 . . . . 15.0 111.616 178.384 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 236' ' ' LEU . . . . . 0.54 HD23 ' HD2' ' A' ' 265' ' ' PRO . 11.4 mt . . . . . 0 N--CA 1.454 -0.245 0 N-CA-C 110.161 -0.311 . . . . 15.0 110.161 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 237' ' ' PRO . . . . . 0.596 ' HD3' ' HD3' ' A' ' 266' ' ' ARG . 13.0 Cg_exo -69.78 172.45 12.63 Favored 'Trans proline' 0 CA--C 1.513 -0.566 0 C-N-CA 122.21 1.94 . . . . 15.0 111.151 167.773 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 14.0 tp10 -69.41 134.57 49.16 Favored 'General case' 0 C--N 1.3 -1.549 0 CA-C-N 114.034 -1.439 . . . . 15.0 111.51 -173.474 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 100.15 9.37 48.44 Favored Glycine 0 CA--C 1.524 0.632 0 CA-C-N 115.74 -0.664 . . . . 15.0 114.31 177.013 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 240' ' ' TYR . . . . . 0.666 ' CD1' ' HB2' ' A' ' 254' ' ' HIS . 86.5 m-85 -111.41 116.88 31.67 Favored 'General case' 0 CA--C 1.517 -0.323 0 CA-C-N 118.129 0.964 . . . . 15.0 111.007 175.166 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 17.7 pt-20 -97.63 123.94 41.72 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 109.198 -0.668 . . . . 15.0 109.198 170.72 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 242' ' ' GLN . . . . . 0.553 ' HG3' ' CE1' ' A' ' 252' ' ' PHE . 1.9 tt0 -89.9 99.13 12.2 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 109.058 -0.719 . . . . 15.0 109.058 -177.841 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 84.2 mtt-85 -92.02 150.01 21.22 Favored 'General case' 0 CA--C 1.5 -0.963 0 CA-C-O 122.428 1.109 . . . . 15.0 113.184 -172.736 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 244' ' ' THR . . . . . . . . . . . . . 16.6 p -118.27 139.83 50.72 Favored 'General case' 0 C--N 1.308 -1.221 0 CA-C-N 112.567 -2.106 . . . . 15.0 109.122 174.777 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 245' ' ' THR . . . . . 1.068 HG21 ' HG2' ' A' ' 247' ' ' GLN . 3.4 t -145.02 150.46 36.93 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 116.406 -0.361 . . . . 15.0 110.124 -173.228 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 6.1 m -48.9 -22.15 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 N-CA-C 113.944 1.09 . . . . 15.0 113.944 -175.454 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 247' ' ' GLN . . . . . 1.068 ' HG2' HG21 ' A' ' 245' ' ' THR . 1.7 pt20 -58.56 -22.67 56.49 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-O 120.705 0.288 . . . . 15.0 110.851 176.539 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 91.08 30.3 11.31 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 121.276 -0.488 . . . . 15.0 112.872 177.356 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 249' ' ' GLN . . . . . 0.404 ' HB3' ' CH2' ' A' ' 262' ' ' TRP . 1.1 mp0 -137.9 143.18 40.71 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.888 0.344 . . . . 15.0 111.621 -178.118 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 29.1 m -90.16 138.39 19.54 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.129 0 CA-C-N 115.901 -0.591 . . . . 15.0 109.426 172.747 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 32.5 p90 -144.09 136.3 26.55 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 120.853 0.358 . . . . 15.0 110.228 -175.529 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 252' ' ' PHE . . . . . 0.653 ' CD2' ' HA ' ' A' ' 264' ' ' ASP . 32.0 m-85 -89.86 119.51 30.3 Favored 'General case' 0 CA--C 1.507 -0.68 0 CA-C-N 116.043 -0.526 . . . . 15.0 111.66 -172.688 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 253' ' ' LEU . . . . . 0.73 HD13 ' HB3' ' B' ' 212' ' ' PRO . 0.4 OUTLIER -113.52 118.62 34.98 Favored 'General case' 0 N--CA 1.441 -0.919 0 CA-C-N 114.854 -1.067 . . . . 15.0 111.141 -175.727 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 254' ' ' HIS . . . . . 0.666 ' HB2' ' CD1' ' A' ' 240' ' ' TYR . 16.6 t-80 -128.07 90.28 3.06 Favored 'General case' 0 C--N 1.313 -0.992 0 N-CA-C 108.132 -1.062 . . . . 15.0 108.132 168.552 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 255' ' ' THR . . . . . 0.593 HG22 ' HA2' ' A' ' 258' ' ' GLY . 0.3 OUTLIER -89.82 87.38 6.94 Favored 'General case' 0 N--CA 1.429 -1.485 0 C-N-CA 116.462 -2.095 . . . . 15.0 109.881 178.772 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 35.9 tt0 -101.49 -56.39 2.31 Favored 'General case' 0 N--CA 1.436 -1.16 0 N-CA-C 105.884 -1.895 . . . . 15.0 105.884 150.327 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 257' ' ' THR . . . . . . . . . . . . . 63.3 p -96.65 -13.63 22.69 Favored 'General case' 0 CA--C 1.486 -1.512 0 CA-C-N 111.73 -2.486 . . . . 15.0 111.601 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 258' ' ' GLY . . . . . 0.593 ' HA2' HG22 ' A' ' 255' ' ' THR . . . 86.27 73.05 1.28 Allowed Glycine 1 C--N 1.24 -4.773 1 CA-C-N 108.3 -4.045 . . . . 15.0 113.236 -172.83 . . . . . . . . 4 3 . 1 . 008 nuclear orig core ' A' A ' 259' ' ' VAL . . . . . 0.611 ' O ' HD21 ' A' ' 253' ' ' LEU . 55.4 t -89.89 123.36 42.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-O 121.202 0.525 . . . . 15.0 112.206 173.539 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 2.5 p -134.53 92.49 2.92 Favored 'General case' 0 C--N 1.317 -0.844 0 N-CA-C 107.818 -1.179 . . . . 15.0 107.818 168.754 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 8.1 t -121.06 150.14 41.64 Favored 'General case' 0 C--N 1.314 -0.938 0 N-CA-C 112.853 0.686 . . . . 15.0 112.853 -165.251 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 262' ' ' TRP . . . . . 0.553 ' HA ' ' CE3' ' A' ' 262' ' ' TRP . 1.9 m95 -80.94 -18.87 45.59 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 114.777 -1.102 . . . . 15.0 111.26 174.971 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 263' ' ' HIS . . . . . . . . . . . . . 4.0 p80 -100.31 133.61 44.46 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.558 -0.457 . . . . 15.0 110.106 -178.431 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 264' ' ' ASP . . . . . 0.804 ' HB3' HG12 ' A' ' 267' ' ' ILE . 9.8 t70 -55.67 132.92 71.97 Favored Pre-proline 0 C--N 1.321 -0.661 0 CA-C-N 115.908 -0.587 . . . . 15.0 109.529 175.836 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 265' ' ' PRO . . . . . 0.54 ' HD2' HD23 ' A' ' 236' ' ' LEU . 91.7 Cg_endo -80.67 -14.6 11.32 Favored 'Trans proline' 0 N--CA 1.462 -0.381 0 C-N-CA 122.42 2.08 . . . . 15.0 113.543 -176.192 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 266' ' ' ARG . . . . . 0.596 ' HD3' ' HD3' ' A' ' 237' ' ' PRO . 25.2 tpt180 -77.08 -8.52 57.61 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-O 122.269 1.033 . . . . 15.0 108.408 175.156 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 267' ' ' ILE . . . . . 0.804 HG12 ' HB3' ' A' ' 264' ' ' ASP . 43.2 mm . . . . . 0 C--O 1.249 1.052 0 CA-C-N 113.505 -1.68 . . . . 15.0 109.749 176.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 210' ' ' SER . . . . . . . . . . . . . 4.7 m . . . . . 0 N--CA 1.471 0.616 0 CA-C-O 120.792 0.33 . . . . 15.0 110.387 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' B' B ' 211' ' ' ASP . . . . . 0.401 ' HA ' ' HD3' ' B' ' 212' ' ' PRO . 9.2 p-10 -150.17 131.79 7.61 Favored Pre-proline 0 C--N 1.326 -0.437 0 CA-C-N 116.262 -0.427 . . . . 15.0 110.337 -178.75 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 212' ' ' PRO . . . . . 0.73 ' HB3' HD13 ' A' ' 253' ' ' LEU . 12.3 Cg_endo -89.98 140.45 3.4 Favored 'Trans proline' 0 N--CA 1.453 -0.89 0 C-N-CA 122.995 2.463 . . . . 15.0 112.199 178.602 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.443 -0.841 0 C-N-CA 120.548 -0.834 . . . . 15.0 111.94 178.895 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 236' ' ' LEU . . . . . 0.434 ' HA ' ' HD3' ' A' ' 266' ' ' ARG . 0.9 OUTLIER . . . . . 0 C--O 1.234 0.286 0 N-CA-C 108.828 -0.804 . . . . 15.0 108.828 . . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 237' ' ' PRO . . . . . 0.751 ' HD3' ' HD3' ' A' ' 266' ' ' ARG . 16.0 Cg_exo -69.24 164.54 33.64 Favored 'Trans proline' 0 CA--C 1.514 -0.524 0 C-N-CA 122.009 1.806 . . . . 15.0 110.399 167.457 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -69.92 143.65 52.65 Favored 'General case' 0 C--N 1.302 -1.465 0 CA-C-N 115.02 -0.991 . . . . 15.0 111.356 -173.695 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 100.16 3.9 55.48 Favored Glycine 0 N--CA 1.447 -0.628 0 CA-C-N 115.29 -0.868 . . . . 15.0 113.294 177.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 240' ' ' TYR . . . . . 0.698 ' CD1' ' HB2' ' A' ' 254' ' ' HIS . 74.7 m-85 -105.58 126.46 52.16 Favored 'General case' 0 CA--C 1.514 -0.434 0 CA-C-N 117.352 0.576 . . . . 15.0 110.874 176.996 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -111.71 125.23 53.75 Favored 'General case' 0 C--N 1.316 -0.871 0 N-CA-C 109.461 -0.57 . . . . 15.0 109.461 169.526 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 242' ' ' GLN . . . . . 0.489 ' HG3' ' CE1' ' A' ' 252' ' ' PHE . 7.2 tt0 -89.74 104.1 16.69 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.772 -0.649 . . . . 15.0 109.296 -178.62 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 36.0 mtt-85 -97.03 150.01 21.28 Favored 'General case' 0 CA--C 1.505 -0.771 0 CA-C-O 122.23 1.014 . . . . 15.0 112.368 -176.205 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 244' ' ' THR . . . . . . . . . . . . . 13.6 p -120.27 133.36 55.48 Favored 'General case' 0 C--N 1.308 -1.234 0 CA-C-N 113.085 -1.871 . . . . 15.0 109.506 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 245' ' ' THR . . . . . 0.549 ' OG1' ' HG2' ' A' ' 247' ' ' GLN . 4.6 t -137.4 150.23 47.51 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 116.462 -0.335 . . . . 15.0 110.911 -176.317 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 3.6 m -57.16 -15.88 3.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 115.777 -0.647 . . . . 15.0 112.117 178.694 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 247' ' ' GLN . . . . . 0.549 ' HG2' ' OG1' ' A' ' 245' ' ' THR . 6.8 mm100 -54.42 -24.04 18.35 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.123 -0.489 . . . . 15.0 110.245 172.918 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 92.9 34.12 7.01 Favored Glycine 0 C--N 1.333 0.374 0 CA-C-N 115.903 -0.589 . . . . 15.0 111.927 175.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 249' ' ' GLN . . . . . 0.456 ' CD ' ' HH2' ' A' ' 262' ' ' TRP . 0.2 OUTLIER -149.42 137.93 20.88 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.449 0.642 . . . . 15.0 111.843 -170.977 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 12.6 m -91.81 128.41 43.51 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.039 0 CA-C-N 114.527 -1.215 . . . . 15.0 109.151 171.16 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 20.5 p90 -132.8 135.27 45.58 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 109.951 -0.389 . . . . 15.0 109.951 -178.081 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 252' ' ' PHE . . . . . 0.664 ' CD2' ' HA ' ' A' ' 264' ' ' ASP . 30.1 m-85 -90.14 121.74 32.46 Favored 'General case' 0 CA--C 1.513 -0.443 0 CA-C-O 121.224 0.535 . . . . 15.0 111.737 -174.346 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 253' ' ' LEU . . . . . 0.65 HD12 ' HB3' ' B' ' 212' ' ' PRO . 0.5 OUTLIER -109.42 116.51 31.95 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 114.783 -1.099 . . . . 15.0 111.148 -175.824 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 254' ' ' HIS . . . . . 0.698 ' HB2' ' CD1' ' A' ' 240' ' ' TYR . 26.4 t-80 -130.21 90.21 2.91 Favored 'General case' 0 CA--C 1.503 -0.859 0 N-CA-C 108.207 -1.035 . . . . 15.0 108.207 169.866 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 3.2 t -91.32 87.95 6.67 Favored 'General case' 0 N--CA 1.432 -1.374 0 C-N-CA 116.659 -2.017 . . . . 15.0 110.111 -179.424 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 48.3 tt0 -101.33 -51.26 3.53 Favored 'General case' 0 N--CA 1.44 -0.963 0 CA-C-N 113.412 -1.722 . . . . 15.0 106.422 150.712 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 257' ' ' THR . . . . . . . . . . . . . 80.9 p -98.19 -13.61 20.78 Favored 'General case' 0 CA--C 1.488 -1.43 0 CA-C-O 124.78 2.229 . . . . 15.0 111.724 178.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 87.62 73.15 1.28 Allowed Glycine 1 C--N 1.24 -4.75 1 CA-C-N 108.258 -4.065 . . . . 15.0 112.742 -170.977 . . . . . . . . 3 2 . 1 . 009 nuclear orig core ' A' A ' 259' ' ' VAL . . . . . 0.552 ' O ' ' HA ' ' A' ' 253' ' ' LEU . 48.7 t -89.66 125.49 42.62 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.339 0 CA-C-O 121.667 0.746 . . . . 15.0 112.18 175.846 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 1.5 p -138.23 92.39 2.64 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-N 113.763 -1.562 . . . . 15.0 107.658 167.617 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 13.2 t -124.4 150.26 45.79 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 121.386 0.612 . . . . 15.0 112.243 -167.426 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 262' ' ' TRP . . . . . 0.456 ' HH2' ' CD ' ' A' ' 249' ' ' GLN . 40.9 m95 -75.44 -25.28 57.33 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 114.794 -1.094 . . . . 15.0 112.201 178.959 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 263' ' ' HIS . . . . . . . . . . . . . 8.1 p80 -92.9 142.26 27.5 Favored 'General case' 0 C--N 1.322 -0.608 0 C-N-CA 120.179 -0.608 . . . . 15.0 110.385 -176.043 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 264' ' ' ASP . . . . . 0.851 ' HB3' HG12 ' A' ' 267' ' ' ILE . 9.9 t0 -61.96 134.22 94.2 Favored Pre-proline 0 C--N 1.321 -0.635 0 N-CA-C 108.541 -0.911 . . . . 15.0 108.541 175.216 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 265' ' ' PRO . . . . . 0.574 ' HD3' ' CD2' ' A' ' 252' ' ' PHE . 71.6 Cg_endo -81.81 -14.46 10.01 Favored 'Trans proline' 0 N--CA 1.452 -0.969 0 C-N-CA 122.039 1.826 . . . . 15.0 113.547 -174.559 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 266' ' ' ARG . . . . . 0.751 ' HD3' ' HD3' ' A' ' 237' ' ' PRO . 17.8 tpt180 -78.87 -7.5 57.98 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-O 122.029 0.919 . . . . 15.0 108.723 174.62 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 267' ' ' ILE . . . . . 0.851 HG12 ' HB3' ' A' ' 264' ' ' ASP . 46.9 mm . . . . . 0 C--O 1.249 1.067 0 CA-C-N 113.846 -1.525 . . . . 15.0 109.663 177.063 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 210' ' ' SER . . . . . . . . . . . . . 20.0 m . . . . . 0 N--CA 1.482 1.132 0 CA-C-O 120.955 0.407 . . . . 15.0 110.969 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' B' B ' 211' ' ' ASP . . . . . 0.468 ' HA ' ' HD3' ' B' ' 212' ' ' PRO . 36.3 t70 -101.58 113.82 65.76 Favored Pre-proline 0 C--N 1.325 -0.488 0 CA-C-N 116.328 -0.396 . . . . 15.0 110.244 -177.701 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 212' ' ' PRO . . . . . 0.65 ' HB3' HD12 ' A' ' 253' ' ' LEU . 6.3 Cg_endo -89.71 160.2 5.19 Favored 'Trans proline' 0 N--CA 1.456 -0.688 0 C-N-CA 123.454 2.769 . . . . 15.0 112.891 -175.985 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.444 -0.813 0 CA-C-N 115.717 -0.674 . . . . 15.0 112.52 -178.151 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 4.8 mt . . . . . 0 C--O 1.232 0.147 0 CA-C-O 120.715 0.293 . . . . 15.0 110.426 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 237' ' ' PRO . . . . . 0.769 ' HD3' ' HD3' ' A' ' 266' ' ' ARG . 16.5 Cg_exo -69.37 169.6 18.04 Favored 'Trans proline' 0 CA--C 1.511 -0.672 0 C-N-CA 122.308 2.005 . . . . 15.0 110.654 165.355 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 60.0 mt-10 -69.5 137.14 52.28 Favored 'General case' 0 C--N 1.303 -1.425 0 CA-C-N 114.594 -1.185 . . . . 15.0 112.375 -172.096 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 100.54 5.76 53.69 Favored Glycine 0 N--CA 1.447 -0.582 0 CA-C-N 113.914 -1.494 . . . . 15.0 113.706 175.245 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 240' ' ' TYR . . . . . 0.671 ' CD1' ' HB2' ' A' ' 254' ' ' HIS . 83.4 m-85 -104.06 122.99 46.41 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 117.741 0.77 . . . . 15.0 110.738 175.891 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 241' ' ' GLU . . . . . 0.458 ' HG3' ' HB3' ' A' ' 253' ' ' LEU . 8.1 pt-20 -105.57 127.37 52.99 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 109.139 -0.689 . . . . 15.0 109.139 170.84 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 242' ' ' GLN . . . . . 0.655 ' HG3' ' CE1' ' A' ' 252' ' ' PHE . 9.6 tt0 -89.86 105.15 17.61 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 108.932 -0.766 . . . . 15.0 108.932 179.86 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 54.9 mtt-85 -92.39 149.28 21.51 Favored 'General case' 0 CA--C 1.506 -0.724 0 CA-C-O 122.288 1.042 . . . . 15.0 112.158 -177.074 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 244' ' ' THR . . . . . . . . . . . . . 20.4 p -126.4 89.91 3.09 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-N 113.066 -1.879 . . . . 15.0 109.101 -174.139 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 245' ' ' THR . . . . . 0.763 HG23 ' HB2' ' A' ' 247' ' ' GLN . 13.4 t -97.24 150.27 21.11 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 115.162 -0.926 . . . . 15.0 110.326 -171.106 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 26.8 t -54.41 -17.91 2.35 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 C-N-CA 122.915 0.486 . . . . 15.0 111.961 -175.069 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 247' ' ' GLN . . . . . 0.763 ' HB2' HG23 ' A' ' 245' ' ' THR . 10.4 mp0 -51.18 -22.89 2.86 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 123.25 0.62 . . . . 15.0 111.318 172.17 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 88.05 16.0 60.08 Favored Glycine 0 C--N 1.33 0.233 0 C-N-CA 121.156 -0.545 . . . . 15.0 112.06 178.23 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 1.8 mt-30 -131.11 137.56 49.13 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 109.884 -0.413 . . . . 15.0 109.884 -176.316 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 14.4 m -89.72 134.05 29.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-N 116.358 -0.383 . . . . 15.0 110.306 177.407 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 14.9 p90 -133.41 137.05 45.61 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.35 -0.386 . . . . 15.0 110.194 -179.698 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 252' ' ' PHE . . . . . 0.694 ' CD2' ' HA ' ' A' ' 264' ' ' ASP . 37.6 m-85 -89.88 121.74 32.28 Favored 'General case' 0 CA--C 1.512 -0.498 0 CA-C-O 121.193 0.521 . . . . 15.0 110.909 -175.8 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 253' ' ' LEU . . . . . 0.861 HD12 ' HB3' ' B' ' 212' ' ' PRO . 0.4 OUTLIER -113.16 124.75 53.28 Favored 'General case' 0 N--CA 1.445 -0.699 0 CA-C-N 114.858 -1.065 . . . . 15.0 110.756 -174.921 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 254' ' ' HIS . . . . . 0.671 ' HB2' ' CD1' ' A' ' 240' ' ' TYR . 14.5 t-80 -138.95 97.51 3.33 Favored 'General case' 0 CA--C 1.499 -1.014 0 N-CA-C 108.645 -0.872 . . . . 15.0 108.645 173.198 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 24.5 m -93.57 87.74 5.63 Favored 'General case' 0 N--CA 1.434 -1.244 0 C-N-CA 116.539 -2.064 . . . . 15.0 110.402 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 35.3 tt0 -101.29 -54.0 2.88 Favored 'General case' 0 N--CA 1.44 -0.956 0 N-CA-C 105.653 -1.981 . . . . 15.0 105.653 148.826 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 257' ' ' THR . . . . . . . . . . . . . 77.8 p -100.06 -13.61 18.96 Favored 'General case' 0 CA--C 1.485 -1.535 0 CA-C-N 112.555 -2.111 . . . . 15.0 112.223 -178.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 86.67 73.7 1.28 Allowed Glycine 1 C--N 1.239 -4.808 0 CA-C-N 108.806 -3.815 . . . . 15.0 112.753 -171.293 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 259' ' ' VAL . . . . . 0.639 ' O ' ' HA ' ' A' ' 253' ' ' LEU . 43.8 t -89.69 124.62 42.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 121.43 0.633 . . . . 15.0 112.02 176.021 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -140.15 102.14 4.31 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 114.407 -1.27 . . . . 15.0 107.915 168.345 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 12.9 t -143.31 150.35 39.07 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.9 -0.591 . . . . 15.0 111.878 -168.746 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 262' ' ' TRP . . . . . . . . . . . . . 92.7 m95 -70.0 -42.57 72.87 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 115.638 -0.71 . . . . 15.0 111.492 178.286 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 263' ' ' HIS . . . . . . . . . . . . . 2.7 p80 -73.53 132.37 42.79 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.255 -0.429 . . . . 15.0 110.246 -175.868 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 264' ' ' ASP . . . . . 0.998 ' HB3' HG12 ' A' ' 267' ' ' ILE . 22.0 t0 -56.38 127.63 72.0 Favored Pre-proline 0 C--N 1.32 -0.715 0 N-CA-C 108.155 -1.054 . . . . 15.0 108.155 172.769 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 265' ' ' PRO . . . . . 0.509 ' HG2' ' CD1' ' A' ' 240' ' ' TYR . 12.1 Cg_exo -69.34 -14.52 37.56 Favored 'Trans proline' 0 C--N 1.329 -0.482 0 C-N-CA 122.27 1.98 . . . . 15.0 112.614 -177.466 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 266' ' ' ARG . . . . . 0.769 ' HD3' ' HD3' ' A' ' 237' ' ' PRO . 16.1 tpt180 -75.39 -11.62 60.08 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 108.7 -0.852 . . . . 15.0 108.7 172.91 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 267' ' ' ILE . . . . . 0.998 HG12 ' HB3' ' A' ' 264' ' ' ASP . 24.6 pt . . . . . 0 C--O 1.248 1.017 0 CA-C-N 114.625 -1.171 . . . . 15.0 111.364 178.101 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 210' ' ' SER . . . . . . . . . . . . . 40.8 m . . . . . 0 N--CA 1.479 0.99 0 CA-C-O 120.77 0.319 . . . . 15.0 111.258 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' B' B ' 211' ' ' ASP . . . . . 0.459 ' HA ' ' HD3' ' B' ' 212' ' ' PRO . 10.1 p-10 -90.44 141.78 27.64 Favored Pre-proline 0 C--N 1.328 -0.363 0 N-CA-C 109.657 -0.498 . . . . 15.0 109.657 179.38 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 212' ' ' PRO . . . . . 0.861 ' HB3' HD12 ' A' ' 253' ' ' LEU . 9.5 Cg_endo -89.6 148.85 5.13 Favored 'Trans proline' 0 N--CA 1.454 -0.822 0 C-N-CA 122.733 2.289 . . . . 15.0 112.581 -177.567 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.443 -0.87 0 C-N-CA 120.746 -0.74 . . . . 15.0 112.075 -179.386 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 236' ' ' LEU . . . . . 0.676 HD22 ' H ' ' A' ' 236' ' ' LEU . 0.1 OUTLIER . . . . . 0 CA--C 1.518 -0.269 0 CA-C-O 121.225 0.536 . . . . 15.0 110.939 . . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 237' ' ' PRO . . . . . 0.45 ' HD3' ' HD3' ' A' ' 266' ' ' ARG . 18.8 Cg_exo -69.65 166.21 28.21 Favored 'Trans proline' 0 CA--C 1.515 -0.455 0 C-N-CA 122.993 2.462 . . . . 15.0 110.323 164.705 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -69.7 150.02 47.41 Favored 'General case' 0 C--N 1.307 -1.278 0 CA-C-N 115.443 -0.799 . . . . 15.0 110.968 -177.207 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 100.03 -2.14 56.63 Favored Glycine 0 N--CA 1.447 -0.593 0 CA-C-N 115.508 -0.769 . . . . 15.0 113.809 179.489 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 240' ' ' TYR . . . . . 0.646 ' CD1' ' HB2' ' A' ' 254' ' ' HIS . 79.6 m-85 -104.28 115.35 30.24 Favored 'General case' 0 CA--C 1.518 -0.283 0 CA-C-N 117.688 0.744 . . . . 15.0 110.626 178.233 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 26.5 mt-10 -95.7 123.13 39.12 Favored 'General case' 0 C--N 1.317 -0.844 0 N-CA-C 109.074 -0.713 . . . . 15.0 109.074 175.015 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 23.7 tm0? -89.91 109.11 20.15 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 108.728 -0.842 . . . . 15.0 108.728 179.845 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 47.9 mtt85 -105.27 150.09 25.45 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 122.143 0.973 . . . . 15.0 112.098 -179.291 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 244' ' ' THR . . . . . . . . . . . . . 5.6 p -127.36 98.25 5.19 Favored 'General case' 0 C--N 1.31 -1.125 0 CA-C-N 113.279 -1.782 . . . . 15.0 109.309 -177.183 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 245' ' ' THR . . . . . 0.456 ' OG1' ' HG2' ' A' ' 247' ' ' GLN . 3.1 t -89.92 150.4 22.19 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 115.567 -0.742 . . . . 15.0 111.098 -174.279 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 8.4 m -50.8 -19.36 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.21 0 CA-C-N 115.413 -0.812 . . . . 15.0 112.236 177.423 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 247' ' ' GLN . . . . . 0.456 ' HG2' ' OG1' ' A' ' 245' ' ' THR . 7.3 mm100 -55.62 -26.08 42.31 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.07 -0.514 . . . . 15.0 110.953 173.514 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 89.01 30.58 14.05 Favored Glycine 0 N--CA 1.449 -0.495 0 CA-C-N 115.943 -0.571 . . . . 15.0 111.996 179.706 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 249' ' ' GLN . . . . . 0.439 ' HG3' ' HB2' ' A' ' 247' ' ' GLN . 0.0 OUTLIER -134.76 142.09 46.64 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.642 0.258 . . . . 15.0 110.388 -177.006 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 17.9 m -89.97 134.89 27.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 115.884 -0.598 . . . . 15.0 109.825 175.373 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 4.3 p90 -142.73 135.77 28.28 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.083 0.468 . . . . 15.0 110.448 179.493 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 252' ' ' PHE . . . . . 0.733 ' CE2' ' HA ' ' A' ' 264' ' ' ASP . 34.5 m-85 -90.27 125.55 35.54 Favored 'General case' 0 CA--C 1.511 -0.526 0 CA-C-N 115.826 -0.625 . . . . 15.0 111.126 -176.57 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 253' ' ' LEU . . . . . 1.012 HD13 ' HB3' ' B' ' 212' ' ' PRO . 0.4 OUTLIER -113.98 111.25 21.37 Favored 'General case' 0 N--CA 1.445 -0.724 0 CA-C-N 115.25 -0.886 . . . . 15.0 111.768 -174.589 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 254' ' ' HIS . . . . . 0.646 ' HB2' ' CD1' ' A' ' 240' ' ' TYR . 36.4 t-80 -122.46 90.11 3.24 Favored 'General case' 0 CA--C 1.499 -0.992 0 N-CA-C 107.981 -1.118 . . . . 15.0 107.981 166.345 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 7.3 t -96.38 88.05 4.63 Favored 'General case' 0 N--CA 1.428 -1.567 0 C-N-CA 116.599 -2.041 . . . . 15.0 110.192 -178.878 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 63.7 tt0 -101.2 -51.48 3.5 Favored 'General case' 0 N--CA 1.437 -1.081 0 CA-C-N 112.875 -1.966 . . . . 15.0 105.838 151.519 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 257' ' ' THR . . . . . . . . . . . . . 79.6 p -96.78 -13.42 22.65 Favored 'General case' 0 CA--C 1.486 -1.506 0 CA-C-O 125.034 2.35 . . . . 15.0 111.623 178.531 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 86.74 74.62 1.27 Allowed Glycine 1 C--N 1.24 -4.783 1 CA-C-N 108.222 -4.081 . . . . 15.0 112.899 -172.92 . . . . . . . . 3 2 . 1 . 011 nuclear orig core ' A' A ' 259' ' ' VAL . . . . . 0.569 ' O ' ' HA ' ' A' ' 253' ' ' LEU . 57.4 t -89.9 121.86 40.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-O 121.556 0.693 . . . . 15.0 112.02 172.855 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 1.3 p -135.27 103.62 5.58 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 114.042 -1.435 . . . . 15.0 107.988 169.878 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 261' ' ' THR . . . . . 0.462 ' OG1' ' HD2' ' A' ' 263' ' ' HIS . 14.3 t -143.41 150.49 39.14 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 112.977 0.732 . . . . 15.0 112.977 -168.085 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 262' ' ' TRP . . . . . . . . . . . . . 89.1 m95 -71.44 -32.6 68.54 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 114.956 -1.02 . . . . 15.0 111.848 178.543 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 263' ' ' HIS . . . . . 0.462 ' HD2' ' OG1' ' A' ' 261' ' ' THR . 5.4 p80 -86.28 137.47 32.58 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.596 -0.441 . . . . 15.0 110.986 -172.241 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 264' ' ' ASP . . . . . 0.983 ' HB3' HG12 ' A' ' 267' ' ' ILE . 7.3 t0 -52.96 129.86 48.53 Favored Pre-proline 0 C--N 1.325 -0.458 0 N-CA-C 108.864 -0.791 . . . . 15.0 108.864 172.92 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 265' ' ' PRO . . . . . 0.574 ' HD2' HD13 ' A' ' 236' ' ' LEU . 67.0 Cg_endo -73.2 -14.87 25.74 Favored 'Trans proline' 0 CA--C 1.51 -0.724 0 C-N-CA 122.193 1.928 . . . . 15.0 113.64 -173.961 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 266' ' ' ARG . . . . . 0.45 ' HD3' ' HD3' ' A' ' 237' ' ' PRO . 8.4 tpt180 -83.93 -5.58 59.25 Favored 'General case' 0 C--N 1.306 -1.293 0 N-CA-C 108.254 -1.017 . . . . 15.0 108.254 174.245 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 267' ' ' ILE . . . . . 0.983 HG12 ' HB3' ' A' ' 264' ' ' ASP . 45.0 pt . . . . . 0 C--O 1.247 0.965 0 CA-C-N 114.023 -1.444 . . . . 15.0 110.728 174.667 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 210' ' ' SER . . . . . . . . . . . . . 19.3 m . . . . . 0 N--CA 1.477 0.891 0 CA-C-O 120.841 0.353 . . . . 15.0 111.038 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' B' B ' 211' ' ' ASP . . . . . 0.416 ' HA ' ' HD3' ' B' ' 212' ' ' PRO . 13.9 m-20 -110.05 115.18 55.25 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 120.76 0.314 . . . . 15.0 110.759 -178.032 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 212' ' ' PRO . . . . . 1.012 ' HB3' HD13 ' A' ' 253' ' ' LEU . 6.1 Cg_exo -89.6 141.55 3.93 Favored 'Trans proline' 0 N--CA 1.461 -0.437 0 C-N-CA 123.422 2.748 . . . . 15.0 112.851 178.99 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.443 -0.866 0 CA-C-N 115.52 -0.764 . . . . 15.0 111.745 178.619 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 236' ' ' LEU . . . . . 0.632 ' H ' HD23 ' A' ' 236' ' ' LEU . 0.2 OUTLIER . . . . . 0 CA--C 1.515 -0.367 0 CA-C-O 121.443 0.639 . . . . 15.0 110.906 . . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 237' ' ' PRO . . . . . 0.483 ' HD2' ' CE2' ' A' ' 240' ' ' TYR . 15.3 Cg_exo -69.65 173.88 10.23 Favored 'Trans proline' 0 CA--C 1.514 -0.516 0 C-N-CA 123.202 2.602 . . . . 15.0 110.672 161.675 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -69.42 143.45 53.61 Favored 'General case' 0 C--N 1.3 -1.581 0 CA-C-N 114.487 -1.233 . . . . 15.0 111.238 -177.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 100.18 8.29 50.68 Favored Glycine 0 N--CA 1.45 -0.386 0 CA-C-N 115.502 -0.772 . . . . 15.0 113.735 177.169 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 240' ' ' TYR . . . . . 0.614 ' CD1' ' HB2' ' A' ' 254' ' ' HIS . 72.2 m-85 -107.32 116.5 32.04 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 117.611 0.705 . . . . 15.0 111.346 178.826 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 241' ' ' GLU . . . . . 0.57 ' HB3' ' HB3' ' A' ' 253' ' ' LEU . 4.5 tp10 -89.84 111.58 22.65 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.156 -0.929 . . . . 15.0 108.737 174.562 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -90.06 102.72 15.43 Favored 'General case' 0 C--N 1.314 -0.943 0 N-CA-C 108.635 -0.876 . . . . 15.0 108.635 178.681 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 51.0 mtt-85 -99.21 148.26 24.29 Favored 'General case' 0 CA--C 1.499 -0.998 0 CA-C-O 121.96 0.886 . . . . 15.0 112.185 -177.742 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 244' ' ' THR . . . . . . . . . . . . . 11.7 m -123.2 93.97 4.12 Favored 'General case' 0 C--N 1.309 -1.191 0 CA-C-N 113.505 -1.68 . . . . 15.0 110.207 -179.413 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 245' ' ' THR . . . . . 1.096 HG22 ' HG2' ' A' ' 247' ' ' GLN . 7.7 t -95.25 150.73 19.91 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.546 -0.752 . . . . 15.0 110.248 179.99 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 15.0 m -41.15 -25.27 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 N-CA-C 114.642 1.349 . . . . 15.0 114.642 -175.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 247' ' ' GLN . . . . . 1.096 ' HG2' HG22 ' A' ' 245' ' ' THR . 3.5 pt20 -54.4 -21.45 9.71 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 117.793 0.27 . . . . 15.0 111.14 177.251 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 87.76 20.64 50.07 Favored Glycine 0 C--N 1.333 0.411 0 C-N-CA 121.206 -0.521 . . . . 15.0 113.036 173.821 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 249' ' ' GLN . . . . . 0.413 ' HB2' ' OE1' ' A' ' 247' ' ' GLN . 18.5 mt-30 -129.98 142.71 50.6 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.586 -0.524 . . . . 15.0 109.586 -177.207 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 29.8 m -91.25 134.75 28.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-O 120.943 0.402 . . . . 15.0 110.924 179.875 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 33.0 p90 -134.27 137.56 44.38 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.778 -0.452 . . . . 15.0 109.778 -178.005 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 252' ' ' PHE . . . . . 0.664 ' CE2' ' HA ' ' A' ' 264' ' ' ASP . 26.6 m-85 -92.01 116.58 29.05 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.218 0.533 . . . . 15.0 111.386 -174.66 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 253' ' ' LEU . . . . . 0.744 HD13 ' HB3' ' B' ' 212' ' ' PRO . 0.5 OUTLIER -106.54 96.87 6.76 Favored 'General case' 0 N--CA 1.447 -0.604 0 CA-C-N 115.063 -0.972 . . . . 15.0 111.3 -175.154 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 254' ' ' HIS . . . . . 0.614 ' HB2' ' CD1' ' A' ' 240' ' ' TYR . 33.5 t-80 -106.53 90.12 3.24 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 108.417 -0.957 . . . . 15.0 108.417 169.5 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 1.9 t -94.65 87.81 5.2 Favored 'General case' 0 N--CA 1.432 -1.342 0 C-N-CA 116.746 -1.982 . . . . 15.0 110.286 -179.698 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 57.4 tt0 -101.18 -50.2 3.86 Favored 'General case' 0 N--CA 1.441 -0.919 0 CA-C-N 112.957 -1.929 . . . . 15.0 106.25 150.876 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 257' ' ' THR . . . . . . . . . . . . . 67.0 p -98.53 -13.56 20.41 Favored 'General case' 0 CA--C 1.486 -1.503 0 CA-C-O 124.706 2.193 . . . . 15.0 111.738 178.469 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 87.07 73.57 1.28 Allowed Glycine 1 C--N 1.24 -4.803 0 CA-C-N 108.493 -3.958 . . . . 15.0 112.851 -172.3 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 259' ' ' VAL . . . . . 0.688 ' O ' ' HA ' ' A' ' 253' ' ' LEU . 52.3 t -89.92 125.3 42.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-O 121.284 0.564 . . . . 15.0 112.135 174.275 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 1.6 p -137.16 98.01 3.63 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 114.699 -1.137 . . . . 15.0 107.987 167.666 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 14.0 t -136.79 150.29 48.27 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.994 -0.548 . . . . 15.0 111.972 -168.464 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 262' ' ' TRP . . . . . 0.403 ' HZ3' ' CB ' ' A' ' 249' ' ' GLN . 83.2 m95 -71.83 -39.46 69.74 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.062 -0.972 . . . . 15.0 111.663 179.481 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 263' ' ' HIS . . . . . . . . . . . . . 5.5 p80 -77.82 137.23 38.3 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.451 -0.341 . . . . 15.0 110.48 -173.496 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 264' ' ' ASP . . . . . 1.033 ' HB3' HG12 ' A' ' 267' ' ' ILE . 27.7 t0 -57.54 124.21 66.41 Favored Pre-proline 0 C--N 1.324 -0.533 0 N-CA-C 108.024 -1.102 . . . . 15.0 108.024 169.899 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 265' ' ' PRO . . . . . 0.617 ' HD3' ' CD2' ' A' ' 252' ' ' PHE . 12.1 Cg_exo -69.13 -14.7 38.55 Favored 'Trans proline' 0 N--CA 1.459 -0.558 0 C-N-CA 122.236 1.957 . . . . 15.0 112.914 -175.997 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 266' ' ' ARG . . . . . 0.438 ' HD3' ' HD3' ' A' ' 237' ' ' PRO . 6.1 tpt180 -76.44 -11.64 59.92 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-O 121.99 0.9 . . . . 15.0 108.918 173.572 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 267' ' ' ILE . . . . . 1.033 HG12 ' HB3' ' A' ' 264' ' ' ASP . 36.5 pt . . . . . 0 C--O 1.246 0.904 0 CA-C-N 114.562 -1.199 . . . . 15.0 111.458 -179.364 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 210' ' ' SER . . . . . . . . . . . . . 17.7 m . . . . . 0 N--CA 1.476 0.863 0 CA-C-O 120.977 0.418 . . . . 15.0 110.327 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' B' B ' 211' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -98.97 116.83 65.05 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.136 -0.484 . . . . 15.0 110.93 -172.577 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 212' ' ' PRO . . . . . 0.744 ' HB3' HD13 ' A' ' 253' ' ' LEU . 6.6 Cg_endo -89.87 144.21 4.34 Favored 'Trans proline' 0 N--CA 1.451 -1.026 0 C-N-CA 122.851 2.367 . . . . 15.0 111.051 171.138 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.442 -0.946 0 C-N-CA 120.192 -1.004 . . . . 15.0 111.923 -179.517 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 236' ' ' LEU . . . . . 0.478 ' H ' HD23 ' A' ' 236' ' ' LEU . 0.6 OUTLIER . . . . . 0 N--CA 1.454 -0.257 0 N-CA-C 110.287 -0.264 . . . . 15.0 110.287 . . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 237' ' ' PRO . . . . . 0.593 ' HD3' ' HD3' ' A' ' 266' ' ' ARG . 20.0 Cg_exo -69.2 170.77 15.15 Favored 'Trans proline' 0 CA--C 1.509 -0.759 0 C-N-CA 122.308 2.005 . . . . 15.0 111.258 166.81 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -69.46 139.1 53.93 Favored 'General case' 0 C--N 1.301 -1.535 0 CA-C-N 114.215 -1.357 . . . . 15.0 110.995 -171.819 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 239' ' ' GLY . . . . . 0.404 ' O ' ' HD2' ' A' ' 254' ' ' HIS . . . 100.22 -2.28 56.41 Favored Glycine 0 N--CA 1.448 -0.509 0 CA-C-N 115.621 -0.718 . . . . 15.0 113.752 179.288 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 240' ' ' TYR . . . . . 0.421 ' HD2' ' O ' ' A' ' 237' ' ' PRO . 84.6 m-85 -97.39 116.52 29.75 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 118.087 0.943 . . . . 15.0 111.167 177.381 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 241' ' ' GLU . . . . . 0.567 ' HB2' ' HB3' ' A' ' 253' ' ' LEU . 5.6 mt-10 -89.9 111.06 21.99 Favored 'General case' 0 N--CA 1.441 -0.915 0 CA-C-N 114.297 -1.319 . . . . 15.0 109.232 177.606 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 242' ' ' GLN . . . . . 0.537 HE22 HG21 ' A' ' 244' ' ' THR . 1.0 OUTLIER -89.88 103.72 16.35 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 108.88 -0.785 . . . . 15.0 108.88 178.355 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 243' ' ' ARG . . . . . 0.406 ' CZ ' ' HG2' ' B' ' 212' ' ' PRO . 8.2 mtp180 -108.33 149.01 29.25 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.768 0.794 . . . . 15.0 112.114 -178.456 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 244' ' ' THR . . . . . 0.537 HG21 HE22 ' A' ' 242' ' ' GLN . 16.2 p -120.39 121.19 38.02 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 114.008 -1.451 . . . . 15.0 109.799 -178.035 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 245' ' ' THR . . . . . 0.512 ' OG1' ' HG2' ' A' ' 247' ' ' GLN . 4.6 t -110.66 150.55 28.85 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 116.24 -0.437 . . . . 15.0 111.013 -176.863 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 5.5 p -50.07 -24.31 1.92 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.262 0 CA-C-N 115.389 -0.823 . . . . 15.0 111.2 175.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 247' ' ' GLN . . . . . 0.512 ' HG2' ' OG1' ' A' ' 245' ' ' THR . 3.9 mm-40 -51.97 -26.84 11.46 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 115.335 -0.848 . . . . 15.0 110.823 175.42 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 104.56 9.36 35.76 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 121.098 -0.572 . . . . 15.0 113.092 174.518 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 2.1 pm0 -123.38 149.04 45.46 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 112.904 0.705 . . . . 15.0 112.904 -174.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 6.2 m -89.79 132.67 33.89 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.435 0 CA-C-N 114.727 -1.124 . . . . 15.0 108.367 166.69 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 2.4 p90 -134.61 140.3 45.97 Favored 'General case' 0 C--N 1.314 -0.946 0 C-N-CA 120.538 -0.465 . . . . 15.0 110.1 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 252' ' ' PHE . . . . . 0.661 ' CD2' ' HA ' ' A' ' 264' ' ' ASP . 24.2 m-85 -90.0 111.66 22.83 Favored 'General case' 0 CA--C 1.507 -0.698 0 CA-C-O 121.854 0.835 . . . . 15.0 111.601 -174.972 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 253' ' ' LEU . . . . . 0.898 HD13 ' HB3' ' B' ' 212' ' ' PRO . 0.5 OUTLIER -99.52 140.96 32.94 Favored 'General case' 0 N--CA 1.438 -1.055 0 CA-C-N 113.696 -1.593 . . . . 15.0 109.192 178.893 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 254' ' ' HIS . . . . . 0.464 ' HB3' ' HB ' ' A' ' 259' ' ' VAL . 13.6 t-80 -149.98 93.13 1.98 Allowed 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 108.335 -0.987 . . . . 15.0 108.335 170.72 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 255' ' ' THR . . . . . 0.494 HG21 ' OE2' ' A' ' 241' ' ' GLU . 2.6 t -90.04 87.95 7.1 Favored 'General case' 0 N--CA 1.431 -1.404 0 C-N-CA 116.387 -2.125 . . . . 15.0 110.328 -179.949 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 56.3 tt0 -101.26 -54.2 2.83 Favored 'General case' 0 N--CA 1.44 -0.963 0 CA-C-N 112.761 -2.018 . . . . 15.0 105.733 148.089 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 257' ' ' THR . . . . . . . . . . . . . 71.3 p -99.94 -13.72 19.01 Favored 'General case' 0 CA--C 1.487 -1.455 0 CA-C-N 112.156 -2.293 . . . . 15.0 112.333 -178.834 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 85.71 72.0 1.3 Allowed Glycine 1 C--N 1.244 -4.546 0 CA-C-N 108.492 -3.958 . . . . 15.0 112.762 -170.986 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 259' ' ' VAL . . . . . 0.553 ' O ' HD21 ' A' ' 253' ' ' LEU . 85.1 t -89.75 134.56 28.53 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.426 0 CA-C-O 121.519 0.676 . . . . 15.0 112.71 178.267 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 1.7 p -144.65 105.02 4.1 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 114.388 -1.278 . . . . 15.0 108.298 168.156 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 8.8 t -141.05 150.32 42.81 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 112.333 0.494 . . . . 15.0 112.333 -170.004 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 262' ' ' TRP . . . . . . . . . . . . . 6.7 m95 -68.54 -27.03 65.73 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.335 -0.848 . . . . 15.0 112.329 177.093 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 263' ' ' HIS . . . . . . . . . . . . . 5.2 p80 -85.68 132.73 34.1 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 120.137 -0.625 . . . . 15.0 111.026 -172.711 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 264' ' ' ASP . . . . . 1.05 ' HB3' HG12 ' A' ' 267' ' ' ILE . 20.5 t0 -64.84 126.4 90.94 Favored Pre-proline 0 C--N 1.319 -0.719 0 N-CA-C 108.546 -0.909 . . . . 15.0 108.546 171.597 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 265' ' ' PRO . . . . . 0.488 ' HD3' ' CD2' ' A' ' 252' ' ' PHE . 2.6 Cg_endo -80.26 -14.79 11.76 Favored 'Trans proline' 0 N--CA 1.456 -0.692 0 C-N-CA 122.642 2.228 . . . . 15.0 113.261 -177.653 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 266' ' ' ARG . . . . . 0.593 ' HD3' ' HD3' ' A' ' 237' ' ' PRO . 11.1 tpt180 -75.69 -12.79 60.26 Favored 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 108.439 -0.949 . . . . 15.0 108.439 173.581 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 267' ' ' ILE . . . . . 1.05 HG12 ' HB3' ' A' ' 264' ' ' ASP . 20.3 pt . . . . . 0 C--O 1.248 1.017 0 CA-C-N 114.324 -1.307 . . . . 15.0 110.761 178.507 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 210' ' ' SER . . . . . . . . . . . . . 19.8 m . . . . . 0 N--CA 1.475 0.786 0 CA-C-O 121.041 0.448 . . . . 15.0 110.038 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' B' B ' 211' ' ' ASP . . . . . 0.483 ' HA ' ' HD3' ' B' ' 212' ' ' PRO . 8.2 p-10 -119.51 127.01 26.67 Favored Pre-proline 0 C--N 1.324 -0.52 0 CA-C-O 121.289 0.566 . . . . 15.0 110.9 -176.244 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 212' ' ' PRO . . . . . 0.898 ' HB3' HD13 ' A' ' 253' ' ' LEU . 4.0 Cg_endo -89.72 156.4 5.14 Favored 'Trans proline' 0 N--CA 1.455 -0.743 0 C-N-CA 123.385 2.723 . . . . 15.0 112.302 179.856 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.442 -0.961 0 C-N-CA 120.608 -0.806 . . . . 15.0 112.392 -179.177 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 236' ' ' LEU . . . . . 0.511 HD12 ' HD2' ' A' ' 265' ' ' PRO . 1.4 mm? . . . . . 0 CA--C 1.517 -0.315 0 N-CA-C 109.162 -0.681 . . . . 15.0 109.162 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 237' ' ' PRO . . . . . 0.637 ' HD3' ' HD3' ' A' ' 266' ' ' ARG . 17.5 Cg_exo -69.37 158.06 58.86 Favored 'Trans proline' 0 N--CA 1.455 -0.771 0 C-N-CA 121.688 1.592 . . . . 15.0 108.957 160.67 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 5.2 mp0 -69.54 142.39 53.65 Favored 'General case' 0 C--N 1.303 -1.425 0 CA-C-O 121.46 0.647 . . . . 15.0 111.761 -171.217 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 100.5 7.81 50.7 Favored Glycine 0 CA--C 1.523 0.547 0 CA-C-N 114.931 -1.031 . . . . 15.0 114.017 -179.774 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 240' ' ' TYR . . . . . 0.737 ' CD1' ' HB2' ' A' ' 254' ' ' HIS . 80.9 m-85 -101.74 121.25 41.7 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 118.103 0.952 . . . . 15.0 110.721 174.845 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 241' ' ' GLU . . . . . 0.624 ' HG3' ' HB3' ' A' ' 253' ' ' LEU . 7.9 pt-20 -104.67 126.59 51.9 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 109.054 -0.721 . . . . 15.0 109.054 173.296 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -89.92 108.09 19.5 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 108.991 -0.744 . . . . 15.0 108.991 179.182 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 243' ' ' ARG . . . . . 0.534 ' HB2' ' CE1' ' A' ' 251' ' ' TYR . 9.7 mtt180 -99.44 133.43 43.76 Favored 'General case' 0 CA--C 1.502 -0.877 0 CA-C-O 122.704 1.24 . . . . 15.0 111.724 178.672 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 244' ' ' THR . . . . . . . . . . . . . 23.5 m -113.32 97.11 6.27 Favored 'General case' 0 C--N 1.301 -1.542 0 CA-C-N 112.631 -2.077 . . . . 15.0 109.067 -175.909 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 245' ' ' THR . . . . . 0.413 ' OG1' ' HG2' ' A' ' 247' ' ' GLN . 9.9 t -92.36 150.3 20.91 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 115.232 -0.894 . . . . 15.0 111.201 -172.325 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 3.5 m -54.94 -15.12 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 N-CA-C 112.882 0.697 . . . . 15.0 112.882 177.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 247' ' ' GLN . . . . . 0.413 ' HG2' ' OG1' ' A' ' 245' ' ' THR . 6.5 mm100 -58.58 -16.83 17.51 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.145 0.498 . . . . 15.0 110.63 173.414 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 88.13 37.78 7.6 Favored Glycine 0 N--CA 1.449 -0.492 0 CA-C-N 115.594 -0.73 . . . . 15.0 111.421 177.494 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 249' ' ' GLN . . . . . 0.456 ' HB2' ' CZ3' ' A' ' 262' ' ' TRP . 9.0 pt20 -149.96 137.58 19.97 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.899 0.38 . . . . 15.0 111.674 -173.684 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 19.1 m -90.2 134.01 30.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 N-CA-C 109.249 -0.649 . . . . 15.0 109.249 172.235 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 251' ' ' TYR . . . . . 0.534 ' CE1' ' HB2' ' A' ' 243' ' ' ARG . 3.7 p90 -137.25 137.37 38.97 Favored 'General case' 0 C--N 1.317 -0.813 0 C-N-CA 120.427 -0.509 . . . . 15.0 110.535 179.753 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 252' ' ' PHE . . . . . 0.667 ' CD2' ' HA ' ' A' ' 264' ' ' ASP . 37.3 m-85 -89.88 118.25 29.32 Favored 'General case' 0 CA--C 1.509 -0.616 0 CA-C-O 121.5 0.667 . . . . 15.0 110.835 -173.647 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 253' ' ' LEU . . . . . 0.746 HD11 ' CB ' ' B' ' 212' ' ' PRO . 0.4 OUTLIER -110.56 118.04 35.16 Favored 'General case' 0 N--CA 1.441 -0.876 0 CA-C-N 114.337 -1.302 . . . . 15.0 110.895 -173.853 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 254' ' ' HIS . . . . . 0.737 ' HB2' ' CD1' ' A' ' 240' ' ' TYR . 17.7 t-80 -132.57 95.48 3.62 Favored 'General case' 0 CA--C 1.495 -1.159 0 N-CA-C 108.546 -0.909 . . . . 15.0 108.546 170.441 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 3.7 t -94.65 87.91 5.23 Favored 'General case' 0 N--CA 1.429 -1.486 0 C-N-CA 116.062 -2.255 . . . . 15.0 110.268 178.196 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 25.1 tt0 -101.22 -51.87 3.4 Favored 'General case' 0 N--CA 1.442 -0.859 0 N-CA-C 105.902 -1.888 . . . . 15.0 105.902 149.177 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 257' ' ' THR . . . . . . . . . . . . . 69.4 p -99.21 -13.67 19.63 Favored 'General case' 0 CA--C 1.489 -1.395 0 CA-C-O 124.958 2.313 . . . . 15.0 111.909 179.575 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 84.84 74.88 1.24 Allowed Glycine 1 C--N 1.244 -4.569 1 CA-C-N 108.352 -4.022 . . . . 15.0 112.838 -172.146 . . . . . . . . 3 2 . 1 . 014 nuclear orig core ' A' A ' 259' ' ' VAL . . . . . 0.529 ' O ' ' HA ' ' A' ' 253' ' ' LEU . 33.1 t -89.89 123.85 42.29 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 CA-C-O 121.316 0.579 . . . . 15.0 112.451 173.307 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 1.8 p -134.15 101.76 5.14 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 114.632 -1.167 . . . . 15.0 107.855 164.366 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 14.1 t -136.55 150.25 48.52 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 121.212 0.529 . . . . 15.0 112.273 -169.561 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 262' ' ' TRP . . . . . 0.456 ' CZ3' ' HB2' ' A' ' 249' ' ' GLN . 10.3 m95 -70.39 -37.12 74.46 Favored 'General case' 0 CA--C 1.518 -0.27 0 CA-C-N 114.967 -1.015 . . . . 15.0 111.948 179.069 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 263' ' ' HIS . . . . . . . . . . . . . 5.9 p80 -85.37 139.99 31.12 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.109 -0.496 . . . . 15.0 110.278 -174.704 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 264' ' ' ASP . . . . . 0.871 ' HB3' HG12 ' A' ' 267' ' ' ILE . 9.8 t70 -55.45 126.54 63.18 Favored Pre-proline 0 C--N 1.322 -0.604 0 N-CA-C 108.212 -1.033 . . . . 15.0 108.212 171.118 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 265' ' ' PRO . . . . . 0.511 ' HD2' HD12 ' A' ' 236' ' ' LEU . 6.2 Cg_exo -71.37 -14.61 31.15 Favored 'Trans proline' 0 N--CA 1.458 -0.581 0 C-N-CA 121.935 1.757 . . . . 15.0 112.882 -174.172 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 266' ' ' ARG . . . . . 0.637 ' HD3' ' HD3' ' A' ' 237' ' ' PRO . 6.1 tpt180 -77.24 -7.81 56.55 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-O 121.817 0.817 . . . . 15.0 108.927 175.163 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 267' ' ' ILE . . . . . 0.871 HG12 ' HB3' ' A' ' 264' ' ' ASP . 43.5 mm . . . . . 0 C--O 1.25 1.085 0 CA-C-N 114.009 -1.451 . . . . 15.0 109.646 176.511 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 210' ' ' SER . . . . . . . . . . . . . 3.9 p . . . . . 0 N--CA 1.475 0.789 0 N-CA-C 110.275 -0.268 . . . . 15.0 110.275 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' B' B ' 211' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -89.98 131.57 38.81 Favored Pre-proline 0 C--N 1.329 -0.313 0 N-CA-C 109.802 -0.444 . . . . 15.0 109.802 178.564 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 212' ' ' PRO . . . . . 0.746 ' CB ' HD11 ' A' ' 253' ' ' LEU . 60.7 Cg_endo -89.84 160.19 5.07 Favored 'Trans proline' 0 N--CA 1.45 -1.03 0 C-N-CA 122.685 2.257 . . . . 15.0 112.105 178.938 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.442 -0.94 0 C-N-CA 120.508 -0.853 . . . . 15.0 112.251 -178.721 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 236' ' ' LEU . . . . . 0.747 HD22 ' H ' ' A' ' 236' ' ' LEU . 0.0 OUTLIER . . . . . 0 CA--C 1.52 -0.202 0 N-CA-C 109.375 -0.602 . . . . 15.0 109.375 . . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 237' ' ' PRO . . . . . 0.682 ' HD3' ' HD3' ' A' ' 266' ' ' ARG . 16.5 Cg_exo -69.6 158.83 55.77 Favored 'Trans proline' 0 N--CA 1.458 -0.61 0 C-N-CA 122.144 1.896 . . . . 15.0 109.855 166.294 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -69.86 149.42 47.88 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-O 121.546 0.689 . . . . 15.0 111.462 -174.044 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 100.17 -8.99 59.35 Favored Glycine 0 N--CA 1.444 -0.803 0 CA-C-N 115.096 -0.956 . . . . 15.0 113.09 -178.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 240' ' ' TYR . . . . . 0.645 ' CD1' ' HB2' ' A' ' 254' ' ' HIS . 87.6 m-85 -100.32 123.81 45.01 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 117.372 0.586 . . . . 15.0 110.353 177.366 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -109.33 126.6 53.56 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 108.938 -0.764 . . . . 15.0 108.938 169.848 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -89.95 108.71 19.88 Favored 'General case' 0 C--N 1.316 -0.853 0 N-CA-C 108.363 -0.977 . . . . 15.0 108.363 177.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 13.2 mtp85 -90.6 139.07 31.05 Favored 'General case' 0 CA--C 1.5 -0.961 0 CA-C-O 122.16 0.981 . . . . 15.0 112.962 -172.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 244' ' ' THR . . . . . . . . . . . . . 28.9 p -105.5 90.9 3.55 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-N 112.919 -1.946 . . . . 15.0 109.37 178.795 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 245' ' ' THR . . . . . 1.077 HG21 ' HG2' ' A' ' 247' ' ' GLN . 9.5 t -104.01 150.7 24.01 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.661 -0.7 . . . . 15.0 110.204 -176.182 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 39.6 t -43.74 -26.81 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 N-CA-C 113.725 1.009 . . . . 15.0 113.725 -172.665 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 247' ' ' GLN . . . . . 1.077 ' HG2' HG21 ' A' ' 245' ' ' THR . 3.5 pt20 -56.06 -23.09 31.49 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-O 120.695 0.283 . . . . 15.0 111.645 177.742 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 80.52 43.05 9.57 Favored Glycine 0 C--N 1.333 0.376 0 CA-C-N 116.264 -0.425 . . . . 15.0 113.15 176.068 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 249' ' ' GLN . . . . . 0.456 HE21 ' CD ' ' A' ' 247' ' ' GLN . 32.1 mt-30 -141.85 148.77 39.35 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.908 0.354 . . . . 15.0 110.082 -178.803 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 17.2 m -89.95 114.16 27.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-O 121.144 0.497 . . . . 15.0 110.638 178.814 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 2.4 p90 -126.43 131.91 51.6 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.565 -0.532 . . . . 15.0 109.565 -178.841 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 252' ' ' PHE . . . . . 0.562 ' CD2' ' HA ' ' A' ' 264' ' ' ASP . 50.7 m-85 -90.04 126.07 35.63 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.137 -0.483 . . . . 15.0 111.281 -175.052 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 253' ' ' LEU . . . . . 0.622 HD11 ' HB3' ' B' ' 212' ' ' PRO . 0.8 OUTLIER -118.55 121.27 39.82 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-N 115.655 -0.702 . . . . 15.0 110.776 -177.623 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 254' ' ' HIS . . . . . 0.645 ' HB2' ' CD1' ' A' ' 240' ' ' TYR . 14.6 t-80 -135.93 96.48 3.42 Favored 'General case' 0 CA--C 1.502 -0.895 0 N-CA-C 108.834 -0.802 . . . . 15.0 108.834 172.544 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 6.1 t -94.03 88.13 5.57 Favored 'General case' 0 C--N 1.311 -1.085 0 C-N-CA 116.525 -2.07 . . . . 15.0 110.797 -179.809 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 44.4 tt0 -101.23 -52.97 3.13 Favored 'General case' 0 N--CA 1.443 -0.824 0 CA-C-N 113.29 -1.777 . . . . 15.0 106.217 151.316 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 257' ' ' THR . . . . . . . . . . . . . 62.7 p -99.92 -13.45 19.14 Favored 'General case' 0 CA--C 1.488 -1.44 0 CA-C-O 124.837 2.256 . . . . 15.0 111.774 -179.279 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 87.74 72.98 1.28 Allowed Glycine 1 C--N 1.238 -4.907 1 CA-C-N 108.391 -4.004 . . . . 15.0 112.782 -169.91 . . . . . . . . 3 2 . 1 . 015 nuclear orig core ' A' A ' 259' ' ' VAL . . . . . 0.492 ' HB ' ' HB3' ' A' ' 254' ' ' HIS . 45.1 t -90.1 127.87 42.39 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.3 0 CA-C-O 121.151 0.5 . . . . 15.0 111.576 174.309 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 260' ' ' SER . . . . . 0.509 ' HA ' ' O ' ' A' ' 252' ' ' PHE . 2.2 p -148.13 103.25 3.45 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 114.721 -1.127 . . . . 15.0 108.195 170.109 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 13.8 t -150.02 150.43 31.77 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 116.099 -0.501 . . . . 15.0 111.358 -168.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 262' ' ' TRP . . . . . . . . . . . . . 92.4 m95 -69.9 -36.78 75.67 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.932 -0.576 . . . . 15.0 111.53 179.423 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 263' ' ' HIS . . . . . . . . . . . . . 2.7 p80 -75.38 129.96 38.21 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.612 -0.435 . . . . 15.0 110.605 -174.916 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 264' ' ' ASP . . . . . 1.09 ' HB3' HG12 ' A' ' 267' ' ' ILE . 67.5 t0 -59.49 124.56 76.06 Favored Pre-proline 0 C--N 1.321 -0.649 0 N-CA-C 108.609 -0.885 . . . . 15.0 108.609 172.016 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 265' ' ' PRO . . . . . 0.511 ' HG2' ' CE1' ' A' ' 240' ' ' TYR . 13.0 Cg_exo -68.83 -14.61 39.26 Favored 'Trans proline' 0 N--CA 1.456 -0.716 0 C-N-CA 121.904 1.736 . . . . 15.0 111.889 178.074 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 266' ' ' ARG . . . . . 0.682 ' HD3' ' HD3' ' A' ' 237' ' ' PRO . 22.7 tpt180 -76.73 -10.18 59.19 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 115.252 -0.885 . . . . 15.0 109.473 173.538 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 267' ' ' ILE . . . . . 1.09 HG12 ' HB3' ' A' ' 264' ' ' ASP . 40.0 pt . . . . . 0 C--O 1.25 1.096 0 CA-C-N 114.813 -1.085 . . . . 15.0 111.297 177.389 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 210' ' ' SER . . . . . . . . . . . . . 16.5 m . . . . . 0 N--CA 1.479 0.987 0 CA-C-O 120.772 0.32 . . . . 15.0 110.963 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' B' B ' 211' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -135.34 120.64 13.82 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.536 -0.302 . . . . 15.0 110.76 -174.922 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 212' ' ' PRO . . . . . 0.622 ' HB3' HD11 ' A' ' 253' ' ' LEU . 53.9 Cg_endo -93.34 143.77 2.07 Favored 'Trans proline' 0 N--CA 1.452 -0.927 0 C-N-CA 122.837 2.358 . . . . 15.0 112.696 176.59 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.698 0 C-N-CA 120.406 -0.902 . . . . 15.0 111.814 179.586 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 236' ' ' LEU . . . . . 0.659 HD21 ' H ' ' A' ' 236' ' ' LEU . 0.0 OUTLIER . . . . . 0 CA--C 1.517 -0.291 0 CA-C-O 121.148 0.499 . . . . 15.0 110.177 . . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 237' ' ' PRO . . . . . 0.5 ' HD3' ' HB2' ' A' ' 266' ' ' ARG . 9.0 Cg_exo -69.79 174.77 9.05 Favored 'Trans proline' 0 CA--C 1.509 -0.765 0 C-N-CA 122.845 2.363 . . . . 15.0 110.802 166.308 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -69.6 126.71 30.55 Favored 'General case' 0 C--N 1.297 -1.706 0 CA-C-N 114.132 -1.394 . . . . 15.0 111.544 -175.316 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 100.06 49.28 1.49 Allowed Glycine 0 C--N 1.333 0.37 0 CA-C-N 115.364 -0.834 . . . . 15.0 113.436 177.195 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 240' ' ' TYR . . . . . 0.626 ' CD1' ' HB2' ' A' ' 254' ' ' HIS . 74.1 m-85 -142.69 123.78 14.51 Favored 'General case' 0 CA--C 1.516 -0.345 0 CA-C-N 117.658 0.729 . . . . 15.0 111.518 176.442 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 34.1 mm-40 -100.07 124.06 45.02 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.337 -0.847 . . . . 15.0 109.164 175.155 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 242' ' ' GLN . . . . . 0.692 ' HG3' ' CE1' ' A' ' 252' ' ' PHE . 31.7 tt0 -90.18 110.78 21.79 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.458 -0.571 . . . . 15.0 109.458 -179.82 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 2.5 mpt_? -93.44 150.39 20.49 Favored 'General case' 0 CA--C 1.506 -0.739 0 CA-C-O 122.185 0.993 . . . . 15.0 113.641 -177.745 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 244' ' ' THR . . . . . . . . . . . . . 23.4 p -130.89 95.35 3.81 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 113.014 -1.903 . . . . 15.0 110.057 -176.848 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 245' ' ' THR . . . . . 0.503 ' OG1' ' HG2' ' A' ' 247' ' ' GLN . 5.5 t -93.96 150.41 20.38 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.872 -0.604 . . . . 15.0 110.044 179.672 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 3.8 p -53.37 -20.58 3.19 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 CA-C-O 121.163 0.506 . . . . 15.0 111.492 -179.244 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 247' ' ' GLN . . . . . 0.503 ' HG2' ' OG1' ' A' ' 245' ' ' THR . 31.6 mm-40 -55.12 -23.5 21.31 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.022 -0.99 . . . . 15.0 110.881 176.23 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 85.88 36.58 10.1 Favored Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 121.103 -0.57 . . . . 15.0 111.801 178.5 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 249' ' ' GLN . . . . . 0.418 ' HB2' ' CZ3' ' A' ' 262' ' ' TRP . 7.3 pt20 -141.43 130.77 23.66 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.866 0.365 . . . . 15.0 110.844 -176.892 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 15.5 m -89.84 124.87 42.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 115.868 -0.605 . . . . 15.0 110.305 177.042 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 16.4 p90 -128.95 137.24 51.27 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.812 -0.631 . . . . 15.0 109.765 -177.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 252' ' ' PHE . . . . . 0.692 ' CE1' ' HG3' ' A' ' 242' ' ' GLN . 29.8 m-85 -89.75 120.17 30.77 Favored 'General case' 0 CA--C 1.511 -0.535 0 CA-C-O 121.239 0.542 . . . . 15.0 112.186 -169.986 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 253' ' ' LEU . . . . . 1.053 HD12 ' HB3' ' B' ' 212' ' ' PRO . 4.6 mt -104.65 110.29 22.54 Favored 'General case' 0 N--CA 1.446 -0.627 0 CA-C-N 114.683 -1.144 . . . . 15.0 111.823 -178.308 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 254' ' ' HIS . . . . . 0.626 ' HB2' ' CD1' ' A' ' 240' ' ' TYR . 12.1 t-80 -117.89 95.65 5.01 Favored 'General case' 0 C--N 1.312 -1.042 0 N-CA-C 107.808 -1.182 . . . . 15.0 107.808 166.405 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 2.9 t -93.98 87.76 5.47 Favored 'General case' 0 N--CA 1.429 -1.507 0 C-N-CA 115.968 -2.293 . . . . 15.0 110.038 -179.115 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 51.1 tt0 -101.34 -54.55 2.75 Favored 'General case' 0 N--CA 1.441 -0.894 0 CA-C-N 113.087 -1.869 . . . . 15.0 106.068 151.208 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 257' ' ' THR . . . . . . . . . . . . . 67.2 p -99.51 -13.74 19.36 Favored 'General case' 0 CA--C 1.49 -1.365 0 CA-C-N 111.881 -2.418 . . . . 15.0 112.013 -177.183 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 87.83 71.57 1.28 Allowed Glycine 1 C--N 1.241 -4.7 1 CA-C-N 108.236 -4.074 . . . . 15.0 112.904 -171.513 . . . . . . . . 3 2 . 1 . 016 nuclear orig core ' A' A ' 259' ' ' VAL . . . . . 0.684 ' O ' ' HA ' ' A' ' 253' ' ' LEU . 40.6 t -89.67 124.58 42.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 121.294 0.569 . . . . 15.0 112.226 176.767 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -137.15 97.04 3.4 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 114.451 -1.25 . . . . 15.0 107.816 166.174 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 14.6 t -132.23 150.35 52.17 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.943 -0.571 . . . . 15.0 111.48 -168.45 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 262' ' ' TRP . . . . . 0.426 ' HA ' ' CE3' ' A' ' 262' ' ' TRP . 10.7 m95 -65.57 -53.75 37.6 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.476 -0.784 . . . . 15.0 111.519 178.615 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 263' ' ' HIS . . . . . . . . . . . . . 4.4 p80 -65.3 133.43 51.41 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.242 -0.435 . . . . 15.0 110.465 -175.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 264' ' ' ASP . . . . . 0.973 ' HB3' HG12 ' A' ' 267' ' ' ILE . 24.0 t0 -53.83 128.9 55.55 Favored Pre-proline 0 C--N 1.321 -0.631 0 N-CA-C 107.833 -1.173 . . . . 15.0 107.833 169.253 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 265' ' ' PRO . . . . . 0.6 ' HD3' ' CD2' ' A' ' 252' ' ' PHE . 13.1 Cg_exo -68.98 -14.57 38.78 Favored 'Trans proline' 0 N--CA 1.458 -0.605 0 C-N-CA 122.01 1.807 . . . . 15.0 112.582 -177.483 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 266' ' ' ARG . . . . . 0.5 ' HB2' ' HD3' ' A' ' 237' ' ' PRO . 19.9 tpt180 -72.53 -14.93 61.76 Favored 'General case' 0 N--CA 1.446 -0.667 0 N-CA-C 108.611 -0.885 . . . . 15.0 108.611 170.953 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 267' ' ' ILE . . . . . 0.973 HG12 ' HB3' ' A' ' 264' ' ' ASP . 26.9 pt . . . . . 0 C--O 1.252 1.199 0 CA-C-N 114.482 -1.236 . . . . 15.0 110.438 177.748 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 210' ' ' SER . . . . . . . . . . . . . 24.4 p . . . . . 0 N--CA 1.479 1.012 0 N-CA-C 111.595 0.22 . . . . 15.0 111.595 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' B' B ' 211' ' ' ASP . . . . . 0.45 ' HA ' ' HD3' ' B' ' 212' ' ' PRO . 23.6 t70 -93.45 120.28 66.59 Favored Pre-proline 0 C--N 1.328 -0.342 0 N-CA-C 110.323 -0.251 . . . . 15.0 110.323 -179.113 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 212' ' ' PRO . . . . . 1.053 ' HB3' HD12 ' A' ' 253' ' ' LEU . 3.6 Cg_endo -89.83 147.25 4.81 Favored 'Trans proline' 0 N--CA 1.453 -0.909 0 C-N-CA 123.078 2.519 . . . . 15.0 112.595 179.714 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.438 -1.172 0 C-N-CA 120.603 -0.808 . . . . 15.0 112.049 -179.581 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 236' ' ' LEU . . . . . 0.613 ' H ' HD23 ' A' ' 236' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.455 -0.194 0 N-CA-C 108.767 -0.827 . . . . 15.0 108.767 . . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 237' ' ' PRO . . . . . 0.827 ' HD3' ' HD3' ' A' ' 266' ' ' ARG . 16.8 Cg_exo -69.57 160.64 48.98 Favored 'Trans proline' 0 N--CA 1.459 -0.519 0 C-N-CA 122.077 1.851 . . . . 15.0 110.286 166.562 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -69.59 142.6 53.51 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-N 115.536 -0.756 . . . . 15.0 111.006 -174.353 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 100.37 8.77 49.16 Favored Glycine 0 CA--C 1.522 0.494 0 CA-C-N 115.807 -0.633 . . . . 15.0 113.815 179.677 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 240' ' ' TYR . . . . . 0.678 ' CD1' ' HB2' ' A' ' 254' ' ' HIS . 77.8 m-85 -109.97 110.43 21.36 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 117.465 0.632 . . . . 15.0 110.458 175.882 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 241' ' ' GLU . . . . . 0.623 ' HG3' ' HB3' ' A' ' 253' ' ' LEU . 8.0 pt-20 -90.13 115.92 27.75 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.697 0.76 . . . . 15.0 109.202 174.105 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 11.7 tm0? -90.0 109.72 20.74 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 108.805 -0.813 . . . . 15.0 108.805 -179.564 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 69.6 mtt-85 -99.14 150.18 22.3 Favored 'General case' 0 CA--C 1.504 -0.803 0 CA-C-O 122.283 1.039 . . . . 15.0 113.355 -170.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 244' ' ' THR . . . . . . . . . . . . . 3.3 p -115.67 105.4 12.71 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 112.87 -1.968 . . . . 15.0 109.725 179.184 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 245' ' ' THR . . . . . 0.903 HG23 ' HG2' ' A' ' 247' ' ' GLN . 6.1 t -116.22 150.35 37.67 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 116.036 -0.529 . . . . 15.0 110.882 -174.874 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 13.0 m -49.22 -25.22 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.313 0 N-CA-C 113.97 1.1 . . . . 15.0 113.97 -176.474 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 247' ' ' GLN . . . . . 0.903 ' HG2' HG23 ' A' ' 245' ' ' THR . 2.6 pt20 -57.75 -21.65 42.49 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-O 120.678 0.275 . . . . 15.0 111.012 178.161 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 93.62 15.41 50.06 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.925 -0.655 . . . . 15.0 113.259 174.936 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 249' ' ' GLN . . . . . 0.669 ' HB2' ' OE1' ' A' ' 247' ' ' GLN . 1.8 mp0 -123.97 147.34 47.84 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.944 0.402 . . . . 15.0 111.598 -178.689 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 31.3 m -90.13 135.71 25.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.765 -0.652 . . . . 15.0 109.89 173.235 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 28.2 p90 -141.95 135.15 29.09 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 109.587 -0.523 . . . . 15.0 109.587 -177.038 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 252' ' ' PHE . . . . . 0.692 ' CD2' ' HA ' ' A' ' 264' ' ' ASP . 29.5 m-85 -90.13 123.39 33.93 Favored 'General case' 0 CA--C 1.51 -0.565 0 CA-C-N 115.982 -0.554 . . . . 15.0 111.593 -173.248 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 253' ' ' LEU . . . . . 0.774 HD12 ' HB3' ' B' ' 212' ' ' PRO . 0.5 OUTLIER -116.69 114.26 23.79 Favored 'General case' 0 N--CA 1.445 -0.715 0 CA-C-N 115.123 -0.944 . . . . 15.0 110.964 -176.343 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 254' ' ' HIS . . . . . 0.678 ' HB2' ' CD1' ' A' ' 240' ' ' TYR . 20.9 t-80 -124.29 95.09 4.41 Favored 'General case' 0 CA--C 1.5 -0.972 0 N-CA-C 108.48 -0.933 . . . . 15.0 108.48 169.747 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 3.0 t -94.54 88.18 5.37 Favored 'General case' 0 N--CA 1.433 -1.304 0 C-N-CA 116.33 -2.148 . . . . 15.0 110.754 179.287 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 256' ' ' GLN . . . . . 0.484 ' HB3' ' CE1' ' A' ' 254' ' ' HIS . 5.8 tt0 -101.29 -52.94 3.13 Favored 'General case' 0 N--CA 1.441 -0.906 0 N-CA-C 106.026 -1.842 . . . . 15.0 106.026 149.861 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 257' ' ' THR . . . . . . . . . . . . . 72.7 p -97.79 -13.7 21.21 Favored 'General case' 0 CA--C 1.488 -1.406 0 CA-C-O 124.634 2.159 . . . . 15.0 111.923 -179.501 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 88.7 71.04 1.27 Allowed Glycine 1 C--N 1.243 -4.598 0 CA-C-N 108.404 -3.998 . . . . 15.0 113.167 -172.933 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 259' ' ' VAL . . . . . 0.605 ' O ' ' HA ' ' A' ' 253' ' ' LEU . 57.8 t -89.83 126.06 42.74 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.289 0 CA-C-O 121.428 0.632 . . . . 15.0 112.387 175.757 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 260' ' ' SER . . . . . 0.442 ' HA ' ' O ' ' A' ' 252' ' ' PHE . 1.4 p -141.66 100.24 3.72 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 114.444 -1.253 . . . . 15.0 107.685 165.934 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 13.4 t -136.39 150.32 48.74 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.853 -0.612 . . . . 15.0 111.788 -167.376 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 262' ' ' TRP . . . . . 0.453 ' HA ' ' CE3' ' A' ' 262' ' ' TRP . 8.9 m95 -70.7 -32.38 69.58 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.349 -0.841 . . . . 15.0 112.374 179.449 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 263' ' ' HIS . . . . . . . . . . . . . 5.0 p80 -84.63 134.67 34.37 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 120.385 -0.526 . . . . 15.0 110.388 -176.289 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 264' ' ' ASP . . . . . 1.009 ' HB3' HG12 ' A' ' 267' ' ' ILE . 43.5 t0 -56.62 124.06 60.72 Favored Pre-proline 0 C--O 1.218 -0.603 0 N-CA-C 108.56 -0.904 . . . . 15.0 108.56 169.843 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 265' ' ' PRO . . . . . 0.506 ' HD3' ' CD2' ' A' ' 252' ' ' PHE . 10.6 Cg_exo -68.93 -14.83 39.44 Favored 'Trans proline' 0 N--CA 1.46 -0.494 0 C-N-CA 122.367 2.045 . . . . 15.0 112.629 -177.55 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 266' ' ' ARG . . . . . 0.827 ' HD3' ' HD3' ' A' ' 237' ' ' PRO . 20.2 tpt180 -75.89 -11.58 60.0 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 115.483 -0.78 . . . . 15.0 109.047 173.623 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 267' ' ' ILE . . . . . 1.009 HG12 ' HB3' ' A' ' 264' ' ' ASP . 36.9 pt . . . . . 0 C--O 1.247 0.945 0 CA-C-N 114.641 -1.163 . . . . 15.0 111.253 178.899 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 210' ' ' SER . . . . . . . . . . . . . 20.4 m . . . . . 0 N--CA 1.481 1.077 0 CA-C-O 120.638 0.256 . . . . 15.0 111.229 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' B' B ' 211' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -116.95 144.32 33.27 Favored Pre-proline 0 C--O 1.235 0.319 0 N-CA-C 109.37 -0.604 . . . . 15.0 109.37 176.053 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 212' ' ' PRO . . . . . 0.774 ' HB3' HD12 ' A' ' 253' ' ' LEU . 8.4 Cg_endo -89.87 143.33 4.16 Favored 'Trans proline' 0 N--CA 1.454 -0.823 0 C-N-CA 122.819 2.346 . . . . 15.0 112.888 -176.715 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.441 -0.976 0 CA-C-N 115.538 -0.755 . . . . 15.0 111.622 176.998 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 236' ' ' LEU . . . . . 0.422 HD13 ' OD1' ' A' ' 264' ' ' ASP . 2.1 mm? . . . . . 0 CA--C 1.517 -0.319 0 CA-C-O 120.85 0.357 . . . . 15.0 110.727 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 237' ' ' PRO . . . . . 0.545 ' HD3' ' HD3' ' A' ' 266' ' ' ARG . 15.0 Cg_exo -69.53 164.28 34.9 Favored 'Trans proline' 0 N--CA 1.456 -0.699 0 C-N-CA 121.92 1.747 . . . . 15.0 109.314 160.835 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 12.2 mm-40 -69.6 142.69 53.47 Favored 'General case' 0 C--N 1.301 -1.522 0 CA-C-N 115.166 -0.925 . . . . 15.0 113.333 -170.098 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 100.11 -1.62 56.37 Favored Glycine 0 CA--C 1.526 0.755 0 CA-C-N 114.124 -1.398 . . . . 15.0 115.166 174.103 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 240' ' ' TYR . . . . . 0.676 ' CD1' ' HB2' ' A' ' 254' ' ' HIS . 78.1 m-85 -87.9 123.46 32.67 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 118.574 1.187 . . . . 15.0 111.486 -179.449 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -96.08 114.81 26.55 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.397 -0.819 . . . . 15.0 109.214 173.332 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -90.13 99.68 12.65 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 108.823 -0.806 . . . . 15.0 108.823 176.233 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 243' ' ' ARG . . . . . 0.687 ' CZ ' ' HD2' ' B' ' 212' ' ' PRO . 34.7 mtt180 -91.28 149.86 21.57 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.531 -0.758 . . . . 15.0 111.823 179.404 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 244' ' ' THR . . . . . . . . . . . . . 6.1 m -127.2 92.05 3.44 Favored 'General case' 0 C--N 1.307 -1.267 0 CA-C-N 113.682 -1.599 . . . . 15.0 109.219 -179.407 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 245' ' ' THR . . . . . 0.425 ' OG1' ' HG2' ' A' ' 247' ' ' GLN . 5.0 t -90.0 150.59 22.05 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.204 -0.907 . . . . 15.0 110.926 -174.666 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 11.6 m -49.0 -20.23 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 CA-C-N 115.429 -0.805 . . . . 15.0 112.617 177.053 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 247' ' ' GLN . . . . . 0.525 ' HB2' ' HG3' ' A' ' 249' ' ' GLN . 6.6 mm100 -58.77 -19.51 41.4 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 116.055 -0.521 . . . . 15.0 111.128 175.307 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 85.98 26.01 35.84 Favored Glycine 0 C--N 1.332 0.357 0 C-N-CA 121.305 -0.474 . . . . 15.0 112.632 177.454 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 249' ' ' GLN . . . . . 0.525 ' HG3' ' HB2' ' A' ' 247' ' ' GLN . 0.3 OUTLIER -126.43 133.96 51.11 Favored 'General case' 0 C--N 1.326 -0.415 0 O-C-N 122.624 -0.339 . . . . 15.0 110.967 -174.493 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 3.6 m -90.01 107.23 18.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 115.768 -0.651 . . . . 15.0 109.537 173.056 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 6.4 p90 -119.48 130.65 55.33 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.922 -0.581 . . . . 15.0 109.981 -173.399 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 252' ' ' PHE . . . . . 0.746 ' CD2' ' HA ' ' A' ' 264' ' ' ASP . 32.2 m-85 -90.03 123.09 33.62 Favored 'General case' 0 CA--C 1.506 -0.75 0 CA-C-N 116.21 -0.45 . . . . 15.0 110.832 -175.365 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 253' ' ' LEU . . . . . 0.95 HD13 ' HB2' ' B' ' 212' ' ' PRO . 1.6 tt -128.82 115.79 18.46 Favored 'General case' 0 N--CA 1.438 -1.048 0 CA-C-N 115.631 -0.713 . . . . 15.0 111.541 -175.554 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 254' ' ' HIS . . . . . 0.676 ' HB2' ' CD1' ' A' ' 240' ' ' TYR . 29.1 t-80 -124.18 92.57 3.69 Favored 'General case' 0 CA--C 1.505 -0.758 0 N-CA-C 108.723 -0.843 . . . . 15.0 108.723 174.861 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 53.0 m -94.7 88.18 5.3 Favored 'General case' 0 N--CA 1.436 -1.159 0 C-N-CA 116.66 -2.016 . . . . 15.0 110.429 179.782 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 7.1 tt0 -100.83 -50.47 3.83 Favored 'General case' 0 N--CA 1.441 -0.917 0 N-CA-C 105.848 -1.908 . . . . 15.0 105.848 151.236 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 257' ' ' THR . . . . . . . . . . . . . 60.3 p -98.46 -13.44 20.54 Favored 'General case' 0 CA--C 1.49 -1.349 0 CA-C-O 124.963 2.316 . . . . 15.0 111.795 177.598 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 88.52 70.8 1.27 Allowed Glycine 1 C--N 1.242 -4.665 1 CA-C-N 108.214 -4.085 . . . . 15.0 113.471 -173.405 . . . . . . . . 3 2 . 1 . 018 nuclear orig core ' A' A ' 259' ' ' VAL . . . . . 0.502 ' O ' ' HA ' ' A' ' 253' ' ' LEU . 76.5 t -89.8 130.42 39.13 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.58 0 CA-C-O 121.271 0.558 . . . . 15.0 111.207 173.711 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 10.1 p -150.09 96.97 2.51 Favored 'General case' 0 C--N 1.307 -1.247 0 CA-C-N 114.598 -1.183 . . . . 15.0 108.817 170.755 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 12.4 t -143.87 150.32 38.27 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.877 -0.601 . . . . 15.0 111.299 -168.377 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 262' ' ' TRP . . . . . . . . . . . . . 92.9 m95 -69.07 -42.15 76.62 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.849 -0.614 . . . . 15.0 111.729 179.845 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 263' ' ' HIS . . . . . . . . . . . . . 2.6 p80 -65.22 132.32 48.8 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-O 120.896 0.379 . . . . 15.0 110.213 -176.345 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 264' ' ' ASP . . . . . 0.933 ' HB3' HG12 ' A' ' 267' ' ' ILE . 28.4 t70 -56.11 124.94 62.26 Favored Pre-proline 0 C--N 1.321 -0.665 0 N-CA-C 108.847 -0.797 . . . . 15.0 108.847 172.428 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 265' ' ' PRO . . . . . 0.653 ' HD3' ' CD2' ' A' ' 252' ' ' PHE . 4.3 Cg_exo -73.44 -14.64 25.12 Favored 'Trans proline' 0 CA--C 1.51 -0.701 0 C-N-CA 122.08 1.853 . . . . 15.0 112.224 -175.978 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 266' ' ' ARG . . . . . 0.554 ' HB3' ' OD2' ' A' ' 264' ' ' ASP . 28.1 tpt180 -72.63 -13.46 61.38 Favored 'General case' 0 C--N 1.316 -0.861 0 N-CA-C 108.542 -0.91 . . . . 15.0 108.542 171.244 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 267' ' ' ILE . . . . . 0.933 HG12 ' HB3' ' A' ' 264' ' ' ASP . 22.5 pt . . . . . 0 C--O 1.251 1.169 0 CA-C-N 114.618 -1.174 . . . . 15.0 110.645 174.667 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 210' ' ' SER . . . . . . . . . . . . . 9.6 p . . . . . 0 N--CA 1.478 0.955 0 N-CA-C 110.366 -0.235 . . . . 15.0 110.366 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' B' B ' 211' ' ' ASP . . . . . 0.466 ' HA ' ' HD3' ' B' ' 212' ' ' PRO . 20.5 t70 -150.04 128.64 6.04 Favored Pre-proline 0 C--N 1.324 -0.52 0 N-CA-C 109.673 -0.492 . . . . 15.0 109.673 177.173 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 212' ' ' PRO . . . . . 0.95 ' HB2' HD13 ' A' ' 253' ' ' LEU . 2.0 Cg_endo -89.33 141.67 4.14 Favored 'Trans proline' 0 N--CA 1.457 -0.623 0 C-N-CA 123.281 2.654 . . . . 15.0 113.734 -177.814 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.449 0 CA-C-N 114.796 -1.093 . . . . 15.0 113.278 -176.466 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 236' ' ' LEU . . . . . 0.415 HD11 ' CE1' ' A' ' 252' ' ' PHE . 19.7 mt . . . . . 0 N--CA 1.452 -0.347 0 N-CA-C 108.97 -0.752 . . . . 15.0 108.97 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 237' ' ' PRO . . . . . 0.845 ' HD3' ' HD3' ' A' ' 266' ' ' ARG . 13.1 Cg_exo -69.7 163.11 39.47 Favored 'Trans proline' 0 N--CA 1.459 -0.536 0 C-N-CA 121.47 1.446 . . . . 15.0 110.247 167.289 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -69.77 140.16 53.36 Favored 'General case' 0 C--N 1.307 -1.248 0 CA-C-N 115.321 -0.854 . . . . 15.0 111.104 -174.125 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 100.29 9.34 48.02 Favored Glycine 0 N--CA 1.451 -0.36 0 CA-C-N 115.642 -0.708 . . . . 15.0 114.211 178.241 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 240' ' ' TYR . . . . . 0.75 ' CD1' ' HB2' ' A' ' 254' ' ' HIS . 85.1 m-85 -104.08 123.43 47.23 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 117.897 0.848 . . . . 15.0 110.637 174.929 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 241' ' ' GLU . . . . . 0.652 ' HG3' ' HB3' ' A' ' 253' ' ' LEU . 7.7 pt-20 -109.41 123.78 49.91 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.682 -0.69 . . . . 15.0 109.627 174.408 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 21.5 tm0? -90.01 116.07 27.77 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 108.684 -0.858 . . . . 15.0 108.684 179.021 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 63.6 mtt-85 -107.3 149.27 27.99 Favored 'General case' 0 CA--C 1.501 -0.932 0 CA-C-O 122.157 0.979 . . . . 15.0 112.579 -177.563 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 244' ' ' THR . . . . . . . . . . . . . 7.5 m -124.18 91.72 3.52 Favored 'General case' 0 C--N 1.307 -1.257 0 CA-C-N 113.288 -1.778 . . . . 15.0 110.029 179.166 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 245' ' ' THR . . . . . 1.094 HG22 ' HG2' ' A' ' 247' ' ' GLN . 8.5 t -91.28 150.67 21.22 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.572 -0.74 . . . . 15.0 109.849 177.516 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 14.9 m -41.03 -24.32 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 N-CA-C 114.968 1.47 . . . . 15.0 114.968 -175.354 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 247' ' ' GLN . . . . . 1.094 ' HG2' HG22 ' A' ' 245' ' ' THR . 3.6 pt20 -55.79 -22.48 24.64 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-O 120.752 0.31 . . . . 15.0 111.013 176.564 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 81.03 34.73 26.12 Favored Glycine 0 C--N 1.333 0.399 0 C-N-CA 121.48 -0.391 . . . . 15.0 113.182 174.196 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 249' ' ' GLN . . . . . 0.428 ' CB ' ' HZ3' ' A' ' 262' ' ' TRP . 32.5 mt-30 -136.37 146.93 47.05 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.759 -0.46 . . . . 15.0 109.759 -178.627 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 23.7 m -89.76 125.47 42.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-O 120.792 0.329 . . . . 15.0 110.989 -178.186 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 12.8 p90 -131.79 133.16 44.43 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 109.622 -0.511 . . . . 15.0 109.622 179.679 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 252' ' ' PHE . . . . . 0.691 ' CD2' ' HA ' ' A' ' 264' ' ' ASP . 36.3 m-85 -90.05 118.68 29.78 Favored 'General case' 0 CA--C 1.512 -0.508 0 CA-C-O 121.206 0.526 . . . . 15.0 110.994 -176.786 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 253' ' ' LEU . . . . . 0.652 ' HB3' ' HG3' ' A' ' 241' ' ' GLU . 0.6 OUTLIER -106.79 122.87 47.24 Favored 'General case' 0 N--CA 1.444 -0.737 0 CA-C-N 115.082 -0.963 . . . . 15.0 110.461 -178.05 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 254' ' ' HIS . . . . . 0.75 ' HB2' ' CD1' ' A' ' 240' ' ' TYR . 29.9 t-80 -135.0 90.27 2.62 Favored 'General case' 0 C--N 1.313 -1.018 0 N-CA-C 108.081 -1.081 . . . . 15.0 108.081 172.024 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 255' ' ' THR . . . . . 0.406 ' HA ' ' HA2' ' A' ' 258' ' ' GLY . 2.8 t -91.41 87.82 6.58 Favored 'General case' 0 N--CA 1.433 -1.277 0 C-N-CA 116.411 -2.116 . . . . 15.0 110.185 -179.215 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 52.0 tt0 -101.53 -54.97 2.63 Favored 'General case' 0 N--CA 1.436 -1.135 0 CA-C-N 112.818 -1.992 . . . . 15.0 105.842 151.254 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 257' ' ' THR . . . . . . . . . . . . . 63.4 p -95.89 -13.53 23.87 Favored 'General case' 0 CA--C 1.486 -1.499 0 CA-C-N 112.214 -2.266 . . . . 15.0 111.449 179.015 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 258' ' ' GLY . . . . . 0.406 ' HA2' ' HA ' ' A' ' 255' ' ' THR . . . 86.66 70.52 1.31 Allowed Glycine 1 C--N 1.246 -4.453 1 CA-C-N 108.187 -4.097 . . . . 15.0 113.093 -172.629 . . . . . . . . 4 3 . 1 . 019 nuclear orig core ' A' A ' 259' ' ' VAL . . . . . 0.585 ' O ' HD21 ' A' ' 253' ' ' LEU . 60.6 t -89.88 129.17 41.23 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.243 0 CA-C-O 121.203 0.525 . . . . 15.0 112.227 176.674 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 1.1 p -143.49 98.83 3.32 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 114.783 -1.098 . . . . 15.0 108.228 169.475 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 9.0 t -139.52 150.31 44.95 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 116.159 -0.473 . . . . 15.0 111.819 -170.305 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 262' ' ' TRP . . . . . 0.428 ' HZ3' ' CB ' ' A' ' 249' ' ' GLN . 91.6 m95 -68.3 -30.64 69.68 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.38 -0.827 . . . . 15.0 111.707 178.587 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 263' ' ' HIS . . . . . . . . . . . . . 4.2 p80 -83.5 136.72 34.17 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 120.725 -0.39 . . . . 15.0 110.757 -172.336 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 264' ' ' ASP . . . . . 0.776 ' HB3' HG12 ' A' ' 267' ' ' ILE . 10.0 t70 -56.32 134.23 75.95 Favored Pre-proline 0 C--N 1.325 -0.469 0 CA-C-N 115.652 -0.704 . . . . 15.0 109.268 174.754 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 265' ' ' PRO . . . . . 0.581 ' HD3' ' CD2' ' A' ' 252' ' ' PHE . 88.8 Cg_endo -84.28 -14.5 6.98 Favored 'Trans proline' 0 N--CA 1.458 -0.617 0 C-N-CA 122.568 2.179 . . . . 15.0 113.995 -174.486 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 266' ' ' ARG . . . . . 0.845 ' HD3' ' HD3' ' A' ' 237' ' ' PRO . 21.8 tpt180 -80.98 -5.21 57.26 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-O 122.418 1.104 . . . . 15.0 108.505 176.265 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 267' ' ' ILE . . . . . 0.776 HG12 ' HB3' ' A' ' 264' ' ' ASP . 48.3 mm . . . . . 0 C--O 1.251 1.174 0 CA-C-N 113.153 -1.84 . . . . 15.0 109.824 176.684 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 210' ' ' SER . . . . . . . . . . . . . 5.4 p . . . . . 0 N--CA 1.474 0.765 0 CA-C-O 121.042 0.448 . . . . 15.0 110.741 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' B' B ' 211' ' ' ASP . . . . . 0.465 ' HA ' ' HD3' ' B' ' 212' ' ' PRO . 2.0 p30 -144.62 118.94 5.77 Favored Pre-proline 0 C--N 1.325 -0.496 0 CA-C-N 115.83 -0.623 . . . . 15.0 110.319 178.766 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 212' ' ' PRO . . . . . 0.651 ' HB3' HD13 ' A' ' 253' ' ' LEU . 12.6 Cg_endo -92.22 151.09 3.11 Favored 'Trans proline' 0 N--CA 1.452 -0.942 0 C-N-CA 123.587 2.858 . . . . 15.0 112.722 -179.927 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.444 -0.771 0 C-N-CA 120.725 -0.75 . . . . 15.0 112.466 179.457 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 2.4 mt . . . . . 0 C--O 1.233 0.187 0 N-CA-C 108.918 -0.771 . . . . 15.0 108.918 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 237' ' ' PRO . . . . . 0.462 ' O ' ' HD2' ' A' ' 240' ' ' TYR . 14.8 Cg_exo -69.81 162.69 41.11 Favored 'Trans proline' 0 N--CA 1.46 -0.46 0 C-N-CA 121.657 1.571 . . . . 15.0 110.093 164.626 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -69.71 148.41 49.28 Favored 'General case' 0 C--N 1.306 -1.29 0 CA-C-N 115.432 -0.804 . . . . 15.0 111.243 -175.266 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 100.28 -7.38 58.35 Favored Glycine 0 N--CA 1.45 -0.411 0 CA-C-N 115.418 -0.81 . . . . 15.0 113.275 -179.521 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 240' ' ' TYR . . . . . 0.653 ' CD1' ' HB2' ' A' ' 254' ' ' HIS . 87.8 m-85 -99.46 113.25 25.5 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 117.461 0.631 . . . . 15.0 110.47 177.351 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 241' ' ' GLU . . . . . 0.426 ' HG3' ' HB3' ' A' ' 253' ' ' LEU . 9.5 pt-20 -90.26 120.29 31.29 Favored 'General case' 0 N--CA 1.439 -0.975 0 N-CA-C 108.725 -0.843 . . . . 15.0 108.725 174.518 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? -89.86 99.1 12.18 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 108.123 -1.066 . . . . 15.0 108.123 -179.862 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 9.4 mtp180 -92.48 150.14 20.96 Favored 'General case' 0 N--CA 1.444 -0.738 0 CA-C-N 115.029 -0.987 . . . . 15.0 111.81 -175.152 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 244' ' ' THR . . . . . . . . . . . . . 4.4 p -117.54 149.92 39.82 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-N 113.733 -1.576 . . . . 15.0 110.077 -176.5 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 245' ' ' THR . . . . . 0.425 ' OG1' ' HG2' ' A' ' 247' ' ' GLN . 5.3 t -150.12 150.23 31.38 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 116.106 -0.497 . . . . 15.0 110.434 -176.003 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 19.8 t -54.82 -17.24 2.1 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 O-C-N 123.669 0.605 . . . . 15.0 111.354 179.078 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 247' ' ' GLN . . . . . 0.536 ' HB2' ' HG2' ' A' ' 249' ' ' GLN . 5.1 mm-40 -63.4 -19.25 64.52 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-O 121.006 0.431 . . . . 15.0 110.498 176.808 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 86.31 13.69 67.8 Favored Glycine 0 N--CA 1.452 -0.244 0 CA-C-N 116.013 -0.539 . . . . 15.0 112.289 176.709 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 249' ' ' GLN . . . . . 0.536 ' HG2' ' HB2' ' A' ' 247' ' ' GLN . 10.4 pt20 -114.02 135.12 54.35 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 120.927 0.394 . . . . 15.0 111.502 -174.701 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 6.0 m -90.0 120.26 38.5 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 N-CA-C 108.783 -0.821 . . . . 15.0 108.783 171.469 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 4.3 p90 -125.75 133.04 52.2 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.863 -0.608 . . . . 15.0 109.855 -174.915 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 252' ' ' PHE . . . . . 0.63 ' CD2' ' HA ' ' A' ' 264' ' ' ASP . 24.5 m-85 -89.76 121.33 31.81 Favored 'General case' 0 CA--C 1.506 -0.728 0 CA-C-O 121.293 0.568 . . . . 15.0 111.619 -170.727 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 253' ' ' LEU . . . . . 0.555 HD12 ' CB ' ' B' ' 212' ' ' PRO . 0.6 OUTLIER -119.67 121.12 38.53 Favored 'General case' 0 N--CA 1.44 -0.944 0 CA-C-N 114.837 -1.074 . . . . 15.0 110.617 -176.017 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 254' ' ' HIS . . . . . 0.653 ' HB2' ' CD1' ' A' ' 240' ' ' TYR . 9.2 t-80 -132.33 96.59 3.9 Favored 'General case' 0 C--N 1.312 -1.065 0 N-CA-C 108.447 -0.945 . . . . 15.0 108.447 170.57 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 5.0 t -92.72 87.92 6.06 Favored 'General case' 0 N--CA 1.432 -1.369 0 C-N-CA 116.554 -2.058 . . . . 15.0 110.183 -179.509 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 256' ' ' GLN . . . . . 0.425 ' HB3' ' CE1' ' A' ' 254' ' ' HIS . 24.9 tt0 -101.36 -57.23 2.12 Favored 'General case' 0 N--CA 1.439 -0.98 0 CA-C-N 112.606 -2.088 . . . . 15.0 106.274 152.875 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 257' ' ' THR . . . . . . . . . . . . . 4.2 t -100.2 -13.56 18.86 Favored 'General case' 0 CA--C 1.488 -1.433 0 CA-C-N 111.326 -2.67 . . . . 15.0 112.085 -177.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 87.35 71.69 1.29 Allowed Glycine 1 C--N 1.238 -4.882 1 CA-C-N 108.136 -4.12 . . . . 15.0 112.635 -169.123 . . . . . . . . 3 2 . 1 . 020 nuclear orig core ' A' A ' 259' ' ' VAL . . . . . 0.545 ' O ' ' HA ' ' A' ' 253' ' ' LEU . 65.7 t -89.37 123.72 41.73 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 CA-C-O 121.667 0.746 . . . . 15.0 112.163 170.607 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 260' ' ' SER . . . . . 0.496 ' HA ' ' O ' ' A' ' 252' ' ' PHE . 2.4 p -140.85 100.57 3.87 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 113.876 -1.511 . . . . 15.0 108.442 170.706 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 261' ' ' THR . . . . . 0.404 ' OG1' ' HD2' ' A' ' 263' ' ' HIS . 8.7 t -141.75 150.51 41.86 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.18 0.514 . . . . 15.0 112.374 -168.35 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 262' ' ' TRP . . . . . . . . . . . . . 29.5 m95 -71.06 -31.62 68.09 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.361 -0.836 . . . . 15.0 111.535 176.761 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 263' ' ' HIS . . . . . 0.404 ' HD2' ' OG1' ' A' ' 261' ' ' THR . 3.1 p80 -84.06 130.83 34.85 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 120.29 -0.564 . . . . 15.0 110.154 -175.737 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 264' ' ' ASP . . . . . 0.95 ' HB3' HG12 ' A' ' 267' ' ' ILE . 20.7 t0 -53.95 126.92 52.56 Favored Pre-proline 0 C--N 1.324 -0.511 0 CA-C-N 115.619 -0.719 . . . . 15.0 109.285 173.131 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 265' ' ' PRO . . . . . 0.536 ' HG2' ' CD1' ' A' ' 240' ' ' TYR . 10.9 Cg_exo -70.5 -14.96 34.24 Favored 'Trans proline' 0 N--CA 1.456 -0.709 0 C-N-CA 122.231 1.954 . . . . 15.0 112.496 -179.361 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 266' ' ' ARG . . . . . 0.449 ' HB3' ' OD2' ' A' ' 264' ' ' ASP . 26.6 tpt180 -72.38 -15.15 61.85 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-O 122.07 0.938 . . . . 15.0 108.788 171.171 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 267' ' ' ILE . . . . . 0.95 HG12 ' HB3' ' A' ' 264' ' ' ASP . 32.8 pt . . . . . 0 C--O 1.25 1.09 0 CA-C-N 114.275 -1.329 . . . . 15.0 110.936 177.117 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 210' ' ' SER . . . . . . . . . . . . . 21.0 m . . . . . 0 N--CA 1.473 0.7 0 N-CA-C 109.962 -0.384 . . . . 15.0 109.962 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' B' B ' 211' ' ' ASP . . . . . 0.492 ' HA ' ' HD3' ' B' ' 212' ' ' PRO . 6.0 p-10 -138.63 134.69 17.42 Favored Pre-proline 0 C--N 1.32 -0.694 0 CA-C-N 115.925 -0.579 . . . . 15.0 109.795 -177.684 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 212' ' ' PRO . . . . . 0.555 ' CB ' HD12 ' A' ' 253' ' ' LEU . 4.6 Cg_endo -89.7 154.78 5.15 Favored 'Trans proline' 0 N--CA 1.456 -0.711 0 C-N-CA 123.393 2.729 . . . . 15.0 112.225 -177.0 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.442 -0.965 0 CA-C-N 115.625 -0.716 . . . . 15.0 112.587 -177.435 . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 236' ' ' LEU . . . . . 0.429 HD13 ' OD2' ' A' ' 264' ' ' ASP . 0.9 OUTLIER . . . . . 0 CA--C 1.521 -0.161 0 N-CA-C 110.376 -0.231 . . . . 15.0 110.376 . . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 237' ' ' PRO . . . . . 0.676 ' HD3' ' HD3' ' A' ' 266' ' ' ARG . 19.5 Cg_exo -69.44 170.1 16.99 Favored 'Trans proline' 0 CA--C 1.516 -0.422 0 C-N-CA 122.335 2.023 . . . . 15.0 110.838 165.577 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -69.78 140.26 53.35 Favored 'General case' 0 C--N 1.303 -1.422 0 CA-C-N 114.691 -1.14 . . . . 15.0 110.865 -176.207 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 239' ' ' GLY . . . . . 0.413 ' O ' ' HA ' ' A' ' 254' ' ' HIS . . . 100.04 11.99 41.15 Favored Glycine 0 N--CA 1.448 -0.516 0 CA-C-N 115.632 -0.713 . . . . 15.0 113.867 179.07 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 240' ' ' TYR . . . . . 0.646 ' CD1' ' HB2' ' A' ' 254' ' ' HIS . 64.2 m-85 -111.99 107.9 17.04 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 117.918 0.859 . . . . 15.0 111.579 178.13 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 13.8 mm-40 -90.15 120.81 31.64 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.021 -0.99 . . . . 15.0 109.841 176.155 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 23.4 tm0? -89.97 109.87 20.88 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 109.103 -0.703 . . . . 15.0 109.103 177.378 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 4.5 mtp180 -112.23 150.23 31.19 Favored 'General case' 0 CA--C 1.508 -0.666 0 CA-C-O 122.564 1.173 . . . . 15.0 113.494 -179.86 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 244' ' ' THR . . . . . . . . . . . . . 21.8 p -116.15 150.1 37.98 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-N 112.555 -2.111 . . . . 15.0 108.67 177.7 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 245' ' ' THR . . . . . 0.456 ' OG1' ' HG2' ' A' ' 247' ' ' GLN . 5.9 t -144.32 150.52 37.95 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 116.82 -0.173 . . . . 15.0 110.697 -175.201 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 21.6 t -52.5 -18.49 1.23 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 O-C-N 123.749 0.656 . . . . 15.0 111.589 178.261 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 247' ' ' GLN . . . . . 0.456 ' HG2' ' OG1' ' A' ' 245' ' ' THR . 4.7 mm100 -63.89 -17.15 62.91 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-O 120.893 0.378 . . . . 15.0 110.555 177.426 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 83.91 38.5 10.3 Favored Glycine 0 C--N 1.334 0.459 0 CA-C-N 116.088 -0.505 . . . . 15.0 112.571 177.275 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 249' ' ' GLN . . . . . 0.43 ' CD ' ' HH2' ' A' ' 262' ' ' TRP . 0.0 OUTLIER -146.72 147.5 31.03 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.044 0.449 . . . . 15.0 111.355 -175.194 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 13.7 m -93.92 138.45 20.44 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-N 115.1 -0.955 . . . . 15.0 109.345 173.737 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 4.9 p90 -145.78 136.62 24.45 Favored 'General case' 0 C--N 1.32 -0.717 0 C-N-CA 120.605 -0.438 . . . . 15.0 110.419 -179.891 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 252' ' ' PHE . . . . . 0.6 ' CE2' ' HA ' ' A' ' 264' ' ' ASP . 43.9 m-85 -91.16 121.54 33.03 Favored 'General case' 0 CA--C 1.515 -0.377 0 CA-C-N 116.059 -0.519 . . . . 15.0 111.839 -174.629 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 253' ' ' LEU . . . . . 0.636 ' HA ' ' O ' ' A' ' 259' ' ' VAL . 13.7 mt -104.26 110.33 22.5 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-N 115.243 -0.89 . . . . 15.0 112.169 179.196 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 254' ' ' HIS . . . . . 0.646 ' HB2' ' CD1' ' A' ' 240' ' ' TYR . 22.7 t-80 -116.17 89.93 3.22 Favored 'General case' 0 C--N 1.311 -1.08 0 N-CA-C 107.696 -1.224 . . . . 15.0 107.696 166.099 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 37.1 m -90.86 88.03 6.89 Favored 'General case' 0 N--CA 1.43 -1.442 0 C-N-CA 116.894 -1.922 . . . . 15.0 110.097 -179.272 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 8.0 tt0 -101.04 -51.76 3.45 Favored 'General case' 0 N--CA 1.441 -0.891 0 N-CA-C 105.721 -1.955 . . . . 15.0 105.721 149.677 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 257' ' ' THR . . . . . . . . . . . . . 58.6 p -99.78 -13.69 19.15 Favored 'General case' 0 CA--C 1.485 -1.533 0 CA-C-O 124.768 2.223 . . . . 15.0 112.047 -179.435 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 85.9 75.51 1.24 Allowed Glycine 1 C--N 1.237 -4.937 0 CA-C-N 108.439 -3.982 . . . . 15.0 112.2 -169.55 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 259' ' ' VAL . . . . . 0.636 ' O ' ' HA ' ' A' ' 253' ' ' LEU . 42.9 t -89.88 123.46 42.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-O 121.395 0.617 . . . . 15.0 111.845 175.578 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 4.6 p -134.65 99.63 4.39 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 114.174 -1.376 . . . . 15.0 108.234 170.117 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 8.9 t -135.8 150.48 49.46 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 121.097 0.475 . . . . 15.0 111.841 -171.256 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 262' ' ' TRP . . . . . 0.43 ' HH2' ' CD ' ' A' ' 249' ' ' GLN . 67.6 m95 -68.31 -33.45 74.33 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.141 -0.936 . . . . 15.0 111.345 176.595 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 263' ' ' HIS . . . . . 0.414 ' HD1' ' HB ' ' A' ' 267' ' ' ILE . 4.7 p80 -82.12 131.36 35.24 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 120.44 -0.504 . . . . 15.0 110.128 -172.783 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 264' ' ' ASP . . . . . 0.932 ' HB3' HG12 ' A' ' 267' ' ' ILE . 9.4 t70 -51.75 133.21 37.24 Favored Pre-proline 0 C--N 1.321 -0.635 0 N-CA-C 108.946 -0.761 . . . . 15.0 108.946 171.578 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 265' ' ' PRO . . . . . 0.427 ' HD3' ' CD2' ' A' ' 252' ' ' PHE . 36.5 Cg_endo -72.7 -14.76 27.18 Favored 'Trans proline' 0 N--CA 1.454 -0.797 0 C-N-CA 121.725 1.617 . . . . 15.0 114.294 -173.969 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 266' ' ' ARG . . . . . 0.676 ' HD3' ' HD3' ' A' ' 237' ' ' PRO . 0.1 OUTLIER -81.69 -6.65 59.22 Favored 'General case' 0 C--N 1.311 -1.107 0 N-CA-C 108.426 -0.953 . . . . 15.0 108.426 174.843 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 267' ' ' ILE . . . . . 0.932 HG12 ' HB3' ' A' ' 264' ' ' ASP . 42.1 mm . . . . . 0 C--O 1.249 1.031 0 CA-C-N 113.865 -1.516 . . . . 15.0 109.921 177.606 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 210' ' ' SER . . . . . . . . . . . . . 5.9 m . . . . . 0 N--CA 1.474 0.737 0 CA-C-O 120.873 0.368 . . . . 15.0 110.2 . . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' B' B ' 211' ' ' ASP . . . . . 0.418 ' HA ' ' HD3' ' B' ' 212' ' ' PRO . 30.4 t70 -150.09 129.39 6.37 Favored Pre-proline 0 C--N 1.324 -0.501 0 N-CA-C 109.504 -0.554 . . . . 15.0 109.504 -179.436 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 212' ' ' PRO . . . . . 0.584 ' CB ' HD11 ' A' ' 253' ' ' LEU . 27.3 Cg_endo -89.9 156.98 4.98 Favored 'Trans proline' 0 N--CA 1.454 -0.837 0 C-N-CA 122.601 2.2 . . . . 15.0 112.967 -176.081 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.442 -0.942 0 CA-C-N 115.493 -0.776 . . . . 15.0 111.458 177.908 . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 236' ' ' LEU . . . . . 0.712 HD13 ' HD2' ' A' ' 265' ' ' PRO . 0.4 OUTLIER . . . . . 0 N--CA 1.452 -0.344 0 CA-C-O 121.273 0.559 . . . . 15.0 110.715 . . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 237' ' ' PRO . . . . . 0.517 ' HD3' ' HD3' ' A' ' 266' ' ' ARG . 23.3 Cg_exo -69.32 171.0 14.75 Favored 'Trans proline' 0 CA--C 1.508 -0.783 0 C-N-CA 122.844 2.363 . . . . 15.0 110.097 162.474 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -69.42 145.1 53.1 Favored 'General case' 0 C--N 1.3 -1.553 0 CA-C-N 115.072 -0.967 . . . . 15.0 111.89 -175.845 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 100.21 10.19 45.93 Favored Glycine 0 N--CA 1.449 -0.484 0 CA-C-N 114.435 -1.257 . . . . 15.0 113.214 -179.868 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 240' ' ' TYR . . . . . 0.606 ' CD1' ' HB2' ' A' ' 254' ' ' HIS . 71.9 m-85 -116.67 123.5 47.41 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 117.235 0.518 . . . . 15.0 110.989 177.904 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -91.52 123.45 34.94 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.648 -0.705 . . . . 15.0 109.446 171.41 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 18.8 tm0? -91.4 99.86 12.74 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 108.646 -0.872 . . . . 15.0 108.646 174.513 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 68.7 mtt-85 -103.16 150.16 23.94 Favored 'General case' 0 CA--C 1.504 -0.825 0 CA-C-O 122.136 0.97 . . . . 15.0 112.087 -176.37 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 244' ' ' THR . . . . . . . . . . . . . 10.9 m -129.47 97.56 4.59 Favored 'General case' 0 C--N 1.308 -1.222 0 CA-C-N 113.28 -1.782 . . . . 15.0 109.399 -177.042 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 245' ' ' THR . . . . . 0.475 ' OG1' ' HG2' ' A' ' 247' ' ' GLN . 3.5 t -94.94 150.48 20.12 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.257 -0.883 . . . . 15.0 110.989 -175.621 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 9.9 m -50.53 -18.36 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.451 0 CA-C-N 115.615 -0.721 . . . . 15.0 112.577 176.97 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 247' ' ' GLN . . . . . 0.475 ' HG2' ' OG1' ' A' ' 245' ' ' THR . 7.3 mm100 -56.3 -21.28 23.07 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.02 -0.536 . . . . 15.0 110.682 173.182 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 89.73 11.91 63.16 Favored Glycine 0 N--CA 1.447 -0.576 0 CA-C-N 115.851 -0.613 . . . . 15.0 112.871 174.845 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 7.1 mt-30 -129.37 141.53 51.04 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 110.205 -0.294 . . . . 15.0 110.205 -176.358 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 17.1 m -89.79 135.0 27.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 116.333 -0.394 . . . . 15.0 110.109 178.235 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 25.6 p90 -134.54 135.05 42.04 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 116.143 -0.48 . . . . 15.0 110.004 -178.437 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 252' ' ' PHE . . . . . 0.711 ' CD2' ' HA ' ' A' ' 264' ' ' ASP . 24.3 m-85 -90.22 125.72 35.58 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.31 0.576 . . . . 15.0 111.147 -175.731 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 253' ' ' LEU . . . . . 1.033 HD12 ' HB3' ' B' ' 212' ' ' PRO . 0.4 OUTLIER -113.73 109.42 18.55 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-N 114.808 -1.087 . . . . 15.0 111.858 -173.398 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 254' ' ' HIS . . . . . 0.606 ' HB2' ' CD1' ' A' ' 240' ' ' TYR . 35.2 t-80 -120.62 89.98 3.23 Favored 'General case' 0 C--N 1.314 -0.963 0 N-CA-C 108.386 -0.968 . . . . 15.0 108.386 167.785 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 8.0 t -94.94 88.03 5.15 Favored 'General case' 0 N--CA 1.433 -1.289 0 C-N-CA 116.5 -2.08 . . . . 15.0 110.998 -179.372 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 -100.76 -51.86 3.47 Favored 'General case' 0 N--CA 1.44 -0.96 0 CA-C-N 112.808 -1.996 . . . . 15.0 106.142 149.415 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 257' ' ' THR . . . . . . . . . . . . . 59.3 p -95.85 -13.23 24.17 Favored 'General case' 0 CA--C 1.487 -1.457 0 CA-C-O 125.039 2.352 . . . . 15.0 111.763 -179.21 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 84.9 73.25 1.27 Allowed Glycine 1 C--N 1.241 -4.705 1 CA-C-N 108.042 -4.163 . . . . 15.0 112.55 -172.873 . . . . . . . . 3 2 . 1 . 022 nuclear orig core ' A' A ' 259' ' ' VAL . . . . . 0.588 ' O ' HD21 ' A' ' 253' ' ' LEU . 66.0 t -89.86 122.59 41.38 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.411 0 CA-C-O 121.676 0.751 . . . . 15.0 111.878 176.664 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 2.2 p -134.47 100.8 4.76 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-N 113.746 -1.57 . . . . 15.0 107.295 170.42 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 9.0 t -136.26 150.32 48.89 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 112.654 0.613 . . . . 15.0 112.654 -166.413 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 262' ' ' TRP . . . . . . . . . . . . . 79.9 m95 -79.02 -23.19 44.49 Favored 'General case' 0 N--CA 1.454 -0.275 0 CA-C-N 115.154 -0.93 . . . . 15.0 111.474 177.788 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 263' ' ' HIS . . . . . . . . . . . . . 5.6 p80 -92.96 134.5 35.05 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 120.271 -0.572 . . . . 15.0 110.521 -176.517 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 264' ' ' ASP . . . . . 0.978 ' HB3' HG12 ' A' ' 267' ' ' ILE . 13.7 t0 -56.99 124.1 63.34 Favored Pre-proline 0 C--N 1.321 -0.673 0 N-CA-C 108.4 -0.963 . . . . 15.0 108.4 171.049 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 265' ' ' PRO . . . . . 0.712 ' HD2' HD13 ' A' ' 236' ' ' LEU . 16.6 Cg_exo -68.39 -14.77 40.87 Favored 'Trans proline' 0 CA--C 1.514 -0.479 0 C-N-CA 122.362 2.041 . . . . 15.0 113.181 -176.45 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 266' ' ' ARG . . . . . 0.517 ' HD3' ' HD3' ' A' ' 237' ' ' PRO . 10.8 tpt180 -76.93 -10.06 59.11 Favored 'General case' 0 C--N 1.313 -1.015 0 N-CA-C 108.473 -0.936 . . . . 15.0 108.473 174.137 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 267' ' ' ILE . . . . . 0.978 HG12 ' HB3' ' A' ' 264' ' ' ASP . 27.9 pt . . . . . 0 C--O 1.251 1.175 0 CA-C-N 114.129 -1.396 . . . . 15.0 110.835 177.334 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' B' B ' 210' ' ' SER . . . . . . . . . . . . . 9.4 t . . . . . 0 N--CA 1.476 0.861 0 N-CA-C 109.141 -0.689 . . . . 15.0 109.141 . . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' B' B ' 211' ' ' ASP . . . . . 0.42 ' HA ' ' HD3' ' B' ' 212' ' ' PRO . 5.0 m-20 -130.58 150.17 75.57 Favored Pre-proline 0 C--N 1.321 -0.654 0 CA-C-N 116.093 -0.503 . . . . 15.0 110.711 -174.077 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' B' B ' 212' ' ' PRO . . . . . 1.033 ' HB3' HD12 ' A' ' 253' ' ' LEU . 5.2 Cg_endo -89.83 151.65 5.0 Favored 'Trans proline' 0 N--CA 1.453 -0.906 0 C-N-CA 123.111 2.541 . . . . 15.0 112.182 179.759 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.442 -0.922 0 C-N-CA 120.674 -0.774 . . . . 15.0 111.643 -179.764 . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 236' ' ' LEU . . . . . 0.44 HD13 ' HB2' ' A' ' 266' ' ' ARG . 0.4 OUTLIER . . . . . 0 C--O 1.234 0.284 0 N-CA-C 109.225 -0.657 . . . . 15.0 109.225 . . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_exo -69.56 164.55 33.92 Favored 'Trans proline' 0 N--CA 1.459 -0.553 0 C-N-CA 121.606 1.538 . . . . 15.0 110.689 170.802 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -69.69 150.34 47.09 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-N 114.976 -1.011 . . . . 15.0 111.707 -174.535 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 100.15 -7.16 58.47 Favored Glycine 0 N--CA 1.448 -0.523 0 CA-C-N 115.656 -0.702 . . . . 15.0 113.644 176.206 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 240' ' ' TYR . . . . . 0.602 ' CD1' ' HB2' ' A' ' 254' ' ' HIS . 60.0 m-85 -102.53 114.05 27.94 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 117.492 0.646 . . . . 15.0 110.628 179.125 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -94.54 131.72 39.98 Favored 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 108.924 -0.769 . . . . 15.0 108.924 171.306 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 23.0 tm0? -89.71 107.97 19.4 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 107.989 -1.115 . . . . 15.0 107.989 179.623 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 13.7 mtp180 -101.85 150.15 23.46 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-O 122.121 0.963 . . . . 15.0 112.175 -175.861 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 244' ' ' THR . . . . . . . . . . . . . 5.1 m -122.69 141.38 51.83 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-N 113.216 -1.811 . . . . 15.0 107.757 -177.798 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 245' ' ' THR . . . . . 0.619 ' CG2' ' HB3' ' A' ' 247' ' ' GLN . 3.1 t -141.96 150.34 41.29 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-O 120.878 0.371 . . . . 15.0 111.717 -169.216 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 8.8 p -55.97 -24.45 17.34 Favored 'Isoleucine or valine' 0 C--O 1.234 0.248 0 CA-C-N 115.31 -0.859 . . . . 15.0 109.886 172.49 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 247' ' ' GLN . . . . . 0.72 ' HG2' ' NE2' ' A' ' 249' ' ' GLN . 40.8 tt0 -50.46 -35.83 30.71 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 114.506 -1.224 . . . . 15.0 110.473 172.699 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 102.04 -15.29 56.76 Favored Glycine 0 C--N 1.333 0.396 0 CA-C-N 116.118 -0.492 . . . . 15.0 112.987 176.645 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 249' ' ' GLN . . . . . 0.72 ' NE2' ' HG2' ' A' ' 247' ' ' GLN . 2.3 mp0 -96.43 147.42 23.85 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 120.64 0.257 . . . . 15.0 111.3 -173.857 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 3.3 m -89.99 130.26 39.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 N-CA-C 109.617 -0.512 . . . . 15.0 109.617 174.16 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 9.4 p90 -142.42 138.95 31.45 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.369 0.605 . . . . 15.0 111.721 -176.206 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 252' ' ' PHE . . . . . 0.611 ' CD2' ' HA ' ' A' ' 264' ' ' ASP . 43.0 m-85 -96.62 125.17 40.91 Favored 'General case' 0 CA--C 1.509 -0.607 0 CA-C-N 115.169 -0.923 . . . . 15.0 110.873 -177.265 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 253' ' ' LEU . . . . . 0.676 ' HA ' ' O ' ' A' ' 259' ' ' VAL . 0.1 OUTLIER -123.95 109.15 13.21 Favored 'General case' 0 N--CA 1.441 -0.919 0 CA-C-O 121.696 0.76 . . . . 15.0 111.979 -177.939 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 254' ' ' HIS . . . . . 0.602 ' HB2' ' CD1' ' A' ' 240' ' ' TYR . 12.4 t-80 -109.61 93.85 4.72 Favored 'General case' 0 CA--C 1.501 -0.928 0 CA-C-N 114.881 -1.054 . . . . 15.0 108.184 169.36 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 3.6 t -93.85 88.2 5.67 Favored 'General case' 0 N--CA 1.434 -1.265 0 C-N-CA 116.35 -2.14 . . . . 15.0 110.556 179.501 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 7.6 tp60 -101.21 -51.9 3.39 Favored 'General case' 0 N--CA 1.442 -0.863 0 CA-C-N 113.19 -1.823 . . . . 15.0 106.269 150.981 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 257' ' ' THR . . . . . . . . . . . . . 71.9 p -99.96 -13.67 19.01 Favored 'General case' 0 CA--C 1.487 -1.461 0 CA-C-O 124.666 2.174 . . . . 15.0 112.118 -179.501 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 88.63 73.89 1.28 Allowed Glycine 1 C--N 1.242 -4.693 0 CA-C-N 108.533 -3.94 . . . . 15.0 112.849 -171.32 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 259' ' ' VAL . . . . . 0.676 ' O ' ' HA ' ' A' ' 253' ' ' LEU . 68.7 t -89.58 126.73 42.5 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.391 0 CA-C-O 121.296 0.57 . . . . 15.0 111.583 173.219 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 260' ' ' SER . . . . . 0.411 ' HA ' ' O ' ' A' ' 252' ' ' PHE . 2.2 p -150.01 94.13 2.11 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 114.039 -1.437 . . . . 15.0 107.72 168.886 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 9.8 t -135.03 150.29 50.27 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.516 -0.765 . . . . 15.0 111.173 -169.151 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 262' ' ' TRP . . . . . 0.477 ' CH2' ' HB3' ' A' ' 249' ' ' GLN . 23.2 m95 -70.1 -17.51 63.22 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 113.19 0.811 . . . . 15.0 113.19 -177.194 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 263' ' ' HIS . . . . . . . . . . . . . 4.6 p80 -96.25 133.0 41.12 Favored 'General case' 0 C--N 1.323 -0.561 0 C-N-CA 120.088 -0.645 . . . . 15.0 110.01 179.961 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 264' ' ' ASP . . . . . 1.01 ' HB3' HG12 ' A' ' 267' ' ' ILE . 9.9 t0 -56.72 131.21 78.19 Favored Pre-proline 0 C--O 1.222 -0.386 0 N-CA-C 107.888 -1.153 . . . . 15.0 107.888 171.283 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 265' ' ' PRO . . . . . 0.49 ' HG2' ' CD1' ' A' ' 240' ' ' TYR . 17.0 Cg_exo -69.33 -15.05 38.42 Favored 'Trans proline' 0 C--N 1.324 -0.75 0 C-N-CA 122.092 1.861 . . . . 15.0 113.415 -176.232 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 266' ' ' ARG . . . . . 0.465 ' HD2' ' HA ' ' A' ' 266' ' ' ARG . 15.9 tpt180 -79.7 -8.02 58.96 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-O 122.037 0.922 . . . . 15.0 108.67 173.881 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 267' ' ' ILE . . . . . 1.01 HG12 ' HB3' ' A' ' 264' ' ' ASP . 33.4 pt . . . . . 0 C--O 1.248 0.984 0 CA-C-N 113.798 -1.546 . . . . 15.0 110.641 175.382 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' B' B ' 210' ' ' SER . . . . . . . . . . . . . 10.7 m . . . . . 0 N--CA 1.475 0.825 0 CA-C-O 120.883 0.373 . . . . 15.0 110.644 . . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' B' B ' 211' ' ' ASP . . . . . 0.436 ' HA ' ' HD3' ' B' ' 212' ' ' PRO . 25.7 t70 -140.08 122.0 9.75 Favored Pre-proline 0 N--CA 1.453 -0.286 0 CA-C-O 121.023 0.44 . . . . 15.0 111.084 -177.31 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' B' B ' 212' ' ' PRO . . . . . 0.654 ' HB2' HD13 ' A' ' 253' ' ' LEU . 1.2 Cg_endo -89.63 160.01 5.27 Favored 'Trans proline' 0 N--CA 1.457 -0.65 0 C-N-CA 123.774 2.983 . . . . 15.0 111.846 176.126 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.617 0 C-N-CA 120.809 -0.71 . . . . 15.0 112.896 -176.168 . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 236' ' ' LEU . . . . . 0.635 ' H ' HD21 ' A' ' 236' ' ' LEU . 0.1 OUTLIER . . . . . 0 CA--C 1.515 -0.397 0 CA-C-O 121.133 0.492 . . . . 15.0 110.166 . . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 237' ' ' PRO . . . . . 0.553 ' HD3' ' HD3' ' A' ' 266' ' ' ARG . 15.1 Cg_exo -69.56 173.8 10.27 Favored 'Trans proline' 0 CA--C 1.507 -0.84 0 C-N-CA 122.672 2.248 . . . . 15.0 110.442 165.861 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 3.7 pm0 -69.48 142.63 53.71 Favored 'General case' 0 C--N 1.291 -1.945 0 CA-C-N 114.253 -1.339 . . . . 15.0 111.613 -173.297 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 100.17 3.36 55.68 Favored Glycine 0 CA--C 1.521 0.446 0 CA-C-N 115.233 -0.894 . . . . 15.0 113.965 177.172 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 240' ' ' TYR . . . . . 0.511 ' CD1' ' HG2' ' A' ' 265' ' ' PRO . 62.4 m-85 -111.17 125.34 53.69 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 117.856 0.828 . . . . 15.0 111.253 178.651 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 241' ' ' GLU . . . . . 0.523 ' HG3' ' HB3' ' A' ' 253' ' ' LEU . 8.6 pt-20 -108.75 123.28 48.76 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 109.199 -0.667 . . . . 15.0 109.199 170.926 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -89.81 106.55 18.54 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 109.203 -0.665 . . . . 15.0 109.203 -177.802 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 27.9 mtt-85 -98.46 148.43 23.73 Favored 'General case' 0 CA--C 1.505 -0.771 0 CA-C-O 122.123 0.963 . . . . 15.0 112.06 -177.531 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 244' ' ' THR . . . . . . . . . . . . . 25.0 p -117.26 146.06 43.54 Favored 'General case' 0 C--N 1.306 -1.285 0 CA-C-N 113.348 -1.751 . . . . 15.0 108.852 178.409 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 245' ' ' THR . . . . . 0.458 HG21 ' HB2' ' A' ' 247' ' ' GLN . 5.9 t -144.26 150.16 37.47 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 116.612 -0.267 . . . . 15.0 110.861 -172.393 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 6.4 m -53.63 -19.17 2.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.824 -0.626 . . . . 15.0 111.974 177.953 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 247' ' ' GLN . . . . . 0.458 ' HB2' HG21 ' A' ' 245' ' ' THR . 8.8 mm100 -58.68 -20.61 49.94 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.735 -0.666 . . . . 15.0 110.901 175.203 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 84.21 26.61 39.64 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 121.107 -0.568 . . . . 15.0 112.542 176.639 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 3.0 mt-30 -133.2 138.9 46.72 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 110.286 -0.264 . . . . 15.0 110.286 -173.904 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 4.4 m -89.65 122.83 41.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 N-CA-C 109.721 -0.474 . . . . 15.0 109.721 173.331 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 2.5 p90 -129.89 134.07 47.28 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.049 0.452 . . . . 15.0 109.856 -175.792 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 252' ' ' PHE . . . . . 0.594 ' CD2' ' HA ' ' A' ' 264' ' ' ASP . 40.1 m-85 -90.05 128.11 36.21 Favored 'General case' 0 CA--C 1.512 -0.499 0 CA-C-O 121.237 0.542 . . . . 15.0 111.483 -175.185 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 253' ' ' LEU . . . . . 0.81 HD12 ' HB3' ' B' ' 212' ' ' PRO . 0.7 OUTLIER -118.66 126.27 51.56 Favored 'General case' 0 N--CA 1.446 -0.673 0 CA-C-N 115.035 -0.984 . . . . 15.0 110.78 -175.909 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 254' ' ' HIS . . . . . 0.534 ' HB3' ' HB ' ' A' ' 259' ' ' VAL . 0.2 OUTLIER -140.61 91.72 2.45 Favored 'General case' 0 C--N 1.313 -0.988 0 N-CA-C 108.595 -0.891 . . . . 15.0 108.595 173.282 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 3.1 t -103.23 87.91 3.0 Favored 'General case' 0 N--CA 1.43 -1.44 0 C-N-CA 116.796 -1.962 . . . . 15.0 111.015 -179.598 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 30.2 tp60 -101.23 -52.85 3.16 Favored 'General case' 0 N--CA 1.437 -1.099 0 CA-C-N 112.681 -2.054 . . . . 15.0 105.574 147.116 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 257' ' ' THR . . . . . . . . . . . . . 31.8 p -97.63 -13.55 21.49 Favored 'General case' 0 CA--C 1.489 -1.38 0 CA-C-O 124.89 2.281 . . . . 15.0 112.0 -177.246 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 84.73 71.37 1.32 Allowed Glycine 1 C--N 1.242 -4.676 1 CA-C-N 108.315 -4.039 . . . . 15.0 113.926 -174.575 . . . . . . . . 3 2 . 1 . 024 nuclear orig core ' A' A ' 259' ' ' VAL . . . . . 0.534 ' HB ' ' HB3' ' A' ' 254' ' ' HIS . 67.5 t -89.91 129.95 39.99 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 CA-C-O 121.405 0.622 . . . . 15.0 111.431 171.597 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 23.8 p -143.79 102.89 3.98 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 114.386 -1.279 . . . . 15.0 108.093 171.553 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 14.4 t -149.32 150.44 32.49 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.966 0.412 . . . . 15.0 111.747 -168.726 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 262' ' ' TRP . . . . . . . . . . . . . 84.7 m95 -71.96 -37.03 70.0 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.721 -0.672 . . . . 15.0 111.282 177.724 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 263' ' ' HIS . . . . . . . . . . . . . 2.8 p80 -73.65 126.85 31.22 Favored 'General case' 0 CA--C 1.515 -0.37 0 C-N-CA 120.52 -0.472 . . . . 15.0 109.923 -174.001 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 264' ' ' ASP . . . . . 1.119 ' HB3' HG12 ' A' ' 267' ' ' ILE . 15.0 t0 -54.47 125.79 53.43 Favored Pre-proline 0 C--N 1.32 -0.699 0 N-CA-C 108.326 -0.99 . . . . 15.0 108.326 173.404 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 265' ' ' PRO . . . . . 0.511 ' HG2' ' CD1' ' A' ' 240' ' ' TYR . 14.2 Cg_exo -68.72 -14.59 39.55 Favored 'Trans proline' 0 CA--C 1.512 -0.581 0 C-N-CA 121.893 1.729 . . . . 15.0 112.667 -177.296 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 266' ' ' ARG . . . . . 0.553 ' HD3' ' HD3' ' A' ' 237' ' ' PRO . 19.8 tpt180 -76.46 -11.94 59.96 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 115.225 -0.898 . . . . 15.0 108.932 173.137 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 267' ' ' ILE . . . . . 1.119 HG12 ' HB3' ' A' ' 264' ' ' ASP . 41.8 pt . . . . . 0 C--O 1.25 1.101 0 CA-C-O 117.549 -1.215 . . . . 15.0 111.529 178.999 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' B' B ' 210' ' ' SER . . . . . . . . . . . . . 18.9 m . . . . . 0 N--CA 1.477 0.892 0 CA-C-O 120.98 0.419 . . . . 15.0 110.806 . . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' B' B ' 211' ' ' ASP . . . . . . . . . . . . . 11.9 p-10 -111.87 109.87 54.85 Favored Pre-proline 0 C--N 1.327 -0.38 0 CA-C-O 121.138 0.494 . . . . 15.0 110.5 -178.29 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' B' B ' 212' ' ' PRO . . . . . 0.81 ' HB3' HD12 ' A' ' 253' ' ' LEU . 6.6 Cg_endo -89.97 147.73 4.71 Favored 'Trans proline' 0 N--CA 1.453 -0.871 0 C-N-CA 122.638 2.225 . . . . 15.0 112.21 176.257 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.442 -0.931 0 C-N-CA 120.543 -0.836 . . . . 15.0 111.598 178.286 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 . . . . . 0 N--CA 1.481 1.079 0 N-CA-C 109.953 -0.388 . . . . 15.0 109.953 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 2.2 mt -105.25 164.88 14.2 Favored Pre-proline 0 C--N 1.32 -0.702 0 N-CA-C 109.789 -0.449 . . . . 15.0 109.789 -177.35 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 237' ' ' PRO . . . . . 0.467 ' O ' ' HD2' ' A' ' 240' ' ' TYR . 14.0 Cg_exo -69.5 166.75 26.2 Favored 'Trans proline' 0 N--CA 1.458 -0.615 0 C-N-CA 121.793 1.662 . . . . 15.0 110.221 165.706 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -69.74 142.99 53.17 Favored 'General case' 0 C--N 1.303 -1.433 0 CA-C-N 114.863 -1.062 . . . . 15.0 111.521 -173.024 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 100.15 5.83 54.27 Favored Glycine 0 N--CA 1.449 -0.485 0 CA-C-N 115.361 -0.836 . . . . 15.0 113.785 178.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 240' ' ' TYR . . . . . 0.623 ' CD1' ' HB2' ' A' ' 254' ' ' HIS . 71.7 m-85 -108.19 116.31 31.72 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 117.636 0.718 . . . . 15.0 111.678 -179.698 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -90.37 113.82 25.79 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.048 -0.978 . . . . 15.0 109.595 174.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 242' ' ' GLN . . . . . 0.661 ' HG3' ' CE1' ' A' ' 252' ' ' PHE . 39.6 tt0 -91.09 103.42 16.12 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 109.523 -0.547 . . . . 15.0 109.523 -179.771 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 243' ' ' ARG . . . . . 0.427 HH11 ' HD2' ' A' ' 243' ' ' ARG . 8.5 mtp180 -109.25 149.87 28.78 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 122.07 0.938 . . . . 15.0 112.637 -176.168 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 244' ' ' THR . . . . . . . . . . . . . 10.2 p -124.72 96.8 5.02 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 113.54 -1.664 . . . . 15.0 109.41 -176.257 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 245' ' ' THR . . . . . 0.683 HG22 ' HB2' ' A' ' 247' ' ' GLN . 2.7 t -89.99 150.28 22.2 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 115.861 -0.609 . . . . 15.0 111.412 -174.71 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 9.7 m -52.06 -19.21 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.315 0 CA-C-N 115.713 -0.676 . . . . 15.0 112.04 175.075 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 247' ' ' GLN . . . . . 0.683 ' HB2' HG22 ' A' ' 245' ' ' THR . 0.2 OUTLIER -49.81 -26.8 4.28 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 115.98 -0.554 . . . . 15.0 110.873 170.239 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 93.17 19.36 36.29 Favored Glycine 0 C--O 1.229 -0.188 0 CA-C-N 115.837 -0.619 . . . . 15.0 112.289 177.041 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 249' ' ' GLN . . . . . 0.436 ' NE2' ' HH2' ' A' ' 262' ' ' TRP . 0.0 OUTLIER -135.41 144.39 46.5 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.01 0.433 . . . . 15.0 110.724 -174.605 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 19.4 m -89.94 142.39 12.99 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 115.444 -0.798 . . . . 15.0 109.677 176.406 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 251' ' ' TYR . . . . . 0.506 ' HB3' ' CG ' ' B' ' 215' ' ' PRO . 6.1 p90 -148.18 142.68 26.43 Favored 'General case' 0 C--N 1.321 -0.646 0 C-N-CA 120.67 -0.412 . . . . 15.0 110.693 -179.38 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 252' ' ' PHE . . . . . 0.678 ' CE2' ' HA ' ' A' ' 264' ' ' ASP . 29.7 m-85 -98.15 119.57 37.02 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.842 -0.617 . . . . 15.0 111.869 -175.631 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 253' ' ' LEU . . . . . 0.594 HD12 ' CB ' ' B' ' 212' ' ' PRO . 2.8 mt -104.36 103.23 12.93 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 114.744 -1.116 . . . . 15.0 112.012 -177.579 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 254' ' ' HIS . . . . . 0.623 ' HB2' ' CD1' ' A' ' 240' ' ' TYR . 36.7 t-80 -113.26 89.95 3.22 Favored 'General case' 0 C--N 1.312 -1.036 0 N-CA-C 107.982 -1.118 . . . . 15.0 107.982 167.413 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 255' ' ' THR . . . . . 0.4 HG21 ' HA2' ' A' ' 258' ' ' GLY . 23.4 m -92.43 87.78 6.13 Favored 'General case' 0 N--CA 1.432 -1.355 0 C-N-CA 116.684 -2.006 . . . . 15.0 109.496 -179.328 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 64.1 tt0 -101.54 -53.43 2.99 Favored 'General case' 0 N--CA 1.439 -1.008 0 N-CA-C 106.199 -1.778 . . . . 15.0 106.199 150.592 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 257' ' ' THR . . . . . . . . . . . . . 82.6 p -96.83 -13.61 22.44 Favored 'General case' 0 CA--C 1.484 -1.561 0 CA-C-O 124.889 2.28 . . . . 15.0 111.733 -178.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 258' ' ' GLY . . . . . 0.4 ' HA2' HG21 ' A' ' 255' ' ' THR . . . 87.73 72.83 1.28 Allowed Glycine 1 C--N 1.241 -4.695 1 CA-C-N 108.174 -4.103 . . . . 15.0 112.703 -171.638 . . . . . . . . 4 3 . 1 . 001 nuclear orig full ' A' A ' 259' ' ' VAL . . . . . 0.482 ' O ' ' HA ' ' A' ' 253' ' ' LEU . 53.0 t -89.89 125.2 42.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 121.585 0.707 . . . . 15.0 112.361 176.182 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 3.3 p -132.34 101.93 5.55 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 114.091 -1.413 . . . . 15.0 107.706 167.129 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 12.3 t -132.15 150.24 52.2 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 121.188 0.518 . . . . 15.0 112.352 -169.563 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 262' ' ' TRP . . . . . 1.175 ' CZ2' ' HB2' ' B' ' 215' ' ' PRO . 77.0 m95 -78.26 -25.57 46.85 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.11 -0.95 . . . . 15.0 111.202 176.877 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 263' ' ' HIS . . . . . . . . . . . . . 6.5 p80 -89.34 131.36 35.46 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.496 -0.481 . . . . 15.0 110.212 -175.022 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 264' ' ' ASP . . . . . 1.106 ' HB3' HG12 ' A' ' 267' ' ' ILE . 19.8 t0 -56.36 125.03 64.33 Favored Pre-proline 0 C--N 1.323 -0.565 0 N-CA-C 107.669 -1.234 . . . . 15.0 107.669 170.061 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 265' ' ' PRO . . . . . 0.541 ' HD3' ' CD2' ' A' ' 252' ' ' PHE . 11.5 Cg_exo -70.54 -14.72 33.87 Favored 'Trans proline' 0 C--N 1.323 -0.766 0 C-N-CA 121.751 1.634 . . . . 15.0 112.573 -175.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 266' ' ' ARG . . . . . 0.429 ' HD3' ' HD3' ' A' ' 237' ' ' PRO . 19.3 tpt180 -76.27 -11.99 60.0 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 115.443 -0.799 . . . . 15.0 108.956 173.223 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 267' ' ' ILE . . . . . 1.106 HG12 ' HB3' ' A' ' 264' ' ' ASP . 40.3 pt . . . . . 0 C--O 1.249 1.027 0 CA-C-N 115.017 -0.992 . . . . 15.0 111.448 178.618 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 210' ' ' SER . . . . . . . . . . . . . 20.3 m . . . . . 0 N--CA 1.477 0.885 0 CA-C-O 120.635 0.255 . . . . 15.0 111.279 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 211' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -133.14 119.61 15.7 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 120.502 0.191 . . . . 15.0 110.519 -179.116 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 212' ' ' PRO . . . . . 0.594 ' CB ' HD12 ' A' ' 253' ' ' LEU . 3.9 Cg_endo -89.7 160.0 5.21 Favored 'Trans proline' 0 N--CA 1.455 -0.79 0 C-N-CA 122.707 2.271 . . . . 15.0 111.524 173.904 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -89.76 147.09 19.18 Favored Glycine 0 N--CA 1.443 -0.879 0 C-N-CA 120.338 -0.934 . . . . 15.0 112.241 -177.388 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 214' ' ' SEP . . . . . 0.429 ' HA ' ' HD3' ' B' ' 215' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 215' ' ' PRO . . . . . 1.175 ' HB2' ' CZ2' ' A' ' 262' ' ' TRP . 6.9 Cg_exo -88.04 138.51 4.19 Favored 'Trans proline' 0 C--O 1.233 0.234 0 C-N-CA 123.069 2.513 . . . . 15.0 111.082 177.471 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 216' ' ' PHE . . . . . . . . . . . . . 67.9 m-85 -90.06 115.88 27.66 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 116.203 -0.453 . . . . 15.0 110.085 -178.425 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 217' ' ' GLN . . . . . 0.67 ' HB2' ' CZ2' ' A' ' 262' ' ' TRP . 25.5 tt0 . . . . . 0 C--O 1.251 1.134 0 CA-C-O 118.442 -0.79 . . . . 15.0 109.602 179.463 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.479 1.002 0 CA-C-O 120.42 0.152 . . . . 15.0 110.848 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 61.1 mt -130.52 163.57 47.35 Favored Pre-proline 0 C--N 1.327 -0.398 0 N-CA-C 109.507 -0.553 . . . . 15.0 109.507 179.118 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 237' ' ' PRO . . . . . 0.932 ' HD3' ' HD3' ' A' ' 266' ' ' ARG . 15.2 Cg_exo -69.47 171.16 14.64 Favored 'Trans proline' 0 CA--C 1.513 -0.57 0 C-N-CA 122.055 1.837 . . . . 15.0 110.92 165.927 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -69.68 133.32 47.4 Favored 'General case' 0 C--N 1.302 -1.492 0 CA-C-N 114.415 -1.266 . . . . 15.0 112.208 -173.248 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 100.16 28.83 7.06 Favored Glycine 0 C--N 1.334 0.434 0 CA-C-N 115.16 -0.927 . . . . 15.0 114.094 174.08 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 240' ' ' TYR . . . . . 0.7 ' CD1' ' HB2' ' A' ' 254' ' ' HIS . 65.0 m-85 -117.36 123.72 47.17 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 117.963 0.881 . . . . 15.0 111.468 177.864 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 241' ' ' GLU . . . . . 0.492 ' HG3' ' HB2' ' A' ' 253' ' ' LEU . 10.6 pt-20 -119.64 119.97 35.28 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.76 -0.654 . . . . 15.0 109.595 172.807 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -90.13 109.45 20.51 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 108.775 -0.824 . . . . 15.0 108.775 178.371 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 243' ' ' ARG . . . . . 0.457 ' HB2' ' CE1' ' A' ' 251' ' ' TYR . 31.3 mtt180 -95.87 149.97 20.95 Favored 'General case' 0 CA--C 1.51 -0.574 0 CA-C-O 122.025 0.917 . . . . 15.0 112.295 -175.218 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 244' ' ' THR . . . . . . . . . . . . . 4.9 p -111.61 97.46 6.75 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-N 113.498 -1.683 . . . . 15.0 110.553 -176.553 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 245' ' ' THR . . . . . 0.695 HG21 ' HB2' ' A' ' 247' ' ' GLN . 0.9 OUTLIER -90.7 150.6 21.58 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.187 -0.915 . . . . 15.0 110.302 177.846 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 25.3 t -50.62 -18.43 0.63 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.489 0 O-C-N 123.52 0.513 . . . . 15.0 110.959 176.335 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 247' ' ' GLN . . . . . 0.695 ' HB2' HG21 ' A' ' 245' ' ' THR . 77.9 mm-40 -50.83 -29.11 10.9 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 116.038 -0.528 . . . . 15.0 111.156 171.916 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 80.94 21.41 63.29 Favored Glycine 0 N--CA 1.452 -0.27 0 N-CA-C 111.624 -0.59 . . . . 15.0 111.624 -178.43 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 249' ' ' GLN . . . . . 0.57 HE21 ' HB3' ' A' ' 247' ' ' GLN . 10.4 mt-30 -121.32 143.96 48.9 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.726 -0.472 . . . . 15.0 109.726 -175.803 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 28.8 m -89.84 133.28 32.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 N-CA-C 109.582 -0.525 . . . . 15.0 109.582 176.601 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 251' ' ' TYR . . . . . 0.57 ' HB2' ' CG ' ' B' ' 215' ' ' PRO . 2.4 p90 -140.49 130.11 24.21 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.054 0.454 . . . . 15.0 110.141 -177.12 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 252' ' ' PHE . . . . . 0.625 ' CD2' ' HA ' ' A' ' 264' ' ' ASP . 34.9 m-85 -90.01 116.49 28.09 Favored 'General case' 0 CA--C 1.513 -0.474 0 CA-C-N 115.874 -0.603 . . . . 15.0 111.857 -173.405 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 253' ' ' LEU . . . . . 0.525 HD12 ' CB ' ' B' ' 212' ' ' PRO . 12.9 mt -98.59 126.76 44.27 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-N 114.816 -1.083 . . . . 15.0 111.233 175.677 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 254' ' ' HIS . . . . . 0.7 ' HB2' ' CD1' ' A' ' 240' ' ' TYR . 33.2 t-80 -133.87 89.78 2.62 Favored 'General case' 0 C--N 1.309 -1.183 0 N-CA-C 107.633 -1.247 . . . . 15.0 107.633 167.032 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 3.3 t -94.13 87.95 5.46 Favored 'General case' 0 N--CA 1.429 -1.491 0 C-N-CA 116.334 -2.147 . . . . 15.0 110.105 -179.732 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 60.0 tt0 -101.61 -54.94 2.63 Favored 'General case' 0 N--CA 1.436 -1.137 0 CA-C-N 112.946 -1.934 . . . . 15.0 105.921 151.02 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 257' ' ' THR . . . . . . . . . . . . . 71.6 p -100.04 -13.63 18.97 Favored 'General case' 0 CA--C 1.489 -1.4 0 CA-C-N 111.989 -2.369 . . . . 15.0 112.401 -179.756 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 89.38 71.42 1.26 Allowed Glycine 1 C--N 1.243 -4.622 0 CA-C-N 108.566 -3.924 . . . . 15.0 113.59 -173.15 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 259' ' ' VAL . . . . . 0.657 ' HB ' ' HB3' ' A' ' 254' ' ' HIS . 52.6 t -90.12 129.24 41.32 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 CA-C-O 121.324 0.583 . . . . 15.0 111.564 172.954 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 1.4 p -143.36 108.15 4.9 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 114.539 -1.209 . . . . 15.0 108.643 169.35 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 7.4 t -149.01 150.34 32.66 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.042 0.448 . . . . 15.0 111.685 -171.616 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 262' ' ' TRP . . . . . 1.152 ' CZ2' ' HB2' ' B' ' 215' ' ' PRO . 89.8 m95 -66.89 -30.21 70.3 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.295 -0.866 . . . . 15.0 111.613 177.119 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 263' ' ' HIS . . . . . . . . . . . . . 3.1 p80 -83.85 133.34 34.75 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.55 -0.46 . . . . 15.0 110.607 -172.248 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 264' ' ' ASP . . . . . 0.874 ' HB3' HG12 ' A' ' 267' ' ' ILE . 9.5 t70 -56.9 129.87 78.44 Favored Pre-proline 0 C--N 1.323 -0.549 0 N-CA-C 108.535 -0.913 . . . . 15.0 108.535 172.766 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 265' ' ' PRO . . . . . 0.472 ' HD3' ' HA ' ' A' ' 264' ' ' ASP . 2.6 Cg_exo -76.33 -14.59 18.28 Favored 'Trans proline' 0 CA--C 1.511 -0.655 0 C-N-CA 122.297 1.998 . . . . 15.0 113.451 -174.524 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 266' ' ' ARG . . . . . 0.932 ' HD3' ' HD3' ' A' ' 237' ' ' PRO . 6.4 tpt180 -79.39 -8.72 59.3 Favored 'General case' 0 C--N 1.31 -1.149 0 CA-C-O 121.953 0.882 . . . . 15.0 108.78 175.635 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 267' ' ' ILE . . . . . 0.874 HG12 ' HB3' ' A' ' 264' ' ' ASP . 42.4 mm . . . . . 0 C--O 1.249 1.033 0 CA-C-N 113.997 -1.456 . . . . 15.0 109.809 178.755 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 210' ' ' SER . . . . . . . . . . . . . 12.5 p . . . . . 0 N--CA 1.476 0.873 0 CA-C-O 121.14 0.495 . . . . 15.0 110.74 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 211' ' ' ASP . . . . . 0.485 ' HA ' ' HD3' ' B' ' 212' ' ' PRO . 7.2 p-10 -150.3 135.38 9.86 Favored Pre-proline 0 C--N 1.325 -0.488 0 CA-C-N 115.945 -0.57 . . . . 15.0 110.672 -179.185 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 212' ' ' PRO . . . . . 0.525 ' CB ' HD12 ' A' ' 253' ' ' LEU . 1.4 Cg_endo -89.79 138.87 3.12 Favored 'Trans proline' 0 N--CA 1.458 -0.599 0 C-N-CA 123.529 2.819 . . . . 15.0 111.99 178.766 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -89.79 141.98 16.35 Favored Glycine 0 N--CA 1.444 -0.816 0 C-N-CA 120.813 -0.708 . . . . 15.0 111.561 -179.101 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 214' ' ' SEP . . . . . 0.456 ' HA ' ' HD3' ' B' ' 215' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 215' ' ' PRO . . . . . 1.152 ' HB2' ' CZ2' ' A' ' 262' ' ' TRP . 16.8 Cg_exo -88.24 147.13 6.47 Favored 'Trans proline' 0 N--CA 1.461 -0.389 0 C-N-CA 123.573 2.848 . . . . 15.0 111.88 -178.989 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 216' ' ' PHE . . . . . . . . . . . . . 71.0 m-85 -120.36 159.19 25.55 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.93 -0.396 . . . . 15.0 109.93 173.557 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 217' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.25 1.123 0 CA-C-O 118.869 -0.586 . . . . 15.0 110.865 -176.536 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 . . . . . 0 N--CA 1.484 1.233 0 N-CA-C 109.863 -0.421 . . . . 15.0 109.863 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 236' ' ' LEU . . . . . 0.443 HD22 ' N ' ' A' ' 236' ' ' LEU . 0.2 OUTLIER -103.31 169.53 7.3 Favored Pre-proline 0 C--N 1.321 -0.634 0 N-CA-C 109.188 -0.671 . . . . 15.0 109.188 -179.875 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 237' ' ' PRO . . . . . 0.628 ' HD3' ' HD3' ' A' ' 266' ' ' ARG . 12.9 Cg_exo -69.84 163.32 38.77 Favored 'Trans proline' 0 CA--C 1.514 -0.487 0 C-N-CA 122.022 1.815 . . . . 15.0 110.143 167.839 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -69.81 146.14 51.6 Favored 'General case' 0 C--N 1.305 -1.365 0 CA-C-N 115.45 -0.795 . . . . 15.0 111.611 -175.456 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 99.96 3.54 55.84 Favored Glycine 0 N--CA 1.449 -0.48 0 CA-C-N 115.353 -0.84 . . . . 15.0 113.896 178.218 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 240' ' ' TYR . . . . . 0.738 ' CD1' ' HB2' ' A' ' 254' ' ' HIS . 83.6 m-85 -107.12 123.73 48.67 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 117.45 0.625 . . . . 15.0 110.878 178.001 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -110.12 130.71 55.49 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 109.534 -0.543 . . . . 15.0 109.534 170.442 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 242' ' ' GLN . . . . . 0.47 ' HG3' ' CE1' ' A' ' 252' ' ' PHE . 18.9 tt0 -89.92 112.04 23.3 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.253 -0.647 . . . . 15.0 109.253 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 31.9 mtp85 -105.94 145.67 31.01 Favored 'General case' 0 CA--C 1.502 -0.893 0 CA-C-O 121.957 0.884 . . . . 15.0 112.665 -177.508 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 244' ' ' THR . . . . . . . . . . . . . 48.6 m -121.74 93.33 3.97 Favored 'General case' 0 C--N 1.309 -1.157 0 CA-C-N 113.412 -1.722 . . . . 15.0 109.86 -178.8 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 245' ' ' THR . . . . . 1.052 HG23 ' HG2' ' A' ' 247' ' ' GLN . 5.2 t -89.97 150.61 22.07 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.15 -0.932 . . . . 15.0 110.484 -178.567 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 34.1 t -44.2 -25.7 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 N-CA-C 113.596 0.962 . . . . 15.0 113.596 -175.305 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 247' ' ' GLN . . . . . 1.052 ' HG2' HG23 ' A' ' 245' ' ' THR . 3.4 pt20 -55.1 -18.72 5.9 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 111.579 0.214 . . . . 15.0 111.579 177.649 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 87.7 26.52 29.44 Favored Glycine 0 C--N 1.334 0.472 0 C-N-CA 121.356 -0.449 . . . . 15.0 112.721 175.254 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 249' ' ' GLN . . . . . 0.487 ' HB2' ' OE1' ' A' ' 247' ' ' GLN . 10.7 mt-30 -138.86 140.34 38.42 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.699 -0.482 . . . . 15.0 109.699 -177.62 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 20.5 m -90.04 141.93 13.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 116.397 -0.365 . . . . 15.0 110.652 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 251' ' ' TYR . . . . . 0.659 ' HB3' ' HG2' ' B' ' 215' ' ' PRO . 18.4 p90 -142.21 140.06 32.21 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.468 -0.567 . . . . 15.0 109.468 -178.936 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 252' ' ' PHE . . . . . 0.737 ' CD2' ' HA ' ' A' ' 264' ' ' ASP . 42.4 m-85 -93.6 119.39 32.58 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.123 -0.49 . . . . 15.0 111.895 -174.708 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 253' ' ' LEU . . . . . 0.584 HD21 ' O ' ' A' ' 259' ' ' VAL . 4.1 mt -101.46 117.05 34.15 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-N 115.225 -0.898 . . . . 15.0 111.136 179.244 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 254' ' ' HIS . . . . . 0.738 ' HB2' ' CD1' ' A' ' 240' ' ' TYR . 34.2 t-80 -130.76 90.02 2.84 Favored 'General case' 0 CA--C 1.5 -0.943 0 N-CA-C 107.916 -1.142 . . . . 15.0 107.916 169.464 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 37.1 m -92.73 87.93 6.06 Favored 'General case' 0 N--CA 1.433 -1.293 0 C-N-CA 116.735 -1.986 . . . . 15.0 110.453 -178.802 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 7.8 tt0 -101.14 -52.2 3.33 Favored 'General case' 0 N--CA 1.443 -0.809 0 N-CA-C 106.041 -1.837 . . . . 15.0 106.041 149.447 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 257' ' ' THR . . . . . . . . . . . . . 73.3 p -97.89 -13.48 21.21 Favored 'General case' 0 CA--C 1.487 -1.452 0 CA-C-O 124.779 2.228 . . . . 15.0 111.727 -179.839 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 86.28 70.83 1.31 Allowed Glycine 1 C--N 1.24 -4.772 0 CA-C-N 108.483 -3.962 . . . . 15.0 113.14 -172.665 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 259' ' ' VAL . . . . . 0.584 ' O ' HD21 ' A' ' 253' ' ' LEU . 48.0 t -89.99 125.33 42.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 N-CA-C 112.637 0.606 . . . . 15.0 112.637 177.103 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -138.07 102.19 4.62 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 107.794 -1.188 . . . . 15.0 107.794 167.217 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 12.5 t -138.02 150.35 46.88 Favored 'General case' 0 C--N 1.317 -0.812 0 C-N-CA 120.533 -0.467 . . . . 15.0 112.208 -167.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 262' ' ' TRP . . . . . 1.196 ' CZ2' ' HB2' ' B' ' 215' ' ' PRO . 80.7 m95 -71.28 -33.26 69.59 Favored 'General case' 0 N--CA 1.455 -0.195 0 CA-C-N 115.391 -0.822 . . . . 15.0 111.719 178.912 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 263' ' ' HIS . . . . . . . . . . . . . 5.0 p80 -83.48 134.68 34.84 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.511 -0.476 . . . . 15.0 110.017 -175.245 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 264' ' ' ASP . . . . . 1.018 ' HB3' HG12 ' A' ' 267' ' ' ILE . 10.8 t70 -55.87 131.9 73.17 Favored Pre-proline 0 C--N 1.323 -0.549 0 N-CA-C 108.664 -0.865 . . . . 15.0 108.664 172.615 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 265' ' ' PRO . . . . . 0.493 ' HD3' ' CD2' ' A' ' 252' ' ' PHE . 72.0 Cg_endo -75.67 -14.76 19.62 Favored 'Trans proline' 0 CA--C 1.507 -0.842 0 C-N-CA 121.456 1.437 . . . . 15.0 113.464 -172.071 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 266' ' ' ARG . . . . . 0.628 ' HD3' ' HD3' ' A' ' 237' ' ' PRO . 8.6 tpt180 -81.51 -7.43 59.58 Favored 'General case' 0 C--N 1.306 -1.283 0 N-CA-C 108.168 -1.049 . . . . 15.0 108.168 175.227 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 267' ' ' ILE . . . . . 1.018 HG12 ' HB3' ' A' ' 264' ' ' ASP . 37.5 pt . . . . . 0 C--O 1.25 1.093 0 CA-C-N 114.002 -1.454 . . . . 15.0 110.85 175.691 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 210' ' ' SER . . . . . . . . . . . . . 10.3 p . . . . . 0 N--CA 1.475 0.808 0 CA-C-O 121.014 0.435 . . . . 15.0 110.555 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 211' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -90.16 118.08 68.56 Favored Pre-proline 0 C--N 1.325 -0.489 0 CA-C-O 121.174 0.512 . . . . 15.0 111.346 -175.284 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 212' ' ' PRO . . . . . 0.541 ' CB ' HD11 ' A' ' 253' ' ' LEU . 9.2 Cg_endo -89.93 146.06 4.58 Favored 'Trans proline' 0 N--CA 1.451 -0.974 0 C-N-CA 122.816 2.344 . . . . 15.0 111.157 172.46 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -89.52 159.32 28.23 Favored Glycine 0 N--CA 1.439 -1.148 0 C-N-CA 120.099 -1.048 . . . . 15.0 111.702 -179.502 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 214' ' ' SEP . . . . . 0.606 ' HB3' HG22 ' A' ' 245' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 215' ' ' PRO . . . . . 1.196 ' HB2' ' CZ2' ' A' ' 262' ' ' TRP 0.262 16.9 Cg_exo -87.41 149.89 7.74 Favored 'Trans proline' 0 C--O 1.236 0.389 0 C-N-CA 123.248 2.632 . . . . 15.0 110.637 179.831 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 216' ' ' PHE . . . . . . . . . . . . . 99.1 m-85 -108.52 118.37 36.6 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 120.809 0.337 . . . . 15.0 110.182 -179.498 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 217' ' ' GLN . . . . . . . . . . . . . 9.4 tt0 . . . . . 0 C--O 1.246 0.91 0 CA-C-O 118.671 -0.681 . . . . 15.0 109.167 176.951 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 235' ' ' GLU . . . . . 0.427 ' H2 ' ' CD ' ' A' ' 235' ' ' GLU . 5.6 mp0 . . . . . 0 N--CA 1.481 1.088 0 CA-C-O 120.853 0.359 . . . . 15.0 110.454 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 5.8 mt -95.63 172.97 4.71 Favored Pre-proline 0 C--N 1.323 -0.582 0 N-CA-C 109.676 -0.49 . . . . 15.0 109.676 -179.66 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 237' ' ' PRO . . . . . 0.597 ' HD3' ' HD3' ' A' ' 266' ' ' ARG . 21.9 Cg_exo -69.37 161.16 46.97 Favored 'Trans proline' 0 C--O 1.235 0.333 0 C-N-CA 121.876 1.717 . . . . 15.0 110.398 164.466 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -69.65 150.39 47.06 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-N 115.496 -0.774 . . . . 15.0 110.914 -175.313 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 100.24 -15.13 59.32 Favored Glycine 0 N--CA 1.447 -0.625 0 CA-C-N 115.688 -0.687 . . . . 15.0 112.599 -177.729 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 240' ' ' TYR . . . . . 0.449 ' CD1' ' HG2' ' A' ' 265' ' ' PRO . 65.9 m-85 -94.61 116.42 28.75 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.142 0.496 . . . . 15.0 110.523 177.057 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -95.3 116.93 29.43 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 115.625 -0.716 . . . . 15.0 109.123 174.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -90.01 97.45 11.2 Favored 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 108.993 -0.743 . . . . 15.0 108.993 178.03 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 243' ' ' ARG . . . . . 0.429 HH11 ' HD2' ' A' ' 243' ' ' ARG . 11.9 mtp180 -100.42 149.54 23.55 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 115.298 -0.865 . . . . 15.0 111.478 -179.162 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 244' ' ' THR . . . . . . . . . . . . . 22.8 m -117.64 128.7 55.18 Favored 'General case' 0 C--N 1.309 -1.172 0 CA-C-N 114.08 -1.418 . . . . 15.0 108.718 -178.629 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 245' ' ' THR . . . . . 0.419 HG23 ' O ' ' A' ' 249' ' ' GLN . 8.3 t -115.28 150.44 36.21 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 116.277 -0.42 . . . . 15.0 111.03 -174.113 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 50.8 t -57.73 -15.78 4.87 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 CA-C-N 115.795 -0.639 . . . . 15.0 111.302 179.865 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 247' ' ' GLN . . . . . . . . . . . . . 8.8 mm100 -61.46 -20.82 63.57 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 121.093 0.473 . . . . 15.0 110.65 175.553 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 90.63 36.98 6.64 Favored Glycine 0 N--CA 1.452 -0.28 0 CA-C-N 115.559 -0.746 . . . . 15.0 112.003 178.546 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 249' ' ' GLN . . . . . 0.437 ' NE2' ' HD2' ' B' ' 215' ' ' PRO . 8.0 pt20 -148.02 139.62 23.75 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.873 0.368 . . . . 15.0 111.12 -175.524 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 15.9 m -89.95 135.58 25.92 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 N-CA-C 109.395 -0.595 . . . . 15.0 109.395 172.557 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 251' ' ' TYR . . . . . 0.676 ' CD2' ' HD3' ' B' ' 215' ' ' PRO . 0.6 OUTLIER -136.81 138.36 40.77 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-O 120.95 0.405 . . . . 15.0 110.123 -179.981 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 252' ' ' PHE . . . . . 0.619 ' CD2' ' HA ' ' A' ' 264' ' ' ASP . 40.6 m-85 -89.99 118.2 29.37 Favored 'General case' 0 CA--C 1.512 -0.491 0 CA-C-O 121.229 0.537 . . . . 15.0 111.449 -173.419 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 253' ' ' LEU . . . . . 0.902 HD13 ' HB3' ' B' ' 212' ' ' PRO . 0.8 OUTLIER -110.26 106.77 16.29 Favored 'General case' 0 N--CA 1.446 -0.653 0 CA-C-N 114.714 -1.13 . . . . 15.0 111.885 -173.048 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 254' ' ' HIS . . . . . . . . . . . . . 26.8 t-80 -115.41 95.03 4.97 Favored 'General case' 0 C--N 1.312 -1.048 0 N-CA-C 108.298 -1.001 . . . . 15.0 108.298 170.104 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 26.3 m -94.08 88.02 5.51 Favored 'General case' 0 N--CA 1.43 -1.436 0 C-N-CA 116.985 -1.886 . . . . 15.0 110.459 -179.08 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 58.9 tt0 -101.12 -51.15 3.59 Favored 'General case' 0 N--CA 1.438 -1.033 0 N-CA-C 105.924 -1.88 . . . . 15.0 105.924 146.768 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 257' ' ' THR . . . . . . . . . . . . . 63.1 p -99.94 -13.69 19.02 Favored 'General case' 0 CA--C 1.484 -1.581 0 CA-C-O 124.735 2.207 . . . . 15.0 112.275 -178.062 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 83.09 76.18 1.14 Allowed Glycine 1 C--N 1.239 -4.851 0 CA-C-N 108.594 -3.912 . . . . 15.0 111.934 -170.225 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 259' ' ' VAL . . . . . 0.66 ' O ' ' HA ' ' A' ' 253' ' ' LEU . 54.8 t -89.35 124.47 42.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-O 121.478 0.656 . . . . 15.0 111.725 176.86 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 3.6 p -135.04 97.41 3.73 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 114.285 -1.325 . . . . 15.0 108.394 171.347 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 10.6 t -134.92 150.26 50.39 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.037 0.446 . . . . 15.0 112.018 -170.387 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 262' ' ' TRP . . . . . 1.127 ' CZ2' ' HB2' ' B' ' 215' ' ' PRO . 42.3 m95 -72.15 -31.04 65.6 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.38 -0.827 . . . . 15.0 111.844 177.341 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 263' ' ' HIS . . . . . . . . . . . . . 5.2 p80 -80.15 130.74 35.45 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 120.196 -0.602 . . . . 15.0 110.155 -174.413 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 264' ' ' ASP . . . . . 1.133 ' HB3' HG12 ' A' ' 267' ' ' ILE . 13.8 t0 -63.12 127.44 90.93 Favored Pre-proline 0 C--N 1.321 -0.64 0 N-CA-C 107.77 -1.196 . . . . 15.0 107.77 171.169 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 265' ' ' PRO . . . . . 0.449 ' HG2' ' CD1' ' A' ' 240' ' ' TYR . 15.9 Cg_exo -69.09 -14.9 39.05 Favored 'Trans proline' 0 C--N 1.323 -0.799 0 C-N-CA 121.878 1.719 . . . . 15.0 113.087 -178.118 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 266' ' ' ARG . . . . . 0.597 ' HD3' ' HD3' ' A' ' 237' ' ' PRO . 4.5 tpt180 -80.83 -6.5 58.66 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-O 121.834 0.826 . . . . 15.0 109.156 175.031 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 267' ' ' ILE . . . . . 1.133 HG12 ' HB3' ' A' ' 264' ' ' ASP . 48.2 pt . . . . . 0 C--O 1.248 0.987 0 CA-C-N 114.299 -1.318 . . . . 15.0 111.689 177.735 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 210' ' ' SER . . . . . . . . . . . . . 9.5 m . . . . . 0 N--CA 1.479 0.988 0 CA-C-O 120.759 0.314 . . . . 15.0 110.72 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 211' ' ' ASP . . . . . 0.421 ' HA ' ' HD3' ' B' ' 212' ' ' PRO . 3.0 m-20 -89.85 119.53 69.41 Favored Pre-proline 0 C--O 1.233 0.185 0 CA-C-N 116.278 -0.419 . . . . 15.0 110.319 -173.243 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 212' ' ' PRO . . . . . 0.902 ' HB3' HD13 ' A' ' 253' ' ' LEU . 1.9 Cg_endo -90.0 149.14 4.77 Favored 'Trans proline' 0 N--CA 1.458 -0.586 0 C-N-CA 123.118 2.545 . . . . 15.0 112.234 177.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -89.61 141.15 15.97 Favored Glycine 0 N--CA 1.446 -0.68 0 C-N-CA 120.925 -0.655 . . . . 15.0 112.607 -179.647 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 214' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 215' ' ' PRO . . . . . 1.127 ' HB2' ' CZ2' ' A' ' 262' ' ' TRP 0.251 16.8 Cg_exo -88.06 139.12 4.38 Favored 'Trans proline' 0 N--CA 1.475 0.428 0 C-N-CA 124.125 3.217 . . . . 15.0 112.932 -172.635 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 216' ' ' PHE . . . . . . . . . . . . . 69.7 m-85 -96.08 127.4 42.06 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.571 -0.741 . . . . 15.0 109.102 175.008 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 217' ' ' GLN . . . . . . . . . . . . . 12.3 pt20 . . . . . 0 C--O 1.247 0.952 0 CA-C-O 118.412 -0.804 . . . . 15.0 111.122 -177.68 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 235' ' ' GLU . . . . . 0.415 ' H2 ' ' CD ' ' A' ' 235' ' ' GLU . 1.7 pm0 . . . . . 0 N--CA 1.48 1.071 0 N-CA-C 109.843 -0.429 . . . . 15.0 109.843 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 236' ' ' LEU . . . . . 0.444 HD23 ' N ' ' A' ' 236' ' ' LEU . 1.1 mm? -114.63 168.04 8.71 Favored Pre-proline 0 C--N 1.32 -0.677 0 N-CA-C 109.765 -0.457 . . . . 15.0 109.765 -179.82 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 237' ' ' PRO . . . . . 0.446 ' O ' ' HD2' ' A' ' 240' ' ' TYR . 16.2 Cg_exo -69.53 164.72 33.23 Favored 'Trans proline' 0 N--CA 1.459 -0.522 0 C-N-CA 121.801 1.667 . . . . 15.0 110.118 165.011 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -69.58 135.65 50.28 Favored 'General case' 0 C--N 1.303 -1.443 0 CA-C-N 115.053 -0.976 . . . . 15.0 111.361 -171.955 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 100.44 21.63 12.68 Favored Glycine 0 CA--C 1.521 0.431 0 CA-C-N 115.504 -0.771 . . . . 15.0 114.349 178.794 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 240' ' ' TYR . . . . . 0.724 ' CD1' ' HB2' ' A' ' 254' ' ' HIS . 73.7 m-85 -112.39 114.43 27.14 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 118.298 1.049 . . . . 15.0 110.798 175.307 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 37.5 mm-40 -98.2 119.44 36.86 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.686 -0.688 . . . . 15.0 109.216 175.341 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -89.93 107.52 19.16 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 108.032 -1.099 . . . . 15.0 108.032 175.909 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 6.3 mtp85 -97.25 132.38 43.06 Favored 'General case' 0 CA--C 1.496 -1.109 0 CA-C-O 122.451 1.119 . . . . 15.0 113.434 -172.774 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 244' ' ' THR . . . . . . . . . . . . . 1.3 m -100.66 89.92 4.07 Favored 'General case' 0 C--N 1.306 -1.314 0 CA-C-N 112.805 -1.998 . . . . 15.0 109.05 177.517 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 245' ' ' THR . . . . . 1.071 HG22 ' HG2' ' A' ' 247' ' ' GLN . 7.8 t -95.04 150.75 19.83 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 114.989 -1.005 . . . . 15.0 110.401 -176.653 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 61.1 t -39.69 -30.9 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 N-CA-C 113.901 1.075 . . . . 15.0 113.901 -174.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 247' ' ' GLN . . . . . 1.071 ' HG2' HG22 ' A' ' 245' ' ' THR . 3.8 pt20 -56.55 -21.14 24.34 Favored 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 111.838 0.31 . . . . 15.0 111.838 178.111 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 80.42 37.21 21.46 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 121.141 -0.552 . . . . 15.0 112.988 176.49 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 249' ' ' GLN . . . . . 0.487 ' HB2' ' OE1' ' A' ' 247' ' ' GLN . 34.3 mt-30 -135.71 149.98 49.4 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.678 -0.49 . . . . 15.0 109.678 179.633 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 15.5 m -89.83 128.23 41.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 120.934 0.397 . . . . 15.0 110.562 178.433 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 251' ' ' TYR . . . . . 0.687 ' CB ' ' HG2' ' B' ' 215' ' ' PRO . 4.0 p90 -138.69 133.19 31.98 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.006 0.431 . . . . 15.0 109.883 -178.647 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 252' ' ' PHE . . . . . 0.686 ' CD2' ' HA ' ' A' ' 264' ' ' ASP . 36.0 m-85 -89.78 118.2 29.2 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.023 -0.535 . . . . 15.0 110.88 -175.007 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 253' ' ' LEU . . . . . 0.544 HD12 ' HB3' ' B' ' 212' ' ' PRO . 0.7 OUTLIER -111.1 119.33 38.62 Favored 'General case' 0 N--CA 1.447 -0.617 0 CA-C-N 115.09 -0.959 . . . . 15.0 110.398 -177.674 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 254' ' ' HIS . . . . . 0.724 ' HB2' ' CD1' ' A' ' 240' ' ' TYR . 9.1 t-80 -133.0 101.31 5.18 Favored 'General case' 0 CA--C 1.495 -1.14 0 N-CA-C 108.956 -0.757 . . . . 15.0 108.956 173.951 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 3.5 t -95.89 87.66 4.69 Favored 'General case' 0 N--CA 1.432 -1.333 0 C-N-CA 116.388 -2.125 . . . . 15.0 110.617 179.74 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 44.3 tt0 -101.35 -55.96 2.42 Favored 'General case' 0 N--CA 1.441 -0.906 0 N-CA-C 105.973 -1.862 . . . . 15.0 105.973 150.807 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 257' ' ' THR . . . . . . . . . . . . . 80.4 p -99.77 -13.72 19.15 Favored 'General case' 0 CA--C 1.489 -1.383 0 CA-C-N 111.893 -2.412 . . . . 15.0 112.047 -176.275 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 89.16 70.6 1.26 Allowed Glycine 1 C--N 1.242 -4.655 0 CA-C-N 108.537 -3.938 . . . . 15.0 112.903 -171.025 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 259' ' ' VAL . . . . . 0.504 ' HB ' ' HB3' ' A' ' 254' ' ' HIS . 54.6 t -90.05 127.38 42.66 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.31 0 CA-C-O 121.207 0.527 . . . . 15.0 112.251 176.861 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 2.3 p -145.68 102.15 3.64 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 114.672 -1.149 . . . . 15.0 108.416 169.686 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 5.5 t -145.48 150.12 35.9 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 115.868 -0.606 . . . . 15.0 111.781 -171.384 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 262' ' ' TRP . . . . . 1.172 ' CZ2' ' HB2' ' B' ' 215' ' ' PRO . 90.2 m95 -71.52 -23.31 61.76 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.358 -0.837 . . . . 15.0 111.199 176.535 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 263' ' ' HIS . . . . . . . . . . . . . 1.9 p80 -87.88 132.07 34.34 Favored 'General case' 0 C--O 1.234 0.266 0 C-N-CA 120.231 -0.587 . . . . 15.0 110.524 -173.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 264' ' ' ASP . . . . . 0.773 ' HB3' HG12 ' A' ' 267' ' ' ILE . 9.2 t70 -51.82 130.92 38.19 Favored Pre-proline 0 C--N 1.326 -0.439 0 CA-C-N 115.359 -0.837 . . . . 15.0 109.574 175.332 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 265' ' ' PRO . . . . . 0.493 ' HD3' ' CD2' ' A' ' 252' ' ' PHE . 71.9 Cg_endo -78.11 -14.89 14.86 Favored 'Trans proline' 0 CA--C 1.514 -0.506 0 C-N-CA 122.384 2.056 . . . . 15.0 113.644 -173.964 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 266' ' ' ARG . . . . . 0.443 ' HD3' ' HD3' ' A' ' 237' ' ' PRO . 7.2 tpt180 -77.08 -8.24 57.12 Favored 'General case' 0 C--N 1.311 -1.074 0 N-CA-C 107.694 -1.224 . . . . 15.0 107.694 174.546 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 267' ' ' ILE . . . . . 0.773 HG12 ' HB3' ' A' ' 264' ' ' ASP . 28.4 mm . . . . . 0 C--O 1.248 0.976 0 CA-C-N 113.537 -1.665 . . . . 15.0 109.216 174.634 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 210' ' ' SER . . . . . . . . . . . . . 14.9 m . . . . . 0 N--CA 1.477 0.889 0 CA-C-O 120.84 0.352 . . . . 15.0 110.572 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 211' ' ' ASP . . . . . 0.433 ' HA ' ' HD3' ' B' ' 212' ' ' PRO . 11.8 m-20 -89.81 130.61 42.27 Favored Pre-proline 0 C--N 1.332 -0.175 0 CA-C-N 116.449 -0.341 . . . . 15.0 110.274 -177.511 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 212' ' ' PRO . . . . . 0.544 ' HB3' HD12 ' A' ' 253' ' ' LEU . 5.0 Cg_endo -90.04 151.37 4.8 Favored 'Trans proline' 0 N--CA 1.46 -0.46 0 C-N-CA 123.483 2.788 . . . . 15.0 113.179 -175.404 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -89.95 160.21 28.41 Favored Glycine 0 N--CA 1.444 -0.796 0 CA-C-N 115.346 -0.843 . . . . 15.0 112.839 178.538 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 214' ' ' SEP . . . . . 0.675 ' HB3' HG21 ' A' ' 245' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 215' ' ' PRO . . . . . 1.172 ' HB2' ' CZ2' ' A' ' 262' ' ' TRP . 30.3 Cg_exo -87.19 146.41 7.55 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 123.172 2.581 . . . . 15.0 111.47 176.672 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 216' ' ' PHE . . . . . . . . . . . . . 87.5 m-85 -122.87 137.79 54.84 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 110.391 -0.225 . . . . 15.0 110.391 179.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 217' ' ' GLN . . . . . . . . . . . . . 10.6 tt0 . . . . . 0 C--O 1.248 1.017 0 O-C-N 124.339 1.025 . . . . 15.0 110.541 179.789 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.479 1.022 0 CA-C-O 120.693 0.282 . . . . 15.0 110.834 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 5.8 mt -103.89 170.37 6.22 Favored Pre-proline 0 C--N 1.325 -0.491 0 N-CA-C 108.948 -0.76 . . . . 15.0 108.948 178.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 237' ' ' PRO . . . . . 0.514 ' HD3' ' HD3' ' A' ' 266' ' ' ARG . 17.2 Cg_exo -69.31 156.96 63.01 Favored 'Trans proline' 0 N--CA 1.458 -0.563 0 C-N-CA 121.55 1.5 . . . . 15.0 109.636 162.842 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 4.6 mp0 -69.71 149.38 48.09 Favored 'General case' 0 C--N 1.31 -1.146 0 CA-C-O 121.341 0.591 . . . . 15.0 111.409 -173.325 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 100.19 -7.36 58.5 Favored Glycine 0 N--CA 1.446 -0.66 0 CA-C-N 115.173 -0.921 . . . . 15.0 113.722 179.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 240' ' ' TYR . . . . . 0.634 ' CD1' ' HB2' ' A' ' 254' ' ' HIS . 67.7 m-85 -91.03 113.13 25.31 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 117.535 0.667 . . . . 15.0 110.81 178.199 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 57.9 mm-40 -92.05 118.41 30.77 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 109.367 -0.605 . . . . 15.0 109.367 174.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 24.8 tm0? -89.94 107.75 19.3 Favored 'General case' 0 C--N 1.314 -0.963 0 N-CA-C 109.163 -0.68 . . . . 15.0 109.163 176.806 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 243' ' ' ARG . . . . . 0.408 ' HB2' ' CE1' ' A' ' 251' ' ' TYR . 17.3 mtp85 -103.47 150.03 24.27 Favored 'General case' 0 CA--C 1.512 -0.519 0 CA-C-O 122.116 0.96 . . . . 15.0 111.982 178.081 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 244' ' ' THR . . . . . . . . . . . . . 24.4 p -111.27 148.24 33.31 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-N 113.504 -1.68 . . . . 15.0 109.367 -179.064 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 245' ' ' THR . . . . . 0.452 ' OG1' ' HG2' ' A' ' 247' ' ' GLN . 6.0 t -145.26 150.11 36.09 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-O 120.641 0.258 . . . . 15.0 111.142 -175.186 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 7.7 p -50.87 -26.79 4.55 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.219 0 CA-C-N 115.541 -0.754 . . . . 15.0 111.256 177.748 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 247' ' ' GLN . . . . . 0.452 ' HG2' ' OG1' ' A' ' 245' ' ' THR . 6.8 mm-40 -53.75 -21.4 7.16 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 114.787 -1.097 . . . . 15.0 111.472 177.959 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 81.82 25.19 53.78 Favored Glycine 0 CA--C 1.509 -0.282 0 C-N-CA 121.255 -0.498 . . . . 15.0 111.871 178.146 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -130.47 138.37 50.24 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.759 -0.46 . . . . 15.0 109.759 -175.614 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 18.8 m -90.02 132.43 34.72 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 N-CA-C 109.354 -0.61 . . . . 15.0 109.354 175.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 251' ' ' TYR . . . . . 0.479 ' CD2' ' HD3' ' B' ' 215' ' ' PRO . 4.4 p90 -135.16 134.19 39.91 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.486 0.66 . . . . 15.0 111.325 -178.7 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 252' ' ' PHE . . . . . 0.725 ' CE2' ' HA ' ' A' ' 264' ' ' ASP . 37.8 m-85 -90.28 118.5 29.84 Favored 'General case' 0 CA--C 1.516 -0.335 0 CA-C-N 115.246 -0.888 . . . . 15.0 111.046 -176.654 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 253' ' ' LEU . . . . . 0.851 HD13 ' HB3' ' B' ' 212' ' ' PRO . 0.5 OUTLIER -109.9 99.21 8.37 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-N 114.942 -1.026 . . . . 15.0 111.205 -174.675 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 254' ' ' HIS . . . . . 0.634 ' HB2' ' CD1' ' A' ' 240' ' ' TYR . 36.9 t-80 -112.17 92.56 4.07 Favored 'General case' 0 CA--C 1.499 -1.018 0 N-CA-C 108.57 -0.9 . . . . 15.0 108.57 169.58 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 7.9 t -96.55 88.06 4.57 Favored 'General case' 0 N--CA 1.432 -1.331 0 C-N-CA 116.524 -2.07 . . . . 15.0 110.729 -179.076 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 49.1 tt0 -101.17 -50.39 3.8 Favored 'General case' 0 N--CA 1.441 -0.924 0 CA-C-N 113.127 -1.851 . . . . 15.0 106.42 151.601 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 257' ' ' THR . . . . . . . . . . . . . 68.7 p -97.99 -13.57 21.05 Favored 'General case' 0 CA--C 1.488 -1.431 0 CA-C-O 124.865 2.269 . . . . 15.0 111.681 -179.565 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 88.71 71.41 1.27 Allowed Glycine 1 C--N 1.241 -4.737 1 CA-C-N 108.224 -4.08 . . . . 15.0 113.109 -171.602 . . . . . . . . 3 2 . 1 . 006 nuclear orig full ' A' A ' 259' ' ' VAL . . . . . 0.556 ' O ' ' HA ' ' A' ' 253' ' ' LEU . 45.8 t -89.81 124.45 42.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 121.376 0.607 . . . . 15.0 111.911 174.962 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -136.94 92.36 2.72 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 114.541 -1.209 . . . . 15.0 108.018 167.763 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 5.0 t -129.27 150.23 50.73 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.705 -0.679 . . . . 15.0 111.966 -166.193 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 262' ' ' TRP . . . . . 1.171 ' CZ2' ' HB2' ' B' ' 215' ' ' PRO . 85.5 m95 -71.61 -50.63 29.04 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.164 -0.926 . . . . 15.0 111.691 179.337 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 263' ' ' HIS . . . . . . . . . . . . . 5.4 p80 -66.49 134.48 52.53 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.912 -0.586 . . . . 15.0 110.629 -175.527 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 264' ' ' ASP . . . . . 1.052 ' HB3' HG12 ' A' ' 267' ' ' ILE . 37.8 t0 -54.29 124.14 45.55 Favored Pre-proline 0 C--O 1.218 -0.554 0 N-CA-C 107.408 -1.33 . . . . 15.0 107.408 167.217 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 265' ' ' PRO . . . . . 0.575 ' HD3' ' CD2' ' A' ' 252' ' ' PHE . 12.6 Cg_exo -69.03 -14.67 38.84 Favored 'Trans proline' 0 C--N 1.323 -0.794 0 C-N-CA 121.788 1.659 . . . . 15.0 112.617 -176.324 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 266' ' ' ARG . . . . . 0.514 ' HD3' ' HD3' ' A' ' 237' ' ' PRO . 5.8 tpt180 -78.28 -9.86 59.41 Favored 'General case' 0 N--CA 1.439 -0.998 0 CA-C-O 121.861 0.838 . . . . 15.0 109.136 173.143 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 267' ' ' ILE . . . . . 1.052 HG12 ' HB3' ' A' ' 264' ' ' ASP . 48.2 pt . . . . . 0 C--O 1.246 0.89 0 CA-C-O 117.543 -1.218 . . . . 15.0 110.875 176.779 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 210' ' ' SER . . . . . . . . . . . . . 16.6 p . . . . . 0 N--CA 1.481 1.125 0 CA-C-O 120.859 0.361 . . . . 15.0 110.735 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 211' ' ' ASP . . . . . 0.409 ' HA ' ' HD3' ' B' ' 212' ' ' PRO . 2.8 m-20 -89.97 115.27 63.55 Favored Pre-proline 0 C--N 1.331 -0.223 0 CA-C-N 116.4 -0.364 . . . . 15.0 110.799 -173.948 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 212' ' ' PRO . . . . . 0.851 ' HB3' HD13 ' A' ' 253' ' ' LEU . 2.6 Cg_endo -89.67 154.13 5.18 Favored 'Trans proline' 0 N--CA 1.456 -0.7 0 C-N-CA 122.752 2.301 . . . . 15.0 112.104 175.789 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -89.95 134.55 12.42 Favored Glycine 0 N--CA 1.446 -0.636 0 C-N-CA 120.554 -0.831 . . . . 15.0 112.296 179.43 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 214' ' ' SEP . . . . . 0.402 ' HA ' ' HD3' ' B' ' 215' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 215' ' ' PRO . . . . . 1.171 ' HB2' ' CZ2' ' A' ' 262' ' ' TRP . 8.0 Cg_exo -87.94 147.62 6.87 Favored 'Trans proline' 0 C--O 1.235 0.333 0 C-N-CA 124.197 3.265 . . . . 15.0 112.38 -169.071 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 216' ' ' PHE . . . . . . . . . . . . . 85.1 m-85 -103.4 112.62 25.59 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 109.012 -0.736 . . . . 15.0 109.012 175.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 217' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.248 1.001 0 CA-C-O 118.427 -0.797 . . . . 15.0 111.635 -175.732 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 235' ' ' GLU . . . . . 0.437 ' H3 ' ' CD ' ' A' ' 235' ' ' GLU . 1.1 mp0 . . . . . 0 N--CA 1.48 1.06 0 N-CA-C 109.582 -0.525 . . . . 15.0 109.582 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 236' ' ' LEU . . . . . 0.441 HD23 ' N ' ' A' ' 236' ' ' LEU . 1.2 mm? -110.59 165.75 12.07 Favored Pre-proline 0 C--N 1.323 -0.584 0 CA-C-O 121.03 0.443 . . . . 15.0 110.586 -176.07 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 237' ' ' PRO . . . . . 0.57 ' HD3' ' HD3' ' A' ' 266' ' ' ARG . 21.9 Cg_exo -69.34 166.58 26.6 Favored 'Trans proline' 0 N--CA 1.46 -0.442 0 C-N-CA 122.257 1.971 . . . . 15.0 110.528 163.885 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 -69.92 147.23 50.49 Favored 'General case' 0 C--N 1.304 -1.391 0 CA-C-N 115.038 -0.983 . . . . 15.0 111.809 -176.382 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 100.25 0.93 55.8 Favored Glycine 0 CA--C 1.518 0.237 0 CA-C-N 115.348 -0.842 . . . . 15.0 113.34 179.736 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 240' ' ' TYR . . . . . 0.489 ' HD2' ' O ' ' A' ' 237' ' ' PRO . 56.5 m-85 -97.45 121.37 39.26 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.552 0.691 . . . . 15.0 111.574 -178.419 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 241' ' ' GLU . . . . . 0.695 ' HB2' ' HB2' ' A' ' 253' ' ' LEU . 7.6 mp0 -89.87 100.45 13.26 Favored 'General case' 0 N--CA 1.442 -0.833 0 CA-C-N 114.885 -1.052 . . . . 15.0 108.777 173.147 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 1.5 tm0? -89.94 113.99 25.73 Favored 'General case' 0 C--N 1.313 -1.006 0 N-CA-C 108.451 -0.944 . . . . 15.0 108.451 179.33 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 243' ' ' ARG . . . . . 0.481 ' CZ ' ' HG2' ' B' ' 212' ' ' PRO . 28.0 mtt180 -112.94 144.94 41.65 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-O 122.392 1.092 . . . . 15.0 111.926 179.511 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 244' ' ' THR . . . . . . . . . . . . . 15.8 m -120.29 92.14 3.7 Favored 'General case' 0 C--N 1.304 -1.373 0 CA-C-N 112.998 -1.91 . . . . 15.0 108.263 178.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 245' ' ' THR . . . . . 0.481 ' OG1' ' HG2' ' A' ' 247' ' ' GLN . 6.7 t -89.72 149.99 22.51 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 115.441 -0.799 . . . . 15.0 110.989 -171.882 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 23.0 t -55.2 -15.13 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 CA-C-N 115.816 -0.629 . . . . 15.0 111.349 -179.194 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 247' ' ' GLN . . . . . 0.481 ' HG2' ' OG1' ' A' ' 245' ' ' THR . 8.3 mm-40 -59.29 -15.27 14.9 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 115.895 -0.593 . . . . 15.0 111.128 176.413 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 89.51 37.4 7.02 Favored Glycine 0 C--N 1.333 0.407 0 C-N-CA 121.218 -0.515 . . . . 15.0 112.164 178.334 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 249' ' ' GLN . . . . . 0.625 ' NE2' ' HD2' ' B' ' 215' ' ' PRO . 0.8 OUTLIER -150.17 147.14 27.37 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.399 0.619 . . . . 15.0 111.515 -174.905 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 16.6 m -100.92 131.41 48.61 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.928 0 CA-C-N 114.561 -1.2 . . . . 15.0 108.386 169.189 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 251' ' ' TYR . . . . . 0.554 ' HB2' ' HG3' ' B' ' 215' ' ' PRO . 2.7 p90 -137.28 137.93 39.52 Favored 'General case' 0 C--N 1.317 -0.811 0 C-N-CA 120.558 -0.457 . . . . 15.0 110.395 -175.149 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 252' ' ' PHE . . . . . 0.742 ' CD2' ' HA ' ' A' ' 264' ' ' ASP . 40.8 m-85 -95.75 110.95 23.02 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.569 0.7 . . . . 15.0 112.329 -172.824 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 253' ' ' LEU . . . . . 0.695 ' HB2' ' HB2' ' A' ' 241' ' ' GLU . 38.9 mt -93.0 144.69 25.0 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 114.241 -1.345 . . . . 15.0 109.848 172.176 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 254' ' ' HIS . . . . . 0.56 ' HB3' ' HB ' ' A' ' 259' ' ' VAL . 40.3 t-80 -143.53 89.77 2.1 Favored 'General case' 0 C--N 1.305 -1.343 0 N-CA-C 107.31 -1.367 . . . . 15.0 107.31 164.143 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 16.3 m -91.72 87.61 6.37 Favored 'General case' 0 N--CA 1.426 -1.632 0 C-N-CA 115.655 -2.418 . . . . 15.0 110.096 -178.307 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 8.1 tt0 -101.53 -53.59 2.95 Favored 'General case' 0 N--CA 1.435 -1.193 0 CA-C-N 112.793 -2.003 . . . . 15.0 105.82 145.753 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 257' ' ' THR . . . . . . . . . . . . . 71.8 p -100.2 -13.52 18.88 Favored 'General case' 0 CA--C 1.49 -1.357 0 CA-C-O 124.727 2.203 . . . . 15.0 112.56 -176.459 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 86.07 73.24 1.28 Allowed Glycine 1 C--N 1.241 -4.747 0 CA-C-N 108.461 -3.972 . . . . 15.0 113.04 -172.529 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 259' ' ' VAL . . . . . 0.583 ' O ' ' HA ' ' A' ' 253' ' ' LEU . 74.9 t -89.71 136.76 22.89 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 CA-C-O 120.923 0.392 . . . . 15.0 112.028 174.127 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 4.0 p -145.62 100.02 3.37 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 114.822 -1.081 . . . . 15.0 108.731 168.834 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 24.3 p -132.39 150.17 52.21 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 112.216 0.45 . . . . 15.0 112.216 -172.364 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 262' ' ' TRP . . . . . 1.172 ' CZ2' ' HB2' ' B' ' 215' ' ' PRO . 71.1 m95 -72.87 -30.0 63.63 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.781 -0.645 . . . . 15.0 110.68 174.347 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 263' ' ' HIS . . . . . . . . . . . . . 3.3 p80 -77.89 129.31 35.21 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.967 0.413 . . . . 15.0 110.252 -177.666 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 264' ' ' ASP . . . . . 1.032 ' HB3' HG12 ' A' ' 267' ' ' ILE . 9.1 t0 -59.21 129.21 86.27 Favored Pre-proline 0 C--N 1.319 -0.734 0 N-CA-C 108.509 -0.923 . . . . 15.0 108.509 172.032 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 265' ' ' PRO . . . . . 0.519 ' HD3' ' CD2' ' A' ' 252' ' ' PHE . 4.4 Cg_exo -74.19 -14.65 23.18 Favored 'Trans proline' 0 CA--C 1.509 -0.729 0 C-N-CA 122.112 1.875 . . . . 15.0 113.228 -175.737 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 266' ' ' ARG . . . . . 0.57 ' HD3' ' HD3' ' A' ' 237' ' ' PRO . 2.1 tpp180 -77.41 -11.55 59.85 Favored 'General case' 0 C--N 1.31 -1.119 0 N-CA-C 108.055 -1.091 . . . . 15.0 108.055 172.978 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 267' ' ' ILE . . . . . 1.032 HG12 ' HB3' ' A' ' 264' ' ' ASP . 31.8 pt . . . . . 0 C--O 1.249 1.05 0 CA-C-N 114.551 -1.204 . . . . 15.0 111.0 176.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 210' ' ' SER . . . . . . . . . . . . . 63.0 p . . . . . 0 N--CA 1.479 1.002 0 CA-C-O 120.72 0.295 . . . . 15.0 110.841 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 211' ' ' ASP . . . . . 0.453 ' HA ' ' HD3' ' B' ' 212' ' ' PRO . 56.6 m-20 -104.49 120.62 49.94 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 120.894 0.378 . . . . 15.0 110.294 179.485 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 212' ' ' PRO . . . . . 0.566 ' CB ' HD12 ' A' ' 253' ' ' LEU . 3.4 Cg_exo -89.64 151.93 5.18 Favored 'Trans proline' 0 N--CA 1.461 -0.435 0 C-N-CA 123.88 3.054 . . . . 15.0 112.17 179.885 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -90.05 132.29 11.19 Favored Glycine 0 N--CA 1.443 -0.888 0 C-N-CA 120.74 -0.743 . . . . 15.0 111.616 178.384 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 214' ' ' SEP . . . . . 0.447 ' HA ' ' HD3' ' B' ' 215' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 215' ' ' PRO . . . . . 1.172 ' HB2' ' CZ2' ' A' ' 262' ' ' TRP . 2.7 Cg_exo -88.41 138.41 3.88 Favored 'Trans proline' 0 N--CA 1.46 -0.444 0 C-N-CA 123.988 3.125 . . . . 15.0 111.394 -177.677 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 216' ' ' PHE . . . . . . . . . . . . . 94.0 m-85 -123.36 -19.82 5.81 Favored 'General case' 0 C--N 1.322 -0.624 0 C-N-CA 120.757 -0.377 . . . . 15.0 110.997 177.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 217' ' ' GLN . . . . . . . . . . . . . 10.1 pt20 . . . . . 0 C--O 1.248 1.02 0 CA-C-O 118.37 -0.824 . . . . 15.0 109.8 177.632 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.481 1.079 0 CA-C-O 121.19 0.519 . . . . 15.0 110.323 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 236' ' ' LEU . . . . . 0.54 HD23 ' HD2' ' A' ' 265' ' ' PRO . 11.4 mt -110.75 172.84 3.25 Favored Pre-proline 0 C--N 1.323 -0.566 0 CA-C-N 115.578 -0.737 . . . . 15.0 110.161 -173.78 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 237' ' ' PRO . . . . . 0.596 ' HD3' ' HD3' ' A' ' 266' ' ' ARG . 13.0 Cg_exo -69.78 172.45 12.63 Favored 'Trans proline' 0 CA--C 1.513 -0.566 0 C-N-CA 122.21 1.94 . . . . 15.0 111.151 167.773 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 14.0 tp10 -69.41 134.57 49.16 Favored 'General case' 0 C--N 1.3 -1.549 0 CA-C-N 114.034 -1.439 . . . . 15.0 111.51 -173.474 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 100.15 9.37 48.44 Favored Glycine 0 CA--C 1.524 0.632 0 CA-C-N 115.74 -0.664 . . . . 15.0 114.31 177.013 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 240' ' ' TYR . . . . . 0.666 ' CD1' ' HB2' ' A' ' 254' ' ' HIS . 86.5 m-85 -111.41 116.88 31.67 Favored 'General case' 0 CA--C 1.517 -0.323 0 CA-C-N 118.129 0.964 . . . . 15.0 111.007 175.166 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 17.7 pt-20 -97.63 123.94 41.72 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 109.198 -0.668 . . . . 15.0 109.198 170.72 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 242' ' ' GLN . . . . . 0.553 ' HG3' ' CE1' ' A' ' 252' ' ' PHE . 1.9 tt0 -89.9 99.13 12.2 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 109.058 -0.719 . . . . 15.0 109.058 -177.841 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 84.2 mtt-85 -92.02 150.01 21.22 Favored 'General case' 0 CA--C 1.5 -0.963 0 CA-C-O 122.428 1.109 . . . . 15.0 113.184 -172.736 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 244' ' ' THR . . . . . . . . . . . . . 16.6 p -118.27 139.83 50.72 Favored 'General case' 0 C--N 1.308 -1.221 0 CA-C-N 112.567 -2.106 . . . . 15.0 109.122 174.777 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 245' ' ' THR . . . . . 1.068 HG21 ' HG2' ' A' ' 247' ' ' GLN . 3.4 t -145.02 150.46 36.93 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 116.406 -0.361 . . . . 15.0 110.124 -173.228 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 6.1 m -48.9 -22.15 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 N-CA-C 113.944 1.09 . . . . 15.0 113.944 -175.454 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 247' ' ' GLN . . . . . 1.068 ' HG2' HG21 ' A' ' 245' ' ' THR . 1.7 pt20 -58.56 -22.67 56.49 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-O 120.705 0.288 . . . . 15.0 110.851 176.539 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 91.08 30.3 11.31 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 121.276 -0.488 . . . . 15.0 112.872 177.356 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 249' ' ' GLN . . . . . 0.404 ' HB3' ' CH2' ' A' ' 262' ' ' TRP . 1.1 mp0 -137.9 143.18 40.71 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.888 0.344 . . . . 15.0 111.621 -178.118 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 29.1 m -90.16 138.39 19.54 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.129 0 CA-C-N 115.901 -0.591 . . . . 15.0 109.426 172.747 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 251' ' ' TYR . . . . . 0.586 ' HB3' ' HG2' ' B' ' 215' ' ' PRO . 32.5 p90 -144.09 136.3 26.55 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 120.853 0.358 . . . . 15.0 110.228 -175.529 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 252' ' ' PHE . . . . . 0.653 ' CD2' ' HA ' ' A' ' 264' ' ' ASP . 32.0 m-85 -89.86 119.51 30.3 Favored 'General case' 0 CA--C 1.507 -0.68 0 CA-C-N 116.043 -0.526 . . . . 15.0 111.66 -172.688 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 253' ' ' LEU . . . . . 0.73 HD13 ' HB3' ' B' ' 212' ' ' PRO . 0.4 OUTLIER -113.52 118.62 34.98 Favored 'General case' 0 N--CA 1.441 -0.919 0 CA-C-N 114.854 -1.067 . . . . 15.0 111.141 -175.727 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 254' ' ' HIS . . . . . 0.666 ' HB2' ' CD1' ' A' ' 240' ' ' TYR . 16.6 t-80 -128.07 90.28 3.06 Favored 'General case' 0 C--N 1.313 -0.992 0 N-CA-C 108.132 -1.062 . . . . 15.0 108.132 168.552 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 255' ' ' THR . . . . . 0.593 HG22 ' HA2' ' A' ' 258' ' ' GLY . 0.3 OUTLIER -89.82 87.38 6.94 Favored 'General case' 0 N--CA 1.429 -1.485 0 C-N-CA 116.462 -2.095 . . . . 15.0 109.881 178.772 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 35.9 tt0 -101.49 -56.39 2.31 Favored 'General case' 0 N--CA 1.436 -1.16 0 N-CA-C 105.884 -1.895 . . . . 15.0 105.884 150.327 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 257' ' ' THR . . . . . . . . . . . . . 63.3 p -96.65 -13.63 22.69 Favored 'General case' 0 CA--C 1.486 -1.512 0 CA-C-N 111.73 -2.486 . . . . 15.0 111.601 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 258' ' ' GLY . . . . . 0.593 ' HA2' HG22 ' A' ' 255' ' ' THR . . . 86.27 73.05 1.28 Allowed Glycine 1 C--N 1.24 -4.773 1 CA-C-N 108.3 -4.045 . . . . 15.0 113.236 -172.83 . . . . . . . . 4 3 . 1 . 008 nuclear orig full ' A' A ' 259' ' ' VAL . . . . . 0.611 ' O ' HD21 ' A' ' 253' ' ' LEU . 55.4 t -89.89 123.36 42.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-O 121.202 0.525 . . . . 15.0 112.206 173.539 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 2.5 p -134.53 92.49 2.92 Favored 'General case' 0 C--N 1.317 -0.844 0 N-CA-C 107.818 -1.179 . . . . 15.0 107.818 168.754 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 8.1 t -121.06 150.14 41.64 Favored 'General case' 0 C--N 1.314 -0.938 0 N-CA-C 112.853 0.686 . . . . 15.0 112.853 -165.251 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 262' ' ' TRP . . . . . 1.16 ' CZ2' ' HB2' ' B' ' 215' ' ' PRO . 1.9 m95 -80.94 -18.87 45.59 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 114.777 -1.102 . . . . 15.0 111.26 174.971 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 263' ' ' HIS . . . . . . . . . . . . . 4.0 p80 -100.31 133.61 44.46 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.558 -0.457 . . . . 15.0 110.106 -178.431 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 264' ' ' ASP . . . . . 0.804 ' HB3' HG12 ' A' ' 267' ' ' ILE . 9.8 t70 -55.67 132.92 71.97 Favored Pre-proline 0 C--N 1.321 -0.661 0 CA-C-N 115.908 -0.587 . . . . 15.0 109.529 175.836 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 265' ' ' PRO . . . . . 0.54 ' HD2' HD23 ' A' ' 236' ' ' LEU . 91.7 Cg_endo -80.67 -14.6 11.32 Favored 'Trans proline' 0 N--CA 1.462 -0.381 0 C-N-CA 122.42 2.08 . . . . 15.0 113.543 -176.192 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 266' ' ' ARG . . . . . 0.596 ' HD3' ' HD3' ' A' ' 237' ' ' PRO . 25.2 tpt180 -77.08 -8.52 57.61 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-O 122.269 1.033 . . . . 15.0 108.408 175.156 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 267' ' ' ILE . . . . . 0.804 HG12 ' HB3' ' A' ' 264' ' ' ASP . 43.2 mm . . . . . 0 C--O 1.249 1.052 0 CA-C-N 113.505 -1.68 . . . . 15.0 109.749 176.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 210' ' ' SER . . . . . . . . . . . . . 4.7 m . . . . . 0 N--CA 1.471 0.616 0 CA-C-O 120.792 0.33 . . . . 15.0 110.387 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B ' 211' ' ' ASP . . . . . 0.401 ' HA ' ' HD3' ' B' ' 212' ' ' PRO . 9.2 p-10 -150.17 131.79 7.61 Favored Pre-proline 0 C--N 1.326 -0.437 0 CA-C-N 116.262 -0.427 . . . . 15.0 110.337 -178.75 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 212' ' ' PRO . . . . . 0.73 ' HB3' HD13 ' A' ' 253' ' ' LEU . 12.3 Cg_endo -89.98 140.45 3.4 Favored 'Trans proline' 0 N--CA 1.453 -0.89 0 C-N-CA 122.995 2.463 . . . . 15.0 112.199 178.602 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -89.81 156.77 25.78 Favored Glycine 0 N--CA 1.443 -0.841 0 C-N-CA 120.548 -0.834 . . . . 15.0 111.94 178.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 214' ' ' SEP . . . . . 0.419 ' HA ' ' HD3' ' B' ' 215' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 215' ' ' PRO . . . . . 1.16 ' HB2' ' CZ2' ' A' ' 262' ' ' TRP . 17.6 Cg_exo -87.55 141.59 5.68 Favored 'Trans proline' 0 N--CA 1.465 -0.189 0 C-N-CA 123.904 3.069 . . . . 15.0 111.232 179.592 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 216' ' ' PHE . . . . . . . . . . . . . 93.2 m-85 -102.5 -78.37 0.54 Allowed 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 109.816 -0.439 . . . . 15.0 109.816 178.587 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 217' ' ' GLN . . . . . . . . . . . . . 8.4 pt20 . . . . . 0 C--O 1.25 1.082 0 CA-C-N 115.997 -0.547 . . . . 15.0 109.731 176.537 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.475 0.803 0 CA-C-O 120.903 0.382 . . . . 15.0 110.612 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 236' ' ' LEU . . . . . 0.434 ' HA ' ' HD3' ' A' ' 266' ' ' ARG . 0.9 OUTLIER -112.3 170.84 4.85 Favored Pre-proline 0 C--N 1.319 -0.751 0 N-CA-C 108.828 -0.804 . . . . 15.0 108.828 175.35 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 237' ' ' PRO . . . . . 0.751 ' HD3' ' HD3' ' A' ' 266' ' ' ARG . 16.0 Cg_exo -69.24 164.54 33.64 Favored 'Trans proline' 0 CA--C 1.514 -0.524 0 C-N-CA 122.009 1.806 . . . . 15.0 110.399 167.457 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -69.92 143.65 52.65 Favored 'General case' 0 C--N 1.302 -1.465 0 CA-C-N 115.02 -0.991 . . . . 15.0 111.356 -173.695 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 100.16 3.9 55.48 Favored Glycine 0 N--CA 1.447 -0.628 0 CA-C-N 115.29 -0.868 . . . . 15.0 113.294 177.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 240' ' ' TYR . . . . . 0.698 ' CD1' ' HB2' ' A' ' 254' ' ' HIS . 74.7 m-85 -105.58 126.46 52.16 Favored 'General case' 0 CA--C 1.514 -0.434 0 CA-C-N 117.352 0.576 . . . . 15.0 110.874 176.996 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -111.71 125.23 53.75 Favored 'General case' 0 C--N 1.316 -0.871 0 N-CA-C 109.461 -0.57 . . . . 15.0 109.461 169.526 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 242' ' ' GLN . . . . . 0.489 ' HG3' ' CE1' ' A' ' 252' ' ' PHE . 7.2 tt0 -89.74 104.1 16.69 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.772 -0.649 . . . . 15.0 109.296 -178.62 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 36.0 mtt-85 -97.03 150.01 21.28 Favored 'General case' 0 CA--C 1.505 -0.771 0 CA-C-O 122.23 1.014 . . . . 15.0 112.368 -176.205 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 244' ' ' THR . . . . . . . . . . . . . 13.6 p -120.27 133.36 55.48 Favored 'General case' 0 C--N 1.308 -1.234 0 CA-C-N 113.085 -1.871 . . . . 15.0 109.506 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 245' ' ' THR . . . . . 0.549 ' OG1' ' HG2' ' A' ' 247' ' ' GLN . 4.6 t -137.4 150.23 47.51 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 116.462 -0.335 . . . . 15.0 110.911 -176.317 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 3.6 m -57.16 -15.88 3.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 115.777 -0.647 . . . . 15.0 112.117 178.694 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 247' ' ' GLN . . . . . 0.549 ' HG2' ' OG1' ' A' ' 245' ' ' THR . 6.8 mm100 -54.42 -24.04 18.35 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.123 -0.489 . . . . 15.0 110.245 172.918 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 92.9 34.12 7.01 Favored Glycine 0 C--N 1.333 0.374 0 CA-C-N 115.903 -0.589 . . . . 15.0 111.927 175.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 249' ' ' GLN . . . . . 0.567 HE21 ' HD2' ' B' ' 215' ' ' PRO . 0.2 OUTLIER -149.42 137.93 20.88 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.449 0.642 . . . . 15.0 111.843 -170.977 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 12.6 m -91.81 128.41 43.51 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.039 0 CA-C-N 114.527 -1.215 . . . . 15.0 109.151 171.16 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 251' ' ' TYR . . . . . 0.599 ' CB ' ' HG3' ' B' ' 215' ' ' PRO . 20.5 p90 -132.8 135.27 45.58 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 109.951 -0.389 . . . . 15.0 109.951 -178.081 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 252' ' ' PHE . . . . . 0.664 ' CD2' ' HA ' ' A' ' 264' ' ' ASP . 30.1 m-85 -90.14 121.74 32.46 Favored 'General case' 0 CA--C 1.513 -0.443 0 CA-C-O 121.224 0.535 . . . . 15.0 111.737 -174.346 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 253' ' ' LEU . . . . . 0.65 HD12 ' HB3' ' B' ' 212' ' ' PRO . 0.5 OUTLIER -109.42 116.51 31.95 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 114.783 -1.099 . . . . 15.0 111.148 -175.824 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 254' ' ' HIS . . . . . 0.698 ' HB2' ' CD1' ' A' ' 240' ' ' TYR . 26.4 t-80 -130.21 90.21 2.91 Favored 'General case' 0 CA--C 1.503 -0.859 0 N-CA-C 108.207 -1.035 . . . . 15.0 108.207 169.866 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 3.2 t -91.32 87.95 6.67 Favored 'General case' 0 N--CA 1.432 -1.374 0 C-N-CA 116.659 -2.017 . . . . 15.0 110.111 -179.424 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 48.3 tt0 -101.33 -51.26 3.53 Favored 'General case' 0 N--CA 1.44 -0.963 0 CA-C-N 113.412 -1.722 . . . . 15.0 106.422 150.712 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 257' ' ' THR . . . . . . . . . . . . . 80.9 p -98.19 -13.61 20.78 Favored 'General case' 0 CA--C 1.488 -1.43 0 CA-C-O 124.78 2.229 . . . . 15.0 111.724 178.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 87.62 73.15 1.28 Allowed Glycine 1 C--N 1.24 -4.75 1 CA-C-N 108.258 -4.065 . . . . 15.0 112.742 -170.977 . . . . . . . . 3 2 . 1 . 009 nuclear orig full ' A' A ' 259' ' ' VAL . . . . . 0.552 ' O ' ' HA ' ' A' ' 253' ' ' LEU . 48.7 t -89.66 125.49 42.62 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.339 0 CA-C-O 121.667 0.746 . . . . 15.0 112.18 175.846 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 1.5 p -138.23 92.39 2.64 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-N 113.763 -1.562 . . . . 15.0 107.658 167.617 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 13.2 t -124.4 150.26 45.79 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 121.386 0.612 . . . . 15.0 112.243 -167.426 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 262' ' ' TRP . . . . . 1.142 ' CZ2' ' HB2' ' B' ' 215' ' ' PRO . 40.9 m95 -75.44 -25.28 57.33 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 114.794 -1.094 . . . . 15.0 112.201 178.959 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 263' ' ' HIS . . . . . . . . . . . . . 8.1 p80 -92.9 142.26 27.5 Favored 'General case' 0 C--N 1.322 -0.608 0 C-N-CA 120.179 -0.608 . . . . 15.0 110.385 -176.043 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 264' ' ' ASP . . . . . 0.851 ' HB3' HG12 ' A' ' 267' ' ' ILE . 9.9 t0 -61.96 134.22 94.2 Favored Pre-proline 0 C--N 1.321 -0.635 0 N-CA-C 108.541 -0.911 . . . . 15.0 108.541 175.216 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 265' ' ' PRO . . . . . 0.574 ' HD3' ' CD2' ' A' ' 252' ' ' PHE . 71.6 Cg_endo -81.81 -14.46 10.01 Favored 'Trans proline' 0 N--CA 1.452 -0.969 0 C-N-CA 122.039 1.826 . . . . 15.0 113.547 -174.559 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 266' ' ' ARG . . . . . 0.751 ' HD3' ' HD3' ' A' ' 237' ' ' PRO . 17.8 tpt180 -78.87 -7.5 57.98 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-O 122.029 0.919 . . . . 15.0 108.723 174.62 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 267' ' ' ILE . . . . . 0.851 HG12 ' HB3' ' A' ' 264' ' ' ASP . 46.9 mm . . . . . 0 C--O 1.249 1.067 0 CA-C-N 113.846 -1.525 . . . . 15.0 109.663 177.063 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 210' ' ' SER . . . . . . . . . . . . . 20.0 m . . . . . 0 N--CA 1.482 1.132 0 CA-C-O 120.955 0.407 . . . . 15.0 110.969 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' 211' ' ' ASP . . . . . 0.468 ' HA ' ' HD3' ' B' ' 212' ' ' PRO . 36.3 t70 -101.58 113.82 65.76 Favored Pre-proline 0 C--N 1.325 -0.488 0 CA-C-N 116.328 -0.396 . . . . 15.0 110.244 -177.701 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 212' ' ' PRO . . . . . 0.65 ' HB3' HD12 ' A' ' 253' ' ' LEU . 6.3 Cg_endo -89.71 160.2 5.19 Favored 'Trans proline' 0 N--CA 1.456 -0.688 0 C-N-CA 123.454 2.769 . . . . 15.0 112.891 -175.985 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -90.08 145.5 18.2 Favored Glycine 0 N--CA 1.444 -0.813 0 CA-C-N 115.717 -0.674 . . . . 15.0 112.52 -178.151 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 214' ' ' SEP . . . . . 0.439 ' HA ' ' HD3' ' B' ' 215' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 215' ' ' PRO . . . . . 1.142 ' HB2' ' CZ2' ' A' ' 262' ' ' TRP . 6.2 Cg_exo -88.3 140.34 4.58 Favored 'Trans proline' 0 C--O 1.234 0.285 0 C-N-CA 123.424 2.749 . . . . 15.0 110.977 179.467 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 216' ' ' PHE . . . . . . . . . . . . . 92.9 m-85 -110.45 101.0 9.74 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 121.061 -0.256 . . . . 15.0 111.282 -178.838 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 217' ' ' GLN . . . . . . . . . . . . . 14.6 mm100 . . . . . 0 C--O 1.25 1.124 0 O-C-N 124.131 0.895 . . . . 15.0 112.463 174.237 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 31.9 mt-10 . . . . . 0 N--CA 1.481 1.098 0 CA-C-O 120.708 0.289 . . . . 15.0 110.276 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 4.8 mt -117.9 166.31 13.87 Favored Pre-proline 0 C--N 1.323 -0.554 0 CA-C-N 116.346 -0.388 . . . . 15.0 110.426 -175.427 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 237' ' ' PRO . . . . . 0.769 ' HD3' ' HD3' ' A' ' 266' ' ' ARG . 16.5 Cg_exo -69.37 169.6 18.04 Favored 'Trans proline' 0 CA--C 1.511 -0.672 0 C-N-CA 122.308 2.005 . . . . 15.0 110.654 165.355 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 60.0 mt-10 -69.5 137.14 52.28 Favored 'General case' 0 C--N 1.303 -1.425 0 CA-C-N 114.594 -1.185 . . . . 15.0 112.375 -172.096 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 100.54 5.76 53.69 Favored Glycine 0 N--CA 1.447 -0.582 0 CA-C-N 113.914 -1.494 . . . . 15.0 113.706 175.245 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 240' ' ' TYR . . . . . 0.671 ' CD1' ' HB2' ' A' ' 254' ' ' HIS . 83.4 m-85 -104.06 122.99 46.41 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 117.741 0.77 . . . . 15.0 110.738 175.891 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 241' ' ' GLU . . . . . 0.458 ' HG3' ' HB3' ' A' ' 253' ' ' LEU . 8.1 pt-20 -105.57 127.37 52.99 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 109.139 -0.689 . . . . 15.0 109.139 170.84 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 242' ' ' GLN . . . . . 0.655 ' HG3' ' CE1' ' A' ' 252' ' ' PHE . 9.6 tt0 -89.86 105.15 17.61 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 108.932 -0.766 . . . . 15.0 108.932 179.86 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 54.9 mtt-85 -92.39 149.28 21.51 Favored 'General case' 0 CA--C 1.506 -0.724 0 CA-C-O 122.288 1.042 . . . . 15.0 112.158 -177.074 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 244' ' ' THR . . . . . . . . . . . . . 20.4 p -126.4 89.91 3.09 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-N 113.066 -1.879 . . . . 15.0 109.101 -174.139 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 245' ' ' THR . . . . . 0.763 HG23 ' HB2' ' A' ' 247' ' ' GLN . 13.4 t -97.24 150.27 21.11 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 115.162 -0.926 . . . . 15.0 110.326 -171.106 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 26.8 t -54.41 -17.91 2.35 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 C-N-CA 122.915 0.486 . . . . 15.0 111.961 -175.069 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 247' ' ' GLN . . . . . 0.763 ' HB2' HG23 ' A' ' 245' ' ' THR . 10.4 mp0 -51.18 -22.89 2.86 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 123.25 0.62 . . . . 15.0 111.318 172.17 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 88.05 16.0 60.08 Favored Glycine 0 C--N 1.33 0.233 0 C-N-CA 121.156 -0.545 . . . . 15.0 112.06 178.23 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 1.8 mt-30 -131.11 137.56 49.13 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 109.884 -0.413 . . . . 15.0 109.884 -176.316 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 14.4 m -89.72 134.05 29.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-N 116.358 -0.383 . . . . 15.0 110.306 177.407 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 251' ' ' TYR . . . . . 0.561 ' HB3' ' CG ' ' B' ' 215' ' ' PRO . 14.9 p90 -133.41 137.05 45.61 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.35 -0.386 . . . . 15.0 110.194 -179.698 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 252' ' ' PHE . . . . . 0.694 ' CD2' ' HA ' ' A' ' 264' ' ' ASP . 37.6 m-85 -89.88 121.74 32.28 Favored 'General case' 0 CA--C 1.512 -0.498 0 CA-C-O 121.193 0.521 . . . . 15.0 110.909 -175.8 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 253' ' ' LEU . . . . . 0.861 HD12 ' HB3' ' B' ' 212' ' ' PRO . 0.4 OUTLIER -113.16 124.75 53.28 Favored 'General case' 0 N--CA 1.445 -0.699 0 CA-C-N 114.858 -1.065 . . . . 15.0 110.756 -174.921 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 254' ' ' HIS . . . . . 0.671 ' HB2' ' CD1' ' A' ' 240' ' ' TYR . 14.5 t-80 -138.95 97.51 3.33 Favored 'General case' 0 CA--C 1.499 -1.014 0 N-CA-C 108.645 -0.872 . . . . 15.0 108.645 173.198 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 24.5 m -93.57 87.74 5.63 Favored 'General case' 0 N--CA 1.434 -1.244 0 C-N-CA 116.539 -2.064 . . . . 15.0 110.402 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 35.3 tt0 -101.29 -54.0 2.88 Favored 'General case' 0 N--CA 1.44 -0.956 0 N-CA-C 105.653 -1.981 . . . . 15.0 105.653 148.826 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 257' ' ' THR . . . . . . . . . . . . . 77.8 p -100.06 -13.61 18.96 Favored 'General case' 0 CA--C 1.485 -1.535 0 CA-C-N 112.555 -2.111 . . . . 15.0 112.223 -178.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 86.67 73.7 1.28 Allowed Glycine 1 C--N 1.239 -4.808 0 CA-C-N 108.806 -3.815 . . . . 15.0 112.753 -171.293 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 259' ' ' VAL . . . . . 0.639 ' O ' ' HA ' ' A' ' 253' ' ' LEU . 43.8 t -89.69 124.62 42.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 121.43 0.633 . . . . 15.0 112.02 176.021 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -140.15 102.14 4.31 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 114.407 -1.27 . . . . 15.0 107.915 168.345 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 12.9 t -143.31 150.35 39.07 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.9 -0.591 . . . . 15.0 111.878 -168.746 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 262' ' ' TRP . . . . . 1.19 ' CZ2' ' HB2' ' B' ' 215' ' ' PRO . 92.7 m95 -70.0 -42.57 72.87 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 115.638 -0.71 . . . . 15.0 111.492 178.286 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 263' ' ' HIS . . . . . . . . . . . . . 2.7 p80 -73.53 132.37 42.79 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.255 -0.429 . . . . 15.0 110.246 -175.868 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 264' ' ' ASP . . . . . 0.998 ' HB3' HG12 ' A' ' 267' ' ' ILE . 22.0 t0 -56.38 127.63 72.0 Favored Pre-proline 0 C--N 1.32 -0.715 0 N-CA-C 108.155 -1.054 . . . . 15.0 108.155 172.769 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 265' ' ' PRO . . . . . 0.509 ' HG2' ' CD1' ' A' ' 240' ' ' TYR . 12.1 Cg_exo -69.34 -14.52 37.56 Favored 'Trans proline' 0 C--N 1.329 -0.482 0 C-N-CA 122.27 1.98 . . . . 15.0 112.614 -177.466 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 266' ' ' ARG . . . . . 0.769 ' HD3' ' HD3' ' A' ' 237' ' ' PRO . 16.1 tpt180 -75.39 -11.62 60.08 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 108.7 -0.852 . . . . 15.0 108.7 172.91 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 267' ' ' ILE . . . . . 0.998 HG12 ' HB3' ' A' ' 264' ' ' ASP . 24.6 pt . . . . . 0 C--O 1.248 1.017 0 CA-C-N 114.625 -1.171 . . . . 15.0 111.364 178.101 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 210' ' ' SER . . . . . . . . . . . . . 40.8 m . . . . . 0 N--CA 1.479 0.99 0 CA-C-O 120.77 0.319 . . . . 15.0 111.258 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 211' ' ' ASP . . . . . 0.459 ' HA ' ' HD3' ' B' ' 212' ' ' PRO . 10.1 p-10 -90.44 141.78 27.64 Favored Pre-proline 0 C--N 1.328 -0.363 0 N-CA-C 109.657 -0.498 . . . . 15.0 109.657 179.38 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 212' ' ' PRO . . . . . 0.861 ' HB3' HD12 ' A' ' 253' ' ' LEU . 9.5 Cg_endo -89.6 148.85 5.13 Favored 'Trans proline' 0 N--CA 1.454 -0.822 0 C-N-CA 122.733 2.289 . . . . 15.0 112.581 -177.567 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -89.88 159.89 28.24 Favored Glycine 0 N--CA 1.443 -0.87 0 C-N-CA 120.746 -0.74 . . . . 15.0 112.075 -179.386 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 214' ' ' SEP . . . . . 0.446 ' HA ' ' HD3' ' B' ' 215' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 215' ' ' PRO . . . . . 1.19 ' HB2' ' CZ2' ' A' ' 262' ' ' TRP . 7.1 Cg_exo -88.19 149.99 6.76 Favored 'Trans proline' 0 C--O 1.235 0.33 0 C-N-CA 123.417 2.745 . . . . 15.0 111.853 175.072 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 216' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -125.8 131.87 52.38 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.869 -0.419 . . . . 15.0 109.869 174.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 217' ' ' GLN . . . . . 0.434 ' HB3' ' NE1' ' A' ' 262' ' ' TRP . 4.0 pt20 . . . . . 0 C--O 1.247 0.96 0 CA-C-O 118.409 -0.805 . . . . 15.0 110.046 176.181 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 26.0 mt-10 . . . . . 0 N--CA 1.48 1.047 0 N-CA-C 109.682 -0.488 . . . . 15.0 109.682 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 236' ' ' LEU . . . . . 0.676 HD22 ' H ' ' A' ' 236' ' ' LEU . 0.1 OUTLIER -93.05 159.52 35.44 Favored Pre-proline 0 C--N 1.326 -0.431 0 CA-C-N 115.987 -0.551 . . . . 15.0 110.939 -170.7 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 237' ' ' PRO . . . . . 0.45 ' HD3' ' HD3' ' A' ' 266' ' ' ARG . 18.8 Cg_exo -69.65 166.21 28.21 Favored 'Trans proline' 0 CA--C 1.515 -0.455 0 C-N-CA 122.993 2.462 . . . . 15.0 110.323 164.705 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -69.7 150.02 47.41 Favored 'General case' 0 C--N 1.307 -1.278 0 CA-C-N 115.443 -0.799 . . . . 15.0 110.968 -177.207 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 100.03 -2.14 56.63 Favored Glycine 0 N--CA 1.447 -0.593 0 CA-C-N 115.508 -0.769 . . . . 15.0 113.809 179.489 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 240' ' ' TYR . . . . . 0.646 ' CD1' ' HB2' ' A' ' 254' ' ' HIS . 79.6 m-85 -104.28 115.35 30.24 Favored 'General case' 0 CA--C 1.518 -0.283 0 CA-C-N 117.688 0.744 . . . . 15.0 110.626 178.233 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 26.5 mt-10 -95.7 123.13 39.12 Favored 'General case' 0 C--N 1.317 -0.844 0 N-CA-C 109.074 -0.713 . . . . 15.0 109.074 175.015 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 23.7 tm0? -89.91 109.11 20.15 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 108.728 -0.842 . . . . 15.0 108.728 179.845 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 47.9 mtt85 -105.27 150.09 25.45 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 122.143 0.973 . . . . 15.0 112.098 -179.291 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 244' ' ' THR . . . . . . . . . . . . . 5.6 p -127.36 98.25 5.19 Favored 'General case' 0 C--N 1.31 -1.125 0 CA-C-N 113.279 -1.782 . . . . 15.0 109.309 -177.183 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 245' ' ' THR . . . . . 0.456 ' OG1' ' HG2' ' A' ' 247' ' ' GLN . 3.1 t -89.92 150.4 22.19 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 115.567 -0.742 . . . . 15.0 111.098 -174.279 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 8.4 m -50.8 -19.36 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.21 0 CA-C-N 115.413 -0.812 . . . . 15.0 112.236 177.423 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 247' ' ' GLN . . . . . 0.456 ' HG2' ' OG1' ' A' ' 245' ' ' THR . 7.3 mm100 -55.62 -26.08 42.31 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.07 -0.514 . . . . 15.0 110.953 173.514 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 89.01 30.58 14.05 Favored Glycine 0 N--CA 1.449 -0.495 0 CA-C-N 115.943 -0.571 . . . . 15.0 111.996 179.706 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 249' ' ' GLN . . . . . 0.439 ' HG3' ' HB2' ' A' ' 247' ' ' GLN . 0.0 OUTLIER -134.76 142.09 46.64 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.642 0.258 . . . . 15.0 110.388 -177.006 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 17.9 m -89.97 134.89 27.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 115.884 -0.598 . . . . 15.0 109.825 175.373 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 251' ' ' TYR . . . . . 0.506 ' HB3' ' CG ' ' B' ' 215' ' ' PRO . 4.3 p90 -142.73 135.77 28.28 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.083 0.468 . . . . 15.0 110.448 179.493 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 252' ' ' PHE . . . . . 0.733 ' CE2' ' HA ' ' A' ' 264' ' ' ASP . 34.5 m-85 -90.27 125.55 35.54 Favored 'General case' 0 CA--C 1.511 -0.526 0 CA-C-N 115.826 -0.625 . . . . 15.0 111.126 -176.57 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 253' ' ' LEU . . . . . 1.012 HD13 ' HB3' ' B' ' 212' ' ' PRO . 0.4 OUTLIER -113.98 111.25 21.37 Favored 'General case' 0 N--CA 1.445 -0.724 0 CA-C-N 115.25 -0.886 . . . . 15.0 111.768 -174.589 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 254' ' ' HIS . . . . . 0.646 ' HB2' ' CD1' ' A' ' 240' ' ' TYR . 36.4 t-80 -122.46 90.11 3.24 Favored 'General case' 0 CA--C 1.499 -0.992 0 N-CA-C 107.981 -1.118 . . . . 15.0 107.981 166.345 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 7.3 t -96.38 88.05 4.63 Favored 'General case' 0 N--CA 1.428 -1.567 0 C-N-CA 116.599 -2.041 . . . . 15.0 110.192 -178.878 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 63.7 tt0 -101.2 -51.48 3.5 Favored 'General case' 0 N--CA 1.437 -1.081 0 CA-C-N 112.875 -1.966 . . . . 15.0 105.838 151.519 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 257' ' ' THR . . . . . . . . . . . . . 79.6 p -96.78 -13.42 22.65 Favored 'General case' 0 CA--C 1.486 -1.506 0 CA-C-O 125.034 2.35 . . . . 15.0 111.623 178.531 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 86.74 74.62 1.27 Allowed Glycine 1 C--N 1.24 -4.783 1 CA-C-N 108.222 -4.081 . . . . 15.0 112.899 -172.92 . . . . . . . . 3 2 . 1 . 011 nuclear orig full ' A' A ' 259' ' ' VAL . . . . . 0.569 ' O ' ' HA ' ' A' ' 253' ' ' LEU . 57.4 t -89.9 121.86 40.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-O 121.556 0.693 . . . . 15.0 112.02 172.855 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 1.3 p -135.27 103.62 5.58 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 114.042 -1.435 . . . . 15.0 107.988 169.878 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 261' ' ' THR . . . . . 0.462 ' OG1' ' HD2' ' A' ' 263' ' ' HIS . 14.3 t -143.41 150.49 39.14 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 112.977 0.732 . . . . 15.0 112.977 -168.085 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 262' ' ' TRP . . . . . 1.178 ' CZ2' ' HB2' ' B' ' 215' ' ' PRO . 89.1 m95 -71.44 -32.6 68.54 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 114.956 -1.02 . . . . 15.0 111.848 178.543 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 263' ' ' HIS . . . . . 0.462 ' HD2' ' OG1' ' A' ' 261' ' ' THR . 5.4 p80 -86.28 137.47 32.58 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.596 -0.441 . . . . 15.0 110.986 -172.241 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 264' ' ' ASP . . . . . 0.983 ' HB3' HG12 ' A' ' 267' ' ' ILE . 7.3 t0 -52.96 129.86 48.53 Favored Pre-proline 0 C--N 1.325 -0.458 0 N-CA-C 108.864 -0.791 . . . . 15.0 108.864 172.92 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 265' ' ' PRO . . . . . 0.574 ' HD2' HD13 ' A' ' 236' ' ' LEU . 67.0 Cg_endo -73.2 -14.87 25.74 Favored 'Trans proline' 0 CA--C 1.51 -0.724 0 C-N-CA 122.193 1.928 . . . . 15.0 113.64 -173.961 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 266' ' ' ARG . . . . . 0.45 ' HD3' ' HD3' ' A' ' 237' ' ' PRO . 8.4 tpt180 -83.93 -5.58 59.25 Favored 'General case' 0 C--N 1.306 -1.293 0 N-CA-C 108.254 -1.017 . . . . 15.0 108.254 174.245 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 267' ' ' ILE . . . . . 0.983 HG12 ' HB3' ' A' ' 264' ' ' ASP . 45.0 pt . . . . . 0 C--O 1.247 0.965 0 CA-C-N 114.023 -1.444 . . . . 15.0 110.728 174.667 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 210' ' ' SER . . . . . . . . . . . . . 19.3 m . . . . . 0 N--CA 1.477 0.891 0 CA-C-O 120.841 0.353 . . . . 15.0 111.038 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' B' B ' 211' ' ' ASP . . . . . 0.416 ' HA ' ' HD3' ' B' ' 212' ' ' PRO . 13.9 m-20 -110.05 115.18 55.25 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 120.76 0.314 . . . . 15.0 110.759 -178.032 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 212' ' ' PRO . . . . . 1.012 ' HB3' HD13 ' A' ' 253' ' ' LEU . 6.1 Cg_exo -89.6 141.55 3.93 Favored 'Trans proline' 0 N--CA 1.461 -0.437 0 C-N-CA 123.422 2.748 . . . . 15.0 112.851 178.99 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -89.98 149.07 20.15 Favored Glycine 0 N--CA 1.443 -0.866 0 CA-C-N 115.52 -0.764 . . . . 15.0 111.745 178.619 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 214' ' ' SEP . . . . . 0.473 ' HA ' ' HD3' ' B' ' 215' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 215' ' ' PRO . . . . . 1.178 ' HB2' ' CZ2' ' A' ' 262' ' ' TRP . 7.2 Cg_exo -88.4 143.39 5.45 Favored 'Trans proline' 0 C--O 1.235 0.352 0 C-N-CA 123.779 2.986 . . . . 15.0 111.459 -178.682 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 216' ' ' PHE . . . . . . . . . . . . . 84.6 m-85 -112.83 171.26 7.64 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.415 -0.357 . . . . 15.0 110.559 -179.624 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 217' ' ' GLN . . . . . . . . . . . . . 2.5 mp0 . . . . . 0 C--O 1.249 1.053 0 CA-C-O 118.402 -0.809 . . . . 15.0 109.617 179.864 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 . . . . . 0 N--CA 1.48 1.052 0 N-CA-C 110.412 -0.218 . . . . 15.0 110.412 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 236' ' ' LEU . . . . . 0.632 ' H ' HD23 ' A' ' 236' ' ' LEU . 0.2 OUTLIER -93.54 153.6 41.28 Favored Pre-proline 0 C--N 1.323 -0.571 0 CA-C-O 121.443 0.639 . . . . 15.0 110.906 -174.522 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 237' ' ' PRO . . . . . 0.483 ' HD2' ' CE2' ' A' ' 240' ' ' TYR . 15.3 Cg_exo -69.65 173.88 10.23 Favored 'Trans proline' 0 CA--C 1.514 -0.516 0 C-N-CA 123.202 2.602 . . . . 15.0 110.672 161.675 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -69.42 143.45 53.61 Favored 'General case' 0 C--N 1.3 -1.581 0 CA-C-N 114.487 -1.233 . . . . 15.0 111.238 -177.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 100.18 8.29 50.68 Favored Glycine 0 N--CA 1.45 -0.386 0 CA-C-N 115.502 -0.772 . . . . 15.0 113.735 177.169 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 240' ' ' TYR . . . . . 0.614 ' CD1' ' HB2' ' A' ' 254' ' ' HIS . 72.2 m-85 -107.32 116.5 32.04 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 117.611 0.705 . . . . 15.0 111.346 178.826 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 241' ' ' GLU . . . . . 0.57 ' HB3' ' HB3' ' A' ' 253' ' ' LEU . 4.5 tp10 -89.84 111.58 22.65 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.156 -0.929 . . . . 15.0 108.737 174.562 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -90.06 102.72 15.43 Favored 'General case' 0 C--N 1.314 -0.943 0 N-CA-C 108.635 -0.876 . . . . 15.0 108.635 178.681 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 51.0 mtt-85 -99.21 148.26 24.29 Favored 'General case' 0 CA--C 1.499 -0.998 0 CA-C-O 121.96 0.886 . . . . 15.0 112.185 -177.742 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 244' ' ' THR . . . . . . . . . . . . . 11.7 m -123.2 93.97 4.12 Favored 'General case' 0 C--N 1.309 -1.191 0 CA-C-N 113.505 -1.68 . . . . 15.0 110.207 -179.413 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 245' ' ' THR . . . . . 1.096 HG22 ' HG2' ' A' ' 247' ' ' GLN . 7.7 t -95.25 150.73 19.91 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.546 -0.752 . . . . 15.0 110.248 179.99 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 15.0 m -41.15 -25.27 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 N-CA-C 114.642 1.349 . . . . 15.0 114.642 -175.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 247' ' ' GLN . . . . . 1.096 ' HG2' HG22 ' A' ' 245' ' ' THR . 3.5 pt20 -54.4 -21.45 9.71 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 117.793 0.27 . . . . 15.0 111.14 177.251 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 87.76 20.64 50.07 Favored Glycine 0 C--N 1.333 0.411 0 C-N-CA 121.206 -0.521 . . . . 15.0 113.036 173.821 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 249' ' ' GLN . . . . . 0.413 ' HB2' ' OE1' ' A' ' 247' ' ' GLN . 18.5 mt-30 -129.98 142.71 50.6 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.586 -0.524 . . . . 15.0 109.586 -177.207 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 29.8 m -91.25 134.75 28.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-O 120.943 0.402 . . . . 15.0 110.924 179.875 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 251' ' ' TYR . . . . . 0.688 ' HB3' ' HG2' ' B' ' 215' ' ' PRO . 33.0 p90 -134.27 137.56 44.38 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.778 -0.452 . . . . 15.0 109.778 -178.005 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 252' ' ' PHE . . . . . 0.664 ' CE2' ' HA ' ' A' ' 264' ' ' ASP . 26.6 m-85 -92.01 116.58 29.05 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.218 0.533 . . . . 15.0 111.386 -174.66 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 253' ' ' LEU . . . . . 0.744 HD13 ' HB3' ' B' ' 212' ' ' PRO . 0.5 OUTLIER -106.54 96.87 6.76 Favored 'General case' 0 N--CA 1.447 -0.604 0 CA-C-N 115.063 -0.972 . . . . 15.0 111.3 -175.154 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 254' ' ' HIS . . . . . 0.614 ' HB2' ' CD1' ' A' ' 240' ' ' TYR . 33.5 t-80 -106.53 90.12 3.24 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 108.417 -0.957 . . . . 15.0 108.417 169.5 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 1.9 t -94.65 87.81 5.2 Favored 'General case' 0 N--CA 1.432 -1.342 0 C-N-CA 116.746 -1.982 . . . . 15.0 110.286 -179.698 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 57.4 tt0 -101.18 -50.2 3.86 Favored 'General case' 0 N--CA 1.441 -0.919 0 CA-C-N 112.957 -1.929 . . . . 15.0 106.25 150.876 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 257' ' ' THR . . . . . . . . . . . . . 67.0 p -98.53 -13.56 20.41 Favored 'General case' 0 CA--C 1.486 -1.503 0 CA-C-O 124.706 2.193 . . . . 15.0 111.738 178.469 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 87.07 73.57 1.28 Allowed Glycine 1 C--N 1.24 -4.803 0 CA-C-N 108.493 -3.958 . . . . 15.0 112.851 -172.3 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 259' ' ' VAL . . . . . 0.688 ' O ' ' HA ' ' A' ' 253' ' ' LEU . 52.3 t -89.92 125.3 42.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-O 121.284 0.564 . . . . 15.0 112.135 174.275 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 1.6 p -137.16 98.01 3.63 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 114.699 -1.137 . . . . 15.0 107.987 167.666 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 14.0 t -136.79 150.29 48.27 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.994 -0.548 . . . . 15.0 111.972 -168.464 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 262' ' ' TRP . . . . . 1.201 ' CZ2' ' HB2' ' B' ' 215' ' ' PRO . 83.2 m95 -71.83 -39.46 69.74 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.062 -0.972 . . . . 15.0 111.663 179.481 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 263' ' ' HIS . . . . . . . . . . . . . 5.5 p80 -77.82 137.23 38.3 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.451 -0.341 . . . . 15.0 110.48 -173.496 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 264' ' ' ASP . . . . . 1.033 ' HB3' HG12 ' A' ' 267' ' ' ILE . 27.7 t0 -57.54 124.21 66.41 Favored Pre-proline 0 C--N 1.324 -0.533 0 N-CA-C 108.024 -1.102 . . . . 15.0 108.024 169.899 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 265' ' ' PRO . . . . . 0.617 ' HD3' ' CD2' ' A' ' 252' ' ' PHE . 12.1 Cg_exo -69.13 -14.7 38.55 Favored 'Trans proline' 0 N--CA 1.459 -0.558 0 C-N-CA 122.236 1.957 . . . . 15.0 112.914 -175.997 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 266' ' ' ARG . . . . . 0.438 ' HD3' ' HD3' ' A' ' 237' ' ' PRO . 6.1 tpt180 -76.44 -11.64 59.92 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-O 121.99 0.9 . . . . 15.0 108.918 173.572 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 267' ' ' ILE . . . . . 1.033 HG12 ' HB3' ' A' ' 264' ' ' ASP . 36.5 pt . . . . . 0 C--O 1.246 0.904 0 CA-C-N 114.562 -1.199 . . . . 15.0 111.458 -179.364 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 210' ' ' SER . . . . . . . . . . . . . 17.7 m . . . . . 0 N--CA 1.476 0.863 0 CA-C-O 120.977 0.418 . . . . 15.0 110.327 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' B' B ' 211' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -98.97 116.83 65.05 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.136 -0.484 . . . . 15.0 110.93 -172.577 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 212' ' ' PRO . . . . . 0.744 ' HB3' HD13 ' A' ' 253' ' ' LEU . 6.6 Cg_endo -89.87 144.21 4.34 Favored 'Trans proline' 0 N--CA 1.451 -1.026 0 C-N-CA 122.851 2.367 . . . . 15.0 111.051 171.138 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -89.85 157.79 26.59 Favored Glycine 0 N--CA 1.442 -0.946 0 C-N-CA 120.192 -1.004 . . . . 15.0 111.923 -179.517 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 214' ' ' SEP . . . . . 0.718 ' HB3' HG21 ' A' ' 245' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 215' ' ' PRO . . . . . 1.201 ' HB2' ' CZ2' ' A' ' 262' ' ' TRP . 14.2 Cg_exo -87.44 144.53 6.77 Favored 'Trans proline' 0 N--CA 1.458 -0.572 0 C-N-CA 123.451 2.767 . . . . 15.0 110.839 179.71 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 216' ' ' PHE . . . . . . . . . . . . . 82.7 m-85 -116.28 146.54 42.31 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 116.357 -0.383 . . . . 15.0 110.096 179.863 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 217' ' ' GLN . . . . . . . . . . . . . 26.2 tt0 . . . . . 0 C--O 1.248 1.022 0 CA-C-O 118.816 -0.612 . . . . 15.0 110.181 -179.285 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 . . . . . 0 N--CA 1.478 0.94 0 CA-C-O 120.835 0.35 . . . . 15.0 110.106 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 236' ' ' LEU . . . . . 0.478 ' H ' HD23 ' A' ' 236' ' ' LEU . 0.6 OUTLIER -91.44 173.27 5.54 Favored Pre-proline 0 C--N 1.324 -0.519 0 CA-C-N 116.052 -0.522 . . . . 15.0 110.287 -174.52 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 237' ' ' PRO . . . . . 0.593 ' HD3' ' HD3' ' A' ' 266' ' ' ARG . 20.0 Cg_exo -69.2 170.77 15.15 Favored 'Trans proline' 0 CA--C 1.509 -0.759 0 C-N-CA 122.308 2.005 . . . . 15.0 111.258 166.81 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -69.46 139.1 53.93 Favored 'General case' 0 C--N 1.301 -1.535 0 CA-C-N 114.215 -1.357 . . . . 15.0 110.995 -171.819 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 239' ' ' GLY . . . . . 0.404 ' O ' ' HD2' ' A' ' 254' ' ' HIS . . . 100.22 -2.28 56.41 Favored Glycine 0 N--CA 1.448 -0.509 0 CA-C-N 115.621 -0.718 . . . . 15.0 113.752 179.288 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 240' ' ' TYR . . . . . 0.421 ' HD2' ' O ' ' A' ' 237' ' ' PRO . 84.6 m-85 -97.39 116.52 29.75 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 118.087 0.943 . . . . 15.0 111.167 177.381 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 241' ' ' GLU . . . . . 0.567 ' HB2' ' HB3' ' A' ' 253' ' ' LEU . 5.6 mt-10 -89.9 111.06 21.99 Favored 'General case' 0 N--CA 1.441 -0.915 0 CA-C-N 114.297 -1.319 . . . . 15.0 109.232 177.606 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 242' ' ' GLN . . . . . 0.537 HE22 HG21 ' A' ' 244' ' ' THR . 1.0 OUTLIER -89.88 103.72 16.35 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 108.88 -0.785 . . . . 15.0 108.88 178.355 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 243' ' ' ARG . . . . . 0.406 ' CZ ' ' HG2' ' B' ' 212' ' ' PRO . 8.2 mtp180 -108.33 149.01 29.25 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.768 0.794 . . . . 15.0 112.114 -178.456 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 244' ' ' THR . . . . . 0.537 HG21 HE22 ' A' ' 242' ' ' GLN . 16.2 p -120.39 121.19 38.02 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 114.008 -1.451 . . . . 15.0 109.799 -178.035 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 245' ' ' THR . . . . . 0.512 ' OG1' ' HG2' ' A' ' 247' ' ' GLN . 4.6 t -110.66 150.55 28.85 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 116.24 -0.437 . . . . 15.0 111.013 -176.863 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 5.5 p -50.07 -24.31 1.92 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.262 0 CA-C-N 115.389 -0.823 . . . . 15.0 111.2 175.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 247' ' ' GLN . . . . . 0.512 ' HG2' ' OG1' ' A' ' 245' ' ' THR . 3.9 mm-40 -51.97 -26.84 11.46 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 115.335 -0.848 . . . . 15.0 110.823 175.42 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 104.56 9.36 35.76 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 121.098 -0.572 . . . . 15.0 113.092 174.518 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 2.1 pm0 -123.38 149.04 45.46 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 112.904 0.705 . . . . 15.0 112.904 -174.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 6.2 m -89.79 132.67 33.89 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.435 0 CA-C-N 114.727 -1.124 . . . . 15.0 108.367 166.69 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 251' ' ' TYR . . . . . 0.545 ' CB ' ' HG3' ' B' ' 215' ' ' PRO . 2.4 p90 -134.61 140.3 45.97 Favored 'General case' 0 C--N 1.314 -0.946 0 C-N-CA 120.538 -0.465 . . . . 15.0 110.1 179.969 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 252' ' ' PHE . . . . . 0.661 ' CD2' ' HA ' ' A' ' 264' ' ' ASP . 24.2 m-85 -90.0 111.66 22.83 Favored 'General case' 0 CA--C 1.507 -0.698 0 CA-C-O 121.854 0.835 . . . . 15.0 111.601 -174.972 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 253' ' ' LEU . . . . . 0.898 HD13 ' HB3' ' B' ' 212' ' ' PRO . 0.5 OUTLIER -99.52 140.96 32.94 Favored 'General case' 0 N--CA 1.438 -1.055 0 CA-C-N 113.696 -1.593 . . . . 15.0 109.192 178.893 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 254' ' ' HIS . . . . . 0.464 ' HB3' ' HB ' ' A' ' 259' ' ' VAL . 13.6 t-80 -149.98 93.13 1.98 Allowed 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 108.335 -0.987 . . . . 15.0 108.335 170.72 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 255' ' ' THR . . . . . 0.494 HG21 ' OE2' ' A' ' 241' ' ' GLU . 2.6 t -90.04 87.95 7.1 Favored 'General case' 0 N--CA 1.431 -1.404 0 C-N-CA 116.387 -2.125 . . . . 15.0 110.328 -179.949 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 56.3 tt0 -101.26 -54.2 2.83 Favored 'General case' 0 N--CA 1.44 -0.963 0 CA-C-N 112.761 -2.018 . . . . 15.0 105.733 148.089 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 257' ' ' THR . . . . . . . . . . . . . 71.3 p -99.94 -13.72 19.01 Favored 'General case' 0 CA--C 1.487 -1.455 0 CA-C-N 112.156 -2.293 . . . . 15.0 112.333 -178.834 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 85.71 72.0 1.3 Allowed Glycine 1 C--N 1.244 -4.546 0 CA-C-N 108.492 -3.958 . . . . 15.0 112.762 -170.986 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 259' ' ' VAL . . . . . 0.553 ' O ' HD21 ' A' ' 253' ' ' LEU . 85.1 t -89.75 134.56 28.53 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.426 0 CA-C-O 121.519 0.676 . . . . 15.0 112.71 178.267 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 1.7 p -144.65 105.02 4.1 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 114.388 -1.278 . . . . 15.0 108.298 168.156 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 8.8 t -141.05 150.32 42.81 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 112.333 0.494 . . . . 15.0 112.333 -170.004 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 262' ' ' TRP . . . . . 1.019 ' CZ2' ' HB2' ' B' ' 215' ' ' PRO . 6.7 m95 -68.54 -27.03 65.73 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.335 -0.848 . . . . 15.0 112.329 177.093 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 263' ' ' HIS . . . . . . . . . . . . . 5.2 p80 -85.68 132.73 34.1 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 120.137 -0.625 . . . . 15.0 111.026 -172.711 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 264' ' ' ASP . . . . . 1.05 ' HB3' HG12 ' A' ' 267' ' ' ILE . 20.5 t0 -64.84 126.4 90.94 Favored Pre-proline 0 C--N 1.319 -0.719 0 N-CA-C 108.546 -0.909 . . . . 15.0 108.546 171.597 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 265' ' ' PRO . . . . . 0.488 ' HD3' ' CD2' ' A' ' 252' ' ' PHE . 2.6 Cg_endo -80.26 -14.79 11.76 Favored 'Trans proline' 0 N--CA 1.456 -0.692 0 C-N-CA 122.642 2.228 . . . . 15.0 113.261 -177.653 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 266' ' ' ARG . . . . . 0.593 ' HD3' ' HD3' ' A' ' 237' ' ' PRO . 11.1 tpt180 -75.69 -12.79 60.26 Favored 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 108.439 -0.949 . . . . 15.0 108.439 173.581 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 267' ' ' ILE . . . . . 1.05 HG12 ' HB3' ' A' ' 264' ' ' ASP . 20.3 pt . . . . . 0 C--O 1.248 1.017 0 CA-C-N 114.324 -1.307 . . . . 15.0 110.761 178.507 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 210' ' ' SER . . . . . . . . . . . . . 19.8 m . . . . . 0 N--CA 1.475 0.786 0 CA-C-O 121.041 0.448 . . . . 15.0 110.038 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' B' B ' 211' ' ' ASP . . . . . 0.483 ' HA ' ' HD3' ' B' ' 212' ' ' PRO . 8.2 p-10 -119.51 127.01 26.67 Favored Pre-proline 0 C--N 1.324 -0.52 0 CA-C-O 121.289 0.566 . . . . 15.0 110.9 -176.244 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 212' ' ' PRO . . . . . 0.898 ' HB3' HD13 ' A' ' 253' ' ' LEU . 4.0 Cg_endo -89.72 156.4 5.14 Favored 'Trans proline' 0 N--CA 1.455 -0.743 0 C-N-CA 123.385 2.723 . . . . 15.0 112.302 179.856 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -89.87 145.52 18.29 Favored Glycine 0 N--CA 1.442 -0.961 0 C-N-CA 120.608 -0.806 . . . . 15.0 112.392 -179.177 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 214' ' ' SEP . . . . . 0.416 ' HA ' ' HD3' ' B' ' 215' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 215' ' ' PRO . . . . . 1.019 ' HB2' ' CZ2' ' A' ' 262' ' ' TRP . 3.3 Cg_exo -87.94 136.37 3.6 Favored 'Trans proline' 0 N--CA 1.461 -0.417 0 C-N-CA 123.524 2.816 . . . . 15.0 111.112 176.422 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 216' ' ' PHE . . . . . . . . . . . . . 57.9 m-85 -89.9 116.2 27.79 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.326 -0.397 . . . . 15.0 110.286 -179.15 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 217' ' ' GLN . . . . . . . . . . . . . 5.2 pm0 . . . . . 0 C--O 1.245 0.843 0 CA-C-O 118.664 -0.684 . . . . 15.0 110.443 179.751 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 . . . . . 0 N--CA 1.48 1.073 0 CA-C-O 120.94 0.4 . . . . 15.0 110.293 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 236' ' ' LEU . . . . . 0.511 HD12 ' HD2' ' A' ' 265' ' ' PRO . 1.4 mm? -106.73 169.02 7.28 Favored Pre-proline 0 C--N 1.323 -0.566 0 N-CA-C 109.162 -0.681 . . . . 15.0 109.162 178.192 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 237' ' ' PRO . . . . . 0.637 ' HD3' ' HD3' ' A' ' 266' ' ' ARG . 17.5 Cg_exo -69.37 158.06 58.86 Favored 'Trans proline' 0 N--CA 1.455 -0.771 0 C-N-CA 121.688 1.592 . . . . 15.0 108.957 160.67 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 5.2 mp0 -69.54 142.39 53.65 Favored 'General case' 0 C--N 1.303 -1.425 0 CA-C-O 121.46 0.647 . . . . 15.0 111.761 -171.217 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 100.5 7.81 50.7 Favored Glycine 0 CA--C 1.523 0.547 0 CA-C-N 114.931 -1.031 . . . . 15.0 114.017 -179.774 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 240' ' ' TYR . . . . . 0.737 ' CD1' ' HB2' ' A' ' 254' ' ' HIS . 80.9 m-85 -101.74 121.25 41.7 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 118.103 0.952 . . . . 15.0 110.721 174.845 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 241' ' ' GLU . . . . . 0.624 ' HG3' ' HB3' ' A' ' 253' ' ' LEU . 7.9 pt-20 -104.67 126.59 51.9 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 109.054 -0.721 . . . . 15.0 109.054 173.296 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -89.92 108.09 19.5 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 108.991 -0.744 . . . . 15.0 108.991 179.182 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 243' ' ' ARG . . . . . 0.534 ' HB2' ' CE1' ' A' ' 251' ' ' TYR . 9.7 mtt180 -99.44 133.43 43.76 Favored 'General case' 0 CA--C 1.502 -0.877 0 CA-C-O 122.704 1.24 . . . . 15.0 111.724 178.672 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 244' ' ' THR . . . . . . . . . . . . . 23.5 m -113.32 97.11 6.27 Favored 'General case' 0 C--N 1.301 -1.542 0 CA-C-N 112.631 -2.077 . . . . 15.0 109.067 -175.909 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 245' ' ' THR . . . . . 0.413 ' OG1' ' HG2' ' A' ' 247' ' ' GLN . 9.9 t -92.36 150.3 20.91 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 115.232 -0.894 . . . . 15.0 111.201 -172.325 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 3.5 m -54.94 -15.12 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 N-CA-C 112.882 0.697 . . . . 15.0 112.882 177.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 247' ' ' GLN . . . . . 0.413 ' HG2' ' OG1' ' A' ' 245' ' ' THR . 6.5 mm100 -58.58 -16.83 17.51 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.145 0.498 . . . . 15.0 110.63 173.414 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 88.13 37.78 7.6 Favored Glycine 0 N--CA 1.449 -0.492 0 CA-C-N 115.594 -0.73 . . . . 15.0 111.421 177.494 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 249' ' ' GLN . . . . . 0.551 ' NE2' ' HD2' ' B' ' 215' ' ' PRO . 9.0 pt20 -149.96 137.58 19.97 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.899 0.38 . . . . 15.0 111.674 -173.684 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 19.1 m -90.2 134.01 30.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 N-CA-C 109.249 -0.649 . . . . 15.0 109.249 172.235 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 251' ' ' TYR . . . . . 0.678 ' CD2' ' HD3' ' B' ' 215' ' ' PRO . 3.7 p90 -137.25 137.37 38.97 Favored 'General case' 0 C--N 1.317 -0.813 0 C-N-CA 120.427 -0.509 . . . . 15.0 110.535 179.753 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 252' ' ' PHE . . . . . 0.667 ' CD2' ' HA ' ' A' ' 264' ' ' ASP . 37.3 m-85 -89.88 118.25 29.32 Favored 'General case' 0 CA--C 1.509 -0.616 0 CA-C-O 121.5 0.667 . . . . 15.0 110.835 -173.647 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 253' ' ' LEU . . . . . 0.746 HD11 ' CB ' ' B' ' 212' ' ' PRO . 0.4 OUTLIER -110.56 118.04 35.16 Favored 'General case' 0 N--CA 1.441 -0.876 0 CA-C-N 114.337 -1.302 . . . . 15.0 110.895 -173.853 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 254' ' ' HIS . . . . . 0.737 ' HB2' ' CD1' ' A' ' 240' ' ' TYR . 17.7 t-80 -132.57 95.48 3.62 Favored 'General case' 0 CA--C 1.495 -1.159 0 N-CA-C 108.546 -0.909 . . . . 15.0 108.546 170.441 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 3.7 t -94.65 87.91 5.23 Favored 'General case' 0 N--CA 1.429 -1.486 0 C-N-CA 116.062 -2.255 . . . . 15.0 110.268 178.196 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 25.1 tt0 -101.22 -51.87 3.4 Favored 'General case' 0 N--CA 1.442 -0.859 0 N-CA-C 105.902 -1.888 . . . . 15.0 105.902 149.177 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 257' ' ' THR . . . . . . . . . . . . . 69.4 p -99.21 -13.67 19.63 Favored 'General case' 0 CA--C 1.489 -1.395 0 CA-C-O 124.958 2.313 . . . . 15.0 111.909 179.575 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 84.84 74.88 1.24 Allowed Glycine 1 C--N 1.244 -4.569 1 CA-C-N 108.352 -4.022 . . . . 15.0 112.838 -172.146 . . . . . . . . 3 2 . 1 . 014 nuclear orig full ' A' A ' 259' ' ' VAL . . . . . 0.529 ' O ' ' HA ' ' A' ' 253' ' ' LEU . 33.1 t -89.89 123.85 42.29 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 CA-C-O 121.316 0.579 . . . . 15.0 112.451 173.307 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 1.8 p -134.15 101.76 5.14 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 114.632 -1.167 . . . . 15.0 107.855 164.366 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 14.1 t -136.55 150.25 48.52 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 121.212 0.529 . . . . 15.0 112.273 -169.561 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 262' ' ' TRP . . . . . 1.086 ' CZ2' ' HB2' ' B' ' 215' ' ' PRO . 10.3 m95 -70.39 -37.12 74.46 Favored 'General case' 0 CA--C 1.518 -0.27 0 CA-C-N 114.967 -1.015 . . . . 15.0 111.948 179.069 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 263' ' ' HIS . . . . . . . . . . . . . 5.9 p80 -85.37 139.99 31.12 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.109 -0.496 . . . . 15.0 110.278 -174.704 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 264' ' ' ASP . . . . . 0.871 ' HB3' HG12 ' A' ' 267' ' ' ILE . 9.8 t70 -55.45 126.54 63.18 Favored Pre-proline 0 C--N 1.322 -0.604 0 N-CA-C 108.212 -1.033 . . . . 15.0 108.212 171.118 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 265' ' ' PRO . . . . . 0.511 ' HD2' HD12 ' A' ' 236' ' ' LEU . 6.2 Cg_exo -71.37 -14.61 31.15 Favored 'Trans proline' 0 N--CA 1.458 -0.581 0 C-N-CA 121.935 1.757 . . . . 15.0 112.882 -174.172 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 266' ' ' ARG . . . . . 0.637 ' HD3' ' HD3' ' A' ' 237' ' ' PRO . 6.1 tpt180 -77.24 -7.81 56.55 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-O 121.817 0.817 . . . . 15.0 108.927 175.163 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 267' ' ' ILE . . . . . 0.871 HG12 ' HB3' ' A' ' 264' ' ' ASP . 43.5 mm . . . . . 0 C--O 1.25 1.085 0 CA-C-N 114.009 -1.451 . . . . 15.0 109.646 176.511 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 210' ' ' SER . . . . . . . . . . . . . 3.9 p . . . . . 0 N--CA 1.475 0.789 0 N-CA-C 110.275 -0.268 . . . . 15.0 110.275 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' B' B ' 211' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -89.98 131.57 38.81 Favored Pre-proline 0 C--N 1.329 -0.313 0 N-CA-C 109.802 -0.444 . . . . 15.0 109.802 178.564 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 212' ' ' PRO . . . . . 0.746 ' CB ' HD11 ' A' ' 253' ' ' LEU . 60.7 Cg_endo -89.84 160.19 5.07 Favored 'Trans proline' 0 N--CA 1.45 -1.03 0 C-N-CA 122.685 2.257 . . . . 15.0 112.105 178.938 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -90.04 133.34 11.75 Favored Glycine 0 N--CA 1.442 -0.94 0 C-N-CA 120.508 -0.853 . . . . 15.0 112.251 -178.721 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 214' ' ' SEP . . . . . 0.462 ' HA ' ' HD3' ' B' ' 215' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 215' ' ' PRO . . . . . 1.086 ' HB2' ' CZ2' ' A' ' 262' ' ' TRP . 9.4 Cg_exo -87.8 124.18 1.84 Allowed 'Trans proline' 0 C--N 1.333 -0.251 0 C-N-CA 123.786 2.991 . . . . 15.0 111.779 -172.056 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 216' ' ' PHE . . . . . . . . . . . . . 94.0 m-85 -119.25 4.54 11.27 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.348 -0.842 . . . . 15.0 110.015 178.636 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 217' ' ' GLN . . . . . 0.599 ' HB2' ' CD1' ' A' ' 262' ' ' TRP . 24.9 mt-30 . . . . . 0 C--O 1.249 1.038 0 CA-C-N 115.334 -0.848 . . . . 15.0 110.661 179.532 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 . . . . . 0 N--CA 1.478 0.94 0 N-CA-C 109.465 -0.569 . . . . 15.0 109.465 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 236' ' ' LEU . . . . . 0.747 HD22 ' H ' ' A' ' 236' ' ' LEU . 0.0 OUTLIER -89.88 170.89 9.55 Favored Pre-proline 0 C--N 1.325 -0.498 0 N-CA-C 109.375 -0.602 . . . . 15.0 109.375 -176.943 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 237' ' ' PRO . . . . . 0.682 ' HD3' ' HD3' ' A' ' 266' ' ' ARG . 16.5 Cg_exo -69.6 158.83 55.77 Favored 'Trans proline' 0 N--CA 1.458 -0.61 0 C-N-CA 122.144 1.896 . . . . 15.0 109.855 166.294 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -69.86 149.42 47.88 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-O 121.546 0.689 . . . . 15.0 111.462 -174.044 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 100.17 -8.99 59.35 Favored Glycine 0 N--CA 1.444 -0.803 0 CA-C-N 115.096 -0.956 . . . . 15.0 113.09 -178.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 240' ' ' TYR . . . . . 0.645 ' CD1' ' HB2' ' A' ' 254' ' ' HIS . 87.6 m-85 -100.32 123.81 45.01 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 117.372 0.586 . . . . 15.0 110.353 177.366 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -109.33 126.6 53.56 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 108.938 -0.764 . . . . 15.0 108.938 169.848 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -89.95 108.71 19.88 Favored 'General case' 0 C--N 1.316 -0.853 0 N-CA-C 108.363 -0.977 . . . . 15.0 108.363 177.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 13.2 mtp85 -90.6 139.07 31.05 Favored 'General case' 0 CA--C 1.5 -0.961 0 CA-C-O 122.16 0.981 . . . . 15.0 112.962 -172.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 244' ' ' THR . . . . . . . . . . . . . 28.9 p -105.5 90.9 3.55 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-N 112.919 -1.946 . . . . 15.0 109.37 178.795 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 245' ' ' THR . . . . . 1.077 HG21 ' HG2' ' A' ' 247' ' ' GLN . 9.5 t -104.01 150.7 24.01 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.661 -0.7 . . . . 15.0 110.204 -176.182 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 39.6 t -43.74 -26.81 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 N-CA-C 113.725 1.009 . . . . 15.0 113.725 -172.665 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 247' ' ' GLN . . . . . 1.077 ' HG2' HG21 ' A' ' 245' ' ' THR . 3.5 pt20 -56.06 -23.09 31.49 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-O 120.695 0.283 . . . . 15.0 111.645 177.742 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 80.52 43.05 9.57 Favored Glycine 0 C--N 1.333 0.376 0 CA-C-N 116.264 -0.425 . . . . 15.0 113.15 176.068 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 249' ' ' GLN . . . . . 0.456 HE21 ' CD ' ' A' ' 247' ' ' GLN . 32.1 mt-30 -141.85 148.77 39.35 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.908 0.354 . . . . 15.0 110.082 -178.803 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 17.2 m -89.95 114.16 27.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-O 121.144 0.497 . . . . 15.0 110.638 178.814 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 251' ' ' TYR . . . . . 0.936 ' HB2' ' HG2' ' B' ' 215' ' ' PRO . 2.4 p90 -126.43 131.91 51.6 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.565 -0.532 . . . . 15.0 109.565 -178.841 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 252' ' ' PHE . . . . . 0.562 ' CD2' ' HA ' ' A' ' 264' ' ' ASP . 50.7 m-85 -90.04 126.07 35.63 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.137 -0.483 . . . . 15.0 111.281 -175.052 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 253' ' ' LEU . . . . . 0.622 HD11 ' HB3' ' B' ' 212' ' ' PRO . 0.8 OUTLIER -118.55 121.27 39.82 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-N 115.655 -0.702 . . . . 15.0 110.776 -177.623 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 254' ' ' HIS . . . . . 0.645 ' HB2' ' CD1' ' A' ' 240' ' ' TYR . 14.6 t-80 -135.93 96.48 3.42 Favored 'General case' 0 CA--C 1.502 -0.895 0 N-CA-C 108.834 -0.802 . . . . 15.0 108.834 172.544 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 6.1 t -94.03 88.13 5.57 Favored 'General case' 0 C--N 1.311 -1.085 0 C-N-CA 116.525 -2.07 . . . . 15.0 110.797 -179.809 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 44.4 tt0 -101.23 -52.97 3.13 Favored 'General case' 0 N--CA 1.443 -0.824 0 CA-C-N 113.29 -1.777 . . . . 15.0 106.217 151.316 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 257' ' ' THR . . . . . . . . . . . . . 62.7 p -99.92 -13.45 19.14 Favored 'General case' 0 CA--C 1.488 -1.44 0 CA-C-O 124.837 2.256 . . . . 15.0 111.774 -179.279 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 87.74 72.98 1.28 Allowed Glycine 1 C--N 1.238 -4.907 1 CA-C-N 108.391 -4.004 . . . . 15.0 112.782 -169.91 . . . . . . . . 3 2 . 1 . 015 nuclear orig full ' A' A ' 259' ' ' VAL . . . . . 0.492 ' HB ' ' HB3' ' A' ' 254' ' ' HIS . 45.1 t -90.1 127.87 42.39 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.3 0 CA-C-O 121.151 0.5 . . . . 15.0 111.576 174.309 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 260' ' ' SER . . . . . 0.509 ' HA ' ' O ' ' A' ' 252' ' ' PHE . 2.2 p -148.13 103.25 3.45 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 114.721 -1.127 . . . . 15.0 108.195 170.109 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 13.8 t -150.02 150.43 31.77 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 116.099 -0.501 . . . . 15.0 111.358 -168.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 262' ' ' TRP . . . . . 1.177 ' CZ2' ' HB2' ' B' ' 215' ' ' PRO . 92.4 m95 -69.9 -36.78 75.67 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.932 -0.576 . . . . 15.0 111.53 179.423 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 263' ' ' HIS . . . . . . . . . . . . . 2.7 p80 -75.38 129.96 38.21 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.612 -0.435 . . . . 15.0 110.605 -174.916 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 264' ' ' ASP . . . . . 1.09 ' HB3' HG12 ' A' ' 267' ' ' ILE . 67.5 t0 -59.49 124.56 76.06 Favored Pre-proline 0 C--N 1.321 -0.649 0 N-CA-C 108.609 -0.885 . . . . 15.0 108.609 172.016 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 265' ' ' PRO . . . . . 0.511 ' HG2' ' CE1' ' A' ' 240' ' ' TYR . 13.0 Cg_exo -68.83 -14.61 39.26 Favored 'Trans proline' 0 N--CA 1.456 -0.716 0 C-N-CA 121.904 1.736 . . . . 15.0 111.889 178.074 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 266' ' ' ARG . . . . . 0.682 ' HD3' ' HD3' ' A' ' 237' ' ' PRO . 22.7 tpt180 -76.73 -10.18 59.19 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 115.252 -0.885 . . . . 15.0 109.473 173.538 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 267' ' ' ILE . . . . . 1.09 HG12 ' HB3' ' A' ' 264' ' ' ASP . 40.0 pt . . . . . 0 C--O 1.25 1.096 0 CA-C-N 114.813 -1.085 . . . . 15.0 111.297 177.389 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 210' ' ' SER . . . . . . . . . . . . . 16.5 m . . . . . 0 N--CA 1.479 0.987 0 CA-C-O 120.772 0.32 . . . . 15.0 110.963 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' B' B ' 211' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -135.34 120.64 13.82 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.536 -0.302 . . . . 15.0 110.76 -174.922 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 212' ' ' PRO . . . . . 0.622 ' HB3' HD11 ' A' ' 253' ' ' LEU . 53.9 Cg_endo -93.34 143.77 2.07 Favored 'Trans proline' 0 N--CA 1.452 -0.927 0 C-N-CA 122.837 2.358 . . . . 15.0 112.696 176.59 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -89.94 154.37 23.75 Favored Glycine 0 N--CA 1.446 -0.698 0 C-N-CA 120.406 -0.902 . . . . 15.0 111.814 179.586 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 214' ' ' SEP . . . . . 0.6 ' HB2' ' NE2' ' A' ' 247' ' ' GLN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 215' ' ' PRO . . . . . 1.177 ' HB2' ' CZ2' ' A' ' 262' ' ' TRP . 27.9 Cg_exo -88.14 151.1 6.88 Favored 'Trans proline' 0 CA--C 1.528 0.219 0 C-N-CA 123.157 2.572 . . . . 15.0 111.807 175.337 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 216' ' ' PHE . . . . . . . . . . . . . 59.0 m-85 -130.94 -46.17 1.03 Allowed 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.976 0.417 . . . . 15.0 110.654 177.902 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 217' ' ' GLN . . . . . . . . . . . . . 2.7 mp0 . . . . . 0 C--O 1.244 0.805 0 CA-C-O 118.422 -0.799 . . . . 15.0 109.727 179.074 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 235' ' ' GLU . . . . . 0.426 ' H2 ' ' CD ' ' A' ' 235' ' ' GLU . 1.8 mp0 . . . . . 0 N--CA 1.483 1.2 0 N-CA-C 109.583 -0.525 . . . . 15.0 109.583 . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 236' ' ' LEU . . . . . 0.659 HD21 ' H ' ' A' ' 236' ' ' LEU . 0.0 OUTLIER -97.35 161.31 26.47 Favored Pre-proline 0 C--N 1.324 -0.53 0 CA-C-O 121.148 0.499 . . . . 15.0 110.177 -175.027 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 237' ' ' PRO . . . . . 0.5 ' HD3' ' HB2' ' A' ' 266' ' ' ARG . 9.0 Cg_exo -69.79 174.77 9.05 Favored 'Trans proline' 0 CA--C 1.509 -0.765 0 C-N-CA 122.845 2.363 . . . . 15.0 110.802 166.308 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -69.6 126.71 30.55 Favored 'General case' 0 C--N 1.297 -1.706 0 CA-C-N 114.132 -1.394 . . . . 15.0 111.544 -175.316 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 100.06 49.28 1.49 Allowed Glycine 0 C--N 1.333 0.37 0 CA-C-N 115.364 -0.834 . . . . 15.0 113.436 177.195 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 240' ' ' TYR . . . . . 0.626 ' CD1' ' HB2' ' A' ' 254' ' ' HIS . 74.1 m-85 -142.69 123.78 14.51 Favored 'General case' 0 CA--C 1.516 -0.345 0 CA-C-N 117.658 0.729 . . . . 15.0 111.518 176.442 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 34.1 mm-40 -100.07 124.06 45.02 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.337 -0.847 . . . . 15.0 109.164 175.155 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 242' ' ' GLN . . . . . 0.692 ' HG3' ' CE1' ' A' ' 252' ' ' PHE . 31.7 tt0 -90.18 110.78 21.79 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.458 -0.571 . . . . 15.0 109.458 -179.82 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 2.5 mpt_? -93.44 150.39 20.49 Favored 'General case' 0 CA--C 1.506 -0.739 0 CA-C-O 122.185 0.993 . . . . 15.0 113.641 -177.745 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 244' ' ' THR . . . . . . . . . . . . . 23.4 p -130.89 95.35 3.81 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 113.014 -1.903 . . . . 15.0 110.057 -176.848 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 245' ' ' THR . . . . . 0.503 ' OG1' ' HG2' ' A' ' 247' ' ' GLN . 5.5 t -93.96 150.41 20.38 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.872 -0.604 . . . . 15.0 110.044 179.672 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 3.8 p -53.37 -20.58 3.19 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 CA-C-O 121.163 0.506 . . . . 15.0 111.492 -179.244 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 247' ' ' GLN . . . . . 0.503 ' HG2' ' OG1' ' A' ' 245' ' ' THR . 31.6 mm-40 -55.12 -23.5 21.31 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.022 -0.99 . . . . 15.0 110.881 176.23 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 85.88 36.58 10.1 Favored Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 121.103 -0.57 . . . . 15.0 111.801 178.5 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 249' ' ' GLN . . . . . 0.418 ' HB2' ' CZ3' ' A' ' 262' ' ' TRP . 7.3 pt20 -141.43 130.77 23.66 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.866 0.365 . . . . 15.0 110.844 -176.892 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 15.5 m -89.84 124.87 42.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 115.868 -0.605 . . . . 15.0 110.305 177.042 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 251' ' ' TYR . . . . . 0.57 ' CD2' ' HD3' ' B' ' 215' ' ' PRO . 16.4 p90 -128.95 137.24 51.27 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.812 -0.631 . . . . 15.0 109.765 -177.976 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 252' ' ' PHE . . . . . 0.692 ' CE1' ' HG3' ' A' ' 242' ' ' GLN . 29.8 m-85 -89.75 120.17 30.77 Favored 'General case' 0 CA--C 1.511 -0.535 0 CA-C-O 121.239 0.542 . . . . 15.0 112.186 -169.986 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 253' ' ' LEU . . . . . 1.053 HD12 ' HB3' ' B' ' 212' ' ' PRO . 4.6 mt -104.65 110.29 22.54 Favored 'General case' 0 N--CA 1.446 -0.627 0 CA-C-N 114.683 -1.144 . . . . 15.0 111.823 -178.308 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 254' ' ' HIS . . . . . 0.626 ' HB2' ' CD1' ' A' ' 240' ' ' TYR . 12.1 t-80 -117.89 95.65 5.01 Favored 'General case' 0 C--N 1.312 -1.042 0 N-CA-C 107.808 -1.182 . . . . 15.0 107.808 166.405 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 2.9 t -93.98 87.76 5.47 Favored 'General case' 0 N--CA 1.429 -1.507 0 C-N-CA 115.968 -2.293 . . . . 15.0 110.038 -179.115 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 51.1 tt0 -101.34 -54.55 2.75 Favored 'General case' 0 N--CA 1.441 -0.894 0 CA-C-N 113.087 -1.869 . . . . 15.0 106.068 151.208 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 257' ' ' THR . . . . . . . . . . . . . 67.2 p -99.51 -13.74 19.36 Favored 'General case' 0 CA--C 1.49 -1.365 0 CA-C-N 111.881 -2.418 . . . . 15.0 112.013 -177.183 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 87.83 71.57 1.28 Allowed Glycine 1 C--N 1.241 -4.7 1 CA-C-N 108.236 -4.074 . . . . 15.0 112.904 -171.513 . . . . . . . . 3 2 . 1 . 016 nuclear orig full ' A' A ' 259' ' ' VAL . . . . . 0.684 ' O ' ' HA ' ' A' ' 253' ' ' LEU . 40.6 t -89.67 124.58 42.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 121.294 0.569 . . . . 15.0 112.226 176.767 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -137.15 97.04 3.4 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 114.451 -1.25 . . . . 15.0 107.816 166.174 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 14.6 t -132.23 150.35 52.17 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.943 -0.571 . . . . 15.0 111.48 -168.45 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 262' ' ' TRP . . . . . 1.085 ' CZ2' ' HB2' ' B' ' 215' ' ' PRO . 10.7 m95 -65.57 -53.75 37.6 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.476 -0.784 . . . . 15.0 111.519 178.615 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 263' ' ' HIS . . . . . . . . . . . . . 4.4 p80 -65.3 133.43 51.41 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.242 -0.435 . . . . 15.0 110.465 -175.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 264' ' ' ASP . . . . . 0.973 ' HB3' HG12 ' A' ' 267' ' ' ILE . 24.0 t0 -53.83 128.9 55.55 Favored Pre-proline 0 C--N 1.321 -0.631 0 N-CA-C 107.833 -1.173 . . . . 15.0 107.833 169.253 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 265' ' ' PRO . . . . . 0.6 ' HD3' ' CD2' ' A' ' 252' ' ' PHE . 13.1 Cg_exo -68.98 -14.57 38.78 Favored 'Trans proline' 0 N--CA 1.458 -0.605 0 C-N-CA 122.01 1.807 . . . . 15.0 112.582 -177.483 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 266' ' ' ARG . . . . . 0.5 ' HB2' ' HD3' ' A' ' 237' ' ' PRO . 19.9 tpt180 -72.53 -14.93 61.76 Favored 'General case' 0 N--CA 1.446 -0.667 0 N-CA-C 108.611 -0.885 . . . . 15.0 108.611 170.953 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 267' ' ' ILE . . . . . 0.973 HG12 ' HB3' ' A' ' 264' ' ' ASP . 26.9 pt . . . . . 0 C--O 1.252 1.199 0 CA-C-N 114.482 -1.236 . . . . 15.0 110.438 177.748 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 210' ' ' SER . . . . . . . . . . . . . 24.4 p . . . . . 0 N--CA 1.479 1.012 0 N-CA-C 111.595 0.22 . . . . 15.0 111.595 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' B' B ' 211' ' ' ASP . . . . . 0.45 ' HA ' ' HD3' ' B' ' 212' ' ' PRO . 23.6 t70 -93.45 120.28 66.59 Favored Pre-proline 0 C--N 1.328 -0.342 0 N-CA-C 110.323 -0.251 . . . . 15.0 110.323 -179.113 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 212' ' ' PRO . . . . . 1.053 ' HB3' HD12 ' A' ' 253' ' ' LEU . 3.6 Cg_endo -89.83 147.25 4.81 Favored 'Trans proline' 0 N--CA 1.453 -0.909 0 C-N-CA 123.078 2.519 . . . . 15.0 112.595 179.714 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -89.87 148.34 19.81 Favored Glycine 0 N--CA 1.438 -1.172 0 C-N-CA 120.603 -0.808 . . . . 15.0 112.049 -179.581 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 214' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' B' B ' 215' ' ' PRO . . . . . 1.085 ' HB2' ' CZ2' ' A' ' 262' ' ' TRP . 15.6 Cg_exo -87.49 112.26 0.84 Allowed 'Trans proline' 0 C--N 1.331 -0.378 0 C-N-CA 123.53 2.82 . . . . 15.0 110.914 -178.681 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 216' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -104.26 -5.45 21.85 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.602 -0.726 . . . . 15.0 111.205 -176.294 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 217' ' ' GLN . . . . . . . . . . . . . 20.3 tt0 . . . . . 0 C--O 1.249 1.038 0 CA-C-O 118.428 -0.796 . . . . 15.0 109.513 178.575 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 . . . . . 0 N--CA 1.482 1.125 0 N-CA-C 110.307 -0.257 . . . . 15.0 110.307 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 236' ' ' LEU . . . . . 0.613 ' H ' HD23 ' A' ' 236' ' ' LEU . 0.1 OUTLIER -95.91 171.78 5.97 Favored Pre-proline 0 C--N 1.324 -0.51 0 N-CA-C 108.767 -0.827 . . . . 15.0 108.767 178.685 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 237' ' ' PRO . . . . . 0.827 ' HD3' ' HD3' ' A' ' 266' ' ' ARG . 16.8 Cg_exo -69.57 160.64 48.98 Favored 'Trans proline' 0 N--CA 1.459 -0.519 0 C-N-CA 122.077 1.851 . . . . 15.0 110.286 166.562 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -69.59 142.6 53.51 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-N 115.536 -0.756 . . . . 15.0 111.006 -174.353 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 100.37 8.77 49.16 Favored Glycine 0 CA--C 1.522 0.494 0 CA-C-N 115.807 -0.633 . . . . 15.0 113.815 179.677 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 240' ' ' TYR . . . . . 0.678 ' CD1' ' HB2' ' A' ' 254' ' ' HIS . 77.8 m-85 -109.97 110.43 21.36 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 117.465 0.632 . . . . 15.0 110.458 175.882 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 241' ' ' GLU . . . . . 0.623 ' HG3' ' HB3' ' A' ' 253' ' ' LEU . 8.0 pt-20 -90.13 115.92 27.75 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.697 0.76 . . . . 15.0 109.202 174.105 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 11.7 tm0? -90.0 109.72 20.74 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 108.805 -0.813 . . . . 15.0 108.805 -179.564 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 69.6 mtt-85 -99.14 150.18 22.3 Favored 'General case' 0 CA--C 1.504 -0.803 0 CA-C-O 122.283 1.039 . . . . 15.0 113.355 -170.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 244' ' ' THR . . . . . . . . . . . . . 3.3 p -115.67 105.4 12.71 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 112.87 -1.968 . . . . 15.0 109.725 179.184 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 245' ' ' THR . . . . . 0.903 HG23 ' HG2' ' A' ' 247' ' ' GLN . 6.1 t -116.22 150.35 37.67 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 116.036 -0.529 . . . . 15.0 110.882 -174.874 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 13.0 m -49.22 -25.22 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.313 0 N-CA-C 113.97 1.1 . . . . 15.0 113.97 -176.474 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 247' ' ' GLN . . . . . 0.903 ' HG2' HG23 ' A' ' 245' ' ' THR . 2.6 pt20 -57.75 -21.65 42.49 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-O 120.678 0.275 . . . . 15.0 111.012 178.161 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 93.62 15.41 50.06 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.925 -0.655 . . . . 15.0 113.259 174.936 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 249' ' ' GLN . . . . . 0.669 ' HB2' ' OE1' ' A' ' 247' ' ' GLN . 1.8 mp0 -123.97 147.34 47.84 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.944 0.402 . . . . 15.0 111.598 -178.689 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 31.3 m -90.13 135.71 25.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.765 -0.652 . . . . 15.0 109.89 173.235 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 251' ' ' TYR . . . . . 0.593 ' HB3' ' HG2' ' B' ' 215' ' ' PRO . 28.2 p90 -141.95 135.15 29.09 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 109.587 -0.523 . . . . 15.0 109.587 -177.038 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 252' ' ' PHE . . . . . 0.692 ' CD2' ' HA ' ' A' ' 264' ' ' ASP . 29.5 m-85 -90.13 123.39 33.93 Favored 'General case' 0 CA--C 1.51 -0.565 0 CA-C-N 115.982 -0.554 . . . . 15.0 111.593 -173.248 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 253' ' ' LEU . . . . . 0.774 HD12 ' HB3' ' B' ' 212' ' ' PRO . 0.5 OUTLIER -116.69 114.26 23.79 Favored 'General case' 0 N--CA 1.445 -0.715 0 CA-C-N 115.123 -0.944 . . . . 15.0 110.964 -176.343 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 254' ' ' HIS . . . . . 0.678 ' HB2' ' CD1' ' A' ' 240' ' ' TYR . 20.9 t-80 -124.29 95.09 4.41 Favored 'General case' 0 CA--C 1.5 -0.972 0 N-CA-C 108.48 -0.933 . . . . 15.0 108.48 169.747 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 3.0 t -94.54 88.18 5.37 Favored 'General case' 0 N--CA 1.433 -1.304 0 C-N-CA 116.33 -2.148 . . . . 15.0 110.754 179.287 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 256' ' ' GLN . . . . . 0.484 ' HB3' ' CE1' ' A' ' 254' ' ' HIS . 5.8 tt0 -101.29 -52.94 3.13 Favored 'General case' 0 N--CA 1.441 -0.906 0 N-CA-C 106.026 -1.842 . . . . 15.0 106.026 149.861 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 257' ' ' THR . . . . . . . . . . . . . 72.7 p -97.79 -13.7 21.21 Favored 'General case' 0 CA--C 1.488 -1.406 0 CA-C-O 124.634 2.159 . . . . 15.0 111.923 -179.501 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 88.7 71.04 1.27 Allowed Glycine 1 C--N 1.243 -4.598 0 CA-C-N 108.404 -3.998 . . . . 15.0 113.167 -172.933 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 259' ' ' VAL . . . . . 0.605 ' O ' ' HA ' ' A' ' 253' ' ' LEU . 57.8 t -89.83 126.06 42.74 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.289 0 CA-C-O 121.428 0.632 . . . . 15.0 112.387 175.757 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 260' ' ' SER . . . . . 0.442 ' HA ' ' O ' ' A' ' 252' ' ' PHE . 1.4 p -141.66 100.24 3.72 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 114.444 -1.253 . . . . 15.0 107.685 165.934 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 13.4 t -136.39 150.32 48.74 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.853 -0.612 . . . . 15.0 111.788 -167.376 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 262' ' ' TRP . . . . . 1.181 ' CZ2' ' HB2' ' B' ' 215' ' ' PRO . 8.9 m95 -70.7 -32.38 69.58 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.349 -0.841 . . . . 15.0 112.374 179.449 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 263' ' ' HIS . . . . . . . . . . . . . 5.0 p80 -84.63 134.67 34.37 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 120.385 -0.526 . . . . 15.0 110.388 -176.289 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 264' ' ' ASP . . . . . 1.009 ' HB3' HG12 ' A' ' 267' ' ' ILE . 43.5 t0 -56.62 124.06 60.72 Favored Pre-proline 0 C--O 1.218 -0.603 0 N-CA-C 108.56 -0.904 . . . . 15.0 108.56 169.843 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 265' ' ' PRO . . . . . 0.506 ' HD3' ' CD2' ' A' ' 252' ' ' PHE . 10.6 Cg_exo -68.93 -14.83 39.44 Favored 'Trans proline' 0 N--CA 1.46 -0.494 0 C-N-CA 122.367 2.045 . . . . 15.0 112.629 -177.55 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 266' ' ' ARG . . . . . 0.827 ' HD3' ' HD3' ' A' ' 237' ' ' PRO . 20.2 tpt180 -75.89 -11.58 60.0 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 115.483 -0.78 . . . . 15.0 109.047 173.623 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 267' ' ' ILE . . . . . 1.009 HG12 ' HB3' ' A' ' 264' ' ' ASP . 36.9 pt . . . . . 0 C--O 1.247 0.945 0 CA-C-N 114.641 -1.163 . . . . 15.0 111.253 178.899 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 210' ' ' SER . . . . . . . . . . . . . 20.4 m . . . . . 0 N--CA 1.481 1.077 0 CA-C-O 120.638 0.256 . . . . 15.0 111.229 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' B' B ' 211' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -116.95 144.32 33.27 Favored Pre-proline 0 C--O 1.235 0.319 0 N-CA-C 109.37 -0.604 . . . . 15.0 109.37 176.053 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 212' ' ' PRO . . . . . 0.774 ' HB3' HD12 ' A' ' 253' ' ' LEU . 8.4 Cg_endo -89.87 143.33 4.16 Favored 'Trans proline' 0 N--CA 1.454 -0.823 0 C-N-CA 122.819 2.346 . . . . 15.0 112.888 -176.715 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -89.77 149.98 20.82 Favored Glycine 0 N--CA 1.441 -0.976 0 CA-C-N 115.538 -0.755 . . . . 15.0 111.622 176.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 214' ' ' SEP . . . . . 0.46 ' HB2' ' NE2' ' A' ' 247' ' ' GLN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 215' ' ' PRO . . . . . 1.181 ' HB2' ' CZ2' ' A' ' 262' ' ' TRP . 12.5 Cg_exo -87.21 134.29 3.52 Favored 'Trans proline' 0 N--CA 1.464 -0.256 0 C-N-CA 123.637 2.891 . . . . 15.0 110.711 179.583 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 216' ' ' PHE . . . . . . . . . . . . . 82.5 m-85 -112.25 -28.31 7.99 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 120.399 -0.521 . . . . 15.0 111.725 -176.764 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 217' ' ' GLN . . . . . . . . . . . . . 29.5 pt20 . . . . . 0 C--O 1.247 0.934 0 N-CA-C 109.381 -0.6 . . . . 15.0 109.381 178.676 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.48 1.07 0 N-CA-C 109.914 -0.402 . . . . 15.0 109.914 . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 236' ' ' LEU . . . . . 0.422 HD13 ' OD1' ' A' ' 264' ' ' ASP . 2.1 mm? -122.0 171.18 6.59 Favored Pre-proline 0 C--N 1.322 -0.614 0 CA-C-O 120.85 0.357 . . . . 15.0 110.727 -176.757 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 237' ' ' PRO . . . . . 0.545 ' HD3' ' HD3' ' A' ' 266' ' ' ARG . 15.0 Cg_exo -69.53 164.28 34.9 Favored 'Trans proline' 0 N--CA 1.456 -0.699 0 C-N-CA 121.92 1.747 . . . . 15.0 109.314 160.835 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 12.2 mm-40 -69.6 142.69 53.47 Favored 'General case' 0 C--N 1.301 -1.522 0 CA-C-N 115.166 -0.925 . . . . 15.0 113.333 -170.098 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 100.11 -1.62 56.37 Favored Glycine 0 CA--C 1.526 0.755 0 CA-C-N 114.124 -1.398 . . . . 15.0 115.166 174.103 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 240' ' ' TYR . . . . . 0.676 ' CD1' ' HB2' ' A' ' 254' ' ' HIS . 78.1 m-85 -87.9 123.46 32.67 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 118.574 1.187 . . . . 15.0 111.486 -179.449 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -96.08 114.81 26.55 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.397 -0.819 . . . . 15.0 109.214 173.332 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -90.13 99.68 12.65 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 108.823 -0.806 . . . . 15.0 108.823 176.233 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 243' ' ' ARG . . . . . 0.687 ' CZ ' ' HD2' ' B' ' 212' ' ' PRO . 34.7 mtt180 -91.28 149.86 21.57 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.531 -0.758 . . . . 15.0 111.823 179.404 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 244' ' ' THR . . . . . . . . . . . . . 6.1 m -127.2 92.05 3.44 Favored 'General case' 0 C--N 1.307 -1.267 0 CA-C-N 113.682 -1.599 . . . . 15.0 109.219 -179.407 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 245' ' ' THR . . . . . 0.425 ' OG1' ' HG2' ' A' ' 247' ' ' GLN . 5.0 t -90.0 150.59 22.05 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.204 -0.907 . . . . 15.0 110.926 -174.666 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 11.6 m -49.0 -20.23 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 CA-C-N 115.429 -0.805 . . . . 15.0 112.617 177.053 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 247' ' ' GLN . . . . . 0.525 ' HB2' ' HG3' ' A' ' 249' ' ' GLN . 6.6 mm100 -58.77 -19.51 41.4 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 116.055 -0.521 . . . . 15.0 111.128 175.307 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 85.98 26.01 35.84 Favored Glycine 0 C--N 1.332 0.357 0 C-N-CA 121.305 -0.474 . . . . 15.0 112.632 177.454 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 249' ' ' GLN . . . . . 0.525 ' HG3' ' HB2' ' A' ' 247' ' ' GLN . 0.3 OUTLIER -126.43 133.96 51.11 Favored 'General case' 0 C--N 1.326 -0.415 0 O-C-N 122.624 -0.339 . . . . 15.0 110.967 -174.493 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 3.6 m -90.01 107.23 18.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 115.768 -0.651 . . . . 15.0 109.537 173.056 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 251' ' ' TYR . . . . . 0.795 ' HB2' ' HG2' ' B' ' 215' ' ' PRO . 6.4 p90 -119.48 130.65 55.33 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.922 -0.581 . . . . 15.0 109.981 -173.399 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 252' ' ' PHE . . . . . 0.746 ' CD2' ' HA ' ' A' ' 264' ' ' ASP . 32.2 m-85 -90.03 123.09 33.62 Favored 'General case' 0 CA--C 1.506 -0.75 0 CA-C-N 116.21 -0.45 . . . . 15.0 110.832 -175.365 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 253' ' ' LEU . . . . . 0.95 HD13 ' HB2' ' B' ' 212' ' ' PRO . 1.6 tt -128.82 115.79 18.46 Favored 'General case' 0 N--CA 1.438 -1.048 0 CA-C-N 115.631 -0.713 . . . . 15.0 111.541 -175.554 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 254' ' ' HIS . . . . . 0.676 ' HB2' ' CD1' ' A' ' 240' ' ' TYR . 29.1 t-80 -124.18 92.57 3.69 Favored 'General case' 0 CA--C 1.505 -0.758 0 N-CA-C 108.723 -0.843 . . . . 15.0 108.723 174.861 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 53.0 m -94.7 88.18 5.3 Favored 'General case' 0 N--CA 1.436 -1.159 0 C-N-CA 116.66 -2.016 . . . . 15.0 110.429 179.782 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 7.1 tt0 -100.83 -50.47 3.83 Favored 'General case' 0 N--CA 1.441 -0.917 0 N-CA-C 105.848 -1.908 . . . . 15.0 105.848 151.236 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 257' ' ' THR . . . . . . . . . . . . . 60.3 p -98.46 -13.44 20.54 Favored 'General case' 0 CA--C 1.49 -1.349 0 CA-C-O 124.963 2.316 . . . . 15.0 111.795 177.598 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 88.52 70.8 1.27 Allowed Glycine 1 C--N 1.242 -4.665 1 CA-C-N 108.214 -4.085 . . . . 15.0 113.471 -173.405 . . . . . . . . 3 2 . 1 . 018 nuclear orig full ' A' A ' 259' ' ' VAL . . . . . 0.502 ' O ' ' HA ' ' A' ' 253' ' ' LEU . 76.5 t -89.8 130.42 39.13 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.58 0 CA-C-O 121.271 0.558 . . . . 15.0 111.207 173.711 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 10.1 p -150.09 96.97 2.51 Favored 'General case' 0 C--N 1.307 -1.247 0 CA-C-N 114.598 -1.183 . . . . 15.0 108.817 170.755 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 12.4 t -143.87 150.32 38.27 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.877 -0.601 . . . . 15.0 111.299 -168.377 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 262' ' ' TRP . . . . . 1.112 ' CZ2' ' HB2' ' B' ' 215' ' ' PRO . 92.9 m95 -69.07 -42.15 76.62 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.849 -0.614 . . . . 15.0 111.729 179.845 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 263' ' ' HIS . . . . . . . . . . . . . 2.6 p80 -65.22 132.32 48.8 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-O 120.896 0.379 . . . . 15.0 110.213 -176.345 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 264' ' ' ASP . . . . . 0.933 ' HB3' HG12 ' A' ' 267' ' ' ILE . 28.4 t70 -56.11 124.94 62.26 Favored Pre-proline 0 C--N 1.321 -0.665 0 N-CA-C 108.847 -0.797 . . . . 15.0 108.847 172.428 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 265' ' ' PRO . . . . . 0.653 ' HD3' ' CD2' ' A' ' 252' ' ' PHE . 4.3 Cg_exo -73.44 -14.64 25.12 Favored 'Trans proline' 0 CA--C 1.51 -0.701 0 C-N-CA 122.08 1.853 . . . . 15.0 112.224 -175.978 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 266' ' ' ARG . . . . . 0.554 ' HB3' ' OD2' ' A' ' 264' ' ' ASP . 28.1 tpt180 -72.63 -13.46 61.38 Favored 'General case' 0 C--N 1.316 -0.861 0 N-CA-C 108.542 -0.91 . . . . 15.0 108.542 171.244 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 267' ' ' ILE . . . . . 0.933 HG12 ' HB3' ' A' ' 264' ' ' ASP . 22.5 pt . . . . . 0 C--O 1.251 1.169 0 CA-C-N 114.618 -1.174 . . . . 15.0 110.645 174.667 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 210' ' ' SER . . . . . . . . . . . . . 9.6 p . . . . . 0 N--CA 1.478 0.955 0 N-CA-C 110.366 -0.235 . . . . 15.0 110.366 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' B' B ' 211' ' ' ASP . . . . . 0.466 ' HA ' ' HD3' ' B' ' 212' ' ' PRO . 20.5 t70 -150.04 128.64 6.04 Favored Pre-proline 0 C--N 1.324 -0.52 0 N-CA-C 109.673 -0.492 . . . . 15.0 109.673 177.173 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 212' ' ' PRO . . . . . 0.95 ' HB2' HD13 ' A' ' 253' ' ' LEU . 2.0 Cg_endo -89.33 141.67 4.14 Favored 'Trans proline' 0 N--CA 1.457 -0.623 0 C-N-CA 123.281 2.654 . . . . 15.0 113.734 -177.814 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -89.67 160.34 28.85 Favored Glycine 0 N--CA 1.449 -0.449 0 CA-C-N 114.796 -1.093 . . . . 15.0 113.278 -176.466 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 214' ' ' SEP . . . . . 0.473 ' HA ' ' HD3' ' B' ' 215' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 215' ' ' PRO . . . . . 1.112 ' HB2' ' CZ2' ' A' ' 262' ' ' TRP . 36.9 Cg_exo -87.36 160.09 8.22 Favored 'Trans proline' 0 C--O 1.233 0.245 0 C-N-CA 124.057 3.172 . . . . 15.0 112.078 176.125 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 216' ' ' PHE . . . . . . . . . . . . . 92.2 m-85 -117.14 122.34 43.82 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.404 -0.362 . . . . 15.0 110.416 -178.696 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 217' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 . . . . . 0 C--O 1.25 1.095 0 CA-C-O 118.504 -0.76 . . . . 15.0 110.505 -177.485 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 . . . . . 0 N--CA 1.478 0.927 0 CA-C-O 121.093 0.473 . . . . 15.0 110.668 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 236' ' ' LEU . . . . . 0.415 HD11 ' CE1' ' A' ' 252' ' ' PHE . 19.7 mt -93.62 175.76 2.88 Favored Pre-proline 0 C--N 1.321 -0.657 0 N-CA-C 108.97 -0.752 . . . . 15.0 108.97 177.663 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 237' ' ' PRO . . . . . 0.845 ' HD3' ' HD3' ' A' ' 266' ' ' ARG . 13.1 Cg_exo -69.7 163.11 39.47 Favored 'Trans proline' 0 N--CA 1.459 -0.536 0 C-N-CA 121.47 1.446 . . . . 15.0 110.247 167.289 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -69.77 140.16 53.36 Favored 'General case' 0 C--N 1.307 -1.248 0 CA-C-N 115.321 -0.854 . . . . 15.0 111.104 -174.125 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 100.29 9.34 48.02 Favored Glycine 0 N--CA 1.451 -0.36 0 CA-C-N 115.642 -0.708 . . . . 15.0 114.211 178.241 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 240' ' ' TYR . . . . . 0.75 ' CD1' ' HB2' ' A' ' 254' ' ' HIS . 85.1 m-85 -104.08 123.43 47.23 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 117.897 0.848 . . . . 15.0 110.637 174.929 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 241' ' ' GLU . . . . . 0.652 ' HG3' ' HB3' ' A' ' 253' ' ' LEU . 7.7 pt-20 -109.41 123.78 49.91 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.682 -0.69 . . . . 15.0 109.627 174.408 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 21.5 tm0? -90.01 116.07 27.77 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 108.684 -0.858 . . . . 15.0 108.684 179.021 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 63.6 mtt-85 -107.3 149.27 27.99 Favored 'General case' 0 CA--C 1.501 -0.932 0 CA-C-O 122.157 0.979 . . . . 15.0 112.579 -177.563 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 244' ' ' THR . . . . . . . . . . . . . 7.5 m -124.18 91.72 3.52 Favored 'General case' 0 C--N 1.307 -1.257 0 CA-C-N 113.288 -1.778 . . . . 15.0 110.029 179.166 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 245' ' ' THR . . . . . 1.094 HG22 ' HG2' ' A' ' 247' ' ' GLN . 8.5 t -91.28 150.67 21.22 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.572 -0.74 . . . . 15.0 109.849 177.516 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 14.9 m -41.03 -24.32 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 N-CA-C 114.968 1.47 . . . . 15.0 114.968 -175.354 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 247' ' ' GLN . . . . . 1.094 ' HG2' HG22 ' A' ' 245' ' ' THR . 3.6 pt20 -55.79 -22.48 24.64 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-O 120.752 0.31 . . . . 15.0 111.013 176.564 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 81.03 34.73 26.12 Favored Glycine 0 C--N 1.333 0.399 0 C-N-CA 121.48 -0.391 . . . . 15.0 113.182 174.196 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 249' ' ' GLN . . . . . 0.428 ' CB ' ' HZ3' ' A' ' 262' ' ' TRP . 32.5 mt-30 -136.37 146.93 47.05 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.759 -0.46 . . . . 15.0 109.759 -178.627 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 23.7 m -89.76 125.47 42.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-O 120.792 0.329 . . . . 15.0 110.989 -178.186 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 251' ' ' TYR . . . . . 0.655 ' HB3' ' HG2' ' B' ' 215' ' ' PRO . 12.8 p90 -131.79 133.16 44.43 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 109.622 -0.511 . . . . 15.0 109.622 179.679 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 252' ' ' PHE . . . . . 0.691 ' CD2' ' HA ' ' A' ' 264' ' ' ASP . 36.3 m-85 -90.05 118.68 29.78 Favored 'General case' 0 CA--C 1.512 -0.508 0 CA-C-O 121.206 0.526 . . . . 15.0 110.994 -176.786 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 253' ' ' LEU . . . . . 0.652 ' HB3' ' HG3' ' A' ' 241' ' ' GLU . 0.6 OUTLIER -106.79 122.87 47.24 Favored 'General case' 0 N--CA 1.444 -0.737 0 CA-C-N 115.082 -0.963 . . . . 15.0 110.461 -178.05 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 254' ' ' HIS . . . . . 0.75 ' HB2' ' CD1' ' A' ' 240' ' ' TYR . 29.9 t-80 -135.0 90.27 2.62 Favored 'General case' 0 C--N 1.313 -1.018 0 N-CA-C 108.081 -1.081 . . . . 15.0 108.081 172.024 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 255' ' ' THR . . . . . 0.406 ' HA ' ' HA2' ' A' ' 258' ' ' GLY . 2.8 t -91.41 87.82 6.58 Favored 'General case' 0 N--CA 1.433 -1.277 0 C-N-CA 116.411 -2.116 . . . . 15.0 110.185 -179.215 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 52.0 tt0 -101.53 -54.97 2.63 Favored 'General case' 0 N--CA 1.436 -1.135 0 CA-C-N 112.818 -1.992 . . . . 15.0 105.842 151.254 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 257' ' ' THR . . . . . . . . . . . . . 63.4 p -95.89 -13.53 23.87 Favored 'General case' 0 CA--C 1.486 -1.499 0 CA-C-N 112.214 -2.266 . . . . 15.0 111.449 179.015 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 258' ' ' GLY . . . . . 0.406 ' HA2' ' HA ' ' A' ' 255' ' ' THR . . . 86.66 70.52 1.31 Allowed Glycine 1 C--N 1.246 -4.453 1 CA-C-N 108.187 -4.097 . . . . 15.0 113.093 -172.629 . . . . . . . . 4 3 . 1 . 019 nuclear orig full ' A' A ' 259' ' ' VAL . . . . . 0.585 ' O ' HD21 ' A' ' 253' ' ' LEU . 60.6 t -89.88 129.17 41.23 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.243 0 CA-C-O 121.203 0.525 . . . . 15.0 112.227 176.674 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 1.1 p -143.49 98.83 3.32 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 114.783 -1.098 . . . . 15.0 108.228 169.475 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 9.0 t -139.52 150.31 44.95 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 116.159 -0.473 . . . . 15.0 111.819 -170.305 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 262' ' ' TRP . . . . . 1.199 ' CZ2' ' HB2' ' B' ' 215' ' ' PRO . 91.6 m95 -68.3 -30.64 69.68 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.38 -0.827 . . . . 15.0 111.707 178.587 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 263' ' ' HIS . . . . . . . . . . . . . 4.2 p80 -83.5 136.72 34.17 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 120.725 -0.39 . . . . 15.0 110.757 -172.336 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 264' ' ' ASP . . . . . 0.776 ' HB3' HG12 ' A' ' 267' ' ' ILE . 10.0 t70 -56.32 134.23 75.95 Favored Pre-proline 0 C--N 1.325 -0.469 0 CA-C-N 115.652 -0.704 . . . . 15.0 109.268 174.754 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 265' ' ' PRO . . . . . 0.581 ' HD3' ' CD2' ' A' ' 252' ' ' PHE . 88.8 Cg_endo -84.28 -14.5 6.98 Favored 'Trans proline' 0 N--CA 1.458 -0.617 0 C-N-CA 122.568 2.179 . . . . 15.0 113.995 -174.486 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 266' ' ' ARG . . . . . 0.845 ' HD3' ' HD3' ' A' ' 237' ' ' PRO . 21.8 tpt180 -80.98 -5.21 57.26 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-O 122.418 1.104 . . . . 15.0 108.505 176.265 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 267' ' ' ILE . . . . . 0.776 HG12 ' HB3' ' A' ' 264' ' ' ASP . 48.3 mm . . . . . 0 C--O 1.251 1.174 0 CA-C-N 113.153 -1.84 . . . . 15.0 109.824 176.684 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 210' ' ' SER . . . . . . . . . . . . . 5.4 p . . . . . 0 N--CA 1.474 0.765 0 CA-C-O 121.042 0.448 . . . . 15.0 110.741 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' B' B ' 211' ' ' ASP . . . . . 0.465 ' HA ' ' HD3' ' B' ' 212' ' ' PRO . 2.0 p30 -144.62 118.94 5.77 Favored Pre-proline 0 C--N 1.325 -0.496 0 CA-C-N 115.83 -0.623 . . . . 15.0 110.319 178.766 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 212' ' ' PRO . . . . . 0.651 ' HB3' HD13 ' A' ' 253' ' ' LEU . 12.6 Cg_endo -92.22 151.09 3.11 Favored 'Trans proline' 0 N--CA 1.452 -0.942 0 C-N-CA 123.587 2.858 . . . . 15.0 112.722 -179.927 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -90.38 159.03 26.99 Favored Glycine 0 N--CA 1.444 -0.771 0 C-N-CA 120.725 -0.75 . . . . 15.0 112.466 179.457 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 214' ' ' SEP . . . . . 0.733 ' HB3' HG21 ' A' ' 245' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 215' ' ' PRO . . . . . 1.199 ' HB2' ' CZ2' ' A' ' 262' ' ' TRP . 15.4 Cg_exo -87.69 132.42 2.95 Favored 'Trans proline' 0 N--CA 1.463 -0.319 0 C-N-CA 122.907 2.405 . . . . 15.0 110.148 176.882 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 216' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -113.58 83.79 1.91 Allowed 'General case' 0 C--N 1.322 -0.602 0 O-C-N 121.965 -0.46 . . . . 15.0 110.778 179.877 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 217' ' ' GLN . . . . . . . . . . . . . 26.1 mm-40 . . . . . 0 C--O 1.245 0.838 0 CA-C-N 114.933 -1.03 . . . . 15.0 110.705 179.57 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.478 0.973 0 N-CA-C 110.266 -0.272 . . . . 15.0 110.266 . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 2.4 mt -121.21 170.86 6.72 Favored Pre-proline 0 C--N 1.326 -0.424 0 N-CA-C 108.918 -0.771 . . . . 15.0 108.918 178.241 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 237' ' ' PRO . . . . . 0.462 ' O ' ' HD2' ' A' ' 240' ' ' TYR . 14.8 Cg_exo -69.81 162.69 41.11 Favored 'Trans proline' 0 N--CA 1.46 -0.46 0 C-N-CA 121.657 1.571 . . . . 15.0 110.093 164.626 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -69.71 148.41 49.28 Favored 'General case' 0 C--N 1.306 -1.29 0 CA-C-N 115.432 -0.804 . . . . 15.0 111.243 -175.266 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 100.28 -7.38 58.35 Favored Glycine 0 N--CA 1.45 -0.411 0 CA-C-N 115.418 -0.81 . . . . 15.0 113.275 -179.521 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 240' ' ' TYR . . . . . 0.653 ' CD1' ' HB2' ' A' ' 254' ' ' HIS . 87.8 m-85 -99.46 113.25 25.5 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 117.461 0.631 . . . . 15.0 110.47 177.351 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 241' ' ' GLU . . . . . 0.426 ' HG3' ' HB3' ' A' ' 253' ' ' LEU . 9.5 pt-20 -90.26 120.29 31.29 Favored 'General case' 0 N--CA 1.439 -0.975 0 N-CA-C 108.725 -0.843 . . . . 15.0 108.725 174.518 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? -89.86 99.1 12.18 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 108.123 -1.066 . . . . 15.0 108.123 -179.862 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 9.4 mtp180 -92.48 150.14 20.96 Favored 'General case' 0 N--CA 1.444 -0.738 0 CA-C-N 115.029 -0.987 . . . . 15.0 111.81 -175.152 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 244' ' ' THR . . . . . . . . . . . . . 4.4 p -117.54 149.92 39.82 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-N 113.733 -1.576 . . . . 15.0 110.077 -176.5 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 245' ' ' THR . . . . . 0.425 ' OG1' ' HG2' ' A' ' 247' ' ' GLN . 5.3 t -150.12 150.23 31.38 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 116.106 -0.497 . . . . 15.0 110.434 -176.003 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 19.8 t -54.82 -17.24 2.1 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 O-C-N 123.669 0.605 . . . . 15.0 111.354 179.078 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 247' ' ' GLN . . . . . 0.536 ' HB2' ' HG2' ' A' ' 249' ' ' GLN . 5.1 mm-40 -63.4 -19.25 64.52 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-O 121.006 0.431 . . . . 15.0 110.498 176.808 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 86.31 13.69 67.8 Favored Glycine 0 N--CA 1.452 -0.244 0 CA-C-N 116.013 -0.539 . . . . 15.0 112.289 176.709 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 249' ' ' GLN . . . . . 0.536 ' HG2' ' HB2' ' A' ' 247' ' ' GLN . 10.4 pt20 -114.02 135.12 54.35 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 120.927 0.394 . . . . 15.0 111.502 -174.701 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 6.0 m -90.0 120.26 38.5 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 N-CA-C 108.783 -0.821 . . . . 15.0 108.783 171.469 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 251' ' ' TYR . . . . . 0.643 ' HB2' ' CG ' ' B' ' 215' ' ' PRO . 4.3 p90 -125.75 133.04 52.2 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.863 -0.608 . . . . 15.0 109.855 -174.915 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 252' ' ' PHE . . . . . 0.63 ' CD2' ' HA ' ' A' ' 264' ' ' ASP . 24.5 m-85 -89.76 121.33 31.81 Favored 'General case' 0 CA--C 1.506 -0.728 0 CA-C-O 121.293 0.568 . . . . 15.0 111.619 -170.727 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 253' ' ' LEU . . . . . 0.555 HD12 ' CB ' ' B' ' 212' ' ' PRO . 0.6 OUTLIER -119.67 121.12 38.53 Favored 'General case' 0 N--CA 1.44 -0.944 0 CA-C-N 114.837 -1.074 . . . . 15.0 110.617 -176.017 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 254' ' ' HIS . . . . . 0.653 ' HB2' ' CD1' ' A' ' 240' ' ' TYR . 9.2 t-80 -132.33 96.59 3.9 Favored 'General case' 0 C--N 1.312 -1.065 0 N-CA-C 108.447 -0.945 . . . . 15.0 108.447 170.57 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 5.0 t -92.72 87.92 6.06 Favored 'General case' 0 N--CA 1.432 -1.369 0 C-N-CA 116.554 -2.058 . . . . 15.0 110.183 -179.509 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 256' ' ' GLN . . . . . 0.425 ' HB3' ' CE1' ' A' ' 254' ' ' HIS . 24.9 tt0 -101.36 -57.23 2.12 Favored 'General case' 0 N--CA 1.439 -0.98 0 CA-C-N 112.606 -2.088 . . . . 15.0 106.274 152.875 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 257' ' ' THR . . . . . . . . . . . . . 4.2 t -100.2 -13.56 18.86 Favored 'General case' 0 CA--C 1.488 -1.433 0 CA-C-N 111.326 -2.67 . . . . 15.0 112.085 -177.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 87.35 71.69 1.29 Allowed Glycine 1 C--N 1.238 -4.882 1 CA-C-N 108.136 -4.12 . . . . 15.0 112.635 -169.123 . . . . . . . . 3 2 . 1 . 020 nuclear orig full ' A' A ' 259' ' ' VAL . . . . . 0.545 ' O ' ' HA ' ' A' ' 253' ' ' LEU . 65.7 t -89.37 123.72 41.73 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 CA-C-O 121.667 0.746 . . . . 15.0 112.163 170.607 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 260' ' ' SER . . . . . 0.496 ' HA ' ' O ' ' A' ' 252' ' ' PHE . 2.4 p -140.85 100.57 3.87 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 113.876 -1.511 . . . . 15.0 108.442 170.706 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 261' ' ' THR . . . . . 0.404 ' OG1' ' HD2' ' A' ' 263' ' ' HIS . 8.7 t -141.75 150.51 41.86 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.18 0.514 . . . . 15.0 112.374 -168.35 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 262' ' ' TRP . . . . . 1.135 ' CZ2' ' HB2' ' B' ' 215' ' ' PRO . 29.5 m95 -71.06 -31.62 68.09 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.361 -0.836 . . . . 15.0 111.535 176.761 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 263' ' ' HIS . . . . . 0.404 ' HD2' ' OG1' ' A' ' 261' ' ' THR . 3.1 p80 -84.06 130.83 34.85 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 120.29 -0.564 . . . . 15.0 110.154 -175.737 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 264' ' ' ASP . . . . . 0.95 ' HB3' HG12 ' A' ' 267' ' ' ILE . 20.7 t0 -53.95 126.92 52.56 Favored Pre-proline 0 C--N 1.324 -0.511 0 CA-C-N 115.619 -0.719 . . . . 15.0 109.285 173.131 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 265' ' ' PRO . . . . . 0.536 ' HG2' ' CD1' ' A' ' 240' ' ' TYR . 10.9 Cg_exo -70.5 -14.96 34.24 Favored 'Trans proline' 0 N--CA 1.456 -0.709 0 C-N-CA 122.231 1.954 . . . . 15.0 112.496 -179.361 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 266' ' ' ARG . . . . . 0.449 ' HB3' ' OD2' ' A' ' 264' ' ' ASP . 26.6 tpt180 -72.38 -15.15 61.85 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-O 122.07 0.938 . . . . 15.0 108.788 171.171 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 267' ' ' ILE . . . . . 0.95 HG12 ' HB3' ' A' ' 264' ' ' ASP . 32.8 pt . . . . . 0 C--O 1.25 1.09 0 CA-C-N 114.275 -1.329 . . . . 15.0 110.936 177.117 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 210' ' ' SER . . . . . . . . . . . . . 21.0 m . . . . . 0 N--CA 1.473 0.7 0 N-CA-C 109.962 -0.384 . . . . 15.0 109.962 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' B' B ' 211' ' ' ASP . . . . . 0.492 ' HA ' ' HD3' ' B' ' 212' ' ' PRO . 6.0 p-10 -138.63 134.69 17.42 Favored Pre-proline 0 C--N 1.32 -0.694 0 CA-C-N 115.925 -0.579 . . . . 15.0 109.795 -177.684 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 212' ' ' PRO . . . . . 0.555 ' CB ' HD12 ' A' ' 253' ' ' LEU . 4.6 Cg_endo -89.7 154.78 5.15 Favored 'Trans proline' 0 N--CA 1.456 -0.711 0 C-N-CA 123.393 2.729 . . . . 15.0 112.225 -177.0 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -89.66 158.55 27.44 Favored Glycine 0 N--CA 1.442 -0.965 0 CA-C-N 115.625 -0.716 . . . . 15.0 112.587 -177.435 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 214' ' ' SEP . . . . . 0.414 ' HA ' ' HD3' ' B' ' 215' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 215' ' ' PRO . . . . . 1.135 ' HB2' ' CZ2' ' A' ' 262' ' ' TRP . 23.6 Cg_exo -87.33 148.47 7.71 Favored 'Trans proline' 0 N--CA 1.464 -0.245 0 C-N-CA 123.15 2.567 . . . . 15.0 111.62 176.207 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 216' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -114.05 -67.27 1.01 Allowed 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.132 0.491 . . . . 15.0 110.06 178.645 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 217' ' ' GLN . . . . . . . . . . . . . 28.2 pt20 . . . . . 0 C--O 1.249 1.074 0 CA-C-O 118.456 -0.783 . . . . 15.0 110.154 -179.441 . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.482 1.158 0 N-CA-C 110.124 -0.324 . . . . 15.0 110.124 . . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 236' ' ' LEU . . . . . 0.429 HD13 ' OD2' ' A' ' 264' ' ' ASP . 0.9 OUTLIER -107.05 172.17 4.06 Favored Pre-proline 0 C--N 1.323 -0.549 0 CA-C-N 116.463 -0.335 . . . . 15.0 110.376 -176.889 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 237' ' ' PRO . . . . . 0.676 ' HD3' ' HD3' ' A' ' 266' ' ' ARG . 19.5 Cg_exo -69.44 170.1 16.99 Favored 'Trans proline' 0 CA--C 1.516 -0.422 0 C-N-CA 122.335 2.023 . . . . 15.0 110.838 165.577 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -69.78 140.26 53.35 Favored 'General case' 0 C--N 1.303 -1.422 0 CA-C-N 114.691 -1.14 . . . . 15.0 110.865 -176.207 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 239' ' ' GLY . . . . . 0.413 ' O ' ' HA ' ' A' ' 254' ' ' HIS . . . 100.04 11.99 41.15 Favored Glycine 0 N--CA 1.448 -0.516 0 CA-C-N 115.632 -0.713 . . . . 15.0 113.867 179.07 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 240' ' ' TYR . . . . . 0.646 ' CD1' ' HB2' ' A' ' 254' ' ' HIS . 64.2 m-85 -111.99 107.9 17.04 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 117.918 0.859 . . . . 15.0 111.579 178.13 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 13.8 mm-40 -90.15 120.81 31.64 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.021 -0.99 . . . . 15.0 109.841 176.155 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 23.4 tm0? -89.97 109.87 20.88 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 109.103 -0.703 . . . . 15.0 109.103 177.378 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 4.5 mtp180 -112.23 150.23 31.19 Favored 'General case' 0 CA--C 1.508 -0.666 0 CA-C-O 122.564 1.173 . . . . 15.0 113.494 -179.86 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 244' ' ' THR . . . . . . . . . . . . . 21.8 p -116.15 150.1 37.98 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-N 112.555 -2.111 . . . . 15.0 108.67 177.7 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 245' ' ' THR . . . . . 0.456 ' OG1' ' HG2' ' A' ' 247' ' ' GLN . 5.9 t -144.32 150.52 37.95 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 116.82 -0.173 . . . . 15.0 110.697 -175.201 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 21.6 t -52.5 -18.49 1.23 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 O-C-N 123.749 0.656 . . . . 15.0 111.589 178.261 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 247' ' ' GLN . . . . . 0.456 ' HG2' ' OG1' ' A' ' 245' ' ' THR . 4.7 mm100 -63.89 -17.15 62.91 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-O 120.893 0.378 . . . . 15.0 110.555 177.426 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 83.91 38.5 10.3 Favored Glycine 0 C--N 1.334 0.459 0 CA-C-N 116.088 -0.505 . . . . 15.0 112.571 177.275 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 249' ' ' GLN . . . . . 0.43 ' CD ' ' HH2' ' A' ' 262' ' ' TRP . 0.0 OUTLIER -146.72 147.5 31.03 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.044 0.449 . . . . 15.0 111.355 -175.194 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 13.7 m -93.92 138.45 20.44 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-N 115.1 -0.955 . . . . 15.0 109.345 173.737 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 251' ' ' TYR . . . . . 0.448 ' HB3' ' CG ' ' B' ' 215' ' ' PRO . 4.9 p90 -145.78 136.62 24.45 Favored 'General case' 0 C--N 1.32 -0.717 0 C-N-CA 120.605 -0.438 . . . . 15.0 110.419 -179.891 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 252' ' ' PHE . . . . . 0.6 ' CE2' ' HA ' ' A' ' 264' ' ' ASP . 43.9 m-85 -91.16 121.54 33.03 Favored 'General case' 0 CA--C 1.515 -0.377 0 CA-C-N 116.059 -0.519 . . . . 15.0 111.839 -174.629 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 253' ' ' LEU . . . . . 0.636 ' HA ' ' O ' ' A' ' 259' ' ' VAL . 13.7 mt -104.26 110.33 22.5 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-N 115.243 -0.89 . . . . 15.0 112.169 179.196 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 254' ' ' HIS . . . . . 0.646 ' HB2' ' CD1' ' A' ' 240' ' ' TYR . 22.7 t-80 -116.17 89.93 3.22 Favored 'General case' 0 C--N 1.311 -1.08 0 N-CA-C 107.696 -1.224 . . . . 15.0 107.696 166.099 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 37.1 m -90.86 88.03 6.89 Favored 'General case' 0 N--CA 1.43 -1.442 0 C-N-CA 116.894 -1.922 . . . . 15.0 110.097 -179.272 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 8.0 tt0 -101.04 -51.76 3.45 Favored 'General case' 0 N--CA 1.441 -0.891 0 N-CA-C 105.721 -1.955 . . . . 15.0 105.721 149.677 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 257' ' ' THR . . . . . . . . . . . . . 58.6 p -99.78 -13.69 19.15 Favored 'General case' 0 CA--C 1.485 -1.533 0 CA-C-O 124.768 2.223 . . . . 15.0 112.047 -179.435 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 85.9 75.51 1.24 Allowed Glycine 1 C--N 1.237 -4.937 0 CA-C-N 108.439 -3.982 . . . . 15.0 112.2 -169.55 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 259' ' ' VAL . . . . . 0.636 ' O ' ' HA ' ' A' ' 253' ' ' LEU . 42.9 t -89.88 123.46 42.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-O 121.395 0.617 . . . . 15.0 111.845 175.578 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 4.6 p -134.65 99.63 4.39 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 114.174 -1.376 . . . . 15.0 108.234 170.117 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 8.9 t -135.8 150.48 49.46 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 121.097 0.475 . . . . 15.0 111.841 -171.256 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 262' ' ' TRP . . . . . 1.12 ' CZ2' ' HB2' ' B' ' 215' ' ' PRO . 67.6 m95 -68.31 -33.45 74.33 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.141 -0.936 . . . . 15.0 111.345 176.595 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 263' ' ' HIS . . . . . 0.414 ' HD1' ' HB ' ' A' ' 267' ' ' ILE . 4.7 p80 -82.12 131.36 35.24 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 120.44 -0.504 . . . . 15.0 110.128 -172.783 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 264' ' ' ASP . . . . . 0.932 ' HB3' HG12 ' A' ' 267' ' ' ILE . 9.4 t70 -51.75 133.21 37.24 Favored Pre-proline 0 C--N 1.321 -0.635 0 N-CA-C 108.946 -0.761 . . . . 15.0 108.946 171.578 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 265' ' ' PRO . . . . . 0.427 ' HD3' ' CD2' ' A' ' 252' ' ' PHE . 36.5 Cg_endo -72.7 -14.76 27.18 Favored 'Trans proline' 0 N--CA 1.454 -0.797 0 C-N-CA 121.725 1.617 . . . . 15.0 114.294 -173.969 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 266' ' ' ARG . . . . . 0.676 ' HD3' ' HD3' ' A' ' 237' ' ' PRO . 0.1 OUTLIER -81.69 -6.65 59.22 Favored 'General case' 0 C--N 1.311 -1.107 0 N-CA-C 108.426 -0.953 . . . . 15.0 108.426 174.843 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 267' ' ' ILE . . . . . 0.932 HG12 ' HB3' ' A' ' 264' ' ' ASP . 42.1 mm . . . . . 0 C--O 1.249 1.031 0 CA-C-N 113.865 -1.516 . . . . 15.0 109.921 177.606 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 210' ' ' SER . . . . . . . . . . . . . 5.9 m . . . . . 0 N--CA 1.474 0.737 0 CA-C-O 120.873 0.368 . . . . 15.0 110.2 . . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' B' B ' 211' ' ' ASP . . . . . 0.418 ' HA ' ' HD3' ' B' ' 212' ' ' PRO . 30.4 t70 -150.09 129.39 6.37 Favored Pre-proline 0 C--N 1.324 -0.501 0 N-CA-C 109.504 -0.554 . . . . 15.0 109.504 -179.436 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 212' ' ' PRO . . . . . 0.584 ' CB ' HD11 ' A' ' 253' ' ' LEU . 27.3 Cg_endo -89.9 156.98 4.98 Favored 'Trans proline' 0 N--CA 1.454 -0.837 0 C-N-CA 122.601 2.2 . . . . 15.0 112.967 -176.081 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -89.89 159.98 28.3 Favored Glycine 0 N--CA 1.442 -0.942 0 CA-C-N 115.493 -0.776 . . . . 15.0 111.458 177.908 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 214' ' ' SEP . . . . . 0.405 ' HA ' ' HD3' ' B' ' 215' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 215' ' ' PRO . . . . . 1.12 ' HB2' ' CZ2' ' A' ' 262' ' ' TRP . 12.0 Cg_exo -88.0 143.29 5.81 Favored 'Trans proline' 0 C--O 1.235 0.326 0 C-N-CA 122.846 2.364 . . . . 15.0 111.731 176.833 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 216' ' ' PHE . . . . . 0.416 ' HB2' ' H ' ' B' ' 217' ' ' GLN . 42.0 m-85 -111.13 -89.42 0.5 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.719 -0.673 . . . . 15.0 110.332 -178.566 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 217' ' ' GLN . . . . . 0.416 ' H ' ' HB2' ' B' ' 216' ' ' PHE . 4.0 pt20 . . . . . 0 C--O 1.248 1.006 0 CA-C-O 118.389 -0.815 . . . . 15.0 110.393 -178.591 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 . . . . . 0 N--CA 1.476 0.875 0 CA-C-O 121.087 0.47 . . . . 15.0 110.099 . . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 236' ' ' LEU . . . . . 0.712 HD13 ' HD2' ' A' ' 265' ' ' PRO . 0.4 OUTLIER -90.03 161.3 38.47 Favored Pre-proline 0 C--N 1.32 -0.693 0 CA-C-N 115.782 -0.644 . . . . 15.0 110.715 -171.675 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 237' ' ' PRO . . . . . 0.517 ' HD3' ' HD3' ' A' ' 266' ' ' ARG . 23.3 Cg_exo -69.32 171.0 14.75 Favored 'Trans proline' 0 CA--C 1.508 -0.783 0 C-N-CA 122.844 2.363 . . . . 15.0 110.097 162.474 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -69.42 145.1 53.1 Favored 'General case' 0 C--N 1.3 -1.553 0 CA-C-N 115.072 -0.967 . . . . 15.0 111.89 -175.845 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 100.21 10.19 45.93 Favored Glycine 0 N--CA 1.449 -0.484 0 CA-C-N 114.435 -1.257 . . . . 15.0 113.214 -179.868 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 240' ' ' TYR . . . . . 0.606 ' CD1' ' HB2' ' A' ' 254' ' ' HIS . 71.9 m-85 -116.67 123.5 47.41 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 117.235 0.518 . . . . 15.0 110.989 177.904 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -91.52 123.45 34.94 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.648 -0.705 . . . . 15.0 109.446 171.41 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 18.8 tm0? -91.4 99.86 12.74 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 108.646 -0.872 . . . . 15.0 108.646 174.513 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 68.7 mtt-85 -103.16 150.16 23.94 Favored 'General case' 0 CA--C 1.504 -0.825 0 CA-C-O 122.136 0.97 . . . . 15.0 112.087 -176.37 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 244' ' ' THR . . . . . . . . . . . . . 10.9 m -129.47 97.56 4.59 Favored 'General case' 0 C--N 1.308 -1.222 0 CA-C-N 113.28 -1.782 . . . . 15.0 109.399 -177.042 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 245' ' ' THR . . . . . 0.475 ' OG1' ' HG2' ' A' ' 247' ' ' GLN . 3.5 t -94.94 150.48 20.12 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.257 -0.883 . . . . 15.0 110.989 -175.621 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 9.9 m -50.53 -18.36 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.451 0 CA-C-N 115.615 -0.721 . . . . 15.0 112.577 176.97 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 247' ' ' GLN . . . . . 0.475 ' HG2' ' OG1' ' A' ' 245' ' ' THR . 7.3 mm100 -56.3 -21.28 23.07 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.02 -0.536 . . . . 15.0 110.682 173.182 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 89.73 11.91 63.16 Favored Glycine 0 N--CA 1.447 -0.576 0 CA-C-N 115.851 -0.613 . . . . 15.0 112.871 174.845 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 7.1 mt-30 -129.37 141.53 51.04 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 110.205 -0.294 . . . . 15.0 110.205 -176.358 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 17.1 m -89.79 135.0 27.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 116.333 -0.394 . . . . 15.0 110.109 178.235 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 251' ' ' TYR . . . . . 0.508 ' HB3' ' HG2' ' B' ' 215' ' ' PRO . 25.6 p90 -134.54 135.05 42.04 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 116.143 -0.48 . . . . 15.0 110.004 -178.437 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 252' ' ' PHE . . . . . 0.711 ' CD2' ' HA ' ' A' ' 264' ' ' ASP . 24.3 m-85 -90.22 125.72 35.58 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.31 0.576 . . . . 15.0 111.147 -175.731 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 253' ' ' LEU . . . . . 1.033 HD12 ' HB3' ' B' ' 212' ' ' PRO . 0.4 OUTLIER -113.73 109.42 18.55 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-N 114.808 -1.087 . . . . 15.0 111.858 -173.398 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 254' ' ' HIS . . . . . 0.606 ' HB2' ' CD1' ' A' ' 240' ' ' TYR . 35.2 t-80 -120.62 89.98 3.23 Favored 'General case' 0 C--N 1.314 -0.963 0 N-CA-C 108.386 -0.968 . . . . 15.0 108.386 167.785 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 8.0 t -94.94 88.03 5.15 Favored 'General case' 0 N--CA 1.433 -1.289 0 C-N-CA 116.5 -2.08 . . . . 15.0 110.998 -179.372 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 -100.76 -51.86 3.47 Favored 'General case' 0 N--CA 1.44 -0.96 0 CA-C-N 112.808 -1.996 . . . . 15.0 106.142 149.415 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 257' ' ' THR . . . . . . . . . . . . . 59.3 p -95.85 -13.23 24.17 Favored 'General case' 0 CA--C 1.487 -1.457 0 CA-C-O 125.039 2.352 . . . . 15.0 111.763 -179.21 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 84.9 73.25 1.27 Allowed Glycine 1 C--N 1.241 -4.705 1 CA-C-N 108.042 -4.163 . . . . 15.0 112.55 -172.873 . . . . . . . . 3 2 . 1 . 022 nuclear orig full ' A' A ' 259' ' ' VAL . . . . . 0.588 ' O ' HD21 ' A' ' 253' ' ' LEU . 66.0 t -89.86 122.59 41.38 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.411 0 CA-C-O 121.676 0.751 . . . . 15.0 111.878 176.664 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 2.2 p -134.47 100.8 4.76 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-N 113.746 -1.57 . . . . 15.0 107.295 170.42 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 9.0 t -136.26 150.32 48.89 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 112.654 0.613 . . . . 15.0 112.654 -166.413 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 262' ' ' TRP . . . . . 1.174 ' CZ2' ' HB2' ' B' ' 215' ' ' PRO . 79.9 m95 -79.02 -23.19 44.49 Favored 'General case' 0 N--CA 1.454 -0.275 0 CA-C-N 115.154 -0.93 . . . . 15.0 111.474 177.788 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 263' ' ' HIS . . . . . . . . . . . . . 5.6 p80 -92.96 134.5 35.05 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 120.271 -0.572 . . . . 15.0 110.521 -176.517 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 264' ' ' ASP . . . . . 0.978 ' HB3' HG12 ' A' ' 267' ' ' ILE . 13.7 t0 -56.99 124.1 63.34 Favored Pre-proline 0 C--N 1.321 -0.673 0 N-CA-C 108.4 -0.963 . . . . 15.0 108.4 171.049 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 265' ' ' PRO . . . . . 0.712 ' HD2' HD13 ' A' ' 236' ' ' LEU . 16.6 Cg_exo -68.39 -14.77 40.87 Favored 'Trans proline' 0 CA--C 1.514 -0.479 0 C-N-CA 122.362 2.041 . . . . 15.0 113.181 -176.45 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 266' ' ' ARG . . . . . 0.517 ' HD3' ' HD3' ' A' ' 237' ' ' PRO . 10.8 tpt180 -76.93 -10.06 59.11 Favored 'General case' 0 C--N 1.313 -1.015 0 N-CA-C 108.473 -0.936 . . . . 15.0 108.473 174.137 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 267' ' ' ILE . . . . . 0.978 HG12 ' HB3' ' A' ' 264' ' ' ASP . 27.9 pt . . . . . 0 C--O 1.251 1.175 0 CA-C-N 114.129 -1.396 . . . . 15.0 110.835 177.334 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 210' ' ' SER . . . . . . . . . . . . . 9.4 t . . . . . 0 N--CA 1.476 0.861 0 N-CA-C 109.141 -0.689 . . . . 15.0 109.141 . . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' B' B ' 211' ' ' ASP . . . . . 0.42 ' HA ' ' HD3' ' B' ' 212' ' ' PRO . 5.0 m-20 -130.58 150.17 75.57 Favored Pre-proline 0 C--N 1.321 -0.654 0 CA-C-N 116.093 -0.503 . . . . 15.0 110.711 -174.077 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 212' ' ' PRO . . . . . 1.033 ' HB3' HD12 ' A' ' 253' ' ' LEU . 5.2 Cg_endo -89.83 151.65 5.0 Favored 'Trans proline' 0 N--CA 1.453 -0.906 0 C-N-CA 123.111 2.541 . . . . 15.0 112.182 179.759 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -89.93 160.08 28.33 Favored Glycine 0 N--CA 1.442 -0.922 0 C-N-CA 120.674 -0.774 . . . . 15.0 111.643 -179.764 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 214' ' ' SEP . . . . . 0.415 ' HA ' ' HD3' ' B' ' 215' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 215' ' ' PRO . . . . . 1.174 ' HB2' ' CZ2' ' A' ' 262' ' ' TRP . 12.1 Cg_exo -88.14 138.82 4.22 Favored 'Trans proline' 0 C--O 1.235 0.37 0 C-N-CA 123.222 2.614 . . . . 15.0 111.302 178.377 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 216' ' ' PHE . . . . . . . . . . . . . 93.8 m-85 -99.88 128.12 46.0 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.97 -0.559 . . . . 15.0 110.216 -178.604 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 217' ' ' GLN . . . . . . . . . . . . . 18.8 mm-40 . . . . . 0 C--O 1.246 0.877 0 CA-C-O 118.506 -0.759 . . . . 15.0 110.193 177.773 . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 . . . . . 0 N--CA 1.483 1.212 0 CA-C-O 121.039 0.447 . . . . 15.0 110.803 . . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 236' ' ' LEU . . . . . 0.44 HD13 ' HB2' ' A' ' 266' ' ' ARG . 0.4 OUTLIER -104.07 171.58 4.94 Favored Pre-proline 0 C--N 1.319 -0.732 0 N-CA-C 109.225 -0.657 . . . . 15.0 109.225 -178.878 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_exo -69.56 164.55 33.92 Favored 'Trans proline' 0 N--CA 1.459 -0.553 0 C-N-CA 121.606 1.538 . . . . 15.0 110.689 170.802 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -69.69 150.34 47.09 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-N 114.976 -1.011 . . . . 15.0 111.707 -174.535 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 100.15 -7.16 58.47 Favored Glycine 0 N--CA 1.448 -0.523 0 CA-C-N 115.656 -0.702 . . . . 15.0 113.644 176.206 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 240' ' ' TYR . . . . . 0.602 ' CD1' ' HB2' ' A' ' 254' ' ' HIS . 60.0 m-85 -102.53 114.05 27.94 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 117.492 0.646 . . . . 15.0 110.628 179.125 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -94.54 131.72 39.98 Favored 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 108.924 -0.769 . . . . 15.0 108.924 171.306 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 23.0 tm0? -89.71 107.97 19.4 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 107.989 -1.115 . . . . 15.0 107.989 179.623 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 13.7 mtp180 -101.85 150.15 23.46 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-O 122.121 0.963 . . . . 15.0 112.175 -175.861 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 244' ' ' THR . . . . . . . . . . . . . 5.1 m -122.69 141.38 51.83 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-N 113.216 -1.811 . . . . 15.0 107.757 -177.798 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 245' ' ' THR . . . . . 0.619 ' CG2' ' HB3' ' A' ' 247' ' ' GLN . 3.1 t -141.96 150.34 41.29 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-O 120.878 0.371 . . . . 15.0 111.717 -169.216 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 8.8 p -55.97 -24.45 17.34 Favored 'Isoleucine or valine' 0 C--O 1.234 0.248 0 CA-C-N 115.31 -0.859 . . . . 15.0 109.886 172.49 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 247' ' ' GLN . . . . . 0.72 ' HG2' ' NE2' ' A' ' 249' ' ' GLN . 40.8 tt0 -50.46 -35.83 30.71 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 114.506 -1.224 . . . . 15.0 110.473 172.699 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 102.04 -15.29 56.76 Favored Glycine 0 C--N 1.333 0.396 0 CA-C-N 116.118 -0.492 . . . . 15.0 112.987 176.645 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 249' ' ' GLN . . . . . 0.72 ' NE2' ' HG2' ' A' ' 247' ' ' GLN . 2.3 mp0 -96.43 147.42 23.85 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 120.64 0.257 . . . . 15.0 111.3 -173.857 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 3.3 m -89.99 130.26 39.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 N-CA-C 109.617 -0.512 . . . . 15.0 109.617 174.16 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 251' ' ' TYR . . . . . 0.522 ' HB3' ' HG2' ' B' ' 215' ' ' PRO . 9.4 p90 -142.42 138.95 31.45 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.369 0.605 . . . . 15.0 111.721 -176.206 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 252' ' ' PHE . . . . . 0.611 ' CD2' ' HA ' ' A' ' 264' ' ' ASP . 43.0 m-85 -96.62 125.17 40.91 Favored 'General case' 0 CA--C 1.509 -0.607 0 CA-C-N 115.169 -0.923 . . . . 15.0 110.873 -177.265 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 253' ' ' LEU . . . . . 0.676 ' HA ' ' O ' ' A' ' 259' ' ' VAL . 0.1 OUTLIER -123.95 109.15 13.21 Favored 'General case' 0 N--CA 1.441 -0.919 0 CA-C-O 121.696 0.76 . . . . 15.0 111.979 -177.939 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 254' ' ' HIS . . . . . 0.602 ' HB2' ' CD1' ' A' ' 240' ' ' TYR . 12.4 t-80 -109.61 93.85 4.72 Favored 'General case' 0 CA--C 1.501 -0.928 0 CA-C-N 114.881 -1.054 . . . . 15.0 108.184 169.36 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 3.6 t -93.85 88.2 5.67 Favored 'General case' 0 N--CA 1.434 -1.265 0 C-N-CA 116.35 -2.14 . . . . 15.0 110.556 179.501 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 7.6 tp60 -101.21 -51.9 3.39 Favored 'General case' 0 N--CA 1.442 -0.863 0 CA-C-N 113.19 -1.823 . . . . 15.0 106.269 150.981 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 257' ' ' THR . . . . . . . . . . . . . 71.9 p -99.96 -13.67 19.01 Favored 'General case' 0 CA--C 1.487 -1.461 0 CA-C-O 124.666 2.174 . . . . 15.0 112.118 -179.501 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 88.63 73.89 1.28 Allowed Glycine 1 C--N 1.242 -4.693 0 CA-C-N 108.533 -3.94 . . . . 15.0 112.849 -171.32 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 259' ' ' VAL . . . . . 0.676 ' O ' ' HA ' ' A' ' 253' ' ' LEU . 68.7 t -89.58 126.73 42.5 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.391 0 CA-C-O 121.296 0.57 . . . . 15.0 111.583 173.219 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 260' ' ' SER . . . . . 0.411 ' HA ' ' O ' ' A' ' 252' ' ' PHE . 2.2 p -150.01 94.13 2.11 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 114.039 -1.437 . . . . 15.0 107.72 168.886 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 9.8 t -135.03 150.29 50.27 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.516 -0.765 . . . . 15.0 111.173 -169.151 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 262' ' ' TRP . . . . . 1.135 ' CZ2' ' HB2' ' B' ' 215' ' ' PRO . 23.2 m95 -70.1 -17.51 63.22 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 113.19 0.811 . . . . 15.0 113.19 -177.194 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 263' ' ' HIS . . . . . . . . . . . . . 4.6 p80 -96.25 133.0 41.12 Favored 'General case' 0 C--N 1.323 -0.561 0 C-N-CA 120.088 -0.645 . . . . 15.0 110.01 179.961 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 264' ' ' ASP . . . . . 1.01 ' HB3' HG12 ' A' ' 267' ' ' ILE . 9.9 t0 -56.72 131.21 78.19 Favored Pre-proline 0 C--O 1.222 -0.386 0 N-CA-C 107.888 -1.153 . . . . 15.0 107.888 171.283 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 265' ' ' PRO . . . . . 0.49 ' HG2' ' CD1' ' A' ' 240' ' ' TYR . 17.0 Cg_exo -69.33 -15.05 38.42 Favored 'Trans proline' 0 C--N 1.324 -0.75 0 C-N-CA 122.092 1.861 . . . . 15.0 113.415 -176.232 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 266' ' ' ARG . . . . . 0.465 ' HD2' ' HA ' ' A' ' 266' ' ' ARG . 15.9 tpt180 -79.7 -8.02 58.96 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-O 122.037 0.922 . . . . 15.0 108.67 173.881 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 267' ' ' ILE . . . . . 1.01 HG12 ' HB3' ' A' ' 264' ' ' ASP . 33.4 pt . . . . . 0 C--O 1.248 0.984 0 CA-C-N 113.798 -1.546 . . . . 15.0 110.641 175.382 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 210' ' ' SER . . . . . . . . . . . . . 10.7 m . . . . . 0 N--CA 1.475 0.825 0 CA-C-O 120.883 0.373 . . . . 15.0 110.644 . . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' B' B ' 211' ' ' ASP . . . . . 0.436 ' HA ' ' HD3' ' B' ' 212' ' ' PRO . 25.7 t70 -140.08 122.0 9.75 Favored Pre-proline 0 N--CA 1.453 -0.286 0 CA-C-O 121.023 0.44 . . . . 15.0 111.084 -177.31 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 212' ' ' PRO . . . . . 0.654 ' HB2' HD13 ' A' ' 253' ' ' LEU . 1.2 Cg_endo -89.63 160.01 5.27 Favored 'Trans proline' 0 N--CA 1.457 -0.65 0 C-N-CA 123.774 2.983 . . . . 15.0 111.846 176.126 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -89.61 160.09 28.73 Favored Glycine 0 N--CA 1.447 -0.617 0 C-N-CA 120.809 -0.71 . . . . 15.0 112.896 -176.168 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 214' ' ' SEP . . . . . 0.462 ' HA ' ' HD3' ' B' ' 215' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 215' ' ' PRO . . . . . 1.135 ' HB2' ' CZ2' ' A' ' 262' ' ' TRP 0.291 22.2 Cg_exo -87.41 132.89 3.15 Favored 'Trans proline' 0 C--O 1.232 0.217 0 C-N-CA 123.69 2.927 . . . . 15.0 111.58 -176.448 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' B' B ' 216' ' ' PHE . . . . . . . . . . . . . 65.5 m-85 -110.52 -38.92 5.07 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 109.348 -0.612 . . . . 15.0 109.348 176.333 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 217' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.247 0.971 0 CA-C-N 115.412 -0.813 . . . . 15.0 109.211 176.288 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 . . . . . 0 N--CA 1.478 0.95 0 N-CA-C 109.974 -0.38 . . . . 15.0 109.974 . . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 236' ' ' LEU . . . . . 0.635 HD21 ' H ' ' A' ' 236' ' ' LEU . 0.1 OUTLIER -94.63 157.92 36.26 Favored Pre-proline 0 C--N 1.323 -0.554 0 CA-C-O 121.133 0.492 . . . . 15.0 110.166 -176.706 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 237' ' ' PRO . . . . . 0.553 ' HD3' ' HD3' ' A' ' 266' ' ' ARG . 15.1 Cg_exo -69.56 173.8 10.27 Favored 'Trans proline' 0 CA--C 1.507 -0.84 0 C-N-CA 122.672 2.248 . . . . 15.0 110.442 165.861 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 3.7 pm0 -69.48 142.63 53.71 Favored 'General case' 0 C--N 1.291 -1.945 0 CA-C-N 114.253 -1.339 . . . . 15.0 111.613 -173.297 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 100.17 3.36 55.68 Favored Glycine 0 CA--C 1.521 0.446 0 CA-C-N 115.233 -0.894 . . . . 15.0 113.965 177.172 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 240' ' ' TYR . . . . . 0.511 ' CD1' ' HG2' ' A' ' 265' ' ' PRO . 62.4 m-85 -111.17 125.34 53.69 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 117.856 0.828 . . . . 15.0 111.253 178.651 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 241' ' ' GLU . . . . . 0.523 ' HG3' ' HB3' ' A' ' 253' ' ' LEU . 8.6 pt-20 -108.75 123.28 48.76 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 109.199 -0.667 . . . . 15.0 109.199 170.926 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -89.81 106.55 18.54 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 109.203 -0.665 . . . . 15.0 109.203 -177.802 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 27.9 mtt-85 -98.46 148.43 23.73 Favored 'General case' 0 CA--C 1.505 -0.771 0 CA-C-O 122.123 0.963 . . . . 15.0 112.06 -177.531 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 244' ' ' THR . . . . . . . . . . . . . 25.0 p -117.26 146.06 43.54 Favored 'General case' 0 C--N 1.306 -1.285 0 CA-C-N 113.348 -1.751 . . . . 15.0 108.852 178.409 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 245' ' ' THR . . . . . 0.458 HG21 ' HB2' ' A' ' 247' ' ' GLN . 5.9 t -144.26 150.16 37.47 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 116.612 -0.267 . . . . 15.0 110.861 -172.393 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 6.4 m -53.63 -19.17 2.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.824 -0.626 . . . . 15.0 111.974 177.953 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 247' ' ' GLN . . . . . 0.458 ' HB2' HG21 ' A' ' 245' ' ' THR . 8.8 mm100 -58.68 -20.61 49.94 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.735 -0.666 . . . . 15.0 110.901 175.203 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 84.21 26.61 39.64 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 121.107 -0.568 . . . . 15.0 112.542 176.639 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 3.0 mt-30 -133.2 138.9 46.72 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 110.286 -0.264 . . . . 15.0 110.286 -173.904 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 4.4 m -89.65 122.83 41.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 N-CA-C 109.721 -0.474 . . . . 15.0 109.721 173.331 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 251' ' ' TYR . . . . . 0.799 ' HB2' ' HG2' ' B' ' 215' ' ' PRO . 2.5 p90 -129.89 134.07 47.28 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.049 0.452 . . . . 15.0 109.856 -175.792 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 252' ' ' PHE . . . . . 0.594 ' CD2' ' HA ' ' A' ' 264' ' ' ASP . 40.1 m-85 -90.05 128.11 36.21 Favored 'General case' 0 CA--C 1.512 -0.499 0 CA-C-O 121.237 0.542 . . . . 15.0 111.483 -175.185 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 253' ' ' LEU . . . . . 0.81 HD12 ' HB3' ' B' ' 212' ' ' PRO . 0.7 OUTLIER -118.66 126.27 51.56 Favored 'General case' 0 N--CA 1.446 -0.673 0 CA-C-N 115.035 -0.984 . . . . 15.0 110.78 -175.909 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 254' ' ' HIS . . . . . 0.534 ' HB3' ' HB ' ' A' ' 259' ' ' VAL . 0.2 OUTLIER -140.61 91.72 2.45 Favored 'General case' 0 C--N 1.313 -0.988 0 N-CA-C 108.595 -0.891 . . . . 15.0 108.595 173.282 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 3.1 t -103.23 87.91 3.0 Favored 'General case' 0 N--CA 1.43 -1.44 0 C-N-CA 116.796 -1.962 . . . . 15.0 111.015 -179.598 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 30.2 tp60 -101.23 -52.85 3.16 Favored 'General case' 0 N--CA 1.437 -1.099 0 CA-C-N 112.681 -2.054 . . . . 15.0 105.574 147.116 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 257' ' ' THR . . . . . . . . . . . . . 31.8 p -97.63 -13.55 21.49 Favored 'General case' 0 CA--C 1.489 -1.38 0 CA-C-O 124.89 2.281 . . . . 15.0 112.0 -177.246 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 84.73 71.37 1.32 Allowed Glycine 1 C--N 1.242 -4.676 1 CA-C-N 108.315 -4.039 . . . . 15.0 113.926 -174.575 . . . . . . . . 3 2 . 1 . 024 nuclear orig full ' A' A ' 259' ' ' VAL . . . . . 0.534 ' HB ' ' HB3' ' A' ' 254' ' ' HIS . 67.5 t -89.91 129.95 39.99 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 CA-C-O 121.405 0.622 . . . . 15.0 111.431 171.597 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 23.8 p -143.79 102.89 3.98 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 114.386 -1.279 . . . . 15.0 108.093 171.553 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 14.4 t -149.32 150.44 32.49 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.966 0.412 . . . . 15.0 111.747 -168.726 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 262' ' ' TRP . . . . . 1.11 ' CZ2' ' HB2' ' B' ' 215' ' ' PRO . 84.7 m95 -71.96 -37.03 70.0 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.721 -0.672 . . . . 15.0 111.282 177.724 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 263' ' ' HIS . . . . . . . . . . . . . 2.8 p80 -73.65 126.85 31.22 Favored 'General case' 0 CA--C 1.515 -0.37 0 C-N-CA 120.52 -0.472 . . . . 15.0 109.923 -174.001 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 264' ' ' ASP . . . . . 1.119 ' HB3' HG12 ' A' ' 267' ' ' ILE . 15.0 t0 -54.47 125.79 53.43 Favored Pre-proline 0 C--N 1.32 -0.699 0 N-CA-C 108.326 -0.99 . . . . 15.0 108.326 173.404 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 265' ' ' PRO . . . . . 0.511 ' HG2' ' CD1' ' A' ' 240' ' ' TYR . 14.2 Cg_exo -68.72 -14.59 39.55 Favored 'Trans proline' 0 CA--C 1.512 -0.581 0 C-N-CA 121.893 1.729 . . . . 15.0 112.667 -177.296 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 266' ' ' ARG . . . . . 0.553 ' HD3' ' HD3' ' A' ' 237' ' ' PRO . 19.8 tpt180 -76.46 -11.94 59.96 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 115.225 -0.898 . . . . 15.0 108.932 173.137 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 267' ' ' ILE . . . . . 1.119 HG12 ' HB3' ' A' ' 264' ' ' ASP . 41.8 pt . . . . . 0 C--O 1.25 1.101 0 CA-C-O 117.549 -1.215 . . . . 15.0 111.529 178.999 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' B' B ' 210' ' ' SER . . . . . . . . . . . . . 18.9 m . . . . . 0 N--CA 1.477 0.892 0 CA-C-O 120.98 0.419 . . . . 15.0 110.806 . . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' B' B ' 211' ' ' ASP . . . . . . . . . . . . . 11.9 p-10 -111.87 109.87 54.85 Favored Pre-proline 0 C--N 1.327 -0.38 0 CA-C-O 121.138 0.494 . . . . 15.0 110.5 -178.29 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' B' B ' 212' ' ' PRO . . . . . 0.81 ' HB3' HD12 ' A' ' 253' ' ' LEU . 6.6 Cg_endo -89.97 147.73 4.71 Favored 'Trans proline' 0 N--CA 1.453 -0.871 0 C-N-CA 122.638 2.225 . . . . 15.0 112.21 176.257 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -89.62 131.78 10.91 Favored Glycine 0 N--CA 1.442 -0.931 0 C-N-CA 120.543 -0.836 . . . . 15.0 111.598 178.286 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' B' B ' 214' ' ' SEP . . . . . 0.462 ' HA ' ' HD3' ' B' ' 215' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' B' B ' 215' ' ' PRO . . . . . 1.11 ' HB2' ' CZ2' ' A' ' 262' ' ' TRP . 16.8 Cg_exo -88.1 144.61 6.1 Favored 'Trans proline' 0 N--CA 1.453 -0.895 0 C-N-CA 123.513 2.809 . . . . 15.0 110.984 177.225 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' B' B ' 216' ' ' PHE . . . . . . . . . . . . . 99.2 m-85 -104.23 -46.25 4.47 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.523 -0.308 . . . . 15.0 110.536 -178.501 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' B' B ' 217' ' ' GLN . . . . . . . . . . . . . 9.2 tt0 . . . . . 0 C--O 1.248 0.993 0 CA-C-N 115.808 -0.633 . . . . 15.0 109.541 177.522 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 2.2 mt . . . . . 0 N--CA 1.453 -0.297 0 N-CA-C 109.789 -0.449 . . . . 15.0 109.789 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 237' ' ' PRO . . . . . 0.465 ' O ' ' HD2' ' A' ' 240' ' ' TYR . 14.0 Cg_exo -69.5 166.75 26.2 Favored 'Trans proline' 0 N--CA 1.458 -0.615 0 C-N-CA 121.793 1.662 . . . . 15.0 110.221 165.706 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -69.74 142.99 53.17 Favored 'General case' 0 C--N 1.303 -1.433 0 CA-C-N 114.863 -1.062 . . . . 15.0 111.521 -173.024 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 100.15 5.83 54.27 Favored Glycine 0 N--CA 1.449 -0.485 0 CA-C-N 115.361 -0.836 . . . . 15.0 113.785 178.895 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 240' ' ' TYR . . . . . 0.649 ' CD1' ' HB2' ' A' ' 254' ' ' HIS . 71.7 m-85 -108.19 116.31 31.72 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 117.636 0.718 . . . . 15.0 111.678 -179.698 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -90.37 113.82 25.79 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.048 -0.978 . . . . 15.0 109.595 174.897 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 242' ' ' GLN . . . . . 0.645 ' HG3' ' CE1' ' A' ' 252' ' ' PHE . 39.6 tt0 -91.09 103.42 16.12 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 109.523 -0.547 . . . . 15.0 109.523 -179.771 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 243' ' ' ARG . . . . . 0.44 HH11 ' HD2' ' A' ' 243' ' ' ARG . 8.5 mtp180 -109.25 149.87 28.78 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 122.07 0.938 . . . . 15.0 112.637 -176.168 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 244' ' ' THR . . . . . 0.421 HG22 HG12 ' A' ' 250' ' ' VAL . 10.2 p -124.72 96.8 5.02 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 113.54 -1.664 . . . . 15.0 109.41 -176.257 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 245' ' ' THR . . . . . 0.703 HG23 ' HB2' ' A' ' 247' ' ' GLN . 2.7 t -89.99 150.28 22.2 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 115.861 -0.609 . . . . 15.0 111.412 -174.71 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 9.7 m -52.06 -19.21 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.315 0 CA-C-N 115.713 -0.676 . . . . 15.0 112.04 175.075 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 247' ' ' GLN . . . . . 0.703 ' HB2' HG23 ' A' ' 245' ' ' THR . 0.2 OUTLIER -49.81 -26.8 4.28 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 115.98 -0.554 . . . . 15.0 110.873 170.239 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 93.17 19.36 36.29 Favored Glycine 0 C--O 1.229 -0.188 0 CA-C-N 115.837 -0.619 . . . . 15.0 112.289 177.041 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 249' ' ' GLN . . . . . 0.476 ' NE2' ' HH2' ' A' ' 262' ' ' TRP . 0.0 OUTLIER -135.41 144.39 46.5 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.01 0.433 . . . . 15.0 110.724 -174.605 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 250' ' ' VAL . . . . . 0.421 HG12 HG22 ' A' ' 244' ' ' THR . 19.4 m -89.94 142.39 12.99 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 115.444 -0.798 . . . . 15.0 109.677 176.406 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 6.1 p90 -148.18 142.68 26.43 Favored 'General case' 0 C--N 1.321 -0.646 0 C-N-CA 120.67 -0.412 . . . . 15.0 110.693 -179.38 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 252' ' ' PHE . . . . . 0.697 ' CE2' ' HA ' ' A' ' 264' ' ' ASP . 29.7 m-85 -98.15 119.57 37.02 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.842 -0.617 . . . . 15.0 111.869 -175.631 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 253' ' ' LEU . . . . . 0.657 HD11 ' HB3' ' B' ' 212' ' ' PRO . 2.8 mt -104.36 103.23 12.93 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 114.744 -1.116 . . . . 15.0 112.012 -177.579 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 254' ' ' HIS . . . . . 0.649 ' HB2' ' CD1' ' A' ' 240' ' ' TYR . 78.5 t60 -113.26 89.95 3.22 Favored 'General case' 0 C--N 1.312 -1.036 0 N-CA-C 107.982 -1.118 . . . . 15.0 107.982 167.413 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 255' ' ' THR . . . . . 0.417 HG23 ' HA2' ' A' ' 258' ' ' GLY . 23.4 m -92.43 87.78 6.13 Favored 'General case' 0 N--CA 1.432 -1.355 0 C-N-CA 116.684 -2.006 . . . . 15.0 109.496 -179.328 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 64.1 tt0 -101.54 -53.43 2.99 Favored 'General case' 0 N--CA 1.439 -1.008 0 N-CA-C 106.199 -1.778 . . . . 15.0 106.199 150.592 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 257' ' ' THR . . . . . . . . . . . . . 82.6 p -96.83 -13.61 22.44 Favored 'General case' 0 CA--C 1.484 -1.561 0 CA-C-O 124.889 2.28 . . . . 15.0 111.733 -178.895 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 258' ' ' GLY . . . . . 0.417 ' HA2' HG23 ' A' ' 255' ' ' THR . . . 87.73 72.83 1.28 Allowed Glycine 1 C--N 1.241 -4.695 1 CA-C-N 108.174 -4.103 . . . . 15.0 112.703 -171.638 . . . . . . . . 4 3 . 1 . 001 nuclear build core ' A' A ' 259' ' ' VAL . . . . . 0.493 ' O ' ' HA ' ' A' ' 253' ' ' LEU . 53.0 t -89.89 125.2 42.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 121.585 0.707 . . . . 15.0 112.361 176.182 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 3.3 p -132.34 101.93 5.55 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 114.091 -1.413 . . . . 15.0 107.706 167.129 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 12.3 t -132.15 150.24 52.2 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 121.188 0.518 . . . . 15.0 112.352 -169.563 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 262' ' ' TRP . . . . . 0.476 ' HH2' ' NE2' ' A' ' 249' ' ' GLN . 77.0 m95 -78.26 -25.57 46.85 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.11 -0.95 . . . . 15.0 111.202 176.877 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 263' ' ' HIS . . . . . 0.418 ' HD2' ' O ' ' A' ' 264' ' ' ASP . 11.9 p-80 -89.34 131.36 35.46 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.496 -0.481 . . . . 15.0 110.212 -175.022 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 264' ' ' ASP . . . . . 1.064 ' HB3' HG12 ' A' ' 267' ' ' ILE . 19.8 t0 -56.36 125.03 64.33 Favored Pre-proline 0 C--N 1.323 -0.565 0 N-CA-C 107.669 -1.234 . . . . 15.0 107.669 170.061 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 265' ' ' PRO . . . . . 0.561 ' HD3' ' CD2' ' A' ' 252' ' ' PHE . 11.5 Cg_exo -70.54 -14.72 33.87 Favored 'Trans proline' 0 C--N 1.323 -0.766 0 C-N-CA 121.751 1.634 . . . . 15.0 112.573 -175.977 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 266' ' ' ARG . . . . . 0.426 ' HD3' ' HD3' ' A' ' 237' ' ' PRO . 19.3 tpt180 -76.27 -11.99 60.0 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 115.443 -0.799 . . . . 15.0 108.956 173.223 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 267' ' ' ILE . . . . . 1.064 HG12 ' HB3' ' A' ' 264' ' ' ASP . 40.3 pt . . . . . 0 C--O 1.249 1.027 0 CA-C-N 115.017 -0.992 . . . . 15.0 111.448 178.618 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 210' ' ' SER . . . . . . . . . . . . . 20.3 m . . . . . 0 N--CA 1.477 0.885 0 CA-C-O 120.635 0.255 . . . . 15.0 111.279 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' B' B ' 211' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -133.14 119.61 15.7 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 120.502 0.191 . . . . 15.0 110.519 -179.116 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 212' ' ' PRO . . . . . 0.657 ' HB3' HD11 ' A' ' 253' ' ' LEU . 3.9 Cg_endo -89.7 160.0 5.21 Favored 'Trans proline' 0 N--CA 1.455 -0.79 0 C-N-CA 122.707 2.271 . . . . 15.0 111.524 173.904 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.443 -0.879 0 C-N-CA 120.338 -0.934 . . . . 15.0 112.241 -177.388 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 61.1 mt . . . . . 0 CA--C 1.518 -0.261 0 N-CA-C 109.507 -0.553 . . . . 15.0 109.507 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 237' ' ' PRO . . . . . 0.929 ' HD3' ' HD3' ' A' ' 266' ' ' ARG . 15.2 Cg_exo -69.47 171.16 14.64 Favored 'Trans proline' 0 CA--C 1.513 -0.57 0 C-N-CA 122.055 1.837 . . . . 15.0 110.92 165.927 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -69.68 133.32 47.4 Favored 'General case' 0 C--N 1.302 -1.492 0 CA-C-N 114.415 -1.266 . . . . 15.0 112.208 -173.248 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 100.16 28.83 7.06 Favored Glycine 0 C--N 1.334 0.434 0 CA-C-N 115.16 -0.927 . . . . 15.0 114.094 174.08 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 240' ' ' TYR . . . . . 0.72 ' CD1' ' HB2' ' A' ' 254' ' ' HIS . 65.0 m-85 -117.36 123.72 47.17 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 117.963 0.881 . . . . 15.0 111.468 177.864 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 241' ' ' GLU . . . . . 0.529 ' HG3' ' HB2' ' A' ' 253' ' ' LEU . 10.6 pt-20 -119.64 119.97 35.28 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.76 -0.654 . . . . 15.0 109.595 172.807 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -90.13 109.45 20.51 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 108.775 -0.824 . . . . 15.0 108.775 178.371 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 243' ' ' ARG . . . . . 0.473 ' HB2' ' CE1' ' A' ' 251' ' ' TYR . 31.3 mtt180 -95.87 149.97 20.95 Favored 'General case' 0 CA--C 1.51 -0.574 0 CA-C-O 122.025 0.917 . . . . 15.0 112.295 -175.218 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 244' ' ' THR . . . . . . . . . . . . . 4.9 p -111.61 97.46 6.75 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-N 113.498 -1.683 . . . . 15.0 110.553 -176.553 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 245' ' ' THR . . . . . 0.701 HG23 ' HB2' ' A' ' 247' ' ' GLN . 0.9 OUTLIER -90.7 150.6 21.58 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.187 -0.915 . . . . 15.0 110.302 177.846 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 25.3 t -50.62 -18.43 0.63 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.489 0 O-C-N 123.52 0.513 . . . . 15.0 110.959 176.335 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 247' ' ' GLN . . . . . 0.701 ' HB2' HG23 ' A' ' 245' ' ' THR . 77.9 mm-40 -50.83 -29.11 10.9 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 116.038 -0.528 . . . . 15.0 111.156 171.916 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 80.94 21.41 63.29 Favored Glycine 0 N--CA 1.452 -0.27 0 N-CA-C 111.624 -0.59 . . . . 15.0 111.624 -178.43 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 9.6 mt-30 -121.32 143.96 48.9 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.726 -0.472 . . . . 15.0 109.726 -175.803 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 28.8 m -89.84 133.28 32.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 N-CA-C 109.582 -0.525 . . . . 15.0 109.582 176.601 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 251' ' ' TYR . . . . . 0.473 ' CE1' ' HB2' ' A' ' 243' ' ' ARG . 2.4 p90 -140.49 130.11 24.21 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.054 0.454 . . . . 15.0 110.141 -177.12 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 252' ' ' PHE . . . . . 0.615 ' CD2' ' HA ' ' A' ' 264' ' ' ASP . 34.9 m-85 -90.01 116.49 28.09 Favored 'General case' 0 CA--C 1.513 -0.474 0 CA-C-N 115.874 -0.603 . . . . 15.0 111.857 -173.405 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 253' ' ' LEU . . . . . 0.586 HD11 ' CB ' ' B' ' 212' ' ' PRO . 12.9 mt -98.59 126.76 44.27 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-N 114.816 -1.083 . . . . 15.0 111.233 175.677 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 254' ' ' HIS . . . . . 0.72 ' HB2' ' CD1' ' A' ' 240' ' ' TYR . 73.7 t60 -133.87 89.78 2.62 Favored 'General case' 0 C--N 1.309 -1.183 0 N-CA-C 107.633 -1.247 . . . . 15.0 107.633 167.032 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 3.3 t -94.13 87.95 5.46 Favored 'General case' 0 N--CA 1.429 -1.491 0 C-N-CA 116.334 -2.147 . . . . 15.0 110.105 -179.732 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 60.0 tt0 -101.61 -54.94 2.63 Favored 'General case' 0 N--CA 1.436 -1.137 0 CA-C-N 112.946 -1.934 . . . . 15.0 105.921 151.02 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 257' ' ' THR . . . . . . . . . . . . . 71.6 p -100.04 -13.63 18.97 Favored 'General case' 0 CA--C 1.489 -1.4 0 CA-C-N 111.989 -2.369 . . . . 15.0 112.401 -179.756 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 89.38 71.42 1.26 Allowed Glycine 1 C--N 1.243 -4.622 0 CA-C-N 108.566 -3.924 . . . . 15.0 113.59 -173.15 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 259' ' ' VAL . . . . . 0.666 ' HB ' ' HB3' ' A' ' 254' ' ' HIS . 52.6 t -90.12 129.24 41.32 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 CA-C-O 121.324 0.583 . . . . 15.0 111.564 172.954 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 1.4 p -143.36 108.15 4.9 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 114.539 -1.209 . . . . 15.0 108.643 169.35 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 7.4 t -149.01 150.34 32.66 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.042 0.448 . . . . 15.0 111.685 -171.616 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 262' ' ' TRP . . . . . . . . . . . . . 89.8 m95 -66.89 -30.21 70.3 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.295 -0.866 . . . . 15.0 111.613 177.119 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 263' ' ' HIS . . . . . . . . . . . . . 3.1 p80 -83.85 133.34 34.75 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.55 -0.46 . . . . 15.0 110.607 -172.248 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 264' ' ' ASP . . . . . 0.87 ' HB3' HG12 ' A' ' 267' ' ' ILE . 9.5 t70 -56.9 129.87 78.44 Favored Pre-proline 0 C--N 1.323 -0.549 0 N-CA-C 108.535 -0.913 . . . . 15.0 108.535 172.766 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 265' ' ' PRO . . . . . 0.518 ' HD3' ' HA ' ' A' ' 264' ' ' ASP . 2.6 Cg_exo -76.33 -14.59 18.28 Favored 'Trans proline' 0 CA--C 1.511 -0.655 0 C-N-CA 122.297 1.998 . . . . 15.0 113.451 -174.524 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 266' ' ' ARG . . . . . 0.929 ' HD3' ' HD3' ' A' ' 237' ' ' PRO . 6.4 tpt180 -79.39 -8.72 59.3 Favored 'General case' 0 C--N 1.31 -1.149 0 CA-C-O 121.953 0.882 . . . . 15.0 108.78 175.635 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 267' ' ' ILE . . . . . 0.87 HG12 ' HB3' ' A' ' 264' ' ' ASP . 42.4 mm . . . . . 0 C--O 1.249 1.033 0 CA-C-N 113.997 -1.456 . . . . 15.0 109.809 178.755 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 210' ' ' SER . . . . . . . . . . . . . 12.5 p . . . . . 0 N--CA 1.476 0.873 0 CA-C-O 121.14 0.495 . . . . 15.0 110.74 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' B' B ' 211' ' ' ASP . . . . . 0.54 ' HA ' ' HD3' ' B' ' 212' ' ' PRO . 7.2 p-10 -150.3 135.38 9.86 Favored Pre-proline 0 C--N 1.325 -0.488 0 CA-C-N 115.945 -0.57 . . . . 15.0 110.672 -179.185 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 212' ' ' PRO . . . . . 0.586 ' CB ' HD11 ' A' ' 253' ' ' LEU . 1.4 Cg_endo -89.79 138.87 3.12 Favored 'Trans proline' 0 N--CA 1.458 -0.599 0 C-N-CA 123.529 2.819 . . . . 15.0 111.99 178.766 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.444 -0.816 0 C-N-CA 120.813 -0.708 . . . . 15.0 111.561 -179.101 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 236' ' ' LEU . . . . . 0.442 HD22 ' N ' ' A' ' 236' ' ' LEU . 0.2 OUTLIER . . . . . 0 CA--C 1.518 -0.261 0 N-CA-C 109.188 -0.671 . . . . 15.0 109.188 . . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 237' ' ' PRO . . . . . 0.638 ' HD3' ' HD3' ' A' ' 266' ' ' ARG . 12.9 Cg_exo -69.84 163.32 38.77 Favored 'Trans proline' 0 CA--C 1.514 -0.487 0 C-N-CA 122.022 1.815 . . . . 15.0 110.143 167.839 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 238' ' ' GLU . . . . . 0.401 ' H ' ' CD ' ' A' ' 238' ' ' GLU . 1.1 pm0 -69.81 146.14 51.6 Favored 'General case' 0 C--N 1.305 -1.365 0 CA-C-N 115.45 -0.795 . . . . 15.0 111.611 -175.456 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 239' ' ' GLY . . . . . 0.415 ' O ' ' HA ' ' A' ' 254' ' ' HIS . . . 99.96 3.54 55.84 Favored Glycine 0 N--CA 1.449 -0.48 0 CA-C-N 115.353 -0.84 . . . . 15.0 113.896 178.218 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 240' ' ' TYR . . . . . 0.765 ' CD1' ' HB2' ' A' ' 254' ' ' HIS . 83.6 m-85 -107.12 123.73 48.67 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 117.45 0.625 . . . . 15.0 110.878 178.001 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -110.12 130.71 55.49 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 109.534 -0.543 . . . . 15.0 109.534 170.442 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 242' ' ' GLN . . . . . 0.457 ' HG3' ' CE1' ' A' ' 252' ' ' PHE . 32.6 tt0 -89.92 112.04 23.3 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.253 -0.647 . . . . 15.0 109.253 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 31.9 mtp85 -105.94 145.67 31.01 Favored 'General case' 0 CA--C 1.502 -0.893 0 CA-C-O 121.957 0.884 . . . . 15.0 112.665 -177.508 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 244' ' ' THR . . . . . . . . . . . . . 48.6 m -121.74 93.33 3.97 Favored 'General case' 0 C--N 1.309 -1.157 0 CA-C-N 113.412 -1.722 . . . . 15.0 109.86 -178.8 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 245' ' ' THR . . . . . 1.059 HG23 ' HG2' ' A' ' 247' ' ' GLN . 5.2 t -89.97 150.61 22.07 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.15 -0.932 . . . . 15.0 110.484 -178.567 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 246' ' ' VAL . . . . . 0.408 ' H ' HG23 ' A' ' 246' ' ' VAL . 34.1 t -44.2 -25.7 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 N-CA-C 113.596 0.962 . . . . 15.0 113.596 -175.305 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 247' ' ' GLN . . . . . 1.059 ' HG2' HG23 ' A' ' 245' ' ' THR . 3.4 pt20 -55.1 -18.72 5.9 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 111.579 0.214 . . . . 15.0 111.579 177.649 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 87.7 26.52 29.44 Favored Glycine 0 C--N 1.334 0.472 0 C-N-CA 121.356 -0.449 . . . . 15.0 112.721 175.254 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 249' ' ' GLN . . . . . 0.486 ' HB2' ' OE1' ' A' ' 247' ' ' GLN . 9.4 mt-30 -138.86 140.34 38.42 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.699 -0.482 . . . . 15.0 109.699 -177.62 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 20.5 m -90.04 141.93 13.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 116.397 -0.365 . . . . 15.0 110.652 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 18.4 p90 -142.21 140.06 32.21 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.468 -0.567 . . . . 15.0 109.468 -178.936 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 252' ' ' PHE . . . . . 0.73 ' CD2' ' HA ' ' A' ' 264' ' ' ASP . 42.4 m-85 -93.6 119.39 32.58 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.123 -0.49 . . . . 15.0 111.895 -174.708 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 253' ' ' LEU . . . . . 0.636 HD11 ' HB3' ' B' ' 212' ' ' PRO . 4.1 mt -101.46 117.05 34.15 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-N 115.225 -0.898 . . . . 15.0 111.136 179.244 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 254' ' ' HIS . . . . . 0.765 ' HB2' ' CD1' ' A' ' 240' ' ' TYR . 71.0 t60 -130.76 90.02 2.84 Favored 'General case' 0 CA--C 1.5 -0.943 0 N-CA-C 107.916 -1.142 . . . . 15.0 107.916 169.464 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 37.1 m -92.73 87.93 6.06 Favored 'General case' 0 N--CA 1.433 -1.293 0 C-N-CA 116.735 -1.986 . . . . 15.0 110.453 -178.802 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 56.7 tt0 -101.14 -52.2 3.33 Favored 'General case' 0 N--CA 1.443 -0.809 0 N-CA-C 106.041 -1.837 . . . . 15.0 106.041 149.447 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 257' ' ' THR . . . . . . . . . . . . . 73.3 p -97.89 -13.48 21.21 Favored 'General case' 0 CA--C 1.487 -1.452 0 CA-C-O 124.779 2.228 . . . . 15.0 111.727 -179.839 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 86.28 70.83 1.31 Allowed Glycine 1 C--N 1.24 -4.772 0 CA-C-N 108.483 -3.962 . . . . 15.0 113.14 -172.665 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 259' ' ' VAL . . . . . 0.617 ' O ' HD23 ' A' ' 253' ' ' LEU . 48.0 t -89.99 125.33 42.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 N-CA-C 112.637 0.606 . . . . 15.0 112.637 177.103 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -138.07 102.19 4.62 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 107.794 -1.188 . . . . 15.0 107.794 167.217 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 12.5 t -138.02 150.35 46.88 Favored 'General case' 0 C--N 1.317 -0.812 0 C-N-CA 120.533 -0.467 . . . . 15.0 112.208 -167.944 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 262' ' ' TRP . . . . . . . . . . . . . 80.7 m95 -71.28 -33.26 69.59 Favored 'General case' 0 N--CA 1.455 -0.195 0 CA-C-N 115.391 -0.822 . . . . 15.0 111.719 178.912 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 263' ' ' HIS . . . . . . . . . . . . . 5.0 p80 -83.48 134.68 34.84 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.511 -0.476 . . . . 15.0 110.017 -175.245 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 264' ' ' ASP . . . . . 1.001 ' HB3' HG12 ' A' ' 267' ' ' ILE . 10.8 t70 -55.87 131.9 73.17 Favored Pre-proline 0 C--N 1.323 -0.549 0 N-CA-C 108.664 -0.865 . . . . 15.0 108.664 172.615 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 265' ' ' PRO . . . . . 0.525 ' HD3' ' CD2' ' A' ' 252' ' ' PHE . 72.0 Cg_endo -75.67 -14.76 19.62 Favored 'Trans proline' 0 CA--C 1.507 -0.842 0 C-N-CA 121.456 1.437 . . . . 15.0 113.464 -172.071 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 266' ' ' ARG . . . . . 0.638 ' HD3' ' HD3' ' A' ' 237' ' ' PRO . 8.6 tpt180 -81.51 -7.43 59.58 Favored 'General case' 0 C--N 1.306 -1.283 0 N-CA-C 108.168 -1.049 . . . . 15.0 108.168 175.227 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 267' ' ' ILE . . . . . 1.001 HG12 ' HB3' ' A' ' 264' ' ' ASP . 37.5 pt . . . . . 0 C--O 1.25 1.093 0 CA-C-N 114.002 -1.454 . . . . 15.0 110.85 175.691 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 210' ' ' SER . . . . . . . . . . . . . 10.3 p . . . . . 0 N--CA 1.475 0.808 0 CA-C-O 121.014 0.435 . . . . 15.0 110.555 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' B' B ' 211' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -90.16 118.08 68.56 Favored Pre-proline 0 C--N 1.325 -0.489 0 CA-C-O 121.174 0.512 . . . . 15.0 111.346 -175.284 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 212' ' ' PRO . . . . . 0.636 ' HB3' HD11 ' A' ' 253' ' ' LEU . 9.2 Cg_endo -89.93 146.06 4.58 Favored 'Trans proline' 0 N--CA 1.451 -0.974 0 C-N-CA 122.816 2.344 . . . . 15.0 111.157 172.46 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.439 -1.148 0 C-N-CA 120.099 -1.048 . . . . 15.0 111.702 -179.502 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 5.8 mt . . . . . 0 C--O 1.233 0.217 0 N-CA-C 109.676 -0.49 . . . . 15.0 109.676 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 237' ' ' PRO . . . . . 0.62 ' HD3' ' HD3' ' A' ' 266' ' ' ARG . 21.9 Cg_exo -69.37 161.16 46.97 Favored 'Trans proline' 0 C--O 1.235 0.333 0 C-N-CA 121.876 1.717 . . . . 15.0 110.398 164.466 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 238' ' ' GLU . . . . . 0.404 ' H ' ' CD ' ' A' ' 238' ' ' GLU . 1.3 pm0 -69.65 150.39 47.06 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-N 115.496 -0.774 . . . . 15.0 110.914 -175.313 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 100.24 -15.13 59.32 Favored Glycine 0 N--CA 1.447 -0.625 0 CA-C-N 115.688 -0.687 . . . . 15.0 112.599 -177.729 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 240' ' ' TYR . . . . . 0.468 ' CD1' ' HG2' ' A' ' 265' ' ' PRO . 65.9 m-85 -94.61 116.42 28.75 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.142 0.496 . . . . 15.0 110.523 177.057 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -95.3 116.93 29.43 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 115.625 -0.716 . . . . 15.0 109.123 174.843 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -90.01 97.45 11.2 Favored 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 108.993 -0.743 . . . . 15.0 108.993 178.03 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 243' ' ' ARG . . . . . 0.439 HH11 ' HD2' ' A' ' 243' ' ' ARG . 11.9 mtp180 -100.42 149.54 23.55 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 115.298 -0.865 . . . . 15.0 111.478 -179.162 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 244' ' ' THR . . . . . . . . . . . . . 22.8 m -117.64 128.7 55.18 Favored 'General case' 0 C--N 1.309 -1.172 0 CA-C-N 114.08 -1.418 . . . . 15.0 108.718 -178.629 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 245' ' ' THR . . . . . 0.422 HG22 ' O ' ' A' ' 249' ' ' GLN . 8.3 t -115.28 150.44 36.21 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 116.277 -0.42 . . . . 15.0 111.03 -174.113 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 50.8 t -57.73 -15.78 4.87 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 CA-C-N 115.795 -0.639 . . . . 15.0 111.302 179.865 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 247' ' ' GLN . . . . . . . . . . . . . 8.8 mm100 -61.46 -20.82 63.57 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 121.093 0.473 . . . . 15.0 110.65 175.553 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 90.63 36.98 6.64 Favored Glycine 0 N--CA 1.452 -0.28 0 CA-C-N 115.559 -0.746 . . . . 15.0 112.003 178.546 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 249' ' ' GLN . . . . . 0.422 ' O ' HG22 ' A' ' 245' ' ' THR . 8.0 pt20 -148.02 139.62 23.75 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.873 0.368 . . . . 15.0 111.12 -175.524 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 15.9 m -89.95 135.58 25.92 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 N-CA-C 109.395 -0.595 . . . . 15.0 109.395 172.557 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -136.81 138.36 40.77 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-O 120.95 0.405 . . . . 15.0 110.123 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 252' ' ' PHE . . . . . 0.623 ' CE2' ' HA ' ' A' ' 264' ' ' ASP . 40.6 m-85 -89.99 118.2 29.37 Favored 'General case' 0 CA--C 1.512 -0.491 0 CA-C-O 121.229 0.537 . . . . 15.0 111.449 -173.419 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 253' ' ' LEU . . . . . 0.898 HD11 ' HB3' ' B' ' 212' ' ' PRO . 0.8 OUTLIER -110.26 106.77 16.29 Favored 'General case' 0 N--CA 1.446 -0.653 0 CA-C-N 114.714 -1.13 . . . . 15.0 111.885 -173.048 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 254' ' ' HIS . . . . . 0.417 ' HB2' ' CD1' ' A' ' 240' ' ' TYR . 26.8 t-80 -115.41 95.03 4.97 Favored 'General case' 0 C--N 1.312 -1.048 0 N-CA-C 108.298 -1.001 . . . . 15.0 108.298 170.104 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 26.3 m -94.08 88.02 5.51 Favored 'General case' 0 N--CA 1.43 -1.436 0 C-N-CA 116.985 -1.886 . . . . 15.0 110.459 -179.08 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 58.9 tt0 -101.12 -51.15 3.59 Favored 'General case' 0 N--CA 1.438 -1.033 0 N-CA-C 105.924 -1.88 . . . . 15.0 105.924 146.768 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 257' ' ' THR . . . . . . . . . . . . . 63.1 p -99.94 -13.69 19.02 Favored 'General case' 0 CA--C 1.484 -1.581 0 CA-C-O 124.735 2.207 . . . . 15.0 112.275 -178.062 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 83.09 76.18 1.14 Allowed Glycine 1 C--N 1.239 -4.851 0 CA-C-N 108.594 -3.912 . . . . 15.0 111.934 -170.225 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 259' ' ' VAL . . . . . 0.677 ' O ' ' HA ' ' A' ' 253' ' ' LEU . 54.8 t -89.35 124.47 42.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-O 121.478 0.656 . . . . 15.0 111.725 176.86 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 3.6 p -135.04 97.41 3.73 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 114.285 -1.325 . . . . 15.0 108.394 171.347 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 10.6 t -134.92 150.26 50.39 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.037 0.446 . . . . 15.0 112.018 -170.387 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 262' ' ' TRP . . . . . . . . . . . . . 42.3 m95 -72.15 -31.04 65.6 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.38 -0.827 . . . . 15.0 111.844 177.341 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 263' ' ' HIS . . . . . . . . . . . . . 10.4 p-80 -80.15 130.74 35.45 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 120.196 -0.602 . . . . 15.0 110.155 -174.413 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 264' ' ' ASP . . . . . 1.094 ' HB3' HG12 ' A' ' 267' ' ' ILE . 13.8 t0 -63.12 127.44 90.93 Favored Pre-proline 0 C--N 1.321 -0.64 0 N-CA-C 107.77 -1.196 . . . . 15.0 107.77 171.169 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 265' ' ' PRO . . . . . 0.468 ' HG2' ' CD1' ' A' ' 240' ' ' TYR . 15.9 Cg_exo -69.09 -14.9 39.05 Favored 'Trans proline' 0 C--N 1.323 -0.799 0 C-N-CA 121.878 1.719 . . . . 15.0 113.087 -178.118 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 266' ' ' ARG . . . . . 0.62 ' HD3' ' HD3' ' A' ' 237' ' ' PRO . 4.5 tpt180 -80.83 -6.5 58.66 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-O 121.834 0.826 . . . . 15.0 109.156 175.031 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 267' ' ' ILE . . . . . 1.094 HG12 ' HB3' ' A' ' 264' ' ' ASP . 48.2 pt . . . . . 0 C--O 1.248 0.987 0 CA-C-N 114.299 -1.318 . . . . 15.0 111.689 177.735 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 210' ' ' SER . . . . . . . . . . . . . 9.5 m . . . . . 0 N--CA 1.479 0.988 0 CA-C-O 120.759 0.314 . . . . 15.0 110.72 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' B' B ' 211' ' ' ASP . . . . . 0.422 ' HA ' ' HD3' ' B' ' 212' ' ' PRO . 3.0 m-20 -89.85 119.53 69.41 Favored Pre-proline 0 C--O 1.233 0.185 0 CA-C-N 116.278 -0.419 . . . . 15.0 110.319 -173.243 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 212' ' ' PRO . . . . . 0.898 ' HB3' HD11 ' A' ' 253' ' ' LEU . 1.9 Cg_endo -90.0 149.14 4.77 Favored 'Trans proline' 0 N--CA 1.458 -0.586 0 C-N-CA 123.118 2.545 . . . . 15.0 112.234 177.995 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.68 0 C-N-CA 120.925 -0.655 . . . . 15.0 112.607 -179.647 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 236' ' ' LEU . . . . . 0.447 HD22 ' N ' ' A' ' 236' ' ' LEU . 1.1 mm? . . . . . 0 N--CA 1.453 -0.28 0 N-CA-C 109.765 -0.457 . . . . 15.0 109.765 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 237' ' ' PRO . . . . . 0.458 ' HD3' ' HD3' ' A' ' 266' ' ' ARG . 16.2 Cg_exo -69.53 164.72 33.23 Favored 'Trans proline' 0 N--CA 1.459 -0.522 0 C-N-CA 121.801 1.667 . . . . 15.0 110.118 165.011 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -69.58 135.65 50.28 Favored 'General case' 0 C--N 1.303 -1.443 0 CA-C-N 115.053 -0.976 . . . . 15.0 111.361 -171.955 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 100.44 21.63 12.68 Favored Glycine 0 CA--C 1.521 0.431 0 CA-C-N 115.504 -0.771 . . . . 15.0 114.349 178.794 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 240' ' ' TYR . . . . . 0.749 ' CD1' ' HB2' ' A' ' 254' ' ' HIS . 73.7 m-85 -112.39 114.43 27.14 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 118.298 1.049 . . . . 15.0 110.798 175.307 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 37.5 mm-40 -98.2 119.44 36.86 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.686 -0.688 . . . . 15.0 109.216 175.341 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -89.93 107.52 19.16 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 108.032 -1.099 . . . . 15.0 108.032 175.909 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 6.3 mtp85 -97.25 132.38 43.06 Favored 'General case' 0 CA--C 1.496 -1.109 0 CA-C-O 122.451 1.119 . . . . 15.0 113.434 -172.774 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 244' ' ' THR . . . . . . . . . . . . . 1.3 m -100.66 89.92 4.07 Favored 'General case' 0 C--N 1.306 -1.314 0 CA-C-N 112.805 -1.998 . . . . 15.0 109.05 177.517 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 245' ' ' THR . . . . . 1.05 HG23 ' HG2' ' A' ' 247' ' ' GLN . 7.8 t -95.04 150.75 19.83 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 114.989 -1.005 . . . . 15.0 110.401 -176.653 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 61.1 t -39.69 -30.9 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 N-CA-C 113.901 1.075 . . . . 15.0 113.901 -174.947 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 247' ' ' GLN . . . . . 1.05 ' HG2' HG23 ' A' ' 245' ' ' THR . 3.8 pt20 -56.55 -21.14 24.34 Favored 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 111.838 0.31 . . . . 15.0 111.838 178.111 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 80.42 37.21 21.46 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 121.141 -0.552 . . . . 15.0 112.988 176.49 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 249' ' ' GLN . . . . . 0.488 ' HB2' ' OE1' ' A' ' 247' ' ' GLN . 32.3 mt-30 -135.71 149.98 49.4 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.678 -0.49 . . . . 15.0 109.678 179.633 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 15.5 m -89.83 128.23 41.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 120.934 0.397 . . . . 15.0 110.562 178.433 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 4.0 p90 -138.69 133.19 31.98 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.006 0.431 . . . . 15.0 109.883 -178.647 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 252' ' ' PHE . . . . . 0.679 ' CD2' ' HA ' ' A' ' 264' ' ' ASP . 36.0 m-85 -89.78 118.2 29.2 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.023 -0.535 . . . . 15.0 110.88 -175.007 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 253' ' ' LEU . . . . . 0.578 HD11 ' HB3' ' B' ' 212' ' ' PRO . 0.7 OUTLIER -111.1 119.33 38.62 Favored 'General case' 0 N--CA 1.447 -0.617 0 CA-C-N 115.09 -0.959 . . . . 15.0 110.398 -177.674 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 254' ' ' HIS . . . . . 0.749 ' HB2' ' CD1' ' A' ' 240' ' ' TYR . 26.3 t60 -133.0 101.31 5.18 Favored 'General case' 0 CA--C 1.495 -1.14 0 N-CA-C 108.956 -0.757 . . . . 15.0 108.956 173.951 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 3.5 t -95.89 87.66 4.69 Favored 'General case' 0 N--CA 1.432 -1.333 0 C-N-CA 116.388 -2.125 . . . . 15.0 110.617 179.74 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 256' ' ' GLN . . . . . 0.478 ' HB2' ' CE1' ' A' ' 254' ' ' HIS . 44.3 tt0 -101.35 -55.96 2.42 Favored 'General case' 0 N--CA 1.441 -0.906 0 N-CA-C 105.973 -1.862 . . . . 15.0 105.973 150.807 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 257' ' ' THR . . . . . . . . . . . . . 80.4 p -99.77 -13.72 19.15 Favored 'General case' 0 CA--C 1.489 -1.383 0 CA-C-N 111.893 -2.412 . . . . 15.0 112.047 -176.275 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 89.16 70.6 1.26 Allowed Glycine 1 C--N 1.242 -4.655 0 CA-C-N 108.537 -3.938 . . . . 15.0 112.903 -171.025 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 259' ' ' VAL . . . . . 0.512 ' O ' ' HA ' ' A' ' 253' ' ' LEU . 54.6 t -90.05 127.38 42.66 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.31 0 CA-C-O 121.207 0.527 . . . . 15.0 112.251 176.861 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 2.3 p -145.68 102.15 3.64 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 114.672 -1.149 . . . . 15.0 108.416 169.686 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 5.5 t -145.48 150.12 35.9 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 115.868 -0.606 . . . . 15.0 111.781 -171.384 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 262' ' ' TRP . . . . . . . . . . . . . 90.2 m95 -71.52 -23.31 61.76 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.358 -0.837 . . . . 15.0 111.199 176.535 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 263' ' ' HIS . . . . . . . . . . . . . 1.9 p80 -87.88 132.07 34.34 Favored 'General case' 0 C--O 1.234 0.266 0 C-N-CA 120.231 -0.587 . . . . 15.0 110.524 -173.939 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 264' ' ' ASP . . . . . 0.775 ' HB3' HG12 ' A' ' 267' ' ' ILE . 9.2 t70 -51.82 130.92 38.19 Favored Pre-proline 0 C--N 1.326 -0.439 0 CA-C-N 115.359 -0.837 . . . . 15.0 109.574 175.332 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 265' ' ' PRO . . . . . 0.519 ' HD3' ' CD2' ' A' ' 252' ' ' PHE . 71.9 Cg_endo -78.11 -14.89 14.86 Favored 'Trans proline' 0 CA--C 1.514 -0.506 0 C-N-CA 122.384 2.056 . . . . 15.0 113.644 -173.964 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 266' ' ' ARG . . . . . 0.458 ' HD3' ' HD3' ' A' ' 237' ' ' PRO . 7.2 tpt180 -77.08 -8.24 57.12 Favored 'General case' 0 C--N 1.311 -1.074 0 N-CA-C 107.694 -1.224 . . . . 15.0 107.694 174.546 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 267' ' ' ILE . . . . . 0.775 HG12 ' HB3' ' A' ' 264' ' ' ASP . 28.4 mm . . . . . 0 C--O 1.248 0.976 0 CA-C-N 113.537 -1.665 . . . . 15.0 109.216 174.634 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 210' ' ' SER . . . . . . . . . . . . . 14.9 m . . . . . 0 N--CA 1.477 0.889 0 CA-C-O 120.84 0.352 . . . . 15.0 110.572 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' B' B ' 211' ' ' ASP . . . . . 0.456 ' HA ' ' HD3' ' B' ' 212' ' ' PRO . 11.8 m-20 -89.81 130.61 42.27 Favored Pre-proline 0 C--N 1.332 -0.175 0 CA-C-N 116.449 -0.341 . . . . 15.0 110.274 -177.511 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 212' ' ' PRO . . . . . 0.578 ' HB3' HD11 ' A' ' 253' ' ' LEU . 5.0 Cg_endo -90.04 151.37 4.8 Favored 'Trans proline' 0 N--CA 1.46 -0.46 0 C-N-CA 123.483 2.788 . . . . 15.0 113.179 -175.404 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.444 -0.796 0 CA-C-N 115.346 -0.843 . . . . 15.0 112.839 178.538 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 5.8 mt . . . . . 0 CA--C 1.517 -0.296 0 N-CA-C 108.948 -0.76 . . . . 15.0 108.948 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 237' ' ' PRO . . . . . 0.52 ' HD3' ' HD3' ' A' ' 266' ' ' ARG . 17.2 Cg_exo -69.31 156.96 63.01 Favored 'Trans proline' 0 N--CA 1.458 -0.563 0 C-N-CA 121.55 1.5 . . . . 15.0 109.636 162.842 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 4.6 mp0 -69.71 149.38 48.09 Favored 'General case' 0 C--N 1.31 -1.146 0 CA-C-O 121.341 0.591 . . . . 15.0 111.409 -173.325 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 100.19 -7.36 58.5 Favored Glycine 0 N--CA 1.446 -0.66 0 CA-C-N 115.173 -0.921 . . . . 15.0 113.722 179.905 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 240' ' ' TYR . . . . . 0.66 ' CD1' ' HB2' ' A' ' 254' ' ' HIS . 67.7 m-85 -91.03 113.13 25.31 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 117.535 0.667 . . . . 15.0 110.81 178.199 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 57.9 mm-40 -92.05 118.41 30.77 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 109.367 -0.605 . . . . 15.0 109.367 174.924 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 24.8 tm0? -89.94 107.75 19.3 Favored 'General case' 0 C--N 1.314 -0.963 0 N-CA-C 109.163 -0.68 . . . . 15.0 109.163 176.806 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 243' ' ' ARG . . . . . 0.429 ' HB2' ' CE1' ' A' ' 251' ' ' TYR . 17.3 mtp85 -103.47 150.03 24.27 Favored 'General case' 0 CA--C 1.512 -0.519 0 CA-C-O 122.116 0.96 . . . . 15.0 111.982 178.081 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 244' ' ' THR . . . . . . . . . . . . . 24.4 p -111.27 148.24 33.31 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-N 113.504 -1.68 . . . . 15.0 109.367 -179.064 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 245' ' ' THR . . . . . 0.463 ' OG1' ' HG2' ' A' ' 247' ' ' GLN . 6.0 t -145.26 150.11 36.09 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-O 120.641 0.258 . . . . 15.0 111.142 -175.186 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 7.7 p -50.87 -26.79 4.55 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.219 0 CA-C-N 115.541 -0.754 . . . . 15.0 111.256 177.748 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 247' ' ' GLN . . . . . 0.463 ' HG2' ' OG1' ' A' ' 245' ' ' THR . 6.8 mm-40 -53.75 -21.4 7.16 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 114.787 -1.097 . . . . 15.0 111.472 177.959 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 81.82 25.19 53.78 Favored Glycine 0 CA--C 1.509 -0.282 0 C-N-CA 121.255 -0.498 . . . . 15.0 111.871 178.146 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 249' ' ' GLN . . . . . 0.419 ' CD ' ' HH2' ' A' ' 262' ' ' TRP . 0.6 OUTLIER -130.47 138.37 50.24 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.759 -0.46 . . . . 15.0 109.759 -175.614 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 18.8 m -90.02 132.43 34.72 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 N-CA-C 109.354 -0.61 . . . . 15.0 109.354 175.968 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 251' ' ' TYR . . . . . 0.429 ' CE1' ' HB2' ' A' ' 243' ' ' ARG . 4.4 p90 -135.16 134.19 39.91 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.486 0.66 . . . . 15.0 111.325 -178.7 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 252' ' ' PHE . . . . . 0.731 ' CE2' ' HA ' ' A' ' 264' ' ' ASP . 37.8 m-85 -90.28 118.5 29.84 Favored 'General case' 0 CA--C 1.516 -0.335 0 CA-C-N 115.246 -0.888 . . . . 15.0 111.046 -176.654 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 253' ' ' LEU . . . . . 0.876 HD11 ' HB3' ' B' ' 212' ' ' PRO . 0.5 OUTLIER -109.9 99.21 8.37 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-N 114.942 -1.026 . . . . 15.0 111.205 -174.675 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 254' ' ' HIS . . . . . 0.66 ' HB2' ' CD1' ' A' ' 240' ' ' TYR . 79.8 t60 -112.17 92.56 4.07 Favored 'General case' 0 CA--C 1.499 -1.018 0 N-CA-C 108.57 -0.9 . . . . 15.0 108.57 169.58 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 7.9 t -96.55 88.06 4.57 Favored 'General case' 0 N--CA 1.432 -1.331 0 C-N-CA 116.524 -2.07 . . . . 15.0 110.729 -179.076 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 49.1 tt0 -101.17 -50.39 3.8 Favored 'General case' 0 N--CA 1.441 -0.924 0 CA-C-N 113.127 -1.851 . . . . 15.0 106.42 151.601 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 257' ' ' THR . . . . . . . . . . . . . 68.7 p -97.99 -13.57 21.05 Favored 'General case' 0 CA--C 1.488 -1.431 0 CA-C-O 124.865 2.269 . . . . 15.0 111.681 -179.565 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 88.71 71.41 1.27 Allowed Glycine 1 C--N 1.241 -4.737 1 CA-C-N 108.224 -4.08 . . . . 15.0 113.109 -171.602 . . . . . . . . 3 2 . 1 . 006 nuclear build core ' A' A ' 259' ' ' VAL . . . . . 0.574 ' O ' ' HA ' ' A' ' 253' ' ' LEU . 45.8 t -89.81 124.45 42.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 121.376 0.607 . . . . 15.0 111.911 174.962 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -136.94 92.36 2.72 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 114.541 -1.209 . . . . 15.0 108.018 167.763 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 5.0 t -129.27 150.23 50.73 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.705 -0.679 . . . . 15.0 111.966 -166.193 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 262' ' ' TRP . . . . . 0.419 ' HH2' ' CD ' ' A' ' 249' ' ' GLN . 85.5 m95 -71.61 -50.63 29.04 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.164 -0.926 . . . . 15.0 111.691 179.337 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 263' ' ' HIS . . . . . . . . . . . . . 5.4 p80 -66.49 134.48 52.53 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.912 -0.586 . . . . 15.0 110.629 -175.527 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 264' ' ' ASP . . . . . 1.083 ' HB3' HG12 ' A' ' 267' ' ' ILE . 37.8 t0 -54.29 124.14 45.55 Favored Pre-proline 0 C--O 1.218 -0.554 0 N-CA-C 107.408 -1.33 . . . . 15.0 107.408 167.217 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 265' ' ' PRO . . . . . 0.597 ' HD3' ' CD2' ' A' ' 252' ' ' PHE . 12.6 Cg_exo -69.03 -14.67 38.84 Favored 'Trans proline' 0 C--N 1.323 -0.794 0 C-N-CA 121.788 1.659 . . . . 15.0 112.617 -176.324 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 266' ' ' ARG . . . . . 0.52 ' HD3' ' HD3' ' A' ' 237' ' ' PRO . 5.8 tpt180 -78.28 -9.86 59.41 Favored 'General case' 0 N--CA 1.439 -0.998 0 CA-C-O 121.861 0.838 . . . . 15.0 109.136 173.143 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 267' ' ' ILE . . . . . 1.083 HG12 ' HB3' ' A' ' 264' ' ' ASP . 48.2 pt . . . . . 0 C--O 1.246 0.89 0 CA-C-O 117.543 -1.218 . . . . 15.0 110.875 176.779 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 210' ' ' SER . . . . . . . . . . . . . 16.6 p . . . . . 0 N--CA 1.481 1.125 0 CA-C-O 120.859 0.361 . . . . 15.0 110.735 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' B' B ' 211' ' ' ASP . . . . . 0.418 ' HA ' ' HD3' ' B' ' 212' ' ' PRO . 2.8 m-20 -89.97 115.27 63.55 Favored Pre-proline 0 C--N 1.331 -0.223 0 CA-C-N 116.4 -0.364 . . . . 15.0 110.799 -173.948 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 212' ' ' PRO . . . . . 0.876 ' HB3' HD11 ' A' ' 253' ' ' LEU . 2.6 Cg_endo -89.67 154.13 5.18 Favored 'Trans proline' 0 N--CA 1.456 -0.7 0 C-N-CA 122.752 2.301 . . . . 15.0 112.104 175.789 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.636 0 C-N-CA 120.554 -0.831 . . . . 15.0 112.296 179.43 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 236' ' ' LEU . . . . . 0.441 HD22 ' N ' ' A' ' 236' ' ' LEU . 1.2 mm? . . . . . 0 CA--C 1.514 -0.404 0 CA-C-O 121.03 0.443 . . . . 15.0 110.586 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 237' ' ' PRO . . . . . 0.548 ' HD3' ' HD3' ' A' ' 266' ' ' ARG . 21.9 Cg_exo -69.34 166.58 26.6 Favored 'Trans proline' 0 N--CA 1.46 -0.442 0 C-N-CA 122.257 1.971 . . . . 15.0 110.528 163.885 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 -69.92 147.23 50.49 Favored 'General case' 0 C--N 1.304 -1.391 0 CA-C-N 115.038 -0.983 . . . . 15.0 111.809 -176.382 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 100.25 0.93 55.8 Favored Glycine 0 CA--C 1.518 0.237 0 CA-C-N 115.348 -0.842 . . . . 15.0 113.34 179.736 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 240' ' ' TYR . . . . . 0.493 ' HD2' ' O ' ' A' ' 237' ' ' PRO . 56.5 m-85 -97.45 121.37 39.26 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.552 0.691 . . . . 15.0 111.574 -178.419 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 241' ' ' GLU . . . . . 0.745 ' HB2' ' HB2' ' A' ' 253' ' ' LEU . 7.6 mp0 -89.87 100.45 13.26 Favored 'General case' 0 N--CA 1.442 -0.833 0 CA-C-N 114.885 -1.052 . . . . 15.0 108.777 173.147 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 1.5 tm0? -89.94 113.99 25.73 Favored 'General case' 0 C--N 1.313 -1.006 0 N-CA-C 108.451 -0.944 . . . . 15.0 108.451 179.33 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 243' ' ' ARG . . . . . 0.503 ' CZ ' ' HG2' ' B' ' 212' ' ' PRO . 28.0 mtt180 -112.94 144.94 41.65 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-O 122.392 1.092 . . . . 15.0 111.926 179.511 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 244' ' ' THR . . . . . . . . . . . . . 15.8 m -120.29 92.14 3.7 Favored 'General case' 0 C--N 1.304 -1.373 0 CA-C-N 112.998 -1.91 . . . . 15.0 108.263 178.93 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 245' ' ' THR . . . . . 0.498 ' OG1' ' HG2' ' A' ' 247' ' ' GLN . 6.7 t -89.72 149.99 22.51 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 115.441 -0.799 . . . . 15.0 110.989 -171.882 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 23.0 t -55.2 -15.13 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 CA-C-N 115.816 -0.629 . . . . 15.0 111.349 -179.194 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 247' ' ' GLN . . . . . 0.498 ' HG2' ' OG1' ' A' ' 245' ' ' THR . 8.3 mm-40 -59.29 -15.27 14.9 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 115.895 -0.593 . . . . 15.0 111.128 176.413 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 89.51 37.4 7.02 Favored Glycine 0 C--N 1.333 0.407 0 C-N-CA 121.218 -0.515 . . . . 15.0 112.164 178.334 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -150.17 147.14 27.37 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.399 0.619 . . . . 15.0 111.515 -174.905 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 16.6 m -100.92 131.41 48.61 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.928 0 CA-C-N 114.561 -1.2 . . . . 15.0 108.386 169.189 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 2.7 p90 -137.28 137.93 39.52 Favored 'General case' 0 C--N 1.317 -0.811 0 C-N-CA 120.558 -0.457 . . . . 15.0 110.395 -175.149 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 252' ' ' PHE . . . . . 0.738 ' CD2' ' HA ' ' A' ' 264' ' ' ASP . 40.8 m-85 -95.75 110.95 23.02 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.569 0.7 . . . . 15.0 112.329 -172.824 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 253' ' ' LEU . . . . . 0.745 ' HB2' ' HB2' ' A' ' 241' ' ' GLU . 38.9 mt -93.0 144.69 25.0 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 114.241 -1.345 . . . . 15.0 109.848 172.176 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 254' ' ' HIS . . . . . 0.56 ' HB3' ' HB ' ' A' ' 259' ' ' VAL . 81.3 t60 -143.53 89.77 2.1 Favored 'General case' 0 C--N 1.305 -1.343 0 N-CA-C 107.31 -1.367 . . . . 15.0 107.31 164.143 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 16.3 m -91.72 87.61 6.37 Favored 'General case' 0 N--CA 1.426 -1.632 0 C-N-CA 115.655 -2.418 . . . . 15.0 110.096 -178.307 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 49.1 tt0 -101.53 -53.59 2.95 Favored 'General case' 0 N--CA 1.435 -1.193 0 CA-C-N 112.793 -2.003 . . . . 15.0 105.82 145.753 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 257' ' ' THR . . . . . . . . . . . . . 71.8 p -100.2 -13.52 18.88 Favored 'General case' 0 CA--C 1.49 -1.357 0 CA-C-O 124.727 2.203 . . . . 15.0 112.56 -176.459 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 86.07 73.24 1.28 Allowed Glycine 1 C--N 1.241 -4.747 0 CA-C-N 108.461 -3.972 . . . . 15.0 113.04 -172.529 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 259' ' ' VAL . . . . . 0.587 ' O ' ' HA ' ' A' ' 253' ' ' LEU . 74.9 t -89.71 136.76 22.89 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 CA-C-O 120.923 0.392 . . . . 15.0 112.028 174.127 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 4.0 p -145.62 100.02 3.37 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 114.822 -1.081 . . . . 15.0 108.731 168.834 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 24.3 p -132.39 150.17 52.21 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 112.216 0.45 . . . . 15.0 112.216 -172.364 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 262' ' ' TRP . . . . . . . . . . . . . 71.1 m95 -72.87 -30.0 63.63 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.781 -0.645 . . . . 15.0 110.68 174.347 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 263' ' ' HIS . . . . . . . . . . . . . 3.3 p80 -77.89 129.31 35.21 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.967 0.413 . . . . 15.0 110.252 -177.666 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 264' ' ' ASP . . . . . 1.038 ' HB3' HG12 ' A' ' 267' ' ' ILE . 9.1 t0 -59.21 129.21 86.27 Favored Pre-proline 0 C--N 1.319 -0.734 0 N-CA-C 108.509 -0.923 . . . . 15.0 108.509 172.032 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 265' ' ' PRO . . . . . 0.545 ' HD3' ' CD2' ' A' ' 252' ' ' PHE . 4.4 Cg_exo -74.19 -14.65 23.18 Favored 'Trans proline' 0 CA--C 1.509 -0.729 0 C-N-CA 122.112 1.875 . . . . 15.0 113.228 -175.737 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 266' ' ' ARG . . . . . 0.548 ' HD3' ' HD3' ' A' ' 237' ' ' PRO . 2.1 tpp180 -77.41 -11.55 59.85 Favored 'General case' 0 C--N 1.31 -1.119 0 N-CA-C 108.055 -1.091 . . . . 15.0 108.055 172.978 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 267' ' ' ILE . . . . . 1.038 HG12 ' HB3' ' A' ' 264' ' ' ASP . 31.8 pt . . . . . 0 C--O 1.249 1.05 0 CA-C-N 114.551 -1.204 . . . . 15.0 111.0 176.886 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 210' ' ' SER . . . . . . . . . . . . . 63.0 p . . . . . 0 N--CA 1.479 1.002 0 CA-C-O 120.72 0.295 . . . . 15.0 110.841 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' B' B ' 211' ' ' ASP . . . . . 0.442 ' HA ' ' HD3' ' B' ' 212' ' ' PRO . 56.6 m-20 -104.49 120.62 49.94 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 120.894 0.378 . . . . 15.0 110.294 179.485 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 212' ' ' PRO . . . . . 0.52 ' CB ' HD11 ' A' ' 253' ' ' LEU . 3.4 Cg_exo -89.64 151.93 5.18 Favored 'Trans proline' 0 N--CA 1.461 -0.435 0 C-N-CA 123.88 3.054 . . . . 15.0 112.17 179.885 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.443 -0.888 0 C-N-CA 120.74 -0.743 . . . . 15.0 111.616 178.384 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 236' ' ' LEU . . . . . 0.534 HD22 ' HD2' ' A' ' 265' ' ' PRO . 11.4 mt . . . . . 0 N--CA 1.454 -0.245 0 N-CA-C 110.161 -0.311 . . . . 15.0 110.161 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 237' ' ' PRO . . . . . 0.591 ' HD3' ' HD3' ' A' ' 266' ' ' ARG . 13.0 Cg_exo -69.78 172.45 12.63 Favored 'Trans proline' 0 CA--C 1.513 -0.566 0 C-N-CA 122.21 1.94 . . . . 15.0 111.151 167.773 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 14.0 tp10 -69.41 134.57 49.16 Favored 'General case' 0 C--N 1.3 -1.549 0 CA-C-N 114.034 -1.439 . . . . 15.0 111.51 -173.474 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 100.15 9.37 48.44 Favored Glycine 0 CA--C 1.524 0.632 0 CA-C-N 115.74 -0.664 . . . . 15.0 114.31 177.013 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 240' ' ' TYR . . . . . 0.69 ' CD1' ' HB2' ' A' ' 254' ' ' HIS . 86.5 m-85 -111.41 116.88 31.67 Favored 'General case' 0 CA--C 1.517 -0.323 0 CA-C-N 118.129 0.964 . . . . 15.0 111.007 175.166 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 17.7 pt-20 -97.63 123.94 41.72 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 109.198 -0.668 . . . . 15.0 109.198 170.72 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 242' ' ' GLN . . . . . 0.564 ' HG3' ' CE1' ' A' ' 252' ' ' PHE . 1.9 tt0 -89.9 99.13 12.2 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 109.058 -0.719 . . . . 15.0 109.058 -177.841 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 84.2 mtt-85 -92.02 150.01 21.22 Favored 'General case' 0 CA--C 1.5 -0.963 0 CA-C-O 122.428 1.109 . . . . 15.0 113.184 -172.736 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 244' ' ' THR . . . . . . . . . . . . . 16.6 p -118.27 139.83 50.72 Favored 'General case' 0 C--N 1.308 -1.221 0 CA-C-N 112.567 -2.106 . . . . 15.0 109.122 174.777 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 245' ' ' THR . . . . . 1.087 HG23 ' HG2' ' A' ' 247' ' ' GLN . 3.4 t -145.02 150.46 36.93 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 116.406 -0.361 . . . . 15.0 110.124 -173.228 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 6.1 m -48.9 -22.15 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 N-CA-C 113.944 1.09 . . . . 15.0 113.944 -175.454 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 247' ' ' GLN . . . . . 1.087 ' HG2' HG23 ' A' ' 245' ' ' THR . 21.0 pt20 -58.56 -22.67 56.49 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-O 120.705 0.288 . . . . 15.0 110.851 176.539 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 91.08 30.3 11.31 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 121.276 -0.488 . . . . 15.0 112.872 177.356 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 249' ' ' GLN . . . . . 0.412 ' HB3' ' CH2' ' A' ' 262' ' ' TRP . 13.3 mp0 -137.9 143.18 40.71 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.888 0.344 . . . . 15.0 111.621 -178.118 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 29.1 m -90.16 138.39 19.54 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.129 0 CA-C-N 115.901 -0.591 . . . . 15.0 109.426 172.747 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 32.5 p90 -144.09 136.3 26.55 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 120.853 0.358 . . . . 15.0 110.228 -175.529 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 252' ' ' PHE . . . . . 0.651 ' CD2' ' HA ' ' A' ' 264' ' ' ASP . 32.0 m-85 -89.86 119.51 30.3 Favored 'General case' 0 CA--C 1.507 -0.68 0 CA-C-N 116.043 -0.526 . . . . 15.0 111.66 -172.688 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 253' ' ' LEU . . . . . 0.8 HD11 ' HB3' ' B' ' 212' ' ' PRO . 0.4 OUTLIER -113.52 118.62 34.98 Favored 'General case' 0 N--CA 1.441 -0.919 0 CA-C-N 114.854 -1.067 . . . . 15.0 111.141 -175.727 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 254' ' ' HIS . . . . . 0.69 ' HB2' ' CD1' ' A' ' 240' ' ' TYR . 48.3 t60 -128.07 90.28 3.06 Favored 'General case' 0 C--N 1.313 -0.992 0 N-CA-C 108.132 -1.062 . . . . 15.0 108.132 168.552 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 255' ' ' THR . . . . . 0.624 HG22 ' HA2' ' A' ' 258' ' ' GLY . 0.3 OUTLIER -89.82 87.38 6.94 Favored 'General case' 0 N--CA 1.429 -1.485 0 C-N-CA 116.462 -2.095 . . . . 15.0 109.881 178.772 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 35.9 tt0 -101.49 -56.39 2.31 Favored 'General case' 0 N--CA 1.436 -1.16 0 N-CA-C 105.884 -1.895 . . . . 15.0 105.884 150.327 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 257' ' ' THR . . . . . . . . . . . . . 63.3 p -96.65 -13.63 22.69 Favored 'General case' 0 CA--C 1.486 -1.512 0 CA-C-N 111.73 -2.486 . . . . 15.0 111.601 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 258' ' ' GLY . . . . . 0.624 ' HA2' HG22 ' A' ' 255' ' ' THR . . . 86.27 73.05 1.28 Allowed Glycine 1 C--N 1.24 -4.773 1 CA-C-N 108.3 -4.045 . . . . 15.0 113.236 -172.83 . . . . . . . . 4 3 . 1 . 008 nuclear build core ' A' A ' 259' ' ' VAL . . . . . 0.619 ' O ' ' HA ' ' A' ' 253' ' ' LEU . 55.4 t -89.89 123.36 42.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-O 121.202 0.525 . . . . 15.0 112.206 173.539 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 2.5 p -134.53 92.49 2.92 Favored 'General case' 0 C--N 1.317 -0.844 0 N-CA-C 107.818 -1.179 . . . . 15.0 107.818 168.754 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 8.1 t -121.06 150.14 41.64 Favored 'General case' 0 C--N 1.314 -0.938 0 N-CA-C 112.853 0.686 . . . . 15.0 112.853 -165.251 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 262' ' ' TRP . . . . . 0.553 ' HA ' ' CE3' ' A' ' 262' ' ' TRP . 1.9 m95 -80.94 -18.87 45.59 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 114.777 -1.102 . . . . 15.0 111.26 174.971 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 263' ' ' HIS . . . . . . . . . . . . . 4.0 p80 -100.31 133.61 44.46 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.558 -0.457 . . . . 15.0 110.106 -178.431 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 264' ' ' ASP . . . . . 0.799 ' HB3' HG12 ' A' ' 267' ' ' ILE . 9.8 t70 -55.67 132.92 71.97 Favored Pre-proline 0 C--N 1.321 -0.661 0 CA-C-N 115.908 -0.587 . . . . 15.0 109.529 175.836 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 265' ' ' PRO . . . . . 0.534 ' HD2' HD22 ' A' ' 236' ' ' LEU . 91.7 Cg_endo -80.67 -14.6 11.32 Favored 'Trans proline' 0 N--CA 1.462 -0.381 0 C-N-CA 122.42 2.08 . . . . 15.0 113.543 -176.192 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 266' ' ' ARG . . . . . 0.591 ' HD3' ' HD3' ' A' ' 237' ' ' PRO . 25.2 tpt180 -77.08 -8.52 57.61 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-O 122.269 1.033 . . . . 15.0 108.408 175.156 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 267' ' ' ILE . . . . . 0.799 HG12 ' HB3' ' A' ' 264' ' ' ASP . 43.2 mm . . . . . 0 C--O 1.249 1.052 0 CA-C-N 113.505 -1.68 . . . . 15.0 109.749 176.898 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 210' ' ' SER . . . . . . . . . . . . . 4.7 m . . . . . 0 N--CA 1.471 0.616 0 CA-C-O 120.792 0.33 . . . . 15.0 110.387 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' B' B ' 211' ' ' ASP . . . . . 0.407 ' HA ' ' HD3' ' B' ' 212' ' ' PRO . 9.2 p-10 -150.17 131.79 7.61 Favored Pre-proline 0 C--N 1.326 -0.437 0 CA-C-N 116.262 -0.427 . . . . 15.0 110.337 -178.75 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 212' ' ' PRO . . . . . 0.8 ' HB3' HD11 ' A' ' 253' ' ' LEU . 12.3 Cg_endo -89.98 140.45 3.4 Favored 'Trans proline' 0 N--CA 1.453 -0.89 0 C-N-CA 122.995 2.463 . . . . 15.0 112.199 178.602 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.443 -0.841 0 C-N-CA 120.548 -0.834 . . . . 15.0 111.94 178.895 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 236' ' ' LEU . . . . . 0.431 HD22 ' N ' ' A' ' 236' ' ' LEU . 0.9 OUTLIER . . . . . 0 C--O 1.234 0.286 0 N-CA-C 108.828 -0.804 . . . . 15.0 108.828 . . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 237' ' ' PRO . . . . . 0.763 ' HD3' ' HD3' ' A' ' 266' ' ' ARG . 16.0 Cg_exo -69.24 164.54 33.64 Favored 'Trans proline' 0 CA--C 1.514 -0.524 0 C-N-CA 122.009 1.806 . . . . 15.0 110.399 167.457 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -69.92 143.65 52.65 Favored 'General case' 0 C--N 1.302 -1.465 0 CA-C-N 115.02 -0.991 . . . . 15.0 111.356 -173.695 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 239' ' ' GLY . . . . . 0.416 ' O ' ' HA ' ' A' ' 254' ' ' HIS . . . 100.16 3.9 55.48 Favored Glycine 0 N--CA 1.447 -0.628 0 CA-C-N 115.29 -0.868 . . . . 15.0 113.294 177.985 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 240' ' ' TYR . . . . . 0.728 ' CD1' ' HB2' ' A' ' 254' ' ' HIS . 74.7 m-85 -105.58 126.46 52.16 Favored 'General case' 0 CA--C 1.514 -0.434 0 CA-C-N 117.352 0.576 . . . . 15.0 110.874 176.996 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -111.71 125.23 53.75 Favored 'General case' 0 C--N 1.316 -0.871 0 N-CA-C 109.461 -0.57 . . . . 15.0 109.461 169.526 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 242' ' ' GLN . . . . . 0.486 ' HG3' ' CE1' ' A' ' 252' ' ' PHE . 7.2 tt0 -89.74 104.1 16.69 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.772 -0.649 . . . . 15.0 109.296 -178.62 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 36.0 mtt-85 -97.03 150.01 21.28 Favored 'General case' 0 CA--C 1.505 -0.771 0 CA-C-O 122.23 1.014 . . . . 15.0 112.368 -176.205 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 244' ' ' THR . . . . . . . . . . . . . 13.6 p -120.27 133.36 55.48 Favored 'General case' 0 C--N 1.308 -1.234 0 CA-C-N 113.085 -1.871 . . . . 15.0 109.506 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 245' ' ' THR . . . . . 0.557 ' OG1' ' HG2' ' A' ' 247' ' ' GLN . 4.6 t -137.4 150.23 47.51 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 116.462 -0.335 . . . . 15.0 110.911 -176.317 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 3.6 m -57.16 -15.88 3.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 115.777 -0.647 . . . . 15.0 112.117 178.694 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 247' ' ' GLN . . . . . 0.557 ' HG2' ' OG1' ' A' ' 245' ' ' THR . 6.8 mm100 -54.42 -24.04 18.35 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.123 -0.489 . . . . 15.0 110.245 172.918 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 92.9 34.12 7.01 Favored Glycine 0 C--N 1.333 0.374 0 CA-C-N 115.903 -0.589 . . . . 15.0 111.927 175.91 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 249' ' ' GLN . . . . . 0.494 ' CD ' ' HH2' ' A' ' 262' ' ' TRP . 0.2 OUTLIER -149.42 137.93 20.88 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.449 0.642 . . . . 15.0 111.843 -170.977 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 12.6 m -91.81 128.41 43.51 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.039 0 CA-C-N 114.527 -1.215 . . . . 15.0 109.151 171.16 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 20.5 p90 -132.8 135.27 45.58 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 109.951 -0.389 . . . . 15.0 109.951 -178.081 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 252' ' ' PHE . . . . . 0.663 ' CD2' ' HA ' ' A' ' 264' ' ' ASP . 30.1 m-85 -90.14 121.74 32.46 Favored 'General case' 0 CA--C 1.513 -0.443 0 CA-C-O 121.224 0.535 . . . . 15.0 111.737 -174.346 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 253' ' ' LEU . . . . . 0.735 HD11 ' HB3' ' B' ' 212' ' ' PRO . 0.5 OUTLIER -109.42 116.51 31.95 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 114.783 -1.099 . . . . 15.0 111.148 -175.824 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 254' ' ' HIS . . . . . 0.728 ' HB2' ' CD1' ' A' ' 240' ' ' TYR . 69.5 t60 -130.21 90.21 2.91 Favored 'General case' 0 CA--C 1.503 -0.859 0 N-CA-C 108.207 -1.035 . . . . 15.0 108.207 169.866 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 3.2 t -91.32 87.95 6.67 Favored 'General case' 0 N--CA 1.432 -1.374 0 C-N-CA 116.659 -2.017 . . . . 15.0 110.111 -179.424 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 48.3 tt0 -101.33 -51.26 3.53 Favored 'General case' 0 N--CA 1.44 -0.963 0 CA-C-N 113.412 -1.722 . . . . 15.0 106.422 150.712 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 257' ' ' THR . . . . . . . . . . . . . 80.9 p -98.19 -13.61 20.78 Favored 'General case' 0 CA--C 1.488 -1.43 0 CA-C-O 124.78 2.229 . . . . 15.0 111.724 178.987 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 87.62 73.15 1.28 Allowed Glycine 1 C--N 1.24 -4.75 1 CA-C-N 108.258 -4.065 . . . . 15.0 112.742 -170.977 . . . . . . . . 3 2 . 1 . 009 nuclear build core ' A' A ' 259' ' ' VAL . . . . . 0.569 ' O ' ' HA ' ' A' ' 253' ' ' LEU . 48.7 t -89.66 125.49 42.62 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.339 0 CA-C-O 121.667 0.746 . . . . 15.0 112.18 175.846 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 1.5 p -138.23 92.39 2.64 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-N 113.763 -1.562 . . . . 15.0 107.658 167.617 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 13.2 t -124.4 150.26 45.79 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 121.386 0.612 . . . . 15.0 112.243 -167.426 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 262' ' ' TRP . . . . . 0.494 ' HH2' ' CD ' ' A' ' 249' ' ' GLN . 40.9 m95 -75.44 -25.28 57.33 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 114.794 -1.094 . . . . 15.0 112.201 178.959 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 263' ' ' HIS . . . . . . . . . . . . . 8.1 p80 -92.9 142.26 27.5 Favored 'General case' 0 C--N 1.322 -0.608 0 C-N-CA 120.179 -0.608 . . . . 15.0 110.385 -176.043 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 264' ' ' ASP . . . . . 0.851 ' HB3' HG12 ' A' ' 267' ' ' ILE . 9.9 t0 -61.96 134.22 94.2 Favored Pre-proline 0 C--N 1.321 -0.635 0 N-CA-C 108.541 -0.911 . . . . 15.0 108.541 175.216 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 265' ' ' PRO . . . . . 0.603 ' HD3' ' CD2' ' A' ' 252' ' ' PHE . 71.6 Cg_endo -81.81 -14.46 10.01 Favored 'Trans proline' 0 N--CA 1.452 -0.969 0 C-N-CA 122.039 1.826 . . . . 15.0 113.547 -174.559 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 266' ' ' ARG . . . . . 0.763 ' HD3' ' HD3' ' A' ' 237' ' ' PRO . 17.8 tpt180 -78.87 -7.5 57.98 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-O 122.029 0.919 . . . . 15.0 108.723 174.62 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 267' ' ' ILE . . . . . 0.851 HG12 ' HB3' ' A' ' 264' ' ' ASP . 46.9 mm . . . . . 0 C--O 1.249 1.067 0 CA-C-N 113.846 -1.525 . . . . 15.0 109.663 177.063 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 210' ' ' SER . . . . . . . . . . . . . 20.0 m . . . . . 0 N--CA 1.482 1.132 0 CA-C-O 120.955 0.407 . . . . 15.0 110.969 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' B' B ' 211' ' ' ASP . . . . . 0.476 ' HA ' ' HD3' ' B' ' 212' ' ' PRO . 36.3 t70 -101.58 113.82 65.76 Favored Pre-proline 0 C--N 1.325 -0.488 0 CA-C-N 116.328 -0.396 . . . . 15.0 110.244 -177.701 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 212' ' ' PRO . . . . . 0.735 ' HB3' HD11 ' A' ' 253' ' ' LEU . 6.3 Cg_endo -89.71 160.2 5.19 Favored 'Trans proline' 0 N--CA 1.456 -0.688 0 C-N-CA 123.454 2.769 . . . . 15.0 112.891 -175.985 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.444 -0.813 0 CA-C-N 115.717 -0.674 . . . . 15.0 112.52 -178.151 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 4.8 mt . . . . . 0 C--O 1.232 0.147 0 CA-C-O 120.715 0.293 . . . . 15.0 110.426 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 237' ' ' PRO . . . . . 0.769 ' HD3' ' HD3' ' A' ' 266' ' ' ARG . 16.5 Cg_exo -69.37 169.6 18.04 Favored 'Trans proline' 0 CA--C 1.511 -0.672 0 C-N-CA 122.308 2.005 . . . . 15.0 110.654 165.355 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 60.0 mt-10 -69.5 137.14 52.28 Favored 'General case' 0 C--N 1.303 -1.425 0 CA-C-N 114.594 -1.185 . . . . 15.0 112.375 -172.096 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 100.54 5.76 53.69 Favored Glycine 0 N--CA 1.447 -0.582 0 CA-C-N 113.914 -1.494 . . . . 15.0 113.706 175.245 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 240' ' ' TYR . . . . . 0.703 ' CD1' ' HB2' ' A' ' 254' ' ' HIS . 83.4 m-85 -104.06 122.99 46.41 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 117.741 0.77 . . . . 15.0 110.738 175.891 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 241' ' ' GLU . . . . . 0.496 ' HG3' ' HB3' ' A' ' 253' ' ' LEU . 8.1 pt-20 -105.57 127.37 52.99 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 109.139 -0.689 . . . . 15.0 109.139 170.84 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 242' ' ' GLN . . . . . 0.641 ' HG3' ' CE1' ' A' ' 252' ' ' PHE . 9.6 tt0 -89.86 105.15 17.61 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 108.932 -0.766 . . . . 15.0 108.932 179.86 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 54.9 mtt-85 -92.39 149.28 21.51 Favored 'General case' 0 CA--C 1.506 -0.724 0 CA-C-O 122.288 1.042 . . . . 15.0 112.158 -177.074 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 244' ' ' THR . . . . . . . . . . . . . 20.4 p -126.4 89.91 3.09 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-N 113.066 -1.879 . . . . 15.0 109.101 -174.139 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 245' ' ' THR . . . . . 0.78 HG23 ' HB2' ' A' ' 247' ' ' GLN . 13.4 t -97.24 150.27 21.11 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 115.162 -0.926 . . . . 15.0 110.326 -171.106 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 26.8 t -54.41 -17.91 2.35 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 C-N-CA 122.915 0.486 . . . . 15.0 111.961 -175.069 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 247' ' ' GLN . . . . . 0.78 ' HB2' HG23 ' A' ' 245' ' ' THR . 10.4 mp0 -51.18 -22.89 2.86 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 123.25 0.62 . . . . 15.0 111.318 172.17 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 88.05 16.0 60.08 Favored Glycine 0 C--N 1.33 0.233 0 C-N-CA 121.156 -0.545 . . . . 15.0 112.06 178.23 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 249' ' ' GLN . . . . . 0.426 ' NE2' ' HH2' ' A' ' 262' ' ' TRP . 1.8 mt-30 -131.11 137.56 49.13 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 109.884 -0.413 . . . . 15.0 109.884 -176.316 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 14.4 m -89.72 134.05 29.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-N 116.358 -0.383 . . . . 15.0 110.306 177.407 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 14.9 p90 -133.41 137.05 45.61 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.35 -0.386 . . . . 15.0 110.194 -179.698 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 252' ' ' PHE . . . . . 0.692 ' CD2' ' HA ' ' A' ' 264' ' ' ASP . 37.6 m-85 -89.88 121.74 32.28 Favored 'General case' 0 CA--C 1.512 -0.498 0 CA-C-O 121.193 0.521 . . . . 15.0 110.909 -175.8 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 253' ' ' LEU . . . . . 0.893 HD11 ' HB3' ' B' ' 212' ' ' PRO . 0.4 OUTLIER -113.16 124.75 53.28 Favored 'General case' 0 N--CA 1.445 -0.699 0 CA-C-N 114.858 -1.065 . . . . 15.0 110.756 -174.921 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 254' ' ' HIS . . . . . 0.703 ' HB2' ' CD1' ' A' ' 240' ' ' TYR . 53.4 t60 -138.95 97.51 3.33 Favored 'General case' 0 CA--C 1.499 -1.014 0 N-CA-C 108.645 -0.872 . . . . 15.0 108.645 173.198 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 24.5 m -93.57 87.74 5.63 Favored 'General case' 0 N--CA 1.434 -1.244 0 C-N-CA 116.539 -2.064 . . . . 15.0 110.402 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 35.3 tt0 -101.29 -54.0 2.88 Favored 'General case' 0 N--CA 1.44 -0.956 0 N-CA-C 105.653 -1.981 . . . . 15.0 105.653 148.826 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 257' ' ' THR . . . . . . . . . . . . . 77.8 p -100.06 -13.61 18.96 Favored 'General case' 0 CA--C 1.485 -1.535 0 CA-C-N 112.555 -2.111 . . . . 15.0 112.223 -178.914 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 86.67 73.7 1.28 Allowed Glycine 1 C--N 1.239 -4.808 0 CA-C-N 108.806 -3.815 . . . . 15.0 112.753 -171.293 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 259' ' ' VAL . . . . . 0.655 ' O ' ' HA ' ' A' ' 253' ' ' LEU . 43.8 t -89.69 124.62 42.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 121.43 0.633 . . . . 15.0 112.02 176.021 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -140.15 102.14 4.31 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 114.407 -1.27 . . . . 15.0 107.915 168.345 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 12.9 t -143.31 150.35 39.07 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.9 -0.591 . . . . 15.0 111.878 -168.746 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 262' ' ' TRP . . . . . 0.426 ' HH2' ' NE2' ' A' ' 249' ' ' GLN . 92.7 m95 -70.0 -42.57 72.87 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 115.638 -0.71 . . . . 15.0 111.492 178.286 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 263' ' ' HIS . . . . . . . . . . . . . 2.7 p80 -73.53 132.37 42.79 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.255 -0.429 . . . . 15.0 110.246 -175.868 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 264' ' ' ASP . . . . . 1.014 ' HB3' HG12 ' A' ' 267' ' ' ILE . 22.0 t0 -56.38 127.63 72.0 Favored Pre-proline 0 C--N 1.32 -0.715 0 N-CA-C 108.155 -1.054 . . . . 15.0 108.155 172.769 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 265' ' ' PRO . . . . . 0.521 ' HG2' ' CD1' ' A' ' 240' ' ' TYR . 12.1 Cg_exo -69.34 -14.52 37.56 Favored 'Trans proline' 0 C--N 1.329 -0.482 0 C-N-CA 122.27 1.98 . . . . 15.0 112.614 -177.466 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 266' ' ' ARG . . . . . 0.769 ' HD3' ' HD3' ' A' ' 237' ' ' PRO . 16.1 tpt180 -75.39 -11.62 60.08 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 108.7 -0.852 . . . . 15.0 108.7 172.91 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 267' ' ' ILE . . . . . 1.014 HG12 ' HB3' ' A' ' 264' ' ' ASP . 24.6 pt . . . . . 0 C--O 1.248 1.017 0 CA-C-N 114.625 -1.171 . . . . 15.0 111.364 178.101 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 210' ' ' SER . . . . . . . . . . . . . 40.8 m . . . . . 0 N--CA 1.479 0.99 0 CA-C-O 120.77 0.319 . . . . 15.0 111.258 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' B' B ' 211' ' ' ASP . . . . . 0.422 ' HA ' ' HD3' ' B' ' 212' ' ' PRO . 10.1 p-10 -90.44 141.78 27.64 Favored Pre-proline 0 C--N 1.328 -0.363 0 N-CA-C 109.657 -0.498 . . . . 15.0 109.657 179.38 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 212' ' ' PRO . . . . . 0.893 ' HB3' HD11 ' A' ' 253' ' ' LEU . 9.5 Cg_endo -89.6 148.85 5.13 Favored 'Trans proline' 0 N--CA 1.454 -0.822 0 C-N-CA 122.733 2.289 . . . . 15.0 112.581 -177.567 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.443 -0.87 0 C-N-CA 120.746 -0.74 . . . . 15.0 112.075 -179.386 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 236' ' ' LEU . . . . . 0.558 HD12 ' HD2' ' A' ' 265' ' ' PRO . 0.1 OUTLIER . . . . . 0 CA--C 1.518 -0.269 0 CA-C-O 121.225 0.536 . . . . 15.0 110.939 . . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 237' ' ' PRO . . . . . 0.455 ' HD3' ' HD3' ' A' ' 266' ' ' ARG . 18.8 Cg_exo -69.65 166.21 28.21 Favored 'Trans proline' 0 CA--C 1.515 -0.455 0 C-N-CA 122.993 2.462 . . . . 15.0 110.323 164.705 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -69.7 150.02 47.41 Favored 'General case' 0 C--N 1.307 -1.278 0 CA-C-N 115.443 -0.799 . . . . 15.0 110.968 -177.207 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 100.03 -2.14 56.63 Favored Glycine 0 N--CA 1.447 -0.593 0 CA-C-N 115.508 -0.769 . . . . 15.0 113.809 179.489 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 240' ' ' TYR . . . . . 0.671 ' CD1' ' HB2' ' A' ' 254' ' ' HIS . 79.6 m-85 -104.28 115.35 30.24 Favored 'General case' 0 CA--C 1.518 -0.283 0 CA-C-N 117.688 0.744 . . . . 15.0 110.626 178.233 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 26.5 mt-10 -95.7 123.13 39.12 Favored 'General case' 0 C--N 1.317 -0.844 0 N-CA-C 109.074 -0.713 . . . . 15.0 109.074 175.015 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 23.7 tm0? -89.91 109.11 20.15 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 108.728 -0.842 . . . . 15.0 108.728 179.845 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 47.9 mtt85 -105.27 150.09 25.45 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 122.143 0.973 . . . . 15.0 112.098 -179.291 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 244' ' ' THR . . . . . . . . . . . . . 5.6 p -127.36 98.25 5.19 Favored 'General case' 0 C--N 1.31 -1.125 0 CA-C-N 113.279 -1.782 . . . . 15.0 109.309 -177.183 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 245' ' ' THR . . . . . 0.463 ' OG1' ' HG2' ' A' ' 247' ' ' GLN . 3.1 t -89.92 150.4 22.19 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 115.567 -0.742 . . . . 15.0 111.098 -174.279 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 8.4 m -50.8 -19.36 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.21 0 CA-C-N 115.413 -0.812 . . . . 15.0 112.236 177.423 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 247' ' ' GLN . . . . . 0.489 ' HB2' ' HG3' ' A' ' 249' ' ' GLN . 7.3 mm100 -55.62 -26.08 42.31 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.07 -0.514 . . . . 15.0 110.953 173.514 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 89.01 30.58 14.05 Favored Glycine 0 N--CA 1.449 -0.495 0 CA-C-N 115.943 -0.571 . . . . 15.0 111.996 179.706 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 249' ' ' GLN . . . . . 0.489 ' HG3' ' HB2' ' A' ' 247' ' ' GLN . 0.0 OUTLIER -134.76 142.09 46.64 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.642 0.258 . . . . 15.0 110.388 -177.006 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 17.9 m -89.97 134.89 27.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 115.884 -0.598 . . . . 15.0 109.825 175.373 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 4.3 p90 -142.73 135.77 28.28 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.083 0.468 . . . . 15.0 110.448 179.493 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 252' ' ' PHE . . . . . 0.717 ' CE2' ' HA ' ' A' ' 264' ' ' ASP . 34.5 m-85 -90.27 125.55 35.54 Favored 'General case' 0 CA--C 1.511 -0.526 0 CA-C-N 115.826 -0.625 . . . . 15.0 111.126 -176.57 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 253' ' ' LEU . . . . . 1.027 HD11 ' HB3' ' B' ' 212' ' ' PRO . 0.4 OUTLIER -113.98 111.25 21.37 Favored 'General case' 0 N--CA 1.445 -0.724 0 CA-C-N 115.25 -0.886 . . . . 15.0 111.768 -174.589 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 254' ' ' HIS . . . . . 0.671 ' HB2' ' CD1' ' A' ' 240' ' ' TYR . 36.4 t-80 -122.46 90.11 3.24 Favored 'General case' 0 CA--C 1.499 -0.992 0 N-CA-C 107.981 -1.118 . . . . 15.0 107.981 166.345 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 7.3 t -96.38 88.05 4.63 Favored 'General case' 0 N--CA 1.428 -1.567 0 C-N-CA 116.599 -2.041 . . . . 15.0 110.192 -178.878 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 63.7 tt0 -101.2 -51.48 3.5 Favored 'General case' 0 N--CA 1.437 -1.081 0 CA-C-N 112.875 -1.966 . . . . 15.0 105.838 151.519 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 257' ' ' THR . . . . . . . . . . . . . 79.6 p -96.78 -13.42 22.65 Favored 'General case' 0 CA--C 1.486 -1.506 0 CA-C-O 125.034 2.35 . . . . 15.0 111.623 178.531 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 86.74 74.62 1.27 Allowed Glycine 1 C--N 1.24 -4.783 1 CA-C-N 108.222 -4.081 . . . . 15.0 112.899 -172.92 . . . . . . . . 3 2 . 1 . 011 nuclear build core ' A' A ' 259' ' ' VAL . . . . . 0.587 ' O ' ' HA ' ' A' ' 253' ' ' LEU . 57.4 t -89.9 121.86 40.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-O 121.556 0.693 . . . . 15.0 112.02 172.855 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 1.3 p -135.27 103.62 5.58 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 114.042 -1.435 . . . . 15.0 107.988 169.878 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 14.3 t -143.41 150.49 39.14 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 112.977 0.732 . . . . 15.0 112.977 -168.085 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 262' ' ' TRP . . . . . 0.44 ' HH2' ' CD ' ' A' ' 249' ' ' GLN . 89.1 m95 -71.44 -32.6 68.54 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 114.956 -1.02 . . . . 15.0 111.848 178.543 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 263' ' ' HIS . . . . . 0.654 ' HD2' ' OXT' ' A' ' 267' ' ' ILE . 20.2 p-80 -86.28 137.47 32.58 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.596 -0.441 . . . . 15.0 110.986 -172.241 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 264' ' ' ASP . . . . . 0.994 ' HB3' HG12 ' A' ' 267' ' ' ILE . 7.3 t0 -52.96 129.86 48.53 Favored Pre-proline 0 C--N 1.325 -0.458 0 N-CA-C 108.864 -0.791 . . . . 15.0 108.864 172.92 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 265' ' ' PRO . . . . . 0.558 ' HD2' HD12 ' A' ' 236' ' ' LEU . 67.0 Cg_endo -73.2 -14.87 25.74 Favored 'Trans proline' 0 CA--C 1.51 -0.724 0 C-N-CA 122.193 1.928 . . . . 15.0 113.64 -173.961 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 266' ' ' ARG . . . . . 0.455 ' HD3' ' HD3' ' A' ' 237' ' ' PRO . 8.4 tpt180 -83.93 -5.58 59.25 Favored 'General case' 0 C--N 1.306 -1.293 0 N-CA-C 108.254 -1.017 . . . . 15.0 108.254 174.245 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 267' ' ' ILE . . . . . 0.994 HG12 ' HB3' ' A' ' 264' ' ' ASP . 45.0 pt . . . . . 0 C--O 1.247 0.965 0 CA-C-N 114.023 -1.444 . . . . 15.0 110.728 174.667 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 210' ' ' SER . . . . . . . . . . . . . 19.3 m . . . . . 0 N--CA 1.477 0.891 0 CA-C-O 120.841 0.353 . . . . 15.0 111.038 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' B' B ' 211' ' ' ASP . . . . . 0.419 ' HA ' ' HD3' ' B' ' 212' ' ' PRO . 13.9 m-20 -110.05 115.18 55.25 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 120.76 0.314 . . . . 15.0 110.759 -178.032 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 212' ' ' PRO . . . . . 1.027 ' HB3' HD11 ' A' ' 253' ' ' LEU . 6.1 Cg_exo -89.6 141.55 3.93 Favored 'Trans proline' 0 N--CA 1.461 -0.437 0 C-N-CA 123.422 2.748 . . . . 15.0 112.851 178.99 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.443 -0.866 0 CA-C-N 115.52 -0.764 . . . . 15.0 111.745 178.619 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 236' ' ' LEU . . . . . 0.65 HD12 ' HD2' ' A' ' 265' ' ' PRO . 0.2 OUTLIER . . . . . 0 CA--C 1.515 -0.367 0 CA-C-O 121.443 0.639 . . . . 15.0 110.906 . . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 237' ' ' PRO . . . . . 0.477 ' HD2' ' CE2' ' A' ' 240' ' ' TYR . 15.3 Cg_exo -69.65 173.88 10.23 Favored 'Trans proline' 0 CA--C 1.514 -0.516 0 C-N-CA 123.202 2.602 . . . . 15.0 110.672 161.675 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -69.42 143.45 53.61 Favored 'General case' 0 C--N 1.3 -1.581 0 CA-C-N 114.487 -1.233 . . . . 15.0 111.238 -177.992 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 100.18 8.29 50.68 Favored Glycine 0 N--CA 1.45 -0.386 0 CA-C-N 115.502 -0.772 . . . . 15.0 113.735 177.169 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 240' ' ' TYR . . . . . 0.641 ' CD1' ' HB2' ' A' ' 254' ' ' HIS . 72.2 m-85 -107.32 116.5 32.04 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 117.611 0.705 . . . . 15.0 111.346 178.826 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 241' ' ' GLU . . . . . 0.585 ' HB3' ' HB3' ' A' ' 253' ' ' LEU . 4.5 tp10 -89.84 111.58 22.65 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.156 -0.929 . . . . 15.0 108.737 174.562 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -90.06 102.72 15.43 Favored 'General case' 0 C--N 1.314 -0.943 0 N-CA-C 108.635 -0.876 . . . . 15.0 108.635 178.681 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 243' ' ' ARG . . . . . 0.437 ' HG3' ' HG3' ' A' ' 241' ' ' GLU . 51.0 mtt-85 -99.21 148.26 24.29 Favored 'General case' 0 CA--C 1.499 -0.998 0 CA-C-O 121.96 0.886 . . . . 15.0 112.185 -177.742 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 244' ' ' THR . . . . . . . . . . . . . 11.7 m -123.2 93.97 4.12 Favored 'General case' 0 C--N 1.309 -1.191 0 CA-C-N 113.505 -1.68 . . . . 15.0 110.207 -179.413 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 245' ' ' THR . . . . . 1.082 HG23 ' HG2' ' A' ' 247' ' ' GLN . 7.7 t -95.25 150.73 19.91 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.546 -0.752 . . . . 15.0 110.248 179.99 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 15.0 m -41.15 -25.27 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 N-CA-C 114.642 1.349 . . . . 15.0 114.642 -175.96 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 247' ' ' GLN . . . . . 1.082 ' HG2' HG23 ' A' ' 245' ' ' THR . 3.5 pt20 -54.4 -21.45 9.71 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 117.793 0.27 . . . . 15.0 111.14 177.251 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 87.76 20.64 50.07 Favored Glycine 0 C--N 1.333 0.411 0 C-N-CA 121.206 -0.521 . . . . 15.0 113.036 173.821 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 249' ' ' GLN . . . . . 0.413 ' HB2' ' OE1' ' A' ' 247' ' ' GLN . 16.4 mt-30 -129.98 142.71 50.6 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.586 -0.524 . . . . 15.0 109.586 -177.207 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 29.8 m -91.25 134.75 28.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-O 120.943 0.402 . . . . 15.0 110.924 179.875 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 33.0 p90 -134.27 137.56 44.38 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.778 -0.452 . . . . 15.0 109.778 -178.005 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 252' ' ' PHE . . . . . 0.67 ' CE2' ' HA ' ' A' ' 264' ' ' ASP . 26.6 m-85 -92.01 116.58 29.05 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.218 0.533 . . . . 15.0 111.386 -174.66 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 253' ' ' LEU . . . . . 0.78 HD11 ' HB3' ' B' ' 212' ' ' PRO . 0.5 OUTLIER -106.54 96.87 6.76 Favored 'General case' 0 N--CA 1.447 -0.604 0 CA-C-N 115.063 -0.972 . . . . 15.0 111.3 -175.154 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 254' ' ' HIS . . . . . 0.641 ' HB2' ' CD1' ' A' ' 240' ' ' TYR . 76.0 t60 -106.53 90.12 3.24 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 108.417 -0.957 . . . . 15.0 108.417 169.5 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 1.9 t -94.65 87.81 5.2 Favored 'General case' 0 N--CA 1.432 -1.342 0 C-N-CA 116.746 -1.982 . . . . 15.0 110.286 -179.698 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 57.4 tt0 -101.18 -50.2 3.86 Favored 'General case' 0 N--CA 1.441 -0.919 0 CA-C-N 112.957 -1.929 . . . . 15.0 106.25 150.876 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 257' ' ' THR . . . . . . . . . . . . . 67.0 p -98.53 -13.56 20.41 Favored 'General case' 0 CA--C 1.486 -1.503 0 CA-C-O 124.706 2.193 . . . . 15.0 111.738 178.469 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 87.07 73.57 1.28 Allowed Glycine 1 C--N 1.24 -4.803 0 CA-C-N 108.493 -3.958 . . . . 15.0 112.851 -172.3 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 259' ' ' VAL . . . . . 0.704 ' O ' ' HA ' ' A' ' 253' ' ' LEU . 52.3 t -89.92 125.3 42.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-O 121.284 0.564 . . . . 15.0 112.135 174.275 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 1.6 p -137.16 98.01 3.63 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 114.699 -1.137 . . . . 15.0 107.987 167.666 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 14.0 t -136.79 150.29 48.27 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.994 -0.548 . . . . 15.0 111.972 -168.464 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 262' ' ' TRP . . . . . . . . . . . . . 83.2 m95 -71.83 -39.46 69.74 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.062 -0.972 . . . . 15.0 111.663 179.481 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 263' ' ' HIS . . . . . 0.486 ' HD2' ' OXT' ' A' ' 267' ' ' ILE . 16.2 p-80 -77.82 137.23 38.3 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.451 -0.341 . . . . 15.0 110.48 -173.496 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 264' ' ' ASP . . . . . 1.021 ' HB3' HG12 ' A' ' 267' ' ' ILE . 27.7 t0 -57.54 124.21 66.41 Favored Pre-proline 0 C--N 1.324 -0.533 0 N-CA-C 108.024 -1.102 . . . . 15.0 108.024 169.899 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 265' ' ' PRO . . . . . 0.65 ' HD2' HD12 ' A' ' 236' ' ' LEU . 12.1 Cg_exo -69.13 -14.7 38.55 Favored 'Trans proline' 0 N--CA 1.459 -0.558 0 C-N-CA 122.236 1.957 . . . . 15.0 112.914 -175.997 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 266' ' ' ARG . . . . . 0.44 ' HD3' ' HD3' ' A' ' 237' ' ' PRO . 6.1 tpt180 -76.44 -11.64 59.92 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-O 121.99 0.9 . . . . 15.0 108.918 173.572 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 267' ' ' ILE . . . . . 1.021 HG12 ' HB3' ' A' ' 264' ' ' ASP . 36.5 pt . . . . . 0 C--O 1.246 0.904 0 CA-C-N 114.562 -1.199 . . . . 15.0 111.458 -179.364 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 210' ' ' SER . . . . . . . . . . . . . 17.7 m . . . . . 0 N--CA 1.476 0.863 0 CA-C-O 120.977 0.418 . . . . 15.0 110.327 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' B' B ' 211' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -98.97 116.83 65.05 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.136 -0.484 . . . . 15.0 110.93 -172.577 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 212' ' ' PRO . . . . . 0.78 ' HB3' HD11 ' A' ' 253' ' ' LEU . 6.6 Cg_endo -89.87 144.21 4.34 Favored 'Trans proline' 0 N--CA 1.451 -1.026 0 C-N-CA 122.851 2.367 . . . . 15.0 111.051 171.138 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.442 -0.946 0 C-N-CA 120.192 -1.004 . . . . 15.0 111.923 -179.517 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 236' ' ' LEU . . . . . 0.451 HD22 ' N ' ' A' ' 236' ' ' LEU . 0.6 OUTLIER . . . . . 0 N--CA 1.454 -0.257 0 N-CA-C 110.287 -0.264 . . . . 15.0 110.287 . . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 237' ' ' PRO . . . . . 0.605 ' HD3' ' HD3' ' A' ' 266' ' ' ARG . 20.0 Cg_exo -69.2 170.77 15.15 Favored 'Trans proline' 0 CA--C 1.509 -0.759 0 C-N-CA 122.308 2.005 . . . . 15.0 111.258 166.81 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -69.46 139.1 53.93 Favored 'General case' 0 C--N 1.301 -1.535 0 CA-C-N 114.215 -1.357 . . . . 15.0 110.995 -171.819 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 100.22 -2.28 56.41 Favored Glycine 0 N--CA 1.448 -0.509 0 CA-C-N 115.621 -0.718 . . . . 15.0 113.752 179.288 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 240' ' ' TYR . . . . . 0.443 ' CD1' ' HB2' ' A' ' 254' ' ' HIS . 84.6 m-85 -97.39 116.52 29.75 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 118.087 0.943 . . . . 15.0 111.167 177.381 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 241' ' ' GLU . . . . . 0.583 ' HB2' ' HB3' ' A' ' 253' ' ' LEU . 5.6 mt-10 -89.9 111.06 21.99 Favored 'General case' 0 N--CA 1.441 -0.915 0 CA-C-N 114.297 -1.319 . . . . 15.0 109.232 177.606 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -89.88 103.72 16.35 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 108.88 -0.785 . . . . 15.0 108.88 178.355 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 243' ' ' ARG . . . . . 0.43 ' CZ ' ' HG2' ' B' ' 212' ' ' PRO . 8.2 mtp180 -108.33 149.01 29.25 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.768 0.794 . . . . 15.0 112.114 -178.456 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 244' ' ' THR . . . . . . . . . . . . . 16.2 p -120.39 121.19 38.02 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 114.008 -1.451 . . . . 15.0 109.799 -178.035 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 245' ' ' THR . . . . . 0.521 ' OG1' ' HG2' ' A' ' 247' ' ' GLN . 4.6 t -110.66 150.55 28.85 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 116.24 -0.437 . . . . 15.0 111.013 -176.863 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 5.5 p -50.07 -24.31 1.92 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.262 0 CA-C-N 115.389 -0.823 . . . . 15.0 111.2 175.977 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 247' ' ' GLN . . . . . 0.521 ' HG2' ' OG1' ' A' ' 245' ' ' THR . 3.9 mm-40 -51.97 -26.84 11.46 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 115.335 -0.848 . . . . 15.0 110.823 175.42 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 104.56 9.36 35.76 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 121.098 -0.572 . . . . 15.0 113.092 174.518 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 2.1 pm0 -123.38 149.04 45.46 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 112.904 0.705 . . . . 15.0 112.904 -174.924 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 6.2 m -89.79 132.67 33.89 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.435 0 CA-C-N 114.727 -1.124 . . . . 15.0 108.367 166.69 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 2.4 p90 -134.61 140.3 45.97 Favored 'General case' 0 C--N 1.314 -0.946 0 C-N-CA 120.538 -0.465 . . . . 15.0 110.1 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 252' ' ' PHE . . . . . 0.661 ' CD2' ' HA ' ' A' ' 264' ' ' ASP . 24.2 m-85 -90.0 111.66 22.83 Favored 'General case' 0 CA--C 1.507 -0.698 0 CA-C-O 121.854 0.835 . . . . 15.0 111.601 -174.972 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 253' ' ' LEU . . . . . 0.921 HD11 ' HB3' ' B' ' 212' ' ' PRO . 0.5 OUTLIER -99.52 140.96 32.94 Favored 'General case' 0 N--CA 1.438 -1.055 0 CA-C-N 113.696 -1.593 . . . . 15.0 109.192 178.893 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 254' ' ' HIS . . . . . 0.466 ' HB3' ' HB ' ' A' ' 259' ' ' VAL . 48.8 t60 -149.98 93.13 1.98 Allowed 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 108.335 -0.987 . . . . 15.0 108.335 170.72 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 255' ' ' THR . . . . . 0.502 HG22 ' OE2' ' A' ' 241' ' ' GLU . 2.6 t -90.04 87.95 7.1 Favored 'General case' 0 N--CA 1.431 -1.404 0 C-N-CA 116.387 -2.125 . . . . 15.0 110.328 -179.949 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 56.3 tt0 -101.26 -54.2 2.83 Favored 'General case' 0 N--CA 1.44 -0.963 0 CA-C-N 112.761 -2.018 . . . . 15.0 105.733 148.089 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 257' ' ' THR . . . . . . . . . . . . . 71.3 p -99.94 -13.72 19.01 Favored 'General case' 0 CA--C 1.487 -1.455 0 CA-C-N 112.156 -2.293 . . . . 15.0 112.333 -178.834 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 85.71 72.0 1.3 Allowed Glycine 1 C--N 1.244 -4.546 0 CA-C-N 108.492 -3.958 . . . . 15.0 112.762 -170.986 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 259' ' ' VAL . . . . . 0.567 ' O ' ' HA ' ' A' ' 253' ' ' LEU . 85.1 t -89.75 134.56 28.53 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.426 0 CA-C-O 121.519 0.676 . . . . 15.0 112.71 178.267 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 1.7 p -144.65 105.02 4.1 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 114.388 -1.278 . . . . 15.0 108.298 168.156 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 8.8 t -141.05 150.32 42.81 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 112.333 0.494 . . . . 15.0 112.333 -170.004 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 262' ' ' TRP . . . . . . . . . . . . . 6.7 m95 -68.54 -27.03 65.73 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.335 -0.848 . . . . 15.0 112.329 177.093 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 263' ' ' HIS . . . . . . . . . . . . . 10.5 p-80 -85.68 132.73 34.1 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 120.137 -0.625 . . . . 15.0 111.026 -172.711 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 264' ' ' ASP . . . . . 1.015 ' HB3' HG12 ' A' ' 267' ' ' ILE . 20.5 t0 -64.84 126.4 90.94 Favored Pre-proline 0 C--N 1.319 -0.719 0 N-CA-C 108.546 -0.909 . . . . 15.0 108.546 171.597 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 265' ' ' PRO . . . . . 0.51 ' HD3' ' CD2' ' A' ' 252' ' ' PHE . 2.6 Cg_endo -80.26 -14.79 11.76 Favored 'Trans proline' 0 N--CA 1.456 -0.692 0 C-N-CA 122.642 2.228 . . . . 15.0 113.261 -177.653 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 266' ' ' ARG . . . . . 0.605 ' HD3' ' HD3' ' A' ' 237' ' ' PRO . 11.1 tpt180 -75.69 -12.79 60.26 Favored 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 108.439 -0.949 . . . . 15.0 108.439 173.581 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 267' ' ' ILE . . . . . 1.015 HG12 ' HB3' ' A' ' 264' ' ' ASP . 20.3 pt . . . . . 0 C--O 1.248 1.017 0 CA-C-N 114.324 -1.307 . . . . 15.0 110.761 178.507 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 210' ' ' SER . . . . . . . . . . . . . 19.8 m . . . . . 0 N--CA 1.475 0.786 0 CA-C-O 121.041 0.448 . . . . 15.0 110.038 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' B' B ' 211' ' ' ASP . . . . . 0.473 ' HA ' ' HD3' ' B' ' 212' ' ' PRO . 8.2 p-10 -119.51 127.01 26.67 Favored Pre-proline 0 C--N 1.324 -0.52 0 CA-C-O 121.289 0.566 . . . . 15.0 110.9 -176.244 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 212' ' ' PRO . . . . . 0.921 ' HB3' HD11 ' A' ' 253' ' ' LEU . 4.0 Cg_endo -89.72 156.4 5.14 Favored 'Trans proline' 0 N--CA 1.455 -0.743 0 C-N-CA 123.385 2.723 . . . . 15.0 112.302 179.856 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.442 -0.961 0 C-N-CA 120.608 -0.806 . . . . 15.0 112.392 -179.177 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 236' ' ' LEU . . . . . 0.525 HD12 ' HD2' ' A' ' 265' ' ' PRO . 1.4 mm? . . . . . 0 CA--C 1.517 -0.315 0 N-CA-C 109.162 -0.681 . . . . 15.0 109.162 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 237' ' ' PRO . . . . . 0.638 ' HD3' ' HD3' ' A' ' 266' ' ' ARG . 17.5 Cg_exo -69.37 158.06 58.86 Favored 'Trans proline' 0 N--CA 1.455 -0.771 0 C-N-CA 121.688 1.592 . . . . 15.0 108.957 160.67 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 5.2 mp0 -69.54 142.39 53.65 Favored 'General case' 0 C--N 1.303 -1.425 0 CA-C-O 121.46 0.647 . . . . 15.0 111.761 -171.217 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 100.5 7.81 50.7 Favored Glycine 0 CA--C 1.523 0.547 0 CA-C-N 114.931 -1.031 . . . . 15.0 114.017 -179.774 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 240' ' ' TYR . . . . . 0.756 ' CD1' ' HB2' ' A' ' 254' ' ' HIS . 80.9 m-85 -101.74 121.25 41.7 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 118.103 0.952 . . . . 15.0 110.721 174.845 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 241' ' ' GLU . . . . . 0.663 ' HG3' ' HB3' ' A' ' 253' ' ' LEU . 7.9 pt-20 -104.67 126.59 51.9 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 109.054 -0.721 . . . . 15.0 109.054 173.296 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -89.92 108.09 19.5 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 108.991 -0.744 . . . . 15.0 108.991 179.182 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 243' ' ' ARG . . . . . 0.559 ' HB2' ' CE1' ' A' ' 251' ' ' TYR . 9.7 mtt180 -99.44 133.43 43.76 Favored 'General case' 0 CA--C 1.502 -0.877 0 CA-C-O 122.704 1.24 . . . . 15.0 111.724 178.672 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 244' ' ' THR . . . . . . . . . . . . . 23.5 m -113.32 97.11 6.27 Favored 'General case' 0 C--N 1.301 -1.542 0 CA-C-N 112.631 -2.077 . . . . 15.0 109.067 -175.909 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 245' ' ' THR . . . . . 0.427 ' OG1' ' HG2' ' A' ' 247' ' ' GLN . 9.9 t -92.36 150.3 20.91 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 115.232 -0.894 . . . . 15.0 111.201 -172.325 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 3.5 m -54.94 -15.12 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 N-CA-C 112.882 0.697 . . . . 15.0 112.882 177.993 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 247' ' ' GLN . . . . . 0.427 ' HG2' ' OG1' ' A' ' 245' ' ' THR . 6.5 mm100 -58.58 -16.83 17.51 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.145 0.498 . . . . 15.0 110.63 173.414 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 88.13 37.78 7.6 Favored Glycine 0 N--CA 1.449 -0.492 0 CA-C-N 115.594 -0.73 . . . . 15.0 111.421 177.494 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 249' ' ' GLN . . . . . 0.475 ' HB2' ' CZ3' ' A' ' 262' ' ' TRP . 9.0 pt20 -149.96 137.58 19.97 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.899 0.38 . . . . 15.0 111.674 -173.684 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 19.1 m -90.2 134.01 30.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 N-CA-C 109.249 -0.649 . . . . 15.0 109.249 172.235 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 251' ' ' TYR . . . . . 0.559 ' CE1' ' HB2' ' A' ' 243' ' ' ARG . 3.7 p90 -137.25 137.37 38.97 Favored 'General case' 0 C--N 1.317 -0.813 0 C-N-CA 120.427 -0.509 . . . . 15.0 110.535 179.753 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 252' ' ' PHE . . . . . 0.663 ' CD2' ' HA ' ' A' ' 264' ' ' ASP . 37.3 m-85 -89.88 118.25 29.32 Favored 'General case' 0 CA--C 1.509 -0.616 0 CA-C-O 121.5 0.667 . . . . 15.0 110.835 -173.647 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 253' ' ' LEU . . . . . 0.788 HD11 ' CB ' ' B' ' 212' ' ' PRO . 0.4 OUTLIER -110.56 118.04 35.16 Favored 'General case' 0 N--CA 1.441 -0.876 0 CA-C-N 114.337 -1.302 . . . . 15.0 110.895 -173.853 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 254' ' ' HIS . . . . . 0.756 ' HB2' ' CD1' ' A' ' 240' ' ' TYR . 48.5 t60 -132.57 95.48 3.62 Favored 'General case' 0 CA--C 1.495 -1.159 0 N-CA-C 108.546 -0.909 . . . . 15.0 108.546 170.441 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 3.7 t -94.65 87.91 5.23 Favored 'General case' 0 N--CA 1.429 -1.486 0 C-N-CA 116.062 -2.255 . . . . 15.0 110.268 178.196 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 25.1 tt0 -101.22 -51.87 3.4 Favored 'General case' 0 N--CA 1.442 -0.859 0 N-CA-C 105.902 -1.888 . . . . 15.0 105.902 149.177 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 257' ' ' THR . . . . . . . . . . . . . 69.4 p -99.21 -13.67 19.63 Favored 'General case' 0 CA--C 1.489 -1.395 0 CA-C-O 124.958 2.313 . . . . 15.0 111.909 179.575 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 84.84 74.88 1.24 Allowed Glycine 1 C--N 1.244 -4.569 1 CA-C-N 108.352 -4.022 . . . . 15.0 112.838 -172.146 . . . . . . . . 3 2 . 1 . 014 nuclear build core ' A' A ' 259' ' ' VAL . . . . . 0.55 ' O ' ' HA ' ' A' ' 253' ' ' LEU . 33.1 t -89.89 123.85 42.29 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 CA-C-O 121.316 0.579 . . . . 15.0 112.451 173.307 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 1.8 p -134.15 101.76 5.14 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 114.632 -1.167 . . . . 15.0 107.855 164.366 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 14.1 t -136.55 150.25 48.52 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 121.212 0.529 . . . . 15.0 112.273 -169.561 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 262' ' ' TRP . . . . . 0.475 ' CZ3' ' HB2' ' A' ' 249' ' ' GLN . 10.3 m95 -70.39 -37.12 74.46 Favored 'General case' 0 CA--C 1.518 -0.27 0 CA-C-N 114.967 -1.015 . . . . 15.0 111.948 179.069 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 263' ' ' HIS . . . . . . . . . . . . . 5.9 p80 -85.37 139.99 31.12 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.109 -0.496 . . . . 15.0 110.278 -174.704 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 264' ' ' ASP . . . . . 0.878 ' HB3' HG12 ' A' ' 267' ' ' ILE . 9.8 t70 -55.45 126.54 63.18 Favored Pre-proline 0 C--N 1.322 -0.604 0 N-CA-C 108.212 -1.033 . . . . 15.0 108.212 171.118 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 265' ' ' PRO . . . . . 0.525 ' HD2' HD12 ' A' ' 236' ' ' LEU . 6.2 Cg_exo -71.37 -14.61 31.15 Favored 'Trans proline' 0 N--CA 1.458 -0.581 0 C-N-CA 121.935 1.757 . . . . 15.0 112.882 -174.172 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 266' ' ' ARG . . . . . 0.638 ' HD3' ' HD3' ' A' ' 237' ' ' PRO . 6.1 tpt180 -77.24 -7.81 56.55 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-O 121.817 0.817 . . . . 15.0 108.927 175.163 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 267' ' ' ILE . . . . . 0.878 HG12 ' HB3' ' A' ' 264' ' ' ASP . 43.5 mm . . . . . 0 C--O 1.25 1.085 0 CA-C-N 114.009 -1.451 . . . . 15.0 109.646 176.511 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 210' ' ' SER . . . . . . . . . . . . . 3.9 p . . . . . 0 N--CA 1.475 0.789 0 N-CA-C 110.275 -0.268 . . . . 15.0 110.275 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' B' B ' 211' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -89.98 131.57 38.81 Favored Pre-proline 0 C--N 1.329 -0.313 0 N-CA-C 109.802 -0.444 . . . . 15.0 109.802 178.564 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 212' ' ' PRO . . . . . 0.788 ' CB ' HD11 ' A' ' 253' ' ' LEU . 60.7 Cg_endo -89.84 160.19 5.07 Favored 'Trans proline' 0 N--CA 1.45 -1.03 0 C-N-CA 122.685 2.257 . . . . 15.0 112.105 178.938 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.442 -0.94 0 C-N-CA 120.508 -0.853 . . . . 15.0 112.251 -178.721 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 236' ' ' LEU . . . . . 0.527 HD12 ' OD1' ' A' ' 264' ' ' ASP . 0.0 OUTLIER . . . . . 0 CA--C 1.52 -0.202 0 N-CA-C 109.375 -0.602 . . . . 15.0 109.375 . . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 237' ' ' PRO . . . . . 0.672 ' HD3' ' HD3' ' A' ' 266' ' ' ARG . 16.5 Cg_exo -69.6 158.83 55.77 Favored 'Trans proline' 0 N--CA 1.458 -0.61 0 C-N-CA 122.144 1.896 . . . . 15.0 109.855 166.294 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 238' ' ' GLU . . . . . 0.461 ' H ' ' CD ' ' A' ' 238' ' ' GLU . 1.5 pm0 -69.86 149.42 47.88 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-O 121.546 0.689 . . . . 15.0 111.462 -174.044 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 100.17 -8.99 59.35 Favored Glycine 0 N--CA 1.444 -0.803 0 CA-C-N 115.096 -0.956 . . . . 15.0 113.09 -178.936 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 240' ' ' TYR . . . . . 0.669 ' CD1' ' HB2' ' A' ' 254' ' ' HIS . 87.6 m-85 -100.32 123.81 45.01 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 117.372 0.586 . . . . 15.0 110.353 177.366 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -109.33 126.6 53.56 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 108.938 -0.764 . . . . 15.0 108.938 169.848 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -89.95 108.71 19.88 Favored 'General case' 0 C--N 1.316 -0.853 0 N-CA-C 108.363 -0.977 . . . . 15.0 108.363 177.947 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 13.2 mtp85 -90.6 139.07 31.05 Favored 'General case' 0 CA--C 1.5 -0.961 0 CA-C-O 122.16 0.981 . . . . 15.0 112.962 -172.997 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 244' ' ' THR . . . . . . . . . . . . . 28.9 p -105.5 90.9 3.55 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-N 112.919 -1.946 . . . . 15.0 109.37 178.795 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 245' ' ' THR . . . . . 1.05 HG23 ' HG2' ' A' ' 247' ' ' GLN . 9.5 t -104.01 150.7 24.01 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.661 -0.7 . . . . 15.0 110.204 -176.182 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 39.6 t -43.74 -26.81 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 N-CA-C 113.725 1.009 . . . . 15.0 113.725 -172.665 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 247' ' ' GLN . . . . . 1.05 ' HG2' HG23 ' A' ' 245' ' ' THR . 3.5 pt20 -56.06 -23.09 31.49 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-O 120.695 0.283 . . . . 15.0 111.645 177.742 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 80.52 43.05 9.57 Favored Glycine 0 C--N 1.333 0.376 0 CA-C-N 116.264 -0.425 . . . . 15.0 113.15 176.068 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 249' ' ' GLN . . . . . 0.443 ' HB2' ' OE1' ' A' ' 247' ' ' GLN . 30.6 mt-30 -141.85 148.77 39.35 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.908 0.354 . . . . 15.0 110.082 -178.803 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 17.2 m -89.95 114.16 27.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-O 121.144 0.497 . . . . 15.0 110.638 178.814 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 2.4 p90 -126.43 131.91 51.6 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.565 -0.532 . . . . 15.0 109.565 -178.841 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 252' ' ' PHE . . . . . 0.553 ' CD2' ' HA ' ' A' ' 264' ' ' ASP . 50.7 m-85 -90.04 126.07 35.63 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.137 -0.483 . . . . 15.0 111.281 -175.052 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 253' ' ' LEU . . . . . 0.657 HD11 ' HB3' ' B' ' 212' ' ' PRO . 0.8 OUTLIER -118.55 121.27 39.82 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-N 115.655 -0.702 . . . . 15.0 110.776 -177.623 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 254' ' ' HIS . . . . . 0.669 ' HB2' ' CD1' ' A' ' 240' ' ' TYR . 49.4 t60 -135.93 96.48 3.42 Favored 'General case' 0 CA--C 1.502 -0.895 0 N-CA-C 108.834 -0.802 . . . . 15.0 108.834 172.544 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 6.1 t -94.03 88.13 5.57 Favored 'General case' 0 C--N 1.311 -1.085 0 C-N-CA 116.525 -2.07 . . . . 15.0 110.797 -179.809 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 44.4 tt0 -101.23 -52.97 3.13 Favored 'General case' 0 N--CA 1.443 -0.824 0 CA-C-N 113.29 -1.777 . . . . 15.0 106.217 151.316 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 257' ' ' THR . . . . . . . . . . . . . 62.7 p -99.92 -13.45 19.14 Favored 'General case' 0 CA--C 1.488 -1.44 0 CA-C-O 124.837 2.256 . . . . 15.0 111.774 -179.279 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 87.74 72.98 1.28 Allowed Glycine 1 C--N 1.238 -4.907 1 CA-C-N 108.391 -4.004 . . . . 15.0 112.782 -169.91 . . . . . . . . 3 2 . 1 . 015 nuclear build core ' A' A ' 259' ' ' VAL . . . . . 0.492 ' O ' ' HA ' ' A' ' 253' ' ' LEU . 45.1 t -90.1 127.87 42.39 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.3 0 CA-C-O 121.151 0.5 . . . . 15.0 111.576 174.309 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 260' ' ' SER . . . . . 0.489 ' HA ' ' O ' ' A' ' 252' ' ' PHE . 2.2 p -148.13 103.25 3.45 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 114.721 -1.127 . . . . 15.0 108.195 170.109 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 13.8 t -150.02 150.43 31.77 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 116.099 -0.501 . . . . 15.0 111.358 -168.994 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 262' ' ' TRP . . . . . . . . . . . . . 92.4 m95 -69.9 -36.78 75.67 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.932 -0.576 . . . . 15.0 111.53 179.423 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 263' ' ' HIS . . . . . . . . . . . . . 8.8 p-80 -75.38 129.96 38.21 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.612 -0.435 . . . . 15.0 110.605 -174.916 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 264' ' ' ASP . . . . . 1.046 ' HB3' HG12 ' A' ' 267' ' ' ILE . 67.5 t0 -59.49 124.56 76.06 Favored Pre-proline 0 C--N 1.321 -0.649 0 N-CA-C 108.609 -0.885 . . . . 15.0 108.609 172.016 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 265' ' ' PRO . . . . . 0.528 ' HG2' ' CE1' ' A' ' 240' ' ' TYR . 13.0 Cg_exo -68.83 -14.61 39.26 Favored 'Trans proline' 0 N--CA 1.456 -0.716 0 C-N-CA 121.904 1.736 . . . . 15.0 111.889 178.074 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 266' ' ' ARG . . . . . 0.672 ' HD3' ' HD3' ' A' ' 237' ' ' PRO . 22.7 tpt180 -76.73 -10.18 59.19 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 115.252 -0.885 . . . . 15.0 109.473 173.538 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 267' ' ' ILE . . . . . 1.046 HG12 ' HB3' ' A' ' 264' ' ' ASP . 40.0 pt . . . . . 0 C--O 1.25 1.096 0 CA-C-N 114.813 -1.085 . . . . 15.0 111.297 177.389 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 210' ' ' SER . . . . . . . . . . . . . 16.5 m . . . . . 0 N--CA 1.479 0.987 0 CA-C-O 120.772 0.32 . . . . 15.0 110.963 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' B' B ' 211' ' ' ASP . . . . . 0.404 ' HA ' ' HD3' ' B' ' 212' ' ' PRO . 13.5 t70 -135.34 120.64 13.82 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.536 -0.302 . . . . 15.0 110.76 -174.922 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 212' ' ' PRO . . . . . 0.657 ' HB3' HD11 ' A' ' 253' ' ' LEU . 53.9 Cg_endo -93.34 143.77 2.07 Favored 'Trans proline' 0 N--CA 1.452 -0.927 0 C-N-CA 122.837 2.358 . . . . 15.0 112.696 176.59 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.698 0 C-N-CA 120.406 -0.902 . . . . 15.0 111.814 179.586 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 236' ' ' LEU . . . . . 0.513 HD22 ' N ' ' A' ' 236' ' ' LEU . 0.0 OUTLIER . . . . . 0 CA--C 1.517 -0.291 0 CA-C-O 121.148 0.499 . . . . 15.0 110.177 . . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 237' ' ' PRO . . . . . 0.522 ' HD3' ' HB2' ' A' ' 266' ' ' ARG . 9.0 Cg_exo -69.79 174.77 9.05 Favored 'Trans proline' 0 CA--C 1.509 -0.765 0 C-N-CA 122.845 2.363 . . . . 15.0 110.802 166.308 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -69.6 126.71 30.55 Favored 'General case' 0 C--N 1.297 -1.706 0 CA-C-N 114.132 -1.394 . . . . 15.0 111.544 -175.316 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 100.06 49.28 1.49 Allowed Glycine 0 C--N 1.333 0.37 0 CA-C-N 115.364 -0.834 . . . . 15.0 113.436 177.195 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 240' ' ' TYR . . . . . 0.646 ' CD1' ' HB2' ' A' ' 254' ' ' HIS . 74.1 m-85 -142.69 123.78 14.51 Favored 'General case' 0 CA--C 1.516 -0.345 0 CA-C-N 117.658 0.729 . . . . 15.0 111.518 176.442 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 241' ' ' GLU . . . . . 0.401 ' HB3' ' NH1' ' A' ' 243' ' ' ARG . 34.1 mm-40 -100.07 124.06 45.02 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.337 -0.847 . . . . 15.0 109.164 175.155 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 242' ' ' GLN . . . . . 0.69 ' HG3' ' CE1' ' A' ' 252' ' ' PHE . 31.7 tt0 -90.18 110.78 21.79 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.458 -0.571 . . . . 15.0 109.458 -179.82 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 243' ' ' ARG . . . . . 0.428 ' CD ' HD12 ' A' ' 253' ' ' LEU . 2.5 mpt_? -93.44 150.39 20.49 Favored 'General case' 0 CA--C 1.506 -0.739 0 CA-C-O 122.185 0.993 . . . . 15.0 113.641 -177.745 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 244' ' ' THR . . . . . . . . . . . . . 23.4 p -130.89 95.35 3.81 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 113.014 -1.903 . . . . 15.0 110.057 -176.848 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 245' ' ' THR . . . . . 0.511 ' OG1' ' HG2' ' A' ' 247' ' ' GLN . 5.5 t -93.96 150.41 20.38 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.872 -0.604 . . . . 15.0 110.044 179.672 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 3.8 p -53.37 -20.58 3.19 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 CA-C-O 121.163 0.506 . . . . 15.0 111.492 -179.244 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 247' ' ' GLN . . . . . 0.511 ' HG2' ' OG1' ' A' ' 245' ' ' THR . 31.6 mm-40 -55.12 -23.5 21.31 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.022 -0.99 . . . . 15.0 110.881 176.23 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 85.88 36.58 10.1 Favored Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 121.103 -0.57 . . . . 15.0 111.801 178.5 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 249' ' ' GLN . . . . . 0.437 ' HG2' ' HB2' ' A' ' 247' ' ' GLN . 7.3 pt20 -141.43 130.77 23.66 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.866 0.365 . . . . 15.0 110.844 -176.892 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 15.5 m -89.84 124.87 42.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 115.868 -0.605 . . . . 15.0 110.305 177.042 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 16.4 p90 -128.95 137.24 51.27 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.812 -0.631 . . . . 15.0 109.765 -177.976 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 252' ' ' PHE . . . . . 0.69 ' CE1' ' HG3' ' A' ' 242' ' ' GLN . 29.8 m-85 -89.75 120.17 30.77 Favored 'General case' 0 CA--C 1.511 -0.535 0 CA-C-O 121.239 0.542 . . . . 15.0 112.186 -169.986 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 253' ' ' LEU . . . . . 1.004 HD11 ' HB3' ' B' ' 212' ' ' PRO . 4.6 mt -104.65 110.29 22.54 Favored 'General case' 0 N--CA 1.446 -0.627 0 CA-C-N 114.683 -1.144 . . . . 15.0 111.823 -178.308 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 254' ' ' HIS . . . . . 0.646 ' HB2' ' CD1' ' A' ' 240' ' ' TYR . 32.9 t60 -117.89 95.65 5.01 Favored 'General case' 0 C--N 1.312 -1.042 0 N-CA-C 107.808 -1.182 . . . . 15.0 107.808 166.405 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 2.9 t -93.98 87.76 5.47 Favored 'General case' 0 N--CA 1.429 -1.507 0 C-N-CA 115.968 -2.293 . . . . 15.0 110.038 -179.115 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 51.1 tt0 -101.34 -54.55 2.75 Favored 'General case' 0 N--CA 1.441 -0.894 0 CA-C-N 113.087 -1.869 . . . . 15.0 106.068 151.208 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 257' ' ' THR . . . . . . . . . . . . . 67.2 p -99.51 -13.74 19.36 Favored 'General case' 0 CA--C 1.49 -1.365 0 CA-C-N 111.881 -2.418 . . . . 15.0 112.013 -177.183 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 87.83 71.57 1.28 Allowed Glycine 1 C--N 1.241 -4.7 1 CA-C-N 108.236 -4.074 . . . . 15.0 112.904 -171.513 . . . . . . . . 3 2 . 1 . 016 nuclear build core ' A' A ' 259' ' ' VAL . . . . . 0.693 ' O ' ' HA ' ' A' ' 253' ' ' LEU . 40.6 t -89.67 124.58 42.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 121.294 0.569 . . . . 15.0 112.226 176.767 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -137.15 97.04 3.4 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 114.451 -1.25 . . . . 15.0 107.816 166.174 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 14.6 t -132.23 150.35 52.17 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.943 -0.571 . . . . 15.0 111.48 -168.45 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 262' ' ' TRP . . . . . 0.426 ' CZ3' ' HB2' ' A' ' 249' ' ' GLN . 10.7 m95 -65.57 -53.75 37.6 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.476 -0.784 . . . . 15.0 111.519 178.615 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 263' ' ' HIS . . . . . . . . . . . . . 4.4 p80 -65.3 133.43 51.41 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.242 -0.435 . . . . 15.0 110.465 -175.995 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 264' ' ' ASP . . . . . 0.978 ' HB3' HG12 ' A' ' 267' ' ' ILE . 24.0 t0 -53.83 128.9 55.55 Favored Pre-proline 0 C--N 1.321 -0.631 0 N-CA-C 107.833 -1.173 . . . . 15.0 107.833 169.253 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 265' ' ' PRO . . . . . 0.625 ' HD3' ' CD2' ' A' ' 252' ' ' PHE . 13.1 Cg_exo -68.98 -14.57 38.78 Favored 'Trans proline' 0 N--CA 1.458 -0.605 0 C-N-CA 122.01 1.807 . . . . 15.0 112.582 -177.483 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 266' ' ' ARG . . . . . 0.522 ' HB2' ' HD3' ' A' ' 237' ' ' PRO . 19.9 tpt180 -72.53 -14.93 61.76 Favored 'General case' 0 N--CA 1.446 -0.667 0 N-CA-C 108.611 -0.885 . . . . 15.0 108.611 170.953 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 267' ' ' ILE . . . . . 0.978 HG12 ' HB3' ' A' ' 264' ' ' ASP . 26.9 pt . . . . . 0 C--O 1.252 1.199 0 CA-C-N 114.482 -1.236 . . . . 15.0 110.438 177.748 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 210' ' ' SER . . . . . . . . . . . . . 24.4 p . . . . . 0 N--CA 1.479 1.012 0 N-CA-C 111.595 0.22 . . . . 15.0 111.595 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' B' B ' 211' ' ' ASP . . . . . 0.477 ' HA ' ' HD3' ' B' ' 212' ' ' PRO . 23.6 t70 -93.45 120.28 66.59 Favored Pre-proline 0 C--N 1.328 -0.342 0 N-CA-C 110.323 -0.251 . . . . 15.0 110.323 -179.113 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 212' ' ' PRO . . . . . 1.004 ' HB3' HD11 ' A' ' 253' ' ' LEU . 3.6 Cg_endo -89.83 147.25 4.81 Favored 'Trans proline' 0 N--CA 1.453 -0.909 0 C-N-CA 123.078 2.519 . . . . 15.0 112.595 179.714 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.438 -1.172 0 C-N-CA 120.603 -0.808 . . . . 15.0 112.049 -179.581 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 236' ' ' LEU . . . . . 0.483 HD22 ' N ' ' A' ' 236' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.455 -0.194 0 N-CA-C 108.767 -0.827 . . . . 15.0 108.767 . . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 237' ' ' PRO . . . . . 0.829 ' HD3' ' HD3' ' A' ' 266' ' ' ARG . 16.8 Cg_exo -69.57 160.64 48.98 Favored 'Trans proline' 0 N--CA 1.459 -0.519 0 C-N-CA 122.077 1.851 . . . . 15.0 110.286 166.562 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -69.59 142.6 53.51 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-N 115.536 -0.756 . . . . 15.0 111.006 -174.353 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 100.37 8.77 49.16 Favored Glycine 0 CA--C 1.522 0.494 0 CA-C-N 115.807 -0.633 . . . . 15.0 113.815 179.677 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 240' ' ' TYR . . . . . 0.707 ' CD1' ' HB2' ' A' ' 254' ' ' HIS . 77.8 m-85 -109.97 110.43 21.36 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 117.465 0.632 . . . . 15.0 110.458 175.882 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 241' ' ' GLU . . . . . 0.655 ' HG3' ' HB3' ' A' ' 253' ' ' LEU . 8.0 pt-20 -90.13 115.92 27.75 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.697 0.76 . . . . 15.0 109.202 174.105 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 11.7 tm0? -90.0 109.72 20.74 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 108.805 -0.813 . . . . 15.0 108.805 -179.564 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 69.6 mtt-85 -99.14 150.18 22.3 Favored 'General case' 0 CA--C 1.504 -0.803 0 CA-C-O 122.283 1.039 . . . . 15.0 113.355 -170.992 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 244' ' ' THR . . . . . . . . . . . . . 3.3 p -115.67 105.4 12.71 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 112.87 -1.968 . . . . 15.0 109.725 179.184 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 245' ' ' THR . . . . . 0.94 HG23 ' HG2' ' A' ' 247' ' ' GLN . 6.1 t -116.22 150.35 37.67 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 116.036 -0.529 . . . . 15.0 110.882 -174.874 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 13.0 m -49.22 -25.22 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.313 0 N-CA-C 113.97 1.1 . . . . 15.0 113.97 -176.474 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 247' ' ' GLN . . . . . 0.94 ' HG2' HG23 ' A' ' 245' ' ' THR . 2.6 pt20 -57.75 -21.65 42.49 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-O 120.678 0.275 . . . . 15.0 111.012 178.161 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 93.62 15.41 50.06 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.925 -0.655 . . . . 15.0 113.259 174.936 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 249' ' ' GLN . . . . . 0.681 ' HB2' ' OE1' ' A' ' 247' ' ' GLN . 21.3 mp0 -123.97 147.34 47.84 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.944 0.402 . . . . 15.0 111.598 -178.689 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 31.3 m -90.13 135.71 25.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.765 -0.652 . . . . 15.0 109.89 173.235 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 28.2 p90 -141.95 135.15 29.09 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 109.587 -0.523 . . . . 15.0 109.587 -177.038 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 252' ' ' PHE . . . . . 0.694 ' CD2' ' HA ' ' A' ' 264' ' ' ASP . 29.5 m-85 -90.13 123.39 33.93 Favored 'General case' 0 CA--C 1.51 -0.565 0 CA-C-N 115.982 -0.554 . . . . 15.0 111.593 -173.248 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 253' ' ' LEU . . . . . 0.812 HD11 ' HB3' ' B' ' 212' ' ' PRO . 0.5 OUTLIER -116.69 114.26 23.79 Favored 'General case' 0 N--CA 1.445 -0.715 0 CA-C-N 115.123 -0.944 . . . . 15.0 110.964 -176.343 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 254' ' ' HIS . . . . . 0.707 ' HB2' ' CD1' ' A' ' 240' ' ' TYR . 59.0 t60 -124.29 95.09 4.41 Favored 'General case' 0 CA--C 1.5 -0.972 0 N-CA-C 108.48 -0.933 . . . . 15.0 108.48 169.747 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 3.0 t -94.54 88.18 5.37 Favored 'General case' 0 N--CA 1.433 -1.304 0 C-N-CA 116.33 -2.148 . . . . 15.0 110.754 179.287 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 40.6 tt0 -101.29 -52.94 3.13 Favored 'General case' 0 N--CA 1.441 -0.906 0 N-CA-C 106.026 -1.842 . . . . 15.0 106.026 149.861 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 257' ' ' THR . . . . . . . . . . . . . 72.7 p -97.79 -13.7 21.21 Favored 'General case' 0 CA--C 1.488 -1.406 0 CA-C-O 124.634 2.159 . . . . 15.0 111.923 -179.501 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 88.7 71.04 1.27 Allowed Glycine 1 C--N 1.243 -4.598 0 CA-C-N 108.404 -3.998 . . . . 15.0 113.167 -172.933 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 259' ' ' VAL . . . . . 0.622 ' O ' ' HA ' ' A' ' 253' ' ' LEU . 57.8 t -89.83 126.06 42.74 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.289 0 CA-C-O 121.428 0.632 . . . . 15.0 112.387 175.757 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 260' ' ' SER . . . . . 0.412 ' HA ' ' O ' ' A' ' 252' ' ' PHE . 1.4 p -141.66 100.24 3.72 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 114.444 -1.253 . . . . 15.0 107.685 165.934 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 13.4 t -136.39 150.32 48.74 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.853 -0.612 . . . . 15.0 111.788 -167.376 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 262' ' ' TRP . . . . . 0.443 ' HA ' ' CE3' ' A' ' 262' ' ' TRP . 8.9 m95 -70.7 -32.38 69.58 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.349 -0.841 . . . . 15.0 112.374 179.449 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 263' ' ' HIS . . . . . . . . . . . . . 5.0 p80 -84.63 134.67 34.37 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 120.385 -0.526 . . . . 15.0 110.388 -176.289 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 264' ' ' ASP . . . . . 1.022 ' HB3' HG12 ' A' ' 267' ' ' ILE . 43.5 t0 -56.62 124.06 60.72 Favored Pre-proline 0 C--O 1.218 -0.603 0 N-CA-C 108.56 -0.904 . . . . 15.0 108.56 169.843 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 265' ' ' PRO . . . . . 0.53 ' HD3' ' CD2' ' A' ' 252' ' ' PHE . 10.6 Cg_exo -68.93 -14.83 39.44 Favored 'Trans proline' 0 N--CA 1.46 -0.494 0 C-N-CA 122.367 2.045 . . . . 15.0 112.629 -177.55 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 266' ' ' ARG . . . . . 0.829 ' HD3' ' HD3' ' A' ' 237' ' ' PRO . 20.2 tpt180 -75.89 -11.58 60.0 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 115.483 -0.78 . . . . 15.0 109.047 173.623 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 267' ' ' ILE . . . . . 1.022 HG12 ' HB3' ' A' ' 264' ' ' ASP . 36.9 pt . . . . . 0 C--O 1.247 0.945 0 CA-C-N 114.641 -1.163 . . . . 15.0 111.253 178.899 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 210' ' ' SER . . . . . . . . . . . . . 20.4 m . . . . . 0 N--CA 1.481 1.077 0 CA-C-O 120.638 0.256 . . . . 15.0 111.229 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' B' B ' 211' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -116.95 144.32 33.27 Favored Pre-proline 0 C--O 1.235 0.319 0 N-CA-C 109.37 -0.604 . . . . 15.0 109.37 176.053 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 212' ' ' PRO . . . . . 0.812 ' HB3' HD11 ' A' ' 253' ' ' LEU . 8.4 Cg_endo -89.87 143.33 4.16 Favored 'Trans proline' 0 N--CA 1.454 -0.823 0 C-N-CA 122.819 2.346 . . . . 15.0 112.888 -176.715 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.441 -0.976 0 CA-C-N 115.538 -0.755 . . . . 15.0 111.622 176.998 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 236' ' ' LEU . . . . . 0.427 HD11 ' OD1' ' A' ' 264' ' ' ASP . 2.1 mm? . . . . . 0 CA--C 1.517 -0.319 0 CA-C-O 120.85 0.357 . . . . 15.0 110.727 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 237' ' ' PRO . . . . . 0.563 ' HD3' ' HD3' ' A' ' 266' ' ' ARG . 15.0 Cg_exo -69.53 164.28 34.9 Favored 'Trans proline' 0 N--CA 1.456 -0.699 0 C-N-CA 121.92 1.747 . . . . 15.0 109.314 160.835 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 12.2 mm-40 -69.6 142.69 53.47 Favored 'General case' 0 C--N 1.301 -1.522 0 CA-C-N 115.166 -0.925 . . . . 15.0 113.333 -170.098 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 100.11 -1.62 56.37 Favored Glycine 0 CA--C 1.526 0.755 0 CA-C-N 114.124 -1.398 . . . . 15.0 115.166 174.103 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 240' ' ' TYR . . . . . 0.7 ' CD1' ' HB2' ' A' ' 254' ' ' HIS . 78.1 m-85 -87.9 123.46 32.67 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 118.574 1.187 . . . . 15.0 111.486 -179.449 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -96.08 114.81 26.55 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.397 -0.819 . . . . 15.0 109.214 173.332 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -90.13 99.68 12.65 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 108.823 -0.806 . . . . 15.0 108.823 176.233 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 243' ' ' ARG . . . . . 0.701 ' CZ ' ' HD2' ' B' ' 212' ' ' PRO . 34.7 mtt180 -91.28 149.86 21.57 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.531 -0.758 . . . . 15.0 111.823 179.404 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 244' ' ' THR . . . . . . . . . . . . . 6.1 m -127.2 92.05 3.44 Favored 'General case' 0 C--N 1.307 -1.267 0 CA-C-N 113.682 -1.599 . . . . 15.0 109.219 -179.407 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 245' ' ' THR . . . . . 0.438 ' OG1' ' HG2' ' A' ' 247' ' ' GLN . 5.0 t -90.0 150.59 22.05 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.204 -0.907 . . . . 15.0 110.926 -174.666 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 11.6 m -49.0 -20.23 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 CA-C-N 115.429 -0.805 . . . . 15.0 112.617 177.053 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 247' ' ' GLN . . . . . 0.565 ' HB2' ' HG3' ' A' ' 249' ' ' GLN . 6.6 mm100 -58.77 -19.51 41.4 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 116.055 -0.521 . . . . 15.0 111.128 175.307 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 85.98 26.01 35.84 Favored Glycine 0 C--N 1.332 0.357 0 C-N-CA 121.305 -0.474 . . . . 15.0 112.632 177.454 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 249' ' ' GLN . . . . . 0.565 ' HG3' ' HB2' ' A' ' 247' ' ' GLN . 0.3 OUTLIER -126.43 133.96 51.11 Favored 'General case' 0 C--N 1.326 -0.415 0 O-C-N 122.624 -0.339 . . . . 15.0 110.967 -174.493 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 3.6 m -90.01 107.23 18.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 115.768 -0.651 . . . . 15.0 109.537 173.056 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 6.4 p90 -119.48 130.65 55.33 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.922 -0.581 . . . . 15.0 109.981 -173.399 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 252' ' ' PHE . . . . . 0.738 ' CD2' ' HA ' ' A' ' 264' ' ' ASP . 32.2 m-85 -90.03 123.09 33.62 Favored 'General case' 0 CA--C 1.506 -0.75 0 CA-C-N 116.21 -0.45 . . . . 15.0 110.832 -175.365 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 253' ' ' LEU . . . . . 0.838 HD13 ' HB2' ' B' ' 212' ' ' PRO . 1.6 tt -128.82 115.79 18.46 Favored 'General case' 0 N--CA 1.438 -1.048 0 CA-C-N 115.631 -0.713 . . . . 15.0 111.541 -175.554 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 254' ' ' HIS . . . . . 0.7 ' HB2' ' CD1' ' A' ' 240' ' ' TYR . 72.4 t60 -124.18 92.57 3.69 Favored 'General case' 0 CA--C 1.505 -0.758 0 N-CA-C 108.723 -0.843 . . . . 15.0 108.723 174.861 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 255' ' ' THR . . . . . 0.405 ' HA ' ' HA2' ' A' ' 258' ' ' GLY . 53.0 m -94.7 88.18 5.3 Favored 'General case' 0 N--CA 1.436 -1.159 0 C-N-CA 116.66 -2.016 . . . . 15.0 110.429 179.782 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 45.2 tt0 -100.83 -50.47 3.83 Favored 'General case' 0 N--CA 1.441 -0.917 0 N-CA-C 105.848 -1.908 . . . . 15.0 105.848 151.236 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 257' ' ' THR . . . . . . . . . . . . . 60.3 p -98.46 -13.44 20.54 Favored 'General case' 0 CA--C 1.49 -1.349 0 CA-C-O 124.963 2.316 . . . . 15.0 111.795 177.598 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 258' ' ' GLY . . . . . 0.405 ' HA2' ' HA ' ' A' ' 255' ' ' THR . . . 88.52 70.8 1.27 Allowed Glycine 1 C--N 1.242 -4.665 1 CA-C-N 108.214 -4.085 . . . . 15.0 113.471 -173.405 . . . . . . . . 4 3 . 1 . 018 nuclear build core ' A' A ' 259' ' ' VAL . . . . . 0.527 ' O ' ' HA ' ' A' ' 253' ' ' LEU . 76.5 t -89.8 130.42 39.13 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.58 0 CA-C-O 121.271 0.558 . . . . 15.0 111.207 173.711 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 10.1 p -150.09 96.97 2.51 Favored 'General case' 0 C--N 1.307 -1.247 0 CA-C-N 114.598 -1.183 . . . . 15.0 108.817 170.755 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 12.4 t -143.87 150.32 38.27 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.877 -0.601 . . . . 15.0 111.299 -168.377 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 262' ' ' TRP . . . . . . . . . . . . . 92.9 m95 -69.07 -42.15 76.62 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.849 -0.614 . . . . 15.0 111.729 179.845 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 263' ' ' HIS . . . . . . . . . . . . . 2.6 p80 -65.22 132.32 48.8 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-O 120.896 0.379 . . . . 15.0 110.213 -176.345 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 264' ' ' ASP . . . . . 0.899 ' HB3' HG12 ' A' ' 267' ' ' ILE . 28.4 t70 -56.11 124.94 62.26 Favored Pre-proline 0 C--N 1.321 -0.665 0 N-CA-C 108.847 -0.797 . . . . 15.0 108.847 172.428 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 265' ' ' PRO . . . . . 0.672 ' HD3' ' CD2' ' A' ' 252' ' ' PHE . 4.3 Cg_exo -73.44 -14.64 25.12 Favored 'Trans proline' 0 CA--C 1.51 -0.701 0 C-N-CA 122.08 1.853 . . . . 15.0 112.224 -175.978 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 266' ' ' ARG . . . . . 0.568 ' HB3' ' OD2' ' A' ' 264' ' ' ASP . 28.1 tpt180 -72.63 -13.46 61.38 Favored 'General case' 0 C--N 1.316 -0.861 0 N-CA-C 108.542 -0.91 . . . . 15.0 108.542 171.244 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 267' ' ' ILE . . . . . 0.899 HG12 ' HB3' ' A' ' 264' ' ' ASP . 22.5 pt . . . . . 0 C--O 1.251 1.169 0 CA-C-N 114.618 -1.174 . . . . 15.0 110.645 174.667 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 210' ' ' SER . . . . . . . . . . . . . 9.6 p . . . . . 0 N--CA 1.478 0.955 0 N-CA-C 110.366 -0.235 . . . . 15.0 110.366 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' B' B ' 211' ' ' ASP . . . . . 0.485 ' HA ' ' HD3' ' B' ' 212' ' ' PRO . 20.5 t70 -150.04 128.64 6.04 Favored Pre-proline 0 C--N 1.324 -0.52 0 N-CA-C 109.673 -0.492 . . . . 15.0 109.673 177.173 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 212' ' ' PRO . . . . . 0.838 ' HB2' HD13 ' A' ' 253' ' ' LEU . 2.0 Cg_endo -89.33 141.67 4.14 Favored 'Trans proline' 0 N--CA 1.457 -0.623 0 C-N-CA 123.281 2.654 . . . . 15.0 113.734 -177.814 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.449 0 CA-C-N 114.796 -1.093 . . . . 15.0 113.278 -176.466 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 236' ' ' LEU . . . . . 0.418 HD11 ' CE1' ' A' ' 252' ' ' PHE . 19.7 mt . . . . . 0 N--CA 1.452 -0.347 0 N-CA-C 108.97 -0.752 . . . . 15.0 108.97 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 237' ' ' PRO . . . . . 0.855 ' HD3' ' HD3' ' A' ' 266' ' ' ARG . 13.1 Cg_exo -69.7 163.11 39.47 Favored 'Trans proline' 0 N--CA 1.459 -0.536 0 C-N-CA 121.47 1.446 . . . . 15.0 110.247 167.289 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -69.77 140.16 53.36 Favored 'General case' 0 C--N 1.307 -1.248 0 CA-C-N 115.321 -0.854 . . . . 15.0 111.104 -174.125 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 100.29 9.34 48.02 Favored Glycine 0 N--CA 1.451 -0.36 0 CA-C-N 115.642 -0.708 . . . . 15.0 114.211 178.241 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 240' ' ' TYR . . . . . 0.769 ' CD1' ' HB2' ' A' ' 254' ' ' HIS . 85.1 m-85 -104.08 123.43 47.23 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 117.897 0.848 . . . . 15.0 110.637 174.929 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 241' ' ' GLU . . . . . 0.689 ' HG3' ' HB3' ' A' ' 253' ' ' LEU . 7.7 pt-20 -109.41 123.78 49.91 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.682 -0.69 . . . . 15.0 109.627 174.408 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 21.5 tm0? -90.01 116.07 27.77 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 108.684 -0.858 . . . . 15.0 108.684 179.021 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 63.6 mtt-85 -107.3 149.27 27.99 Favored 'General case' 0 CA--C 1.501 -0.932 0 CA-C-O 122.157 0.979 . . . . 15.0 112.579 -177.563 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 244' ' ' THR . . . . . . . . . . . . . 7.5 m -124.18 91.72 3.52 Favored 'General case' 0 C--N 1.307 -1.257 0 CA-C-N 113.288 -1.778 . . . . 15.0 110.029 179.166 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 245' ' ' THR . . . . . 1.083 HG23 ' HG2' ' A' ' 247' ' ' GLN . 8.5 t -91.28 150.67 21.22 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.572 -0.74 . . . . 15.0 109.849 177.516 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 14.9 m -41.03 -24.32 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 N-CA-C 114.968 1.47 . . . . 15.0 114.968 -175.354 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 247' ' ' GLN . . . . . 1.083 ' HG2' HG23 ' A' ' 245' ' ' THR . 3.6 pt20 -55.79 -22.48 24.64 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-O 120.752 0.31 . . . . 15.0 111.013 176.564 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 81.03 34.73 26.12 Favored Glycine 0 C--N 1.333 0.399 0 C-N-CA 121.48 -0.391 . . . . 15.0 113.182 174.196 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 249' ' ' GLN . . . . . 0.425 ' HB3' ' CZ3' ' A' ' 262' ' ' TRP . 30.8 mt-30 -136.37 146.93 47.05 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.759 -0.46 . . . . 15.0 109.759 -178.627 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 23.7 m -89.76 125.47 42.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-O 120.792 0.329 . . . . 15.0 110.989 -178.186 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 12.8 p90 -131.79 133.16 44.43 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 109.622 -0.511 . . . . 15.0 109.622 179.679 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 252' ' ' PHE . . . . . 0.683 ' CD2' ' HA ' ' A' ' 264' ' ' ASP . 36.3 m-85 -90.05 118.68 29.78 Favored 'General case' 0 CA--C 1.512 -0.508 0 CA-C-O 121.206 0.526 . . . . 15.0 110.994 -176.786 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 253' ' ' LEU . . . . . 0.689 ' HB3' ' HG3' ' A' ' 241' ' ' GLU . 0.6 OUTLIER -106.79 122.87 47.24 Favored 'General case' 0 N--CA 1.444 -0.737 0 CA-C-N 115.082 -0.963 . . . . 15.0 110.461 -178.05 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 254' ' ' HIS . . . . . 0.769 ' HB2' ' CD1' ' A' ' 240' ' ' TYR . 73.7 t60 -135.0 90.27 2.62 Favored 'General case' 0 C--N 1.313 -1.018 0 N-CA-C 108.081 -1.081 . . . . 15.0 108.081 172.024 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 255' ' ' THR . . . . . 0.419 ' HA ' ' HA2' ' A' ' 258' ' ' GLY . 2.8 t -91.41 87.82 6.58 Favored 'General case' 0 N--CA 1.433 -1.277 0 C-N-CA 116.411 -2.116 . . . . 15.0 110.185 -179.215 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 52.0 tt0 -101.53 -54.97 2.63 Favored 'General case' 0 N--CA 1.436 -1.135 0 CA-C-N 112.818 -1.992 . . . . 15.0 105.842 151.254 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 257' ' ' THR . . . . . . . . . . . . . 63.4 p -95.89 -13.53 23.87 Favored 'General case' 0 CA--C 1.486 -1.499 0 CA-C-N 112.214 -2.266 . . . . 15.0 111.449 179.015 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 258' ' ' GLY . . . . . 0.419 ' HA2' ' HA ' ' A' ' 255' ' ' THR . . . 86.66 70.52 1.31 Allowed Glycine 1 C--N 1.246 -4.453 1 CA-C-N 108.187 -4.097 . . . . 15.0 113.093 -172.629 . . . . . . . . 4 3 . 1 . 019 nuclear build core ' A' A ' 259' ' ' VAL . . . . . 0.571 ' O ' ' HA ' ' A' ' 253' ' ' LEU . 60.6 t -89.88 129.17 41.23 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.243 0 CA-C-O 121.203 0.525 . . . . 15.0 112.227 176.674 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 1.1 p -143.49 98.83 3.32 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 114.783 -1.098 . . . . 15.0 108.228 169.475 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 9.0 t -139.52 150.31 44.95 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 116.159 -0.473 . . . . 15.0 111.819 -170.305 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 262' ' ' TRP . . . . . 0.425 ' CZ3' ' HB3' ' A' ' 249' ' ' GLN . 91.6 m95 -68.3 -30.64 69.68 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.38 -0.827 . . . . 15.0 111.707 178.587 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 263' ' ' HIS . . . . . . . . . . . . . 4.2 p80 -83.5 136.72 34.17 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 120.725 -0.39 . . . . 15.0 110.757 -172.336 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 264' ' ' ASP . . . . . 0.776 ' HB3' HG12 ' A' ' 267' ' ' ILE . 10.0 t70 -56.32 134.23 75.95 Favored Pre-proline 0 C--N 1.325 -0.469 0 CA-C-N 115.652 -0.704 . . . . 15.0 109.268 174.754 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 265' ' ' PRO . . . . . 0.603 ' HD3' ' CD2' ' A' ' 252' ' ' PHE . 88.8 Cg_endo -84.28 -14.5 6.98 Favored 'Trans proline' 0 N--CA 1.458 -0.617 0 C-N-CA 122.568 2.179 . . . . 15.0 113.995 -174.486 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 266' ' ' ARG . . . . . 0.855 ' HD3' ' HD3' ' A' ' 237' ' ' PRO . 21.8 tpt180 -80.98 -5.21 57.26 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-O 122.418 1.104 . . . . 15.0 108.505 176.265 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 267' ' ' ILE . . . . . 0.776 HG12 ' HB3' ' A' ' 264' ' ' ASP . 48.3 mm . . . . . 0 C--O 1.251 1.174 0 CA-C-N 113.153 -1.84 . . . . 15.0 109.824 176.684 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 210' ' ' SER . . . . . . . . . . . . . 5.4 p . . . . . 0 N--CA 1.474 0.765 0 CA-C-O 121.042 0.448 . . . . 15.0 110.741 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' B' B ' 211' ' ' ASP . . . . . 0.465 ' HA ' ' HD3' ' B' ' 212' ' ' PRO . 2.0 p30 -144.62 118.94 5.77 Favored Pre-proline 0 C--N 1.325 -0.496 0 CA-C-N 115.83 -0.623 . . . . 15.0 110.319 178.766 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 212' ' ' PRO . . . . . 0.689 ' HB3' HD11 ' A' ' 253' ' ' LEU . 12.6 Cg_endo -92.22 151.09 3.11 Favored 'Trans proline' 0 N--CA 1.452 -0.942 0 C-N-CA 123.587 2.858 . . . . 15.0 112.722 -179.927 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.444 -0.771 0 C-N-CA 120.725 -0.75 . . . . 15.0 112.466 179.457 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 2.4 mt . . . . . 0 C--O 1.233 0.187 0 N-CA-C 108.918 -0.771 . . . . 15.0 108.918 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 237' ' ' PRO . . . . . 0.465 ' O ' ' HD2' ' A' ' 240' ' ' TYR . 14.8 Cg_exo -69.81 162.69 41.11 Favored 'Trans proline' 0 N--CA 1.46 -0.46 0 C-N-CA 121.657 1.571 . . . . 15.0 110.093 164.626 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 238' ' ' GLU . . . . . 0.483 ' CD ' ' H ' ' A' ' 238' ' ' GLU . 0.9 OUTLIER -69.71 148.41 49.28 Favored 'General case' 0 C--N 1.306 -1.29 0 CA-C-N 115.432 -0.804 . . . . 15.0 111.243 -175.266 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 100.28 -7.38 58.35 Favored Glycine 0 N--CA 1.45 -0.411 0 CA-C-N 115.418 -0.81 . . . . 15.0 113.275 -179.521 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 240' ' ' TYR . . . . . 0.685 ' CD1' ' HB2' ' A' ' 254' ' ' HIS . 87.8 m-85 -99.46 113.25 25.5 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 117.461 0.631 . . . . 15.0 110.47 177.351 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 241' ' ' GLU . . . . . 0.465 ' HG3' ' HB3' ' A' ' 253' ' ' LEU . 9.5 pt-20 -90.26 120.29 31.29 Favored 'General case' 0 N--CA 1.439 -0.975 0 N-CA-C 108.725 -0.843 . . . . 15.0 108.725 174.518 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -89.86 99.1 12.18 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 108.123 -1.066 . . . . 15.0 108.123 -179.862 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 9.4 mtp180 -92.48 150.14 20.96 Favored 'General case' 0 N--CA 1.444 -0.738 0 CA-C-N 115.029 -0.987 . . . . 15.0 111.81 -175.152 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 244' ' ' THR . . . . . . . . . . . . . 4.4 p -117.54 149.92 39.82 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-N 113.733 -1.576 . . . . 15.0 110.077 -176.5 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 245' ' ' THR . . . . . 0.436 ' OG1' ' HG2' ' A' ' 247' ' ' GLN . 5.3 t -150.12 150.23 31.38 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 116.106 -0.497 . . . . 15.0 110.434 -176.003 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 19.8 t -54.82 -17.24 2.1 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 O-C-N 123.669 0.605 . . . . 15.0 111.354 179.078 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 247' ' ' GLN . . . . . 0.555 ' HB2' ' HG2' ' A' ' 249' ' ' GLN . 5.1 mm-40 -63.4 -19.25 64.52 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-O 121.006 0.431 . . . . 15.0 110.498 176.808 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 86.31 13.69 67.8 Favored Glycine 0 N--CA 1.452 -0.244 0 CA-C-N 116.013 -0.539 . . . . 15.0 112.289 176.709 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 249' ' ' GLN . . . . . 0.555 ' HG2' ' HB2' ' A' ' 247' ' ' GLN . 10.4 pt20 -114.02 135.12 54.35 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 120.927 0.394 . . . . 15.0 111.502 -174.701 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 6.0 m -90.0 120.26 38.5 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 N-CA-C 108.783 -0.821 . . . . 15.0 108.783 171.469 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 4.3 p90 -125.75 133.04 52.2 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.863 -0.608 . . . . 15.0 109.855 -174.915 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 252' ' ' PHE . . . . . 0.613 ' CD2' ' HA ' ' A' ' 264' ' ' ASP . 24.5 m-85 -89.76 121.33 31.81 Favored 'General case' 0 CA--C 1.506 -0.728 0 CA-C-O 121.293 0.568 . . . . 15.0 111.619 -170.727 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 253' ' ' LEU . . . . . 0.57 HD11 ' CB ' ' B' ' 212' ' ' PRO . 0.6 OUTLIER -119.67 121.12 38.53 Favored 'General case' 0 N--CA 1.44 -0.944 0 CA-C-N 114.837 -1.074 . . . . 15.0 110.617 -176.017 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 254' ' ' HIS . . . . . 0.685 ' HB2' ' CD1' ' A' ' 240' ' ' TYR . 18.4 t60 -132.33 96.59 3.9 Favored 'General case' 0 C--N 1.312 -1.065 0 N-CA-C 108.447 -0.945 . . . . 15.0 108.447 170.57 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 5.0 t -92.72 87.92 6.06 Favored 'General case' 0 N--CA 1.432 -1.369 0 C-N-CA 116.554 -2.058 . . . . 15.0 110.183 -179.509 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 24.9 tt0 -101.36 -57.23 2.12 Favored 'General case' 0 N--CA 1.439 -0.98 0 CA-C-N 112.606 -2.088 . . . . 15.0 106.274 152.875 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 257' ' ' THR . . . . . . . . . . . . . 4.2 t -100.2 -13.56 18.86 Favored 'General case' 0 CA--C 1.488 -1.433 0 CA-C-N 111.326 -2.67 . . . . 15.0 112.085 -177.972 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 87.35 71.69 1.29 Allowed Glycine 1 C--N 1.238 -4.882 1 CA-C-N 108.136 -4.12 . . . . 15.0 112.635 -169.123 . . . . . . . . 3 2 . 1 . 020 nuclear build core ' A' A ' 259' ' ' VAL . . . . . 0.567 ' O ' ' HA ' ' A' ' 253' ' ' LEU . 65.7 t -89.37 123.72 41.73 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 CA-C-O 121.667 0.746 . . . . 15.0 112.163 170.607 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 260' ' ' SER . . . . . 0.479 ' HA ' ' O ' ' A' ' 252' ' ' PHE . 2.4 p -140.85 100.57 3.87 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 113.876 -1.511 . . . . 15.0 108.442 170.706 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 8.7 t -141.75 150.51 41.86 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.18 0.514 . . . . 15.0 112.374 -168.35 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 262' ' ' TRP . . . . . 0.433 ' HH2' ' CD ' ' A' ' 249' ' ' GLN . 29.5 m95 -71.06 -31.62 68.09 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.361 -0.836 . . . . 15.0 111.535 176.761 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 263' ' ' HIS . . . . . 0.503 ' HD2' ' OXT' ' A' ' 267' ' ' ILE . 10.2 p-80 -84.06 130.83 34.85 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 120.29 -0.564 . . . . 15.0 110.154 -175.737 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 264' ' ' ASP . . . . . 0.917 ' HB3' HG12 ' A' ' 267' ' ' ILE . 20.7 t0 -53.95 126.92 52.56 Favored Pre-proline 0 C--N 1.324 -0.511 0 CA-C-N 115.619 -0.719 . . . . 15.0 109.285 173.131 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 265' ' ' PRO . . . . . 0.548 ' HG2' ' CD1' ' A' ' 240' ' ' TYR . 10.9 Cg_exo -70.5 -14.96 34.24 Favored 'Trans proline' 0 N--CA 1.456 -0.709 0 C-N-CA 122.231 1.954 . . . . 15.0 112.496 -179.361 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 266' ' ' ARG . . . . . 0.462 ' HB3' ' OD2' ' A' ' 264' ' ' ASP . 26.6 tpt180 -72.38 -15.15 61.85 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-O 122.07 0.938 . . . . 15.0 108.788 171.171 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 267' ' ' ILE . . . . . 0.917 HG12 ' HB3' ' A' ' 264' ' ' ASP . 32.8 pt . . . . . 0 C--O 1.25 1.09 0 CA-C-N 114.275 -1.329 . . . . 15.0 110.936 177.117 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 210' ' ' SER . . . . . . . . . . . . . 21.0 m . . . . . 0 N--CA 1.473 0.7 0 N-CA-C 109.962 -0.384 . . . . 15.0 109.962 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' B' B ' 211' ' ' ASP . . . . . 0.431 ' HA ' ' HD3' ' B' ' 212' ' ' PRO . 6.0 p-10 -138.63 134.69 17.42 Favored Pre-proline 0 C--N 1.32 -0.694 0 CA-C-N 115.925 -0.579 . . . . 15.0 109.795 -177.684 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 212' ' ' PRO . . . . . 0.57 ' CB ' HD11 ' A' ' 253' ' ' LEU . 4.6 Cg_endo -89.7 154.78 5.15 Favored 'Trans proline' 0 N--CA 1.456 -0.711 0 C-N-CA 123.393 2.729 . . . . 15.0 112.225 -177.0 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.442 -0.965 0 CA-C-N 115.625 -0.716 . . . . 15.0 112.587 -177.435 . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 236' ' ' LEU . . . . . 0.443 HD11 ' OD2' ' A' ' 264' ' ' ASP . 0.9 OUTLIER . . . . . 0 CA--C 1.521 -0.161 0 N-CA-C 110.376 -0.231 . . . . 15.0 110.376 . . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 237' ' ' PRO . . . . . 0.67 ' HD3' ' HD3' ' A' ' 266' ' ' ARG . 19.5 Cg_exo -69.44 170.1 16.99 Favored 'Trans proline' 0 CA--C 1.516 -0.422 0 C-N-CA 122.335 2.023 . . . . 15.0 110.838 165.577 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -69.78 140.26 53.35 Favored 'General case' 0 C--N 1.303 -1.422 0 CA-C-N 114.691 -1.14 . . . . 15.0 110.865 -176.207 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 239' ' ' GLY . . . . . 0.458 ' O ' ' HA ' ' A' ' 254' ' ' HIS . . . 100.04 11.99 41.15 Favored Glycine 0 N--CA 1.448 -0.516 0 CA-C-N 115.632 -0.713 . . . . 15.0 113.867 179.07 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 240' ' ' TYR . . . . . 0.669 ' CD1' ' HB2' ' A' ' 254' ' ' HIS . 64.2 m-85 -111.99 107.9 17.04 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 117.918 0.859 . . . . 15.0 111.579 178.13 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 13.8 mm-40 -90.15 120.81 31.64 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.021 -0.99 . . . . 15.0 109.841 176.155 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 23.4 tm0? -89.97 109.87 20.88 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 109.103 -0.703 . . . . 15.0 109.103 177.378 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 4.5 mtp180 -112.23 150.23 31.19 Favored 'General case' 0 CA--C 1.508 -0.666 0 CA-C-O 122.564 1.173 . . . . 15.0 113.494 -179.86 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 244' ' ' THR . . . . . . . . . . . . . 21.8 p -116.15 150.1 37.98 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-N 112.555 -2.111 . . . . 15.0 108.67 177.7 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 245' ' ' THR . . . . . 0.472 ' OG1' ' HG2' ' A' ' 247' ' ' GLN . 5.9 t -144.32 150.52 37.95 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 116.82 -0.173 . . . . 15.0 110.697 -175.201 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 21.6 t -52.5 -18.49 1.23 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 O-C-N 123.749 0.656 . . . . 15.0 111.589 178.261 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 247' ' ' GLN . . . . . 0.472 ' HG2' ' OG1' ' A' ' 245' ' ' THR . 4.7 mm100 -63.89 -17.15 62.91 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-O 120.893 0.378 . . . . 15.0 110.555 177.426 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 83.91 38.5 10.3 Favored Glycine 0 C--N 1.334 0.459 0 CA-C-N 116.088 -0.505 . . . . 15.0 112.571 177.275 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 249' ' ' GLN . . . . . 0.5 ' CD ' ' HH2' ' A' ' 262' ' ' TRP . 0.0 OUTLIER -146.72 147.5 31.03 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.044 0.449 . . . . 15.0 111.355 -175.194 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 13.7 m -93.92 138.45 20.44 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-N 115.1 -0.955 . . . . 15.0 109.345 173.737 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 4.9 p90 -145.78 136.62 24.45 Favored 'General case' 0 C--N 1.32 -0.717 0 C-N-CA 120.605 -0.438 . . . . 15.0 110.419 -179.891 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 252' ' ' PHE . . . . . 0.607 ' CE2' ' HA ' ' A' ' 264' ' ' ASP . 43.9 m-85 -91.16 121.54 33.03 Favored 'General case' 0 CA--C 1.515 -0.377 0 CA-C-N 116.059 -0.519 . . . . 15.0 111.839 -174.629 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 253' ' ' LEU . . . . . 0.643 ' HA ' ' O ' ' A' ' 259' ' ' VAL . 13.7 mt -104.26 110.33 22.5 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-N 115.243 -0.89 . . . . 15.0 112.169 179.196 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 254' ' ' HIS . . . . . 0.669 ' HB2' ' CD1' ' A' ' 240' ' ' TYR . 22.7 t-80 -116.17 89.93 3.22 Favored 'General case' 0 C--N 1.311 -1.08 0 N-CA-C 107.696 -1.224 . . . . 15.0 107.696 166.099 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 37.1 m -90.86 88.03 6.89 Favored 'General case' 0 N--CA 1.43 -1.442 0 C-N-CA 116.894 -1.922 . . . . 15.0 110.097 -179.272 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 53.5 tt0 -101.04 -51.76 3.45 Favored 'General case' 0 N--CA 1.441 -0.891 0 N-CA-C 105.721 -1.955 . . . . 15.0 105.721 149.677 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 257' ' ' THR . . . . . . . . . . . . . 58.6 p -99.78 -13.69 19.15 Favored 'General case' 0 CA--C 1.485 -1.533 0 CA-C-O 124.768 2.223 . . . . 15.0 112.047 -179.435 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 85.9 75.51 1.24 Allowed Glycine 1 C--N 1.237 -4.937 0 CA-C-N 108.439 -3.982 . . . . 15.0 112.2 -169.55 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 259' ' ' VAL . . . . . 0.643 ' O ' ' HA ' ' A' ' 253' ' ' LEU . 42.9 t -89.88 123.46 42.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-O 121.395 0.617 . . . . 15.0 111.845 175.578 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 4.6 p -134.65 99.63 4.39 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 114.174 -1.376 . . . . 15.0 108.234 170.117 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 8.9 t -135.8 150.48 49.46 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 121.097 0.475 . . . . 15.0 111.841 -171.256 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 262' ' ' TRP . . . . . 0.5 ' HH2' ' CD ' ' A' ' 249' ' ' GLN . 67.6 m95 -68.31 -33.45 74.33 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.141 -0.936 . . . . 15.0 111.345 176.595 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 263' ' ' HIS . . . . . . . . . . . . . 4.7 p80 -82.12 131.36 35.24 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 120.44 -0.504 . . . . 15.0 110.128 -172.783 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 264' ' ' ASP . . . . . 0.928 ' HB3' HG12 ' A' ' 267' ' ' ILE . 9.4 t70 -51.75 133.21 37.24 Favored Pre-proline 0 C--N 1.321 -0.635 0 N-CA-C 108.946 -0.761 . . . . 15.0 108.946 171.578 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 265' ' ' PRO . . . . . 0.457 ' HD3' ' CD2' ' A' ' 252' ' ' PHE . 36.5 Cg_endo -72.7 -14.76 27.18 Favored 'Trans proline' 0 N--CA 1.454 -0.797 0 C-N-CA 121.725 1.617 . . . . 15.0 114.294 -173.969 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 266' ' ' ARG . . . . . 0.67 ' HD3' ' HD3' ' A' ' 237' ' ' PRO . 0.1 OUTLIER -81.69 -6.65 59.22 Favored 'General case' 0 C--N 1.311 -1.107 0 N-CA-C 108.426 -0.953 . . . . 15.0 108.426 174.843 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 267' ' ' ILE . . . . . 0.928 HG12 ' HB3' ' A' ' 264' ' ' ASP . 42.1 mm . . . . . 0 C--O 1.249 1.031 0 CA-C-N 113.865 -1.516 . . . . 15.0 109.921 177.606 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 210' ' ' SER . . . . . . . . . . . . . 5.9 m . . . . . 0 N--CA 1.474 0.737 0 CA-C-O 120.873 0.368 . . . . 15.0 110.2 . . . . . . . . . 0 0 . 1 . 021 nuclear build core ' B' B ' 211' ' ' ASP . . . . . 0.437 ' HA ' ' HD3' ' B' ' 212' ' ' PRO . 30.4 t70 -150.09 129.39 6.37 Favored Pre-proline 0 C--N 1.324 -0.501 0 N-CA-C 109.504 -0.554 . . . . 15.0 109.504 -179.436 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 212' ' ' PRO . . . . . 0.591 ' CB ' HD11 ' A' ' 253' ' ' LEU . 27.3 Cg_endo -89.9 156.98 4.98 Favored 'Trans proline' 0 N--CA 1.454 -0.837 0 C-N-CA 122.601 2.2 . . . . 15.0 112.967 -176.081 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.442 -0.942 0 CA-C-N 115.493 -0.776 . . . . 15.0 111.458 177.908 . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 236' ' ' LEU . . . . . 0.734 HD12 ' HD2' ' A' ' 265' ' ' PRO . 0.4 OUTLIER . . . . . 0 N--CA 1.452 -0.344 0 CA-C-O 121.273 0.559 . . . . 15.0 110.715 . . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 237' ' ' PRO . . . . . 0.519 ' HD3' ' HD3' ' A' ' 266' ' ' ARG . 23.3 Cg_exo -69.32 171.0 14.75 Favored 'Trans proline' 0 CA--C 1.508 -0.783 0 C-N-CA 122.844 2.363 . . . . 15.0 110.097 162.474 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -69.42 145.1 53.1 Favored 'General case' 0 C--N 1.3 -1.553 0 CA-C-N 115.072 -0.967 . . . . 15.0 111.89 -175.845 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 100.21 10.19 45.93 Favored Glycine 0 N--CA 1.449 -0.484 0 CA-C-N 114.435 -1.257 . . . . 15.0 113.214 -179.868 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 240' ' ' TYR . . . . . 0.631 ' CD1' ' HB2' ' A' ' 254' ' ' HIS . 71.9 m-85 -116.67 123.5 47.41 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 117.235 0.518 . . . . 15.0 110.989 177.904 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -91.52 123.45 34.94 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.648 -0.705 . . . . 15.0 109.446 171.41 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 18.8 tm0? -91.4 99.86 12.74 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 108.646 -0.872 . . . . 15.0 108.646 174.513 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 68.7 mtt-85 -103.16 150.16 23.94 Favored 'General case' 0 CA--C 1.504 -0.825 0 CA-C-O 122.136 0.97 . . . . 15.0 112.087 -176.37 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 244' ' ' THR . . . . . . . . . . . . . 10.9 m -129.47 97.56 4.59 Favored 'General case' 0 C--N 1.308 -1.222 0 CA-C-N 113.28 -1.782 . . . . 15.0 109.399 -177.042 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 245' ' ' THR . . . . . 0.487 ' OG1' ' HG2' ' A' ' 247' ' ' GLN . 3.5 t -94.94 150.48 20.12 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.257 -0.883 . . . . 15.0 110.989 -175.621 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 9.9 m -50.53 -18.36 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.451 0 CA-C-N 115.615 -0.721 . . . . 15.0 112.577 176.97 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 247' ' ' GLN . . . . . 0.487 ' HG2' ' OG1' ' A' ' 245' ' ' THR . 7.3 mm100 -56.3 -21.28 23.07 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.02 -0.536 . . . . 15.0 110.682 173.182 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 89.73 11.91 63.16 Favored Glycine 0 N--CA 1.447 -0.576 0 CA-C-N 115.851 -0.613 . . . . 15.0 112.871 174.845 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 6.0 mt-30 -129.37 141.53 51.04 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 110.205 -0.294 . . . . 15.0 110.205 -176.358 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 17.1 m -89.79 135.0 27.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 116.333 -0.394 . . . . 15.0 110.109 178.235 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 25.6 p90 -134.54 135.05 42.04 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 116.143 -0.48 . . . . 15.0 110.004 -178.437 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 252' ' ' PHE . . . . . 0.701 ' CD2' ' HA ' ' A' ' 264' ' ' ASP . 24.3 m-85 -90.22 125.72 35.58 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.31 0.576 . . . . 15.0 111.147 -175.731 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 253' ' ' LEU . . . . . 1.071 HD11 ' HB3' ' B' ' 212' ' ' PRO . 0.4 OUTLIER -113.73 109.42 18.55 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-N 114.808 -1.087 . . . . 15.0 111.858 -173.398 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 254' ' ' HIS . . . . . 0.631 ' HB2' ' CD1' ' A' ' 240' ' ' TYR . 76.9 t60 -120.62 89.98 3.23 Favored 'General case' 0 C--N 1.314 -0.963 0 N-CA-C 108.386 -0.968 . . . . 15.0 108.386 167.785 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 8.0 t -94.94 88.03 5.15 Favored 'General case' 0 N--CA 1.433 -1.289 0 C-N-CA 116.5 -2.08 . . . . 15.0 110.998 -179.372 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 53.6 tt0 -100.76 -51.86 3.47 Favored 'General case' 0 N--CA 1.44 -0.96 0 CA-C-N 112.808 -1.996 . . . . 15.0 106.142 149.415 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 257' ' ' THR . . . . . . . . . . . . . 59.3 p -95.85 -13.23 24.17 Favored 'General case' 0 CA--C 1.487 -1.457 0 CA-C-O 125.039 2.352 . . . . 15.0 111.763 -179.21 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 84.9 73.25 1.27 Allowed Glycine 1 C--N 1.241 -4.705 1 CA-C-N 108.042 -4.163 . . . . 15.0 112.55 -172.873 . . . . . . . . 3 2 . 1 . 022 nuclear build core ' A' A ' 259' ' ' VAL . . . . . 0.597 ' O ' HD23 ' A' ' 253' ' ' LEU . 66.0 t -89.86 122.59 41.38 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.411 0 CA-C-O 121.676 0.751 . . . . 15.0 111.878 176.664 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 2.2 p -134.47 100.8 4.76 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-N 113.746 -1.57 . . . . 15.0 107.295 170.42 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 9.0 t -136.26 150.32 48.89 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 112.654 0.613 . . . . 15.0 112.654 -166.413 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 262' ' ' TRP . . . . . . . . . . . . . 79.9 m95 -79.02 -23.19 44.49 Favored 'General case' 0 N--CA 1.454 -0.275 0 CA-C-N 115.154 -0.93 . . . . 15.0 111.474 177.788 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 263' ' ' HIS . . . . . . . . . . . . . 13.8 p-80 -92.96 134.5 35.05 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 120.271 -0.572 . . . . 15.0 110.521 -176.517 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 264' ' ' ASP . . . . . 0.965 ' HB3' HG12 ' A' ' 267' ' ' ILE . 13.7 t0 -56.99 124.1 63.34 Favored Pre-proline 0 C--N 1.321 -0.673 0 N-CA-C 108.4 -0.963 . . . . 15.0 108.4 171.049 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 265' ' ' PRO . . . . . 0.734 ' HD2' HD12 ' A' ' 236' ' ' LEU . 16.6 Cg_exo -68.39 -14.77 40.87 Favored 'Trans proline' 0 CA--C 1.514 -0.479 0 C-N-CA 122.362 2.041 . . . . 15.0 113.181 -176.45 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 266' ' ' ARG . . . . . 0.519 ' HD3' ' HD3' ' A' ' 237' ' ' PRO . 10.8 tpt180 -76.93 -10.06 59.11 Favored 'General case' 0 C--N 1.313 -1.015 0 N-CA-C 108.473 -0.936 . . . . 15.0 108.473 174.137 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 267' ' ' ILE . . . . . 0.965 HG12 ' HB3' ' A' ' 264' ' ' ASP . 27.9 pt . . . . . 0 C--O 1.251 1.175 0 CA-C-N 114.129 -1.396 . . . . 15.0 110.835 177.334 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' B' B ' 210' ' ' SER . . . . . . . . . . . . . 9.4 t . . . . . 0 N--CA 1.476 0.861 0 N-CA-C 109.141 -0.689 . . . . 15.0 109.141 . . . . . . . . . 0 0 . 1 . 022 nuclear build core ' B' B ' 211' ' ' ASP . . . . . 0.441 ' HA ' ' HD3' ' B' ' 212' ' ' PRO . 5.0 m-20 -130.58 150.17 75.57 Favored Pre-proline 0 C--N 1.321 -0.654 0 CA-C-N 116.093 -0.503 . . . . 15.0 110.711 -174.077 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 212' ' ' PRO . . . . . 1.071 ' HB3' HD11 ' A' ' 253' ' ' LEU . 5.2 Cg_endo -89.83 151.65 5.0 Favored 'Trans proline' 0 N--CA 1.453 -0.906 0 C-N-CA 123.111 2.541 . . . . 15.0 112.182 179.759 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.442 -0.922 0 C-N-CA 120.674 -0.774 . . . . 15.0 111.643 -179.764 . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 236' ' ' LEU . . . . . 0.465 HD12 ' HB2' ' A' ' 266' ' ' ARG . 0.4 OUTLIER . . . . . 0 C--O 1.234 0.284 0 N-CA-C 109.225 -0.657 . . . . 15.0 109.225 . . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 237' ' ' PRO . . . . . 0.407 ' HD3' ' HD3' ' A' ' 266' ' ' ARG . 12.0 Cg_exo -69.56 164.55 33.92 Favored 'Trans proline' 0 N--CA 1.459 -0.553 0 C-N-CA 121.606 1.538 . . . . 15.0 110.689 170.802 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -69.69 150.34 47.09 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-N 114.976 -1.011 . . . . 15.0 111.707 -174.535 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 239' ' ' GLY . . . . . 0.41 ' O ' ' HA ' ' A' ' 254' ' ' HIS . . . 100.15 -7.16 58.47 Favored Glycine 0 N--CA 1.448 -0.523 0 CA-C-N 115.656 -0.702 . . . . 15.0 113.644 176.206 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 240' ' ' TYR . . . . . 0.627 ' CD1' ' HB2' ' A' ' 254' ' ' HIS . 60.0 m-85 -102.53 114.05 27.94 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 117.492 0.646 . . . . 15.0 110.628 179.125 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -94.54 131.72 39.98 Favored 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 108.924 -0.769 . . . . 15.0 108.924 171.306 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 23.0 tm0? -89.71 107.97 19.4 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 107.989 -1.115 . . . . 15.0 107.989 179.623 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 13.7 mtp180 -101.85 150.15 23.46 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-O 122.121 0.963 . . . . 15.0 112.175 -175.861 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 244' ' ' THR . . . . . . . . . . . . . 5.1 m -122.69 141.38 51.83 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-N 113.216 -1.811 . . . . 15.0 107.757 -177.798 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 245' ' ' THR . . . . . 0.631 ' CG2' ' HB3' ' A' ' 247' ' ' GLN . 3.1 t -141.96 150.34 41.29 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-O 120.878 0.371 . . . . 15.0 111.717 -169.216 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 8.8 p -55.97 -24.45 17.34 Favored 'Isoleucine or valine' 0 C--O 1.234 0.248 0 CA-C-N 115.31 -0.859 . . . . 15.0 109.886 172.49 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 247' ' ' GLN . . . . . 0.631 ' HB3' ' CG2' ' A' ' 245' ' ' THR . 40.8 tt0 -50.46 -35.83 30.71 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 114.506 -1.224 . . . . 15.0 110.473 172.699 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 102.04 -15.29 56.76 Favored Glycine 0 C--N 1.333 0.396 0 CA-C-N 116.118 -0.492 . . . . 15.0 112.987 176.645 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 249' ' ' GLN . . . . . 0.582 ' OE1' ' HG2' ' A' ' 247' ' ' GLN . 2.8 mp0 -96.43 147.42 23.85 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 120.64 0.257 . . . . 15.0 111.3 -173.857 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 3.3 m -89.99 130.26 39.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 N-CA-C 109.617 -0.512 . . . . 15.0 109.617 174.16 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 9.4 p90 -142.42 138.95 31.45 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.369 0.605 . . . . 15.0 111.721 -176.206 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 252' ' ' PHE . . . . . 0.62 ' CD2' ' HA ' ' A' ' 264' ' ' ASP . 43.0 m-85 -96.62 125.17 40.91 Favored 'General case' 0 CA--C 1.509 -0.607 0 CA-C-N 115.169 -0.923 . . . . 15.0 110.873 -177.265 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 253' ' ' LEU . . . . . 0.689 ' HA ' ' O ' ' A' ' 259' ' ' VAL . 0.1 OUTLIER -123.95 109.15 13.21 Favored 'General case' 0 N--CA 1.441 -0.919 0 CA-C-O 121.696 0.76 . . . . 15.0 111.979 -177.939 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 254' ' ' HIS . . . . . 0.627 ' HB2' ' CD1' ' A' ' 240' ' ' TYR . 35.5 t60 -109.61 93.85 4.72 Favored 'General case' 0 CA--C 1.501 -0.928 0 CA-C-N 114.881 -1.054 . . . . 15.0 108.184 169.36 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 3.6 t -93.85 88.2 5.67 Favored 'General case' 0 N--CA 1.434 -1.265 0 C-N-CA 116.35 -2.14 . . . . 15.0 110.556 179.501 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 7.6 tp60 -101.21 -51.9 3.39 Favored 'General case' 0 N--CA 1.442 -0.863 0 CA-C-N 113.19 -1.823 . . . . 15.0 106.269 150.981 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 257' ' ' THR . . . . . . . . . . . . . 71.9 p -99.96 -13.67 19.01 Favored 'General case' 0 CA--C 1.487 -1.461 0 CA-C-O 124.666 2.174 . . . . 15.0 112.118 -179.501 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 88.63 73.89 1.28 Allowed Glycine 1 C--N 1.242 -4.693 0 CA-C-N 108.533 -3.94 . . . . 15.0 112.849 -171.32 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 259' ' ' VAL . . . . . 0.689 ' O ' ' HA ' ' A' ' 253' ' ' LEU . 68.7 t -89.58 126.73 42.5 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.391 0 CA-C-O 121.296 0.57 . . . . 15.0 111.583 173.219 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 2.2 p -150.01 94.13 2.11 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 114.039 -1.437 . . . . 15.0 107.72 168.886 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 9.8 t -135.03 150.29 50.27 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.516 -0.765 . . . . 15.0 111.173 -169.151 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 262' ' ' TRP . . . . . 0.483 ' CH2' ' HB3' ' A' ' 249' ' ' GLN . 23.2 m95 -70.1 -17.51 63.22 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 113.19 0.811 . . . . 15.0 113.19 -177.194 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 263' ' ' HIS . . . . . . . . . . . . . 4.6 p80 -96.25 133.0 41.12 Favored 'General case' 0 C--N 1.323 -0.561 0 C-N-CA 120.088 -0.645 . . . . 15.0 110.01 179.961 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 264' ' ' ASP . . . . . 0.995 ' HB3' HG12 ' A' ' 267' ' ' ILE . 9.9 t0 -56.72 131.21 78.19 Favored Pre-proline 0 C--O 1.222 -0.386 0 N-CA-C 107.888 -1.153 . . . . 15.0 107.888 171.283 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 265' ' ' PRO . . . . . 0.508 ' HG2' ' CD1' ' A' ' 240' ' ' TYR . 17.0 Cg_exo -69.33 -15.05 38.42 Favored 'Trans proline' 0 C--N 1.324 -0.75 0 C-N-CA 122.092 1.861 . . . . 15.0 113.415 -176.232 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 266' ' ' ARG . . . . . 0.485 ' HD2' ' HA ' ' A' ' 266' ' ' ARG . 15.9 tpt180 -79.7 -8.02 58.96 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-O 122.037 0.922 . . . . 15.0 108.67 173.881 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 267' ' ' ILE . . . . . 0.995 HG12 ' HB3' ' A' ' 264' ' ' ASP . 33.4 pt . . . . . 0 C--O 1.248 0.984 0 CA-C-N 113.798 -1.546 . . . . 15.0 110.641 175.382 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' B' B ' 210' ' ' SER . . . . . . . . . . . . . 10.7 m . . . . . 0 N--CA 1.475 0.825 0 CA-C-O 120.883 0.373 . . . . 15.0 110.644 . . . . . . . . . 0 0 . 1 . 023 nuclear build core ' B' B ' 211' ' ' ASP . . . . . 0.507 ' HA ' ' HD3' ' B' ' 212' ' ' PRO . 25.7 t70 -140.08 122.0 9.75 Favored Pre-proline 0 N--CA 1.453 -0.286 0 CA-C-O 121.023 0.44 . . . . 15.0 111.084 -177.31 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' B' B ' 212' ' ' PRO . . . . . 0.6 ' HB2' HD13 ' A' ' 253' ' ' LEU . 1.2 Cg_endo -89.63 160.01 5.27 Favored 'Trans proline' 0 N--CA 1.457 -0.65 0 C-N-CA 123.774 2.983 . . . . 15.0 111.846 176.126 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.617 0 C-N-CA 120.809 -0.71 . . . . 15.0 112.896 -176.168 . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 236' ' ' LEU . . . . . 0.541 HD22 ' N ' ' A' ' 236' ' ' LEU . 0.1 OUTLIER . . . . . 0 CA--C 1.515 -0.397 0 CA-C-O 121.133 0.492 . . . . 15.0 110.166 . . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 237' ' ' PRO . . . . . 0.557 ' HD3' ' HD3' ' A' ' 266' ' ' ARG . 15.1 Cg_exo -69.56 173.8 10.27 Favored 'Trans proline' 0 CA--C 1.507 -0.84 0 C-N-CA 122.672 2.248 . . . . 15.0 110.442 165.861 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 3.7 pm0 -69.48 142.63 53.71 Favored 'General case' 0 C--N 1.291 -1.945 0 CA-C-N 114.253 -1.339 . . . . 15.0 111.613 -173.297 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 100.17 3.36 55.68 Favored Glycine 0 CA--C 1.521 0.446 0 CA-C-N 115.233 -0.894 . . . . 15.0 113.965 177.172 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 240' ' ' TYR . . . . . 0.526 ' CD1' ' HG2' ' A' ' 265' ' ' PRO . 62.4 m-85 -111.17 125.34 53.69 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 117.856 0.828 . . . . 15.0 111.253 178.651 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 241' ' ' GLU . . . . . 0.561 ' HG3' ' HB3' ' A' ' 253' ' ' LEU . 8.6 pt-20 -108.75 123.28 48.76 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 109.199 -0.667 . . . . 15.0 109.199 170.926 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -89.81 106.55 18.54 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 109.203 -0.665 . . . . 15.0 109.203 -177.802 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 27.9 mtt-85 -98.46 148.43 23.73 Favored 'General case' 0 CA--C 1.505 -0.771 0 CA-C-O 122.123 0.963 . . . . 15.0 112.06 -177.531 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 244' ' ' THR . . . . . . . . . . . . . 25.0 p -117.26 146.06 43.54 Favored 'General case' 0 C--N 1.306 -1.285 0 CA-C-N 113.348 -1.751 . . . . 15.0 108.852 178.409 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 245' ' ' THR . . . . . 0.432 HG23 ' HB2' ' A' ' 247' ' ' GLN . 5.9 t -144.26 150.16 37.47 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 116.612 -0.267 . . . . 15.0 110.861 -172.393 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 6.4 m -53.63 -19.17 2.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.824 -0.626 . . . . 15.0 111.974 177.953 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 247' ' ' GLN . . . . . 0.432 ' HB2' HG23 ' A' ' 245' ' ' THR . 8.8 mm100 -58.68 -20.61 49.94 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.735 -0.666 . . . . 15.0 110.901 175.203 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 84.21 26.61 39.64 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 121.107 -0.568 . . . . 15.0 112.542 176.639 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 3.0 mt-30 -133.2 138.9 46.72 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 110.286 -0.264 . . . . 15.0 110.286 -173.904 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 4.4 m -89.65 122.83 41.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 N-CA-C 109.721 -0.474 . . . . 15.0 109.721 173.331 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 2.5 p90 -129.89 134.07 47.28 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.049 0.452 . . . . 15.0 109.856 -175.792 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 252' ' ' PHE . . . . . 0.582 ' CD2' ' HA ' ' A' ' 264' ' ' ASP . 40.1 m-85 -90.05 128.11 36.21 Favored 'General case' 0 CA--C 1.512 -0.499 0 CA-C-O 121.237 0.542 . . . . 15.0 111.483 -175.185 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 253' ' ' LEU . . . . . 0.899 HD11 ' HB3' ' B' ' 212' ' ' PRO . 0.7 OUTLIER -118.66 126.27 51.56 Favored 'General case' 0 N--CA 1.446 -0.673 0 CA-C-N 115.035 -0.984 . . . . 15.0 110.78 -175.909 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 254' ' ' HIS . . . . . 0.522 ' HB3' ' HB ' ' A' ' 259' ' ' VAL . 0.2 OUTLIER -140.61 91.72 2.45 Favored 'General case' 0 C--N 1.313 -0.988 0 N-CA-C 108.595 -0.891 . . . . 15.0 108.595 173.282 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 3.1 t -103.23 87.91 3.0 Favored 'General case' 0 N--CA 1.43 -1.44 0 C-N-CA 116.796 -1.962 . . . . 15.0 111.015 -179.598 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 30.2 tp60 -101.23 -52.85 3.16 Favored 'General case' 0 N--CA 1.437 -1.099 0 CA-C-N 112.681 -2.054 . . . . 15.0 105.574 147.116 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 257' ' ' THR . . . . . . . . . . . . . 31.8 p -97.63 -13.55 21.49 Favored 'General case' 0 CA--C 1.489 -1.38 0 CA-C-O 124.89 2.281 . . . . 15.0 112.0 -177.246 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 84.73 71.37 1.32 Allowed Glycine 1 C--N 1.242 -4.676 1 CA-C-N 108.315 -4.039 . . . . 15.0 113.926 -174.575 . . . . . . . . 3 2 . 1 . 024 nuclear build core ' A' A ' 259' ' ' VAL . . . . . 0.522 ' HB ' ' HB3' ' A' ' 254' ' ' HIS . 67.5 t -89.91 129.95 39.99 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 CA-C-O 121.405 0.622 . . . . 15.0 111.431 171.597 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 23.8 p -143.79 102.89 3.98 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 114.386 -1.279 . . . . 15.0 108.093 171.553 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 14.4 t -149.32 150.44 32.49 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.966 0.412 . . . . 15.0 111.747 -168.726 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 262' ' ' TRP . . . . . . . . . . . . . 84.7 m95 -71.96 -37.03 70.0 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.721 -0.672 . . . . 15.0 111.282 177.724 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 263' ' ' HIS . . . . . . . . . . . . . 2.8 p80 -73.65 126.85 31.22 Favored 'General case' 0 CA--C 1.515 -0.37 0 C-N-CA 120.52 -0.472 . . . . 15.0 109.923 -174.001 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 264' ' ' ASP . . . . . 1.084 ' HB3' HG12 ' A' ' 267' ' ' ILE . 15.0 t0 -54.47 125.79 53.43 Favored Pre-proline 0 C--N 1.32 -0.699 0 N-CA-C 108.326 -0.99 . . . . 15.0 108.326 173.404 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 265' ' ' PRO . . . . . 0.526 ' HG2' ' CD1' ' A' ' 240' ' ' TYR . 14.2 Cg_exo -68.72 -14.59 39.55 Favored 'Trans proline' 0 CA--C 1.512 -0.581 0 C-N-CA 121.893 1.729 . . . . 15.0 112.667 -177.296 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 266' ' ' ARG . . . . . 0.557 ' HD3' ' HD3' ' A' ' 237' ' ' PRO . 19.8 tpt180 -76.46 -11.94 59.96 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 115.225 -0.898 . . . . 15.0 108.932 173.137 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 267' ' ' ILE . . . . . 1.084 HG12 ' HB3' ' A' ' 264' ' ' ASP . 41.8 pt . . . . . 0 C--O 1.25 1.101 0 CA-C-O 117.549 -1.215 . . . . 15.0 111.529 178.999 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' B' B ' 210' ' ' SER . . . . . . . . . . . . . 18.9 m . . . . . 0 N--CA 1.477 0.892 0 CA-C-O 120.98 0.419 . . . . 15.0 110.806 . . . . . . . . . 0 0 . 1 . 024 nuclear build core ' B' B ' 211' ' ' ASP . . . . . . . . . . . . . 11.9 p-10 -111.87 109.87 54.85 Favored Pre-proline 0 C--N 1.327 -0.38 0 CA-C-O 121.138 0.494 . . . . 15.0 110.5 -178.29 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' B' B ' 212' ' ' PRO . . . . . 0.899 ' HB3' HD11 ' A' ' 253' ' ' LEU . 6.6 Cg_endo -89.97 147.73 4.71 Favored 'Trans proline' 0 N--CA 1.453 -0.871 0 C-N-CA 122.638 2.225 . . . . 15.0 112.21 176.257 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.442 -0.931 0 C-N-CA 120.543 -0.836 . . . . 15.0 111.598 178.286 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 . . . . . 0 N--CA 1.481 1.079 0 N-CA-C 109.953 -0.388 . . . . 15.0 109.953 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 2.2 mt -105.25 164.88 14.2 Favored Pre-proline 0 C--N 1.32 -0.702 0 N-CA-C 109.789 -0.449 . . . . 15.0 109.789 -177.35 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 237' ' ' PRO . . . . . 0.465 ' O ' ' HD2' ' A' ' 240' ' ' TYR . 14.0 Cg_exo -69.5 166.75 26.2 Favored 'Trans proline' 0 N--CA 1.458 -0.615 0 C-N-CA 121.793 1.662 . . . . 15.0 110.221 165.706 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -69.74 142.99 53.17 Favored 'General case' 0 C--N 1.303 -1.433 0 CA-C-N 114.863 -1.062 . . . . 15.0 111.521 -173.024 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 100.15 5.83 54.27 Favored Glycine 0 N--CA 1.449 -0.485 0 CA-C-N 115.361 -0.836 . . . . 15.0 113.785 178.895 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 240' ' ' TYR . . . . . 0.649 ' CD1' ' HB2' ' A' ' 254' ' ' HIS . 71.7 m-85 -108.19 116.31 31.72 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 117.636 0.718 . . . . 15.0 111.678 -179.698 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -90.37 113.82 25.79 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.048 -0.978 . . . . 15.0 109.595 174.897 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 242' ' ' GLN . . . . . 0.645 ' HG3' ' CE1' ' A' ' 252' ' ' PHE . 39.6 tt0 -91.09 103.42 16.12 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 109.523 -0.547 . . . . 15.0 109.523 -179.771 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 243' ' ' ARG . . . . . 0.44 HH11 ' HD2' ' A' ' 243' ' ' ARG . 8.5 mtp180 -109.25 149.87 28.78 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 122.07 0.938 . . . . 15.0 112.637 -176.168 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 244' ' ' THR . . . . . 0.421 HG22 HG12 ' A' ' 250' ' ' VAL . 10.2 p -124.72 96.8 5.02 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 113.54 -1.664 . . . . 15.0 109.41 -176.257 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 245' ' ' THR . . . . . 0.703 HG23 ' HB2' ' A' ' 247' ' ' GLN . 2.7 t -89.99 150.28 22.2 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 115.861 -0.609 . . . . 15.0 111.412 -174.71 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 9.7 m -52.06 -19.21 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.315 0 CA-C-N 115.713 -0.676 . . . . 15.0 112.04 175.075 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 247' ' ' GLN . . . . . 0.703 ' HB2' HG23 ' A' ' 245' ' ' THR . 0.2 OUTLIER -49.81 -26.8 4.28 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 115.98 -0.554 . . . . 15.0 110.873 170.239 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 93.17 19.36 36.29 Favored Glycine 0 C--O 1.229 -0.188 0 CA-C-N 115.837 -0.619 . . . . 15.0 112.289 177.041 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 249' ' ' GLN . . . . . 0.476 ' NE2' ' HH2' ' A' ' 262' ' ' TRP . 0.0 OUTLIER -135.41 144.39 46.5 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.01 0.433 . . . . 15.0 110.724 -174.605 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 250' ' ' VAL . . . . . 0.421 HG12 HG22 ' A' ' 244' ' ' THR . 19.4 m -89.94 142.39 12.99 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 115.444 -0.798 . . . . 15.0 109.677 176.406 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 251' ' ' TYR . . . . . 0.543 ' HB3' ' CG ' ' B' ' 215' ' ' PRO . 6.1 p90 -148.18 142.68 26.43 Favored 'General case' 0 C--N 1.321 -0.646 0 C-N-CA 120.67 -0.412 . . . . 15.0 110.693 -179.38 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 252' ' ' PHE . . . . . 0.697 ' CE2' ' HA ' ' A' ' 264' ' ' ASP . 29.7 m-85 -98.15 119.57 37.02 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.842 -0.617 . . . . 15.0 111.869 -175.631 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 253' ' ' LEU . . . . . 0.657 HD11 ' HB3' ' B' ' 212' ' ' PRO . 2.8 mt -104.36 103.23 12.93 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 114.744 -1.116 . . . . 15.0 112.012 -177.579 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 254' ' ' HIS . . . . . 0.649 ' HB2' ' CD1' ' A' ' 240' ' ' TYR . 78.5 t60 -113.26 89.95 3.22 Favored 'General case' 0 C--N 1.312 -1.036 0 N-CA-C 107.982 -1.118 . . . . 15.0 107.982 167.413 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 255' ' ' THR . . . . . 0.417 HG23 ' HA2' ' A' ' 258' ' ' GLY . 23.4 m -92.43 87.78 6.13 Favored 'General case' 0 N--CA 1.432 -1.355 0 C-N-CA 116.684 -2.006 . . . . 15.0 109.496 -179.328 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 64.1 tt0 -101.54 -53.43 2.99 Favored 'General case' 0 N--CA 1.439 -1.008 0 N-CA-C 106.199 -1.778 . . . . 15.0 106.199 150.592 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 257' ' ' THR . . . . . . . . . . . . . 82.6 p -96.83 -13.61 22.44 Favored 'General case' 0 CA--C 1.484 -1.561 0 CA-C-O 124.889 2.28 . . . . 15.0 111.733 -178.895 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 258' ' ' GLY . . . . . 0.417 ' HA2' HG23 ' A' ' 255' ' ' THR . . . 87.73 72.83 1.28 Allowed Glycine 1 C--N 1.241 -4.695 1 CA-C-N 108.174 -4.103 . . . . 15.0 112.703 -171.638 . . . . . . . . 4 3 . 1 . 001 nuclear build full ' A' A ' 259' ' ' VAL . . . . . 0.493 ' O ' ' HA ' ' A' ' 253' ' ' LEU . 53.0 t -89.89 125.2 42.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 121.585 0.707 . . . . 15.0 112.361 176.182 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 3.3 p -132.34 101.93 5.55 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 114.091 -1.413 . . . . 15.0 107.706 167.129 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 12.3 t -132.15 150.24 52.2 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 121.188 0.518 . . . . 15.0 112.352 -169.563 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 262' ' ' TRP . . . . . 1.199 ' CZ2' ' HB2' ' B' ' 215' ' ' PRO . 77.0 m95 -78.26 -25.57 46.85 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.11 -0.95 . . . . 15.0 111.202 176.877 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 263' ' ' HIS . . . . . 0.418 ' HD2' ' O ' ' A' ' 264' ' ' ASP . 11.9 p-80 -89.34 131.36 35.46 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.496 -0.481 . . . . 15.0 110.212 -175.022 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 264' ' ' ASP . . . . . 1.064 ' HB3' HG12 ' A' ' 267' ' ' ILE . 19.8 t0 -56.36 125.03 64.33 Favored Pre-proline 0 C--N 1.323 -0.565 0 N-CA-C 107.669 -1.234 . . . . 15.0 107.669 170.061 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 265' ' ' PRO . . . . . 0.561 ' HD3' ' CD2' ' A' ' 252' ' ' PHE . 11.5 Cg_exo -70.54 -14.72 33.87 Favored 'Trans proline' 0 C--N 1.323 -0.766 0 C-N-CA 121.751 1.634 . . . . 15.0 112.573 -175.977 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 266' ' ' ARG . . . . . 0.426 ' HD3' ' HD3' ' A' ' 237' ' ' PRO . 19.3 tpt180 -76.27 -11.99 60.0 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 115.443 -0.799 . . . . 15.0 108.956 173.223 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 267' ' ' ILE . . . . . 1.064 HG12 ' HB3' ' A' ' 264' ' ' ASP . 40.3 pt . . . . . 0 C--O 1.249 1.027 0 CA-C-N 115.017 -0.992 . . . . 15.0 111.448 178.618 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 210' ' ' SER . . . . . . . . . . . . . 20.3 m . . . . . 0 N--CA 1.477 0.885 0 CA-C-O 120.635 0.255 . . . . 15.0 111.279 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 211' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -133.14 119.61 15.7 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 120.502 0.191 . . . . 15.0 110.519 -179.116 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 212' ' ' PRO . . . . . 0.657 ' HB3' HD11 ' A' ' 253' ' ' LEU . 3.9 Cg_endo -89.7 160.0 5.21 Favored 'Trans proline' 0 N--CA 1.455 -0.79 0 C-N-CA 122.707 2.271 . . . . 15.0 111.524 173.904 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -89.76 147.09 19.18 Favored Glycine 0 N--CA 1.443 -0.879 0 C-N-CA 120.338 -0.934 . . . . 15.0 112.241 -177.388 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 214' ' ' SEP . . . . . 0.453 ' HA ' ' HD3' ' B' ' 215' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 215' ' ' PRO . . . . . 1.199 ' HB2' ' CZ2' ' A' ' 262' ' ' TRP . 6.9 Cg_exo -88.04 138.51 4.19 Favored 'Trans proline' 0 C--O 1.233 0.234 0 C-N-CA 123.069 2.513 . . . . 15.0 111.082 177.471 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 216' ' ' PHE . . . . . . . . . . . . . 67.9 m-85 -90.06 115.88 27.66 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 116.203 -0.453 . . . . 15.0 110.085 -178.425 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 217' ' ' GLN . . . . . 0.687 ' HB2' ' CZ2' ' A' ' 262' ' ' TRP . 25.5 tt0 . . . . . 0 C--O 1.251 1.134 0 CA-C-O 118.442 -0.79 . . . . 15.0 109.602 179.463 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.479 1.002 0 CA-C-O 120.42 0.152 . . . . 15.0 110.848 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 61.1 mt -130.52 163.57 47.35 Favored Pre-proline 0 C--N 1.327 -0.398 0 N-CA-C 109.507 -0.553 . . . . 15.0 109.507 179.118 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 237' ' ' PRO . . . . . 0.929 ' HD3' ' HD3' ' A' ' 266' ' ' ARG . 15.2 Cg_exo -69.47 171.16 14.64 Favored 'Trans proline' 0 CA--C 1.513 -0.57 0 C-N-CA 122.055 1.837 . . . . 15.0 110.92 165.927 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -69.68 133.32 47.4 Favored 'General case' 0 C--N 1.302 -1.492 0 CA-C-N 114.415 -1.266 . . . . 15.0 112.208 -173.248 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 100.16 28.83 7.06 Favored Glycine 0 C--N 1.334 0.434 0 CA-C-N 115.16 -0.927 . . . . 15.0 114.094 174.08 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 240' ' ' TYR . . . . . 0.72 ' CD1' ' HB2' ' A' ' 254' ' ' HIS . 65.0 m-85 -117.36 123.72 47.17 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 117.963 0.881 . . . . 15.0 111.468 177.864 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 241' ' ' GLU . . . . . 0.529 ' HG3' ' HB2' ' A' ' 253' ' ' LEU . 10.6 pt-20 -119.64 119.97 35.28 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.76 -0.654 . . . . 15.0 109.595 172.807 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -90.13 109.45 20.51 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 108.775 -0.824 . . . . 15.0 108.775 178.371 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 243' ' ' ARG . . . . . 0.473 ' HB2' ' CE1' ' A' ' 251' ' ' TYR . 31.3 mtt180 -95.87 149.97 20.95 Favored 'General case' 0 CA--C 1.51 -0.574 0 CA-C-O 122.025 0.917 . . . . 15.0 112.295 -175.218 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 244' ' ' THR . . . . . . . . . . . . . 4.9 p -111.61 97.46 6.75 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-N 113.498 -1.683 . . . . 15.0 110.553 -176.553 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 245' ' ' THR . . . . . 0.701 HG23 ' HB2' ' A' ' 247' ' ' GLN . 0.9 OUTLIER -90.7 150.6 21.58 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.187 -0.915 . . . . 15.0 110.302 177.846 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 25.3 t -50.62 -18.43 0.63 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.489 0 O-C-N 123.52 0.513 . . . . 15.0 110.959 176.335 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 247' ' ' GLN . . . . . 0.701 ' HB2' HG23 ' A' ' 245' ' ' THR . 77.9 mm-40 -50.83 -29.11 10.9 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 116.038 -0.528 . . . . 15.0 111.156 171.916 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 80.94 21.41 63.29 Favored Glycine 0 N--CA 1.452 -0.27 0 N-CA-C 111.624 -0.59 . . . . 15.0 111.624 -178.43 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 9.6 mt-30 -121.32 143.96 48.9 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.726 -0.472 . . . . 15.0 109.726 -175.803 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 28.8 m -89.84 133.28 32.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 N-CA-C 109.582 -0.525 . . . . 15.0 109.582 176.601 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 251' ' ' TYR . . . . . 0.592 ' CB ' ' HG2' ' B' ' 215' ' ' PRO . 2.4 p90 -140.49 130.11 24.21 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.054 0.454 . . . . 15.0 110.141 -177.12 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 252' ' ' PHE . . . . . 0.615 ' CD2' ' HA ' ' A' ' 264' ' ' ASP . 34.9 m-85 -90.01 116.49 28.09 Favored 'General case' 0 CA--C 1.513 -0.474 0 CA-C-N 115.874 -0.603 . . . . 15.0 111.857 -173.405 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 253' ' ' LEU . . . . . 0.586 HD11 ' CB ' ' B' ' 212' ' ' PRO . 12.9 mt -98.59 126.76 44.27 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-N 114.816 -1.083 . . . . 15.0 111.233 175.677 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 254' ' ' HIS . . . . . 0.72 ' HB2' ' CD1' ' A' ' 240' ' ' TYR . 73.7 t60 -133.87 89.78 2.62 Favored 'General case' 0 C--N 1.309 -1.183 0 N-CA-C 107.633 -1.247 . . . . 15.0 107.633 167.032 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 3.3 t -94.13 87.95 5.46 Favored 'General case' 0 N--CA 1.429 -1.491 0 C-N-CA 116.334 -2.147 . . . . 15.0 110.105 -179.732 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 60.0 tt0 -101.61 -54.94 2.63 Favored 'General case' 0 N--CA 1.436 -1.137 0 CA-C-N 112.946 -1.934 . . . . 15.0 105.921 151.02 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 257' ' ' THR . . . . . . . . . . . . . 71.6 p -100.04 -13.63 18.97 Favored 'General case' 0 CA--C 1.489 -1.4 0 CA-C-N 111.989 -2.369 . . . . 15.0 112.401 -179.756 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 89.38 71.42 1.26 Allowed Glycine 1 C--N 1.243 -4.622 0 CA-C-N 108.566 -3.924 . . . . 15.0 113.59 -173.15 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 259' ' ' VAL . . . . . 0.666 ' HB ' ' HB3' ' A' ' 254' ' ' HIS . 52.6 t -90.12 129.24 41.32 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 CA-C-O 121.324 0.583 . . . . 15.0 111.564 172.954 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 1.4 p -143.36 108.15 4.9 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 114.539 -1.209 . . . . 15.0 108.643 169.35 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 7.4 t -149.01 150.34 32.66 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.042 0.448 . . . . 15.0 111.685 -171.616 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 262' ' ' TRP . . . . . 1.156 ' CZ2' ' HB2' ' B' ' 215' ' ' PRO . 89.8 m95 -66.89 -30.21 70.3 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.295 -0.866 . . . . 15.0 111.613 177.119 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 263' ' ' HIS . . . . . . . . . . . . . 3.1 p80 -83.85 133.34 34.75 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.55 -0.46 . . . . 15.0 110.607 -172.248 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 264' ' ' ASP . . . . . 0.87 ' HB3' HG12 ' A' ' 267' ' ' ILE . 9.5 t70 -56.9 129.87 78.44 Favored Pre-proline 0 C--N 1.323 -0.549 0 N-CA-C 108.535 -0.913 . . . . 15.0 108.535 172.766 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 265' ' ' PRO . . . . . 0.518 ' HD3' ' HA ' ' A' ' 264' ' ' ASP . 2.6 Cg_exo -76.33 -14.59 18.28 Favored 'Trans proline' 0 CA--C 1.511 -0.655 0 C-N-CA 122.297 1.998 . . . . 15.0 113.451 -174.524 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 266' ' ' ARG . . . . . 0.929 ' HD3' ' HD3' ' A' ' 237' ' ' PRO . 6.4 tpt180 -79.39 -8.72 59.3 Favored 'General case' 0 C--N 1.31 -1.149 0 CA-C-O 121.953 0.882 . . . . 15.0 108.78 175.635 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 267' ' ' ILE . . . . . 0.87 HG12 ' HB3' ' A' ' 264' ' ' ASP . 42.4 mm . . . . . 0 C--O 1.249 1.033 0 CA-C-N 113.997 -1.456 . . . . 15.0 109.809 178.755 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 210' ' ' SER . . . . . . . . . . . . . 12.5 p . . . . . 0 N--CA 1.476 0.873 0 CA-C-O 121.14 0.495 . . . . 15.0 110.74 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 211' ' ' ASP . . . . . 0.54 ' HA ' ' HD3' ' B' ' 212' ' ' PRO . 7.2 p-10 -150.3 135.38 9.86 Favored Pre-proline 0 C--N 1.325 -0.488 0 CA-C-N 115.945 -0.57 . . . . 15.0 110.672 -179.185 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 212' ' ' PRO . . . . . 0.586 ' CB ' HD11 ' A' ' 253' ' ' LEU . 1.4 Cg_endo -89.79 138.87 3.12 Favored 'Trans proline' 0 N--CA 1.458 -0.599 0 C-N-CA 123.529 2.819 . . . . 15.0 111.99 178.766 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -89.79 141.98 16.35 Favored Glycine 0 N--CA 1.444 -0.816 0 C-N-CA 120.813 -0.708 . . . . 15.0 111.561 -179.101 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 214' ' ' SEP . . . . . 0.468 ' HA ' ' HD3' ' B' ' 215' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 215' ' ' PRO . . . . . 1.156 ' HB2' ' CZ2' ' A' ' 262' ' ' TRP . 16.8 Cg_exo -88.24 147.13 6.47 Favored 'Trans proline' 0 N--CA 1.461 -0.389 0 C-N-CA 123.573 2.848 . . . . 15.0 111.88 -178.989 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 216' ' ' PHE . . . . . . . . . . . . . 71.0 m-85 -120.36 159.19 25.55 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.93 -0.396 . . . . 15.0 109.93 173.557 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 217' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.25 1.123 0 CA-C-O 118.869 -0.586 . . . . 15.0 110.865 -176.536 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 . . . . . 0 N--CA 1.484 1.233 0 N-CA-C 109.863 -0.421 . . . . 15.0 109.863 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 236' ' ' LEU . . . . . 0.459 HD22 ' H ' ' A' ' 236' ' ' LEU . 0.2 OUTLIER -103.31 169.53 7.3 Favored Pre-proline 0 C--N 1.321 -0.634 0 N-CA-C 109.188 -0.671 . . . . 15.0 109.188 -179.875 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 237' ' ' PRO . . . . . 0.638 ' HD3' ' HD3' ' A' ' 266' ' ' ARG . 12.9 Cg_exo -69.84 163.32 38.77 Favored 'Trans proline' 0 CA--C 1.514 -0.487 0 C-N-CA 122.022 1.815 . . . . 15.0 110.143 167.839 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 238' ' ' GLU . . . . . 0.401 ' H ' ' CD ' ' A' ' 238' ' ' GLU . 1.1 pm0 -69.81 146.14 51.6 Favored 'General case' 0 C--N 1.305 -1.365 0 CA-C-N 115.45 -0.795 . . . . 15.0 111.611 -175.456 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 239' ' ' GLY . . . . . 0.415 ' O ' ' HA ' ' A' ' 254' ' ' HIS . . . 99.96 3.54 55.84 Favored Glycine 0 N--CA 1.449 -0.48 0 CA-C-N 115.353 -0.84 . . . . 15.0 113.896 178.218 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 240' ' ' TYR . . . . . 0.765 ' CD1' ' HB2' ' A' ' 254' ' ' HIS . 83.6 m-85 -107.12 123.73 48.67 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 117.45 0.625 . . . . 15.0 110.878 178.001 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -110.12 130.71 55.49 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 109.534 -0.543 . . . . 15.0 109.534 170.442 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 242' ' ' GLN . . . . . 0.457 ' HG3' ' CE1' ' A' ' 252' ' ' PHE . 32.6 tt0 -89.92 112.04 23.3 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.253 -0.647 . . . . 15.0 109.253 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 31.9 mtp85 -105.94 145.67 31.01 Favored 'General case' 0 CA--C 1.502 -0.893 0 CA-C-O 121.957 0.884 . . . . 15.0 112.665 -177.508 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 244' ' ' THR . . . . . . . . . . . . . 48.6 m -121.74 93.33 3.97 Favored 'General case' 0 C--N 1.309 -1.157 0 CA-C-N 113.412 -1.722 . . . . 15.0 109.86 -178.8 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 245' ' ' THR . . . . . 1.059 HG23 ' HG2' ' A' ' 247' ' ' GLN . 5.2 t -89.97 150.61 22.07 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.15 -0.932 . . . . 15.0 110.484 -178.567 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 246' ' ' VAL . . . . . 0.408 ' H ' HG23 ' A' ' 246' ' ' VAL . 34.1 t -44.2 -25.7 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 N-CA-C 113.596 0.962 . . . . 15.0 113.596 -175.305 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 247' ' ' GLN . . . . . 1.059 ' HG2' HG23 ' A' ' 245' ' ' THR . 3.4 pt20 -55.1 -18.72 5.9 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 111.579 0.214 . . . . 15.0 111.579 177.649 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 87.7 26.52 29.44 Favored Glycine 0 C--N 1.334 0.472 0 C-N-CA 121.356 -0.449 . . . . 15.0 112.721 175.254 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 249' ' ' GLN . . . . . 0.486 ' HB2' ' OE1' ' A' ' 247' ' ' GLN . 9.4 mt-30 -138.86 140.34 38.42 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.699 -0.482 . . . . 15.0 109.699 -177.62 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 20.5 m -90.04 141.93 13.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 116.397 -0.365 . . . . 15.0 110.652 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 251' ' ' TYR . . . . . 0.743 ' HB3' ' HG2' ' B' ' 215' ' ' PRO . 18.4 p90 -142.21 140.06 32.21 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.468 -0.567 . . . . 15.0 109.468 -178.936 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 252' ' ' PHE . . . . . 0.73 ' CD2' ' HA ' ' A' ' 264' ' ' ASP . 42.4 m-85 -93.6 119.39 32.58 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.123 -0.49 . . . . 15.0 111.895 -174.708 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 253' ' ' LEU . . . . . 0.636 HD11 ' HB3' ' B' ' 212' ' ' PRO . 4.1 mt -101.46 117.05 34.15 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-N 115.225 -0.898 . . . . 15.0 111.136 179.244 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 254' ' ' HIS . . . . . 0.765 ' HB2' ' CD1' ' A' ' 240' ' ' TYR . 71.0 t60 -130.76 90.02 2.84 Favored 'General case' 0 CA--C 1.5 -0.943 0 N-CA-C 107.916 -1.142 . . . . 15.0 107.916 169.464 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 37.1 m -92.73 87.93 6.06 Favored 'General case' 0 N--CA 1.433 -1.293 0 C-N-CA 116.735 -1.986 . . . . 15.0 110.453 -178.802 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 56.7 tt0 -101.14 -52.2 3.33 Favored 'General case' 0 N--CA 1.443 -0.809 0 N-CA-C 106.041 -1.837 . . . . 15.0 106.041 149.447 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 257' ' ' THR . . . . . . . . . . . . . 73.3 p -97.89 -13.48 21.21 Favored 'General case' 0 CA--C 1.487 -1.452 0 CA-C-O 124.779 2.228 . . . . 15.0 111.727 -179.839 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 86.28 70.83 1.31 Allowed Glycine 1 C--N 1.24 -4.772 0 CA-C-N 108.483 -3.962 . . . . 15.0 113.14 -172.665 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 259' ' ' VAL . . . . . 0.617 ' O ' HD23 ' A' ' 253' ' ' LEU . 48.0 t -89.99 125.33 42.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 N-CA-C 112.637 0.606 . . . . 15.0 112.637 177.103 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -138.07 102.19 4.62 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 107.794 -1.188 . . . . 15.0 107.794 167.217 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 12.5 t -138.02 150.35 46.88 Favored 'General case' 0 C--N 1.317 -0.812 0 C-N-CA 120.533 -0.467 . . . . 15.0 112.208 -167.944 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 262' ' ' TRP . . . . . 1.206 ' CZ2' ' HB2' ' B' ' 215' ' ' PRO . 80.7 m95 -71.28 -33.26 69.59 Favored 'General case' 0 N--CA 1.455 -0.195 0 CA-C-N 115.391 -0.822 . . . . 15.0 111.719 178.912 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 263' ' ' HIS . . . . . . . . . . . . . 5.0 p80 -83.48 134.68 34.84 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.511 -0.476 . . . . 15.0 110.017 -175.245 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 264' ' ' ASP . . . . . 1.001 ' HB3' HG12 ' A' ' 267' ' ' ILE . 10.8 t70 -55.87 131.9 73.17 Favored Pre-proline 0 C--N 1.323 -0.549 0 N-CA-C 108.664 -0.865 . . . . 15.0 108.664 172.615 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 265' ' ' PRO . . . . . 0.525 ' HD3' ' CD2' ' A' ' 252' ' ' PHE . 72.0 Cg_endo -75.67 -14.76 19.62 Favored 'Trans proline' 0 CA--C 1.507 -0.842 0 C-N-CA 121.456 1.437 . . . . 15.0 113.464 -172.071 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 266' ' ' ARG . . . . . 0.638 ' HD3' ' HD3' ' A' ' 237' ' ' PRO . 8.6 tpt180 -81.51 -7.43 59.58 Favored 'General case' 0 C--N 1.306 -1.283 0 N-CA-C 108.168 -1.049 . . . . 15.0 108.168 175.227 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 267' ' ' ILE . . . . . 1.001 HG12 ' HB3' ' A' ' 264' ' ' ASP . 37.5 pt . . . . . 0 C--O 1.25 1.093 0 CA-C-N 114.002 -1.454 . . . . 15.0 110.85 175.691 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 210' ' ' SER . . . . . . . . . . . . . 10.3 p . . . . . 0 N--CA 1.475 0.808 0 CA-C-O 121.014 0.435 . . . . 15.0 110.555 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 211' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -90.16 118.08 68.56 Favored Pre-proline 0 C--N 1.325 -0.489 0 CA-C-O 121.174 0.512 . . . . 15.0 111.346 -175.284 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 212' ' ' PRO . . . . . 0.636 ' HB3' HD11 ' A' ' 253' ' ' LEU . 9.2 Cg_endo -89.93 146.06 4.58 Favored 'Trans proline' 0 N--CA 1.451 -0.974 0 C-N-CA 122.816 2.344 . . . . 15.0 111.157 172.46 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -89.52 159.32 28.23 Favored Glycine 0 N--CA 1.439 -1.148 0 C-N-CA 120.099 -1.048 . . . . 15.0 111.702 -179.502 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 214' ' ' SEP . . . . . 0.636 ' HB2' HG21 ' A' ' 245' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 215' ' ' PRO . . . . . 1.206 ' HB2' ' CZ2' ' A' ' 262' ' ' TRP 0.262 16.9 Cg_exo -87.41 149.89 7.74 Favored 'Trans proline' 0 C--O 1.236 0.389 0 C-N-CA 123.248 2.632 . . . . 15.0 110.637 179.831 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 216' ' ' PHE . . . . . . . . . . . . . 99.1 m-85 -108.52 118.37 36.6 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 120.809 0.337 . . . . 15.0 110.182 -179.498 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 217' ' ' GLN . . . . . . . . . . . . . 63.8 tt0 . . . . . 0 C--O 1.246 0.91 0 CA-C-O 118.671 -0.681 . . . . 15.0 109.167 176.951 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 5.6 mp0 . . . . . 0 N--CA 1.481 1.088 0 CA-C-O 120.853 0.359 . . . . 15.0 110.454 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 5.8 mt -95.63 172.97 4.71 Favored Pre-proline 0 C--N 1.323 -0.582 0 N-CA-C 109.676 -0.49 . . . . 15.0 109.676 -179.66 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 237' ' ' PRO . . . . . 0.62 ' HD3' ' HD3' ' A' ' 266' ' ' ARG . 21.9 Cg_exo -69.37 161.16 46.97 Favored 'Trans proline' 0 C--O 1.235 0.333 0 C-N-CA 121.876 1.717 . . . . 15.0 110.398 164.466 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 238' ' ' GLU . . . . . 0.404 ' H ' ' CD ' ' A' ' 238' ' ' GLU . 1.3 pm0 -69.65 150.39 47.06 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-N 115.496 -0.774 . . . . 15.0 110.914 -175.313 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 100.24 -15.13 59.32 Favored Glycine 0 N--CA 1.447 -0.625 0 CA-C-N 115.688 -0.687 . . . . 15.0 112.599 -177.729 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 240' ' ' TYR . . . . . 0.468 ' CD1' ' HG2' ' A' ' 265' ' ' PRO . 65.9 m-85 -94.61 116.42 28.75 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.142 0.496 . . . . 15.0 110.523 177.057 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -95.3 116.93 29.43 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 115.625 -0.716 . . . . 15.0 109.123 174.843 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -90.01 97.45 11.2 Favored 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 108.993 -0.743 . . . . 15.0 108.993 178.03 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 243' ' ' ARG . . . . . 0.439 HH11 ' HD2' ' A' ' 243' ' ' ARG . 11.9 mtp180 -100.42 149.54 23.55 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 115.298 -0.865 . . . . 15.0 111.478 -179.162 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 244' ' ' THR . . . . . . . . . . . . . 22.8 m -117.64 128.7 55.18 Favored 'General case' 0 C--N 1.309 -1.172 0 CA-C-N 114.08 -1.418 . . . . 15.0 108.718 -178.629 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 245' ' ' THR . . . . . 0.422 HG22 ' O ' ' A' ' 249' ' ' GLN . 8.3 t -115.28 150.44 36.21 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 116.277 -0.42 . . . . 15.0 111.03 -174.113 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 50.8 t -57.73 -15.78 4.87 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 CA-C-N 115.795 -0.639 . . . . 15.0 111.302 179.865 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 247' ' ' GLN . . . . . . . . . . . . . 8.8 mm100 -61.46 -20.82 63.57 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 121.093 0.473 . . . . 15.0 110.65 175.553 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 90.63 36.98 6.64 Favored Glycine 0 N--CA 1.452 -0.28 0 CA-C-N 115.559 -0.746 . . . . 15.0 112.003 178.546 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 249' ' ' GLN . . . . . 0.456 ' NE2' ' HD2' ' B' ' 215' ' ' PRO . 8.0 pt20 -148.02 139.62 23.75 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.873 0.368 . . . . 15.0 111.12 -175.524 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 15.9 m -89.95 135.58 25.92 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 N-CA-C 109.395 -0.595 . . . . 15.0 109.395 172.557 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 251' ' ' TYR . . . . . 0.697 ' CD2' ' HD3' ' B' ' 215' ' ' PRO . 0.6 OUTLIER -136.81 138.36 40.77 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-O 120.95 0.405 . . . . 15.0 110.123 -179.981 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 252' ' ' PHE . . . . . 0.623 ' CE2' ' HA ' ' A' ' 264' ' ' ASP . 40.6 m-85 -89.99 118.2 29.37 Favored 'General case' 0 CA--C 1.512 -0.491 0 CA-C-O 121.229 0.537 . . . . 15.0 111.449 -173.419 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 253' ' ' LEU . . . . . 0.898 HD11 ' HB3' ' B' ' 212' ' ' PRO . 0.8 OUTLIER -110.26 106.77 16.29 Favored 'General case' 0 N--CA 1.446 -0.653 0 CA-C-N 114.714 -1.13 . . . . 15.0 111.885 -173.048 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 254' ' ' HIS . . . . . 0.417 ' HB2' ' CD1' ' A' ' 240' ' ' TYR . 26.8 t-80 -115.41 95.03 4.97 Favored 'General case' 0 C--N 1.312 -1.048 0 N-CA-C 108.298 -1.001 . . . . 15.0 108.298 170.104 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 26.3 m -94.08 88.02 5.51 Favored 'General case' 0 N--CA 1.43 -1.436 0 C-N-CA 116.985 -1.886 . . . . 15.0 110.459 -179.08 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 58.9 tt0 -101.12 -51.15 3.59 Favored 'General case' 0 N--CA 1.438 -1.033 0 N-CA-C 105.924 -1.88 . . . . 15.0 105.924 146.768 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 257' ' ' THR . . . . . . . . . . . . . 63.1 p -99.94 -13.69 19.02 Favored 'General case' 0 CA--C 1.484 -1.581 0 CA-C-O 124.735 2.207 . . . . 15.0 112.275 -178.062 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 83.09 76.18 1.14 Allowed Glycine 1 C--N 1.239 -4.851 0 CA-C-N 108.594 -3.912 . . . . 15.0 111.934 -170.225 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 259' ' ' VAL . . . . . 0.677 ' O ' ' HA ' ' A' ' 253' ' ' LEU . 54.8 t -89.35 124.47 42.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-O 121.478 0.656 . . . . 15.0 111.725 176.86 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 3.6 p -135.04 97.41 3.73 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 114.285 -1.325 . . . . 15.0 108.394 171.347 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 10.6 t -134.92 150.26 50.39 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.037 0.446 . . . . 15.0 112.018 -170.387 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 262' ' ' TRP . . . . . 1.148 ' CZ2' ' HB2' ' B' ' 215' ' ' PRO . 42.3 m95 -72.15 -31.04 65.6 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.38 -0.827 . . . . 15.0 111.844 177.341 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 263' ' ' HIS . . . . . . . . . . . . . 10.4 p-80 -80.15 130.74 35.45 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 120.196 -0.602 . . . . 15.0 110.155 -174.413 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 264' ' ' ASP . . . . . 1.094 ' HB3' HG12 ' A' ' 267' ' ' ILE . 13.8 t0 -63.12 127.44 90.93 Favored Pre-proline 0 C--N 1.321 -0.64 0 N-CA-C 107.77 -1.196 . . . . 15.0 107.77 171.169 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 265' ' ' PRO . . . . . 0.468 ' HG2' ' CD1' ' A' ' 240' ' ' TYR . 15.9 Cg_exo -69.09 -14.9 39.05 Favored 'Trans proline' 0 C--N 1.323 -0.799 0 C-N-CA 121.878 1.719 . . . . 15.0 113.087 -178.118 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 266' ' ' ARG . . . . . 0.62 ' HD3' ' HD3' ' A' ' 237' ' ' PRO . 4.5 tpt180 -80.83 -6.5 58.66 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-O 121.834 0.826 . . . . 15.0 109.156 175.031 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 267' ' ' ILE . . . . . 1.094 HG12 ' HB3' ' A' ' 264' ' ' ASP . 48.2 pt . . . . . 0 C--O 1.248 0.987 0 CA-C-N 114.299 -1.318 . . . . 15.0 111.689 177.735 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 210' ' ' SER . . . . . . . . . . . . . 9.5 m . . . . . 0 N--CA 1.479 0.988 0 CA-C-O 120.759 0.314 . . . . 15.0 110.72 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 211' ' ' ASP . . . . . 0.422 ' HA ' ' HD3' ' B' ' 212' ' ' PRO . 3.0 m-20 -89.85 119.53 69.41 Favored Pre-proline 0 C--O 1.233 0.185 0 CA-C-N 116.278 -0.419 . . . . 15.0 110.319 -173.243 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 212' ' ' PRO . . . . . 0.898 ' HB3' HD11 ' A' ' 253' ' ' LEU . 1.9 Cg_endo -90.0 149.14 4.77 Favored 'Trans proline' 0 N--CA 1.458 -0.586 0 C-N-CA 123.118 2.545 . . . . 15.0 112.234 177.995 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -89.61 141.15 15.97 Favored Glycine 0 N--CA 1.446 -0.68 0 C-N-CA 120.925 -0.655 . . . . 15.0 112.607 -179.647 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 214' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 215' ' ' PRO . . . . . 1.148 ' HB2' ' CZ2' ' A' ' 262' ' ' TRP 0.251 16.8 Cg_exo -88.06 139.12 4.38 Favored 'Trans proline' 0 N--CA 1.475 0.428 0 C-N-CA 124.125 3.217 . . . . 15.0 112.932 -172.635 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 216' ' ' PHE . . . . . . . . . . . . . 69.7 m-85 -96.08 127.4 42.06 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.571 -0.741 . . . . 15.0 109.102 175.008 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 217' ' ' GLN . . . . . . . . . . . . . 12.3 pt20 . . . . . 0 C--O 1.247 0.952 0 CA-C-O 118.412 -0.804 . . . . 15.0 111.122 -177.68 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 . . . . . 0 N--CA 1.48 1.071 0 N-CA-C 109.843 -0.429 . . . . 15.0 109.843 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 236' ' ' LEU . . . . . 0.447 HD22 ' N ' ' A' ' 236' ' ' LEU . 1.1 mm? -114.63 168.04 8.71 Favored Pre-proline 0 C--N 1.32 -0.677 0 N-CA-C 109.765 -0.457 . . . . 15.0 109.765 -179.82 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 237' ' ' PRO . . . . . 0.458 ' HD3' ' HD3' ' A' ' 266' ' ' ARG . 16.2 Cg_exo -69.53 164.72 33.23 Favored 'Trans proline' 0 N--CA 1.459 -0.522 0 C-N-CA 121.801 1.667 . . . . 15.0 110.118 165.011 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -69.58 135.65 50.28 Favored 'General case' 0 C--N 1.303 -1.443 0 CA-C-N 115.053 -0.976 . . . . 15.0 111.361 -171.955 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 100.44 21.63 12.68 Favored Glycine 0 CA--C 1.521 0.431 0 CA-C-N 115.504 -0.771 . . . . 15.0 114.349 178.794 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 240' ' ' TYR . . . . . 0.749 ' CD1' ' HB2' ' A' ' 254' ' ' HIS . 73.7 m-85 -112.39 114.43 27.14 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 118.298 1.049 . . . . 15.0 110.798 175.307 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 37.5 mm-40 -98.2 119.44 36.86 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.686 -0.688 . . . . 15.0 109.216 175.341 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -89.93 107.52 19.16 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 108.032 -1.099 . . . . 15.0 108.032 175.909 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 6.3 mtp85 -97.25 132.38 43.06 Favored 'General case' 0 CA--C 1.496 -1.109 0 CA-C-O 122.451 1.119 . . . . 15.0 113.434 -172.774 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 244' ' ' THR . . . . . . . . . . . . . 1.3 m -100.66 89.92 4.07 Favored 'General case' 0 C--N 1.306 -1.314 0 CA-C-N 112.805 -1.998 . . . . 15.0 109.05 177.517 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 245' ' ' THR . . . . . 1.05 HG23 ' HG2' ' A' ' 247' ' ' GLN . 7.8 t -95.04 150.75 19.83 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 114.989 -1.005 . . . . 15.0 110.401 -176.653 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 61.1 t -39.69 -30.9 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 N-CA-C 113.901 1.075 . . . . 15.0 113.901 -174.947 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 247' ' ' GLN . . . . . 1.05 ' HG2' HG23 ' A' ' 245' ' ' THR . 3.8 pt20 -56.55 -21.14 24.34 Favored 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 111.838 0.31 . . . . 15.0 111.838 178.111 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 80.42 37.21 21.46 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 121.141 -0.552 . . . . 15.0 112.988 176.49 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 249' ' ' GLN . . . . . 0.488 ' HB2' ' OE1' ' A' ' 247' ' ' GLN . 32.3 mt-30 -135.71 149.98 49.4 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.678 -0.49 . . . . 15.0 109.678 179.633 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 15.5 m -89.83 128.23 41.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 120.934 0.397 . . . . 15.0 110.562 178.433 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 251' ' ' TYR . . . . . 0.715 ' CB ' ' HG2' ' B' ' 215' ' ' PRO . 4.0 p90 -138.69 133.19 31.98 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.006 0.431 . . . . 15.0 109.883 -178.647 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 252' ' ' PHE . . . . . 0.679 ' CD2' ' HA ' ' A' ' 264' ' ' ASP . 36.0 m-85 -89.78 118.2 29.2 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.023 -0.535 . . . . 15.0 110.88 -175.007 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 253' ' ' LEU . . . . . 0.578 HD11 ' HB3' ' B' ' 212' ' ' PRO . 0.7 OUTLIER -111.1 119.33 38.62 Favored 'General case' 0 N--CA 1.447 -0.617 0 CA-C-N 115.09 -0.959 . . . . 15.0 110.398 -177.674 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 254' ' ' HIS . . . . . 0.749 ' HB2' ' CD1' ' A' ' 240' ' ' TYR . 26.3 t60 -133.0 101.31 5.18 Favored 'General case' 0 CA--C 1.495 -1.14 0 N-CA-C 108.956 -0.757 . . . . 15.0 108.956 173.951 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 3.5 t -95.89 87.66 4.69 Favored 'General case' 0 N--CA 1.432 -1.333 0 C-N-CA 116.388 -2.125 . . . . 15.0 110.617 179.74 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 256' ' ' GLN . . . . . 0.478 ' HB2' ' CE1' ' A' ' 254' ' ' HIS . 44.3 tt0 -101.35 -55.96 2.42 Favored 'General case' 0 N--CA 1.441 -0.906 0 N-CA-C 105.973 -1.862 . . . . 15.0 105.973 150.807 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 257' ' ' THR . . . . . . . . . . . . . 80.4 p -99.77 -13.72 19.15 Favored 'General case' 0 CA--C 1.489 -1.383 0 CA-C-N 111.893 -2.412 . . . . 15.0 112.047 -176.275 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 89.16 70.6 1.26 Allowed Glycine 1 C--N 1.242 -4.655 0 CA-C-N 108.537 -3.938 . . . . 15.0 112.903 -171.025 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 259' ' ' VAL . . . . . 0.512 ' O ' ' HA ' ' A' ' 253' ' ' LEU . 54.6 t -90.05 127.38 42.66 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.31 0 CA-C-O 121.207 0.527 . . . . 15.0 112.251 176.861 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 2.3 p -145.68 102.15 3.64 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 114.672 -1.149 . . . . 15.0 108.416 169.686 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 5.5 t -145.48 150.12 35.9 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 115.868 -0.606 . . . . 15.0 111.781 -171.384 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 262' ' ' TRP . . . . . 1.18 ' CZ2' ' HB2' ' B' ' 215' ' ' PRO . 90.2 m95 -71.52 -23.31 61.76 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.358 -0.837 . . . . 15.0 111.199 176.535 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 263' ' ' HIS . . . . . . . . . . . . . 1.9 p80 -87.88 132.07 34.34 Favored 'General case' 0 C--O 1.234 0.266 0 C-N-CA 120.231 -0.587 . . . . 15.0 110.524 -173.939 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 264' ' ' ASP . . . . . 0.775 ' HB3' HG12 ' A' ' 267' ' ' ILE . 9.2 t70 -51.82 130.92 38.19 Favored Pre-proline 0 C--N 1.326 -0.439 0 CA-C-N 115.359 -0.837 . . . . 15.0 109.574 175.332 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 265' ' ' PRO . . . . . 0.519 ' HD3' ' CD2' ' A' ' 252' ' ' PHE . 71.9 Cg_endo -78.11 -14.89 14.86 Favored 'Trans proline' 0 CA--C 1.514 -0.506 0 C-N-CA 122.384 2.056 . . . . 15.0 113.644 -173.964 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 266' ' ' ARG . . . . . 0.458 ' HD3' ' HD3' ' A' ' 237' ' ' PRO . 7.2 tpt180 -77.08 -8.24 57.12 Favored 'General case' 0 C--N 1.311 -1.074 0 N-CA-C 107.694 -1.224 . . . . 15.0 107.694 174.546 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 267' ' ' ILE . . . . . 0.775 HG12 ' HB3' ' A' ' 264' ' ' ASP . 28.4 mm . . . . . 0 C--O 1.248 0.976 0 CA-C-N 113.537 -1.665 . . . . 15.0 109.216 174.634 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 210' ' ' SER . . . . . . . . . . . . . 14.9 m . . . . . 0 N--CA 1.477 0.889 0 CA-C-O 120.84 0.352 . . . . 15.0 110.572 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 211' ' ' ASP . . . . . 0.456 ' HA ' ' HD3' ' B' ' 212' ' ' PRO . 11.8 m-20 -89.81 130.61 42.27 Favored Pre-proline 0 C--N 1.332 -0.175 0 CA-C-N 116.449 -0.341 . . . . 15.0 110.274 -177.511 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 212' ' ' PRO . . . . . 0.578 ' HB3' HD11 ' A' ' 253' ' ' LEU . 5.0 Cg_endo -90.04 151.37 4.8 Favored 'Trans proline' 0 N--CA 1.46 -0.46 0 C-N-CA 123.483 2.788 . . . . 15.0 113.179 -175.404 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -89.95 160.21 28.41 Favored Glycine 0 N--CA 1.444 -0.796 0 CA-C-N 115.346 -0.843 . . . . 15.0 112.839 178.538 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 214' ' ' SEP . . . . . 0.673 ' HB2' HG21 ' A' ' 245' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 215' ' ' PRO . . . . . 1.18 ' HB2' ' CZ2' ' A' ' 262' ' ' TRP . 30.3 Cg_exo -87.19 146.41 7.55 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 123.172 2.581 . . . . 15.0 111.47 176.672 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 216' ' ' PHE . . . . . . . . . . . . . 87.5 m-85 -122.87 137.79 54.84 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 110.391 -0.225 . . . . 15.0 110.391 179.929 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 217' ' ' GLN . . . . . . . . . . . . . 10.6 tt0 . . . . . 0 C--O 1.248 1.017 0 O-C-N 124.339 1.025 . . . . 15.0 110.541 179.789 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.479 1.022 0 CA-C-O 120.693 0.282 . . . . 15.0 110.834 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 5.8 mt -103.89 170.37 6.22 Favored Pre-proline 0 C--N 1.325 -0.491 0 N-CA-C 108.948 -0.76 . . . . 15.0 108.948 178.92 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 237' ' ' PRO . . . . . 0.52 ' HD3' ' HD3' ' A' ' 266' ' ' ARG . 17.2 Cg_exo -69.31 156.96 63.01 Favored 'Trans proline' 0 N--CA 1.458 -0.563 0 C-N-CA 121.55 1.5 . . . . 15.0 109.636 162.842 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 4.6 mp0 -69.71 149.38 48.09 Favored 'General case' 0 C--N 1.31 -1.146 0 CA-C-O 121.341 0.591 . . . . 15.0 111.409 -173.325 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 100.19 -7.36 58.5 Favored Glycine 0 N--CA 1.446 -0.66 0 CA-C-N 115.173 -0.921 . . . . 15.0 113.722 179.905 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 240' ' ' TYR . . . . . 0.66 ' CD1' ' HB2' ' A' ' 254' ' ' HIS . 67.7 m-85 -91.03 113.13 25.31 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 117.535 0.667 . . . . 15.0 110.81 178.199 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 57.9 mm-40 -92.05 118.41 30.77 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 109.367 -0.605 . . . . 15.0 109.367 174.924 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 24.8 tm0? -89.94 107.75 19.3 Favored 'General case' 0 C--N 1.314 -0.963 0 N-CA-C 109.163 -0.68 . . . . 15.0 109.163 176.806 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 243' ' ' ARG . . . . . 0.429 ' HB2' ' CE1' ' A' ' 251' ' ' TYR . 17.3 mtp85 -103.47 150.03 24.27 Favored 'General case' 0 CA--C 1.512 -0.519 0 CA-C-O 122.116 0.96 . . . . 15.0 111.982 178.081 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 244' ' ' THR . . . . . . . . . . . . . 24.4 p -111.27 148.24 33.31 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-N 113.504 -1.68 . . . . 15.0 109.367 -179.064 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 245' ' ' THR . . . . . 0.463 ' OG1' ' HG2' ' A' ' 247' ' ' GLN . 6.0 t -145.26 150.11 36.09 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-O 120.641 0.258 . . . . 15.0 111.142 -175.186 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 7.7 p -50.87 -26.79 4.55 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.219 0 CA-C-N 115.541 -0.754 . . . . 15.0 111.256 177.748 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 247' ' ' GLN . . . . . 0.463 ' HG2' ' OG1' ' A' ' 245' ' ' THR . 6.8 mm-40 -53.75 -21.4 7.16 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 114.787 -1.097 . . . . 15.0 111.472 177.959 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 81.82 25.19 53.78 Favored Glycine 0 CA--C 1.509 -0.282 0 C-N-CA 121.255 -0.498 . . . . 15.0 111.871 178.146 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 249' ' ' GLN . . . . . 0.419 ' CD ' ' HH2' ' A' ' 262' ' ' TRP . 0.6 OUTLIER -130.47 138.37 50.24 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.759 -0.46 . . . . 15.0 109.759 -175.614 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 18.8 m -90.02 132.43 34.72 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 N-CA-C 109.354 -0.61 . . . . 15.0 109.354 175.968 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 251' ' ' TYR . . . . . 0.511 ' HB3' ' HG2' ' B' ' 215' ' ' PRO . 4.4 p90 -135.16 134.19 39.91 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.486 0.66 . . . . 15.0 111.325 -178.7 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 252' ' ' PHE . . . . . 0.731 ' CE2' ' HA ' ' A' ' 264' ' ' ASP . 37.8 m-85 -90.28 118.5 29.84 Favored 'General case' 0 CA--C 1.516 -0.335 0 CA-C-N 115.246 -0.888 . . . . 15.0 111.046 -176.654 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 253' ' ' LEU . . . . . 0.876 HD11 ' HB3' ' B' ' 212' ' ' PRO . 0.5 OUTLIER -109.9 99.21 8.37 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-N 114.942 -1.026 . . . . 15.0 111.205 -174.675 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 254' ' ' HIS . . . . . 0.66 ' HB2' ' CD1' ' A' ' 240' ' ' TYR . 79.8 t60 -112.17 92.56 4.07 Favored 'General case' 0 CA--C 1.499 -1.018 0 N-CA-C 108.57 -0.9 . . . . 15.0 108.57 169.58 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 7.9 t -96.55 88.06 4.57 Favored 'General case' 0 N--CA 1.432 -1.331 0 C-N-CA 116.524 -2.07 . . . . 15.0 110.729 -179.076 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 49.1 tt0 -101.17 -50.39 3.8 Favored 'General case' 0 N--CA 1.441 -0.924 0 CA-C-N 113.127 -1.851 . . . . 15.0 106.42 151.601 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 257' ' ' THR . . . . . . . . . . . . . 68.7 p -97.99 -13.57 21.05 Favored 'General case' 0 CA--C 1.488 -1.431 0 CA-C-O 124.865 2.269 . . . . 15.0 111.681 -179.565 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 88.71 71.41 1.27 Allowed Glycine 1 C--N 1.241 -4.737 1 CA-C-N 108.224 -4.08 . . . . 15.0 113.109 -171.602 . . . . . . . . 3 2 . 1 . 006 nuclear build full ' A' A ' 259' ' ' VAL . . . . . 0.574 ' O ' ' HA ' ' A' ' 253' ' ' LEU . 45.8 t -89.81 124.45 42.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 121.376 0.607 . . . . 15.0 111.911 174.962 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -136.94 92.36 2.72 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 114.541 -1.209 . . . . 15.0 108.018 167.763 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 5.0 t -129.27 150.23 50.73 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.705 -0.679 . . . . 15.0 111.966 -166.193 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 262' ' ' TRP . . . . . 1.185 ' CZ2' ' HB2' ' B' ' 215' ' ' PRO . 85.5 m95 -71.61 -50.63 29.04 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.164 -0.926 . . . . 15.0 111.691 179.337 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 263' ' ' HIS . . . . . . . . . . . . . 5.4 p80 -66.49 134.48 52.53 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.912 -0.586 . . . . 15.0 110.629 -175.527 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 264' ' ' ASP . . . . . 1.083 ' HB3' HG12 ' A' ' 267' ' ' ILE . 37.8 t0 -54.29 124.14 45.55 Favored Pre-proline 0 C--O 1.218 -0.554 0 N-CA-C 107.408 -1.33 . . . . 15.0 107.408 167.217 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 265' ' ' PRO . . . . . 0.597 ' HD3' ' CD2' ' A' ' 252' ' ' PHE . 12.6 Cg_exo -69.03 -14.67 38.84 Favored 'Trans proline' 0 C--N 1.323 -0.794 0 C-N-CA 121.788 1.659 . . . . 15.0 112.617 -176.324 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 266' ' ' ARG . . . . . 0.52 ' HD3' ' HD3' ' A' ' 237' ' ' PRO . 5.8 tpt180 -78.28 -9.86 59.41 Favored 'General case' 0 N--CA 1.439 -0.998 0 CA-C-O 121.861 0.838 . . . . 15.0 109.136 173.143 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 267' ' ' ILE . . . . . 1.083 HG12 ' HB3' ' A' ' 264' ' ' ASP . 48.2 pt . . . . . 0 C--O 1.246 0.89 0 CA-C-O 117.543 -1.218 . . . . 15.0 110.875 176.779 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 210' ' ' SER . . . . . . . . . . . . . 16.6 p . . . . . 0 N--CA 1.481 1.125 0 CA-C-O 120.859 0.361 . . . . 15.0 110.735 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' 211' ' ' ASP . . . . . 0.418 ' HA ' ' HD3' ' B' ' 212' ' ' PRO . 2.8 m-20 -89.97 115.27 63.55 Favored Pre-proline 0 C--N 1.331 -0.223 0 CA-C-N 116.4 -0.364 . . . . 15.0 110.799 -173.948 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 212' ' ' PRO . . . . . 0.876 ' HB3' HD11 ' A' ' 253' ' ' LEU . 2.6 Cg_endo -89.67 154.13 5.18 Favored 'Trans proline' 0 N--CA 1.456 -0.7 0 C-N-CA 122.752 2.301 . . . . 15.0 112.104 175.789 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -89.95 134.55 12.42 Favored Glycine 0 N--CA 1.446 -0.636 0 C-N-CA 120.554 -0.831 . . . . 15.0 112.296 179.43 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 214' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' 215' ' ' PRO . . . . . 1.185 ' HB2' ' CZ2' ' A' ' 262' ' ' TRP . 8.0 Cg_exo -87.94 147.62 6.87 Favored 'Trans proline' 0 C--O 1.235 0.333 0 C-N-CA 124.197 3.265 . . . . 15.0 112.38 -169.071 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 216' ' ' PHE . . . . . . . . . . . . . 85.1 m-85 -103.4 112.62 25.59 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 109.012 -0.736 . . . . 15.0 109.012 175.903 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 217' ' ' GLN . . . . . 0.476 ' H ' ' HG3' ' B' ' 217' ' ' GLN . 0.5 OUTLIER . . . . . 0 C--O 1.248 1.001 0 CA-C-O 118.427 -0.797 . . . . 15.0 111.635 -175.732 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 . . . . . 0 N--CA 1.48 1.06 0 N-CA-C 109.582 -0.525 . . . . 15.0 109.582 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 236' ' ' LEU . . . . . 0.441 HD22 ' N ' ' A' ' 236' ' ' LEU . 1.2 mm? -110.59 165.75 12.07 Favored Pre-proline 0 C--N 1.323 -0.584 0 CA-C-O 121.03 0.443 . . . . 15.0 110.586 -176.07 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 237' ' ' PRO . . . . . 0.548 ' HD3' ' HD3' ' A' ' 266' ' ' ARG . 21.9 Cg_exo -69.34 166.58 26.6 Favored 'Trans proline' 0 N--CA 1.46 -0.442 0 C-N-CA 122.257 1.971 . . . . 15.0 110.528 163.885 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 -69.92 147.23 50.49 Favored 'General case' 0 C--N 1.304 -1.391 0 CA-C-N 115.038 -0.983 . . . . 15.0 111.809 -176.382 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 100.25 0.93 55.8 Favored Glycine 0 CA--C 1.518 0.237 0 CA-C-N 115.348 -0.842 . . . . 15.0 113.34 179.736 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 240' ' ' TYR . . . . . 0.493 ' HD2' ' O ' ' A' ' 237' ' ' PRO . 56.5 m-85 -97.45 121.37 39.26 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.552 0.691 . . . . 15.0 111.574 -178.419 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 241' ' ' GLU . . . . . 0.745 ' HB2' ' HB2' ' A' ' 253' ' ' LEU . 7.6 mp0 -89.87 100.45 13.26 Favored 'General case' 0 N--CA 1.442 -0.833 0 CA-C-N 114.885 -1.052 . . . . 15.0 108.777 173.147 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 1.5 tm0? -89.94 113.99 25.73 Favored 'General case' 0 C--N 1.313 -1.006 0 N-CA-C 108.451 -0.944 . . . . 15.0 108.451 179.33 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 243' ' ' ARG . . . . . 0.503 ' CZ ' ' HG2' ' B' ' 212' ' ' PRO . 28.0 mtt180 -112.94 144.94 41.65 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-O 122.392 1.092 . . . . 15.0 111.926 179.511 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 244' ' ' THR . . . . . . . . . . . . . 15.8 m -120.29 92.14 3.7 Favored 'General case' 0 C--N 1.304 -1.373 0 CA-C-N 112.998 -1.91 . . . . 15.0 108.263 178.93 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 245' ' ' THR . . . . . 0.498 ' OG1' ' HG2' ' A' ' 247' ' ' GLN . 6.7 t -89.72 149.99 22.51 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 115.441 -0.799 . . . . 15.0 110.989 -171.882 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 23.0 t -55.2 -15.13 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 CA-C-N 115.816 -0.629 . . . . 15.0 111.349 -179.194 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 247' ' ' GLN . . . . . 0.498 ' HG2' ' OG1' ' A' ' 245' ' ' THR . 8.3 mm-40 -59.29 -15.27 14.9 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 115.895 -0.593 . . . . 15.0 111.128 176.413 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 89.51 37.4 7.02 Favored Glycine 0 C--N 1.333 0.407 0 C-N-CA 121.218 -0.515 . . . . 15.0 112.164 178.334 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 249' ' ' GLN . . . . . 0.482 ' OE1' ' HD2' ' B' ' 215' ' ' PRO . 0.6 OUTLIER -150.17 147.14 27.37 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.399 0.619 . . . . 15.0 111.515 -174.905 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 16.6 m -100.92 131.41 48.61 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.928 0 CA-C-N 114.561 -1.2 . . . . 15.0 108.386 169.189 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 251' ' ' TYR . . . . . 0.549 ' CD2' ' HD3' ' B' ' 215' ' ' PRO . 2.7 p90 -137.28 137.93 39.52 Favored 'General case' 0 C--N 1.317 -0.811 0 C-N-CA 120.558 -0.457 . . . . 15.0 110.395 -175.149 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 252' ' ' PHE . . . . . 0.738 ' CD2' ' HA ' ' A' ' 264' ' ' ASP . 40.8 m-85 -95.75 110.95 23.02 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.569 0.7 . . . . 15.0 112.329 -172.824 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 253' ' ' LEU . . . . . 0.745 ' HB2' ' HB2' ' A' ' 241' ' ' GLU . 38.9 mt -93.0 144.69 25.0 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 114.241 -1.345 . . . . 15.0 109.848 172.176 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 254' ' ' HIS . . . . . 0.56 ' HB3' ' HB ' ' A' ' 259' ' ' VAL . 81.3 t60 -143.53 89.77 2.1 Favored 'General case' 0 C--N 1.305 -1.343 0 N-CA-C 107.31 -1.367 . . . . 15.0 107.31 164.143 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 16.3 m -91.72 87.61 6.37 Favored 'General case' 0 N--CA 1.426 -1.632 0 C-N-CA 115.655 -2.418 . . . . 15.0 110.096 -178.307 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 49.1 tt0 -101.53 -53.59 2.95 Favored 'General case' 0 N--CA 1.435 -1.193 0 CA-C-N 112.793 -2.003 . . . . 15.0 105.82 145.753 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 257' ' ' THR . . . . . . . . . . . . . 71.8 p -100.2 -13.52 18.88 Favored 'General case' 0 CA--C 1.49 -1.357 0 CA-C-O 124.727 2.203 . . . . 15.0 112.56 -176.459 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 86.07 73.24 1.28 Allowed Glycine 1 C--N 1.241 -4.747 0 CA-C-N 108.461 -3.972 . . . . 15.0 113.04 -172.529 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 259' ' ' VAL . . . . . 0.587 ' O ' ' HA ' ' A' ' 253' ' ' LEU . 74.9 t -89.71 136.76 22.89 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 CA-C-O 120.923 0.392 . . . . 15.0 112.028 174.127 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 4.0 p -145.62 100.02 3.37 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 114.822 -1.081 . . . . 15.0 108.731 168.834 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 24.3 p -132.39 150.17 52.21 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 112.216 0.45 . . . . 15.0 112.216 -172.364 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 262' ' ' TRP . . . . . 1.184 ' CZ2' ' HB2' ' B' ' 215' ' ' PRO . 71.1 m95 -72.87 -30.0 63.63 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.781 -0.645 . . . . 15.0 110.68 174.347 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 263' ' ' HIS . . . . . . . . . . . . . 3.3 p80 -77.89 129.31 35.21 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.967 0.413 . . . . 15.0 110.252 -177.666 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 264' ' ' ASP . . . . . 1.038 ' HB3' HG12 ' A' ' 267' ' ' ILE . 9.1 t0 -59.21 129.21 86.27 Favored Pre-proline 0 C--N 1.319 -0.734 0 N-CA-C 108.509 -0.923 . . . . 15.0 108.509 172.032 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 265' ' ' PRO . . . . . 0.545 ' HD3' ' CD2' ' A' ' 252' ' ' PHE . 4.4 Cg_exo -74.19 -14.65 23.18 Favored 'Trans proline' 0 CA--C 1.509 -0.729 0 C-N-CA 122.112 1.875 . . . . 15.0 113.228 -175.737 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 266' ' ' ARG . . . . . 0.548 ' HD3' ' HD3' ' A' ' 237' ' ' PRO . 2.1 tpp180 -77.41 -11.55 59.85 Favored 'General case' 0 C--N 1.31 -1.119 0 N-CA-C 108.055 -1.091 . . . . 15.0 108.055 172.978 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 267' ' ' ILE . . . . . 1.038 HG12 ' HB3' ' A' ' 264' ' ' ASP . 31.8 pt . . . . . 0 C--O 1.249 1.05 0 CA-C-N 114.551 -1.204 . . . . 15.0 111.0 176.886 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 210' ' ' SER . . . . . . . . . . . . . 63.0 p . . . . . 0 N--CA 1.479 1.002 0 CA-C-O 120.72 0.295 . . . . 15.0 110.841 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 211' ' ' ASP . . . . . 0.442 ' HA ' ' HD3' ' B' ' 212' ' ' PRO . 56.6 m-20 -104.49 120.62 49.94 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 120.894 0.378 . . . . 15.0 110.294 179.485 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 212' ' ' PRO . . . . . 0.52 ' CB ' HD11 ' A' ' 253' ' ' LEU . 3.4 Cg_exo -89.64 151.93 5.18 Favored 'Trans proline' 0 N--CA 1.461 -0.435 0 C-N-CA 123.88 3.054 . . . . 15.0 112.17 179.885 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -90.05 132.29 11.19 Favored Glycine 0 N--CA 1.443 -0.888 0 C-N-CA 120.74 -0.743 . . . . 15.0 111.616 178.384 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 214' ' ' SEP . . . . . 0.471 ' HA ' ' HD3' ' B' ' 215' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 215' ' ' PRO . . . . . 1.184 ' HB2' ' CZ2' ' A' ' 262' ' ' TRP . 2.7 Cg_exo -88.41 138.41 3.88 Favored 'Trans proline' 0 N--CA 1.46 -0.444 0 C-N-CA 123.988 3.125 . . . . 15.0 111.394 -177.677 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 216' ' ' PHE . . . . . . . . . . . . . 94.0 m-85 -123.36 -19.82 5.81 Favored 'General case' 0 C--N 1.322 -0.624 0 C-N-CA 120.757 -0.377 . . . . 15.0 110.997 177.947 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 217' ' ' GLN . . . . . . . . . . . . . 10.1 pt20 . . . . . 0 C--O 1.248 1.02 0 CA-C-O 118.37 -0.824 . . . . 15.0 109.8 177.632 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.481 1.079 0 CA-C-O 121.19 0.519 . . . . 15.0 110.323 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 236' ' ' LEU . . . . . 0.534 HD22 ' HD2' ' A' ' 265' ' ' PRO . 11.4 mt -110.75 172.84 3.25 Favored Pre-proline 0 C--N 1.323 -0.566 0 CA-C-N 115.578 -0.737 . . . . 15.0 110.161 -173.78 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 237' ' ' PRO . . . . . 0.591 ' HD3' ' HD3' ' A' ' 266' ' ' ARG . 13.0 Cg_exo -69.78 172.45 12.63 Favored 'Trans proline' 0 CA--C 1.513 -0.566 0 C-N-CA 122.21 1.94 . . . . 15.0 111.151 167.773 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 14.0 tp10 -69.41 134.57 49.16 Favored 'General case' 0 C--N 1.3 -1.549 0 CA-C-N 114.034 -1.439 . . . . 15.0 111.51 -173.474 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 100.15 9.37 48.44 Favored Glycine 0 CA--C 1.524 0.632 0 CA-C-N 115.74 -0.664 . . . . 15.0 114.31 177.013 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 240' ' ' TYR . . . . . 0.69 ' CD1' ' HB2' ' A' ' 254' ' ' HIS . 86.5 m-85 -111.41 116.88 31.67 Favored 'General case' 0 CA--C 1.517 -0.323 0 CA-C-N 118.129 0.964 . . . . 15.0 111.007 175.166 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 17.7 pt-20 -97.63 123.94 41.72 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 109.198 -0.668 . . . . 15.0 109.198 170.72 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 242' ' ' GLN . . . . . 0.564 ' HG3' ' CE1' ' A' ' 252' ' ' PHE . 1.9 tt0 -89.9 99.13 12.2 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 109.058 -0.719 . . . . 15.0 109.058 -177.841 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 84.2 mtt-85 -92.02 150.01 21.22 Favored 'General case' 0 CA--C 1.5 -0.963 0 CA-C-O 122.428 1.109 . . . . 15.0 113.184 -172.736 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 244' ' ' THR . . . . . . . . . . . . . 16.6 p -118.27 139.83 50.72 Favored 'General case' 0 C--N 1.308 -1.221 0 CA-C-N 112.567 -2.106 . . . . 15.0 109.122 174.777 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 245' ' ' THR . . . . . 1.087 HG23 ' HG2' ' A' ' 247' ' ' GLN . 3.4 t -145.02 150.46 36.93 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 116.406 -0.361 . . . . 15.0 110.124 -173.228 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 6.1 m -48.9 -22.15 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 N-CA-C 113.944 1.09 . . . . 15.0 113.944 -175.454 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 247' ' ' GLN . . . . . 1.087 ' HG2' HG23 ' A' ' 245' ' ' THR . 1.7 pt20 -58.56 -22.67 56.49 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-O 120.705 0.288 . . . . 15.0 110.851 176.539 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 91.08 30.3 11.31 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 121.276 -0.488 . . . . 15.0 112.872 177.356 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 249' ' ' GLN . . . . . 0.412 ' HB3' ' CH2' ' A' ' 262' ' ' TRP . 13.3 mp0 -137.9 143.18 40.71 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.888 0.344 . . . . 15.0 111.621 -178.118 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 29.1 m -90.16 138.39 19.54 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.129 0 CA-C-N 115.901 -0.591 . . . . 15.0 109.426 172.747 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 251' ' ' TYR . . . . . 0.686 ' HB3' ' HG2' ' B' ' 215' ' ' PRO . 32.5 p90 -144.09 136.3 26.55 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 120.853 0.358 . . . . 15.0 110.228 -175.529 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 252' ' ' PHE . . . . . 0.651 ' CD2' ' HA ' ' A' ' 264' ' ' ASP . 32.0 m-85 -89.86 119.51 30.3 Favored 'General case' 0 CA--C 1.507 -0.68 0 CA-C-N 116.043 -0.526 . . . . 15.0 111.66 -172.688 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 253' ' ' LEU . . . . . 0.8 HD11 ' HB3' ' B' ' 212' ' ' PRO . 0.4 OUTLIER -113.52 118.62 34.98 Favored 'General case' 0 N--CA 1.441 -0.919 0 CA-C-N 114.854 -1.067 . . . . 15.0 111.141 -175.727 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 254' ' ' HIS . . . . . 0.69 ' HB2' ' CD1' ' A' ' 240' ' ' TYR . 48.3 t60 -128.07 90.28 3.06 Favored 'General case' 0 C--N 1.313 -0.992 0 N-CA-C 108.132 -1.062 . . . . 15.0 108.132 168.552 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 255' ' ' THR . . . . . 0.624 HG22 ' HA2' ' A' ' 258' ' ' GLY . 0.3 OUTLIER -89.82 87.38 6.94 Favored 'General case' 0 N--CA 1.429 -1.485 0 C-N-CA 116.462 -2.095 . . . . 15.0 109.881 178.772 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 35.9 tt0 -101.49 -56.39 2.31 Favored 'General case' 0 N--CA 1.436 -1.16 0 N-CA-C 105.884 -1.895 . . . . 15.0 105.884 150.327 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 257' ' ' THR . . . . . . . . . . . . . 63.3 p -96.65 -13.63 22.69 Favored 'General case' 0 CA--C 1.486 -1.512 0 CA-C-N 111.73 -2.486 . . . . 15.0 111.601 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 258' ' ' GLY . . . . . 0.624 ' HA2' HG22 ' A' ' 255' ' ' THR . . . 86.27 73.05 1.28 Allowed Glycine 1 C--N 1.24 -4.773 1 CA-C-N 108.3 -4.045 . . . . 15.0 113.236 -172.83 . . . . . . . . 4 3 . 1 . 008 nuclear build full ' A' A ' 259' ' ' VAL . . . . . 0.619 ' O ' ' HA ' ' A' ' 253' ' ' LEU . 55.4 t -89.89 123.36 42.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-O 121.202 0.525 . . . . 15.0 112.206 173.539 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 2.5 p -134.53 92.49 2.92 Favored 'General case' 0 C--N 1.317 -0.844 0 N-CA-C 107.818 -1.179 . . . . 15.0 107.818 168.754 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 8.1 t -121.06 150.14 41.64 Favored 'General case' 0 C--N 1.314 -0.938 0 N-CA-C 112.853 0.686 . . . . 15.0 112.853 -165.251 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 262' ' ' TRP . . . . . 1.175 ' CZ2' ' HB2' ' B' ' 215' ' ' PRO . 1.9 m95 -80.94 -18.87 45.59 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 114.777 -1.102 . . . . 15.0 111.26 174.971 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 263' ' ' HIS . . . . . . . . . . . . . 4.0 p80 -100.31 133.61 44.46 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.558 -0.457 . . . . 15.0 110.106 -178.431 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 264' ' ' ASP . . . . . 0.799 ' HB3' HG12 ' A' ' 267' ' ' ILE . 9.8 t70 -55.67 132.92 71.97 Favored Pre-proline 0 C--N 1.321 -0.661 0 CA-C-N 115.908 -0.587 . . . . 15.0 109.529 175.836 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 265' ' ' PRO . . . . . 0.534 ' HD2' HD22 ' A' ' 236' ' ' LEU . 91.7 Cg_endo -80.67 -14.6 11.32 Favored 'Trans proline' 0 N--CA 1.462 -0.381 0 C-N-CA 122.42 2.08 . . . . 15.0 113.543 -176.192 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 266' ' ' ARG . . . . . 0.591 ' HD3' ' HD3' ' A' ' 237' ' ' PRO . 25.2 tpt180 -77.08 -8.52 57.61 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-O 122.269 1.033 . . . . 15.0 108.408 175.156 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 267' ' ' ILE . . . . . 0.799 HG12 ' HB3' ' A' ' 264' ' ' ASP . 43.2 mm . . . . . 0 C--O 1.249 1.052 0 CA-C-N 113.505 -1.68 . . . . 15.0 109.749 176.898 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 210' ' ' SER . . . . . . . . . . . . . 4.7 m . . . . . 0 N--CA 1.471 0.616 0 CA-C-O 120.792 0.33 . . . . 15.0 110.387 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' 211' ' ' ASP . . . . . 0.407 ' HA ' ' HD3' ' B' ' 212' ' ' PRO . 9.2 p-10 -150.17 131.79 7.61 Favored Pre-proline 0 C--N 1.326 -0.437 0 CA-C-N 116.262 -0.427 . . . . 15.0 110.337 -178.75 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 212' ' ' PRO . . . . . 0.8 ' HB3' HD11 ' A' ' 253' ' ' LEU . 12.3 Cg_endo -89.98 140.45 3.4 Favored 'Trans proline' 0 N--CA 1.453 -0.89 0 C-N-CA 122.995 2.463 . . . . 15.0 112.199 178.602 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -89.81 156.77 25.78 Favored Glycine 0 N--CA 1.443 -0.841 0 C-N-CA 120.548 -0.834 . . . . 15.0 111.94 178.895 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 214' ' ' SEP . . . . . 0.434 ' HA ' ' HD3' ' B' ' 215' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 215' ' ' PRO . . . . . 1.175 ' HB2' ' CZ2' ' A' ' 262' ' ' TRP . 17.6 Cg_exo -87.55 141.59 5.68 Favored 'Trans proline' 0 N--CA 1.465 -0.189 0 C-N-CA 123.904 3.069 . . . . 15.0 111.232 179.592 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 216' ' ' PHE . . . . . . . . . . . . . 93.2 m-85 -102.5 -78.37 0.54 Allowed 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 109.816 -0.439 . . . . 15.0 109.816 178.587 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 217' ' ' GLN . . . . . . . . . . . . . 8.4 pt20 . . . . . 0 C--O 1.25 1.082 0 CA-C-N 115.997 -0.547 . . . . 15.0 109.731 176.537 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.475 0.803 0 CA-C-O 120.903 0.382 . . . . 15.0 110.612 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 236' ' ' LEU . . . . . 0.431 HD22 ' N ' ' A' ' 236' ' ' LEU . 0.9 OUTLIER -112.3 170.84 4.85 Favored Pre-proline 0 C--N 1.319 -0.751 0 N-CA-C 108.828 -0.804 . . . . 15.0 108.828 175.35 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 237' ' ' PRO . . . . . 0.763 ' HD3' ' HD3' ' A' ' 266' ' ' ARG . 16.0 Cg_exo -69.24 164.54 33.64 Favored 'Trans proline' 0 CA--C 1.514 -0.524 0 C-N-CA 122.009 1.806 . . . . 15.0 110.399 167.457 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -69.92 143.65 52.65 Favored 'General case' 0 C--N 1.302 -1.465 0 CA-C-N 115.02 -0.991 . . . . 15.0 111.356 -173.695 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 239' ' ' GLY . . . . . 0.416 ' O ' ' HA ' ' A' ' 254' ' ' HIS . . . 100.16 3.9 55.48 Favored Glycine 0 N--CA 1.447 -0.628 0 CA-C-N 115.29 -0.868 . . . . 15.0 113.294 177.985 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 240' ' ' TYR . . . . . 0.728 ' CD1' ' HB2' ' A' ' 254' ' ' HIS . 74.7 m-85 -105.58 126.46 52.16 Favored 'General case' 0 CA--C 1.514 -0.434 0 CA-C-N 117.352 0.576 . . . . 15.0 110.874 176.996 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -111.71 125.23 53.75 Favored 'General case' 0 C--N 1.316 -0.871 0 N-CA-C 109.461 -0.57 . . . . 15.0 109.461 169.526 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 242' ' ' GLN . . . . . 0.486 ' HG3' ' CE1' ' A' ' 252' ' ' PHE . 7.2 tt0 -89.74 104.1 16.69 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.772 -0.649 . . . . 15.0 109.296 -178.62 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 36.0 mtt-85 -97.03 150.01 21.28 Favored 'General case' 0 CA--C 1.505 -0.771 0 CA-C-O 122.23 1.014 . . . . 15.0 112.368 -176.205 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 244' ' ' THR . . . . . . . . . . . . . 13.6 p -120.27 133.36 55.48 Favored 'General case' 0 C--N 1.308 -1.234 0 CA-C-N 113.085 -1.871 . . . . 15.0 109.506 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 245' ' ' THR . . . . . 0.557 ' OG1' ' HG2' ' A' ' 247' ' ' GLN . 4.6 t -137.4 150.23 47.51 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 116.462 -0.335 . . . . 15.0 110.911 -176.317 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 3.6 m -57.16 -15.88 3.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 115.777 -0.647 . . . . 15.0 112.117 178.694 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 247' ' ' GLN . . . . . 0.557 ' HG2' ' OG1' ' A' ' 245' ' ' THR . 6.8 mm100 -54.42 -24.04 18.35 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.123 -0.489 . . . . 15.0 110.245 172.918 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 92.9 34.12 7.01 Favored Glycine 0 C--N 1.333 0.374 0 CA-C-N 115.903 -0.589 . . . . 15.0 111.927 175.91 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 249' ' ' GLN . . . . . 0.494 ' CD ' ' HH2' ' A' ' 262' ' ' TRP . 0.1 OUTLIER -149.42 137.93 20.88 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.449 0.642 . . . . 15.0 111.843 -170.977 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 12.6 m -91.81 128.41 43.51 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.039 0 CA-C-N 114.527 -1.215 . . . . 15.0 109.151 171.16 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 251' ' ' TYR . . . . . 0.625 ' CB ' ' HG3' ' B' ' 215' ' ' PRO . 20.5 p90 -132.8 135.27 45.58 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 109.951 -0.389 . . . . 15.0 109.951 -178.081 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 252' ' ' PHE . . . . . 0.663 ' CD2' ' HA ' ' A' ' 264' ' ' ASP . 30.1 m-85 -90.14 121.74 32.46 Favored 'General case' 0 CA--C 1.513 -0.443 0 CA-C-O 121.224 0.535 . . . . 15.0 111.737 -174.346 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 253' ' ' LEU . . . . . 0.735 HD11 ' HB3' ' B' ' 212' ' ' PRO . 0.5 OUTLIER -109.42 116.51 31.95 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 114.783 -1.099 . . . . 15.0 111.148 -175.824 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 254' ' ' HIS . . . . . 0.728 ' HB2' ' CD1' ' A' ' 240' ' ' TYR . 69.5 t60 -130.21 90.21 2.91 Favored 'General case' 0 CA--C 1.503 -0.859 0 N-CA-C 108.207 -1.035 . . . . 15.0 108.207 169.866 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 3.2 t -91.32 87.95 6.67 Favored 'General case' 0 N--CA 1.432 -1.374 0 C-N-CA 116.659 -2.017 . . . . 15.0 110.111 -179.424 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 48.3 tt0 -101.33 -51.26 3.53 Favored 'General case' 0 N--CA 1.44 -0.963 0 CA-C-N 113.412 -1.722 . . . . 15.0 106.422 150.712 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 257' ' ' THR . . . . . . . . . . . . . 80.9 p -98.19 -13.61 20.78 Favored 'General case' 0 CA--C 1.488 -1.43 0 CA-C-O 124.78 2.229 . . . . 15.0 111.724 178.987 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 87.62 73.15 1.28 Allowed Glycine 1 C--N 1.24 -4.75 1 CA-C-N 108.258 -4.065 . . . . 15.0 112.742 -170.977 . . . . . . . . 3 2 . 1 . 009 nuclear build full ' A' A ' 259' ' ' VAL . . . . . 0.569 ' O ' ' HA ' ' A' ' 253' ' ' LEU . 48.7 t -89.66 125.49 42.62 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.339 0 CA-C-O 121.667 0.746 . . . . 15.0 112.18 175.846 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 1.5 p -138.23 92.39 2.64 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-N 113.763 -1.562 . . . . 15.0 107.658 167.617 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 13.2 t -124.4 150.26 45.79 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 121.386 0.612 . . . . 15.0 112.243 -167.426 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 262' ' ' TRP . . . . . 1.178 ' CZ2' ' HB2' ' B' ' 215' ' ' PRO . 40.9 m95 -75.44 -25.28 57.33 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 114.794 -1.094 . . . . 15.0 112.201 178.959 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 263' ' ' HIS . . . . . . . . . . . . . 8.1 p80 -92.9 142.26 27.5 Favored 'General case' 0 C--N 1.322 -0.608 0 C-N-CA 120.179 -0.608 . . . . 15.0 110.385 -176.043 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 264' ' ' ASP . . . . . 0.851 ' HB3' HG12 ' A' ' 267' ' ' ILE . 9.9 t0 -61.96 134.22 94.2 Favored Pre-proline 0 C--N 1.321 -0.635 0 N-CA-C 108.541 -0.911 . . . . 15.0 108.541 175.216 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 265' ' ' PRO . . . . . 0.603 ' HD3' ' CD2' ' A' ' 252' ' ' PHE . 71.6 Cg_endo -81.81 -14.46 10.01 Favored 'Trans proline' 0 N--CA 1.452 -0.969 0 C-N-CA 122.039 1.826 . . . . 15.0 113.547 -174.559 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 266' ' ' ARG . . . . . 0.763 ' HD3' ' HD3' ' A' ' 237' ' ' PRO . 17.8 tpt180 -78.87 -7.5 57.98 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-O 122.029 0.919 . . . . 15.0 108.723 174.62 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 267' ' ' ILE . . . . . 0.851 HG12 ' HB3' ' A' ' 264' ' ' ASP . 46.9 mm . . . . . 0 C--O 1.249 1.067 0 CA-C-N 113.846 -1.525 . . . . 15.0 109.663 177.063 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 210' ' ' SER . . . . . . . . . . . . . 20.0 m . . . . . 0 N--CA 1.482 1.132 0 CA-C-O 120.955 0.407 . . . . 15.0 110.969 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' 211' ' ' ASP . . . . . 0.476 ' HA ' ' HD3' ' B' ' 212' ' ' PRO . 36.3 t70 -101.58 113.82 65.76 Favored Pre-proline 0 C--N 1.325 -0.488 0 CA-C-N 116.328 -0.396 . . . . 15.0 110.244 -177.701 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 212' ' ' PRO . . . . . 0.735 ' HB3' HD11 ' A' ' 253' ' ' LEU . 6.3 Cg_endo -89.71 160.2 5.19 Favored 'Trans proline' 0 N--CA 1.456 -0.688 0 C-N-CA 123.454 2.769 . . . . 15.0 112.891 -175.985 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -90.08 145.5 18.2 Favored Glycine 0 N--CA 1.444 -0.813 0 CA-C-N 115.717 -0.674 . . . . 15.0 112.52 -178.151 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 214' ' ' SEP . . . . . 0.459 ' HA ' ' HD3' ' B' ' 215' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 215' ' ' PRO . . . . . 1.178 ' HB2' ' CZ2' ' A' ' 262' ' ' TRP . 6.2 Cg_exo -88.3 140.34 4.58 Favored 'Trans proline' 0 C--O 1.234 0.285 0 C-N-CA 123.424 2.749 . . . . 15.0 110.977 179.467 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 216' ' ' PHE . . . . . . . . . . . . . 92.9 m-85 -110.45 101.0 9.74 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 121.061 -0.256 . . . . 15.0 111.282 -178.838 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 217' ' ' GLN . . . . . . . . . . . . . 75.3 mm-40 . . . . . 0 C--O 1.25 1.124 0 O-C-N 124.131 0.895 . . . . 15.0 112.463 174.237 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 31.9 mt-10 . . . . . 0 N--CA 1.481 1.098 0 CA-C-O 120.708 0.289 . . . . 15.0 110.276 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 4.8 mt -117.9 166.31 13.87 Favored Pre-proline 0 C--N 1.323 -0.554 0 CA-C-N 116.346 -0.388 . . . . 15.0 110.426 -175.427 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 237' ' ' PRO . . . . . 0.769 ' HD3' ' HD3' ' A' ' 266' ' ' ARG . 16.5 Cg_exo -69.37 169.6 18.04 Favored 'Trans proline' 0 CA--C 1.511 -0.672 0 C-N-CA 122.308 2.005 . . . . 15.0 110.654 165.355 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 60.0 mt-10 -69.5 137.14 52.28 Favored 'General case' 0 C--N 1.303 -1.425 0 CA-C-N 114.594 -1.185 . . . . 15.0 112.375 -172.096 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 100.54 5.76 53.69 Favored Glycine 0 N--CA 1.447 -0.582 0 CA-C-N 113.914 -1.494 . . . . 15.0 113.706 175.245 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 240' ' ' TYR . . . . . 0.703 ' CD1' ' HB2' ' A' ' 254' ' ' HIS . 83.4 m-85 -104.06 122.99 46.41 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 117.741 0.77 . . . . 15.0 110.738 175.891 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 241' ' ' GLU . . . . . 0.496 ' HG3' ' HB3' ' A' ' 253' ' ' LEU . 8.1 pt-20 -105.57 127.37 52.99 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 109.139 -0.689 . . . . 15.0 109.139 170.84 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 242' ' ' GLN . . . . . 0.641 ' HG3' ' CE1' ' A' ' 252' ' ' PHE . 9.6 tt0 -89.86 105.15 17.61 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 108.932 -0.766 . . . . 15.0 108.932 179.86 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 54.9 mtt-85 -92.39 149.28 21.51 Favored 'General case' 0 CA--C 1.506 -0.724 0 CA-C-O 122.288 1.042 . . . . 15.0 112.158 -177.074 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 244' ' ' THR . . . . . . . . . . . . . 20.4 p -126.4 89.91 3.09 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-N 113.066 -1.879 . . . . 15.0 109.101 -174.139 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 245' ' ' THR . . . . . 0.78 HG23 ' HB2' ' A' ' 247' ' ' GLN . 13.4 t -97.24 150.27 21.11 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 115.162 -0.926 . . . . 15.0 110.326 -171.106 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 26.8 t -54.41 -17.91 2.35 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 C-N-CA 122.915 0.486 . . . . 15.0 111.961 -175.069 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 247' ' ' GLN . . . . . 0.78 ' HB2' HG23 ' A' ' 245' ' ' THR . 10.4 mp0 -51.18 -22.89 2.86 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 123.25 0.62 . . . . 15.0 111.318 172.17 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 88.05 16.0 60.08 Favored Glycine 0 C--N 1.33 0.233 0 C-N-CA 121.156 -0.545 . . . . 15.0 112.06 178.23 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 249' ' ' GLN . . . . . 0.426 ' NE2' ' HH2' ' A' ' 262' ' ' TRP . 1.8 mt-30 -131.11 137.56 49.13 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 109.884 -0.413 . . . . 15.0 109.884 -176.316 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 14.4 m -89.72 134.05 29.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-N 116.358 -0.383 . . . . 15.0 110.306 177.407 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 251' ' ' TYR . . . . . 0.59 ' HB3' ' CG ' ' B' ' 215' ' ' PRO . 14.9 p90 -133.41 137.05 45.61 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.35 -0.386 . . . . 15.0 110.194 -179.698 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 252' ' ' PHE . . . . . 0.692 ' CD2' ' HA ' ' A' ' 264' ' ' ASP . 37.6 m-85 -89.88 121.74 32.28 Favored 'General case' 0 CA--C 1.512 -0.498 0 CA-C-O 121.193 0.521 . . . . 15.0 110.909 -175.8 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 253' ' ' LEU . . . . . 0.893 HD11 ' HB3' ' B' ' 212' ' ' PRO . 0.4 OUTLIER -113.16 124.75 53.28 Favored 'General case' 0 N--CA 1.445 -0.699 0 CA-C-N 114.858 -1.065 . . . . 15.0 110.756 -174.921 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 254' ' ' HIS . . . . . 0.703 ' HB2' ' CD1' ' A' ' 240' ' ' TYR . 53.4 t60 -138.95 97.51 3.33 Favored 'General case' 0 CA--C 1.499 -1.014 0 N-CA-C 108.645 -0.872 . . . . 15.0 108.645 173.198 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 24.5 m -93.57 87.74 5.63 Favored 'General case' 0 N--CA 1.434 -1.244 0 C-N-CA 116.539 -2.064 . . . . 15.0 110.402 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 35.3 tt0 -101.29 -54.0 2.88 Favored 'General case' 0 N--CA 1.44 -0.956 0 N-CA-C 105.653 -1.981 . . . . 15.0 105.653 148.826 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 257' ' ' THR . . . . . . . . . . . . . 77.8 p -100.06 -13.61 18.96 Favored 'General case' 0 CA--C 1.485 -1.535 0 CA-C-N 112.555 -2.111 . . . . 15.0 112.223 -178.914 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 86.67 73.7 1.28 Allowed Glycine 1 C--N 1.239 -4.808 0 CA-C-N 108.806 -3.815 . . . . 15.0 112.753 -171.293 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 259' ' ' VAL . . . . . 0.655 ' O ' ' HA ' ' A' ' 253' ' ' LEU . 43.8 t -89.69 124.62 42.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 121.43 0.633 . . . . 15.0 112.02 176.021 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -140.15 102.14 4.31 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 114.407 -1.27 . . . . 15.0 107.915 168.345 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 12.9 t -143.31 150.35 39.07 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.9 -0.591 . . . . 15.0 111.878 -168.746 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 262' ' ' TRP . . . . . 1.208 ' CZ2' ' HB2' ' B' ' 215' ' ' PRO . 92.7 m95 -70.0 -42.57 72.87 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 115.638 -0.71 . . . . 15.0 111.492 178.286 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 263' ' ' HIS . . . . . . . . . . . . . 2.7 p80 -73.53 132.37 42.79 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.255 -0.429 . . . . 15.0 110.246 -175.868 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 264' ' ' ASP . . . . . 1.014 ' HB3' HG12 ' A' ' 267' ' ' ILE . 22.0 t0 -56.38 127.63 72.0 Favored Pre-proline 0 C--N 1.32 -0.715 0 N-CA-C 108.155 -1.054 . . . . 15.0 108.155 172.769 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 265' ' ' PRO . . . . . 0.521 ' HG2' ' CD1' ' A' ' 240' ' ' TYR . 12.1 Cg_exo -69.34 -14.52 37.56 Favored 'Trans proline' 0 C--N 1.329 -0.482 0 C-N-CA 122.27 1.98 . . . . 15.0 112.614 -177.466 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 266' ' ' ARG . . . . . 0.769 ' HD3' ' HD3' ' A' ' 237' ' ' PRO . 16.1 tpt180 -75.39 -11.62 60.08 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 108.7 -0.852 . . . . 15.0 108.7 172.91 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 267' ' ' ILE . . . . . 1.014 HG12 ' HB3' ' A' ' 264' ' ' ASP . 24.6 pt . . . . . 0 C--O 1.248 1.017 0 CA-C-N 114.625 -1.171 . . . . 15.0 111.364 178.101 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 210' ' ' SER . . . . . . . . . . . . . 40.8 m . . . . . 0 N--CA 1.479 0.99 0 CA-C-O 120.77 0.319 . . . . 15.0 111.258 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' 211' ' ' ASP . . . . . 0.422 ' HA ' ' HD3' ' B' ' 212' ' ' PRO . 10.1 p-10 -90.44 141.78 27.64 Favored Pre-proline 0 C--N 1.328 -0.363 0 N-CA-C 109.657 -0.498 . . . . 15.0 109.657 179.38 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 212' ' ' PRO . . . . . 0.893 ' HB3' HD11 ' A' ' 253' ' ' LEU . 9.5 Cg_endo -89.6 148.85 5.13 Favored 'Trans proline' 0 N--CA 1.454 -0.822 0 C-N-CA 122.733 2.289 . . . . 15.0 112.581 -177.567 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -89.88 159.89 28.24 Favored Glycine 0 N--CA 1.443 -0.87 0 C-N-CA 120.746 -0.74 . . . . 15.0 112.075 -179.386 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 214' ' ' SEP . . . . . 0.44 ' P ' HE21 ' A' ' 247' ' ' GLN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 215' ' ' PRO . . . . . 1.208 ' HB2' ' CZ2' ' A' ' 262' ' ' TRP . 7.1 Cg_exo -88.19 149.99 6.76 Favored 'Trans proline' 0 C--O 1.235 0.33 0 C-N-CA 123.417 2.745 . . . . 15.0 111.853 175.072 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 216' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -125.8 131.87 52.38 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.869 -0.419 . . . . 15.0 109.869 174.865 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 217' ' ' GLN . . . . . 0.434 ' HB3' ' NE1' ' A' ' 262' ' ' TRP . 11.9 pt20 . . . . . 0 C--O 1.247 0.96 0 CA-C-O 118.409 -0.805 . . . . 15.0 110.046 176.181 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 26.0 mt-10 . . . . . 0 N--CA 1.48 1.047 0 N-CA-C 109.682 -0.488 . . . . 15.0 109.682 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 236' ' ' LEU . . . . . 0.701 HD22 ' H ' ' A' ' 236' ' ' LEU . 0.1 OUTLIER -93.05 159.52 35.44 Favored Pre-proline 0 C--N 1.326 -0.431 0 CA-C-N 115.987 -0.551 . . . . 15.0 110.939 -170.7 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 237' ' ' PRO . . . . . 0.455 ' HD3' ' HD3' ' A' ' 266' ' ' ARG . 18.8 Cg_exo -69.65 166.21 28.21 Favored 'Trans proline' 0 CA--C 1.515 -0.455 0 C-N-CA 122.993 2.462 . . . . 15.0 110.323 164.705 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -69.7 150.02 47.41 Favored 'General case' 0 C--N 1.307 -1.278 0 CA-C-N 115.443 -0.799 . . . . 15.0 110.968 -177.207 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 100.03 -2.14 56.63 Favored Glycine 0 N--CA 1.447 -0.593 0 CA-C-N 115.508 -0.769 . . . . 15.0 113.809 179.489 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 240' ' ' TYR . . . . . 0.671 ' CD1' ' HB2' ' A' ' 254' ' ' HIS . 79.6 m-85 -104.28 115.35 30.24 Favored 'General case' 0 CA--C 1.518 -0.283 0 CA-C-N 117.688 0.744 . . . . 15.0 110.626 178.233 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 26.5 mt-10 -95.7 123.13 39.12 Favored 'General case' 0 C--N 1.317 -0.844 0 N-CA-C 109.074 -0.713 . . . . 15.0 109.074 175.015 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 23.7 tm0? -89.91 109.11 20.15 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 108.728 -0.842 . . . . 15.0 108.728 179.845 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 47.9 mtt85 -105.27 150.09 25.45 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 122.143 0.973 . . . . 15.0 112.098 -179.291 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 244' ' ' THR . . . . . . . . . . . . . 5.6 p -127.36 98.25 5.19 Favored 'General case' 0 C--N 1.31 -1.125 0 CA-C-N 113.279 -1.782 . . . . 15.0 109.309 -177.183 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 245' ' ' THR . . . . . 0.463 ' OG1' ' HG2' ' A' ' 247' ' ' GLN . 3.1 t -89.92 150.4 22.19 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 115.567 -0.742 . . . . 15.0 111.098 -174.279 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 8.4 m -50.8 -19.36 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.21 0 CA-C-N 115.413 -0.812 . . . . 15.0 112.236 177.423 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 247' ' ' GLN . . . . . 0.489 ' HB2' ' HG3' ' A' ' 249' ' ' GLN . 7.3 mm100 -55.62 -26.08 42.31 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.07 -0.514 . . . . 15.0 110.953 173.514 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 89.01 30.58 14.05 Favored Glycine 0 N--CA 1.449 -0.495 0 CA-C-N 115.943 -0.571 . . . . 15.0 111.996 179.706 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 249' ' ' GLN . . . . . 0.489 ' HG3' ' HB2' ' A' ' 247' ' ' GLN . 0.0 OUTLIER -134.76 142.09 46.64 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.642 0.258 . . . . 15.0 110.388 -177.006 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 17.9 m -89.97 134.89 27.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 115.884 -0.598 . . . . 15.0 109.825 175.373 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 251' ' ' TYR . . . . . 0.545 ' HB3' ' CG ' ' B' ' 215' ' ' PRO . 4.3 p90 -142.73 135.77 28.28 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.083 0.468 . . . . 15.0 110.448 179.493 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 252' ' ' PHE . . . . . 0.717 ' CE2' ' HA ' ' A' ' 264' ' ' ASP . 34.5 m-85 -90.27 125.55 35.54 Favored 'General case' 0 CA--C 1.511 -0.526 0 CA-C-N 115.826 -0.625 . . . . 15.0 111.126 -176.57 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 253' ' ' LEU . . . . . 1.027 HD11 ' HB3' ' B' ' 212' ' ' PRO . 0.4 OUTLIER -113.98 111.25 21.37 Favored 'General case' 0 N--CA 1.445 -0.724 0 CA-C-N 115.25 -0.886 . . . . 15.0 111.768 -174.589 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 254' ' ' HIS . . . . . 0.671 ' HB2' ' CD1' ' A' ' 240' ' ' TYR . 36.4 t-80 -122.46 90.11 3.24 Favored 'General case' 0 CA--C 1.499 -0.992 0 N-CA-C 107.981 -1.118 . . . . 15.0 107.981 166.345 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 7.3 t -96.38 88.05 4.63 Favored 'General case' 0 N--CA 1.428 -1.567 0 C-N-CA 116.599 -2.041 . . . . 15.0 110.192 -178.878 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 63.7 tt0 -101.2 -51.48 3.5 Favored 'General case' 0 N--CA 1.437 -1.081 0 CA-C-N 112.875 -1.966 . . . . 15.0 105.838 151.519 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 257' ' ' THR . . . . . . . . . . . . . 79.6 p -96.78 -13.42 22.65 Favored 'General case' 0 CA--C 1.486 -1.506 0 CA-C-O 125.034 2.35 . . . . 15.0 111.623 178.531 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 86.74 74.62 1.27 Allowed Glycine 1 C--N 1.24 -4.783 1 CA-C-N 108.222 -4.081 . . . . 15.0 112.899 -172.92 . . . . . . . . 3 2 . 1 . 011 nuclear build full ' A' A ' 259' ' ' VAL . . . . . 0.587 ' O ' ' HA ' ' A' ' 253' ' ' LEU . 57.4 t -89.9 121.86 40.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-O 121.556 0.693 . . . . 15.0 112.02 172.855 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 1.3 p -135.27 103.62 5.58 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 114.042 -1.435 . . . . 15.0 107.988 169.878 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 14.3 t -143.41 150.49 39.14 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 112.977 0.732 . . . . 15.0 112.977 -168.085 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 262' ' ' TRP . . . . . 1.197 ' CZ2' ' HB2' ' B' ' 215' ' ' PRO . 89.1 m95 -71.44 -32.6 68.54 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 114.956 -1.02 . . . . 15.0 111.848 178.543 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 263' ' ' HIS . . . . . 0.654 ' HD2' ' OXT' ' A' ' 267' ' ' ILE . 20.2 p-80 -86.28 137.47 32.58 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.596 -0.441 . . . . 15.0 110.986 -172.241 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 264' ' ' ASP . . . . . 0.994 ' HB3' HG12 ' A' ' 267' ' ' ILE . 7.3 t0 -52.96 129.86 48.53 Favored Pre-proline 0 C--N 1.325 -0.458 0 N-CA-C 108.864 -0.791 . . . . 15.0 108.864 172.92 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 265' ' ' PRO . . . . . 0.558 ' HD2' HD12 ' A' ' 236' ' ' LEU . 67.0 Cg_endo -73.2 -14.87 25.74 Favored 'Trans proline' 0 CA--C 1.51 -0.724 0 C-N-CA 122.193 1.928 . . . . 15.0 113.64 -173.961 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 266' ' ' ARG . . . . . 0.455 ' HD3' ' HD3' ' A' ' 237' ' ' PRO . 8.4 tpt180 -83.93 -5.58 59.25 Favored 'General case' 0 C--N 1.306 -1.293 0 N-CA-C 108.254 -1.017 . . . . 15.0 108.254 174.245 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 267' ' ' ILE . . . . . 0.994 HG12 ' HB3' ' A' ' 264' ' ' ASP . 45.0 pt . . . . . 0 C--O 1.247 0.965 0 CA-C-N 114.023 -1.444 . . . . 15.0 110.728 174.667 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 210' ' ' SER . . . . . . . . . . . . . 19.3 m . . . . . 0 N--CA 1.477 0.891 0 CA-C-O 120.841 0.353 . . . . 15.0 111.038 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' B' B ' 211' ' ' ASP . . . . . 0.419 ' HA ' ' HD3' ' B' ' 212' ' ' PRO . 13.9 m-20 -110.05 115.18 55.25 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 120.76 0.314 . . . . 15.0 110.759 -178.032 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 212' ' ' PRO . . . . . 1.027 ' HB3' HD11 ' A' ' 253' ' ' LEU . 6.1 Cg_exo -89.6 141.55 3.93 Favored 'Trans proline' 0 N--CA 1.461 -0.437 0 C-N-CA 123.422 2.748 . . . . 15.0 112.851 178.99 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -89.98 149.07 20.15 Favored Glycine 0 N--CA 1.443 -0.866 0 CA-C-N 115.52 -0.764 . . . . 15.0 111.745 178.619 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 214' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' B' B ' 215' ' ' PRO . . . . . 1.197 ' HB2' ' CZ2' ' A' ' 262' ' ' TRP . 7.2 Cg_exo -88.4 143.39 5.45 Favored 'Trans proline' 0 C--O 1.235 0.352 0 C-N-CA 123.779 2.986 . . . . 15.0 111.459 -178.682 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 216' ' ' PHE . . . . . . . . . . . . . 84.6 m-85 -112.83 171.26 7.64 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.415 -0.357 . . . . 15.0 110.559 -179.624 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 217' ' ' GLN . . . . . . . . . . . . . 2.5 mp0 . . . . . 0 C--O 1.249 1.053 0 CA-C-O 118.402 -0.809 . . . . 15.0 109.617 179.864 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 . . . . . 0 N--CA 1.48 1.052 0 N-CA-C 110.412 -0.218 . . . . 15.0 110.412 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 236' ' ' LEU . . . . . 0.65 HD12 ' HD2' ' A' ' 265' ' ' PRO . 0.2 OUTLIER -93.54 153.6 41.28 Favored Pre-proline 0 C--N 1.323 -0.571 0 CA-C-O 121.443 0.639 . . . . 15.0 110.906 -174.522 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 237' ' ' PRO . . . . . 0.477 ' HD2' ' CE2' ' A' ' 240' ' ' TYR . 15.3 Cg_exo -69.65 173.88 10.23 Favored 'Trans proline' 0 CA--C 1.514 -0.516 0 C-N-CA 123.202 2.602 . . . . 15.0 110.672 161.675 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -69.42 143.45 53.61 Favored 'General case' 0 C--N 1.3 -1.581 0 CA-C-N 114.487 -1.233 . . . . 15.0 111.238 -177.992 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 100.18 8.29 50.68 Favored Glycine 0 N--CA 1.45 -0.386 0 CA-C-N 115.502 -0.772 . . . . 15.0 113.735 177.169 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 240' ' ' TYR . . . . . 0.641 ' CD1' ' HB2' ' A' ' 254' ' ' HIS . 72.2 m-85 -107.32 116.5 32.04 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 117.611 0.705 . . . . 15.0 111.346 178.826 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 241' ' ' GLU . . . . . 0.585 ' HB3' ' HB3' ' A' ' 253' ' ' LEU . 4.5 tp10 -89.84 111.58 22.65 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.156 -0.929 . . . . 15.0 108.737 174.562 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -90.06 102.72 15.43 Favored 'General case' 0 C--N 1.314 -0.943 0 N-CA-C 108.635 -0.876 . . . . 15.0 108.635 178.681 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 243' ' ' ARG . . . . . 0.437 ' HG3' ' HG3' ' A' ' 241' ' ' GLU . 51.0 mtt-85 -99.21 148.26 24.29 Favored 'General case' 0 CA--C 1.499 -0.998 0 CA-C-O 121.96 0.886 . . . . 15.0 112.185 -177.742 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 244' ' ' THR . . . . . . . . . . . . . 11.7 m -123.2 93.97 4.12 Favored 'General case' 0 C--N 1.309 -1.191 0 CA-C-N 113.505 -1.68 . . . . 15.0 110.207 -179.413 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 245' ' ' THR . . . . . 1.082 HG23 ' HG2' ' A' ' 247' ' ' GLN . 7.7 t -95.25 150.73 19.91 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.546 -0.752 . . . . 15.0 110.248 179.99 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 15.0 m -41.15 -25.27 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 N-CA-C 114.642 1.349 . . . . 15.0 114.642 -175.96 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 247' ' ' GLN . . . . . 1.082 ' HG2' HG23 ' A' ' 245' ' ' THR . 3.5 pt20 -54.4 -21.45 9.71 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 117.793 0.27 . . . . 15.0 111.14 177.251 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 87.76 20.64 50.07 Favored Glycine 0 C--N 1.333 0.411 0 C-N-CA 121.206 -0.521 . . . . 15.0 113.036 173.821 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 249' ' ' GLN . . . . . 0.413 ' HB2' ' OE1' ' A' ' 247' ' ' GLN . 16.4 mt-30 -129.98 142.71 50.6 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.586 -0.524 . . . . 15.0 109.586 -177.207 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 29.8 m -91.25 134.75 28.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-O 120.943 0.402 . . . . 15.0 110.924 179.875 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 251' ' ' TYR . . . . . 0.767 ' HB3' ' HG2' ' B' ' 215' ' ' PRO . 33.0 p90 -134.27 137.56 44.38 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.778 -0.452 . . . . 15.0 109.778 -178.005 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 252' ' ' PHE . . . . . 0.67 ' CE2' ' HA ' ' A' ' 264' ' ' ASP . 26.6 m-85 -92.01 116.58 29.05 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.218 0.533 . . . . 15.0 111.386 -174.66 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 253' ' ' LEU . . . . . 0.78 HD11 ' HB3' ' B' ' 212' ' ' PRO . 0.5 OUTLIER -106.54 96.87 6.76 Favored 'General case' 0 N--CA 1.447 -0.604 0 CA-C-N 115.063 -0.972 . . . . 15.0 111.3 -175.154 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 254' ' ' HIS . . . . . 0.641 ' HB2' ' CD1' ' A' ' 240' ' ' TYR . 76.0 t60 -106.53 90.12 3.24 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 108.417 -0.957 . . . . 15.0 108.417 169.5 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 1.9 t -94.65 87.81 5.2 Favored 'General case' 0 N--CA 1.432 -1.342 0 C-N-CA 116.746 -1.982 . . . . 15.0 110.286 -179.698 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 57.4 tt0 -101.18 -50.2 3.86 Favored 'General case' 0 N--CA 1.441 -0.919 0 CA-C-N 112.957 -1.929 . . . . 15.0 106.25 150.876 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 257' ' ' THR . . . . . . . . . . . . . 67.0 p -98.53 -13.56 20.41 Favored 'General case' 0 CA--C 1.486 -1.503 0 CA-C-O 124.706 2.193 . . . . 15.0 111.738 178.469 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 87.07 73.57 1.28 Allowed Glycine 1 C--N 1.24 -4.803 0 CA-C-N 108.493 -3.958 . . . . 15.0 112.851 -172.3 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 259' ' ' VAL . . . . . 0.704 ' O ' ' HA ' ' A' ' 253' ' ' LEU . 52.3 t -89.92 125.3 42.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-O 121.284 0.564 . . . . 15.0 112.135 174.275 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 1.6 p -137.16 98.01 3.63 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 114.699 -1.137 . . . . 15.0 107.987 167.666 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 14.0 t -136.79 150.29 48.27 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.994 -0.548 . . . . 15.0 111.972 -168.464 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 262' ' ' TRP . . . . . 1.219 ' CZ2' ' HB2' ' B' ' 215' ' ' PRO . 83.2 m95 -71.83 -39.46 69.74 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.062 -0.972 . . . . 15.0 111.663 179.481 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 263' ' ' HIS . . . . . 0.486 ' HD2' ' OXT' ' A' ' 267' ' ' ILE . 16.2 p-80 -77.82 137.23 38.3 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.451 -0.341 . . . . 15.0 110.48 -173.496 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 264' ' ' ASP . . . . . 1.021 ' HB3' HG12 ' A' ' 267' ' ' ILE . 27.7 t0 -57.54 124.21 66.41 Favored Pre-proline 0 C--N 1.324 -0.533 0 N-CA-C 108.024 -1.102 . . . . 15.0 108.024 169.899 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 265' ' ' PRO . . . . . 0.65 ' HD2' HD12 ' A' ' 236' ' ' LEU . 12.1 Cg_exo -69.13 -14.7 38.55 Favored 'Trans proline' 0 N--CA 1.459 -0.558 0 C-N-CA 122.236 1.957 . . . . 15.0 112.914 -175.997 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 266' ' ' ARG . . . . . 0.44 ' HD3' ' HD3' ' A' ' 237' ' ' PRO . 6.1 tpt180 -76.44 -11.64 59.92 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-O 121.99 0.9 . . . . 15.0 108.918 173.572 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 267' ' ' ILE . . . . . 1.021 HG12 ' HB3' ' A' ' 264' ' ' ASP . 36.5 pt . . . . . 0 C--O 1.246 0.904 0 CA-C-N 114.562 -1.199 . . . . 15.0 111.458 -179.364 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 210' ' ' SER . . . . . . . . . . . . . 17.7 m . . . . . 0 N--CA 1.476 0.863 0 CA-C-O 120.977 0.418 . . . . 15.0 110.327 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' B' B ' 211' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -98.97 116.83 65.05 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.136 -0.484 . . . . 15.0 110.93 -172.577 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 212' ' ' PRO . . . . . 0.78 ' HB3' HD11 ' A' ' 253' ' ' LEU . 6.6 Cg_endo -89.87 144.21 4.34 Favored 'Trans proline' 0 N--CA 1.451 -1.026 0 C-N-CA 122.851 2.367 . . . . 15.0 111.051 171.138 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -89.85 157.79 26.59 Favored Glycine 0 N--CA 1.442 -0.946 0 C-N-CA 120.192 -1.004 . . . . 15.0 111.923 -179.517 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 214' ' ' SEP . . . . . 0.759 ' HB2' HG21 ' A' ' 245' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 215' ' ' PRO . . . . . 1.219 ' HB2' ' CZ2' ' A' ' 262' ' ' TRP . 14.2 Cg_exo -87.44 144.53 6.77 Favored 'Trans proline' 0 N--CA 1.458 -0.572 0 C-N-CA 123.451 2.767 . . . . 15.0 110.839 179.71 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 216' ' ' PHE . . . . . . . . . . . . . 82.7 m-85 -116.28 146.54 42.31 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 116.357 -0.383 . . . . 15.0 110.096 179.863 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 217' ' ' GLN . . . . . . . . . . . . . 26.2 tt0 . . . . . 0 C--O 1.248 1.022 0 CA-C-O 118.816 -0.612 . . . . 15.0 110.181 -179.285 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 . . . . . 0 N--CA 1.478 0.94 0 CA-C-O 120.835 0.35 . . . . 15.0 110.106 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 236' ' ' LEU . . . . . 0.538 HD22 ' H ' ' A' ' 236' ' ' LEU . 0.6 OUTLIER -91.44 173.27 5.54 Favored Pre-proline 0 C--N 1.324 -0.519 0 CA-C-N 116.052 -0.522 . . . . 15.0 110.287 -174.52 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 237' ' ' PRO . . . . . 0.605 ' HD3' ' HD3' ' A' ' 266' ' ' ARG . 20.0 Cg_exo -69.2 170.77 15.15 Favored 'Trans proline' 0 CA--C 1.509 -0.759 0 C-N-CA 122.308 2.005 . . . . 15.0 111.258 166.81 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -69.46 139.1 53.93 Favored 'General case' 0 C--N 1.301 -1.535 0 CA-C-N 114.215 -1.357 . . . . 15.0 110.995 -171.819 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 100.22 -2.28 56.41 Favored Glycine 0 N--CA 1.448 -0.509 0 CA-C-N 115.621 -0.718 . . . . 15.0 113.752 179.288 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 240' ' ' TYR . . . . . 0.443 ' CD1' ' HB2' ' A' ' 254' ' ' HIS . 84.6 m-85 -97.39 116.52 29.75 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 118.087 0.943 . . . . 15.0 111.167 177.381 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 241' ' ' GLU . . . . . 0.583 ' HB2' ' HB3' ' A' ' 253' ' ' LEU . 5.6 mt-10 -89.9 111.06 21.99 Favored 'General case' 0 N--CA 1.441 -0.915 0 CA-C-N 114.297 -1.319 . . . . 15.0 109.232 177.606 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -89.88 103.72 16.35 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 108.88 -0.785 . . . . 15.0 108.88 178.355 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 243' ' ' ARG . . . . . 0.43 ' CZ ' ' HG2' ' B' ' 212' ' ' PRO . 8.2 mtp180 -108.33 149.01 29.25 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.768 0.794 . . . . 15.0 112.114 -178.456 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 244' ' ' THR . . . . . . . . . . . . . 16.2 p -120.39 121.19 38.02 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 114.008 -1.451 . . . . 15.0 109.799 -178.035 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 245' ' ' THR . . . . . 0.521 ' OG1' ' HG2' ' A' ' 247' ' ' GLN . 4.6 t -110.66 150.55 28.85 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 116.24 -0.437 . . . . 15.0 111.013 -176.863 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 5.5 p -50.07 -24.31 1.92 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.262 0 CA-C-N 115.389 -0.823 . . . . 15.0 111.2 175.977 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 247' ' ' GLN . . . . . 0.521 ' HG2' ' OG1' ' A' ' 245' ' ' THR . 3.9 mm-40 -51.97 -26.84 11.46 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 115.335 -0.848 . . . . 15.0 110.823 175.42 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 104.56 9.36 35.76 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 121.098 -0.572 . . . . 15.0 113.092 174.518 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 2.1 pm0 -123.38 149.04 45.46 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 112.904 0.705 . . . . 15.0 112.904 -174.924 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 6.2 m -89.79 132.67 33.89 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.435 0 CA-C-N 114.727 -1.124 . . . . 15.0 108.367 166.69 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 251' ' ' TYR . . . . . 0.584 ' HB3' ' HG3' ' B' ' 215' ' ' PRO . 2.4 p90 -134.61 140.3 45.97 Favored 'General case' 0 C--N 1.314 -0.946 0 C-N-CA 120.538 -0.465 . . . . 15.0 110.1 179.969 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 252' ' ' PHE . . . . . 0.661 ' CD2' ' HA ' ' A' ' 264' ' ' ASP . 24.2 m-85 -90.0 111.66 22.83 Favored 'General case' 0 CA--C 1.507 -0.698 0 CA-C-O 121.854 0.835 . . . . 15.0 111.601 -174.972 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 253' ' ' LEU . . . . . 0.921 HD11 ' HB3' ' B' ' 212' ' ' PRO . 0.5 OUTLIER -99.52 140.96 32.94 Favored 'General case' 0 N--CA 1.438 -1.055 0 CA-C-N 113.696 -1.593 . . . . 15.0 109.192 178.893 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 254' ' ' HIS . . . . . 0.466 ' HB3' ' HB ' ' A' ' 259' ' ' VAL . 48.8 t60 -149.98 93.13 1.98 Allowed 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 108.335 -0.987 . . . . 15.0 108.335 170.72 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 255' ' ' THR . . . . . 0.502 HG22 ' OE2' ' A' ' 241' ' ' GLU . 2.6 t -90.04 87.95 7.1 Favored 'General case' 0 N--CA 1.431 -1.404 0 C-N-CA 116.387 -2.125 . . . . 15.0 110.328 -179.949 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 56.3 tt0 -101.26 -54.2 2.83 Favored 'General case' 0 N--CA 1.44 -0.963 0 CA-C-N 112.761 -2.018 . . . . 15.0 105.733 148.089 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 257' ' ' THR . . . . . . . . . . . . . 71.3 p -99.94 -13.72 19.01 Favored 'General case' 0 CA--C 1.487 -1.455 0 CA-C-N 112.156 -2.293 . . . . 15.0 112.333 -178.834 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 85.71 72.0 1.3 Allowed Glycine 1 C--N 1.244 -4.546 0 CA-C-N 108.492 -3.958 . . . . 15.0 112.762 -170.986 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 259' ' ' VAL . . . . . 0.567 ' O ' ' HA ' ' A' ' 253' ' ' LEU . 85.1 t -89.75 134.56 28.53 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.426 0 CA-C-O 121.519 0.676 . . . . 15.0 112.71 178.267 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 1.7 p -144.65 105.02 4.1 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 114.388 -1.278 . . . . 15.0 108.298 168.156 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 8.8 t -141.05 150.32 42.81 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 112.333 0.494 . . . . 15.0 112.333 -170.004 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 262' ' ' TRP . . . . . 1.054 ' CZ2' ' HB2' ' B' ' 215' ' ' PRO . 6.7 m95 -68.54 -27.03 65.73 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.335 -0.848 . . . . 15.0 112.329 177.093 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 263' ' ' HIS . . . . . . . . . . . . . 10.5 p-80 -85.68 132.73 34.1 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 120.137 -0.625 . . . . 15.0 111.026 -172.711 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 264' ' ' ASP . . . . . 1.015 ' HB3' HG12 ' A' ' 267' ' ' ILE . 20.5 t0 -64.84 126.4 90.94 Favored Pre-proline 0 C--N 1.319 -0.719 0 N-CA-C 108.546 -0.909 . . . . 15.0 108.546 171.597 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 265' ' ' PRO . . . . . 0.51 ' HD3' ' CD2' ' A' ' 252' ' ' PHE . 2.6 Cg_endo -80.26 -14.79 11.76 Favored 'Trans proline' 0 N--CA 1.456 -0.692 0 C-N-CA 122.642 2.228 . . . . 15.0 113.261 -177.653 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 266' ' ' ARG . . . . . 0.605 ' HD3' ' HD3' ' A' ' 237' ' ' PRO . 11.1 tpt180 -75.69 -12.79 60.26 Favored 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 108.439 -0.949 . . . . 15.0 108.439 173.581 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 267' ' ' ILE . . . . . 1.015 HG12 ' HB3' ' A' ' 264' ' ' ASP . 20.3 pt . . . . . 0 C--O 1.248 1.017 0 CA-C-N 114.324 -1.307 . . . . 15.0 110.761 178.507 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 210' ' ' SER . . . . . . . . . . . . . 19.8 m . . . . . 0 N--CA 1.475 0.786 0 CA-C-O 121.041 0.448 . . . . 15.0 110.038 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' B' B ' 211' ' ' ASP . . . . . 0.473 ' HA ' ' HD3' ' B' ' 212' ' ' PRO . 8.2 p-10 -119.51 127.01 26.67 Favored Pre-proline 0 C--N 1.324 -0.52 0 CA-C-O 121.289 0.566 . . . . 15.0 110.9 -176.244 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 212' ' ' PRO . . . . . 0.921 ' HB3' HD11 ' A' ' 253' ' ' LEU . 4.0 Cg_endo -89.72 156.4 5.14 Favored 'Trans proline' 0 N--CA 1.455 -0.743 0 C-N-CA 123.385 2.723 . . . . 15.0 112.302 179.856 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -89.87 145.52 18.29 Favored Glycine 0 N--CA 1.442 -0.961 0 C-N-CA 120.608 -0.806 . . . . 15.0 112.392 -179.177 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 214' ' ' SEP . . . . . 0.423 ' HA ' ' HD3' ' B' ' 215' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 215' ' ' PRO . . . . . 1.054 ' HB2' ' CZ2' ' A' ' 262' ' ' TRP . 3.3 Cg_exo -87.94 136.37 3.6 Favored 'Trans proline' 0 N--CA 1.461 -0.417 0 C-N-CA 123.524 2.816 . . . . 15.0 111.112 176.422 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 216' ' ' PHE . . . . . . . . . . . . . 57.9 m-85 -89.9 116.2 27.79 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.326 -0.397 . . . . 15.0 110.286 -179.15 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 217' ' ' GLN . . . . . . . . . . . . . 5.2 pm0 . . . . . 0 C--O 1.245 0.843 0 CA-C-O 118.664 -0.684 . . . . 15.0 110.443 179.751 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 . . . . . 0 N--CA 1.48 1.073 0 CA-C-O 120.94 0.4 . . . . 15.0 110.293 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 236' ' ' LEU . . . . . 0.525 HD12 ' HD2' ' A' ' 265' ' ' PRO . 1.4 mm? -106.73 169.02 7.28 Favored Pre-proline 0 C--N 1.323 -0.566 0 N-CA-C 109.162 -0.681 . . . . 15.0 109.162 178.192 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 237' ' ' PRO . . . . . 0.638 ' HD3' ' HD3' ' A' ' 266' ' ' ARG . 17.5 Cg_exo -69.37 158.06 58.86 Favored 'Trans proline' 0 N--CA 1.455 -0.771 0 C-N-CA 121.688 1.592 . . . . 15.0 108.957 160.67 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 5.2 mp0 -69.54 142.39 53.65 Favored 'General case' 0 C--N 1.303 -1.425 0 CA-C-O 121.46 0.647 . . . . 15.0 111.761 -171.217 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 100.5 7.81 50.7 Favored Glycine 0 CA--C 1.523 0.547 0 CA-C-N 114.931 -1.031 . . . . 15.0 114.017 -179.774 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 240' ' ' TYR . . . . . 0.756 ' CD1' ' HB2' ' A' ' 254' ' ' HIS . 80.9 m-85 -101.74 121.25 41.7 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 118.103 0.952 . . . . 15.0 110.721 174.845 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 241' ' ' GLU . . . . . 0.663 ' HG3' ' HB3' ' A' ' 253' ' ' LEU . 7.9 pt-20 -104.67 126.59 51.9 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 109.054 -0.721 . . . . 15.0 109.054 173.296 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -89.92 108.09 19.5 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 108.991 -0.744 . . . . 15.0 108.991 179.182 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 243' ' ' ARG . . . . . 0.559 ' HB2' ' CE1' ' A' ' 251' ' ' TYR . 9.7 mtt180 -99.44 133.43 43.76 Favored 'General case' 0 CA--C 1.502 -0.877 0 CA-C-O 122.704 1.24 . . . . 15.0 111.724 178.672 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 244' ' ' THR . . . . . . . . . . . . . 23.5 m -113.32 97.11 6.27 Favored 'General case' 0 C--N 1.301 -1.542 0 CA-C-N 112.631 -2.077 . . . . 15.0 109.067 -175.909 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 245' ' ' THR . . . . . 0.427 ' OG1' ' HG2' ' A' ' 247' ' ' GLN . 9.9 t -92.36 150.3 20.91 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 115.232 -0.894 . . . . 15.0 111.201 -172.325 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 3.5 m -54.94 -15.12 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 N-CA-C 112.882 0.697 . . . . 15.0 112.882 177.993 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 247' ' ' GLN . . . . . 0.427 ' HG2' ' OG1' ' A' ' 245' ' ' THR . 6.5 mm100 -58.58 -16.83 17.51 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.145 0.498 . . . . 15.0 110.63 173.414 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 88.13 37.78 7.6 Favored Glycine 0 N--CA 1.449 -0.492 0 CA-C-N 115.594 -0.73 . . . . 15.0 111.421 177.494 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 249' ' ' GLN . . . . . 0.563 ' NE2' ' HD2' ' B' ' 215' ' ' PRO . 9.0 pt20 -149.96 137.58 19.97 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.899 0.38 . . . . 15.0 111.674 -173.684 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 19.1 m -90.2 134.01 30.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 N-CA-C 109.249 -0.649 . . . . 15.0 109.249 172.235 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 251' ' ' TYR . . . . . 0.707 ' CD2' ' HD3' ' B' ' 215' ' ' PRO . 3.7 p90 -137.25 137.37 38.97 Favored 'General case' 0 C--N 1.317 -0.813 0 C-N-CA 120.427 -0.509 . . . . 15.0 110.535 179.753 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 252' ' ' PHE . . . . . 0.663 ' CD2' ' HA ' ' A' ' 264' ' ' ASP . 37.3 m-85 -89.88 118.25 29.32 Favored 'General case' 0 CA--C 1.509 -0.616 0 CA-C-O 121.5 0.667 . . . . 15.0 110.835 -173.647 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 253' ' ' LEU . . . . . 0.788 HD11 ' CB ' ' B' ' 212' ' ' PRO . 0.4 OUTLIER -110.56 118.04 35.16 Favored 'General case' 0 N--CA 1.441 -0.876 0 CA-C-N 114.337 -1.302 . . . . 15.0 110.895 -173.853 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 254' ' ' HIS . . . . . 0.756 ' HB2' ' CD1' ' A' ' 240' ' ' TYR . 48.5 t60 -132.57 95.48 3.62 Favored 'General case' 0 CA--C 1.495 -1.159 0 N-CA-C 108.546 -0.909 . . . . 15.0 108.546 170.441 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 3.7 t -94.65 87.91 5.23 Favored 'General case' 0 N--CA 1.429 -1.486 0 C-N-CA 116.062 -2.255 . . . . 15.0 110.268 178.196 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 25.1 tt0 -101.22 -51.87 3.4 Favored 'General case' 0 N--CA 1.442 -0.859 0 N-CA-C 105.902 -1.888 . . . . 15.0 105.902 149.177 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 257' ' ' THR . . . . . . . . . . . . . 69.4 p -99.21 -13.67 19.63 Favored 'General case' 0 CA--C 1.489 -1.395 0 CA-C-O 124.958 2.313 . . . . 15.0 111.909 179.575 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 84.84 74.88 1.24 Allowed Glycine 1 C--N 1.244 -4.569 1 CA-C-N 108.352 -4.022 . . . . 15.0 112.838 -172.146 . . . . . . . . 3 2 . 1 . 014 nuclear build full ' A' A ' 259' ' ' VAL . . . . . 0.55 ' O ' ' HA ' ' A' ' 253' ' ' LEU . 33.1 t -89.89 123.85 42.29 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 CA-C-O 121.316 0.579 . . . . 15.0 112.451 173.307 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 1.8 p -134.15 101.76 5.14 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 114.632 -1.167 . . . . 15.0 107.855 164.366 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 14.1 t -136.55 150.25 48.52 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 121.212 0.529 . . . . 15.0 112.273 -169.561 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 262' ' ' TRP . . . . . 1.114 ' CZ2' ' HB2' ' B' ' 215' ' ' PRO . 10.3 m95 -70.39 -37.12 74.46 Favored 'General case' 0 CA--C 1.518 -0.27 0 CA-C-N 114.967 -1.015 . . . . 15.0 111.948 179.069 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 263' ' ' HIS . . . . . . . . . . . . . 5.9 p80 -85.37 139.99 31.12 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.109 -0.496 . . . . 15.0 110.278 -174.704 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 264' ' ' ASP . . . . . 0.878 ' HB3' HG12 ' A' ' 267' ' ' ILE . 9.8 t70 -55.45 126.54 63.18 Favored Pre-proline 0 C--N 1.322 -0.604 0 N-CA-C 108.212 -1.033 . . . . 15.0 108.212 171.118 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 265' ' ' PRO . . . . . 0.525 ' HD2' HD12 ' A' ' 236' ' ' LEU . 6.2 Cg_exo -71.37 -14.61 31.15 Favored 'Trans proline' 0 N--CA 1.458 -0.581 0 C-N-CA 121.935 1.757 . . . . 15.0 112.882 -174.172 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 266' ' ' ARG . . . . . 0.638 ' HD3' ' HD3' ' A' ' 237' ' ' PRO . 6.1 tpt180 -77.24 -7.81 56.55 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-O 121.817 0.817 . . . . 15.0 108.927 175.163 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 267' ' ' ILE . . . . . 0.878 HG12 ' HB3' ' A' ' 264' ' ' ASP . 43.5 mm . . . . . 0 C--O 1.25 1.085 0 CA-C-N 114.009 -1.451 . . . . 15.0 109.646 176.511 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 210' ' ' SER . . . . . . . . . . . . . 3.9 p . . . . . 0 N--CA 1.475 0.789 0 N-CA-C 110.275 -0.268 . . . . 15.0 110.275 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' B' B ' 211' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -89.98 131.57 38.81 Favored Pre-proline 0 C--N 1.329 -0.313 0 N-CA-C 109.802 -0.444 . . . . 15.0 109.802 178.564 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 212' ' ' PRO . . . . . 0.788 ' CB ' HD11 ' A' ' 253' ' ' LEU . 60.7 Cg_endo -89.84 160.19 5.07 Favored 'Trans proline' 0 N--CA 1.45 -1.03 0 C-N-CA 122.685 2.257 . . . . 15.0 112.105 178.938 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -90.04 133.34 11.75 Favored Glycine 0 N--CA 1.442 -0.94 0 C-N-CA 120.508 -0.853 . . . . 15.0 112.251 -178.721 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 214' ' ' SEP . . . . . 0.456 ' HA ' ' HD3' ' B' ' 215' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 215' ' ' PRO . . . . . 1.114 ' HB2' ' CZ2' ' A' ' 262' ' ' TRP . 9.4 Cg_exo -87.8 124.18 1.84 Allowed 'Trans proline' 0 C--N 1.333 -0.251 0 C-N-CA 123.786 2.991 . . . . 15.0 111.779 -172.056 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 216' ' ' PHE . . . . . . . . . . . . . 94.0 m-85 -119.25 4.54 11.27 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.348 -0.842 . . . . 15.0 110.015 178.636 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 217' ' ' GLN . . . . . 0.608 ' HB2' ' CD1' ' A' ' 262' ' ' TRP . 72.7 mt-30 . . . . . 0 C--O 1.249 1.038 0 CA-C-N 115.334 -0.848 . . . . 15.0 110.661 179.532 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 . . . . . 0 N--CA 1.478 0.94 0 N-CA-C 109.465 -0.569 . . . . 15.0 109.465 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 236' ' ' LEU . . . . . 0.807 HD22 ' H ' ' A' ' 236' ' ' LEU . 0.0 OUTLIER -89.88 170.89 9.55 Favored Pre-proline 0 C--N 1.325 -0.498 0 N-CA-C 109.375 -0.602 . . . . 15.0 109.375 -176.943 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 237' ' ' PRO . . . . . 0.672 ' HD3' ' HD3' ' A' ' 266' ' ' ARG . 16.5 Cg_exo -69.6 158.83 55.77 Favored 'Trans proline' 0 N--CA 1.458 -0.61 0 C-N-CA 122.144 1.896 . . . . 15.0 109.855 166.294 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 238' ' ' GLU . . . . . 0.461 ' H ' ' CD ' ' A' ' 238' ' ' GLU . 1.5 pm0 -69.86 149.42 47.88 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-O 121.546 0.689 . . . . 15.0 111.462 -174.044 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 100.17 -8.99 59.35 Favored Glycine 0 N--CA 1.444 -0.803 0 CA-C-N 115.096 -0.956 . . . . 15.0 113.09 -178.936 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 240' ' ' TYR . . . . . 0.669 ' CD1' ' HB2' ' A' ' 254' ' ' HIS . 87.6 m-85 -100.32 123.81 45.01 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 117.372 0.586 . . . . 15.0 110.353 177.366 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -109.33 126.6 53.56 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 108.938 -0.764 . . . . 15.0 108.938 169.848 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -89.95 108.71 19.88 Favored 'General case' 0 C--N 1.316 -0.853 0 N-CA-C 108.363 -0.977 . . . . 15.0 108.363 177.947 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 13.2 mtp85 -90.6 139.07 31.05 Favored 'General case' 0 CA--C 1.5 -0.961 0 CA-C-O 122.16 0.981 . . . . 15.0 112.962 -172.997 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 244' ' ' THR . . . . . . . . . . . . . 28.9 p -105.5 90.9 3.55 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-N 112.919 -1.946 . . . . 15.0 109.37 178.795 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 245' ' ' THR . . . . . 1.05 HG23 ' HG2' ' A' ' 247' ' ' GLN . 9.5 t -104.01 150.7 24.01 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.661 -0.7 . . . . 15.0 110.204 -176.182 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 39.6 t -43.74 -26.81 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 N-CA-C 113.725 1.009 . . . . 15.0 113.725 -172.665 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 247' ' ' GLN . . . . . 1.05 ' HG2' HG23 ' A' ' 245' ' ' THR . 3.5 pt20 -56.06 -23.09 31.49 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-O 120.695 0.283 . . . . 15.0 111.645 177.742 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 80.52 43.05 9.57 Favored Glycine 0 C--N 1.333 0.376 0 CA-C-N 116.264 -0.425 . . . . 15.0 113.15 176.068 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 249' ' ' GLN . . . . . 0.443 ' HB2' ' OE1' ' A' ' 247' ' ' GLN . 30.6 mt-30 -141.85 148.77 39.35 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.908 0.354 . . . . 15.0 110.082 -178.803 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 17.2 m -89.95 114.16 27.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-O 121.144 0.497 . . . . 15.0 110.638 178.814 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 251' ' ' TYR . . . . . 0.891 ' HB2' ' HG2' ' B' ' 215' ' ' PRO . 2.4 p90 -126.43 131.91 51.6 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.565 -0.532 . . . . 15.0 109.565 -178.841 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 252' ' ' PHE . . . . . 0.553 ' CD2' ' HA ' ' A' ' 264' ' ' ASP . 50.7 m-85 -90.04 126.07 35.63 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.137 -0.483 . . . . 15.0 111.281 -175.052 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 253' ' ' LEU . . . . . 0.657 HD11 ' HB3' ' B' ' 212' ' ' PRO . 0.8 OUTLIER -118.55 121.27 39.82 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-N 115.655 -0.702 . . . . 15.0 110.776 -177.623 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 254' ' ' HIS . . . . . 0.669 ' HB2' ' CD1' ' A' ' 240' ' ' TYR . 49.4 t60 -135.93 96.48 3.42 Favored 'General case' 0 CA--C 1.502 -0.895 0 N-CA-C 108.834 -0.802 . . . . 15.0 108.834 172.544 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 6.1 t -94.03 88.13 5.57 Favored 'General case' 0 C--N 1.311 -1.085 0 C-N-CA 116.525 -2.07 . . . . 15.0 110.797 -179.809 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 44.4 tt0 -101.23 -52.97 3.13 Favored 'General case' 0 N--CA 1.443 -0.824 0 CA-C-N 113.29 -1.777 . . . . 15.0 106.217 151.316 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 257' ' ' THR . . . . . . . . . . . . . 62.7 p -99.92 -13.45 19.14 Favored 'General case' 0 CA--C 1.488 -1.44 0 CA-C-O 124.837 2.256 . . . . 15.0 111.774 -179.279 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 87.74 72.98 1.28 Allowed Glycine 1 C--N 1.238 -4.907 1 CA-C-N 108.391 -4.004 . . . . 15.0 112.782 -169.91 . . . . . . . . 3 2 . 1 . 015 nuclear build full ' A' A ' 259' ' ' VAL . . . . . 0.492 ' O ' ' HA ' ' A' ' 253' ' ' LEU . 45.1 t -90.1 127.87 42.39 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.3 0 CA-C-O 121.151 0.5 . . . . 15.0 111.576 174.309 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 260' ' ' SER . . . . . 0.489 ' HA ' ' O ' ' A' ' 252' ' ' PHE . 2.2 p -148.13 103.25 3.45 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 114.721 -1.127 . . . . 15.0 108.195 170.109 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 13.8 t -150.02 150.43 31.77 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 116.099 -0.501 . . . . 15.0 111.358 -168.994 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 262' ' ' TRP . . . . . 1.182 ' CZ2' ' HB2' ' B' ' 215' ' ' PRO . 92.4 m95 -69.9 -36.78 75.67 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.932 -0.576 . . . . 15.0 111.53 179.423 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 263' ' ' HIS . . . . . . . . . . . . . 8.8 p-80 -75.38 129.96 38.21 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.612 -0.435 . . . . 15.0 110.605 -174.916 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 264' ' ' ASP . . . . . 1.046 ' HB3' HG12 ' A' ' 267' ' ' ILE . 67.5 t0 -59.49 124.56 76.06 Favored Pre-proline 0 C--N 1.321 -0.649 0 N-CA-C 108.609 -0.885 . . . . 15.0 108.609 172.016 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 265' ' ' PRO . . . . . 0.528 ' HG2' ' CE1' ' A' ' 240' ' ' TYR . 13.0 Cg_exo -68.83 -14.61 39.26 Favored 'Trans proline' 0 N--CA 1.456 -0.716 0 C-N-CA 121.904 1.736 . . . . 15.0 111.889 178.074 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 266' ' ' ARG . . . . . 0.672 ' HD3' ' HD3' ' A' ' 237' ' ' PRO . 22.7 tpt180 -76.73 -10.18 59.19 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 115.252 -0.885 . . . . 15.0 109.473 173.538 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 267' ' ' ILE . . . . . 1.046 HG12 ' HB3' ' A' ' 264' ' ' ASP . 40.0 pt . . . . . 0 C--O 1.25 1.096 0 CA-C-N 114.813 -1.085 . . . . 15.0 111.297 177.389 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 210' ' ' SER . . . . . . . . . . . . . 16.5 m . . . . . 0 N--CA 1.479 0.987 0 CA-C-O 120.772 0.32 . . . . 15.0 110.963 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' B' B ' 211' ' ' ASP . . . . . 0.404 ' HA ' ' HD3' ' B' ' 212' ' ' PRO . 13.5 t70 -135.34 120.64 13.82 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.536 -0.302 . . . . 15.0 110.76 -174.922 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 212' ' ' PRO . . . . . 0.657 ' HB3' HD11 ' A' ' 253' ' ' LEU . 53.9 Cg_endo -93.34 143.77 2.07 Favored 'Trans proline' 0 N--CA 1.452 -0.927 0 C-N-CA 122.837 2.358 . . . . 15.0 112.696 176.59 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -89.94 154.37 23.75 Favored Glycine 0 N--CA 1.446 -0.698 0 C-N-CA 120.406 -0.902 . . . . 15.0 111.814 179.586 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 214' ' ' SEP . . . . . 0.605 ' HB3' ' NE2' ' A' ' 247' ' ' GLN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 215' ' ' PRO . . . . . 1.182 ' HB2' ' CZ2' ' A' ' 262' ' ' TRP . 27.9 Cg_exo -88.14 151.1 6.88 Favored 'Trans proline' 0 CA--C 1.528 0.219 0 C-N-CA 123.157 2.572 . . . . 15.0 111.807 175.337 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 216' ' ' PHE . . . . . . . . . . . . . 59.0 m-85 -130.94 -46.17 1.03 Allowed 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.976 0.417 . . . . 15.0 110.654 177.902 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 217' ' ' GLN . . . . . . . . . . . . . 2.7 mp0 . . . . . 0 C--O 1.244 0.805 0 CA-C-O 118.422 -0.799 . . . . 15.0 109.727 179.074 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 . . . . . 0 N--CA 1.483 1.2 0 N-CA-C 109.583 -0.525 . . . . 15.0 109.583 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 236' ' ' LEU . . . . . 0.656 HD22 ' H ' ' A' ' 236' ' ' LEU . 0.0 OUTLIER -97.35 161.31 26.47 Favored Pre-proline 0 C--N 1.324 -0.53 0 CA-C-O 121.148 0.499 . . . . 15.0 110.177 -175.027 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 237' ' ' PRO . . . . . 0.522 ' HD3' ' HB2' ' A' ' 266' ' ' ARG . 9.0 Cg_exo -69.79 174.77 9.05 Favored 'Trans proline' 0 CA--C 1.509 -0.765 0 C-N-CA 122.845 2.363 . . . . 15.0 110.802 166.308 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -69.6 126.71 30.55 Favored 'General case' 0 C--N 1.297 -1.706 0 CA-C-N 114.132 -1.394 . . . . 15.0 111.544 -175.316 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 100.06 49.28 1.49 Allowed Glycine 0 C--N 1.333 0.37 0 CA-C-N 115.364 -0.834 . . . . 15.0 113.436 177.195 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 240' ' ' TYR . . . . . 0.646 ' CD1' ' HB2' ' A' ' 254' ' ' HIS . 74.1 m-85 -142.69 123.78 14.51 Favored 'General case' 0 CA--C 1.516 -0.345 0 CA-C-N 117.658 0.729 . . . . 15.0 111.518 176.442 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 241' ' ' GLU . . . . . 0.401 ' HB3' ' NH1' ' A' ' 243' ' ' ARG . 34.1 mm-40 -100.07 124.06 45.02 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.337 -0.847 . . . . 15.0 109.164 175.155 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 242' ' ' GLN . . . . . 0.69 ' HG3' ' CE1' ' A' ' 252' ' ' PHE . 31.7 tt0 -90.18 110.78 21.79 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.458 -0.571 . . . . 15.0 109.458 -179.82 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 243' ' ' ARG . . . . . 0.428 ' CD ' HD12 ' A' ' 253' ' ' LEU . 2.5 mpt_? -93.44 150.39 20.49 Favored 'General case' 0 CA--C 1.506 -0.739 0 CA-C-O 122.185 0.993 . . . . 15.0 113.641 -177.745 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 244' ' ' THR . . . . . . . . . . . . . 23.4 p -130.89 95.35 3.81 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 113.014 -1.903 . . . . 15.0 110.057 -176.848 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 245' ' ' THR . . . . . 0.511 ' OG1' ' HG2' ' A' ' 247' ' ' GLN . 5.5 t -93.96 150.41 20.38 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.872 -0.604 . . . . 15.0 110.044 179.672 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 3.8 p -53.37 -20.58 3.19 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 CA-C-O 121.163 0.506 . . . . 15.0 111.492 -179.244 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 247' ' ' GLN . . . . . 0.511 ' HG2' ' OG1' ' A' ' 245' ' ' THR . 31.6 mm-40 -55.12 -23.5 21.31 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.022 -0.99 . . . . 15.0 110.881 176.23 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 85.88 36.58 10.1 Favored Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 121.103 -0.57 . . . . 15.0 111.801 178.5 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 249' ' ' GLN . . . . . 0.437 ' HG2' ' HB2' ' A' ' 247' ' ' GLN . 7.3 pt20 -141.43 130.77 23.66 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.866 0.365 . . . . 15.0 110.844 -176.892 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 15.5 m -89.84 124.87 42.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 115.868 -0.605 . . . . 15.0 110.305 177.042 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 251' ' ' TYR . . . . . 0.596 ' CD2' ' HD3' ' B' ' 215' ' ' PRO . 16.4 p90 -128.95 137.24 51.27 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.812 -0.631 . . . . 15.0 109.765 -177.976 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 252' ' ' PHE . . . . . 0.69 ' CE1' ' HG3' ' A' ' 242' ' ' GLN . 29.8 m-85 -89.75 120.17 30.77 Favored 'General case' 0 CA--C 1.511 -0.535 0 CA-C-O 121.239 0.542 . . . . 15.0 112.186 -169.986 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 253' ' ' LEU . . . . . 1.004 HD11 ' HB3' ' B' ' 212' ' ' PRO . 4.6 mt -104.65 110.29 22.54 Favored 'General case' 0 N--CA 1.446 -0.627 0 CA-C-N 114.683 -1.144 . . . . 15.0 111.823 -178.308 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 254' ' ' HIS . . . . . 0.646 ' HB2' ' CD1' ' A' ' 240' ' ' TYR . 32.9 t60 -117.89 95.65 5.01 Favored 'General case' 0 C--N 1.312 -1.042 0 N-CA-C 107.808 -1.182 . . . . 15.0 107.808 166.405 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 2.9 t -93.98 87.76 5.47 Favored 'General case' 0 N--CA 1.429 -1.507 0 C-N-CA 115.968 -2.293 . . . . 15.0 110.038 -179.115 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 51.1 tt0 -101.34 -54.55 2.75 Favored 'General case' 0 N--CA 1.441 -0.894 0 CA-C-N 113.087 -1.869 . . . . 15.0 106.068 151.208 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 257' ' ' THR . . . . . . . . . . . . . 67.2 p -99.51 -13.74 19.36 Favored 'General case' 0 CA--C 1.49 -1.365 0 CA-C-N 111.881 -2.418 . . . . 15.0 112.013 -177.183 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 87.83 71.57 1.28 Allowed Glycine 1 C--N 1.241 -4.7 1 CA-C-N 108.236 -4.074 . . . . 15.0 112.904 -171.513 . . . . . . . . 3 2 . 1 . 016 nuclear build full ' A' A ' 259' ' ' VAL . . . . . 0.693 ' O ' ' HA ' ' A' ' 253' ' ' LEU . 40.6 t -89.67 124.58 42.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 121.294 0.569 . . . . 15.0 112.226 176.767 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -137.15 97.04 3.4 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 114.451 -1.25 . . . . 15.0 107.816 166.174 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 14.6 t -132.23 150.35 52.17 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.943 -0.571 . . . . 15.0 111.48 -168.45 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 262' ' ' TRP . . . . . 1.107 ' CZ2' ' HB2' ' B' ' 215' ' ' PRO . 10.7 m95 -65.57 -53.75 37.6 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.476 -0.784 . . . . 15.0 111.519 178.615 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 263' ' ' HIS . . . . . . . . . . . . . 4.4 p80 -65.3 133.43 51.41 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.242 -0.435 . . . . 15.0 110.465 -175.995 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 264' ' ' ASP . . . . . 0.978 ' HB3' HG12 ' A' ' 267' ' ' ILE . 24.0 t0 -53.83 128.9 55.55 Favored Pre-proline 0 C--N 1.321 -0.631 0 N-CA-C 107.833 -1.173 . . . . 15.0 107.833 169.253 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 265' ' ' PRO . . . . . 0.625 ' HD3' ' CD2' ' A' ' 252' ' ' PHE . 13.1 Cg_exo -68.98 -14.57 38.78 Favored 'Trans proline' 0 N--CA 1.458 -0.605 0 C-N-CA 122.01 1.807 . . . . 15.0 112.582 -177.483 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 266' ' ' ARG . . . . . 0.522 ' HB2' ' HD3' ' A' ' 237' ' ' PRO . 19.9 tpt180 -72.53 -14.93 61.76 Favored 'General case' 0 N--CA 1.446 -0.667 0 N-CA-C 108.611 -0.885 . . . . 15.0 108.611 170.953 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 267' ' ' ILE . . . . . 0.978 HG12 ' HB3' ' A' ' 264' ' ' ASP . 26.9 pt . . . . . 0 C--O 1.252 1.199 0 CA-C-N 114.482 -1.236 . . . . 15.0 110.438 177.748 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 210' ' ' SER . . . . . . . . . . . . . 24.4 p . . . . . 0 N--CA 1.479 1.012 0 N-CA-C 111.595 0.22 . . . . 15.0 111.595 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' B' B ' 211' ' ' ASP . . . . . 0.477 ' HA ' ' HD3' ' B' ' 212' ' ' PRO . 23.6 t70 -93.45 120.28 66.59 Favored Pre-proline 0 C--N 1.328 -0.342 0 N-CA-C 110.323 -0.251 . . . . 15.0 110.323 -179.113 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 212' ' ' PRO . . . . . 1.004 ' HB3' HD11 ' A' ' 253' ' ' LEU . 3.6 Cg_endo -89.83 147.25 4.81 Favored 'Trans proline' 0 N--CA 1.453 -0.909 0 C-N-CA 123.078 2.519 . . . . 15.0 112.595 179.714 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -89.87 148.34 19.81 Favored Glycine 0 N--CA 1.438 -1.172 0 C-N-CA 120.603 -0.808 . . . . 15.0 112.049 -179.581 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 214' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' B' B ' 215' ' ' PRO . . . . . 1.107 ' HB2' ' CZ2' ' A' ' 262' ' ' TRP . 15.6 Cg_exo -87.49 112.26 0.84 Allowed 'Trans proline' 0 C--N 1.331 -0.378 0 C-N-CA 123.53 2.82 . . . . 15.0 110.914 -178.681 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 216' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -104.26 -5.45 21.85 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.602 -0.726 . . . . 15.0 111.205 -176.294 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 217' ' ' GLN . . . . . . . . . . . . . 20.3 tt0 . . . . . 0 C--O 1.249 1.038 0 CA-C-O 118.428 -0.796 . . . . 15.0 109.513 178.575 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 . . . . . 0 N--CA 1.482 1.125 0 N-CA-C 110.307 -0.257 . . . . 15.0 110.307 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 236' ' ' LEU . . . . . 0.662 HD22 ' H ' ' A' ' 236' ' ' LEU . 0.1 OUTLIER -95.91 171.78 5.97 Favored Pre-proline 0 C--N 1.324 -0.51 0 N-CA-C 108.767 -0.827 . . . . 15.0 108.767 178.685 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 237' ' ' PRO . . . . . 0.829 ' HD3' ' HD3' ' A' ' 266' ' ' ARG . 16.8 Cg_exo -69.57 160.64 48.98 Favored 'Trans proline' 0 N--CA 1.459 -0.519 0 C-N-CA 122.077 1.851 . . . . 15.0 110.286 166.562 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -69.59 142.6 53.51 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-N 115.536 -0.756 . . . . 15.0 111.006 -174.353 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 100.37 8.77 49.16 Favored Glycine 0 CA--C 1.522 0.494 0 CA-C-N 115.807 -0.633 . . . . 15.0 113.815 179.677 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 240' ' ' TYR . . . . . 0.707 ' CD1' ' HB2' ' A' ' 254' ' ' HIS . 77.8 m-85 -109.97 110.43 21.36 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 117.465 0.632 . . . . 15.0 110.458 175.882 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 241' ' ' GLU . . . . . 0.655 ' HG3' ' HB3' ' A' ' 253' ' ' LEU . 8.0 pt-20 -90.13 115.92 27.75 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.697 0.76 . . . . 15.0 109.202 174.105 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 11.7 tm0? -90.0 109.72 20.74 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 108.805 -0.813 . . . . 15.0 108.805 -179.564 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 69.6 mtt-85 -99.14 150.18 22.3 Favored 'General case' 0 CA--C 1.504 -0.803 0 CA-C-O 122.283 1.039 . . . . 15.0 113.355 -170.992 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 244' ' ' THR . . . . . . . . . . . . . 3.3 p -115.67 105.4 12.71 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 112.87 -1.968 . . . . 15.0 109.725 179.184 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 245' ' ' THR . . . . . 0.94 HG23 ' HG2' ' A' ' 247' ' ' GLN . 6.1 t -116.22 150.35 37.67 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 116.036 -0.529 . . . . 15.0 110.882 -174.874 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 13.0 m -49.22 -25.22 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.313 0 N-CA-C 113.97 1.1 . . . . 15.0 113.97 -176.474 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 247' ' ' GLN . . . . . 0.94 ' HG2' HG23 ' A' ' 245' ' ' THR . 2.6 pt20 -57.75 -21.65 42.49 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-O 120.678 0.275 . . . . 15.0 111.012 178.161 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 93.62 15.41 50.06 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.925 -0.655 . . . . 15.0 113.259 174.936 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 249' ' ' GLN . . . . . 0.681 ' HB2' ' OE1' ' A' ' 247' ' ' GLN . 21.3 mp0 -123.97 147.34 47.84 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.944 0.402 . . . . 15.0 111.598 -178.689 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 31.3 m -90.13 135.71 25.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.765 -0.652 . . . . 15.0 109.89 173.235 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 251' ' ' TYR . . . . . 0.692 ' HB3' ' HG2' ' B' ' 215' ' ' PRO . 28.2 p90 -141.95 135.15 29.09 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 109.587 -0.523 . . . . 15.0 109.587 -177.038 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 252' ' ' PHE . . . . . 0.694 ' CD2' ' HA ' ' A' ' 264' ' ' ASP . 29.5 m-85 -90.13 123.39 33.93 Favored 'General case' 0 CA--C 1.51 -0.565 0 CA-C-N 115.982 -0.554 . . . . 15.0 111.593 -173.248 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 253' ' ' LEU . . . . . 0.812 HD11 ' HB3' ' B' ' 212' ' ' PRO . 0.5 OUTLIER -116.69 114.26 23.79 Favored 'General case' 0 N--CA 1.445 -0.715 0 CA-C-N 115.123 -0.944 . . . . 15.0 110.964 -176.343 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 254' ' ' HIS . . . . . 0.707 ' HB2' ' CD1' ' A' ' 240' ' ' TYR . 59.0 t60 -124.29 95.09 4.41 Favored 'General case' 0 CA--C 1.5 -0.972 0 N-CA-C 108.48 -0.933 . . . . 15.0 108.48 169.747 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 3.0 t -94.54 88.18 5.37 Favored 'General case' 0 N--CA 1.433 -1.304 0 C-N-CA 116.33 -2.148 . . . . 15.0 110.754 179.287 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 40.6 tt0 -101.29 -52.94 3.13 Favored 'General case' 0 N--CA 1.441 -0.906 0 N-CA-C 106.026 -1.842 . . . . 15.0 106.026 149.861 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 257' ' ' THR . . . . . . . . . . . . . 72.7 p -97.79 -13.7 21.21 Favored 'General case' 0 CA--C 1.488 -1.406 0 CA-C-O 124.634 2.159 . . . . 15.0 111.923 -179.501 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 88.7 71.04 1.27 Allowed Glycine 1 C--N 1.243 -4.598 0 CA-C-N 108.404 -3.998 . . . . 15.0 113.167 -172.933 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 259' ' ' VAL . . . . . 0.622 ' O ' ' HA ' ' A' ' 253' ' ' LEU . 57.8 t -89.83 126.06 42.74 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.289 0 CA-C-O 121.428 0.632 . . . . 15.0 112.387 175.757 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 260' ' ' SER . . . . . 0.412 ' HA ' ' O ' ' A' ' 252' ' ' PHE . 1.4 p -141.66 100.24 3.72 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 114.444 -1.253 . . . . 15.0 107.685 165.934 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 13.4 t -136.39 150.32 48.74 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.853 -0.612 . . . . 15.0 111.788 -167.376 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 262' ' ' TRP . . . . . 1.199 ' CZ2' ' HB2' ' B' ' 215' ' ' PRO . 8.9 m95 -70.7 -32.38 69.58 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.349 -0.841 . . . . 15.0 112.374 179.449 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 263' ' ' HIS . . . . . . . . . . . . . 5.0 p80 -84.63 134.67 34.37 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 120.385 -0.526 . . . . 15.0 110.388 -176.289 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 264' ' ' ASP . . . . . 1.022 ' HB3' HG12 ' A' ' 267' ' ' ILE . 43.5 t0 -56.62 124.06 60.72 Favored Pre-proline 0 C--O 1.218 -0.603 0 N-CA-C 108.56 -0.904 . . . . 15.0 108.56 169.843 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 265' ' ' PRO . . . . . 0.53 ' HD3' ' CD2' ' A' ' 252' ' ' PHE . 10.6 Cg_exo -68.93 -14.83 39.44 Favored 'Trans proline' 0 N--CA 1.46 -0.494 0 C-N-CA 122.367 2.045 . . . . 15.0 112.629 -177.55 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 266' ' ' ARG . . . . . 0.829 ' HD3' ' HD3' ' A' ' 237' ' ' PRO . 20.2 tpt180 -75.89 -11.58 60.0 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 115.483 -0.78 . . . . 15.0 109.047 173.623 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 267' ' ' ILE . . . . . 1.022 HG12 ' HB3' ' A' ' 264' ' ' ASP . 36.9 pt . . . . . 0 C--O 1.247 0.945 0 CA-C-N 114.641 -1.163 . . . . 15.0 111.253 178.899 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 210' ' ' SER . . . . . . . . . . . . . 20.4 m . . . . . 0 N--CA 1.481 1.077 0 CA-C-O 120.638 0.256 . . . . 15.0 111.229 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' B' B ' 211' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -116.95 144.32 33.27 Favored Pre-proline 0 C--O 1.235 0.319 0 N-CA-C 109.37 -0.604 . . . . 15.0 109.37 176.053 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 212' ' ' PRO . . . . . 0.812 ' HB3' HD11 ' A' ' 253' ' ' LEU . 8.4 Cg_endo -89.87 143.33 4.16 Favored 'Trans proline' 0 N--CA 1.454 -0.823 0 C-N-CA 122.819 2.346 . . . . 15.0 112.888 -176.715 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -89.77 149.98 20.82 Favored Glycine 0 N--CA 1.441 -0.976 0 CA-C-N 115.538 -0.755 . . . . 15.0 111.622 176.998 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 214' ' ' SEP . . . . . 0.463 ' HB3' ' NE2' ' A' ' 247' ' ' GLN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 215' ' ' PRO . . . . . 1.199 ' HB2' ' CZ2' ' A' ' 262' ' ' TRP . 12.5 Cg_exo -87.21 134.29 3.52 Favored 'Trans proline' 0 N--CA 1.464 -0.256 0 C-N-CA 123.637 2.891 . . . . 15.0 110.711 179.583 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 216' ' ' PHE . . . . . . . . . . . . . 82.5 m-85 -112.25 -28.31 7.99 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 120.399 -0.521 . . . . 15.0 111.725 -176.764 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 217' ' ' GLN . . . . . . . . . . . . . 29.5 pt20 . . . . . 0 C--O 1.247 0.934 0 N-CA-C 109.381 -0.6 . . . . 15.0 109.381 178.676 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.48 1.07 0 N-CA-C 109.914 -0.402 . . . . 15.0 109.914 . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 236' ' ' LEU . . . . . 0.427 HD11 ' OD1' ' A' ' 264' ' ' ASP . 2.1 mm? -122.0 171.18 6.59 Favored Pre-proline 0 C--N 1.322 -0.614 0 CA-C-O 120.85 0.357 . . . . 15.0 110.727 -176.757 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 237' ' ' PRO . . . . . 0.563 ' HD3' ' HD3' ' A' ' 266' ' ' ARG . 15.0 Cg_exo -69.53 164.28 34.9 Favored 'Trans proline' 0 N--CA 1.456 -0.699 0 C-N-CA 121.92 1.747 . . . . 15.0 109.314 160.835 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 12.2 mm-40 -69.6 142.69 53.47 Favored 'General case' 0 C--N 1.301 -1.522 0 CA-C-N 115.166 -0.925 . . . . 15.0 113.333 -170.098 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 100.11 -1.62 56.37 Favored Glycine 0 CA--C 1.526 0.755 0 CA-C-N 114.124 -1.398 . . . . 15.0 115.166 174.103 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 240' ' ' TYR . . . . . 0.7 ' CD1' ' HB2' ' A' ' 254' ' ' HIS . 78.1 m-85 -87.9 123.46 32.67 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 118.574 1.187 . . . . 15.0 111.486 -179.449 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -96.08 114.81 26.55 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.397 -0.819 . . . . 15.0 109.214 173.332 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -90.13 99.68 12.65 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 108.823 -0.806 . . . . 15.0 108.823 176.233 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 243' ' ' ARG . . . . . 0.701 ' CZ ' ' HD2' ' B' ' 212' ' ' PRO . 34.7 mtt180 -91.28 149.86 21.57 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.531 -0.758 . . . . 15.0 111.823 179.404 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 244' ' ' THR . . . . . . . . . . . . . 6.1 m -127.2 92.05 3.44 Favored 'General case' 0 C--N 1.307 -1.267 0 CA-C-N 113.682 -1.599 . . . . 15.0 109.219 -179.407 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 245' ' ' THR . . . . . 0.438 ' OG1' ' HG2' ' A' ' 247' ' ' GLN . 5.0 t -90.0 150.59 22.05 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.204 -0.907 . . . . 15.0 110.926 -174.666 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 11.6 m -49.0 -20.23 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 CA-C-N 115.429 -0.805 . . . . 15.0 112.617 177.053 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 247' ' ' GLN . . . . . 0.565 ' HB2' ' HG3' ' A' ' 249' ' ' GLN . 6.6 mm100 -58.77 -19.51 41.4 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 116.055 -0.521 . . . . 15.0 111.128 175.307 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 85.98 26.01 35.84 Favored Glycine 0 C--N 1.332 0.357 0 C-N-CA 121.305 -0.474 . . . . 15.0 112.632 177.454 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 249' ' ' GLN . . . . . 0.565 ' HG3' ' HB2' ' A' ' 247' ' ' GLN . 0.3 OUTLIER -126.43 133.96 51.11 Favored 'General case' 0 C--N 1.326 -0.415 0 O-C-N 122.624 -0.339 . . . . 15.0 110.967 -174.493 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 3.6 m -90.01 107.23 18.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 115.768 -0.651 . . . . 15.0 109.537 173.056 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 251' ' ' TYR . . . . . 0.747 ' HB2' ' HG2' ' B' ' 215' ' ' PRO . 6.4 p90 -119.48 130.65 55.33 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.922 -0.581 . . . . 15.0 109.981 -173.399 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 252' ' ' PHE . . . . . 0.738 ' CD2' ' HA ' ' A' ' 264' ' ' ASP . 32.2 m-85 -90.03 123.09 33.62 Favored 'General case' 0 CA--C 1.506 -0.75 0 CA-C-N 116.21 -0.45 . . . . 15.0 110.832 -175.365 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 253' ' ' LEU . . . . . 0.838 HD13 ' HB2' ' B' ' 212' ' ' PRO . 1.6 tt -128.82 115.79 18.46 Favored 'General case' 0 N--CA 1.438 -1.048 0 CA-C-N 115.631 -0.713 . . . . 15.0 111.541 -175.554 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 254' ' ' HIS . . . . . 0.7 ' HB2' ' CD1' ' A' ' 240' ' ' TYR . 72.4 t60 -124.18 92.57 3.69 Favored 'General case' 0 CA--C 1.505 -0.758 0 N-CA-C 108.723 -0.843 . . . . 15.0 108.723 174.861 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 255' ' ' THR . . . . . 0.405 ' HA ' ' HA2' ' A' ' 258' ' ' GLY . 53.0 m -94.7 88.18 5.3 Favored 'General case' 0 N--CA 1.436 -1.159 0 C-N-CA 116.66 -2.016 . . . . 15.0 110.429 179.782 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 45.2 tt0 -100.83 -50.47 3.83 Favored 'General case' 0 N--CA 1.441 -0.917 0 N-CA-C 105.848 -1.908 . . . . 15.0 105.848 151.236 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 257' ' ' THR . . . . . . . . . . . . . 60.3 p -98.46 -13.44 20.54 Favored 'General case' 0 CA--C 1.49 -1.349 0 CA-C-O 124.963 2.316 . . . . 15.0 111.795 177.598 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 258' ' ' GLY . . . . . 0.405 ' HA2' ' HA ' ' A' ' 255' ' ' THR . . . 88.52 70.8 1.27 Allowed Glycine 1 C--N 1.242 -4.665 1 CA-C-N 108.214 -4.085 . . . . 15.0 113.471 -173.405 . . . . . . . . 4 3 . 1 . 018 nuclear build full ' A' A ' 259' ' ' VAL . . . . . 0.527 ' O ' ' HA ' ' A' ' 253' ' ' LEU . 76.5 t -89.8 130.42 39.13 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.58 0 CA-C-O 121.271 0.558 . . . . 15.0 111.207 173.711 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 10.1 p -150.09 96.97 2.51 Favored 'General case' 0 C--N 1.307 -1.247 0 CA-C-N 114.598 -1.183 . . . . 15.0 108.817 170.755 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 12.4 t -143.87 150.32 38.27 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.877 -0.601 . . . . 15.0 111.299 -168.377 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 262' ' ' TRP . . . . . 1.117 ' CZ2' ' HB2' ' B' ' 215' ' ' PRO . 92.9 m95 -69.07 -42.15 76.62 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.849 -0.614 . . . . 15.0 111.729 179.845 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 263' ' ' HIS . . . . . . . . . . . . . 2.6 p80 -65.22 132.32 48.8 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-O 120.896 0.379 . . . . 15.0 110.213 -176.345 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 264' ' ' ASP . . . . . 0.899 ' HB3' HG12 ' A' ' 267' ' ' ILE . 28.4 t70 -56.11 124.94 62.26 Favored Pre-proline 0 C--N 1.321 -0.665 0 N-CA-C 108.847 -0.797 . . . . 15.0 108.847 172.428 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 265' ' ' PRO . . . . . 0.672 ' HD3' ' CD2' ' A' ' 252' ' ' PHE . 4.3 Cg_exo -73.44 -14.64 25.12 Favored 'Trans proline' 0 CA--C 1.51 -0.701 0 C-N-CA 122.08 1.853 . . . . 15.0 112.224 -175.978 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 266' ' ' ARG . . . . . 0.568 ' HB3' ' OD2' ' A' ' 264' ' ' ASP . 28.1 tpt180 -72.63 -13.46 61.38 Favored 'General case' 0 C--N 1.316 -0.861 0 N-CA-C 108.542 -0.91 . . . . 15.0 108.542 171.244 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 267' ' ' ILE . . . . . 0.899 HG12 ' HB3' ' A' ' 264' ' ' ASP . 22.5 pt . . . . . 0 C--O 1.251 1.169 0 CA-C-N 114.618 -1.174 . . . . 15.0 110.645 174.667 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 210' ' ' SER . . . . . . . . . . . . . 9.6 p . . . . . 0 N--CA 1.478 0.955 0 N-CA-C 110.366 -0.235 . . . . 15.0 110.366 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' B' B ' 211' ' ' ASP . . . . . 0.485 ' HA ' ' HD3' ' B' ' 212' ' ' PRO . 20.5 t70 -150.04 128.64 6.04 Favored Pre-proline 0 C--N 1.324 -0.52 0 N-CA-C 109.673 -0.492 . . . . 15.0 109.673 177.173 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 212' ' ' PRO . . . . . 0.838 ' HB2' HD13 ' A' ' 253' ' ' LEU . 2.0 Cg_endo -89.33 141.67 4.14 Favored 'Trans proline' 0 N--CA 1.457 -0.623 0 C-N-CA 123.281 2.654 . . . . 15.0 113.734 -177.814 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -89.67 160.34 28.85 Favored Glycine 0 N--CA 1.449 -0.449 0 CA-C-N 114.796 -1.093 . . . . 15.0 113.278 -176.466 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 214' ' ' SEP . . . . . 0.482 ' HA ' ' HD3' ' B' ' 215' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 215' ' ' PRO . . . . . 1.117 ' HB2' ' CZ2' ' A' ' 262' ' ' TRP . 36.9 Cg_exo -87.36 160.09 8.22 Favored 'Trans proline' 0 C--O 1.233 0.245 0 C-N-CA 124.057 3.172 . . . . 15.0 112.078 176.125 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 216' ' ' PHE . . . . . . . . . . . . . 92.2 m-85 -117.14 122.34 43.82 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.404 -0.362 . . . . 15.0 110.416 -178.696 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 217' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 . . . . . 0 C--O 1.25 1.095 0 CA-C-O 118.504 -0.76 . . . . 15.0 110.505 -177.485 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 . . . . . 0 N--CA 1.478 0.927 0 CA-C-O 121.093 0.473 . . . . 15.0 110.668 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 236' ' ' LEU . . . . . 0.418 HD11 ' CE1' ' A' ' 252' ' ' PHE . 19.7 mt -93.62 175.76 2.88 Favored Pre-proline 0 C--N 1.321 -0.657 0 N-CA-C 108.97 -0.752 . . . . 15.0 108.97 177.663 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 237' ' ' PRO . . . . . 0.855 ' HD3' ' HD3' ' A' ' 266' ' ' ARG . 13.1 Cg_exo -69.7 163.11 39.47 Favored 'Trans proline' 0 N--CA 1.459 -0.536 0 C-N-CA 121.47 1.446 . . . . 15.0 110.247 167.289 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -69.77 140.16 53.36 Favored 'General case' 0 C--N 1.307 -1.248 0 CA-C-N 115.321 -0.854 . . . . 15.0 111.104 -174.125 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 100.29 9.34 48.02 Favored Glycine 0 N--CA 1.451 -0.36 0 CA-C-N 115.642 -0.708 . . . . 15.0 114.211 178.241 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 240' ' ' TYR . . . . . 0.769 ' CD1' ' HB2' ' A' ' 254' ' ' HIS . 85.1 m-85 -104.08 123.43 47.23 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 117.897 0.848 . . . . 15.0 110.637 174.929 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 241' ' ' GLU . . . . . 0.689 ' HG3' ' HB3' ' A' ' 253' ' ' LEU . 7.7 pt-20 -109.41 123.78 49.91 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.682 -0.69 . . . . 15.0 109.627 174.408 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 21.5 tm0? -90.01 116.07 27.77 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 108.684 -0.858 . . . . 15.0 108.684 179.021 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 63.6 mtt-85 -107.3 149.27 27.99 Favored 'General case' 0 CA--C 1.501 -0.932 0 CA-C-O 122.157 0.979 . . . . 15.0 112.579 -177.563 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 244' ' ' THR . . . . . . . . . . . . . 7.5 m -124.18 91.72 3.52 Favored 'General case' 0 C--N 1.307 -1.257 0 CA-C-N 113.288 -1.778 . . . . 15.0 110.029 179.166 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 245' ' ' THR . . . . . 1.083 HG23 ' HG2' ' A' ' 247' ' ' GLN . 8.5 t -91.28 150.67 21.22 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.572 -0.74 . . . . 15.0 109.849 177.516 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 14.9 m -41.03 -24.32 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 N-CA-C 114.968 1.47 . . . . 15.0 114.968 -175.354 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 247' ' ' GLN . . . . . 1.083 ' HG2' HG23 ' A' ' 245' ' ' THR . 3.6 pt20 -55.79 -22.48 24.64 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-O 120.752 0.31 . . . . 15.0 111.013 176.564 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 81.03 34.73 26.12 Favored Glycine 0 C--N 1.333 0.399 0 C-N-CA 121.48 -0.391 . . . . 15.0 113.182 174.196 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 249' ' ' GLN . . . . . 0.425 ' HB3' ' CZ3' ' A' ' 262' ' ' TRP . 30.8 mt-30 -136.37 146.93 47.05 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.759 -0.46 . . . . 15.0 109.759 -178.627 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 23.7 m -89.76 125.47 42.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-O 120.792 0.329 . . . . 15.0 110.989 -178.186 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 251' ' ' TYR . . . . . 0.736 ' HB3' ' HG2' ' B' ' 215' ' ' PRO . 12.8 p90 -131.79 133.16 44.43 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 109.622 -0.511 . . . . 15.0 109.622 179.679 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 252' ' ' PHE . . . . . 0.683 ' CD2' ' HA ' ' A' ' 264' ' ' ASP . 36.3 m-85 -90.05 118.68 29.78 Favored 'General case' 0 CA--C 1.512 -0.508 0 CA-C-O 121.206 0.526 . . . . 15.0 110.994 -176.786 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 253' ' ' LEU . . . . . 0.689 ' HB3' ' HG3' ' A' ' 241' ' ' GLU . 0.6 OUTLIER -106.79 122.87 47.24 Favored 'General case' 0 N--CA 1.444 -0.737 0 CA-C-N 115.082 -0.963 . . . . 15.0 110.461 -178.05 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 254' ' ' HIS . . . . . 0.769 ' HB2' ' CD1' ' A' ' 240' ' ' TYR . 73.7 t60 -135.0 90.27 2.62 Favored 'General case' 0 C--N 1.313 -1.018 0 N-CA-C 108.081 -1.081 . . . . 15.0 108.081 172.024 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 255' ' ' THR . . . . . 0.419 ' HA ' ' HA2' ' A' ' 258' ' ' GLY . 2.8 t -91.41 87.82 6.58 Favored 'General case' 0 N--CA 1.433 -1.277 0 C-N-CA 116.411 -2.116 . . . . 15.0 110.185 -179.215 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 52.0 tt0 -101.53 -54.97 2.63 Favored 'General case' 0 N--CA 1.436 -1.135 0 CA-C-N 112.818 -1.992 . . . . 15.0 105.842 151.254 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 257' ' ' THR . . . . . . . . . . . . . 63.4 p -95.89 -13.53 23.87 Favored 'General case' 0 CA--C 1.486 -1.499 0 CA-C-N 112.214 -2.266 . . . . 15.0 111.449 179.015 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 258' ' ' GLY . . . . . 0.419 ' HA2' ' HA ' ' A' ' 255' ' ' THR . . . 86.66 70.52 1.31 Allowed Glycine 1 C--N 1.246 -4.453 1 CA-C-N 108.187 -4.097 . . . . 15.0 113.093 -172.629 . . . . . . . . 4 3 . 1 . 019 nuclear build full ' A' A ' 259' ' ' VAL . . . . . 0.571 ' O ' ' HA ' ' A' ' 253' ' ' LEU . 60.6 t -89.88 129.17 41.23 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.243 0 CA-C-O 121.203 0.525 . . . . 15.0 112.227 176.674 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 1.1 p -143.49 98.83 3.32 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 114.783 -1.098 . . . . 15.0 108.228 169.475 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 9.0 t -139.52 150.31 44.95 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 116.159 -0.473 . . . . 15.0 111.819 -170.305 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 262' ' ' TRP . . . . . 1.217 ' CZ2' ' HB2' ' B' ' 215' ' ' PRO . 91.6 m95 -68.3 -30.64 69.68 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.38 -0.827 . . . . 15.0 111.707 178.587 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 263' ' ' HIS . . . . . . . . . . . . . 4.2 p80 -83.5 136.72 34.17 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 120.725 -0.39 . . . . 15.0 110.757 -172.336 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 264' ' ' ASP . . . . . 0.776 ' HB3' HG12 ' A' ' 267' ' ' ILE . 10.0 t70 -56.32 134.23 75.95 Favored Pre-proline 0 C--N 1.325 -0.469 0 CA-C-N 115.652 -0.704 . . . . 15.0 109.268 174.754 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 265' ' ' PRO . . . . . 0.603 ' HD3' ' CD2' ' A' ' 252' ' ' PHE . 88.8 Cg_endo -84.28 -14.5 6.98 Favored 'Trans proline' 0 N--CA 1.458 -0.617 0 C-N-CA 122.568 2.179 . . . . 15.0 113.995 -174.486 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 266' ' ' ARG . . . . . 0.855 ' HD3' ' HD3' ' A' ' 237' ' ' PRO . 21.8 tpt180 -80.98 -5.21 57.26 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-O 122.418 1.104 . . . . 15.0 108.505 176.265 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 267' ' ' ILE . . . . . 0.776 HG12 ' HB3' ' A' ' 264' ' ' ASP . 48.3 mm . . . . . 0 C--O 1.251 1.174 0 CA-C-N 113.153 -1.84 . . . . 15.0 109.824 176.684 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 210' ' ' SER . . . . . . . . . . . . . 5.4 p . . . . . 0 N--CA 1.474 0.765 0 CA-C-O 121.042 0.448 . . . . 15.0 110.741 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' B' B ' 211' ' ' ASP . . . . . 0.465 ' HA ' ' HD3' ' B' ' 212' ' ' PRO . 2.0 p30 -144.62 118.94 5.77 Favored Pre-proline 0 C--N 1.325 -0.496 0 CA-C-N 115.83 -0.623 . . . . 15.0 110.319 178.766 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 212' ' ' PRO . . . . . 0.689 ' HB3' HD11 ' A' ' 253' ' ' LEU . 12.6 Cg_endo -92.22 151.09 3.11 Favored 'Trans proline' 0 N--CA 1.452 -0.942 0 C-N-CA 123.587 2.858 . . . . 15.0 112.722 -179.927 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -90.38 159.03 26.99 Favored Glycine 0 N--CA 1.444 -0.771 0 C-N-CA 120.725 -0.75 . . . . 15.0 112.466 179.457 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 214' ' ' SEP . . . . . 0.763 ' HB2' HG21 ' A' ' 245' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 215' ' ' PRO . . . . . 1.217 ' HB2' ' CZ2' ' A' ' 262' ' ' TRP . 15.4 Cg_exo -87.69 132.42 2.95 Favored 'Trans proline' 0 N--CA 1.463 -0.319 0 C-N-CA 122.907 2.405 . . . . 15.0 110.148 176.882 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 216' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -113.58 83.79 1.91 Allowed 'General case' 0 C--N 1.322 -0.602 0 O-C-N 121.965 -0.46 . . . . 15.0 110.778 179.877 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 217' ' ' GLN . . . . . . . . . . . . . 11.2 mm100 . . . . . 0 C--O 1.245 0.838 0 CA-C-N 114.933 -1.03 . . . . 15.0 110.705 179.57 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.478 0.973 0 N-CA-C 110.266 -0.272 . . . . 15.0 110.266 . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 2.4 mt -121.21 170.86 6.72 Favored Pre-proline 0 C--N 1.326 -0.424 0 N-CA-C 108.918 -0.771 . . . . 15.0 108.918 178.241 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 237' ' ' PRO . . . . . 0.465 ' O ' ' HD2' ' A' ' 240' ' ' TYR . 14.8 Cg_exo -69.81 162.69 41.11 Favored 'Trans proline' 0 N--CA 1.46 -0.46 0 C-N-CA 121.657 1.571 . . . . 15.0 110.093 164.626 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 238' ' ' GLU . . . . . 0.483 ' CD ' ' H ' ' A' ' 238' ' ' GLU . 0.9 OUTLIER -69.71 148.41 49.28 Favored 'General case' 0 C--N 1.306 -1.29 0 CA-C-N 115.432 -0.804 . . . . 15.0 111.243 -175.266 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 100.28 -7.38 58.35 Favored Glycine 0 N--CA 1.45 -0.411 0 CA-C-N 115.418 -0.81 . . . . 15.0 113.275 -179.521 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 240' ' ' TYR . . . . . 0.685 ' CD1' ' HB2' ' A' ' 254' ' ' HIS . 87.8 m-85 -99.46 113.25 25.5 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 117.461 0.631 . . . . 15.0 110.47 177.351 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 241' ' ' GLU . . . . . 0.465 ' HG3' ' HB3' ' A' ' 253' ' ' LEU . 9.5 pt-20 -90.26 120.29 31.29 Favored 'General case' 0 N--CA 1.439 -0.975 0 N-CA-C 108.725 -0.843 . . . . 15.0 108.725 174.518 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -89.86 99.1 12.18 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 108.123 -1.066 . . . . 15.0 108.123 -179.862 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 9.4 mtp180 -92.48 150.14 20.96 Favored 'General case' 0 N--CA 1.444 -0.738 0 CA-C-N 115.029 -0.987 . . . . 15.0 111.81 -175.152 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 244' ' ' THR . . . . . . . . . . . . . 4.4 p -117.54 149.92 39.82 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-N 113.733 -1.576 . . . . 15.0 110.077 -176.5 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 245' ' ' THR . . . . . 0.436 ' OG1' ' HG2' ' A' ' 247' ' ' GLN . 5.3 t -150.12 150.23 31.38 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 116.106 -0.497 . . . . 15.0 110.434 -176.003 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 19.8 t -54.82 -17.24 2.1 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 O-C-N 123.669 0.605 . . . . 15.0 111.354 179.078 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 247' ' ' GLN . . . . . 0.555 ' HB2' ' HG2' ' A' ' 249' ' ' GLN . 5.1 mm-40 -63.4 -19.25 64.52 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-O 121.006 0.431 . . . . 15.0 110.498 176.808 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 86.31 13.69 67.8 Favored Glycine 0 N--CA 1.452 -0.244 0 CA-C-N 116.013 -0.539 . . . . 15.0 112.289 176.709 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 249' ' ' GLN . . . . . 0.555 ' HG2' ' HB2' ' A' ' 247' ' ' GLN . 10.4 pt20 -114.02 135.12 54.35 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 120.927 0.394 . . . . 15.0 111.502 -174.701 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 6.0 m -90.0 120.26 38.5 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 N-CA-C 108.783 -0.821 . . . . 15.0 108.783 171.469 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 251' ' ' TYR . . . . . 0.624 ' CB ' ' HG2' ' B' ' 215' ' ' PRO . 4.3 p90 -125.75 133.04 52.2 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.863 -0.608 . . . . 15.0 109.855 -174.915 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 252' ' ' PHE . . . . . 0.613 ' CD2' ' HA ' ' A' ' 264' ' ' ASP . 24.5 m-85 -89.76 121.33 31.81 Favored 'General case' 0 CA--C 1.506 -0.728 0 CA-C-O 121.293 0.568 . . . . 15.0 111.619 -170.727 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 253' ' ' LEU . . . . . 0.57 HD11 ' CB ' ' B' ' 212' ' ' PRO . 0.6 OUTLIER -119.67 121.12 38.53 Favored 'General case' 0 N--CA 1.44 -0.944 0 CA-C-N 114.837 -1.074 . . . . 15.0 110.617 -176.017 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 254' ' ' HIS . . . . . 0.685 ' HB2' ' CD1' ' A' ' 240' ' ' TYR . 18.4 t60 -132.33 96.59 3.9 Favored 'General case' 0 C--N 1.312 -1.065 0 N-CA-C 108.447 -0.945 . . . . 15.0 108.447 170.57 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 5.0 t -92.72 87.92 6.06 Favored 'General case' 0 N--CA 1.432 -1.369 0 C-N-CA 116.554 -2.058 . . . . 15.0 110.183 -179.509 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 24.9 tt0 -101.36 -57.23 2.12 Favored 'General case' 0 N--CA 1.439 -0.98 0 CA-C-N 112.606 -2.088 . . . . 15.0 106.274 152.875 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 257' ' ' THR . . . . . . . . . . . . . 4.2 t -100.2 -13.56 18.86 Favored 'General case' 0 CA--C 1.488 -1.433 0 CA-C-N 111.326 -2.67 . . . . 15.0 112.085 -177.972 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 87.35 71.69 1.29 Allowed Glycine 1 C--N 1.238 -4.882 1 CA-C-N 108.136 -4.12 . . . . 15.0 112.635 -169.123 . . . . . . . . 3 2 . 1 . 020 nuclear build full ' A' A ' 259' ' ' VAL . . . . . 0.567 ' O ' ' HA ' ' A' ' 253' ' ' LEU . 65.7 t -89.37 123.72 41.73 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 CA-C-O 121.667 0.746 . . . . 15.0 112.163 170.607 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 260' ' ' SER . . . . . 0.479 ' HA ' ' O ' ' A' ' 252' ' ' PHE . 2.4 p -140.85 100.57 3.87 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 113.876 -1.511 . . . . 15.0 108.442 170.706 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 8.7 t -141.75 150.51 41.86 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.18 0.514 . . . . 15.0 112.374 -168.35 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 262' ' ' TRP . . . . . 1.143 ' CZ2' ' HB2' ' B' ' 215' ' ' PRO . 29.5 m95 -71.06 -31.62 68.09 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.361 -0.836 . . . . 15.0 111.535 176.761 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 263' ' ' HIS . . . . . 0.503 ' HD2' ' OXT' ' A' ' 267' ' ' ILE . 10.2 p-80 -84.06 130.83 34.85 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 120.29 -0.564 . . . . 15.0 110.154 -175.737 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 264' ' ' ASP . . . . . 0.917 ' HB3' HG12 ' A' ' 267' ' ' ILE . 20.7 t0 -53.95 126.92 52.56 Favored Pre-proline 0 C--N 1.324 -0.511 0 CA-C-N 115.619 -0.719 . . . . 15.0 109.285 173.131 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 265' ' ' PRO . . . . . 0.548 ' HG2' ' CD1' ' A' ' 240' ' ' TYR . 10.9 Cg_exo -70.5 -14.96 34.24 Favored 'Trans proline' 0 N--CA 1.456 -0.709 0 C-N-CA 122.231 1.954 . . . . 15.0 112.496 -179.361 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 266' ' ' ARG . . . . . 0.462 ' HB3' ' OD2' ' A' ' 264' ' ' ASP . 26.6 tpt180 -72.38 -15.15 61.85 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-O 122.07 0.938 . . . . 15.0 108.788 171.171 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 267' ' ' ILE . . . . . 0.917 HG12 ' HB3' ' A' ' 264' ' ' ASP . 32.8 pt . . . . . 0 C--O 1.25 1.09 0 CA-C-N 114.275 -1.329 . . . . 15.0 110.936 177.117 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 210' ' ' SER . . . . . . . . . . . . . 21.0 m . . . . . 0 N--CA 1.473 0.7 0 N-CA-C 109.962 -0.384 . . . . 15.0 109.962 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' B' B ' 211' ' ' ASP . . . . . 0.431 ' HA ' ' HD3' ' B' ' 212' ' ' PRO . 6.0 p-10 -138.63 134.69 17.42 Favored Pre-proline 0 C--N 1.32 -0.694 0 CA-C-N 115.925 -0.579 . . . . 15.0 109.795 -177.684 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 212' ' ' PRO . . . . . 0.57 ' CB ' HD11 ' A' ' 253' ' ' LEU . 4.6 Cg_endo -89.7 154.78 5.15 Favored 'Trans proline' 0 N--CA 1.456 -0.711 0 C-N-CA 123.393 2.729 . . . . 15.0 112.225 -177.0 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -89.66 158.55 27.44 Favored Glycine 0 N--CA 1.442 -0.965 0 CA-C-N 115.625 -0.716 . . . . 15.0 112.587 -177.435 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 214' ' ' SEP . . . . . 0.411 ' HA ' ' HD3' ' B' ' 215' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 215' ' ' PRO . . . . . 1.143 ' HB2' ' CZ2' ' A' ' 262' ' ' TRP . 23.6 Cg_exo -87.33 148.47 7.71 Favored 'Trans proline' 0 N--CA 1.464 -0.245 0 C-N-CA 123.15 2.567 . . . . 15.0 111.62 176.207 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 216' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -114.05 -67.27 1.01 Allowed 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.132 0.491 . . . . 15.0 110.06 178.645 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 217' ' ' GLN . . . . . . . . . . . . . 28.2 pt20 . . . . . 0 C--O 1.249 1.074 0 CA-C-O 118.456 -0.783 . . . . 15.0 110.154 -179.441 . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.482 1.158 0 N-CA-C 110.124 -0.324 . . . . 15.0 110.124 . . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 236' ' ' LEU . . . . . 0.443 HD11 ' OD2' ' A' ' 264' ' ' ASP . 0.9 OUTLIER -107.05 172.17 4.06 Favored Pre-proline 0 C--N 1.323 -0.549 0 CA-C-N 116.463 -0.335 . . . . 15.0 110.376 -176.889 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 237' ' ' PRO . . . . . 0.67 ' HD3' ' HD3' ' A' ' 266' ' ' ARG . 19.5 Cg_exo -69.44 170.1 16.99 Favored 'Trans proline' 0 CA--C 1.516 -0.422 0 C-N-CA 122.335 2.023 . . . . 15.0 110.838 165.577 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -69.78 140.26 53.35 Favored 'General case' 0 C--N 1.303 -1.422 0 CA-C-N 114.691 -1.14 . . . . 15.0 110.865 -176.207 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 239' ' ' GLY . . . . . 0.458 ' O ' ' HA ' ' A' ' 254' ' ' HIS . . . 100.04 11.99 41.15 Favored Glycine 0 N--CA 1.448 -0.516 0 CA-C-N 115.632 -0.713 . . . . 15.0 113.867 179.07 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 240' ' ' TYR . . . . . 0.669 ' CD1' ' HB2' ' A' ' 254' ' ' HIS . 64.2 m-85 -111.99 107.9 17.04 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 117.918 0.859 . . . . 15.0 111.579 178.13 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 13.8 mm-40 -90.15 120.81 31.64 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.021 -0.99 . . . . 15.0 109.841 176.155 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 23.4 tm0? -89.97 109.87 20.88 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 109.103 -0.703 . . . . 15.0 109.103 177.378 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 4.5 mtp180 -112.23 150.23 31.19 Favored 'General case' 0 CA--C 1.508 -0.666 0 CA-C-O 122.564 1.173 . . . . 15.0 113.494 -179.86 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 244' ' ' THR . . . . . . . . . . . . . 21.8 p -116.15 150.1 37.98 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-N 112.555 -2.111 . . . . 15.0 108.67 177.7 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 245' ' ' THR . . . . . 0.472 ' OG1' ' HG2' ' A' ' 247' ' ' GLN . 5.9 t -144.32 150.52 37.95 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 116.82 -0.173 . . . . 15.0 110.697 -175.201 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 21.6 t -52.5 -18.49 1.23 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 O-C-N 123.749 0.656 . . . . 15.0 111.589 178.261 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 247' ' ' GLN . . . . . 0.472 ' HG2' ' OG1' ' A' ' 245' ' ' THR . 4.7 mm100 -63.89 -17.15 62.91 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-O 120.893 0.378 . . . . 15.0 110.555 177.426 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 83.91 38.5 10.3 Favored Glycine 0 C--N 1.334 0.459 0 CA-C-N 116.088 -0.505 . . . . 15.0 112.571 177.275 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 249' ' ' GLN . . . . . 0.5 ' CD ' ' HH2' ' A' ' 262' ' ' TRP . 0.0 OUTLIER -146.72 147.5 31.03 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.044 0.449 . . . . 15.0 111.355 -175.194 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 13.7 m -93.92 138.45 20.44 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-N 115.1 -0.955 . . . . 15.0 109.345 173.737 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 251' ' ' TYR . . . . . 0.487 ' HB3' ' CG ' ' B' ' 215' ' ' PRO . 4.9 p90 -145.78 136.62 24.45 Favored 'General case' 0 C--N 1.32 -0.717 0 C-N-CA 120.605 -0.438 . . . . 15.0 110.419 -179.891 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 252' ' ' PHE . . . . . 0.607 ' CE2' ' HA ' ' A' ' 264' ' ' ASP . 43.9 m-85 -91.16 121.54 33.03 Favored 'General case' 0 CA--C 1.515 -0.377 0 CA-C-N 116.059 -0.519 . . . . 15.0 111.839 -174.629 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 253' ' ' LEU . . . . . 0.643 ' HA ' ' O ' ' A' ' 259' ' ' VAL . 13.7 mt -104.26 110.33 22.5 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-N 115.243 -0.89 . . . . 15.0 112.169 179.196 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 254' ' ' HIS . . . . . 0.669 ' HB2' ' CD1' ' A' ' 240' ' ' TYR . 22.7 t-80 -116.17 89.93 3.22 Favored 'General case' 0 C--N 1.311 -1.08 0 N-CA-C 107.696 -1.224 . . . . 15.0 107.696 166.099 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 37.1 m -90.86 88.03 6.89 Favored 'General case' 0 N--CA 1.43 -1.442 0 C-N-CA 116.894 -1.922 . . . . 15.0 110.097 -179.272 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 53.5 tt0 -101.04 -51.76 3.45 Favored 'General case' 0 N--CA 1.441 -0.891 0 N-CA-C 105.721 -1.955 . . . . 15.0 105.721 149.677 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 257' ' ' THR . . . . . . . . . . . . . 58.6 p -99.78 -13.69 19.15 Favored 'General case' 0 CA--C 1.485 -1.533 0 CA-C-O 124.768 2.223 . . . . 15.0 112.047 -179.435 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 85.9 75.51 1.24 Allowed Glycine 1 C--N 1.237 -4.937 0 CA-C-N 108.439 -3.982 . . . . 15.0 112.2 -169.55 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 259' ' ' VAL . . . . . 0.643 ' O ' ' HA ' ' A' ' 253' ' ' LEU . 42.9 t -89.88 123.46 42.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-O 121.395 0.617 . . . . 15.0 111.845 175.578 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 4.6 p -134.65 99.63 4.39 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 114.174 -1.376 . . . . 15.0 108.234 170.117 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 8.9 t -135.8 150.48 49.46 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 121.097 0.475 . . . . 15.0 111.841 -171.256 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 262' ' ' TRP . . . . . 1.144 ' CZ2' ' HB2' ' B' ' 215' ' ' PRO . 67.6 m95 -68.31 -33.45 74.33 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.141 -0.936 . . . . 15.0 111.345 176.595 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 263' ' ' HIS . . . . . . . . . . . . . 4.7 p80 -82.12 131.36 35.24 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 120.44 -0.504 . . . . 15.0 110.128 -172.783 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 264' ' ' ASP . . . . . 0.928 ' HB3' HG12 ' A' ' 267' ' ' ILE . 9.4 t70 -51.75 133.21 37.24 Favored Pre-proline 0 C--N 1.321 -0.635 0 N-CA-C 108.946 -0.761 . . . . 15.0 108.946 171.578 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 265' ' ' PRO . . . . . 0.457 ' HD3' ' CD2' ' A' ' 252' ' ' PHE . 36.5 Cg_endo -72.7 -14.76 27.18 Favored 'Trans proline' 0 N--CA 1.454 -0.797 0 C-N-CA 121.725 1.617 . . . . 15.0 114.294 -173.969 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 266' ' ' ARG . . . . . 0.67 ' HD3' ' HD3' ' A' ' 237' ' ' PRO . 0.1 OUTLIER -81.69 -6.65 59.22 Favored 'General case' 0 C--N 1.311 -1.107 0 N-CA-C 108.426 -0.953 . . . . 15.0 108.426 174.843 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 267' ' ' ILE . . . . . 0.928 HG12 ' HB3' ' A' ' 264' ' ' ASP . 42.1 mm . . . . . 0 C--O 1.249 1.031 0 CA-C-N 113.865 -1.516 . . . . 15.0 109.921 177.606 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 210' ' ' SER . . . . . . . . . . . . . 5.9 m . . . . . 0 N--CA 1.474 0.737 0 CA-C-O 120.873 0.368 . . . . 15.0 110.2 . . . . . . . . . 0 0 . 1 . 021 nuclear build full ' B' B ' 211' ' ' ASP . . . . . 0.437 ' HA ' ' HD3' ' B' ' 212' ' ' PRO . 30.4 t70 -150.09 129.39 6.37 Favored Pre-proline 0 C--N 1.324 -0.501 0 N-CA-C 109.504 -0.554 . . . . 15.0 109.504 -179.436 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 212' ' ' PRO . . . . . 0.591 ' CB ' HD11 ' A' ' 253' ' ' LEU . 27.3 Cg_endo -89.9 156.98 4.98 Favored 'Trans proline' 0 N--CA 1.454 -0.837 0 C-N-CA 122.601 2.2 . . . . 15.0 112.967 -176.081 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -89.89 159.98 28.3 Favored Glycine 0 N--CA 1.442 -0.942 0 CA-C-N 115.493 -0.776 . . . . 15.0 111.458 177.908 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 214' ' ' SEP . . . . . 0.417 ' HA ' ' HD3' ' B' ' 215' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 215' ' ' PRO . . . . . 1.144 ' HB2' ' CZ2' ' A' ' 262' ' ' TRP . 12.0 Cg_exo -88.0 143.29 5.81 Favored 'Trans proline' 0 C--O 1.235 0.326 0 C-N-CA 122.846 2.364 . . . . 15.0 111.731 176.833 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 216' ' ' PHE . . . . . . . . . . . . . 42.0 m-85 -111.13 -89.42 0.5 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.719 -0.673 . . . . 15.0 110.332 -178.566 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 217' ' ' GLN . . . . . . . . . . . . . 23.4 pt20 . . . . . 0 C--O 1.248 1.006 0 CA-C-O 118.389 -0.815 . . . . 15.0 110.393 -178.591 . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 . . . . . 0 N--CA 1.476 0.875 0 CA-C-O 121.087 0.47 . . . . 15.0 110.099 . . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 236' ' ' LEU . . . . . 0.734 HD12 ' HD2' ' A' ' 265' ' ' PRO . 0.4 OUTLIER -90.03 161.3 38.47 Favored Pre-proline 0 C--N 1.32 -0.693 0 CA-C-N 115.782 -0.644 . . . . 15.0 110.715 -171.675 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 237' ' ' PRO . . . . . 0.519 ' HD3' ' HD3' ' A' ' 266' ' ' ARG . 23.3 Cg_exo -69.32 171.0 14.75 Favored 'Trans proline' 0 CA--C 1.508 -0.783 0 C-N-CA 122.844 2.363 . . . . 15.0 110.097 162.474 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -69.42 145.1 53.1 Favored 'General case' 0 C--N 1.3 -1.553 0 CA-C-N 115.072 -0.967 . . . . 15.0 111.89 -175.845 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 100.21 10.19 45.93 Favored Glycine 0 N--CA 1.449 -0.484 0 CA-C-N 114.435 -1.257 . . . . 15.0 113.214 -179.868 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 240' ' ' TYR . . . . . 0.631 ' CD1' ' HB2' ' A' ' 254' ' ' HIS . 71.9 m-85 -116.67 123.5 47.41 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 117.235 0.518 . . . . 15.0 110.989 177.904 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -91.52 123.45 34.94 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.648 -0.705 . . . . 15.0 109.446 171.41 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 18.8 tm0? -91.4 99.86 12.74 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 108.646 -0.872 . . . . 15.0 108.646 174.513 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 68.7 mtt-85 -103.16 150.16 23.94 Favored 'General case' 0 CA--C 1.504 -0.825 0 CA-C-O 122.136 0.97 . . . . 15.0 112.087 -176.37 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 244' ' ' THR . . . . . . . . . . . . . 10.9 m -129.47 97.56 4.59 Favored 'General case' 0 C--N 1.308 -1.222 0 CA-C-N 113.28 -1.782 . . . . 15.0 109.399 -177.042 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 245' ' ' THR . . . . . 0.487 ' OG1' ' HG2' ' A' ' 247' ' ' GLN . 3.5 t -94.94 150.48 20.12 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.257 -0.883 . . . . 15.0 110.989 -175.621 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 9.9 m -50.53 -18.36 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.451 0 CA-C-N 115.615 -0.721 . . . . 15.0 112.577 176.97 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 247' ' ' GLN . . . . . 0.487 ' HG2' ' OG1' ' A' ' 245' ' ' THR . 7.3 mm100 -56.3 -21.28 23.07 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.02 -0.536 . . . . 15.0 110.682 173.182 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 89.73 11.91 63.16 Favored Glycine 0 N--CA 1.447 -0.576 0 CA-C-N 115.851 -0.613 . . . . 15.0 112.871 174.845 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 7.1 mt-30 -129.37 141.53 51.04 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 110.205 -0.294 . . . . 15.0 110.205 -176.358 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 17.1 m -89.79 135.0 27.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 116.333 -0.394 . . . . 15.0 110.109 178.235 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 251' ' ' TYR . . . . . 0.564 ' HB3' ' HG2' ' B' ' 215' ' ' PRO . 25.6 p90 -134.54 135.05 42.04 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 116.143 -0.48 . . . . 15.0 110.004 -178.437 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 252' ' ' PHE . . . . . 0.701 ' CD2' ' HA ' ' A' ' 264' ' ' ASP . 24.3 m-85 -90.22 125.72 35.58 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.31 0.576 . . . . 15.0 111.147 -175.731 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 253' ' ' LEU . . . . . 1.071 HD11 ' HB3' ' B' ' 212' ' ' PRO . 0.4 OUTLIER -113.73 109.42 18.55 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-N 114.808 -1.087 . . . . 15.0 111.858 -173.398 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 254' ' ' HIS . . . . . 0.631 ' HB2' ' CD1' ' A' ' 240' ' ' TYR . 76.9 t60 -120.62 89.98 3.23 Favored 'General case' 0 C--N 1.314 -0.963 0 N-CA-C 108.386 -0.968 . . . . 15.0 108.386 167.785 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 8.0 t -94.94 88.03 5.15 Favored 'General case' 0 N--CA 1.433 -1.289 0 C-N-CA 116.5 -2.08 . . . . 15.0 110.998 -179.372 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 53.6 tt0 -100.76 -51.86 3.47 Favored 'General case' 0 N--CA 1.44 -0.96 0 CA-C-N 112.808 -1.996 . . . . 15.0 106.142 149.415 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 257' ' ' THR . . . . . . . . . . . . . 59.3 p -95.85 -13.23 24.17 Favored 'General case' 0 CA--C 1.487 -1.457 0 CA-C-O 125.039 2.352 . . . . 15.0 111.763 -179.21 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 84.9 73.25 1.27 Allowed Glycine 1 C--N 1.241 -4.705 1 CA-C-N 108.042 -4.163 . . . . 15.0 112.55 -172.873 . . . . . . . . 3 2 . 1 . 022 nuclear build full ' A' A ' 259' ' ' VAL . . . . . 0.597 ' O ' HD23 ' A' ' 253' ' ' LEU . 66.0 t -89.86 122.59 41.38 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.411 0 CA-C-O 121.676 0.751 . . . . 15.0 111.878 176.664 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 2.2 p -134.47 100.8 4.76 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-N 113.746 -1.57 . . . . 15.0 107.295 170.42 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 9.0 t -136.26 150.32 48.89 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 112.654 0.613 . . . . 15.0 112.654 -166.413 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 262' ' ' TRP . . . . . 1.202 ' CZ2' ' HB2' ' B' ' 215' ' ' PRO . 79.9 m95 -79.02 -23.19 44.49 Favored 'General case' 0 N--CA 1.454 -0.275 0 CA-C-N 115.154 -0.93 . . . . 15.0 111.474 177.788 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 263' ' ' HIS . . . . . . . . . . . . . 13.8 p-80 -92.96 134.5 35.05 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 120.271 -0.572 . . . . 15.0 110.521 -176.517 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 264' ' ' ASP . . . . . 0.965 ' HB3' HG12 ' A' ' 267' ' ' ILE . 13.7 t0 -56.99 124.1 63.34 Favored Pre-proline 0 C--N 1.321 -0.673 0 N-CA-C 108.4 -0.963 . . . . 15.0 108.4 171.049 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 265' ' ' PRO . . . . . 0.734 ' HD2' HD12 ' A' ' 236' ' ' LEU . 16.6 Cg_exo -68.39 -14.77 40.87 Favored 'Trans proline' 0 CA--C 1.514 -0.479 0 C-N-CA 122.362 2.041 . . . . 15.0 113.181 -176.45 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 266' ' ' ARG . . . . . 0.519 ' HD3' ' HD3' ' A' ' 237' ' ' PRO . 10.8 tpt180 -76.93 -10.06 59.11 Favored 'General case' 0 C--N 1.313 -1.015 0 N-CA-C 108.473 -0.936 . . . . 15.0 108.473 174.137 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 267' ' ' ILE . . . . . 0.965 HG12 ' HB3' ' A' ' 264' ' ' ASP . 27.9 pt . . . . . 0 C--O 1.251 1.175 0 CA-C-N 114.129 -1.396 . . . . 15.0 110.835 177.334 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' B' B ' 210' ' ' SER . . . . . . . . . . . . . 9.4 t . . . . . 0 N--CA 1.476 0.861 0 N-CA-C 109.141 -0.689 . . . . 15.0 109.141 . . . . . . . . . 0 0 . 1 . 022 nuclear build full ' B' B ' 211' ' ' ASP . . . . . 0.441 ' HA ' ' HD3' ' B' ' 212' ' ' PRO . 5.0 m-20 -130.58 150.17 75.57 Favored Pre-proline 0 C--N 1.321 -0.654 0 CA-C-N 116.093 -0.503 . . . . 15.0 110.711 -174.077 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 212' ' ' PRO . . . . . 1.071 ' HB3' HD11 ' A' ' 253' ' ' LEU . 5.2 Cg_endo -89.83 151.65 5.0 Favored 'Trans proline' 0 N--CA 1.453 -0.906 0 C-N-CA 123.111 2.541 . . . . 15.0 112.182 179.759 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -89.93 160.08 28.33 Favored Glycine 0 N--CA 1.442 -0.922 0 C-N-CA 120.674 -0.774 . . . . 15.0 111.643 -179.764 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' B' B ' 214' ' ' SEP . . . . . 0.435 ' HA ' ' HD3' ' B' ' 215' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 022 nuclear build full ' B' B ' 215' ' ' PRO . . . . . 1.202 ' HB2' ' CZ2' ' A' ' 262' ' ' TRP . 12.1 Cg_exo -88.14 138.82 4.22 Favored 'Trans proline' 0 C--O 1.235 0.37 0 C-N-CA 123.222 2.614 . . . . 15.0 111.302 178.377 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 216' ' ' PHE . . . . . . . . . . . . . 93.8 m-85 -99.88 128.12 46.0 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.97 -0.559 . . . . 15.0 110.216 -178.604 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' B' B ' 217' ' ' GLN . . . . . . . . . . . . . 18.8 mm-40 . . . . . 0 C--O 1.246 0.877 0 CA-C-O 118.506 -0.759 . . . . 15.0 110.193 177.773 . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 . . . . . 0 N--CA 1.483 1.212 0 CA-C-O 121.039 0.447 . . . . 15.0 110.803 . . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 236' ' ' LEU . . . . . 0.465 HD12 ' HB2' ' A' ' 266' ' ' ARG . 0.4 OUTLIER -104.07 171.58 4.94 Favored Pre-proline 0 C--N 1.319 -0.732 0 N-CA-C 109.225 -0.657 . . . . 15.0 109.225 -178.878 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 237' ' ' PRO . . . . . 0.407 ' HD3' ' HD3' ' A' ' 266' ' ' ARG . 12.0 Cg_exo -69.56 164.55 33.92 Favored 'Trans proline' 0 N--CA 1.459 -0.553 0 C-N-CA 121.606 1.538 . . . . 15.0 110.689 170.802 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -69.69 150.34 47.09 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-N 114.976 -1.011 . . . . 15.0 111.707 -174.535 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 239' ' ' GLY . . . . . 0.41 ' O ' ' HA ' ' A' ' 254' ' ' HIS . . . 100.15 -7.16 58.47 Favored Glycine 0 N--CA 1.448 -0.523 0 CA-C-N 115.656 -0.702 . . . . 15.0 113.644 176.206 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 240' ' ' TYR . . . . . 0.627 ' CD1' ' HB2' ' A' ' 254' ' ' HIS . 60.0 m-85 -102.53 114.05 27.94 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 117.492 0.646 . . . . 15.0 110.628 179.125 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -94.54 131.72 39.98 Favored 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 108.924 -0.769 . . . . 15.0 108.924 171.306 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 23.0 tm0? -89.71 107.97 19.4 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 107.989 -1.115 . . . . 15.0 107.989 179.623 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 13.7 mtp180 -101.85 150.15 23.46 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-O 122.121 0.963 . . . . 15.0 112.175 -175.861 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 244' ' ' THR . . . . . . . . . . . . . 5.1 m -122.69 141.38 51.83 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-N 113.216 -1.811 . . . . 15.0 107.757 -177.798 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 245' ' ' THR . . . . . 0.631 ' CG2' ' HB3' ' A' ' 247' ' ' GLN . 3.1 t -141.96 150.34 41.29 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-O 120.878 0.371 . . . . 15.0 111.717 -169.216 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 8.8 p -55.97 -24.45 17.34 Favored 'Isoleucine or valine' 0 C--O 1.234 0.248 0 CA-C-N 115.31 -0.859 . . . . 15.0 109.886 172.49 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 247' ' ' GLN . . . . . 0.631 ' HB3' ' CG2' ' A' ' 245' ' ' THR . 40.8 tt0 -50.46 -35.83 30.71 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 114.506 -1.224 . . . . 15.0 110.473 172.699 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 102.04 -15.29 56.76 Favored Glycine 0 C--N 1.333 0.396 0 CA-C-N 116.118 -0.492 . . . . 15.0 112.987 176.645 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 249' ' ' GLN . . . . . 0.582 ' OE1' ' HG2' ' A' ' 247' ' ' GLN . 2.8 mp0 -96.43 147.42 23.85 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 120.64 0.257 . . . . 15.0 111.3 -173.857 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 3.3 m -89.99 130.26 39.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 N-CA-C 109.617 -0.512 . . . . 15.0 109.617 174.16 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 251' ' ' TYR . . . . . 0.6 ' HB3' ' HG2' ' B' ' 215' ' ' PRO . 9.4 p90 -142.42 138.95 31.45 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.369 0.605 . . . . 15.0 111.721 -176.206 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 252' ' ' PHE . . . . . 0.62 ' CD2' ' HA ' ' A' ' 264' ' ' ASP . 43.0 m-85 -96.62 125.17 40.91 Favored 'General case' 0 CA--C 1.509 -0.607 0 CA-C-N 115.169 -0.923 . . . . 15.0 110.873 -177.265 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 253' ' ' LEU . . . . . 0.689 ' HA ' ' O ' ' A' ' 259' ' ' VAL . 0.1 OUTLIER -123.95 109.15 13.21 Favored 'General case' 0 N--CA 1.441 -0.919 0 CA-C-O 121.696 0.76 . . . . 15.0 111.979 -177.939 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 254' ' ' HIS . . . . . 0.627 ' HB2' ' CD1' ' A' ' 240' ' ' TYR . 35.5 t60 -109.61 93.85 4.72 Favored 'General case' 0 CA--C 1.501 -0.928 0 CA-C-N 114.881 -1.054 . . . . 15.0 108.184 169.36 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 3.6 t -93.85 88.2 5.67 Favored 'General case' 0 N--CA 1.434 -1.265 0 C-N-CA 116.35 -2.14 . . . . 15.0 110.556 179.501 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 7.6 tp60 -101.21 -51.9 3.39 Favored 'General case' 0 N--CA 1.442 -0.863 0 CA-C-N 113.19 -1.823 . . . . 15.0 106.269 150.981 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 257' ' ' THR . . . . . . . . . . . . . 71.9 p -99.96 -13.67 19.01 Favored 'General case' 0 CA--C 1.487 -1.461 0 CA-C-O 124.666 2.174 . . . . 15.0 112.118 -179.501 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 88.63 73.89 1.28 Allowed Glycine 1 C--N 1.242 -4.693 0 CA-C-N 108.533 -3.94 . . . . 15.0 112.849 -171.32 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 259' ' ' VAL . . . . . 0.689 ' O ' ' HA ' ' A' ' 253' ' ' LEU . 68.7 t -89.58 126.73 42.5 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.391 0 CA-C-O 121.296 0.57 . . . . 15.0 111.583 173.219 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 2.2 p -150.01 94.13 2.11 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 114.039 -1.437 . . . . 15.0 107.72 168.886 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 9.8 t -135.03 150.29 50.27 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.516 -0.765 . . . . 15.0 111.173 -169.151 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 262' ' ' TRP . . . . . 1.161 ' CZ2' ' HB2' ' B' ' 215' ' ' PRO . 23.2 m95 -70.1 -17.51 63.22 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 113.19 0.811 . . . . 15.0 113.19 -177.194 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 263' ' ' HIS . . . . . . . . . . . . . 4.6 p80 -96.25 133.0 41.12 Favored 'General case' 0 C--N 1.323 -0.561 0 C-N-CA 120.088 -0.645 . . . . 15.0 110.01 179.961 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 264' ' ' ASP . . . . . 0.995 ' HB3' HG12 ' A' ' 267' ' ' ILE . 9.9 t0 -56.72 131.21 78.19 Favored Pre-proline 0 C--O 1.222 -0.386 0 N-CA-C 107.888 -1.153 . . . . 15.0 107.888 171.283 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 265' ' ' PRO . . . . . 0.508 ' HG2' ' CD1' ' A' ' 240' ' ' TYR . 17.0 Cg_exo -69.33 -15.05 38.42 Favored 'Trans proline' 0 C--N 1.324 -0.75 0 C-N-CA 122.092 1.861 . . . . 15.0 113.415 -176.232 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 266' ' ' ARG . . . . . 0.485 ' HD2' ' HA ' ' A' ' 266' ' ' ARG . 15.9 tpt180 -79.7 -8.02 58.96 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-O 122.037 0.922 . . . . 15.0 108.67 173.881 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 267' ' ' ILE . . . . . 0.995 HG12 ' HB3' ' A' ' 264' ' ' ASP . 33.4 pt . . . . . 0 C--O 1.248 0.984 0 CA-C-N 113.798 -1.546 . . . . 15.0 110.641 175.382 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' B' B ' 210' ' ' SER . . . . . . . . . . . . . 10.7 m . . . . . 0 N--CA 1.475 0.825 0 CA-C-O 120.883 0.373 . . . . 15.0 110.644 . . . . . . . . . 0 0 . 1 . 023 nuclear build full ' B' B ' 211' ' ' ASP . . . . . 0.507 ' HA ' ' HD3' ' B' ' 212' ' ' PRO . 25.7 t70 -140.08 122.0 9.75 Favored Pre-proline 0 N--CA 1.453 -0.286 0 CA-C-O 121.023 0.44 . . . . 15.0 111.084 -177.31 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 212' ' ' PRO . . . . . 0.6 ' HB2' HD13 ' A' ' 253' ' ' LEU . 1.2 Cg_endo -89.63 160.01 5.27 Favored 'Trans proline' 0 N--CA 1.457 -0.65 0 C-N-CA 123.774 2.983 . . . . 15.0 111.846 176.126 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -89.61 160.09 28.73 Favored Glycine 0 N--CA 1.447 -0.617 0 C-N-CA 120.809 -0.71 . . . . 15.0 112.896 -176.168 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' B' B ' 214' ' ' SEP . . . . . 0.475 ' HA ' ' HD3' ' B' ' 215' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 023 nuclear build full ' B' B ' 215' ' ' PRO . . . . . 1.161 ' HB2' ' CZ2' ' A' ' 262' ' ' TRP 0.291 22.2 Cg_exo -87.41 132.89 3.15 Favored 'Trans proline' 0 C--O 1.232 0.217 0 C-N-CA 123.69 2.927 . . . . 15.0 111.58 -176.448 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' B' B ' 216' ' ' PHE . . . . . . . . . . . . . 65.5 m-85 -110.52 -38.92 5.07 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 109.348 -0.612 . . . . 15.0 109.348 176.333 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' B' B ' 217' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.247 0.971 0 CA-C-N 115.412 -0.813 . . . . 15.0 109.211 176.288 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 . . . . . 0 N--CA 1.478 0.95 0 N-CA-C 109.974 -0.38 . . . . 15.0 109.974 . . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 236' ' ' LEU . . . . . 0.668 HD22 ' H ' ' A' ' 236' ' ' LEU . 0.1 OUTLIER -94.63 157.92 36.26 Favored Pre-proline 0 C--N 1.323 -0.554 0 CA-C-O 121.133 0.492 . . . . 15.0 110.166 -176.706 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 237' ' ' PRO . . . . . 0.557 ' HD3' ' HD3' ' A' ' 266' ' ' ARG . 15.1 Cg_exo -69.56 173.8 10.27 Favored 'Trans proline' 0 CA--C 1.507 -0.84 0 C-N-CA 122.672 2.248 . . . . 15.0 110.442 165.861 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 3.7 pm0 -69.48 142.63 53.71 Favored 'General case' 0 C--N 1.291 -1.945 0 CA-C-N 114.253 -1.339 . . . . 15.0 111.613 -173.297 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 100.17 3.36 55.68 Favored Glycine 0 CA--C 1.521 0.446 0 CA-C-N 115.233 -0.894 . . . . 15.0 113.965 177.172 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 240' ' ' TYR . . . . . 0.526 ' CD1' ' HG2' ' A' ' 265' ' ' PRO . 62.4 m-85 -111.17 125.34 53.69 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 117.856 0.828 . . . . 15.0 111.253 178.651 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 241' ' ' GLU . . . . . 0.561 ' HG3' ' HB3' ' A' ' 253' ' ' LEU . 8.6 pt-20 -108.75 123.28 48.76 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 109.199 -0.667 . . . . 15.0 109.199 170.926 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -89.81 106.55 18.54 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 109.203 -0.665 . . . . 15.0 109.203 -177.802 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 27.9 mtt-85 -98.46 148.43 23.73 Favored 'General case' 0 CA--C 1.505 -0.771 0 CA-C-O 122.123 0.963 . . . . 15.0 112.06 -177.531 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 244' ' ' THR . . . . . . . . . . . . . 25.0 p -117.26 146.06 43.54 Favored 'General case' 0 C--N 1.306 -1.285 0 CA-C-N 113.348 -1.751 . . . . 15.0 108.852 178.409 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 245' ' ' THR . . . . . 0.432 HG23 ' HB2' ' A' ' 247' ' ' GLN . 5.9 t -144.26 150.16 37.47 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 116.612 -0.267 . . . . 15.0 110.861 -172.393 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 6.4 m -53.63 -19.17 2.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.824 -0.626 . . . . 15.0 111.974 177.953 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 247' ' ' GLN . . . . . 0.432 ' HB2' HG23 ' A' ' 245' ' ' THR . 8.8 mm100 -58.68 -20.61 49.94 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.735 -0.666 . . . . 15.0 110.901 175.203 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 84.21 26.61 39.64 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 121.107 -0.568 . . . . 15.0 112.542 176.639 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 3.0 mt-30 -133.2 138.9 46.72 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 110.286 -0.264 . . . . 15.0 110.286 -173.904 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 4.4 m -89.65 122.83 41.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 N-CA-C 109.721 -0.474 . . . . 15.0 109.721 173.331 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 251' ' ' TYR . . . . . 0.759 ' HB2' ' HG2' ' B' ' 215' ' ' PRO . 2.5 p90 -129.89 134.07 47.28 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.049 0.452 . . . . 15.0 109.856 -175.792 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 252' ' ' PHE . . . . . 0.582 ' CD2' ' HA ' ' A' ' 264' ' ' ASP . 40.1 m-85 -90.05 128.11 36.21 Favored 'General case' 0 CA--C 1.512 -0.499 0 CA-C-O 121.237 0.542 . . . . 15.0 111.483 -175.185 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 253' ' ' LEU . . . . . 0.899 HD11 ' HB3' ' B' ' 212' ' ' PRO . 0.7 OUTLIER -118.66 126.27 51.56 Favored 'General case' 0 N--CA 1.446 -0.673 0 CA-C-N 115.035 -0.984 . . . . 15.0 110.78 -175.909 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 254' ' ' HIS . . . . . 0.522 ' HB3' ' HB ' ' A' ' 259' ' ' VAL . 0.2 OUTLIER -140.61 91.72 2.45 Favored 'General case' 0 C--N 1.313 -0.988 0 N-CA-C 108.595 -0.891 . . . . 15.0 108.595 173.282 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 3.1 t -103.23 87.91 3.0 Favored 'General case' 0 N--CA 1.43 -1.44 0 C-N-CA 116.796 -1.962 . . . . 15.0 111.015 -179.598 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 30.2 tp60 -101.23 -52.85 3.16 Favored 'General case' 0 N--CA 1.437 -1.099 0 CA-C-N 112.681 -2.054 . . . . 15.0 105.574 147.116 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 257' ' ' THR . . . . . . . . . . . . . 31.8 p -97.63 -13.55 21.49 Favored 'General case' 0 CA--C 1.489 -1.38 0 CA-C-O 124.89 2.281 . . . . 15.0 112.0 -177.246 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 84.73 71.37 1.32 Allowed Glycine 1 C--N 1.242 -4.676 1 CA-C-N 108.315 -4.039 . . . . 15.0 113.926 -174.575 . . . . . . . . 3 2 . 1 . 024 nuclear build full ' A' A ' 259' ' ' VAL . . . . . 0.522 ' HB ' ' HB3' ' A' ' 254' ' ' HIS . 67.5 t -89.91 129.95 39.99 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 CA-C-O 121.405 0.622 . . . . 15.0 111.431 171.597 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 23.8 p -143.79 102.89 3.98 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 114.386 -1.279 . . . . 15.0 108.093 171.553 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 14.4 t -149.32 150.44 32.49 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.966 0.412 . . . . 15.0 111.747 -168.726 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 262' ' ' TRP . . . . . 1.113 ' CZ2' ' HB2' ' B' ' 215' ' ' PRO . 84.7 m95 -71.96 -37.03 70.0 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.721 -0.672 . . . . 15.0 111.282 177.724 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 263' ' ' HIS . . . . . . . . . . . . . 2.8 p80 -73.65 126.85 31.22 Favored 'General case' 0 CA--C 1.515 -0.37 0 C-N-CA 120.52 -0.472 . . . . 15.0 109.923 -174.001 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 264' ' ' ASP . . . . . 1.084 ' HB3' HG12 ' A' ' 267' ' ' ILE . 15.0 t0 -54.47 125.79 53.43 Favored Pre-proline 0 C--N 1.32 -0.699 0 N-CA-C 108.326 -0.99 . . . . 15.0 108.326 173.404 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 265' ' ' PRO . . . . . 0.526 ' HG2' ' CD1' ' A' ' 240' ' ' TYR . 14.2 Cg_exo -68.72 -14.59 39.55 Favored 'Trans proline' 0 CA--C 1.512 -0.581 0 C-N-CA 121.893 1.729 . . . . 15.0 112.667 -177.296 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 266' ' ' ARG . . . . . 0.557 ' HD3' ' HD3' ' A' ' 237' ' ' PRO . 19.8 tpt180 -76.46 -11.94 59.96 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 115.225 -0.898 . . . . 15.0 108.932 173.137 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 267' ' ' ILE . . . . . 1.084 HG12 ' HB3' ' A' ' 264' ' ' ASP . 41.8 pt . . . . . 0 C--O 1.25 1.101 0 CA-C-O 117.549 -1.215 . . . . 15.0 111.529 178.999 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' B' B ' 210' ' ' SER . . . . . . . . . . . . . 18.9 m . . . . . 0 N--CA 1.477 0.892 0 CA-C-O 120.98 0.419 . . . . 15.0 110.806 . . . . . . . . . 0 0 . 1 . 024 nuclear build full ' B' B ' 211' ' ' ASP . . . . . . . . . . . . . 11.9 p-10 -111.87 109.87 54.85 Favored Pre-proline 0 C--N 1.327 -0.38 0 CA-C-O 121.138 0.494 . . . . 15.0 110.5 -178.29 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' B' B ' 212' ' ' PRO . . . . . 0.899 ' HB3' HD11 ' A' ' 253' ' ' LEU . 6.6 Cg_endo -89.97 147.73 4.71 Favored 'Trans proline' 0 N--CA 1.453 -0.871 0 C-N-CA 122.638 2.225 . . . . 15.0 112.21 176.257 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -89.62 131.78 10.91 Favored Glycine 0 N--CA 1.442 -0.931 0 C-N-CA 120.543 -0.836 . . . . 15.0 111.598 178.286 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' B' B ' 214' ' ' SEP . . . . . 0.471 ' HA ' ' HD3' ' B' ' 215' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 024 nuclear build full ' B' B ' 215' ' ' PRO . . . . . 1.113 ' HB2' ' CZ2' ' A' ' 262' ' ' TRP . 16.8 Cg_exo -88.1 144.61 6.1 Favored 'Trans proline' 0 N--CA 1.453 -0.895 0 C-N-CA 123.513 2.809 . . . . 15.0 110.984 177.225 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' B' B ' 216' ' ' PHE . . . . . . . . . . . . . 99.2 m-85 -104.23 -46.25 4.47 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.523 -0.308 . . . . 15.0 110.536 -178.501 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' B' B ' 217' ' ' GLN . . . . . . . . . . . . . 60.5 tt0 . . . . . 0 C--O 1.248 0.993 0 CA-C-N 115.808 -0.633 . . . . 15.0 109.541 177.522 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 2.2 mt . . . . . 0 N--CA 1.453 -0.297 0 N-CA-C 109.789 -0.449 . . . . 15.0 109.789 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 237' ' ' PRO . . . . . 0.465 ' O ' ' HD2' ' A' ' 240' ' ' TYR . 14.0 Cg_exo -69.5 166.75 26.2 Favored 'Trans proline' 0 N--CA 1.458 -0.615 0 C-N-CA 121.793 1.662 . . . . 15.0 110.221 165.706 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -69.74 142.99 53.17 Favored 'General case' 0 C--N 1.303 -1.433 0 CA-C-N 114.863 -1.062 . . . . 15.0 111.521 -173.024 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 100.15 5.83 54.27 Favored Glycine 0 N--CA 1.449 -0.485 0 CA-C-N 115.361 -0.836 . . . . 15.0 113.785 178.895 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 240' ' ' TYR . . . . . 0.649 ' CD1' ' HB2' ' A' ' 254' ' ' HIS . 71.7 m-85 -108.19 116.31 31.72 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 117.636 0.718 . . . . 15.0 111.678 -179.698 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -90.37 113.82 25.79 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.048 -0.978 . . . . 15.0 109.595 174.897 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 242' ' ' GLN . . . . . 0.645 ' HG3' ' CE1' ' A' ' 252' ' ' PHE . 39.6 tt0 -91.09 103.42 16.12 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 109.523 -0.547 . . . . 15.0 109.523 -179.771 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 243' ' ' ARG . . . . . 0.44 HH11 ' HD2' ' A' ' 243' ' ' ARG . 8.5 mtp180 -109.25 149.87 28.78 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 122.07 0.938 . . . . 15.0 112.637 -176.168 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 244' ' ' THR . . . . . 0.421 HG22 HG12 ' A' ' 250' ' ' VAL . 10.2 p -124.72 96.8 5.02 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 113.54 -1.664 . . . . 15.0 109.41 -176.257 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 245' ' ' THR . . . . . 0.703 HG23 ' HB2' ' A' ' 247' ' ' GLN . 2.7 t -89.99 150.28 22.2 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 115.861 -0.609 . . . . 15.0 111.412 -174.71 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 9.7 m -52.06 -19.21 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.315 0 CA-C-N 115.713 -0.676 . . . . 15.0 112.04 175.075 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 247' ' ' GLN . . . . . 0.703 ' HB2' HG23 ' A' ' 245' ' ' THR . 0.2 OUTLIER -49.81 -26.8 4.28 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 115.98 -0.554 . . . . 15.0 110.873 170.239 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 93.17 19.36 36.29 Favored Glycine 0 C--O 1.229 -0.188 0 CA-C-N 115.837 -0.619 . . . . 15.0 112.289 177.041 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 249' ' ' GLN . . . . . 0.476 ' NE2' ' HH2' ' A' ' 262' ' ' TRP . 0.0 OUTLIER -135.41 144.39 46.5 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.01 0.433 . . . . 15.0 110.724 -174.605 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 250' ' ' VAL . . . . . 0.421 HG12 HG22 ' A' ' 244' ' ' THR . 19.4 m -89.94 142.39 12.99 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 115.444 -0.798 . . . . 15.0 109.677 176.406 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 6.1 p90 -148.18 142.68 26.43 Favored 'General case' 0 C--N 1.321 -0.646 0 C-N-CA 120.67 -0.412 . . . . 15.0 110.693 -179.38 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 252' ' ' PHE . . . . . 0.697 ' CE2' ' HA ' ' A' ' 264' ' ' ASP . 29.7 m-85 -98.15 119.57 37.02 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.842 -0.617 . . . . 15.0 111.869 -175.631 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 253' ' ' LEU . . . . . 0.657 HD11 ' HB3' ' B' ' 212' ' ' PRO . 2.8 mt -104.36 103.23 12.93 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 114.744 -1.116 . . . . 15.0 112.012 -177.579 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 254' ' ' HIS . . . . . 0.649 ' HB2' ' CD1' ' A' ' 240' ' ' TYR . 36.7 t-80 -113.26 89.95 3.22 Favored 'General case' 0 C--N 1.312 -1.036 0 N-CA-C 107.982 -1.118 . . . . 15.0 107.982 167.413 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 255' ' ' THR . . . . . 0.417 HG23 ' HA2' ' A' ' 258' ' ' GLY . 23.4 m -92.43 87.78 6.13 Favored 'General case' 0 N--CA 1.432 -1.355 0 C-N-CA 116.684 -2.006 . . . . 15.0 109.496 -179.328 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 64.1 tt0 -101.54 -53.43 2.99 Favored 'General case' 0 N--CA 1.439 -1.008 0 N-CA-C 106.199 -1.778 . . . . 15.0 106.199 150.592 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 257' ' ' THR . . . . . . . . . . . . . 82.6 p -96.83 -13.61 22.44 Favored 'General case' 0 CA--C 1.484 -1.561 0 CA-C-O 124.889 2.28 . . . . 15.0 111.733 -178.895 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 258' ' ' GLY . . . . . 0.417 ' HA2' HG23 ' A' ' 255' ' ' THR . . . 87.73 72.83 1.28 Allowed Glycine 1 C--N 1.241 -4.695 1 CA-C-N 108.174 -4.103 . . . . 15.0 112.703 -171.638 . . . . . . . . 4 3 . 1 . 001 nuclear nobuild core ' A' A ' 259' ' ' VAL . . . . . 0.493 ' O ' ' HA ' ' A' ' 253' ' ' LEU . 53.0 t -89.89 125.2 42.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 121.585 0.707 . . . . 15.0 112.361 176.182 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 3.3 p -132.34 101.93 5.55 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 114.091 -1.413 . . . . 15.0 107.706 167.129 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 12.3 t -132.15 150.24 52.2 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 121.188 0.518 . . . . 15.0 112.352 -169.563 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 262' ' ' TRP . . . . . 0.476 ' HH2' ' NE2' ' A' ' 249' ' ' GLN . 77.0 m95 -78.26 -25.57 46.85 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.11 -0.95 . . . . 15.0 111.202 176.877 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 263' ' ' HIS . . . . . . . . . . . . . 6.5 p80 -89.34 131.36 35.46 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.496 -0.481 . . . . 15.0 110.212 -175.022 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 264' ' ' ASP . . . . . 1.064 ' HB3' HG12 ' A' ' 267' ' ' ILE . 19.8 t0 -56.36 125.03 64.33 Favored Pre-proline 0 C--N 1.323 -0.565 0 N-CA-C 107.669 -1.234 . . . . 15.0 107.669 170.061 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 265' ' ' PRO . . . . . 0.561 ' HD3' ' CD2' ' A' ' 252' ' ' PHE . 11.5 Cg_exo -70.54 -14.72 33.87 Favored 'Trans proline' 0 C--N 1.323 -0.766 0 C-N-CA 121.751 1.634 . . . . 15.0 112.573 -175.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 266' ' ' ARG . . . . . 0.426 ' HD3' ' HD3' ' A' ' 237' ' ' PRO . 19.3 tpt180 -76.27 -11.99 60.0 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 115.443 -0.799 . . . . 15.0 108.956 173.223 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 267' ' ' ILE . . . . . 1.064 HG12 ' HB3' ' A' ' 264' ' ' ASP . 40.3 pt . . . . . 0 C--O 1.249 1.027 0 CA-C-N 115.017 -0.992 . . . . 15.0 111.448 178.618 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 210' ' ' SER . . . . . . . . . . . . . 20.3 m . . . . . 0 N--CA 1.477 0.885 0 CA-C-O 120.635 0.255 . . . . 15.0 111.279 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' B' B ' 211' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -133.14 119.61 15.7 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 120.502 0.191 . . . . 15.0 110.519 -179.116 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 212' ' ' PRO . . . . . 0.657 ' HB3' HD11 ' A' ' 253' ' ' LEU . 3.9 Cg_endo -89.7 160.0 5.21 Favored 'Trans proline' 0 N--CA 1.455 -0.79 0 C-N-CA 122.707 2.271 . . . . 15.0 111.524 173.904 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.443 -0.879 0 C-N-CA 120.338 -0.934 . . . . 15.0 112.241 -177.388 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 61.1 mt . . . . . 0 CA--C 1.518 -0.261 0 N-CA-C 109.507 -0.553 . . . . 15.0 109.507 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 237' ' ' PRO . . . . . 0.929 ' HD3' ' HD3' ' A' ' 266' ' ' ARG . 15.2 Cg_exo -69.47 171.16 14.64 Favored 'Trans proline' 0 CA--C 1.513 -0.57 0 C-N-CA 122.055 1.837 . . . . 15.0 110.92 165.927 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -69.68 133.32 47.4 Favored 'General case' 0 C--N 1.302 -1.492 0 CA-C-N 114.415 -1.266 . . . . 15.0 112.208 -173.248 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 100.16 28.83 7.06 Favored Glycine 0 C--N 1.334 0.434 0 CA-C-N 115.16 -0.927 . . . . 15.0 114.094 174.08 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 240' ' ' TYR . . . . . 0.72 ' CD1' ' HB2' ' A' ' 254' ' ' HIS . 65.0 m-85 -117.36 123.72 47.17 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 117.963 0.881 . . . . 15.0 111.468 177.864 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 241' ' ' GLU . . . . . 0.529 ' HG3' ' HB2' ' A' ' 253' ' ' LEU . 10.6 pt-20 -119.64 119.97 35.28 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.76 -0.654 . . . . 15.0 109.595 172.807 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -90.13 109.45 20.51 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 108.775 -0.824 . . . . 15.0 108.775 178.371 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 243' ' ' ARG . . . . . 0.473 ' HB2' ' CE1' ' A' ' 251' ' ' TYR . 31.3 mtt180 -95.87 149.97 20.95 Favored 'General case' 0 CA--C 1.51 -0.574 0 CA-C-O 122.025 0.917 . . . . 15.0 112.295 -175.218 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 244' ' ' THR . . . . . . . . . . . . . 4.9 p -111.61 97.46 6.75 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-N 113.498 -1.683 . . . . 15.0 110.553 -176.553 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 245' ' ' THR . . . . . 0.701 HG23 ' HB2' ' A' ' 247' ' ' GLN . 0.9 OUTLIER -90.7 150.6 21.58 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.187 -0.915 . . . . 15.0 110.302 177.846 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 25.3 t -50.62 -18.43 0.63 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.489 0 O-C-N 123.52 0.513 . . . . 15.0 110.959 176.335 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 247' ' ' GLN . . . . . 0.701 ' HB2' HG23 ' A' ' 245' ' ' THR . 77.9 mm-40 -50.83 -29.11 10.9 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 116.038 -0.528 . . . . 15.0 111.156 171.916 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 80.94 21.41 63.29 Favored Glycine 0 N--CA 1.452 -0.27 0 N-CA-C 111.624 -0.59 . . . . 15.0 111.624 -178.43 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 249' ' ' GLN . . . . . 0.571 HE21 ' HB3' ' A' ' 247' ' ' GLN . 10.4 mt-30 -121.32 143.96 48.9 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.726 -0.472 . . . . 15.0 109.726 -175.803 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 28.8 m -89.84 133.28 32.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 N-CA-C 109.582 -0.525 . . . . 15.0 109.582 176.601 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 251' ' ' TYR . . . . . 0.473 ' CE1' ' HB2' ' A' ' 243' ' ' ARG . 2.4 p90 -140.49 130.11 24.21 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.054 0.454 . . . . 15.0 110.141 -177.12 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 252' ' ' PHE . . . . . 0.615 ' CD2' ' HA ' ' A' ' 264' ' ' ASP . 34.9 m-85 -90.01 116.49 28.09 Favored 'General case' 0 CA--C 1.513 -0.474 0 CA-C-N 115.874 -0.603 . . . . 15.0 111.857 -173.405 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 253' ' ' LEU . . . . . 0.586 HD11 ' CB ' ' B' ' 212' ' ' PRO . 12.9 mt -98.59 126.76 44.27 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-N 114.816 -1.083 . . . . 15.0 111.233 175.677 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 254' ' ' HIS . . . . . 0.72 ' HB2' ' CD1' ' A' ' 240' ' ' TYR . 33.2 t-80 -133.87 89.78 2.62 Favored 'General case' 0 C--N 1.309 -1.183 0 N-CA-C 107.633 -1.247 . . . . 15.0 107.633 167.032 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 3.3 t -94.13 87.95 5.46 Favored 'General case' 0 N--CA 1.429 -1.491 0 C-N-CA 116.334 -2.147 . . . . 15.0 110.105 -179.732 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 60.0 tt0 -101.61 -54.94 2.63 Favored 'General case' 0 N--CA 1.436 -1.137 0 CA-C-N 112.946 -1.934 . . . . 15.0 105.921 151.02 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 257' ' ' THR . . . . . . . . . . . . . 71.6 p -100.04 -13.63 18.97 Favored 'General case' 0 CA--C 1.489 -1.4 0 CA-C-N 111.989 -2.369 . . . . 15.0 112.401 -179.756 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 89.38 71.42 1.26 Allowed Glycine 1 C--N 1.243 -4.622 0 CA-C-N 108.566 -3.924 . . . . 15.0 113.59 -173.15 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 259' ' ' VAL . . . . . 0.666 ' HB ' ' HB3' ' A' ' 254' ' ' HIS . 52.6 t -90.12 129.24 41.32 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 CA-C-O 121.324 0.583 . . . . 15.0 111.564 172.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 1.4 p -143.36 108.15 4.9 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 114.539 -1.209 . . . . 15.0 108.643 169.35 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 7.4 t -149.01 150.34 32.66 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.042 0.448 . . . . 15.0 111.685 -171.616 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 262' ' ' TRP . . . . . . . . . . . . . 89.8 m95 -66.89 -30.21 70.3 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.295 -0.866 . . . . 15.0 111.613 177.119 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 263' ' ' HIS . . . . . . . . . . . . . 3.1 p80 -83.85 133.34 34.75 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.55 -0.46 . . . . 15.0 110.607 -172.248 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 264' ' ' ASP . . . . . 0.87 ' HB3' HG12 ' A' ' 267' ' ' ILE . 9.5 t70 -56.9 129.87 78.44 Favored Pre-proline 0 C--N 1.323 -0.549 0 N-CA-C 108.535 -0.913 . . . . 15.0 108.535 172.766 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 265' ' ' PRO . . . . . 0.518 ' HD3' ' HA ' ' A' ' 264' ' ' ASP . 2.6 Cg_exo -76.33 -14.59 18.28 Favored 'Trans proline' 0 CA--C 1.511 -0.655 0 C-N-CA 122.297 1.998 . . . . 15.0 113.451 -174.524 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 266' ' ' ARG . . . . . 0.929 ' HD3' ' HD3' ' A' ' 237' ' ' PRO . 6.4 tpt180 -79.39 -8.72 59.3 Favored 'General case' 0 C--N 1.31 -1.149 0 CA-C-O 121.953 0.882 . . . . 15.0 108.78 175.635 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 267' ' ' ILE . . . . . 0.87 HG12 ' HB3' ' A' ' 264' ' ' ASP . 42.4 mm . . . . . 0 C--O 1.249 1.033 0 CA-C-N 113.997 -1.456 . . . . 15.0 109.809 178.755 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 210' ' ' SER . . . . . . . . . . . . . 12.5 p . . . . . 0 N--CA 1.476 0.873 0 CA-C-O 121.14 0.495 . . . . 15.0 110.74 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' B' B ' 211' ' ' ASP . . . . . 0.54 ' HA ' ' HD3' ' B' ' 212' ' ' PRO . 7.2 p-10 -150.3 135.38 9.86 Favored Pre-proline 0 C--N 1.325 -0.488 0 CA-C-N 115.945 -0.57 . . . . 15.0 110.672 -179.185 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 212' ' ' PRO . . . . . 0.586 ' CB ' HD11 ' A' ' 253' ' ' LEU . 1.4 Cg_endo -89.79 138.87 3.12 Favored 'Trans proline' 0 N--CA 1.458 -0.599 0 C-N-CA 123.529 2.819 . . . . 15.0 111.99 178.766 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.444 -0.816 0 C-N-CA 120.813 -0.708 . . . . 15.0 111.561 -179.101 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 236' ' ' LEU . . . . . 0.442 HD22 ' N ' ' A' ' 236' ' ' LEU . 0.2 OUTLIER . . . . . 0 CA--C 1.518 -0.261 0 N-CA-C 109.188 -0.671 . . . . 15.0 109.188 . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 237' ' ' PRO . . . . . 0.638 ' HD3' ' HD3' ' A' ' 266' ' ' ARG . 12.9 Cg_exo -69.84 163.32 38.77 Favored 'Trans proline' 0 CA--C 1.514 -0.487 0 C-N-CA 122.022 1.815 . . . . 15.0 110.143 167.839 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 238' ' ' GLU . . . . . 0.401 ' H ' ' CD ' ' A' ' 238' ' ' GLU . 1.1 pm0 -69.81 146.14 51.6 Favored 'General case' 0 C--N 1.305 -1.365 0 CA-C-N 115.45 -0.795 . . . . 15.0 111.611 -175.456 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 239' ' ' GLY . . . . . 0.415 ' O ' ' HA ' ' A' ' 254' ' ' HIS . . . 99.96 3.54 55.84 Favored Glycine 0 N--CA 1.449 -0.48 0 CA-C-N 115.353 -0.84 . . . . 15.0 113.896 178.218 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 240' ' ' TYR . . . . . 0.765 ' CD1' ' HB2' ' A' ' 254' ' ' HIS . 83.6 m-85 -107.12 123.73 48.67 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 117.45 0.625 . . . . 15.0 110.878 178.001 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -110.12 130.71 55.49 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 109.534 -0.543 . . . . 15.0 109.534 170.442 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 242' ' ' GLN . . . . . 0.457 ' HG3' ' CE1' ' A' ' 252' ' ' PHE . 18.9 tt0 -89.92 112.04 23.3 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.253 -0.647 . . . . 15.0 109.253 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 31.9 mtp85 -105.94 145.67 31.01 Favored 'General case' 0 CA--C 1.502 -0.893 0 CA-C-O 121.957 0.884 . . . . 15.0 112.665 -177.508 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 244' ' ' THR . . . . . . . . . . . . . 48.6 m -121.74 93.33 3.97 Favored 'General case' 0 C--N 1.309 -1.157 0 CA-C-N 113.412 -1.722 . . . . 15.0 109.86 -178.8 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 245' ' ' THR . . . . . 1.059 HG23 ' HG2' ' A' ' 247' ' ' GLN . 5.2 t -89.97 150.61 22.07 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.15 -0.932 . . . . 15.0 110.484 -178.567 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 246' ' ' VAL . . . . . 0.408 ' H ' HG23 ' A' ' 246' ' ' VAL . 34.1 t -44.2 -25.7 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 N-CA-C 113.596 0.962 . . . . 15.0 113.596 -175.305 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 247' ' ' GLN . . . . . 1.059 ' HG2' HG23 ' A' ' 245' ' ' THR . 3.4 pt20 -55.1 -18.72 5.9 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 111.579 0.214 . . . . 15.0 111.579 177.649 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 87.7 26.52 29.44 Favored Glycine 0 C--N 1.334 0.472 0 C-N-CA 121.356 -0.449 . . . . 15.0 112.721 175.254 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 249' ' ' GLN . . . . . 0.489 HE21 ' CD ' ' A' ' 247' ' ' GLN . 10.7 mt-30 -138.86 140.34 38.42 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.699 -0.482 . . . . 15.0 109.699 -177.62 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 20.5 m -90.04 141.93 13.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 116.397 -0.365 . . . . 15.0 110.652 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 18.4 p90 -142.21 140.06 32.21 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.468 -0.567 . . . . 15.0 109.468 -178.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 252' ' ' PHE . . . . . 0.73 ' CD2' ' HA ' ' A' ' 264' ' ' ASP . 42.4 m-85 -93.6 119.39 32.58 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.123 -0.49 . . . . 15.0 111.895 -174.708 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 253' ' ' LEU . . . . . 0.636 HD11 ' HB3' ' B' ' 212' ' ' PRO . 4.1 mt -101.46 117.05 34.15 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-N 115.225 -0.898 . . . . 15.0 111.136 179.244 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 254' ' ' HIS . . . . . 0.765 ' HB2' ' CD1' ' A' ' 240' ' ' TYR . 34.2 t-80 -130.76 90.02 2.84 Favored 'General case' 0 CA--C 1.5 -0.943 0 N-CA-C 107.916 -1.142 . . . . 15.0 107.916 169.464 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 37.1 m -92.73 87.93 6.06 Favored 'General case' 0 N--CA 1.433 -1.293 0 C-N-CA 116.735 -1.986 . . . . 15.0 110.453 -178.802 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 7.8 tt0 -101.14 -52.2 3.33 Favored 'General case' 0 N--CA 1.443 -0.809 0 N-CA-C 106.041 -1.837 . . . . 15.0 106.041 149.447 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 257' ' ' THR . . . . . . . . . . . . . 73.3 p -97.89 -13.48 21.21 Favored 'General case' 0 CA--C 1.487 -1.452 0 CA-C-O 124.779 2.228 . . . . 15.0 111.727 -179.839 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 86.28 70.83 1.31 Allowed Glycine 1 C--N 1.24 -4.772 0 CA-C-N 108.483 -3.962 . . . . 15.0 113.14 -172.665 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 259' ' ' VAL . . . . . 0.617 ' O ' HD23 ' A' ' 253' ' ' LEU . 48.0 t -89.99 125.33 42.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 N-CA-C 112.637 0.606 . . . . 15.0 112.637 177.103 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -138.07 102.19 4.62 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 107.794 -1.188 . . . . 15.0 107.794 167.217 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 12.5 t -138.02 150.35 46.88 Favored 'General case' 0 C--N 1.317 -0.812 0 C-N-CA 120.533 -0.467 . . . . 15.0 112.208 -167.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 262' ' ' TRP . . . . . . . . . . . . . 80.7 m95 -71.28 -33.26 69.59 Favored 'General case' 0 N--CA 1.455 -0.195 0 CA-C-N 115.391 -0.822 . . . . 15.0 111.719 178.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 263' ' ' HIS . . . . . . . . . . . . . 5.0 p80 -83.48 134.68 34.84 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.511 -0.476 . . . . 15.0 110.017 -175.245 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 264' ' ' ASP . . . . . 1.001 ' HB3' HG12 ' A' ' 267' ' ' ILE . 10.8 t70 -55.87 131.9 73.17 Favored Pre-proline 0 C--N 1.323 -0.549 0 N-CA-C 108.664 -0.865 . . . . 15.0 108.664 172.615 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 265' ' ' PRO . . . . . 0.525 ' HD3' ' CD2' ' A' ' 252' ' ' PHE . 72.0 Cg_endo -75.67 -14.76 19.62 Favored 'Trans proline' 0 CA--C 1.507 -0.842 0 C-N-CA 121.456 1.437 . . . . 15.0 113.464 -172.071 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 266' ' ' ARG . . . . . 0.638 ' HD3' ' HD3' ' A' ' 237' ' ' PRO . 8.6 tpt180 -81.51 -7.43 59.58 Favored 'General case' 0 C--N 1.306 -1.283 0 N-CA-C 108.168 -1.049 . . . . 15.0 108.168 175.227 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 267' ' ' ILE . . . . . 1.001 HG12 ' HB3' ' A' ' 264' ' ' ASP . 37.5 pt . . . . . 0 C--O 1.25 1.093 0 CA-C-N 114.002 -1.454 . . . . 15.0 110.85 175.691 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 210' ' ' SER . . . . . . . . . . . . . 10.3 p . . . . . 0 N--CA 1.475 0.808 0 CA-C-O 121.014 0.435 . . . . 15.0 110.555 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' B' B ' 211' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -90.16 118.08 68.56 Favored Pre-proline 0 C--N 1.325 -0.489 0 CA-C-O 121.174 0.512 . . . . 15.0 111.346 -175.284 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 212' ' ' PRO . . . . . 0.636 ' HB3' HD11 ' A' ' 253' ' ' LEU . 9.2 Cg_endo -89.93 146.06 4.58 Favored 'Trans proline' 0 N--CA 1.451 -0.974 0 C-N-CA 122.816 2.344 . . . . 15.0 111.157 172.46 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.439 -1.148 0 C-N-CA 120.099 -1.048 . . . . 15.0 111.702 -179.502 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 5.8 mt . . . . . 0 C--O 1.233 0.217 0 N-CA-C 109.676 -0.49 . . . . 15.0 109.676 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 237' ' ' PRO . . . . . 0.62 ' HD3' ' HD3' ' A' ' 266' ' ' ARG . 21.9 Cg_exo -69.37 161.16 46.97 Favored 'Trans proline' 0 C--O 1.235 0.333 0 C-N-CA 121.876 1.717 . . . . 15.0 110.398 164.466 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 238' ' ' GLU . . . . . 0.404 ' H ' ' CD ' ' A' ' 238' ' ' GLU . 1.3 pm0 -69.65 150.39 47.06 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-N 115.496 -0.774 . . . . 15.0 110.914 -175.313 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 100.24 -15.13 59.32 Favored Glycine 0 N--CA 1.447 -0.625 0 CA-C-N 115.688 -0.687 . . . . 15.0 112.599 -177.729 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 240' ' ' TYR . . . . . 0.468 ' CD1' ' HG2' ' A' ' 265' ' ' PRO . 65.9 m-85 -94.61 116.42 28.75 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.142 0.496 . . . . 15.0 110.523 177.057 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -95.3 116.93 29.43 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 115.625 -0.716 . . . . 15.0 109.123 174.843 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -90.01 97.45 11.2 Favored 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 108.993 -0.743 . . . . 15.0 108.993 178.03 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 243' ' ' ARG . . . . . 0.439 HH11 ' HD2' ' A' ' 243' ' ' ARG . 11.9 mtp180 -100.42 149.54 23.55 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 115.298 -0.865 . . . . 15.0 111.478 -179.162 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 244' ' ' THR . . . . . . . . . . . . . 22.8 m -117.64 128.7 55.18 Favored 'General case' 0 C--N 1.309 -1.172 0 CA-C-N 114.08 -1.418 . . . . 15.0 108.718 -178.629 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 245' ' ' THR . . . . . 0.422 HG22 ' O ' ' A' ' 249' ' ' GLN . 8.3 t -115.28 150.44 36.21 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 116.277 -0.42 . . . . 15.0 111.03 -174.113 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 50.8 t -57.73 -15.78 4.87 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 CA-C-N 115.795 -0.639 . . . . 15.0 111.302 179.865 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 247' ' ' GLN . . . . . . . . . . . . . 8.8 mm100 -61.46 -20.82 63.57 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 121.093 0.473 . . . . 15.0 110.65 175.553 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 90.63 36.98 6.64 Favored Glycine 0 N--CA 1.452 -0.28 0 CA-C-N 115.559 -0.746 . . . . 15.0 112.003 178.546 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 249' ' ' GLN . . . . . 0.422 ' O ' HG22 ' A' ' 245' ' ' THR . 8.0 pt20 -148.02 139.62 23.75 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.873 0.368 . . . . 15.0 111.12 -175.524 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 15.9 m -89.95 135.58 25.92 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 N-CA-C 109.395 -0.595 . . . . 15.0 109.395 172.557 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -136.81 138.36 40.77 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-O 120.95 0.405 . . . . 15.0 110.123 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 252' ' ' PHE . . . . . 0.623 ' CE2' ' HA ' ' A' ' 264' ' ' ASP . 40.6 m-85 -89.99 118.2 29.37 Favored 'General case' 0 CA--C 1.512 -0.491 0 CA-C-O 121.229 0.537 . . . . 15.0 111.449 -173.419 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 253' ' ' LEU . . . . . 0.898 HD11 ' HB3' ' B' ' 212' ' ' PRO . 0.8 OUTLIER -110.26 106.77 16.29 Favored 'General case' 0 N--CA 1.446 -0.653 0 CA-C-N 114.714 -1.13 . . . . 15.0 111.885 -173.048 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 254' ' ' HIS . . . . . 0.417 ' HB2' ' CD1' ' A' ' 240' ' ' TYR . 26.8 t-80 -115.41 95.03 4.97 Favored 'General case' 0 C--N 1.312 -1.048 0 N-CA-C 108.298 -1.001 . . . . 15.0 108.298 170.104 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 26.3 m -94.08 88.02 5.51 Favored 'General case' 0 N--CA 1.43 -1.436 0 C-N-CA 116.985 -1.886 . . . . 15.0 110.459 -179.08 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 58.9 tt0 -101.12 -51.15 3.59 Favored 'General case' 0 N--CA 1.438 -1.033 0 N-CA-C 105.924 -1.88 . . . . 15.0 105.924 146.768 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 257' ' ' THR . . . . . . . . . . . . . 63.1 p -99.94 -13.69 19.02 Favored 'General case' 0 CA--C 1.484 -1.581 0 CA-C-O 124.735 2.207 . . . . 15.0 112.275 -178.062 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 83.09 76.18 1.14 Allowed Glycine 1 C--N 1.239 -4.851 0 CA-C-N 108.594 -3.912 . . . . 15.0 111.934 -170.225 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 259' ' ' VAL . . . . . 0.677 ' O ' ' HA ' ' A' ' 253' ' ' LEU . 54.8 t -89.35 124.47 42.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-O 121.478 0.656 . . . . 15.0 111.725 176.86 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 3.6 p -135.04 97.41 3.73 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 114.285 -1.325 . . . . 15.0 108.394 171.347 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 10.6 t -134.92 150.26 50.39 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.037 0.446 . . . . 15.0 112.018 -170.387 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 262' ' ' TRP . . . . . . . . . . . . . 42.3 m95 -72.15 -31.04 65.6 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.38 -0.827 . . . . 15.0 111.844 177.341 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 263' ' ' HIS . . . . . . . . . . . . . 5.2 p80 -80.15 130.74 35.45 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 120.196 -0.602 . . . . 15.0 110.155 -174.413 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 264' ' ' ASP . . . . . 1.094 ' HB3' HG12 ' A' ' 267' ' ' ILE . 13.8 t0 -63.12 127.44 90.93 Favored Pre-proline 0 C--N 1.321 -0.64 0 N-CA-C 107.77 -1.196 . . . . 15.0 107.77 171.169 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 265' ' ' PRO . . . . . 0.468 ' HG2' ' CD1' ' A' ' 240' ' ' TYR . 15.9 Cg_exo -69.09 -14.9 39.05 Favored 'Trans proline' 0 C--N 1.323 -0.799 0 C-N-CA 121.878 1.719 . . . . 15.0 113.087 -178.118 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 266' ' ' ARG . . . . . 0.62 ' HD3' ' HD3' ' A' ' 237' ' ' PRO . 4.5 tpt180 -80.83 -6.5 58.66 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-O 121.834 0.826 . . . . 15.0 109.156 175.031 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 267' ' ' ILE . . . . . 1.094 HG12 ' HB3' ' A' ' 264' ' ' ASP . 48.2 pt . . . . . 0 C--O 1.248 0.987 0 CA-C-N 114.299 -1.318 . . . . 15.0 111.689 177.735 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 210' ' ' SER . . . . . . . . . . . . . 9.5 m . . . . . 0 N--CA 1.479 0.988 0 CA-C-O 120.759 0.314 . . . . 15.0 110.72 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' B' B ' 211' ' ' ASP . . . . . 0.422 ' HA ' ' HD3' ' B' ' 212' ' ' PRO . 3.0 m-20 -89.85 119.53 69.41 Favored Pre-proline 0 C--O 1.233 0.185 0 CA-C-N 116.278 -0.419 . . . . 15.0 110.319 -173.243 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 212' ' ' PRO . . . . . 0.898 ' HB3' HD11 ' A' ' 253' ' ' LEU . 1.9 Cg_endo -90.0 149.14 4.77 Favored 'Trans proline' 0 N--CA 1.458 -0.586 0 C-N-CA 123.118 2.545 . . . . 15.0 112.234 177.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.68 0 C-N-CA 120.925 -0.655 . . . . 15.0 112.607 -179.647 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 236' ' ' LEU . . . . . 0.447 HD22 ' N ' ' A' ' 236' ' ' LEU . 1.1 mm? . . . . . 0 N--CA 1.453 -0.28 0 N-CA-C 109.765 -0.457 . . . . 15.0 109.765 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 237' ' ' PRO . . . . . 0.458 ' HD3' ' HD3' ' A' ' 266' ' ' ARG . 16.2 Cg_exo -69.53 164.72 33.23 Favored 'Trans proline' 0 N--CA 1.459 -0.522 0 C-N-CA 121.801 1.667 . . . . 15.0 110.118 165.011 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -69.58 135.65 50.28 Favored 'General case' 0 C--N 1.303 -1.443 0 CA-C-N 115.053 -0.976 . . . . 15.0 111.361 -171.955 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 100.44 21.63 12.68 Favored Glycine 0 CA--C 1.521 0.431 0 CA-C-N 115.504 -0.771 . . . . 15.0 114.349 178.794 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 240' ' ' TYR . . . . . 0.749 ' CD1' ' HB2' ' A' ' 254' ' ' HIS . 73.7 m-85 -112.39 114.43 27.14 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 118.298 1.049 . . . . 15.0 110.798 175.307 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 37.5 mm-40 -98.2 119.44 36.86 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.686 -0.688 . . . . 15.0 109.216 175.341 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -89.93 107.52 19.16 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 108.032 -1.099 . . . . 15.0 108.032 175.909 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 6.3 mtp85 -97.25 132.38 43.06 Favored 'General case' 0 CA--C 1.496 -1.109 0 CA-C-O 122.451 1.119 . . . . 15.0 113.434 -172.774 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 244' ' ' THR . . . . . . . . . . . . . 1.3 m -100.66 89.92 4.07 Favored 'General case' 0 C--N 1.306 -1.314 0 CA-C-N 112.805 -1.998 . . . . 15.0 109.05 177.517 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 245' ' ' THR . . . . . 1.05 HG23 ' HG2' ' A' ' 247' ' ' GLN . 7.8 t -95.04 150.75 19.83 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 114.989 -1.005 . . . . 15.0 110.401 -176.653 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 61.1 t -39.69 -30.9 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 N-CA-C 113.901 1.075 . . . . 15.0 113.901 -174.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 247' ' ' GLN . . . . . 1.05 ' HG2' HG23 ' A' ' 245' ' ' THR . 3.8 pt20 -56.55 -21.14 24.34 Favored 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 111.838 0.31 . . . . 15.0 111.838 178.111 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 80.42 37.21 21.46 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 121.141 -0.552 . . . . 15.0 112.988 176.49 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 249' ' ' GLN . . . . . 0.488 ' HB2' ' OE1' ' A' ' 247' ' ' GLN . 34.3 mt-30 -135.71 149.98 49.4 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.678 -0.49 . . . . 15.0 109.678 179.633 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 15.5 m -89.83 128.23 41.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 120.934 0.397 . . . . 15.0 110.562 178.433 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 4.0 p90 -138.69 133.19 31.98 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.006 0.431 . . . . 15.0 109.883 -178.647 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 252' ' ' PHE . . . . . 0.679 ' CD2' ' HA ' ' A' ' 264' ' ' ASP . 36.0 m-85 -89.78 118.2 29.2 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.023 -0.535 . . . . 15.0 110.88 -175.007 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 253' ' ' LEU . . . . . 0.578 HD11 ' HB3' ' B' ' 212' ' ' PRO . 0.7 OUTLIER -111.1 119.33 38.62 Favored 'General case' 0 N--CA 1.447 -0.617 0 CA-C-N 115.09 -0.959 . . . . 15.0 110.398 -177.674 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 254' ' ' HIS . . . . . 0.749 ' HB2' ' CD1' ' A' ' 240' ' ' TYR . 9.1 t-80 -133.0 101.31 5.18 Favored 'General case' 0 CA--C 1.495 -1.14 0 N-CA-C 108.956 -0.757 . . . . 15.0 108.956 173.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 3.5 t -95.89 87.66 4.69 Favored 'General case' 0 N--CA 1.432 -1.333 0 C-N-CA 116.388 -2.125 . . . . 15.0 110.617 179.74 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 44.3 tt0 -101.35 -55.96 2.42 Favored 'General case' 0 N--CA 1.441 -0.906 0 N-CA-C 105.973 -1.862 . . . . 15.0 105.973 150.807 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 257' ' ' THR . . . . . . . . . . . . . 80.4 p -99.77 -13.72 19.15 Favored 'General case' 0 CA--C 1.489 -1.383 0 CA-C-N 111.893 -2.412 . . . . 15.0 112.047 -176.275 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 89.16 70.6 1.26 Allowed Glycine 1 C--N 1.242 -4.655 0 CA-C-N 108.537 -3.938 . . . . 15.0 112.903 -171.025 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 259' ' ' VAL . . . . . 0.512 ' O ' ' HA ' ' A' ' 253' ' ' LEU . 54.6 t -90.05 127.38 42.66 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.31 0 CA-C-O 121.207 0.527 . . . . 15.0 112.251 176.861 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 2.3 p -145.68 102.15 3.64 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 114.672 -1.149 . . . . 15.0 108.416 169.686 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 5.5 t -145.48 150.12 35.9 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 115.868 -0.606 . . . . 15.0 111.781 -171.384 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 262' ' ' TRP . . . . . . . . . . . . . 90.2 m95 -71.52 -23.31 61.76 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.358 -0.837 . . . . 15.0 111.199 176.535 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 263' ' ' HIS . . . . . . . . . . . . . 1.9 p80 -87.88 132.07 34.34 Favored 'General case' 0 C--O 1.234 0.266 0 C-N-CA 120.231 -0.587 . . . . 15.0 110.524 -173.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 264' ' ' ASP . . . . . 0.775 ' HB3' HG12 ' A' ' 267' ' ' ILE . 9.2 t70 -51.82 130.92 38.19 Favored Pre-proline 0 C--N 1.326 -0.439 0 CA-C-N 115.359 -0.837 . . . . 15.0 109.574 175.332 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 265' ' ' PRO . . . . . 0.519 ' HD3' ' CD2' ' A' ' 252' ' ' PHE . 71.9 Cg_endo -78.11 -14.89 14.86 Favored 'Trans proline' 0 CA--C 1.514 -0.506 0 C-N-CA 122.384 2.056 . . . . 15.0 113.644 -173.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 266' ' ' ARG . . . . . 0.458 ' HD3' ' HD3' ' A' ' 237' ' ' PRO . 7.2 tpt180 -77.08 -8.24 57.12 Favored 'General case' 0 C--N 1.311 -1.074 0 N-CA-C 107.694 -1.224 . . . . 15.0 107.694 174.546 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 267' ' ' ILE . . . . . 0.775 HG12 ' HB3' ' A' ' 264' ' ' ASP . 28.4 mm . . . . . 0 C--O 1.248 0.976 0 CA-C-N 113.537 -1.665 . . . . 15.0 109.216 174.634 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 210' ' ' SER . . . . . . . . . . . . . 14.9 m . . . . . 0 N--CA 1.477 0.889 0 CA-C-O 120.84 0.352 . . . . 15.0 110.572 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' B' B ' 211' ' ' ASP . . . . . 0.456 ' HA ' ' HD3' ' B' ' 212' ' ' PRO . 11.8 m-20 -89.81 130.61 42.27 Favored Pre-proline 0 C--N 1.332 -0.175 0 CA-C-N 116.449 -0.341 . . . . 15.0 110.274 -177.511 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 212' ' ' PRO . . . . . 0.578 ' HB3' HD11 ' A' ' 253' ' ' LEU . 5.0 Cg_endo -90.04 151.37 4.8 Favored 'Trans proline' 0 N--CA 1.46 -0.46 0 C-N-CA 123.483 2.788 . . . . 15.0 113.179 -175.404 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.444 -0.796 0 CA-C-N 115.346 -0.843 . . . . 15.0 112.839 178.538 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 5.8 mt . . . . . 0 CA--C 1.517 -0.296 0 N-CA-C 108.948 -0.76 . . . . 15.0 108.948 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 237' ' ' PRO . . . . . 0.52 ' HD3' ' HD3' ' A' ' 266' ' ' ARG . 17.2 Cg_exo -69.31 156.96 63.01 Favored 'Trans proline' 0 N--CA 1.458 -0.563 0 C-N-CA 121.55 1.5 . . . . 15.0 109.636 162.842 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 4.6 mp0 -69.71 149.38 48.09 Favored 'General case' 0 C--N 1.31 -1.146 0 CA-C-O 121.341 0.591 . . . . 15.0 111.409 -173.325 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 100.19 -7.36 58.5 Favored Glycine 0 N--CA 1.446 -0.66 0 CA-C-N 115.173 -0.921 . . . . 15.0 113.722 179.905 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 240' ' ' TYR . . . . . 0.66 ' CD1' ' HB2' ' A' ' 254' ' ' HIS . 67.7 m-85 -91.03 113.13 25.31 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 117.535 0.667 . . . . 15.0 110.81 178.199 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 57.9 mm-40 -92.05 118.41 30.77 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 109.367 -0.605 . . . . 15.0 109.367 174.924 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 24.8 tm0? -89.94 107.75 19.3 Favored 'General case' 0 C--N 1.314 -0.963 0 N-CA-C 109.163 -0.68 . . . . 15.0 109.163 176.806 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 243' ' ' ARG . . . . . 0.429 ' HB2' ' CE1' ' A' ' 251' ' ' TYR . 17.3 mtp85 -103.47 150.03 24.27 Favored 'General case' 0 CA--C 1.512 -0.519 0 CA-C-O 122.116 0.96 . . . . 15.0 111.982 178.081 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 244' ' ' THR . . . . . . . . . . . . . 24.4 p -111.27 148.24 33.31 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-N 113.504 -1.68 . . . . 15.0 109.367 -179.064 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 245' ' ' THR . . . . . 0.463 ' OG1' ' HG2' ' A' ' 247' ' ' GLN . 6.0 t -145.26 150.11 36.09 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-O 120.641 0.258 . . . . 15.0 111.142 -175.186 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 7.7 p -50.87 -26.79 4.55 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.219 0 CA-C-N 115.541 -0.754 . . . . 15.0 111.256 177.748 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 247' ' ' GLN . . . . . 0.463 ' HG2' ' OG1' ' A' ' 245' ' ' THR . 6.8 mm-40 -53.75 -21.4 7.16 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 114.787 -1.097 . . . . 15.0 111.472 177.959 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 81.82 25.19 53.78 Favored Glycine 0 CA--C 1.509 -0.282 0 C-N-CA 121.255 -0.498 . . . . 15.0 111.871 178.146 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 249' ' ' GLN . . . . . 0.419 ' CD ' ' HH2' ' A' ' 262' ' ' TRP . 0.6 OUTLIER -130.47 138.37 50.24 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.759 -0.46 . . . . 15.0 109.759 -175.614 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 18.8 m -90.02 132.43 34.72 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 N-CA-C 109.354 -0.61 . . . . 15.0 109.354 175.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 251' ' ' TYR . . . . . 0.429 ' CE1' ' HB2' ' A' ' 243' ' ' ARG . 4.4 p90 -135.16 134.19 39.91 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.486 0.66 . . . . 15.0 111.325 -178.7 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 252' ' ' PHE . . . . . 0.731 ' CE2' ' HA ' ' A' ' 264' ' ' ASP . 37.8 m-85 -90.28 118.5 29.84 Favored 'General case' 0 CA--C 1.516 -0.335 0 CA-C-N 115.246 -0.888 . . . . 15.0 111.046 -176.654 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 253' ' ' LEU . . . . . 0.876 HD11 ' HB3' ' B' ' 212' ' ' PRO . 0.5 OUTLIER -109.9 99.21 8.37 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-N 114.942 -1.026 . . . . 15.0 111.205 -174.675 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 254' ' ' HIS . . . . . 0.66 ' HB2' ' CD1' ' A' ' 240' ' ' TYR . 36.9 t-80 -112.17 92.56 4.07 Favored 'General case' 0 CA--C 1.499 -1.018 0 N-CA-C 108.57 -0.9 . . . . 15.0 108.57 169.58 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 7.9 t -96.55 88.06 4.57 Favored 'General case' 0 N--CA 1.432 -1.331 0 C-N-CA 116.524 -2.07 . . . . 15.0 110.729 -179.076 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 49.1 tt0 -101.17 -50.39 3.8 Favored 'General case' 0 N--CA 1.441 -0.924 0 CA-C-N 113.127 -1.851 . . . . 15.0 106.42 151.601 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 257' ' ' THR . . . . . . . . . . . . . 68.7 p -97.99 -13.57 21.05 Favored 'General case' 0 CA--C 1.488 -1.431 0 CA-C-O 124.865 2.269 . . . . 15.0 111.681 -179.565 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 88.71 71.41 1.27 Allowed Glycine 1 C--N 1.241 -4.737 1 CA-C-N 108.224 -4.08 . . . . 15.0 113.109 -171.602 . . . . . . . . 3 2 . 1 . 006 nuclear nobuild core ' A' A ' 259' ' ' VAL . . . . . 0.574 ' O ' ' HA ' ' A' ' 253' ' ' LEU . 45.8 t -89.81 124.45 42.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 121.376 0.607 . . . . 15.0 111.911 174.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -136.94 92.36 2.72 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 114.541 -1.209 . . . . 15.0 108.018 167.763 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 5.0 t -129.27 150.23 50.73 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.705 -0.679 . . . . 15.0 111.966 -166.193 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 262' ' ' TRP . . . . . 0.419 ' HH2' ' CD ' ' A' ' 249' ' ' GLN . 85.5 m95 -71.61 -50.63 29.04 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.164 -0.926 . . . . 15.0 111.691 179.337 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 263' ' ' HIS . . . . . . . . . . . . . 5.4 p80 -66.49 134.48 52.53 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.912 -0.586 . . . . 15.0 110.629 -175.527 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 264' ' ' ASP . . . . . 1.083 ' HB3' HG12 ' A' ' 267' ' ' ILE . 37.8 t0 -54.29 124.14 45.55 Favored Pre-proline 0 C--O 1.218 -0.554 0 N-CA-C 107.408 -1.33 . . . . 15.0 107.408 167.217 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 265' ' ' PRO . . . . . 0.597 ' HD3' ' CD2' ' A' ' 252' ' ' PHE . 12.6 Cg_exo -69.03 -14.67 38.84 Favored 'Trans proline' 0 C--N 1.323 -0.794 0 C-N-CA 121.788 1.659 . . . . 15.0 112.617 -176.324 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 266' ' ' ARG . . . . . 0.52 ' HD3' ' HD3' ' A' ' 237' ' ' PRO . 5.8 tpt180 -78.28 -9.86 59.41 Favored 'General case' 0 N--CA 1.439 -0.998 0 CA-C-O 121.861 0.838 . . . . 15.0 109.136 173.143 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 267' ' ' ILE . . . . . 1.083 HG12 ' HB3' ' A' ' 264' ' ' ASP . 48.2 pt . . . . . 0 C--O 1.246 0.89 0 CA-C-O 117.543 -1.218 . . . . 15.0 110.875 176.779 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 210' ' ' SER . . . . . . . . . . . . . 16.6 p . . . . . 0 N--CA 1.481 1.125 0 CA-C-O 120.859 0.361 . . . . 15.0 110.735 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' B' B ' 211' ' ' ASP . . . . . 0.418 ' HA ' ' HD3' ' B' ' 212' ' ' PRO . 2.8 m-20 -89.97 115.27 63.55 Favored Pre-proline 0 C--N 1.331 -0.223 0 CA-C-N 116.4 -0.364 . . . . 15.0 110.799 -173.948 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 212' ' ' PRO . . . . . 0.876 ' HB3' HD11 ' A' ' 253' ' ' LEU . 2.6 Cg_endo -89.67 154.13 5.18 Favored 'Trans proline' 0 N--CA 1.456 -0.7 0 C-N-CA 122.752 2.301 . . . . 15.0 112.104 175.789 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.636 0 C-N-CA 120.554 -0.831 . . . . 15.0 112.296 179.43 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 236' ' ' LEU . . . . . 0.441 HD22 ' N ' ' A' ' 236' ' ' LEU . 1.2 mm? . . . . . 0 CA--C 1.514 -0.404 0 CA-C-O 121.03 0.443 . . . . 15.0 110.586 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 237' ' ' PRO . . . . . 0.548 ' HD3' ' HD3' ' A' ' 266' ' ' ARG . 21.9 Cg_exo -69.34 166.58 26.6 Favored 'Trans proline' 0 N--CA 1.46 -0.442 0 C-N-CA 122.257 1.971 . . . . 15.0 110.528 163.885 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 -69.92 147.23 50.49 Favored 'General case' 0 C--N 1.304 -1.391 0 CA-C-N 115.038 -0.983 . . . . 15.0 111.809 -176.382 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 100.25 0.93 55.8 Favored Glycine 0 CA--C 1.518 0.237 0 CA-C-N 115.348 -0.842 . . . . 15.0 113.34 179.736 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 240' ' ' TYR . . . . . 0.493 ' HD2' ' O ' ' A' ' 237' ' ' PRO . 56.5 m-85 -97.45 121.37 39.26 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.552 0.691 . . . . 15.0 111.574 -178.419 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 241' ' ' GLU . . . . . 0.745 ' HB2' ' HB2' ' A' ' 253' ' ' LEU . 7.6 mp0 -89.87 100.45 13.26 Favored 'General case' 0 N--CA 1.442 -0.833 0 CA-C-N 114.885 -1.052 . . . . 15.0 108.777 173.147 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 1.5 tm0? -89.94 113.99 25.73 Favored 'General case' 0 C--N 1.313 -1.006 0 N-CA-C 108.451 -0.944 . . . . 15.0 108.451 179.33 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 243' ' ' ARG . . . . . 0.503 ' CZ ' ' HG2' ' B' ' 212' ' ' PRO . 28.0 mtt180 -112.94 144.94 41.65 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-O 122.392 1.092 . . . . 15.0 111.926 179.511 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 244' ' ' THR . . . . . . . . . . . . . 15.8 m -120.29 92.14 3.7 Favored 'General case' 0 C--N 1.304 -1.373 0 CA-C-N 112.998 -1.91 . . . . 15.0 108.263 178.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 245' ' ' THR . . . . . 0.498 ' OG1' ' HG2' ' A' ' 247' ' ' GLN . 6.7 t -89.72 149.99 22.51 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 115.441 -0.799 . . . . 15.0 110.989 -171.882 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 23.0 t -55.2 -15.13 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 CA-C-N 115.816 -0.629 . . . . 15.0 111.349 -179.194 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 247' ' ' GLN . . . . . 0.498 ' HG2' ' OG1' ' A' ' 245' ' ' THR . 8.3 mm-40 -59.29 -15.27 14.9 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 115.895 -0.593 . . . . 15.0 111.128 176.413 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 89.51 37.4 7.02 Favored Glycine 0 C--N 1.333 0.407 0 C-N-CA 121.218 -0.515 . . . . 15.0 112.164 178.334 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -150.17 147.14 27.37 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.399 0.619 . . . . 15.0 111.515 -174.905 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 16.6 m -100.92 131.41 48.61 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.928 0 CA-C-N 114.561 -1.2 . . . . 15.0 108.386 169.189 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 2.7 p90 -137.28 137.93 39.52 Favored 'General case' 0 C--N 1.317 -0.811 0 C-N-CA 120.558 -0.457 . . . . 15.0 110.395 -175.149 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 252' ' ' PHE . . . . . 0.738 ' CD2' ' HA ' ' A' ' 264' ' ' ASP . 40.8 m-85 -95.75 110.95 23.02 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.569 0.7 . . . . 15.0 112.329 -172.824 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 253' ' ' LEU . . . . . 0.745 ' HB2' ' HB2' ' A' ' 241' ' ' GLU . 38.9 mt -93.0 144.69 25.0 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 114.241 -1.345 . . . . 15.0 109.848 172.176 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 254' ' ' HIS . . . . . 0.56 ' HB3' ' HB ' ' A' ' 259' ' ' VAL . 40.3 t-80 -143.53 89.77 2.1 Favored 'General case' 0 C--N 1.305 -1.343 0 N-CA-C 107.31 -1.367 . . . . 15.0 107.31 164.143 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 16.3 m -91.72 87.61 6.37 Favored 'General case' 0 N--CA 1.426 -1.632 0 C-N-CA 115.655 -2.418 . . . . 15.0 110.096 -178.307 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 8.1 tt0 -101.53 -53.59 2.95 Favored 'General case' 0 N--CA 1.435 -1.193 0 CA-C-N 112.793 -2.003 . . . . 15.0 105.82 145.753 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 257' ' ' THR . . . . . . . . . . . . . 71.8 p -100.2 -13.52 18.88 Favored 'General case' 0 CA--C 1.49 -1.357 0 CA-C-O 124.727 2.203 . . . . 15.0 112.56 -176.459 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 86.07 73.24 1.28 Allowed Glycine 1 C--N 1.241 -4.747 0 CA-C-N 108.461 -3.972 . . . . 15.0 113.04 -172.529 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 259' ' ' VAL . . . . . 0.587 ' O ' ' HA ' ' A' ' 253' ' ' LEU . 74.9 t -89.71 136.76 22.89 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 CA-C-O 120.923 0.392 . . . . 15.0 112.028 174.127 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 4.0 p -145.62 100.02 3.37 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 114.822 -1.081 . . . . 15.0 108.731 168.834 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 24.3 p -132.39 150.17 52.21 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 112.216 0.45 . . . . 15.0 112.216 -172.364 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 262' ' ' TRP . . . . . . . . . . . . . 71.1 m95 -72.87 -30.0 63.63 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.781 -0.645 . . . . 15.0 110.68 174.347 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 263' ' ' HIS . . . . . . . . . . . . . 3.3 p80 -77.89 129.31 35.21 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.967 0.413 . . . . 15.0 110.252 -177.666 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 264' ' ' ASP . . . . . 1.038 ' HB3' HG12 ' A' ' 267' ' ' ILE . 9.1 t0 -59.21 129.21 86.27 Favored Pre-proline 0 C--N 1.319 -0.734 0 N-CA-C 108.509 -0.923 . . . . 15.0 108.509 172.032 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 265' ' ' PRO . . . . . 0.545 ' HD3' ' CD2' ' A' ' 252' ' ' PHE . 4.4 Cg_exo -74.19 -14.65 23.18 Favored 'Trans proline' 0 CA--C 1.509 -0.729 0 C-N-CA 122.112 1.875 . . . . 15.0 113.228 -175.737 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 266' ' ' ARG . . . . . 0.548 ' HD3' ' HD3' ' A' ' 237' ' ' PRO . 2.1 tpp180 -77.41 -11.55 59.85 Favored 'General case' 0 C--N 1.31 -1.119 0 N-CA-C 108.055 -1.091 . . . . 15.0 108.055 172.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 267' ' ' ILE . . . . . 1.038 HG12 ' HB3' ' A' ' 264' ' ' ASP . 31.8 pt . . . . . 0 C--O 1.249 1.05 0 CA-C-N 114.551 -1.204 . . . . 15.0 111.0 176.886 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 210' ' ' SER . . . . . . . . . . . . . 63.0 p . . . . . 0 N--CA 1.479 1.002 0 CA-C-O 120.72 0.295 . . . . 15.0 110.841 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' B' B ' 211' ' ' ASP . . . . . 0.442 ' HA ' ' HD3' ' B' ' 212' ' ' PRO . 56.6 m-20 -104.49 120.62 49.94 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 120.894 0.378 . . . . 15.0 110.294 179.485 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 212' ' ' PRO . . . . . 0.52 ' CB ' HD11 ' A' ' 253' ' ' LEU . 3.4 Cg_exo -89.64 151.93 5.18 Favored 'Trans proline' 0 N--CA 1.461 -0.435 0 C-N-CA 123.88 3.054 . . . . 15.0 112.17 179.885 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.443 -0.888 0 C-N-CA 120.74 -0.743 . . . . 15.0 111.616 178.384 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 236' ' ' LEU . . . . . 0.534 HD22 ' HD2' ' A' ' 265' ' ' PRO . 11.4 mt . . . . . 0 N--CA 1.454 -0.245 0 N-CA-C 110.161 -0.311 . . . . 15.0 110.161 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 237' ' ' PRO . . . . . 0.591 ' HD3' ' HD3' ' A' ' 266' ' ' ARG . 13.0 Cg_exo -69.78 172.45 12.63 Favored 'Trans proline' 0 CA--C 1.513 -0.566 0 C-N-CA 122.21 1.94 . . . . 15.0 111.151 167.773 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 14.0 tp10 -69.41 134.57 49.16 Favored 'General case' 0 C--N 1.3 -1.549 0 CA-C-N 114.034 -1.439 . . . . 15.0 111.51 -173.474 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 100.15 9.37 48.44 Favored Glycine 0 CA--C 1.524 0.632 0 CA-C-N 115.74 -0.664 . . . . 15.0 114.31 177.013 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 240' ' ' TYR . . . . . 0.69 ' CD1' ' HB2' ' A' ' 254' ' ' HIS . 86.5 m-85 -111.41 116.88 31.67 Favored 'General case' 0 CA--C 1.517 -0.323 0 CA-C-N 118.129 0.964 . . . . 15.0 111.007 175.166 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 17.7 pt-20 -97.63 123.94 41.72 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 109.198 -0.668 . . . . 15.0 109.198 170.72 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 242' ' ' GLN . . . . . 0.564 ' HG3' ' CE1' ' A' ' 252' ' ' PHE . 1.9 tt0 -89.9 99.13 12.2 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 109.058 -0.719 . . . . 15.0 109.058 -177.841 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 84.2 mtt-85 -92.02 150.01 21.22 Favored 'General case' 0 CA--C 1.5 -0.963 0 CA-C-O 122.428 1.109 . . . . 15.0 113.184 -172.736 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 244' ' ' THR . . . . . . . . . . . . . 16.6 p -118.27 139.83 50.72 Favored 'General case' 0 C--N 1.308 -1.221 0 CA-C-N 112.567 -2.106 . . . . 15.0 109.122 174.777 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 245' ' ' THR . . . . . 1.087 HG23 ' HG2' ' A' ' 247' ' ' GLN . 3.4 t -145.02 150.46 36.93 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 116.406 -0.361 . . . . 15.0 110.124 -173.228 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 6.1 m -48.9 -22.15 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 N-CA-C 113.944 1.09 . . . . 15.0 113.944 -175.454 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 247' ' ' GLN . . . . . 1.087 ' HG2' HG23 ' A' ' 245' ' ' THR . 1.7 pt20 -58.56 -22.67 56.49 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-O 120.705 0.288 . . . . 15.0 110.851 176.539 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 91.08 30.3 11.31 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 121.276 -0.488 . . . . 15.0 112.872 177.356 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 249' ' ' GLN . . . . . 0.412 ' HB3' ' CH2' ' A' ' 262' ' ' TRP . 1.1 mp0 -137.9 143.18 40.71 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.888 0.344 . . . . 15.0 111.621 -178.118 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 29.1 m -90.16 138.39 19.54 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.129 0 CA-C-N 115.901 -0.591 . . . . 15.0 109.426 172.747 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 32.5 p90 -144.09 136.3 26.55 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 120.853 0.358 . . . . 15.0 110.228 -175.529 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 252' ' ' PHE . . . . . 0.651 ' CD2' ' HA ' ' A' ' 264' ' ' ASP . 32.0 m-85 -89.86 119.51 30.3 Favored 'General case' 0 CA--C 1.507 -0.68 0 CA-C-N 116.043 -0.526 . . . . 15.0 111.66 -172.688 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 253' ' ' LEU . . . . . 0.8 HD11 ' HB3' ' B' ' 212' ' ' PRO . 0.4 OUTLIER -113.52 118.62 34.98 Favored 'General case' 0 N--CA 1.441 -0.919 0 CA-C-N 114.854 -1.067 . . . . 15.0 111.141 -175.727 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 254' ' ' HIS . . . . . 0.69 ' HB2' ' CD1' ' A' ' 240' ' ' TYR . 16.6 t-80 -128.07 90.28 3.06 Favored 'General case' 0 C--N 1.313 -0.992 0 N-CA-C 108.132 -1.062 . . . . 15.0 108.132 168.552 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 255' ' ' THR . . . . . 0.624 HG22 ' HA2' ' A' ' 258' ' ' GLY . 0.3 OUTLIER -89.82 87.38 6.94 Favored 'General case' 0 N--CA 1.429 -1.485 0 C-N-CA 116.462 -2.095 . . . . 15.0 109.881 178.772 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 35.9 tt0 -101.49 -56.39 2.31 Favored 'General case' 0 N--CA 1.436 -1.16 0 N-CA-C 105.884 -1.895 . . . . 15.0 105.884 150.327 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 257' ' ' THR . . . . . . . . . . . . . 63.3 p -96.65 -13.63 22.69 Favored 'General case' 0 CA--C 1.486 -1.512 0 CA-C-N 111.73 -2.486 . . . . 15.0 111.601 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 258' ' ' GLY . . . . . 0.624 ' HA2' HG22 ' A' ' 255' ' ' THR . . . 86.27 73.05 1.28 Allowed Glycine 1 C--N 1.24 -4.773 1 CA-C-N 108.3 -4.045 . . . . 15.0 113.236 -172.83 . . . . . . . . 4 3 . 1 . 008 nuclear nobuild core ' A' A ' 259' ' ' VAL . . . . . 0.619 ' O ' ' HA ' ' A' ' 253' ' ' LEU . 55.4 t -89.89 123.36 42.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-O 121.202 0.525 . . . . 15.0 112.206 173.539 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 2.5 p -134.53 92.49 2.92 Favored 'General case' 0 C--N 1.317 -0.844 0 N-CA-C 107.818 -1.179 . . . . 15.0 107.818 168.754 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 8.1 t -121.06 150.14 41.64 Favored 'General case' 0 C--N 1.314 -0.938 0 N-CA-C 112.853 0.686 . . . . 15.0 112.853 -165.251 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 262' ' ' TRP . . . . . 0.553 ' HA ' ' CE3' ' A' ' 262' ' ' TRP . 1.9 m95 -80.94 -18.87 45.59 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 114.777 -1.102 . . . . 15.0 111.26 174.971 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 263' ' ' HIS . . . . . . . . . . . . . 4.0 p80 -100.31 133.61 44.46 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.558 -0.457 . . . . 15.0 110.106 -178.431 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 264' ' ' ASP . . . . . 0.799 ' HB3' HG12 ' A' ' 267' ' ' ILE . 9.8 t70 -55.67 132.92 71.97 Favored Pre-proline 0 C--N 1.321 -0.661 0 CA-C-N 115.908 -0.587 . . . . 15.0 109.529 175.836 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 265' ' ' PRO . . . . . 0.534 ' HD2' HD22 ' A' ' 236' ' ' LEU . 91.7 Cg_endo -80.67 -14.6 11.32 Favored 'Trans proline' 0 N--CA 1.462 -0.381 0 C-N-CA 122.42 2.08 . . . . 15.0 113.543 -176.192 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 266' ' ' ARG . . . . . 0.591 ' HD3' ' HD3' ' A' ' 237' ' ' PRO . 25.2 tpt180 -77.08 -8.52 57.61 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-O 122.269 1.033 . . . . 15.0 108.408 175.156 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 267' ' ' ILE . . . . . 0.799 HG12 ' HB3' ' A' ' 264' ' ' ASP . 43.2 mm . . . . . 0 C--O 1.249 1.052 0 CA-C-N 113.505 -1.68 . . . . 15.0 109.749 176.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 210' ' ' SER . . . . . . . . . . . . . 4.7 m . . . . . 0 N--CA 1.471 0.616 0 CA-C-O 120.792 0.33 . . . . 15.0 110.387 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' B' B ' 211' ' ' ASP . . . . . 0.407 ' HA ' ' HD3' ' B' ' 212' ' ' PRO . 9.2 p-10 -150.17 131.79 7.61 Favored Pre-proline 0 C--N 1.326 -0.437 0 CA-C-N 116.262 -0.427 . . . . 15.0 110.337 -178.75 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 212' ' ' PRO . . . . . 0.8 ' HB3' HD11 ' A' ' 253' ' ' LEU . 12.3 Cg_endo -89.98 140.45 3.4 Favored 'Trans proline' 0 N--CA 1.453 -0.89 0 C-N-CA 122.995 2.463 . . . . 15.0 112.199 178.602 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.443 -0.841 0 C-N-CA 120.548 -0.834 . . . . 15.0 111.94 178.895 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 236' ' ' LEU . . . . . 0.431 HD22 ' N ' ' A' ' 236' ' ' LEU . 0.9 OUTLIER . . . . . 0 C--O 1.234 0.286 0 N-CA-C 108.828 -0.804 . . . . 15.0 108.828 . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 237' ' ' PRO . . . . . 0.763 ' HD3' ' HD3' ' A' ' 266' ' ' ARG . 16.0 Cg_exo -69.24 164.54 33.64 Favored 'Trans proline' 0 CA--C 1.514 -0.524 0 C-N-CA 122.009 1.806 . . . . 15.0 110.399 167.457 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -69.92 143.65 52.65 Favored 'General case' 0 C--N 1.302 -1.465 0 CA-C-N 115.02 -0.991 . . . . 15.0 111.356 -173.695 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 239' ' ' GLY . . . . . 0.416 ' O ' ' HA ' ' A' ' 254' ' ' HIS . . . 100.16 3.9 55.48 Favored Glycine 0 N--CA 1.447 -0.628 0 CA-C-N 115.29 -0.868 . . . . 15.0 113.294 177.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 240' ' ' TYR . . . . . 0.728 ' CD1' ' HB2' ' A' ' 254' ' ' HIS . 74.7 m-85 -105.58 126.46 52.16 Favored 'General case' 0 CA--C 1.514 -0.434 0 CA-C-N 117.352 0.576 . . . . 15.0 110.874 176.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -111.71 125.23 53.75 Favored 'General case' 0 C--N 1.316 -0.871 0 N-CA-C 109.461 -0.57 . . . . 15.0 109.461 169.526 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 242' ' ' GLN . . . . . 0.486 ' HG3' ' CE1' ' A' ' 252' ' ' PHE . 7.2 tt0 -89.74 104.1 16.69 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.772 -0.649 . . . . 15.0 109.296 -178.62 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 36.0 mtt-85 -97.03 150.01 21.28 Favored 'General case' 0 CA--C 1.505 -0.771 0 CA-C-O 122.23 1.014 . . . . 15.0 112.368 -176.205 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 244' ' ' THR . . . . . . . . . . . . . 13.6 p -120.27 133.36 55.48 Favored 'General case' 0 C--N 1.308 -1.234 0 CA-C-N 113.085 -1.871 . . . . 15.0 109.506 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 245' ' ' THR . . . . . 0.557 ' OG1' ' HG2' ' A' ' 247' ' ' GLN . 4.6 t -137.4 150.23 47.51 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 116.462 -0.335 . . . . 15.0 110.911 -176.317 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 3.6 m -57.16 -15.88 3.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 115.777 -0.647 . . . . 15.0 112.117 178.694 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 247' ' ' GLN . . . . . 0.557 ' HG2' ' OG1' ' A' ' 245' ' ' THR . 6.8 mm100 -54.42 -24.04 18.35 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.123 -0.489 . . . . 15.0 110.245 172.918 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 92.9 34.12 7.01 Favored Glycine 0 C--N 1.333 0.374 0 CA-C-N 115.903 -0.589 . . . . 15.0 111.927 175.91 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 249' ' ' GLN . . . . . 0.494 ' CD ' ' HH2' ' A' ' 262' ' ' TRP . 0.2 OUTLIER -149.42 137.93 20.88 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.449 0.642 . . . . 15.0 111.843 -170.977 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 12.6 m -91.81 128.41 43.51 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.039 0 CA-C-N 114.527 -1.215 . . . . 15.0 109.151 171.16 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 20.5 p90 -132.8 135.27 45.58 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 109.951 -0.389 . . . . 15.0 109.951 -178.081 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 252' ' ' PHE . . . . . 0.663 ' CD2' ' HA ' ' A' ' 264' ' ' ASP . 30.1 m-85 -90.14 121.74 32.46 Favored 'General case' 0 CA--C 1.513 -0.443 0 CA-C-O 121.224 0.535 . . . . 15.0 111.737 -174.346 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 253' ' ' LEU . . . . . 0.735 HD11 ' HB3' ' B' ' 212' ' ' PRO . 0.5 OUTLIER -109.42 116.51 31.95 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 114.783 -1.099 . . . . 15.0 111.148 -175.824 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 254' ' ' HIS . . . . . 0.728 ' HB2' ' CD1' ' A' ' 240' ' ' TYR . 26.4 t-80 -130.21 90.21 2.91 Favored 'General case' 0 CA--C 1.503 -0.859 0 N-CA-C 108.207 -1.035 . . . . 15.0 108.207 169.866 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 3.2 t -91.32 87.95 6.67 Favored 'General case' 0 N--CA 1.432 -1.374 0 C-N-CA 116.659 -2.017 . . . . 15.0 110.111 -179.424 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 48.3 tt0 -101.33 -51.26 3.53 Favored 'General case' 0 N--CA 1.44 -0.963 0 CA-C-N 113.412 -1.722 . . . . 15.0 106.422 150.712 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 257' ' ' THR . . . . . . . . . . . . . 80.9 p -98.19 -13.61 20.78 Favored 'General case' 0 CA--C 1.488 -1.43 0 CA-C-O 124.78 2.229 . . . . 15.0 111.724 178.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 87.62 73.15 1.28 Allowed Glycine 1 C--N 1.24 -4.75 1 CA-C-N 108.258 -4.065 . . . . 15.0 112.742 -170.977 . . . . . . . . 3 2 . 1 . 009 nuclear nobuild core ' A' A ' 259' ' ' VAL . . . . . 0.569 ' O ' ' HA ' ' A' ' 253' ' ' LEU . 48.7 t -89.66 125.49 42.62 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.339 0 CA-C-O 121.667 0.746 . . . . 15.0 112.18 175.846 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 1.5 p -138.23 92.39 2.64 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-N 113.763 -1.562 . . . . 15.0 107.658 167.617 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 13.2 t -124.4 150.26 45.79 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 121.386 0.612 . . . . 15.0 112.243 -167.426 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 262' ' ' TRP . . . . . 0.494 ' HH2' ' CD ' ' A' ' 249' ' ' GLN . 40.9 m95 -75.44 -25.28 57.33 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 114.794 -1.094 . . . . 15.0 112.201 178.959 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 263' ' ' HIS . . . . . . . . . . . . . 8.1 p80 -92.9 142.26 27.5 Favored 'General case' 0 C--N 1.322 -0.608 0 C-N-CA 120.179 -0.608 . . . . 15.0 110.385 -176.043 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 264' ' ' ASP . . . . . 0.851 ' HB3' HG12 ' A' ' 267' ' ' ILE . 9.9 t0 -61.96 134.22 94.2 Favored Pre-proline 0 C--N 1.321 -0.635 0 N-CA-C 108.541 -0.911 . . . . 15.0 108.541 175.216 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 265' ' ' PRO . . . . . 0.603 ' HD3' ' CD2' ' A' ' 252' ' ' PHE . 71.6 Cg_endo -81.81 -14.46 10.01 Favored 'Trans proline' 0 N--CA 1.452 -0.969 0 C-N-CA 122.039 1.826 . . . . 15.0 113.547 -174.559 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 266' ' ' ARG . . . . . 0.763 ' HD3' ' HD3' ' A' ' 237' ' ' PRO . 17.8 tpt180 -78.87 -7.5 57.98 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-O 122.029 0.919 . . . . 15.0 108.723 174.62 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 267' ' ' ILE . . . . . 0.851 HG12 ' HB3' ' A' ' 264' ' ' ASP . 46.9 mm . . . . . 0 C--O 1.249 1.067 0 CA-C-N 113.846 -1.525 . . . . 15.0 109.663 177.063 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 210' ' ' SER . . . . . . . . . . . . . 20.0 m . . . . . 0 N--CA 1.482 1.132 0 CA-C-O 120.955 0.407 . . . . 15.0 110.969 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' B' B ' 211' ' ' ASP . . . . . 0.476 ' HA ' ' HD3' ' B' ' 212' ' ' PRO . 36.3 t70 -101.58 113.82 65.76 Favored Pre-proline 0 C--N 1.325 -0.488 0 CA-C-N 116.328 -0.396 . . . . 15.0 110.244 -177.701 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 212' ' ' PRO . . . . . 0.735 ' HB3' HD11 ' A' ' 253' ' ' LEU . 6.3 Cg_endo -89.71 160.2 5.19 Favored 'Trans proline' 0 N--CA 1.456 -0.688 0 C-N-CA 123.454 2.769 . . . . 15.0 112.891 -175.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.444 -0.813 0 CA-C-N 115.717 -0.674 . . . . 15.0 112.52 -178.151 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 4.8 mt . . . . . 0 C--O 1.232 0.147 0 CA-C-O 120.715 0.293 . . . . 15.0 110.426 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 237' ' ' PRO . . . . . 0.769 ' HD3' ' HD3' ' A' ' 266' ' ' ARG . 16.5 Cg_exo -69.37 169.6 18.04 Favored 'Trans proline' 0 CA--C 1.511 -0.672 0 C-N-CA 122.308 2.005 . . . . 15.0 110.654 165.355 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 60.0 mt-10 -69.5 137.14 52.28 Favored 'General case' 0 C--N 1.303 -1.425 0 CA-C-N 114.594 -1.185 . . . . 15.0 112.375 -172.096 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 100.54 5.76 53.69 Favored Glycine 0 N--CA 1.447 -0.582 0 CA-C-N 113.914 -1.494 . . . . 15.0 113.706 175.245 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 240' ' ' TYR . . . . . 0.703 ' CD1' ' HB2' ' A' ' 254' ' ' HIS . 83.4 m-85 -104.06 122.99 46.41 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 117.741 0.77 . . . . 15.0 110.738 175.891 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 241' ' ' GLU . . . . . 0.496 ' HG3' ' HB3' ' A' ' 253' ' ' LEU . 8.1 pt-20 -105.57 127.37 52.99 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 109.139 -0.689 . . . . 15.0 109.139 170.84 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 242' ' ' GLN . . . . . 0.641 ' HG3' ' CE1' ' A' ' 252' ' ' PHE . 9.6 tt0 -89.86 105.15 17.61 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 108.932 -0.766 . . . . 15.0 108.932 179.86 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 54.9 mtt-85 -92.39 149.28 21.51 Favored 'General case' 0 CA--C 1.506 -0.724 0 CA-C-O 122.288 1.042 . . . . 15.0 112.158 -177.074 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 244' ' ' THR . . . . . . . . . . . . . 20.4 p -126.4 89.91 3.09 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-N 113.066 -1.879 . . . . 15.0 109.101 -174.139 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 245' ' ' THR . . . . . 0.78 HG23 ' HB2' ' A' ' 247' ' ' GLN . 13.4 t -97.24 150.27 21.11 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 115.162 -0.926 . . . . 15.0 110.326 -171.106 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 26.8 t -54.41 -17.91 2.35 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 C-N-CA 122.915 0.486 . . . . 15.0 111.961 -175.069 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 247' ' ' GLN . . . . . 0.78 ' HB2' HG23 ' A' ' 245' ' ' THR . 10.4 mp0 -51.18 -22.89 2.86 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 123.25 0.62 . . . . 15.0 111.318 172.17 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 88.05 16.0 60.08 Favored Glycine 0 C--N 1.33 0.233 0 C-N-CA 121.156 -0.545 . . . . 15.0 112.06 178.23 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 249' ' ' GLN . . . . . 0.426 ' NE2' ' HH2' ' A' ' 262' ' ' TRP . 1.8 mt-30 -131.11 137.56 49.13 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 109.884 -0.413 . . . . 15.0 109.884 -176.316 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 14.4 m -89.72 134.05 29.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-N 116.358 -0.383 . . . . 15.0 110.306 177.407 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 14.9 p90 -133.41 137.05 45.61 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.35 -0.386 . . . . 15.0 110.194 -179.698 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 252' ' ' PHE . . . . . 0.692 ' CD2' ' HA ' ' A' ' 264' ' ' ASP . 37.6 m-85 -89.88 121.74 32.28 Favored 'General case' 0 CA--C 1.512 -0.498 0 CA-C-O 121.193 0.521 . . . . 15.0 110.909 -175.8 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 253' ' ' LEU . . . . . 0.893 HD11 ' HB3' ' B' ' 212' ' ' PRO . 0.4 OUTLIER -113.16 124.75 53.28 Favored 'General case' 0 N--CA 1.445 -0.699 0 CA-C-N 114.858 -1.065 . . . . 15.0 110.756 -174.921 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 254' ' ' HIS . . . . . 0.703 ' HB2' ' CD1' ' A' ' 240' ' ' TYR . 14.5 t-80 -138.95 97.51 3.33 Favored 'General case' 0 CA--C 1.499 -1.014 0 N-CA-C 108.645 -0.872 . . . . 15.0 108.645 173.198 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 24.5 m -93.57 87.74 5.63 Favored 'General case' 0 N--CA 1.434 -1.244 0 C-N-CA 116.539 -2.064 . . . . 15.0 110.402 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 35.3 tt0 -101.29 -54.0 2.88 Favored 'General case' 0 N--CA 1.44 -0.956 0 N-CA-C 105.653 -1.981 . . . . 15.0 105.653 148.826 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 257' ' ' THR . . . . . . . . . . . . . 77.8 p -100.06 -13.61 18.96 Favored 'General case' 0 CA--C 1.485 -1.535 0 CA-C-N 112.555 -2.111 . . . . 15.0 112.223 -178.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 86.67 73.7 1.28 Allowed Glycine 1 C--N 1.239 -4.808 0 CA-C-N 108.806 -3.815 . . . . 15.0 112.753 -171.293 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 259' ' ' VAL . . . . . 0.655 ' O ' ' HA ' ' A' ' 253' ' ' LEU . 43.8 t -89.69 124.62 42.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 121.43 0.633 . . . . 15.0 112.02 176.021 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -140.15 102.14 4.31 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 114.407 -1.27 . . . . 15.0 107.915 168.345 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 12.9 t -143.31 150.35 39.07 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.9 -0.591 . . . . 15.0 111.878 -168.746 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 262' ' ' TRP . . . . . 0.426 ' HH2' ' NE2' ' A' ' 249' ' ' GLN . 92.7 m95 -70.0 -42.57 72.87 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 115.638 -0.71 . . . . 15.0 111.492 178.286 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 263' ' ' HIS . . . . . . . . . . . . . 2.7 p80 -73.53 132.37 42.79 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.255 -0.429 . . . . 15.0 110.246 -175.868 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 264' ' ' ASP . . . . . 1.014 ' HB3' HG12 ' A' ' 267' ' ' ILE . 22.0 t0 -56.38 127.63 72.0 Favored Pre-proline 0 C--N 1.32 -0.715 0 N-CA-C 108.155 -1.054 . . . . 15.0 108.155 172.769 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 265' ' ' PRO . . . . . 0.521 ' HG2' ' CD1' ' A' ' 240' ' ' TYR . 12.1 Cg_exo -69.34 -14.52 37.56 Favored 'Trans proline' 0 C--N 1.329 -0.482 0 C-N-CA 122.27 1.98 . . . . 15.0 112.614 -177.466 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 266' ' ' ARG . . . . . 0.769 ' HD3' ' HD3' ' A' ' 237' ' ' PRO . 16.1 tpt180 -75.39 -11.62 60.08 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 108.7 -0.852 . . . . 15.0 108.7 172.91 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 267' ' ' ILE . . . . . 1.014 HG12 ' HB3' ' A' ' 264' ' ' ASP . 24.6 pt . . . . . 0 C--O 1.248 1.017 0 CA-C-N 114.625 -1.171 . . . . 15.0 111.364 178.101 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 210' ' ' SER . . . . . . . . . . . . . 40.8 m . . . . . 0 N--CA 1.479 0.99 0 CA-C-O 120.77 0.319 . . . . 15.0 111.258 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' B' B ' 211' ' ' ASP . . . . . 0.422 ' HA ' ' HD3' ' B' ' 212' ' ' PRO . 10.1 p-10 -90.44 141.78 27.64 Favored Pre-proline 0 C--N 1.328 -0.363 0 N-CA-C 109.657 -0.498 . . . . 15.0 109.657 179.38 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 212' ' ' PRO . . . . . 0.893 ' HB3' HD11 ' A' ' 253' ' ' LEU . 9.5 Cg_endo -89.6 148.85 5.13 Favored 'Trans proline' 0 N--CA 1.454 -0.822 0 C-N-CA 122.733 2.289 . . . . 15.0 112.581 -177.567 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.443 -0.87 0 C-N-CA 120.746 -0.74 . . . . 15.0 112.075 -179.386 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 236' ' ' LEU . . . . . 0.558 HD12 ' HD2' ' A' ' 265' ' ' PRO . 0.1 OUTLIER . . . . . 0 CA--C 1.518 -0.269 0 CA-C-O 121.225 0.536 . . . . 15.0 110.939 . . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 237' ' ' PRO . . . . . 0.455 ' HD3' ' HD3' ' A' ' 266' ' ' ARG . 18.8 Cg_exo -69.65 166.21 28.21 Favored 'Trans proline' 0 CA--C 1.515 -0.455 0 C-N-CA 122.993 2.462 . . . . 15.0 110.323 164.705 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -69.7 150.02 47.41 Favored 'General case' 0 C--N 1.307 -1.278 0 CA-C-N 115.443 -0.799 . . . . 15.0 110.968 -177.207 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 100.03 -2.14 56.63 Favored Glycine 0 N--CA 1.447 -0.593 0 CA-C-N 115.508 -0.769 . . . . 15.0 113.809 179.489 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 240' ' ' TYR . . . . . 0.671 ' CD1' ' HB2' ' A' ' 254' ' ' HIS . 79.6 m-85 -104.28 115.35 30.24 Favored 'General case' 0 CA--C 1.518 -0.283 0 CA-C-N 117.688 0.744 . . . . 15.0 110.626 178.233 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 26.5 mt-10 -95.7 123.13 39.12 Favored 'General case' 0 C--N 1.317 -0.844 0 N-CA-C 109.074 -0.713 . . . . 15.0 109.074 175.015 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 23.7 tm0? -89.91 109.11 20.15 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 108.728 -0.842 . . . . 15.0 108.728 179.845 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 47.9 mtt85 -105.27 150.09 25.45 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 122.143 0.973 . . . . 15.0 112.098 -179.291 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 244' ' ' THR . . . . . . . . . . . . . 5.6 p -127.36 98.25 5.19 Favored 'General case' 0 C--N 1.31 -1.125 0 CA-C-N 113.279 -1.782 . . . . 15.0 109.309 -177.183 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 245' ' ' THR . . . . . 0.463 ' OG1' ' HG2' ' A' ' 247' ' ' GLN . 3.1 t -89.92 150.4 22.19 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 115.567 -0.742 . . . . 15.0 111.098 -174.279 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 8.4 m -50.8 -19.36 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.21 0 CA-C-N 115.413 -0.812 . . . . 15.0 112.236 177.423 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 247' ' ' GLN . . . . . 0.489 ' HB2' ' HG3' ' A' ' 249' ' ' GLN . 7.3 mm100 -55.62 -26.08 42.31 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.07 -0.514 . . . . 15.0 110.953 173.514 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 89.01 30.58 14.05 Favored Glycine 0 N--CA 1.449 -0.495 0 CA-C-N 115.943 -0.571 . . . . 15.0 111.996 179.706 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 249' ' ' GLN . . . . . 0.489 ' HG3' ' HB2' ' A' ' 247' ' ' GLN . 0.0 OUTLIER -134.76 142.09 46.64 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.642 0.258 . . . . 15.0 110.388 -177.006 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 17.9 m -89.97 134.89 27.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 115.884 -0.598 . . . . 15.0 109.825 175.373 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 4.3 p90 -142.73 135.77 28.28 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.083 0.468 . . . . 15.0 110.448 179.493 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 252' ' ' PHE . . . . . 0.717 ' CE2' ' HA ' ' A' ' 264' ' ' ASP . 34.5 m-85 -90.27 125.55 35.54 Favored 'General case' 0 CA--C 1.511 -0.526 0 CA-C-N 115.826 -0.625 . . . . 15.0 111.126 -176.57 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 253' ' ' LEU . . . . . 1.027 HD11 ' HB3' ' B' ' 212' ' ' PRO . 0.4 OUTLIER -113.98 111.25 21.37 Favored 'General case' 0 N--CA 1.445 -0.724 0 CA-C-N 115.25 -0.886 . . . . 15.0 111.768 -174.589 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 254' ' ' HIS . . . . . 0.671 ' HB2' ' CD1' ' A' ' 240' ' ' TYR . 36.4 t-80 -122.46 90.11 3.24 Favored 'General case' 0 CA--C 1.499 -0.992 0 N-CA-C 107.981 -1.118 . . . . 15.0 107.981 166.345 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 7.3 t -96.38 88.05 4.63 Favored 'General case' 0 N--CA 1.428 -1.567 0 C-N-CA 116.599 -2.041 . . . . 15.0 110.192 -178.878 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 63.7 tt0 -101.2 -51.48 3.5 Favored 'General case' 0 N--CA 1.437 -1.081 0 CA-C-N 112.875 -1.966 . . . . 15.0 105.838 151.519 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 257' ' ' THR . . . . . . . . . . . . . 79.6 p -96.78 -13.42 22.65 Favored 'General case' 0 CA--C 1.486 -1.506 0 CA-C-O 125.034 2.35 . . . . 15.0 111.623 178.531 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 86.74 74.62 1.27 Allowed Glycine 1 C--N 1.24 -4.783 1 CA-C-N 108.222 -4.081 . . . . 15.0 112.899 -172.92 . . . . . . . . 3 2 . 1 . 011 nuclear nobuild core ' A' A ' 259' ' ' VAL . . . . . 0.587 ' O ' ' HA ' ' A' ' 253' ' ' LEU . 57.4 t -89.9 121.86 40.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-O 121.556 0.693 . . . . 15.0 112.02 172.855 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 1.3 p -135.27 103.62 5.58 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 114.042 -1.435 . . . . 15.0 107.988 169.878 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 261' ' ' THR . . . . . 0.458 ' OG1' ' HD2' ' A' ' 263' ' ' HIS . 14.3 t -143.41 150.49 39.14 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 112.977 0.732 . . . . 15.0 112.977 -168.085 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 262' ' ' TRP . . . . . 0.44 ' HH2' ' CD ' ' A' ' 249' ' ' GLN . 89.1 m95 -71.44 -32.6 68.54 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 114.956 -1.02 . . . . 15.0 111.848 178.543 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 263' ' ' HIS . . . . . 0.458 ' HD2' ' OG1' ' A' ' 261' ' ' THR . 5.4 p80 -86.28 137.47 32.58 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.596 -0.441 . . . . 15.0 110.986 -172.241 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 264' ' ' ASP . . . . . 0.994 ' HB3' HG12 ' A' ' 267' ' ' ILE . 7.3 t0 -52.96 129.86 48.53 Favored Pre-proline 0 C--N 1.325 -0.458 0 N-CA-C 108.864 -0.791 . . . . 15.0 108.864 172.92 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 265' ' ' PRO . . . . . 0.558 ' HD2' HD12 ' A' ' 236' ' ' LEU . 67.0 Cg_endo -73.2 -14.87 25.74 Favored 'Trans proline' 0 CA--C 1.51 -0.724 0 C-N-CA 122.193 1.928 . . . . 15.0 113.64 -173.961 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 266' ' ' ARG . . . . . 0.455 ' HD3' ' HD3' ' A' ' 237' ' ' PRO . 8.4 tpt180 -83.93 -5.58 59.25 Favored 'General case' 0 C--N 1.306 -1.293 0 N-CA-C 108.254 -1.017 . . . . 15.0 108.254 174.245 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 267' ' ' ILE . . . . . 0.994 HG12 ' HB3' ' A' ' 264' ' ' ASP . 45.0 pt . . . . . 0 C--O 1.247 0.965 0 CA-C-N 114.023 -1.444 . . . . 15.0 110.728 174.667 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 210' ' ' SER . . . . . . . . . . . . . 19.3 m . . . . . 0 N--CA 1.477 0.891 0 CA-C-O 120.841 0.353 . . . . 15.0 111.038 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' B' B ' 211' ' ' ASP . . . . . 0.419 ' HA ' ' HD3' ' B' ' 212' ' ' PRO . 13.9 m-20 -110.05 115.18 55.25 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 120.76 0.314 . . . . 15.0 110.759 -178.032 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 212' ' ' PRO . . . . . 1.027 ' HB3' HD11 ' A' ' 253' ' ' LEU . 6.1 Cg_exo -89.6 141.55 3.93 Favored 'Trans proline' 0 N--CA 1.461 -0.437 0 C-N-CA 123.422 2.748 . . . . 15.0 112.851 178.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.443 -0.866 0 CA-C-N 115.52 -0.764 . . . . 15.0 111.745 178.619 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 236' ' ' LEU . . . . . 0.65 HD12 ' HD2' ' A' ' 265' ' ' PRO . 0.2 OUTLIER . . . . . 0 CA--C 1.515 -0.367 0 CA-C-O 121.443 0.639 . . . . 15.0 110.906 . . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 237' ' ' PRO . . . . . 0.477 ' HD2' ' CE2' ' A' ' 240' ' ' TYR . 15.3 Cg_exo -69.65 173.88 10.23 Favored 'Trans proline' 0 CA--C 1.514 -0.516 0 C-N-CA 123.202 2.602 . . . . 15.0 110.672 161.675 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -69.42 143.45 53.61 Favored 'General case' 0 C--N 1.3 -1.581 0 CA-C-N 114.487 -1.233 . . . . 15.0 111.238 -177.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 100.18 8.29 50.68 Favored Glycine 0 N--CA 1.45 -0.386 0 CA-C-N 115.502 -0.772 . . . . 15.0 113.735 177.169 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 240' ' ' TYR . . . . . 0.641 ' CD1' ' HB2' ' A' ' 254' ' ' HIS . 72.2 m-85 -107.32 116.5 32.04 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 117.611 0.705 . . . . 15.0 111.346 178.826 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 241' ' ' GLU . . . . . 0.585 ' HB3' ' HB3' ' A' ' 253' ' ' LEU . 4.5 tp10 -89.84 111.58 22.65 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.156 -0.929 . . . . 15.0 108.737 174.562 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -90.06 102.72 15.43 Favored 'General case' 0 C--N 1.314 -0.943 0 N-CA-C 108.635 -0.876 . . . . 15.0 108.635 178.681 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 243' ' ' ARG . . . . . 0.437 ' HG3' ' HG3' ' A' ' 241' ' ' GLU . 51.0 mtt-85 -99.21 148.26 24.29 Favored 'General case' 0 CA--C 1.499 -0.998 0 CA-C-O 121.96 0.886 . . . . 15.0 112.185 -177.742 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 244' ' ' THR . . . . . . . . . . . . . 11.7 m -123.2 93.97 4.12 Favored 'General case' 0 C--N 1.309 -1.191 0 CA-C-N 113.505 -1.68 . . . . 15.0 110.207 -179.413 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 245' ' ' THR . . . . . 1.082 HG23 ' HG2' ' A' ' 247' ' ' GLN . 7.7 t -95.25 150.73 19.91 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.546 -0.752 . . . . 15.0 110.248 179.99 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 15.0 m -41.15 -25.27 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 N-CA-C 114.642 1.349 . . . . 15.0 114.642 -175.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 247' ' ' GLN . . . . . 1.082 ' HG2' HG23 ' A' ' 245' ' ' THR . 3.5 pt20 -54.4 -21.45 9.71 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 117.793 0.27 . . . . 15.0 111.14 177.251 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 87.76 20.64 50.07 Favored Glycine 0 C--N 1.333 0.411 0 C-N-CA 121.206 -0.521 . . . . 15.0 113.036 173.821 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 249' ' ' GLN . . . . . 0.414 HE21 ' CD ' ' A' ' 247' ' ' GLN . 18.5 mt-30 -129.98 142.71 50.6 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.586 -0.524 . . . . 15.0 109.586 -177.207 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 29.8 m -91.25 134.75 28.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-O 120.943 0.402 . . . . 15.0 110.924 179.875 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 33.0 p90 -134.27 137.56 44.38 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.778 -0.452 . . . . 15.0 109.778 -178.005 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 252' ' ' PHE . . . . . 0.67 ' CE2' ' HA ' ' A' ' 264' ' ' ASP . 26.6 m-85 -92.01 116.58 29.05 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.218 0.533 . . . . 15.0 111.386 -174.66 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 253' ' ' LEU . . . . . 0.78 HD11 ' HB3' ' B' ' 212' ' ' PRO . 0.5 OUTLIER -106.54 96.87 6.76 Favored 'General case' 0 N--CA 1.447 -0.604 0 CA-C-N 115.063 -0.972 . . . . 15.0 111.3 -175.154 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 254' ' ' HIS . . . . . 0.641 ' HB2' ' CD1' ' A' ' 240' ' ' TYR . 33.5 t-80 -106.53 90.12 3.24 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 108.417 -0.957 . . . . 15.0 108.417 169.5 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 1.9 t -94.65 87.81 5.2 Favored 'General case' 0 N--CA 1.432 -1.342 0 C-N-CA 116.746 -1.982 . . . . 15.0 110.286 -179.698 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 57.4 tt0 -101.18 -50.2 3.86 Favored 'General case' 0 N--CA 1.441 -0.919 0 CA-C-N 112.957 -1.929 . . . . 15.0 106.25 150.876 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 257' ' ' THR . . . . . . . . . . . . . 67.0 p -98.53 -13.56 20.41 Favored 'General case' 0 CA--C 1.486 -1.503 0 CA-C-O 124.706 2.193 . . . . 15.0 111.738 178.469 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 87.07 73.57 1.28 Allowed Glycine 1 C--N 1.24 -4.803 0 CA-C-N 108.493 -3.958 . . . . 15.0 112.851 -172.3 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 259' ' ' VAL . . . . . 0.704 ' O ' ' HA ' ' A' ' 253' ' ' LEU . 52.3 t -89.92 125.3 42.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-O 121.284 0.564 . . . . 15.0 112.135 174.275 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 1.6 p -137.16 98.01 3.63 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 114.699 -1.137 . . . . 15.0 107.987 167.666 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 14.0 t -136.79 150.29 48.27 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.994 -0.548 . . . . 15.0 111.972 -168.464 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 262' ' ' TRP . . . . . . . . . . . . . 83.2 m95 -71.83 -39.46 69.74 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.062 -0.972 . . . . 15.0 111.663 179.481 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 263' ' ' HIS . . . . . . . . . . . . . 5.5 p80 -77.82 137.23 38.3 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.451 -0.341 . . . . 15.0 110.48 -173.496 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 264' ' ' ASP . . . . . 1.021 ' HB3' HG12 ' A' ' 267' ' ' ILE . 27.7 t0 -57.54 124.21 66.41 Favored Pre-proline 0 C--N 1.324 -0.533 0 N-CA-C 108.024 -1.102 . . . . 15.0 108.024 169.899 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 265' ' ' PRO . . . . . 0.65 ' HD2' HD12 ' A' ' 236' ' ' LEU . 12.1 Cg_exo -69.13 -14.7 38.55 Favored 'Trans proline' 0 N--CA 1.459 -0.558 0 C-N-CA 122.236 1.957 . . . . 15.0 112.914 -175.997 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 266' ' ' ARG . . . . . 0.44 ' HD3' ' HD3' ' A' ' 237' ' ' PRO . 6.1 tpt180 -76.44 -11.64 59.92 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-O 121.99 0.9 . . . . 15.0 108.918 173.572 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 267' ' ' ILE . . . . . 1.021 HG12 ' HB3' ' A' ' 264' ' ' ASP . 36.5 pt . . . . . 0 C--O 1.246 0.904 0 CA-C-N 114.562 -1.199 . . . . 15.0 111.458 -179.364 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 210' ' ' SER . . . . . . . . . . . . . 17.7 m . . . . . 0 N--CA 1.476 0.863 0 CA-C-O 120.977 0.418 . . . . 15.0 110.327 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' B' B ' 211' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -98.97 116.83 65.05 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.136 -0.484 . . . . 15.0 110.93 -172.577 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 212' ' ' PRO . . . . . 0.78 ' HB3' HD11 ' A' ' 253' ' ' LEU . 6.6 Cg_endo -89.87 144.21 4.34 Favored 'Trans proline' 0 N--CA 1.451 -1.026 0 C-N-CA 122.851 2.367 . . . . 15.0 111.051 171.138 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.442 -0.946 0 C-N-CA 120.192 -1.004 . . . . 15.0 111.923 -179.517 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 236' ' ' LEU . . . . . 0.451 HD22 ' N ' ' A' ' 236' ' ' LEU . 0.6 OUTLIER . . . . . 0 N--CA 1.454 -0.257 0 N-CA-C 110.287 -0.264 . . . . 15.0 110.287 . . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 237' ' ' PRO . . . . . 0.605 ' HD3' ' HD3' ' A' ' 266' ' ' ARG . 20.0 Cg_exo -69.2 170.77 15.15 Favored 'Trans proline' 0 CA--C 1.509 -0.759 0 C-N-CA 122.308 2.005 . . . . 15.0 111.258 166.81 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -69.46 139.1 53.93 Favored 'General case' 0 C--N 1.301 -1.535 0 CA-C-N 114.215 -1.357 . . . . 15.0 110.995 -171.819 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 239' ' ' GLY . . . . . 0.402 ' O ' ' HD2' ' A' ' 254' ' ' HIS . . . 100.22 -2.28 56.41 Favored Glycine 0 N--CA 1.448 -0.509 0 CA-C-N 115.621 -0.718 . . . . 15.0 113.752 179.288 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 240' ' ' TYR . . . . . 0.443 ' CD1' ' HB2' ' A' ' 254' ' ' HIS . 84.6 m-85 -97.39 116.52 29.75 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 118.087 0.943 . . . . 15.0 111.167 177.381 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 241' ' ' GLU . . . . . 0.583 ' HB2' ' HB3' ' A' ' 253' ' ' LEU . 5.6 mt-10 -89.9 111.06 21.99 Favored 'General case' 0 N--CA 1.441 -0.915 0 CA-C-N 114.297 -1.319 . . . . 15.0 109.232 177.606 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 242' ' ' GLN . . . . . 0.607 HE22 HG23 ' A' ' 244' ' ' THR . 1.0 OUTLIER -89.88 103.72 16.35 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 108.88 -0.785 . . . . 15.0 108.88 178.355 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 243' ' ' ARG . . . . . 0.43 ' CZ ' ' HG2' ' B' ' 212' ' ' PRO . 8.2 mtp180 -108.33 149.01 29.25 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.768 0.794 . . . . 15.0 112.114 -178.456 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 244' ' ' THR . . . . . 0.607 HG23 HE22 ' A' ' 242' ' ' GLN . 16.2 p -120.39 121.19 38.02 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 114.008 -1.451 . . . . 15.0 109.799 -178.035 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 245' ' ' THR . . . . . 0.521 ' OG1' ' HG2' ' A' ' 247' ' ' GLN . 4.6 t -110.66 150.55 28.85 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 116.24 -0.437 . . . . 15.0 111.013 -176.863 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 5.5 p -50.07 -24.31 1.92 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.262 0 CA-C-N 115.389 -0.823 . . . . 15.0 111.2 175.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 247' ' ' GLN . . . . . 0.521 ' HG2' ' OG1' ' A' ' 245' ' ' THR . 3.9 mm-40 -51.97 -26.84 11.46 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 115.335 -0.848 . . . . 15.0 110.823 175.42 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 104.56 9.36 35.76 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 121.098 -0.572 . . . . 15.0 113.092 174.518 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 2.1 pm0 -123.38 149.04 45.46 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 112.904 0.705 . . . . 15.0 112.904 -174.924 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 6.2 m -89.79 132.67 33.89 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.435 0 CA-C-N 114.727 -1.124 . . . . 15.0 108.367 166.69 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 2.4 p90 -134.61 140.3 45.97 Favored 'General case' 0 C--N 1.314 -0.946 0 C-N-CA 120.538 -0.465 . . . . 15.0 110.1 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 252' ' ' PHE . . . . . 0.661 ' CD2' ' HA ' ' A' ' 264' ' ' ASP . 24.2 m-85 -90.0 111.66 22.83 Favored 'General case' 0 CA--C 1.507 -0.698 0 CA-C-O 121.854 0.835 . . . . 15.0 111.601 -174.972 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 253' ' ' LEU . . . . . 0.921 HD11 ' HB3' ' B' ' 212' ' ' PRO . 0.5 OUTLIER -99.52 140.96 32.94 Favored 'General case' 0 N--CA 1.438 -1.055 0 CA-C-N 113.696 -1.593 . . . . 15.0 109.192 178.893 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 254' ' ' HIS . . . . . 0.466 ' HB3' ' HB ' ' A' ' 259' ' ' VAL . 13.6 t-80 -149.98 93.13 1.98 Allowed 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 108.335 -0.987 . . . . 15.0 108.335 170.72 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 255' ' ' THR . . . . . 0.502 HG22 ' OE2' ' A' ' 241' ' ' GLU . 2.6 t -90.04 87.95 7.1 Favored 'General case' 0 N--CA 1.431 -1.404 0 C-N-CA 116.387 -2.125 . . . . 15.0 110.328 -179.949 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 56.3 tt0 -101.26 -54.2 2.83 Favored 'General case' 0 N--CA 1.44 -0.963 0 CA-C-N 112.761 -2.018 . . . . 15.0 105.733 148.089 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 257' ' ' THR . . . . . . . . . . . . . 71.3 p -99.94 -13.72 19.01 Favored 'General case' 0 CA--C 1.487 -1.455 0 CA-C-N 112.156 -2.293 . . . . 15.0 112.333 -178.834 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 85.71 72.0 1.3 Allowed Glycine 1 C--N 1.244 -4.546 0 CA-C-N 108.492 -3.958 . . . . 15.0 112.762 -170.986 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 259' ' ' VAL . . . . . 0.567 ' O ' ' HA ' ' A' ' 253' ' ' LEU . 85.1 t -89.75 134.56 28.53 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.426 0 CA-C-O 121.519 0.676 . . . . 15.0 112.71 178.267 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 1.7 p -144.65 105.02 4.1 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 114.388 -1.278 . . . . 15.0 108.298 168.156 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 8.8 t -141.05 150.32 42.81 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 112.333 0.494 . . . . 15.0 112.333 -170.004 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 262' ' ' TRP . . . . . . . . . . . . . 6.7 m95 -68.54 -27.03 65.73 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.335 -0.848 . . . . 15.0 112.329 177.093 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 263' ' ' HIS . . . . . . . . . . . . . 5.2 p80 -85.68 132.73 34.1 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 120.137 -0.625 . . . . 15.0 111.026 -172.711 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 264' ' ' ASP . . . . . 1.015 ' HB3' HG12 ' A' ' 267' ' ' ILE . 20.5 t0 -64.84 126.4 90.94 Favored Pre-proline 0 C--N 1.319 -0.719 0 N-CA-C 108.546 -0.909 . . . . 15.0 108.546 171.597 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 265' ' ' PRO . . . . . 0.51 ' HD3' ' CD2' ' A' ' 252' ' ' PHE . 2.6 Cg_endo -80.26 -14.79 11.76 Favored 'Trans proline' 0 N--CA 1.456 -0.692 0 C-N-CA 122.642 2.228 . . . . 15.0 113.261 -177.653 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 266' ' ' ARG . . . . . 0.605 ' HD3' ' HD3' ' A' ' 237' ' ' PRO . 11.1 tpt180 -75.69 -12.79 60.26 Favored 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 108.439 -0.949 . . . . 15.0 108.439 173.581 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 267' ' ' ILE . . . . . 1.015 HG12 ' HB3' ' A' ' 264' ' ' ASP . 20.3 pt . . . . . 0 C--O 1.248 1.017 0 CA-C-N 114.324 -1.307 . . . . 15.0 110.761 178.507 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 210' ' ' SER . . . . . . . . . . . . . 19.8 m . . . . . 0 N--CA 1.475 0.786 0 CA-C-O 121.041 0.448 . . . . 15.0 110.038 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' B' B ' 211' ' ' ASP . . . . . 0.473 ' HA ' ' HD3' ' B' ' 212' ' ' PRO . 8.2 p-10 -119.51 127.01 26.67 Favored Pre-proline 0 C--N 1.324 -0.52 0 CA-C-O 121.289 0.566 . . . . 15.0 110.9 -176.244 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 212' ' ' PRO . . . . . 0.921 ' HB3' HD11 ' A' ' 253' ' ' LEU . 4.0 Cg_endo -89.72 156.4 5.14 Favored 'Trans proline' 0 N--CA 1.455 -0.743 0 C-N-CA 123.385 2.723 . . . . 15.0 112.302 179.856 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.442 -0.961 0 C-N-CA 120.608 -0.806 . . . . 15.0 112.392 -179.177 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 236' ' ' LEU . . . . . 0.525 HD12 ' HD2' ' A' ' 265' ' ' PRO . 1.4 mm? . . . . . 0 CA--C 1.517 -0.315 0 N-CA-C 109.162 -0.681 . . . . 15.0 109.162 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 237' ' ' PRO . . . . . 0.638 ' HD3' ' HD3' ' A' ' 266' ' ' ARG . 17.5 Cg_exo -69.37 158.06 58.86 Favored 'Trans proline' 0 N--CA 1.455 -0.771 0 C-N-CA 121.688 1.592 . . . . 15.0 108.957 160.67 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 5.2 mp0 -69.54 142.39 53.65 Favored 'General case' 0 C--N 1.303 -1.425 0 CA-C-O 121.46 0.647 . . . . 15.0 111.761 -171.217 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 100.5 7.81 50.7 Favored Glycine 0 CA--C 1.523 0.547 0 CA-C-N 114.931 -1.031 . . . . 15.0 114.017 -179.774 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 240' ' ' TYR . . . . . 0.756 ' CD1' ' HB2' ' A' ' 254' ' ' HIS . 80.9 m-85 -101.74 121.25 41.7 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 118.103 0.952 . . . . 15.0 110.721 174.845 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 241' ' ' GLU . . . . . 0.663 ' HG3' ' HB3' ' A' ' 253' ' ' LEU . 7.9 pt-20 -104.67 126.59 51.9 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 109.054 -0.721 . . . . 15.0 109.054 173.296 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -89.92 108.09 19.5 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 108.991 -0.744 . . . . 15.0 108.991 179.182 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 243' ' ' ARG . . . . . 0.559 ' HB2' ' CE1' ' A' ' 251' ' ' TYR . 9.7 mtt180 -99.44 133.43 43.76 Favored 'General case' 0 CA--C 1.502 -0.877 0 CA-C-O 122.704 1.24 . . . . 15.0 111.724 178.672 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 244' ' ' THR . . . . . . . . . . . . . 23.5 m -113.32 97.11 6.27 Favored 'General case' 0 C--N 1.301 -1.542 0 CA-C-N 112.631 -2.077 . . . . 15.0 109.067 -175.909 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 245' ' ' THR . . . . . 0.427 ' OG1' ' HG2' ' A' ' 247' ' ' GLN . 9.9 t -92.36 150.3 20.91 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 115.232 -0.894 . . . . 15.0 111.201 -172.325 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 3.5 m -54.94 -15.12 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 N-CA-C 112.882 0.697 . . . . 15.0 112.882 177.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 247' ' ' GLN . . . . . 0.427 ' HG2' ' OG1' ' A' ' 245' ' ' THR . 6.5 mm100 -58.58 -16.83 17.51 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.145 0.498 . . . . 15.0 110.63 173.414 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 88.13 37.78 7.6 Favored Glycine 0 N--CA 1.449 -0.492 0 CA-C-N 115.594 -0.73 . . . . 15.0 111.421 177.494 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 249' ' ' GLN . . . . . 0.475 ' HB2' ' CZ3' ' A' ' 262' ' ' TRP . 9.0 pt20 -149.96 137.58 19.97 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.899 0.38 . . . . 15.0 111.674 -173.684 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 19.1 m -90.2 134.01 30.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 N-CA-C 109.249 -0.649 . . . . 15.0 109.249 172.235 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 251' ' ' TYR . . . . . 0.559 ' CE1' ' HB2' ' A' ' 243' ' ' ARG . 3.7 p90 -137.25 137.37 38.97 Favored 'General case' 0 C--N 1.317 -0.813 0 C-N-CA 120.427 -0.509 . . . . 15.0 110.535 179.753 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 252' ' ' PHE . . . . . 0.663 ' CD2' ' HA ' ' A' ' 264' ' ' ASP . 37.3 m-85 -89.88 118.25 29.32 Favored 'General case' 0 CA--C 1.509 -0.616 0 CA-C-O 121.5 0.667 . . . . 15.0 110.835 -173.647 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 253' ' ' LEU . . . . . 0.788 HD11 ' CB ' ' B' ' 212' ' ' PRO . 0.4 OUTLIER -110.56 118.04 35.16 Favored 'General case' 0 N--CA 1.441 -0.876 0 CA-C-N 114.337 -1.302 . . . . 15.0 110.895 -173.853 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 254' ' ' HIS . . . . . 0.756 ' HB2' ' CD1' ' A' ' 240' ' ' TYR . 17.7 t-80 -132.57 95.48 3.62 Favored 'General case' 0 CA--C 1.495 -1.159 0 N-CA-C 108.546 -0.909 . . . . 15.0 108.546 170.441 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 3.7 t -94.65 87.91 5.23 Favored 'General case' 0 N--CA 1.429 -1.486 0 C-N-CA 116.062 -2.255 . . . . 15.0 110.268 178.196 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 25.1 tt0 -101.22 -51.87 3.4 Favored 'General case' 0 N--CA 1.442 -0.859 0 N-CA-C 105.902 -1.888 . . . . 15.0 105.902 149.177 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 257' ' ' THR . . . . . . . . . . . . . 69.4 p -99.21 -13.67 19.63 Favored 'General case' 0 CA--C 1.489 -1.395 0 CA-C-O 124.958 2.313 . . . . 15.0 111.909 179.575 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 84.84 74.88 1.24 Allowed Glycine 1 C--N 1.244 -4.569 1 CA-C-N 108.352 -4.022 . . . . 15.0 112.838 -172.146 . . . . . . . . 3 2 . 1 . 014 nuclear nobuild core ' A' A ' 259' ' ' VAL . . . . . 0.55 ' O ' ' HA ' ' A' ' 253' ' ' LEU . 33.1 t -89.89 123.85 42.29 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 CA-C-O 121.316 0.579 . . . . 15.0 112.451 173.307 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 1.8 p -134.15 101.76 5.14 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 114.632 -1.167 . . . . 15.0 107.855 164.366 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 14.1 t -136.55 150.25 48.52 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 121.212 0.529 . . . . 15.0 112.273 -169.561 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 262' ' ' TRP . . . . . 0.475 ' CZ3' ' HB2' ' A' ' 249' ' ' GLN . 10.3 m95 -70.39 -37.12 74.46 Favored 'General case' 0 CA--C 1.518 -0.27 0 CA-C-N 114.967 -1.015 . . . . 15.0 111.948 179.069 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 263' ' ' HIS . . . . . . . . . . . . . 5.9 p80 -85.37 139.99 31.12 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.109 -0.496 . . . . 15.0 110.278 -174.704 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 264' ' ' ASP . . . . . 0.878 ' HB3' HG12 ' A' ' 267' ' ' ILE . 9.8 t70 -55.45 126.54 63.18 Favored Pre-proline 0 C--N 1.322 -0.604 0 N-CA-C 108.212 -1.033 . . . . 15.0 108.212 171.118 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 265' ' ' PRO . . . . . 0.525 ' HD2' HD12 ' A' ' 236' ' ' LEU . 6.2 Cg_exo -71.37 -14.61 31.15 Favored 'Trans proline' 0 N--CA 1.458 -0.581 0 C-N-CA 121.935 1.757 . . . . 15.0 112.882 -174.172 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 266' ' ' ARG . . . . . 0.638 ' HD3' ' HD3' ' A' ' 237' ' ' PRO . 6.1 tpt180 -77.24 -7.81 56.55 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-O 121.817 0.817 . . . . 15.0 108.927 175.163 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 267' ' ' ILE . . . . . 0.878 HG12 ' HB3' ' A' ' 264' ' ' ASP . 43.5 mm . . . . . 0 C--O 1.25 1.085 0 CA-C-N 114.009 -1.451 . . . . 15.0 109.646 176.511 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 210' ' ' SER . . . . . . . . . . . . . 3.9 p . . . . . 0 N--CA 1.475 0.789 0 N-CA-C 110.275 -0.268 . . . . 15.0 110.275 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' B' B ' 211' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -89.98 131.57 38.81 Favored Pre-proline 0 C--N 1.329 -0.313 0 N-CA-C 109.802 -0.444 . . . . 15.0 109.802 178.564 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 212' ' ' PRO . . . . . 0.788 ' CB ' HD11 ' A' ' 253' ' ' LEU . 60.7 Cg_endo -89.84 160.19 5.07 Favored 'Trans proline' 0 N--CA 1.45 -1.03 0 C-N-CA 122.685 2.257 . . . . 15.0 112.105 178.938 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.442 -0.94 0 C-N-CA 120.508 -0.853 . . . . 15.0 112.251 -178.721 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 236' ' ' LEU . . . . . 0.527 HD12 ' OD1' ' A' ' 264' ' ' ASP . 0.0 OUTLIER . . . . . 0 CA--C 1.52 -0.202 0 N-CA-C 109.375 -0.602 . . . . 15.0 109.375 . . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 237' ' ' PRO . . . . . 0.672 ' HD3' ' HD3' ' A' ' 266' ' ' ARG . 16.5 Cg_exo -69.6 158.83 55.77 Favored 'Trans proline' 0 N--CA 1.458 -0.61 0 C-N-CA 122.144 1.896 . . . . 15.0 109.855 166.294 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 238' ' ' GLU . . . . . 0.461 ' H ' ' CD ' ' A' ' 238' ' ' GLU . 1.5 pm0 -69.86 149.42 47.88 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-O 121.546 0.689 . . . . 15.0 111.462 -174.044 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 100.17 -8.99 59.35 Favored Glycine 0 N--CA 1.444 -0.803 0 CA-C-N 115.096 -0.956 . . . . 15.0 113.09 -178.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 240' ' ' TYR . . . . . 0.669 ' CD1' ' HB2' ' A' ' 254' ' ' HIS . 87.6 m-85 -100.32 123.81 45.01 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 117.372 0.586 . . . . 15.0 110.353 177.366 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -109.33 126.6 53.56 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 108.938 -0.764 . . . . 15.0 108.938 169.848 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -89.95 108.71 19.88 Favored 'General case' 0 C--N 1.316 -0.853 0 N-CA-C 108.363 -0.977 . . . . 15.0 108.363 177.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 13.2 mtp85 -90.6 139.07 31.05 Favored 'General case' 0 CA--C 1.5 -0.961 0 CA-C-O 122.16 0.981 . . . . 15.0 112.962 -172.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 244' ' ' THR . . . . . . . . . . . . . 28.9 p -105.5 90.9 3.55 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-N 112.919 -1.946 . . . . 15.0 109.37 178.795 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 245' ' ' THR . . . . . 1.05 HG23 ' HG2' ' A' ' 247' ' ' GLN . 9.5 t -104.01 150.7 24.01 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.661 -0.7 . . . . 15.0 110.204 -176.182 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 39.6 t -43.74 -26.81 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 N-CA-C 113.725 1.009 . . . . 15.0 113.725 -172.665 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 247' ' ' GLN . . . . . 1.05 ' HG2' HG23 ' A' ' 245' ' ' THR . 3.5 pt20 -56.06 -23.09 31.49 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-O 120.695 0.283 . . . . 15.0 111.645 177.742 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 80.52 43.05 9.57 Favored Glycine 0 C--N 1.333 0.376 0 CA-C-N 116.264 -0.425 . . . . 15.0 113.15 176.068 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 249' ' ' GLN . . . . . 0.495 HE21 ' CD ' ' A' ' 247' ' ' GLN . 32.1 mt-30 -141.85 148.77 39.35 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.908 0.354 . . . . 15.0 110.082 -178.803 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 17.2 m -89.95 114.16 27.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-O 121.144 0.497 . . . . 15.0 110.638 178.814 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 2.4 p90 -126.43 131.91 51.6 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.565 -0.532 . . . . 15.0 109.565 -178.841 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 252' ' ' PHE . . . . . 0.553 ' CD2' ' HA ' ' A' ' 264' ' ' ASP . 50.7 m-85 -90.04 126.07 35.63 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.137 -0.483 . . . . 15.0 111.281 -175.052 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 253' ' ' LEU . . . . . 0.657 HD11 ' HB3' ' B' ' 212' ' ' PRO . 0.8 OUTLIER -118.55 121.27 39.82 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-N 115.655 -0.702 . . . . 15.0 110.776 -177.623 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 254' ' ' HIS . . . . . 0.669 ' HB2' ' CD1' ' A' ' 240' ' ' TYR . 14.6 t-80 -135.93 96.48 3.42 Favored 'General case' 0 CA--C 1.502 -0.895 0 N-CA-C 108.834 -0.802 . . . . 15.0 108.834 172.544 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 6.1 t -94.03 88.13 5.57 Favored 'General case' 0 C--N 1.311 -1.085 0 C-N-CA 116.525 -2.07 . . . . 15.0 110.797 -179.809 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 44.4 tt0 -101.23 -52.97 3.13 Favored 'General case' 0 N--CA 1.443 -0.824 0 CA-C-N 113.29 -1.777 . . . . 15.0 106.217 151.316 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 257' ' ' THR . . . . . . . . . . . . . 62.7 p -99.92 -13.45 19.14 Favored 'General case' 0 CA--C 1.488 -1.44 0 CA-C-O 124.837 2.256 . . . . 15.0 111.774 -179.279 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 87.74 72.98 1.28 Allowed Glycine 1 C--N 1.238 -4.907 1 CA-C-N 108.391 -4.004 . . . . 15.0 112.782 -169.91 . . . . . . . . 3 2 . 1 . 015 nuclear nobuild core ' A' A ' 259' ' ' VAL . . . . . 0.492 ' O ' ' HA ' ' A' ' 253' ' ' LEU . 45.1 t -90.1 127.87 42.39 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.3 0 CA-C-O 121.151 0.5 . . . . 15.0 111.576 174.309 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 260' ' ' SER . . . . . 0.489 ' HA ' ' O ' ' A' ' 252' ' ' PHE . 2.2 p -148.13 103.25 3.45 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 114.721 -1.127 . . . . 15.0 108.195 170.109 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 13.8 t -150.02 150.43 31.77 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 116.099 -0.501 . . . . 15.0 111.358 -168.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 262' ' ' TRP . . . . . . . . . . . . . 92.4 m95 -69.9 -36.78 75.67 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.932 -0.576 . . . . 15.0 111.53 179.423 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 263' ' ' HIS . . . . . . . . . . . . . 2.7 p80 -75.38 129.96 38.21 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.612 -0.435 . . . . 15.0 110.605 -174.916 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 264' ' ' ASP . . . . . 1.046 ' HB3' HG12 ' A' ' 267' ' ' ILE . 67.5 t0 -59.49 124.56 76.06 Favored Pre-proline 0 C--N 1.321 -0.649 0 N-CA-C 108.609 -0.885 . . . . 15.0 108.609 172.016 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 265' ' ' PRO . . . . . 0.528 ' HG2' ' CE1' ' A' ' 240' ' ' TYR . 13.0 Cg_exo -68.83 -14.61 39.26 Favored 'Trans proline' 0 N--CA 1.456 -0.716 0 C-N-CA 121.904 1.736 . . . . 15.0 111.889 178.074 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 266' ' ' ARG . . . . . 0.672 ' HD3' ' HD3' ' A' ' 237' ' ' PRO . 22.7 tpt180 -76.73 -10.18 59.19 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 115.252 -0.885 . . . . 15.0 109.473 173.538 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 267' ' ' ILE . . . . . 1.046 HG12 ' HB3' ' A' ' 264' ' ' ASP . 40.0 pt . . . . . 0 C--O 1.25 1.096 0 CA-C-N 114.813 -1.085 . . . . 15.0 111.297 177.389 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 210' ' ' SER . . . . . . . . . . . . . 16.5 m . . . . . 0 N--CA 1.479 0.987 0 CA-C-O 120.772 0.32 . . . . 15.0 110.963 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' B' B ' 211' ' ' ASP . . . . . 0.404 ' HA ' ' HD3' ' B' ' 212' ' ' PRO . 13.5 t70 -135.34 120.64 13.82 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.536 -0.302 . . . . 15.0 110.76 -174.922 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 212' ' ' PRO . . . . . 0.657 ' HB3' HD11 ' A' ' 253' ' ' LEU . 53.9 Cg_endo -93.34 143.77 2.07 Favored 'Trans proline' 0 N--CA 1.452 -0.927 0 C-N-CA 122.837 2.358 . . . . 15.0 112.696 176.59 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.698 0 C-N-CA 120.406 -0.902 . . . . 15.0 111.814 179.586 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 236' ' ' LEU . . . . . 0.513 HD22 ' N ' ' A' ' 236' ' ' LEU . 0.0 OUTLIER . . . . . 0 CA--C 1.517 -0.291 0 CA-C-O 121.148 0.499 . . . . 15.0 110.177 . . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 237' ' ' PRO . . . . . 0.522 ' HD3' ' HB2' ' A' ' 266' ' ' ARG . 9.0 Cg_exo -69.79 174.77 9.05 Favored 'Trans proline' 0 CA--C 1.509 -0.765 0 C-N-CA 122.845 2.363 . . . . 15.0 110.802 166.308 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -69.6 126.71 30.55 Favored 'General case' 0 C--N 1.297 -1.706 0 CA-C-N 114.132 -1.394 . . . . 15.0 111.544 -175.316 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 100.06 49.28 1.49 Allowed Glycine 0 C--N 1.333 0.37 0 CA-C-N 115.364 -0.834 . . . . 15.0 113.436 177.195 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 240' ' ' TYR . . . . . 0.646 ' CD1' ' HB2' ' A' ' 254' ' ' HIS . 74.1 m-85 -142.69 123.78 14.51 Favored 'General case' 0 CA--C 1.516 -0.345 0 CA-C-N 117.658 0.729 . . . . 15.0 111.518 176.442 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 241' ' ' GLU . . . . . 0.401 ' HB3' ' NH1' ' A' ' 243' ' ' ARG . 34.1 mm-40 -100.07 124.06 45.02 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.337 -0.847 . . . . 15.0 109.164 175.155 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 242' ' ' GLN . . . . . 0.69 ' HG3' ' CE1' ' A' ' 252' ' ' PHE . 31.7 tt0 -90.18 110.78 21.79 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.458 -0.571 . . . . 15.0 109.458 -179.82 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 243' ' ' ARG . . . . . 0.428 ' CD ' HD12 ' A' ' 253' ' ' LEU . 2.5 mpt_? -93.44 150.39 20.49 Favored 'General case' 0 CA--C 1.506 -0.739 0 CA-C-O 122.185 0.993 . . . . 15.0 113.641 -177.745 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 244' ' ' THR . . . . . . . . . . . . . 23.4 p -130.89 95.35 3.81 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 113.014 -1.903 . . . . 15.0 110.057 -176.848 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 245' ' ' THR . . . . . 0.511 ' OG1' ' HG2' ' A' ' 247' ' ' GLN . 5.5 t -93.96 150.41 20.38 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.872 -0.604 . . . . 15.0 110.044 179.672 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 3.8 p -53.37 -20.58 3.19 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 CA-C-O 121.163 0.506 . . . . 15.0 111.492 -179.244 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 247' ' ' GLN . . . . . 0.511 ' HG2' ' OG1' ' A' ' 245' ' ' THR . 31.6 mm-40 -55.12 -23.5 21.31 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.022 -0.99 . . . . 15.0 110.881 176.23 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 85.88 36.58 10.1 Favored Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 121.103 -0.57 . . . . 15.0 111.801 178.5 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 249' ' ' GLN . . . . . 0.437 ' HG2' ' HB2' ' A' ' 247' ' ' GLN . 7.3 pt20 -141.43 130.77 23.66 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.866 0.365 . . . . 15.0 110.844 -176.892 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 15.5 m -89.84 124.87 42.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 115.868 -0.605 . . . . 15.0 110.305 177.042 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 16.4 p90 -128.95 137.24 51.27 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.812 -0.631 . . . . 15.0 109.765 -177.976 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 252' ' ' PHE . . . . . 0.69 ' CE1' ' HG3' ' A' ' 242' ' ' GLN . 29.8 m-85 -89.75 120.17 30.77 Favored 'General case' 0 CA--C 1.511 -0.535 0 CA-C-O 121.239 0.542 . . . . 15.0 112.186 -169.986 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 253' ' ' LEU . . . . . 1.004 HD11 ' HB3' ' B' ' 212' ' ' PRO . 4.6 mt -104.65 110.29 22.54 Favored 'General case' 0 N--CA 1.446 -0.627 0 CA-C-N 114.683 -1.144 . . . . 15.0 111.823 -178.308 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 254' ' ' HIS . . . . . 0.646 ' HB2' ' CD1' ' A' ' 240' ' ' TYR . 12.1 t-80 -117.89 95.65 5.01 Favored 'General case' 0 C--N 1.312 -1.042 0 N-CA-C 107.808 -1.182 . . . . 15.0 107.808 166.405 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 2.9 t -93.98 87.76 5.47 Favored 'General case' 0 N--CA 1.429 -1.507 0 C-N-CA 115.968 -2.293 . . . . 15.0 110.038 -179.115 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 51.1 tt0 -101.34 -54.55 2.75 Favored 'General case' 0 N--CA 1.441 -0.894 0 CA-C-N 113.087 -1.869 . . . . 15.0 106.068 151.208 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 257' ' ' THR . . . . . . . . . . . . . 67.2 p -99.51 -13.74 19.36 Favored 'General case' 0 CA--C 1.49 -1.365 0 CA-C-N 111.881 -2.418 . . . . 15.0 112.013 -177.183 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 87.83 71.57 1.28 Allowed Glycine 1 C--N 1.241 -4.7 1 CA-C-N 108.236 -4.074 . . . . 15.0 112.904 -171.513 . . . . . . . . 3 2 . 1 . 016 nuclear nobuild core ' A' A ' 259' ' ' VAL . . . . . 0.693 ' O ' ' HA ' ' A' ' 253' ' ' LEU . 40.6 t -89.67 124.58 42.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 121.294 0.569 . . . . 15.0 112.226 176.767 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -137.15 97.04 3.4 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 114.451 -1.25 . . . . 15.0 107.816 166.174 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 14.6 t -132.23 150.35 52.17 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.943 -0.571 . . . . 15.0 111.48 -168.45 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 262' ' ' TRP . . . . . 0.426 ' CZ3' ' HB2' ' A' ' 249' ' ' GLN . 10.7 m95 -65.57 -53.75 37.6 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.476 -0.784 . . . . 15.0 111.519 178.615 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 263' ' ' HIS . . . . . . . . . . . . . 4.4 p80 -65.3 133.43 51.41 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.242 -0.435 . . . . 15.0 110.465 -175.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 264' ' ' ASP . . . . . 0.978 ' HB3' HG12 ' A' ' 267' ' ' ILE . 24.0 t0 -53.83 128.9 55.55 Favored Pre-proline 0 C--N 1.321 -0.631 0 N-CA-C 107.833 -1.173 . . . . 15.0 107.833 169.253 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 265' ' ' PRO . . . . . 0.625 ' HD3' ' CD2' ' A' ' 252' ' ' PHE . 13.1 Cg_exo -68.98 -14.57 38.78 Favored 'Trans proline' 0 N--CA 1.458 -0.605 0 C-N-CA 122.01 1.807 . . . . 15.0 112.582 -177.483 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 266' ' ' ARG . . . . . 0.522 ' HB2' ' HD3' ' A' ' 237' ' ' PRO . 19.9 tpt180 -72.53 -14.93 61.76 Favored 'General case' 0 N--CA 1.446 -0.667 0 N-CA-C 108.611 -0.885 . . . . 15.0 108.611 170.953 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 267' ' ' ILE . . . . . 0.978 HG12 ' HB3' ' A' ' 264' ' ' ASP . 26.9 pt . . . . . 0 C--O 1.252 1.199 0 CA-C-N 114.482 -1.236 . . . . 15.0 110.438 177.748 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 210' ' ' SER . . . . . . . . . . . . . 24.4 p . . . . . 0 N--CA 1.479 1.012 0 N-CA-C 111.595 0.22 . . . . 15.0 111.595 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' B' B ' 211' ' ' ASP . . . . . 0.477 ' HA ' ' HD3' ' B' ' 212' ' ' PRO . 23.6 t70 -93.45 120.28 66.59 Favored Pre-proline 0 C--N 1.328 -0.342 0 N-CA-C 110.323 -0.251 . . . . 15.0 110.323 -179.113 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 212' ' ' PRO . . . . . 1.004 ' HB3' HD11 ' A' ' 253' ' ' LEU . 3.6 Cg_endo -89.83 147.25 4.81 Favored 'Trans proline' 0 N--CA 1.453 -0.909 0 C-N-CA 123.078 2.519 . . . . 15.0 112.595 179.714 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.438 -1.172 0 C-N-CA 120.603 -0.808 . . . . 15.0 112.049 -179.581 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 236' ' ' LEU . . . . . 0.483 HD22 ' N ' ' A' ' 236' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.455 -0.194 0 N-CA-C 108.767 -0.827 . . . . 15.0 108.767 . . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 237' ' ' PRO . . . . . 0.829 ' HD3' ' HD3' ' A' ' 266' ' ' ARG . 16.8 Cg_exo -69.57 160.64 48.98 Favored 'Trans proline' 0 N--CA 1.459 -0.519 0 C-N-CA 122.077 1.851 . . . . 15.0 110.286 166.562 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -69.59 142.6 53.51 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-N 115.536 -0.756 . . . . 15.0 111.006 -174.353 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 100.37 8.77 49.16 Favored Glycine 0 CA--C 1.522 0.494 0 CA-C-N 115.807 -0.633 . . . . 15.0 113.815 179.677 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 240' ' ' TYR . . . . . 0.707 ' CD1' ' HB2' ' A' ' 254' ' ' HIS . 77.8 m-85 -109.97 110.43 21.36 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 117.465 0.632 . . . . 15.0 110.458 175.882 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 241' ' ' GLU . . . . . 0.655 ' HG3' ' HB3' ' A' ' 253' ' ' LEU . 8.0 pt-20 -90.13 115.92 27.75 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.697 0.76 . . . . 15.0 109.202 174.105 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 11.7 tm0? -90.0 109.72 20.74 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 108.805 -0.813 . . . . 15.0 108.805 -179.564 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 69.6 mtt-85 -99.14 150.18 22.3 Favored 'General case' 0 CA--C 1.504 -0.803 0 CA-C-O 122.283 1.039 . . . . 15.0 113.355 -170.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 244' ' ' THR . . . . . . . . . . . . . 3.3 p -115.67 105.4 12.71 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 112.87 -1.968 . . . . 15.0 109.725 179.184 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 245' ' ' THR . . . . . 0.94 HG23 ' HG2' ' A' ' 247' ' ' GLN . 6.1 t -116.22 150.35 37.67 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 116.036 -0.529 . . . . 15.0 110.882 -174.874 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 13.0 m -49.22 -25.22 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.313 0 N-CA-C 113.97 1.1 . . . . 15.0 113.97 -176.474 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 247' ' ' GLN . . . . . 0.94 ' HG2' HG23 ' A' ' 245' ' ' THR . 2.6 pt20 -57.75 -21.65 42.49 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-O 120.678 0.275 . . . . 15.0 111.012 178.161 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 93.62 15.41 50.06 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.925 -0.655 . . . . 15.0 113.259 174.936 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 249' ' ' GLN . . . . . 0.681 ' HB2' ' OE1' ' A' ' 247' ' ' GLN . 1.8 mp0 -123.97 147.34 47.84 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.944 0.402 . . . . 15.0 111.598 -178.689 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 31.3 m -90.13 135.71 25.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.765 -0.652 . . . . 15.0 109.89 173.235 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 28.2 p90 -141.95 135.15 29.09 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 109.587 -0.523 . . . . 15.0 109.587 -177.038 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 252' ' ' PHE . . . . . 0.694 ' CD2' ' HA ' ' A' ' 264' ' ' ASP . 29.5 m-85 -90.13 123.39 33.93 Favored 'General case' 0 CA--C 1.51 -0.565 0 CA-C-N 115.982 -0.554 . . . . 15.0 111.593 -173.248 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 253' ' ' LEU . . . . . 0.812 HD11 ' HB3' ' B' ' 212' ' ' PRO . 0.5 OUTLIER -116.69 114.26 23.79 Favored 'General case' 0 N--CA 1.445 -0.715 0 CA-C-N 115.123 -0.944 . . . . 15.0 110.964 -176.343 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 254' ' ' HIS . . . . . 0.707 ' HB2' ' CD1' ' A' ' 240' ' ' TYR . 20.9 t-80 -124.29 95.09 4.41 Favored 'General case' 0 CA--C 1.5 -0.972 0 N-CA-C 108.48 -0.933 . . . . 15.0 108.48 169.747 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 3.0 t -94.54 88.18 5.37 Favored 'General case' 0 N--CA 1.433 -1.304 0 C-N-CA 116.33 -2.148 . . . . 15.0 110.754 179.287 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 256' ' ' GLN . . . . . 0.503 ' HB3' ' CE1' ' A' ' 254' ' ' HIS . 5.8 tt0 -101.29 -52.94 3.13 Favored 'General case' 0 N--CA 1.441 -0.906 0 N-CA-C 106.026 -1.842 . . . . 15.0 106.026 149.861 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 257' ' ' THR . . . . . . . . . . . . . 72.7 p -97.79 -13.7 21.21 Favored 'General case' 0 CA--C 1.488 -1.406 0 CA-C-O 124.634 2.159 . . . . 15.0 111.923 -179.501 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 88.7 71.04 1.27 Allowed Glycine 1 C--N 1.243 -4.598 0 CA-C-N 108.404 -3.998 . . . . 15.0 113.167 -172.933 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 259' ' ' VAL . . . . . 0.622 ' O ' ' HA ' ' A' ' 253' ' ' LEU . 57.8 t -89.83 126.06 42.74 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.289 0 CA-C-O 121.428 0.632 . . . . 15.0 112.387 175.757 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 260' ' ' SER . . . . . 0.412 ' HA ' ' O ' ' A' ' 252' ' ' PHE . 1.4 p -141.66 100.24 3.72 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 114.444 -1.253 . . . . 15.0 107.685 165.934 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 13.4 t -136.39 150.32 48.74 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.853 -0.612 . . . . 15.0 111.788 -167.376 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 262' ' ' TRP . . . . . 0.443 ' HA ' ' CE3' ' A' ' 262' ' ' TRP . 8.9 m95 -70.7 -32.38 69.58 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.349 -0.841 . . . . 15.0 112.374 179.449 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 263' ' ' HIS . . . . . . . . . . . . . 5.0 p80 -84.63 134.67 34.37 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 120.385 -0.526 . . . . 15.0 110.388 -176.289 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 264' ' ' ASP . . . . . 1.022 ' HB3' HG12 ' A' ' 267' ' ' ILE . 43.5 t0 -56.62 124.06 60.72 Favored Pre-proline 0 C--O 1.218 -0.603 0 N-CA-C 108.56 -0.904 . . . . 15.0 108.56 169.843 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 265' ' ' PRO . . . . . 0.53 ' HD3' ' CD2' ' A' ' 252' ' ' PHE . 10.6 Cg_exo -68.93 -14.83 39.44 Favored 'Trans proline' 0 N--CA 1.46 -0.494 0 C-N-CA 122.367 2.045 . . . . 15.0 112.629 -177.55 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 266' ' ' ARG . . . . . 0.829 ' HD3' ' HD3' ' A' ' 237' ' ' PRO . 20.2 tpt180 -75.89 -11.58 60.0 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 115.483 -0.78 . . . . 15.0 109.047 173.623 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 267' ' ' ILE . . . . . 1.022 HG12 ' HB3' ' A' ' 264' ' ' ASP . 36.9 pt . . . . . 0 C--O 1.247 0.945 0 CA-C-N 114.641 -1.163 . . . . 15.0 111.253 178.899 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 210' ' ' SER . . . . . . . . . . . . . 20.4 m . . . . . 0 N--CA 1.481 1.077 0 CA-C-O 120.638 0.256 . . . . 15.0 111.229 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' B' B ' 211' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -116.95 144.32 33.27 Favored Pre-proline 0 C--O 1.235 0.319 0 N-CA-C 109.37 -0.604 . . . . 15.0 109.37 176.053 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 212' ' ' PRO . . . . . 0.812 ' HB3' HD11 ' A' ' 253' ' ' LEU . 8.4 Cg_endo -89.87 143.33 4.16 Favored 'Trans proline' 0 N--CA 1.454 -0.823 0 C-N-CA 122.819 2.346 . . . . 15.0 112.888 -176.715 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.441 -0.976 0 CA-C-N 115.538 -0.755 . . . . 15.0 111.622 176.998 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 236' ' ' LEU . . . . . 0.427 HD11 ' OD1' ' A' ' 264' ' ' ASP . 2.1 mm? . . . . . 0 CA--C 1.517 -0.319 0 CA-C-O 120.85 0.357 . . . . 15.0 110.727 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 237' ' ' PRO . . . . . 0.563 ' HD3' ' HD3' ' A' ' 266' ' ' ARG . 15.0 Cg_exo -69.53 164.28 34.9 Favored 'Trans proline' 0 N--CA 1.456 -0.699 0 C-N-CA 121.92 1.747 . . . . 15.0 109.314 160.835 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 12.2 mm-40 -69.6 142.69 53.47 Favored 'General case' 0 C--N 1.301 -1.522 0 CA-C-N 115.166 -0.925 . . . . 15.0 113.333 -170.098 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 100.11 -1.62 56.37 Favored Glycine 0 CA--C 1.526 0.755 0 CA-C-N 114.124 -1.398 . . . . 15.0 115.166 174.103 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 240' ' ' TYR . . . . . 0.7 ' CD1' ' HB2' ' A' ' 254' ' ' HIS . 78.1 m-85 -87.9 123.46 32.67 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 118.574 1.187 . . . . 15.0 111.486 -179.449 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -96.08 114.81 26.55 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.397 -0.819 . . . . 15.0 109.214 173.332 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -90.13 99.68 12.65 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 108.823 -0.806 . . . . 15.0 108.823 176.233 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 243' ' ' ARG . . . . . 0.701 ' CZ ' ' HD2' ' B' ' 212' ' ' PRO . 34.7 mtt180 -91.28 149.86 21.57 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.531 -0.758 . . . . 15.0 111.823 179.404 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 244' ' ' THR . . . . . . . . . . . . . 6.1 m -127.2 92.05 3.44 Favored 'General case' 0 C--N 1.307 -1.267 0 CA-C-N 113.682 -1.599 . . . . 15.0 109.219 -179.407 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 245' ' ' THR . . . . . 0.438 ' OG1' ' HG2' ' A' ' 247' ' ' GLN . 5.0 t -90.0 150.59 22.05 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.204 -0.907 . . . . 15.0 110.926 -174.666 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 11.6 m -49.0 -20.23 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 CA-C-N 115.429 -0.805 . . . . 15.0 112.617 177.053 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 247' ' ' GLN . . . . . 0.565 ' HB2' ' HG3' ' A' ' 249' ' ' GLN . 6.6 mm100 -58.77 -19.51 41.4 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 116.055 -0.521 . . . . 15.0 111.128 175.307 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 85.98 26.01 35.84 Favored Glycine 0 C--N 1.332 0.357 0 C-N-CA 121.305 -0.474 . . . . 15.0 112.632 177.454 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 249' ' ' GLN . . . . . 0.565 ' HG3' ' HB2' ' A' ' 247' ' ' GLN . 0.3 OUTLIER -126.43 133.96 51.11 Favored 'General case' 0 C--N 1.326 -0.415 0 O-C-N 122.624 -0.339 . . . . 15.0 110.967 -174.493 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 3.6 m -90.01 107.23 18.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 115.768 -0.651 . . . . 15.0 109.537 173.056 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 6.4 p90 -119.48 130.65 55.33 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.922 -0.581 . . . . 15.0 109.981 -173.399 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 252' ' ' PHE . . . . . 0.738 ' CD2' ' HA ' ' A' ' 264' ' ' ASP . 32.2 m-85 -90.03 123.09 33.62 Favored 'General case' 0 CA--C 1.506 -0.75 0 CA-C-N 116.21 -0.45 . . . . 15.0 110.832 -175.365 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 253' ' ' LEU . . . . . 0.838 HD13 ' HB2' ' B' ' 212' ' ' PRO . 1.6 tt -128.82 115.79 18.46 Favored 'General case' 0 N--CA 1.438 -1.048 0 CA-C-N 115.631 -0.713 . . . . 15.0 111.541 -175.554 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 254' ' ' HIS . . . . . 0.7 ' HB2' ' CD1' ' A' ' 240' ' ' TYR . 29.1 t-80 -124.18 92.57 3.69 Favored 'General case' 0 CA--C 1.505 -0.758 0 N-CA-C 108.723 -0.843 . . . . 15.0 108.723 174.861 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 255' ' ' THR . . . . . 0.405 ' HA ' ' HA2' ' A' ' 258' ' ' GLY . 53.0 m -94.7 88.18 5.3 Favored 'General case' 0 N--CA 1.436 -1.159 0 C-N-CA 116.66 -2.016 . . . . 15.0 110.429 179.782 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 7.1 tt0 -100.83 -50.47 3.83 Favored 'General case' 0 N--CA 1.441 -0.917 0 N-CA-C 105.848 -1.908 . . . . 15.0 105.848 151.236 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 257' ' ' THR . . . . . . . . . . . . . 60.3 p -98.46 -13.44 20.54 Favored 'General case' 0 CA--C 1.49 -1.349 0 CA-C-O 124.963 2.316 . . . . 15.0 111.795 177.598 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 258' ' ' GLY . . . . . 0.405 ' HA2' ' HA ' ' A' ' 255' ' ' THR . . . 88.52 70.8 1.27 Allowed Glycine 1 C--N 1.242 -4.665 1 CA-C-N 108.214 -4.085 . . . . 15.0 113.471 -173.405 . . . . . . . . 4 3 . 1 . 018 nuclear nobuild core ' A' A ' 259' ' ' VAL . . . . . 0.527 ' O ' ' HA ' ' A' ' 253' ' ' LEU . 76.5 t -89.8 130.42 39.13 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.58 0 CA-C-O 121.271 0.558 . . . . 15.0 111.207 173.711 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 10.1 p -150.09 96.97 2.51 Favored 'General case' 0 C--N 1.307 -1.247 0 CA-C-N 114.598 -1.183 . . . . 15.0 108.817 170.755 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 12.4 t -143.87 150.32 38.27 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.877 -0.601 . . . . 15.0 111.299 -168.377 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 262' ' ' TRP . . . . . . . . . . . . . 92.9 m95 -69.07 -42.15 76.62 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.849 -0.614 . . . . 15.0 111.729 179.845 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 263' ' ' HIS . . . . . . . . . . . . . 2.6 p80 -65.22 132.32 48.8 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-O 120.896 0.379 . . . . 15.0 110.213 -176.345 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 264' ' ' ASP . . . . . 0.899 ' HB3' HG12 ' A' ' 267' ' ' ILE . 28.4 t70 -56.11 124.94 62.26 Favored Pre-proline 0 C--N 1.321 -0.665 0 N-CA-C 108.847 -0.797 . . . . 15.0 108.847 172.428 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 265' ' ' PRO . . . . . 0.672 ' HD3' ' CD2' ' A' ' 252' ' ' PHE . 4.3 Cg_exo -73.44 -14.64 25.12 Favored 'Trans proline' 0 CA--C 1.51 -0.701 0 C-N-CA 122.08 1.853 . . . . 15.0 112.224 -175.978 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 266' ' ' ARG . . . . . 0.568 ' HB3' ' OD2' ' A' ' 264' ' ' ASP . 28.1 tpt180 -72.63 -13.46 61.38 Favored 'General case' 0 C--N 1.316 -0.861 0 N-CA-C 108.542 -0.91 . . . . 15.0 108.542 171.244 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 267' ' ' ILE . . . . . 0.899 HG12 ' HB3' ' A' ' 264' ' ' ASP . 22.5 pt . . . . . 0 C--O 1.251 1.169 0 CA-C-N 114.618 -1.174 . . . . 15.0 110.645 174.667 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 210' ' ' SER . . . . . . . . . . . . . 9.6 p . . . . . 0 N--CA 1.478 0.955 0 N-CA-C 110.366 -0.235 . . . . 15.0 110.366 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' B' B ' 211' ' ' ASP . . . . . 0.485 ' HA ' ' HD3' ' B' ' 212' ' ' PRO . 20.5 t70 -150.04 128.64 6.04 Favored Pre-proline 0 C--N 1.324 -0.52 0 N-CA-C 109.673 -0.492 . . . . 15.0 109.673 177.173 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 212' ' ' PRO . . . . . 0.838 ' HB2' HD13 ' A' ' 253' ' ' LEU . 2.0 Cg_endo -89.33 141.67 4.14 Favored 'Trans proline' 0 N--CA 1.457 -0.623 0 C-N-CA 123.281 2.654 . . . . 15.0 113.734 -177.814 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.449 0 CA-C-N 114.796 -1.093 . . . . 15.0 113.278 -176.466 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 236' ' ' LEU . . . . . 0.418 HD11 ' CE1' ' A' ' 252' ' ' PHE . 19.7 mt . . . . . 0 N--CA 1.452 -0.347 0 N-CA-C 108.97 -0.752 . . . . 15.0 108.97 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 237' ' ' PRO . . . . . 0.855 ' HD3' ' HD3' ' A' ' 266' ' ' ARG . 13.1 Cg_exo -69.7 163.11 39.47 Favored 'Trans proline' 0 N--CA 1.459 -0.536 0 C-N-CA 121.47 1.446 . . . . 15.0 110.247 167.289 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -69.77 140.16 53.36 Favored 'General case' 0 C--N 1.307 -1.248 0 CA-C-N 115.321 -0.854 . . . . 15.0 111.104 -174.125 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 100.29 9.34 48.02 Favored Glycine 0 N--CA 1.451 -0.36 0 CA-C-N 115.642 -0.708 . . . . 15.0 114.211 178.241 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 240' ' ' TYR . . . . . 0.769 ' CD1' ' HB2' ' A' ' 254' ' ' HIS . 85.1 m-85 -104.08 123.43 47.23 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 117.897 0.848 . . . . 15.0 110.637 174.929 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 241' ' ' GLU . . . . . 0.689 ' HG3' ' HB3' ' A' ' 253' ' ' LEU . 7.7 pt-20 -109.41 123.78 49.91 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.682 -0.69 . . . . 15.0 109.627 174.408 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 21.5 tm0? -90.01 116.07 27.77 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 108.684 -0.858 . . . . 15.0 108.684 179.021 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 63.6 mtt-85 -107.3 149.27 27.99 Favored 'General case' 0 CA--C 1.501 -0.932 0 CA-C-O 122.157 0.979 . . . . 15.0 112.579 -177.563 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 244' ' ' THR . . . . . . . . . . . . . 7.5 m -124.18 91.72 3.52 Favored 'General case' 0 C--N 1.307 -1.257 0 CA-C-N 113.288 -1.778 . . . . 15.0 110.029 179.166 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 245' ' ' THR . . . . . 1.083 HG23 ' HG2' ' A' ' 247' ' ' GLN . 8.5 t -91.28 150.67 21.22 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.572 -0.74 . . . . 15.0 109.849 177.516 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 14.9 m -41.03 -24.32 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 N-CA-C 114.968 1.47 . . . . 15.0 114.968 -175.354 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 247' ' ' GLN . . . . . 1.083 ' HG2' HG23 ' A' ' 245' ' ' THR . 3.6 pt20 -55.79 -22.48 24.64 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-O 120.752 0.31 . . . . 15.0 111.013 176.564 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 81.03 34.73 26.12 Favored Glycine 0 C--N 1.333 0.399 0 C-N-CA 121.48 -0.391 . . . . 15.0 113.182 174.196 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 249' ' ' GLN . . . . . 0.425 ' HB3' ' CZ3' ' A' ' 262' ' ' TRP . 32.5 mt-30 -136.37 146.93 47.05 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.759 -0.46 . . . . 15.0 109.759 -178.627 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 23.7 m -89.76 125.47 42.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-O 120.792 0.329 . . . . 15.0 110.989 -178.186 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 12.8 p90 -131.79 133.16 44.43 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 109.622 -0.511 . . . . 15.0 109.622 179.679 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 252' ' ' PHE . . . . . 0.683 ' CD2' ' HA ' ' A' ' 264' ' ' ASP . 36.3 m-85 -90.05 118.68 29.78 Favored 'General case' 0 CA--C 1.512 -0.508 0 CA-C-O 121.206 0.526 . . . . 15.0 110.994 -176.786 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 253' ' ' LEU . . . . . 0.689 ' HB3' ' HG3' ' A' ' 241' ' ' GLU . 0.6 OUTLIER -106.79 122.87 47.24 Favored 'General case' 0 N--CA 1.444 -0.737 0 CA-C-N 115.082 -0.963 . . . . 15.0 110.461 -178.05 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 254' ' ' HIS . . . . . 0.769 ' HB2' ' CD1' ' A' ' 240' ' ' TYR . 29.9 t-80 -135.0 90.27 2.62 Favored 'General case' 0 C--N 1.313 -1.018 0 N-CA-C 108.081 -1.081 . . . . 15.0 108.081 172.024 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 255' ' ' THR . . . . . 0.419 ' HA ' ' HA2' ' A' ' 258' ' ' GLY . 2.8 t -91.41 87.82 6.58 Favored 'General case' 0 N--CA 1.433 -1.277 0 C-N-CA 116.411 -2.116 . . . . 15.0 110.185 -179.215 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 52.0 tt0 -101.53 -54.97 2.63 Favored 'General case' 0 N--CA 1.436 -1.135 0 CA-C-N 112.818 -1.992 . . . . 15.0 105.842 151.254 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 257' ' ' THR . . . . . . . . . . . . . 63.4 p -95.89 -13.53 23.87 Favored 'General case' 0 CA--C 1.486 -1.499 0 CA-C-N 112.214 -2.266 . . . . 15.0 111.449 179.015 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 258' ' ' GLY . . . . . 0.419 ' HA2' ' HA ' ' A' ' 255' ' ' THR . . . 86.66 70.52 1.31 Allowed Glycine 1 C--N 1.246 -4.453 1 CA-C-N 108.187 -4.097 . . . . 15.0 113.093 -172.629 . . . . . . . . 4 3 . 1 . 019 nuclear nobuild core ' A' A ' 259' ' ' VAL . . . . . 0.571 ' O ' ' HA ' ' A' ' 253' ' ' LEU . 60.6 t -89.88 129.17 41.23 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.243 0 CA-C-O 121.203 0.525 . . . . 15.0 112.227 176.674 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 1.1 p -143.49 98.83 3.32 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 114.783 -1.098 . . . . 15.0 108.228 169.475 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 9.0 t -139.52 150.31 44.95 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 116.159 -0.473 . . . . 15.0 111.819 -170.305 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 262' ' ' TRP . . . . . 0.425 ' CZ3' ' HB3' ' A' ' 249' ' ' GLN . 91.6 m95 -68.3 -30.64 69.68 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.38 -0.827 . . . . 15.0 111.707 178.587 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 263' ' ' HIS . . . . . . . . . . . . . 4.2 p80 -83.5 136.72 34.17 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 120.725 -0.39 . . . . 15.0 110.757 -172.336 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 264' ' ' ASP . . . . . 0.776 ' HB3' HG12 ' A' ' 267' ' ' ILE . 10.0 t70 -56.32 134.23 75.95 Favored Pre-proline 0 C--N 1.325 -0.469 0 CA-C-N 115.652 -0.704 . . . . 15.0 109.268 174.754 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 265' ' ' PRO . . . . . 0.603 ' HD3' ' CD2' ' A' ' 252' ' ' PHE . 88.8 Cg_endo -84.28 -14.5 6.98 Favored 'Trans proline' 0 N--CA 1.458 -0.617 0 C-N-CA 122.568 2.179 . . . . 15.0 113.995 -174.486 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 266' ' ' ARG . . . . . 0.855 ' HD3' ' HD3' ' A' ' 237' ' ' PRO . 21.8 tpt180 -80.98 -5.21 57.26 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-O 122.418 1.104 . . . . 15.0 108.505 176.265 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 267' ' ' ILE . . . . . 0.776 HG12 ' HB3' ' A' ' 264' ' ' ASP . 48.3 mm . . . . . 0 C--O 1.251 1.174 0 CA-C-N 113.153 -1.84 . . . . 15.0 109.824 176.684 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 210' ' ' SER . . . . . . . . . . . . . 5.4 p . . . . . 0 N--CA 1.474 0.765 0 CA-C-O 121.042 0.448 . . . . 15.0 110.741 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' B' B ' 211' ' ' ASP . . . . . 0.465 ' HA ' ' HD3' ' B' ' 212' ' ' PRO . 2.0 p30 -144.62 118.94 5.77 Favored Pre-proline 0 C--N 1.325 -0.496 0 CA-C-N 115.83 -0.623 . . . . 15.0 110.319 178.766 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 212' ' ' PRO . . . . . 0.689 ' HB3' HD11 ' A' ' 253' ' ' LEU . 12.6 Cg_endo -92.22 151.09 3.11 Favored 'Trans proline' 0 N--CA 1.452 -0.942 0 C-N-CA 123.587 2.858 . . . . 15.0 112.722 -179.927 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.444 -0.771 0 C-N-CA 120.725 -0.75 . . . . 15.0 112.466 179.457 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 2.4 mt . . . . . 0 C--O 1.233 0.187 0 N-CA-C 108.918 -0.771 . . . . 15.0 108.918 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 237' ' ' PRO . . . . . 0.465 ' O ' ' HD2' ' A' ' 240' ' ' TYR . 14.8 Cg_exo -69.81 162.69 41.11 Favored 'Trans proline' 0 N--CA 1.46 -0.46 0 C-N-CA 121.657 1.571 . . . . 15.0 110.093 164.626 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 238' ' ' GLU . . . . . 0.483 ' CD ' ' H ' ' A' ' 238' ' ' GLU . 0.9 OUTLIER -69.71 148.41 49.28 Favored 'General case' 0 C--N 1.306 -1.29 0 CA-C-N 115.432 -0.804 . . . . 15.0 111.243 -175.266 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 100.28 -7.38 58.35 Favored Glycine 0 N--CA 1.45 -0.411 0 CA-C-N 115.418 -0.81 . . . . 15.0 113.275 -179.521 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 240' ' ' TYR . . . . . 0.685 ' CD1' ' HB2' ' A' ' 254' ' ' HIS . 87.8 m-85 -99.46 113.25 25.5 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 117.461 0.631 . . . . 15.0 110.47 177.351 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 241' ' ' GLU . . . . . 0.465 ' HG3' ' HB3' ' A' ' 253' ' ' LEU . 9.5 pt-20 -90.26 120.29 31.29 Favored 'General case' 0 N--CA 1.439 -0.975 0 N-CA-C 108.725 -0.843 . . . . 15.0 108.725 174.518 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? -89.86 99.1 12.18 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 108.123 -1.066 . . . . 15.0 108.123 -179.862 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 9.4 mtp180 -92.48 150.14 20.96 Favored 'General case' 0 N--CA 1.444 -0.738 0 CA-C-N 115.029 -0.987 . . . . 15.0 111.81 -175.152 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 244' ' ' THR . . . . . . . . . . . . . 4.4 p -117.54 149.92 39.82 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-N 113.733 -1.576 . . . . 15.0 110.077 -176.5 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 245' ' ' THR . . . . . 0.436 ' OG1' ' HG2' ' A' ' 247' ' ' GLN . 5.3 t -150.12 150.23 31.38 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 116.106 -0.497 . . . . 15.0 110.434 -176.003 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 19.8 t -54.82 -17.24 2.1 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 O-C-N 123.669 0.605 . . . . 15.0 111.354 179.078 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 247' ' ' GLN . . . . . 0.555 ' HB2' ' HG2' ' A' ' 249' ' ' GLN . 5.1 mm-40 -63.4 -19.25 64.52 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-O 121.006 0.431 . . . . 15.0 110.498 176.808 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 86.31 13.69 67.8 Favored Glycine 0 N--CA 1.452 -0.244 0 CA-C-N 116.013 -0.539 . . . . 15.0 112.289 176.709 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 249' ' ' GLN . . . . . 0.555 ' HG2' ' HB2' ' A' ' 247' ' ' GLN . 10.4 pt20 -114.02 135.12 54.35 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 120.927 0.394 . . . . 15.0 111.502 -174.701 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 6.0 m -90.0 120.26 38.5 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 N-CA-C 108.783 -0.821 . . . . 15.0 108.783 171.469 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 4.3 p90 -125.75 133.04 52.2 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.863 -0.608 . . . . 15.0 109.855 -174.915 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 252' ' ' PHE . . . . . 0.613 ' CD2' ' HA ' ' A' ' 264' ' ' ASP . 24.5 m-85 -89.76 121.33 31.81 Favored 'General case' 0 CA--C 1.506 -0.728 0 CA-C-O 121.293 0.568 . . . . 15.0 111.619 -170.727 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 253' ' ' LEU . . . . . 0.57 HD11 ' CB ' ' B' ' 212' ' ' PRO . 0.6 OUTLIER -119.67 121.12 38.53 Favored 'General case' 0 N--CA 1.44 -0.944 0 CA-C-N 114.837 -1.074 . . . . 15.0 110.617 -176.017 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 254' ' ' HIS . . . . . 0.685 ' HB2' ' CD1' ' A' ' 240' ' ' TYR . 9.2 t-80 -132.33 96.59 3.9 Favored 'General case' 0 C--N 1.312 -1.065 0 N-CA-C 108.447 -0.945 . . . . 15.0 108.447 170.57 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 5.0 t -92.72 87.92 6.06 Favored 'General case' 0 N--CA 1.432 -1.369 0 C-N-CA 116.554 -2.058 . . . . 15.0 110.183 -179.509 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 256' ' ' GLN . . . . . 0.445 ' HB3' ' CE1' ' A' ' 254' ' ' HIS . 24.9 tt0 -101.36 -57.23 2.12 Favored 'General case' 0 N--CA 1.439 -0.98 0 CA-C-N 112.606 -2.088 . . . . 15.0 106.274 152.875 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 257' ' ' THR . . . . . . . . . . . . . 4.2 t -100.2 -13.56 18.86 Favored 'General case' 0 CA--C 1.488 -1.433 0 CA-C-N 111.326 -2.67 . . . . 15.0 112.085 -177.972 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 87.35 71.69 1.29 Allowed Glycine 1 C--N 1.238 -4.882 1 CA-C-N 108.136 -4.12 . . . . 15.0 112.635 -169.123 . . . . . . . . 3 2 . 1 . 020 nuclear nobuild core ' A' A ' 259' ' ' VAL . . . . . 0.567 ' O ' ' HA ' ' A' ' 253' ' ' LEU . 65.7 t -89.37 123.72 41.73 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 CA-C-O 121.667 0.746 . . . . 15.0 112.163 170.607 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 260' ' ' SER . . . . . 0.479 ' HA ' ' O ' ' A' ' 252' ' ' PHE . 2.4 p -140.85 100.57 3.87 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 113.876 -1.511 . . . . 15.0 108.442 170.706 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 261' ' ' THR . . . . . 0.4 ' OG1' ' HD2' ' A' ' 263' ' ' HIS . 8.7 t -141.75 150.51 41.86 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.18 0.514 . . . . 15.0 112.374 -168.35 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 262' ' ' TRP . . . . . 0.433 ' HH2' ' CD ' ' A' ' 249' ' ' GLN . 29.5 m95 -71.06 -31.62 68.09 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.361 -0.836 . . . . 15.0 111.535 176.761 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 263' ' ' HIS . . . . . 0.4 ' HD2' ' OG1' ' A' ' 261' ' ' THR . 3.1 p80 -84.06 130.83 34.85 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 120.29 -0.564 . . . . 15.0 110.154 -175.737 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 264' ' ' ASP . . . . . 0.917 ' HB3' HG12 ' A' ' 267' ' ' ILE . 20.7 t0 -53.95 126.92 52.56 Favored Pre-proline 0 C--N 1.324 -0.511 0 CA-C-N 115.619 -0.719 . . . . 15.0 109.285 173.131 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 265' ' ' PRO . . . . . 0.548 ' HG2' ' CD1' ' A' ' 240' ' ' TYR . 10.9 Cg_exo -70.5 -14.96 34.24 Favored 'Trans proline' 0 N--CA 1.456 -0.709 0 C-N-CA 122.231 1.954 . . . . 15.0 112.496 -179.361 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 266' ' ' ARG . . . . . 0.462 ' HB3' ' OD2' ' A' ' 264' ' ' ASP . 26.6 tpt180 -72.38 -15.15 61.85 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-O 122.07 0.938 . . . . 15.0 108.788 171.171 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 267' ' ' ILE . . . . . 0.917 HG12 ' HB3' ' A' ' 264' ' ' ASP . 32.8 pt . . . . . 0 C--O 1.25 1.09 0 CA-C-N 114.275 -1.329 . . . . 15.0 110.936 177.117 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 210' ' ' SER . . . . . . . . . . . . . 21.0 m . . . . . 0 N--CA 1.473 0.7 0 N-CA-C 109.962 -0.384 . . . . 15.0 109.962 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' B' B ' 211' ' ' ASP . . . . . 0.431 ' HA ' ' HD3' ' B' ' 212' ' ' PRO . 6.0 p-10 -138.63 134.69 17.42 Favored Pre-proline 0 C--N 1.32 -0.694 0 CA-C-N 115.925 -0.579 . . . . 15.0 109.795 -177.684 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 212' ' ' PRO . . . . . 0.57 ' CB ' HD11 ' A' ' 253' ' ' LEU . 4.6 Cg_endo -89.7 154.78 5.15 Favored 'Trans proline' 0 N--CA 1.456 -0.711 0 C-N-CA 123.393 2.729 . . . . 15.0 112.225 -177.0 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.442 -0.965 0 CA-C-N 115.625 -0.716 . . . . 15.0 112.587 -177.435 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 236' ' ' LEU . . . . . 0.443 HD11 ' OD2' ' A' ' 264' ' ' ASP . 0.9 OUTLIER . . . . . 0 CA--C 1.521 -0.161 0 N-CA-C 110.376 -0.231 . . . . 15.0 110.376 . . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 237' ' ' PRO . . . . . 0.67 ' HD3' ' HD3' ' A' ' 266' ' ' ARG . 19.5 Cg_exo -69.44 170.1 16.99 Favored 'Trans proline' 0 CA--C 1.516 -0.422 0 C-N-CA 122.335 2.023 . . . . 15.0 110.838 165.577 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -69.78 140.26 53.35 Favored 'General case' 0 C--N 1.303 -1.422 0 CA-C-N 114.691 -1.14 . . . . 15.0 110.865 -176.207 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 239' ' ' GLY . . . . . 0.458 ' O ' ' HA ' ' A' ' 254' ' ' HIS . . . 100.04 11.99 41.15 Favored Glycine 0 N--CA 1.448 -0.516 0 CA-C-N 115.632 -0.713 . . . . 15.0 113.867 179.07 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 240' ' ' TYR . . . . . 0.669 ' CD1' ' HB2' ' A' ' 254' ' ' HIS . 64.2 m-85 -111.99 107.9 17.04 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 117.918 0.859 . . . . 15.0 111.579 178.13 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 13.8 mm-40 -90.15 120.81 31.64 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.021 -0.99 . . . . 15.0 109.841 176.155 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 23.4 tm0? -89.97 109.87 20.88 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 109.103 -0.703 . . . . 15.0 109.103 177.378 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 4.5 mtp180 -112.23 150.23 31.19 Favored 'General case' 0 CA--C 1.508 -0.666 0 CA-C-O 122.564 1.173 . . . . 15.0 113.494 -179.86 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 244' ' ' THR . . . . . . . . . . . . . 21.8 p -116.15 150.1 37.98 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-N 112.555 -2.111 . . . . 15.0 108.67 177.7 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 245' ' ' THR . . . . . 0.472 ' OG1' ' HG2' ' A' ' 247' ' ' GLN . 5.9 t -144.32 150.52 37.95 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 116.82 -0.173 . . . . 15.0 110.697 -175.201 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 21.6 t -52.5 -18.49 1.23 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 O-C-N 123.749 0.656 . . . . 15.0 111.589 178.261 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 247' ' ' GLN . . . . . 0.472 ' HG2' ' OG1' ' A' ' 245' ' ' THR . 4.7 mm100 -63.89 -17.15 62.91 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-O 120.893 0.378 . . . . 15.0 110.555 177.426 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 83.91 38.5 10.3 Favored Glycine 0 C--N 1.334 0.459 0 CA-C-N 116.088 -0.505 . . . . 15.0 112.571 177.275 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 249' ' ' GLN . . . . . 0.5 ' CD ' ' HH2' ' A' ' 262' ' ' TRP . 0.0 OUTLIER -146.72 147.5 31.03 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.044 0.449 . . . . 15.0 111.355 -175.194 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 13.7 m -93.92 138.45 20.44 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-N 115.1 -0.955 . . . . 15.0 109.345 173.737 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 4.9 p90 -145.78 136.62 24.45 Favored 'General case' 0 C--N 1.32 -0.717 0 C-N-CA 120.605 -0.438 . . . . 15.0 110.419 -179.891 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 252' ' ' PHE . . . . . 0.607 ' CE2' ' HA ' ' A' ' 264' ' ' ASP . 43.9 m-85 -91.16 121.54 33.03 Favored 'General case' 0 CA--C 1.515 -0.377 0 CA-C-N 116.059 -0.519 . . . . 15.0 111.839 -174.629 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 253' ' ' LEU . . . . . 0.643 ' HA ' ' O ' ' A' ' 259' ' ' VAL . 13.7 mt -104.26 110.33 22.5 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-N 115.243 -0.89 . . . . 15.0 112.169 179.196 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 254' ' ' HIS . . . . . 0.669 ' HB2' ' CD1' ' A' ' 240' ' ' TYR . 22.7 t-80 -116.17 89.93 3.22 Favored 'General case' 0 C--N 1.311 -1.08 0 N-CA-C 107.696 -1.224 . . . . 15.0 107.696 166.099 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 37.1 m -90.86 88.03 6.89 Favored 'General case' 0 N--CA 1.43 -1.442 0 C-N-CA 116.894 -1.922 . . . . 15.0 110.097 -179.272 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 8.0 tt0 -101.04 -51.76 3.45 Favored 'General case' 0 N--CA 1.441 -0.891 0 N-CA-C 105.721 -1.955 . . . . 15.0 105.721 149.677 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 257' ' ' THR . . . . . . . . . . . . . 58.6 p -99.78 -13.69 19.15 Favored 'General case' 0 CA--C 1.485 -1.533 0 CA-C-O 124.768 2.223 . . . . 15.0 112.047 -179.435 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 85.9 75.51 1.24 Allowed Glycine 1 C--N 1.237 -4.937 0 CA-C-N 108.439 -3.982 . . . . 15.0 112.2 -169.55 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 259' ' ' VAL . . . . . 0.643 ' O ' ' HA ' ' A' ' 253' ' ' LEU . 42.9 t -89.88 123.46 42.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-O 121.395 0.617 . . . . 15.0 111.845 175.578 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 4.6 p -134.65 99.63 4.39 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 114.174 -1.376 . . . . 15.0 108.234 170.117 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 8.9 t -135.8 150.48 49.46 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 121.097 0.475 . . . . 15.0 111.841 -171.256 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 262' ' ' TRP . . . . . 0.5 ' HH2' ' CD ' ' A' ' 249' ' ' GLN . 67.6 m95 -68.31 -33.45 74.33 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.141 -0.936 . . . . 15.0 111.345 176.595 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 263' ' ' HIS . . . . . . . . . . . . . 4.7 p80 -82.12 131.36 35.24 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 120.44 -0.504 . . . . 15.0 110.128 -172.783 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 264' ' ' ASP . . . . . 0.928 ' HB3' HG12 ' A' ' 267' ' ' ILE . 9.4 t70 -51.75 133.21 37.24 Favored Pre-proline 0 C--N 1.321 -0.635 0 N-CA-C 108.946 -0.761 . . . . 15.0 108.946 171.578 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 265' ' ' PRO . . . . . 0.457 ' HD3' ' CD2' ' A' ' 252' ' ' PHE . 36.5 Cg_endo -72.7 -14.76 27.18 Favored 'Trans proline' 0 N--CA 1.454 -0.797 0 C-N-CA 121.725 1.617 . . . . 15.0 114.294 -173.969 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 266' ' ' ARG . . . . . 0.67 ' HD3' ' HD3' ' A' ' 237' ' ' PRO . 0.1 OUTLIER -81.69 -6.65 59.22 Favored 'General case' 0 C--N 1.311 -1.107 0 N-CA-C 108.426 -0.953 . . . . 15.0 108.426 174.843 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 267' ' ' ILE . . . . . 0.928 HG12 ' HB3' ' A' ' 264' ' ' ASP . 42.1 mm . . . . . 0 C--O 1.249 1.031 0 CA-C-N 113.865 -1.516 . . . . 15.0 109.921 177.606 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 210' ' ' SER . . . . . . . . . . . . . 5.9 m . . . . . 0 N--CA 1.474 0.737 0 CA-C-O 120.873 0.368 . . . . 15.0 110.2 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' B' B ' 211' ' ' ASP . . . . . 0.437 ' HA ' ' HD3' ' B' ' 212' ' ' PRO . 30.4 t70 -150.09 129.39 6.37 Favored Pre-proline 0 C--N 1.324 -0.501 0 N-CA-C 109.504 -0.554 . . . . 15.0 109.504 -179.436 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 212' ' ' PRO . . . . . 0.591 ' CB ' HD11 ' A' ' 253' ' ' LEU . 27.3 Cg_endo -89.9 156.98 4.98 Favored 'Trans proline' 0 N--CA 1.454 -0.837 0 C-N-CA 122.601 2.2 . . . . 15.0 112.967 -176.081 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.442 -0.942 0 CA-C-N 115.493 -0.776 . . . . 15.0 111.458 177.908 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 236' ' ' LEU . . . . . 0.734 HD12 ' HD2' ' A' ' 265' ' ' PRO . 0.4 OUTLIER . . . . . 0 N--CA 1.452 -0.344 0 CA-C-O 121.273 0.559 . . . . 15.0 110.715 . . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 237' ' ' PRO . . . . . 0.519 ' HD3' ' HD3' ' A' ' 266' ' ' ARG . 23.3 Cg_exo -69.32 171.0 14.75 Favored 'Trans proline' 0 CA--C 1.508 -0.783 0 C-N-CA 122.844 2.363 . . . . 15.0 110.097 162.474 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -69.42 145.1 53.1 Favored 'General case' 0 C--N 1.3 -1.553 0 CA-C-N 115.072 -0.967 . . . . 15.0 111.89 -175.845 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 100.21 10.19 45.93 Favored Glycine 0 N--CA 1.449 -0.484 0 CA-C-N 114.435 -1.257 . . . . 15.0 113.214 -179.868 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 240' ' ' TYR . . . . . 0.631 ' CD1' ' HB2' ' A' ' 254' ' ' HIS . 71.9 m-85 -116.67 123.5 47.41 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 117.235 0.518 . . . . 15.0 110.989 177.904 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -91.52 123.45 34.94 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.648 -0.705 . . . . 15.0 109.446 171.41 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 18.8 tm0? -91.4 99.86 12.74 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 108.646 -0.872 . . . . 15.0 108.646 174.513 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 68.7 mtt-85 -103.16 150.16 23.94 Favored 'General case' 0 CA--C 1.504 -0.825 0 CA-C-O 122.136 0.97 . . . . 15.0 112.087 -176.37 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 244' ' ' THR . . . . . . . . . . . . . 10.9 m -129.47 97.56 4.59 Favored 'General case' 0 C--N 1.308 -1.222 0 CA-C-N 113.28 -1.782 . . . . 15.0 109.399 -177.042 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 245' ' ' THR . . . . . 0.487 ' OG1' ' HG2' ' A' ' 247' ' ' GLN . 3.5 t -94.94 150.48 20.12 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.257 -0.883 . . . . 15.0 110.989 -175.621 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 9.9 m -50.53 -18.36 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.451 0 CA-C-N 115.615 -0.721 . . . . 15.0 112.577 176.97 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 247' ' ' GLN . . . . . 0.487 ' HG2' ' OG1' ' A' ' 245' ' ' THR . 7.3 mm100 -56.3 -21.28 23.07 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.02 -0.536 . . . . 15.0 110.682 173.182 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 89.73 11.91 63.16 Favored Glycine 0 N--CA 1.447 -0.576 0 CA-C-N 115.851 -0.613 . . . . 15.0 112.871 174.845 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 7.1 mt-30 -129.37 141.53 51.04 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 110.205 -0.294 . . . . 15.0 110.205 -176.358 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 17.1 m -89.79 135.0 27.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 116.333 -0.394 . . . . 15.0 110.109 178.235 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 25.6 p90 -134.54 135.05 42.04 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 116.143 -0.48 . . . . 15.0 110.004 -178.437 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 252' ' ' PHE . . . . . 0.701 ' CD2' ' HA ' ' A' ' 264' ' ' ASP . 24.3 m-85 -90.22 125.72 35.58 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.31 0.576 . . . . 15.0 111.147 -175.731 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 253' ' ' LEU . . . . . 1.071 HD11 ' HB3' ' B' ' 212' ' ' PRO . 0.4 OUTLIER -113.73 109.42 18.55 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-N 114.808 -1.087 . . . . 15.0 111.858 -173.398 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 254' ' ' HIS . . . . . 0.631 ' HB2' ' CD1' ' A' ' 240' ' ' TYR . 35.2 t-80 -120.62 89.98 3.23 Favored 'General case' 0 C--N 1.314 -0.963 0 N-CA-C 108.386 -0.968 . . . . 15.0 108.386 167.785 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 8.0 t -94.94 88.03 5.15 Favored 'General case' 0 N--CA 1.433 -1.289 0 C-N-CA 116.5 -2.08 . . . . 15.0 110.998 -179.372 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 -100.76 -51.86 3.47 Favored 'General case' 0 N--CA 1.44 -0.96 0 CA-C-N 112.808 -1.996 . . . . 15.0 106.142 149.415 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 257' ' ' THR . . . . . . . . . . . . . 59.3 p -95.85 -13.23 24.17 Favored 'General case' 0 CA--C 1.487 -1.457 0 CA-C-O 125.039 2.352 . . . . 15.0 111.763 -179.21 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 84.9 73.25 1.27 Allowed Glycine 1 C--N 1.241 -4.705 1 CA-C-N 108.042 -4.163 . . . . 15.0 112.55 -172.873 . . . . . . . . 3 2 . 1 . 022 nuclear nobuild core ' A' A ' 259' ' ' VAL . . . . . 0.597 ' O ' HD23 ' A' ' 253' ' ' LEU . 66.0 t -89.86 122.59 41.38 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.411 0 CA-C-O 121.676 0.751 . . . . 15.0 111.878 176.664 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 2.2 p -134.47 100.8 4.76 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-N 113.746 -1.57 . . . . 15.0 107.295 170.42 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 9.0 t -136.26 150.32 48.89 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 112.654 0.613 . . . . 15.0 112.654 -166.413 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 262' ' ' TRP . . . . . . . . . . . . . 79.9 m95 -79.02 -23.19 44.49 Favored 'General case' 0 N--CA 1.454 -0.275 0 CA-C-N 115.154 -0.93 . . . . 15.0 111.474 177.788 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 263' ' ' HIS . . . . . . . . . . . . . 5.6 p80 -92.96 134.5 35.05 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 120.271 -0.572 . . . . 15.0 110.521 -176.517 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 264' ' ' ASP . . . . . 0.965 ' HB3' HG12 ' A' ' 267' ' ' ILE . 13.7 t0 -56.99 124.1 63.34 Favored Pre-proline 0 C--N 1.321 -0.673 0 N-CA-C 108.4 -0.963 . . . . 15.0 108.4 171.049 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 265' ' ' PRO . . . . . 0.734 ' HD2' HD12 ' A' ' 236' ' ' LEU . 16.6 Cg_exo -68.39 -14.77 40.87 Favored 'Trans proline' 0 CA--C 1.514 -0.479 0 C-N-CA 122.362 2.041 . . . . 15.0 113.181 -176.45 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 266' ' ' ARG . . . . . 0.519 ' HD3' ' HD3' ' A' ' 237' ' ' PRO . 10.8 tpt180 -76.93 -10.06 59.11 Favored 'General case' 0 C--N 1.313 -1.015 0 N-CA-C 108.473 -0.936 . . . . 15.0 108.473 174.137 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 267' ' ' ILE . . . . . 0.965 HG12 ' HB3' ' A' ' 264' ' ' ASP . 27.9 pt . . . . . 0 C--O 1.251 1.175 0 CA-C-N 114.129 -1.396 . . . . 15.0 110.835 177.334 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' B' B ' 210' ' ' SER . . . . . . . . . . . . . 9.4 t . . . . . 0 N--CA 1.476 0.861 0 N-CA-C 109.141 -0.689 . . . . 15.0 109.141 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' B' B ' 211' ' ' ASP . . . . . 0.441 ' HA ' ' HD3' ' B' ' 212' ' ' PRO . 5.0 m-20 -130.58 150.17 75.57 Favored Pre-proline 0 C--N 1.321 -0.654 0 CA-C-N 116.093 -0.503 . . . . 15.0 110.711 -174.077 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 212' ' ' PRO . . . . . 1.071 ' HB3' HD11 ' A' ' 253' ' ' LEU . 5.2 Cg_endo -89.83 151.65 5.0 Favored 'Trans proline' 0 N--CA 1.453 -0.906 0 C-N-CA 123.111 2.541 . . . . 15.0 112.182 179.759 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.442 -0.922 0 C-N-CA 120.674 -0.774 . . . . 15.0 111.643 -179.764 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 236' ' ' LEU . . . . . 0.465 HD12 ' HB2' ' A' ' 266' ' ' ARG . 0.4 OUTLIER . . . . . 0 C--O 1.234 0.284 0 N-CA-C 109.225 -0.657 . . . . 15.0 109.225 . . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 237' ' ' PRO . . . . . 0.407 ' HD3' ' HD3' ' A' ' 266' ' ' ARG . 12.0 Cg_exo -69.56 164.55 33.92 Favored 'Trans proline' 0 N--CA 1.459 -0.553 0 C-N-CA 121.606 1.538 . . . . 15.0 110.689 170.802 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -69.69 150.34 47.09 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-N 114.976 -1.011 . . . . 15.0 111.707 -174.535 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 239' ' ' GLY . . . . . 0.41 ' O ' ' HA ' ' A' ' 254' ' ' HIS . . . 100.15 -7.16 58.47 Favored Glycine 0 N--CA 1.448 -0.523 0 CA-C-N 115.656 -0.702 . . . . 15.0 113.644 176.206 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 240' ' ' TYR . . . . . 0.627 ' CD1' ' HB2' ' A' ' 254' ' ' HIS . 60.0 m-85 -102.53 114.05 27.94 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 117.492 0.646 . . . . 15.0 110.628 179.125 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -94.54 131.72 39.98 Favored 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 108.924 -0.769 . . . . 15.0 108.924 171.306 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 23.0 tm0? -89.71 107.97 19.4 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 107.989 -1.115 . . . . 15.0 107.989 179.623 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 13.7 mtp180 -101.85 150.15 23.46 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-O 122.121 0.963 . . . . 15.0 112.175 -175.861 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 244' ' ' THR . . . . . . . . . . . . . 5.1 m -122.69 141.38 51.83 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-N 113.216 -1.811 . . . . 15.0 107.757 -177.798 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 245' ' ' THR . . . . . 0.631 ' CG2' ' HB3' ' A' ' 247' ' ' GLN . 3.1 t -141.96 150.34 41.29 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-O 120.878 0.371 . . . . 15.0 111.717 -169.216 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 8.8 p -55.97 -24.45 17.34 Favored 'Isoleucine or valine' 0 C--O 1.234 0.248 0 CA-C-N 115.31 -0.859 . . . . 15.0 109.886 172.49 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 247' ' ' GLN . . . . . 0.732 ' HG2' ' NE2' ' A' ' 249' ' ' GLN . 40.8 tt0 -50.46 -35.83 30.71 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 114.506 -1.224 . . . . 15.0 110.473 172.699 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 102.04 -15.29 56.76 Favored Glycine 0 C--N 1.333 0.396 0 CA-C-N 116.118 -0.492 . . . . 15.0 112.987 176.645 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 249' ' ' GLN . . . . . 0.732 ' NE2' ' HG2' ' A' ' 247' ' ' GLN . 2.3 mp0 -96.43 147.42 23.85 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 120.64 0.257 . . . . 15.0 111.3 -173.857 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 3.3 m -89.99 130.26 39.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 N-CA-C 109.617 -0.512 . . . . 15.0 109.617 174.16 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 9.4 p90 -142.42 138.95 31.45 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.369 0.605 . . . . 15.0 111.721 -176.206 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 252' ' ' PHE . . . . . 0.62 ' CD2' ' HA ' ' A' ' 264' ' ' ASP . 43.0 m-85 -96.62 125.17 40.91 Favored 'General case' 0 CA--C 1.509 -0.607 0 CA-C-N 115.169 -0.923 . . . . 15.0 110.873 -177.265 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 253' ' ' LEU . . . . . 0.689 ' HA ' ' O ' ' A' ' 259' ' ' VAL . 0.1 OUTLIER -123.95 109.15 13.21 Favored 'General case' 0 N--CA 1.441 -0.919 0 CA-C-O 121.696 0.76 . . . . 15.0 111.979 -177.939 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 254' ' ' HIS . . . . . 0.627 ' HB2' ' CD1' ' A' ' 240' ' ' TYR . 12.4 t-80 -109.61 93.85 4.72 Favored 'General case' 0 CA--C 1.501 -0.928 0 CA-C-N 114.881 -1.054 . . . . 15.0 108.184 169.36 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 3.6 t -93.85 88.2 5.67 Favored 'General case' 0 N--CA 1.434 -1.265 0 C-N-CA 116.35 -2.14 . . . . 15.0 110.556 179.501 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 7.6 tp60 -101.21 -51.9 3.39 Favored 'General case' 0 N--CA 1.442 -0.863 0 CA-C-N 113.19 -1.823 . . . . 15.0 106.269 150.981 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 257' ' ' THR . . . . . . . . . . . . . 71.9 p -99.96 -13.67 19.01 Favored 'General case' 0 CA--C 1.487 -1.461 0 CA-C-O 124.666 2.174 . . . . 15.0 112.118 -179.501 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 88.63 73.89 1.28 Allowed Glycine 1 C--N 1.242 -4.693 0 CA-C-N 108.533 -3.94 . . . . 15.0 112.849 -171.32 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 259' ' ' VAL . . . . . 0.689 ' O ' ' HA ' ' A' ' 253' ' ' LEU . 68.7 t -89.58 126.73 42.5 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.391 0 CA-C-O 121.296 0.57 . . . . 15.0 111.583 173.219 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 2.2 p -150.01 94.13 2.11 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 114.039 -1.437 . . . . 15.0 107.72 168.886 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 9.8 t -135.03 150.29 50.27 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.516 -0.765 . . . . 15.0 111.173 -169.151 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 262' ' ' TRP . . . . . 0.483 ' CH2' ' HB3' ' A' ' 249' ' ' GLN . 23.2 m95 -70.1 -17.51 63.22 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 113.19 0.811 . . . . 15.0 113.19 -177.194 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 263' ' ' HIS . . . . . . . . . . . . . 4.6 p80 -96.25 133.0 41.12 Favored 'General case' 0 C--N 1.323 -0.561 0 C-N-CA 120.088 -0.645 . . . . 15.0 110.01 179.961 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 264' ' ' ASP . . . . . 0.995 ' HB3' HG12 ' A' ' 267' ' ' ILE . 9.9 t0 -56.72 131.21 78.19 Favored Pre-proline 0 C--O 1.222 -0.386 0 N-CA-C 107.888 -1.153 . . . . 15.0 107.888 171.283 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 265' ' ' PRO . . . . . 0.508 ' HG2' ' CD1' ' A' ' 240' ' ' TYR . 17.0 Cg_exo -69.33 -15.05 38.42 Favored 'Trans proline' 0 C--N 1.324 -0.75 0 C-N-CA 122.092 1.861 . . . . 15.0 113.415 -176.232 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 266' ' ' ARG . . . . . 0.485 ' HD2' ' HA ' ' A' ' 266' ' ' ARG . 15.9 tpt180 -79.7 -8.02 58.96 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-O 122.037 0.922 . . . . 15.0 108.67 173.881 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 267' ' ' ILE . . . . . 0.995 HG12 ' HB3' ' A' ' 264' ' ' ASP . 33.4 pt . . . . . 0 C--O 1.248 0.984 0 CA-C-N 113.798 -1.546 . . . . 15.0 110.641 175.382 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' B' B ' 210' ' ' SER . . . . . . . . . . . . . 10.7 m . . . . . 0 N--CA 1.475 0.825 0 CA-C-O 120.883 0.373 . . . . 15.0 110.644 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' B' B ' 211' ' ' ASP . . . . . 0.507 ' HA ' ' HD3' ' B' ' 212' ' ' PRO . 25.7 t70 -140.08 122.0 9.75 Favored Pre-proline 0 N--CA 1.453 -0.286 0 CA-C-O 121.023 0.44 . . . . 15.0 111.084 -177.31 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' B' B ' 212' ' ' PRO . . . . . 0.6 ' HB2' HD13 ' A' ' 253' ' ' LEU . 1.2 Cg_endo -89.63 160.01 5.27 Favored 'Trans proline' 0 N--CA 1.457 -0.65 0 C-N-CA 123.774 2.983 . . . . 15.0 111.846 176.126 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.617 0 C-N-CA 120.809 -0.71 . . . . 15.0 112.896 -176.168 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 236' ' ' LEU . . . . . 0.541 HD22 ' N ' ' A' ' 236' ' ' LEU . 0.1 OUTLIER . . . . . 0 CA--C 1.515 -0.397 0 CA-C-O 121.133 0.492 . . . . 15.0 110.166 . . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 237' ' ' PRO . . . . . 0.557 ' HD3' ' HD3' ' A' ' 266' ' ' ARG . 15.1 Cg_exo -69.56 173.8 10.27 Favored 'Trans proline' 0 CA--C 1.507 -0.84 0 C-N-CA 122.672 2.248 . . . . 15.0 110.442 165.861 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 3.7 pm0 -69.48 142.63 53.71 Favored 'General case' 0 C--N 1.291 -1.945 0 CA-C-N 114.253 -1.339 . . . . 15.0 111.613 -173.297 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 100.17 3.36 55.68 Favored Glycine 0 CA--C 1.521 0.446 0 CA-C-N 115.233 -0.894 . . . . 15.0 113.965 177.172 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 240' ' ' TYR . . . . . 0.526 ' CD1' ' HG2' ' A' ' 265' ' ' PRO . 62.4 m-85 -111.17 125.34 53.69 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 117.856 0.828 . . . . 15.0 111.253 178.651 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 241' ' ' GLU . . . . . 0.561 ' HG3' ' HB3' ' A' ' 253' ' ' LEU . 8.6 pt-20 -108.75 123.28 48.76 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 109.199 -0.667 . . . . 15.0 109.199 170.926 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -89.81 106.55 18.54 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 109.203 -0.665 . . . . 15.0 109.203 -177.802 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 27.9 mtt-85 -98.46 148.43 23.73 Favored 'General case' 0 CA--C 1.505 -0.771 0 CA-C-O 122.123 0.963 . . . . 15.0 112.06 -177.531 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 244' ' ' THR . . . . . . . . . . . . . 25.0 p -117.26 146.06 43.54 Favored 'General case' 0 C--N 1.306 -1.285 0 CA-C-N 113.348 -1.751 . . . . 15.0 108.852 178.409 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 245' ' ' THR . . . . . 0.432 HG23 ' HB2' ' A' ' 247' ' ' GLN . 5.9 t -144.26 150.16 37.47 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 116.612 -0.267 . . . . 15.0 110.861 -172.393 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 6.4 m -53.63 -19.17 2.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.824 -0.626 . . . . 15.0 111.974 177.953 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 247' ' ' GLN . . . . . 0.432 ' HB2' HG23 ' A' ' 245' ' ' THR . 8.8 mm100 -58.68 -20.61 49.94 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.735 -0.666 . . . . 15.0 110.901 175.203 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 84.21 26.61 39.64 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 121.107 -0.568 . . . . 15.0 112.542 176.639 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 3.0 mt-30 -133.2 138.9 46.72 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 110.286 -0.264 . . . . 15.0 110.286 -173.904 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 4.4 m -89.65 122.83 41.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 N-CA-C 109.721 -0.474 . . . . 15.0 109.721 173.331 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 2.5 p90 -129.89 134.07 47.28 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.049 0.452 . . . . 15.0 109.856 -175.792 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 252' ' ' PHE . . . . . 0.582 ' CD2' ' HA ' ' A' ' 264' ' ' ASP . 40.1 m-85 -90.05 128.11 36.21 Favored 'General case' 0 CA--C 1.512 -0.499 0 CA-C-O 121.237 0.542 . . . . 15.0 111.483 -175.185 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 253' ' ' LEU . . . . . 0.899 HD11 ' HB3' ' B' ' 212' ' ' PRO . 0.7 OUTLIER -118.66 126.27 51.56 Favored 'General case' 0 N--CA 1.446 -0.673 0 CA-C-N 115.035 -0.984 . . . . 15.0 110.78 -175.909 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 254' ' ' HIS . . . . . 0.522 ' HB3' ' HB ' ' A' ' 259' ' ' VAL . 0.2 OUTLIER -140.61 91.72 2.45 Favored 'General case' 0 C--N 1.313 -0.988 0 N-CA-C 108.595 -0.891 . . . . 15.0 108.595 173.282 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 3.1 t -103.23 87.91 3.0 Favored 'General case' 0 N--CA 1.43 -1.44 0 C-N-CA 116.796 -1.962 . . . . 15.0 111.015 -179.598 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 30.2 tp60 -101.23 -52.85 3.16 Favored 'General case' 0 N--CA 1.437 -1.099 0 CA-C-N 112.681 -2.054 . . . . 15.0 105.574 147.116 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 257' ' ' THR . . . . . . . . . . . . . 31.8 p -97.63 -13.55 21.49 Favored 'General case' 0 CA--C 1.489 -1.38 0 CA-C-O 124.89 2.281 . . . . 15.0 112.0 -177.246 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 84.73 71.37 1.32 Allowed Glycine 1 C--N 1.242 -4.676 1 CA-C-N 108.315 -4.039 . . . . 15.0 113.926 -174.575 . . . . . . . . 3 2 . 1 . 024 nuclear nobuild core ' A' A ' 259' ' ' VAL . . . . . 0.522 ' HB ' ' HB3' ' A' ' 254' ' ' HIS . 67.5 t -89.91 129.95 39.99 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 CA-C-O 121.405 0.622 . . . . 15.0 111.431 171.597 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 23.8 p -143.79 102.89 3.98 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 114.386 -1.279 . . . . 15.0 108.093 171.553 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 14.4 t -149.32 150.44 32.49 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.966 0.412 . . . . 15.0 111.747 -168.726 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 262' ' ' TRP . . . . . . . . . . . . . 84.7 m95 -71.96 -37.03 70.0 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.721 -0.672 . . . . 15.0 111.282 177.724 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 263' ' ' HIS . . . . . . . . . . . . . 2.8 p80 -73.65 126.85 31.22 Favored 'General case' 0 CA--C 1.515 -0.37 0 C-N-CA 120.52 -0.472 . . . . 15.0 109.923 -174.001 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 264' ' ' ASP . . . . . 1.084 ' HB3' HG12 ' A' ' 267' ' ' ILE . 15.0 t0 -54.47 125.79 53.43 Favored Pre-proline 0 C--N 1.32 -0.699 0 N-CA-C 108.326 -0.99 . . . . 15.0 108.326 173.404 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 265' ' ' PRO . . . . . 0.526 ' HG2' ' CD1' ' A' ' 240' ' ' TYR . 14.2 Cg_exo -68.72 -14.59 39.55 Favored 'Trans proline' 0 CA--C 1.512 -0.581 0 C-N-CA 121.893 1.729 . . . . 15.0 112.667 -177.296 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 266' ' ' ARG . . . . . 0.557 ' HD3' ' HD3' ' A' ' 237' ' ' PRO . 19.8 tpt180 -76.46 -11.94 59.96 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 115.225 -0.898 . . . . 15.0 108.932 173.137 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 267' ' ' ILE . . . . . 1.084 HG12 ' HB3' ' A' ' 264' ' ' ASP . 41.8 pt . . . . . 0 C--O 1.25 1.101 0 CA-C-O 117.549 -1.215 . . . . 15.0 111.529 178.999 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' B' B ' 210' ' ' SER . . . . . . . . . . . . . 18.9 m . . . . . 0 N--CA 1.477 0.892 0 CA-C-O 120.98 0.419 . . . . 15.0 110.806 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' B' B ' 211' ' ' ASP . . . . . . . . . . . . . 11.9 p-10 -111.87 109.87 54.85 Favored Pre-proline 0 C--N 1.327 -0.38 0 CA-C-O 121.138 0.494 . . . . 15.0 110.5 -178.29 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' B' B ' 212' ' ' PRO . . . . . 0.899 ' HB3' HD11 ' A' ' 253' ' ' LEU . 6.6 Cg_endo -89.97 147.73 4.71 Favored 'Trans proline' 0 N--CA 1.453 -0.871 0 C-N-CA 122.638 2.225 . . . . 15.0 112.21 176.257 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.442 -0.931 0 C-N-CA 120.543 -0.836 . . . . 15.0 111.598 178.286 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 . . . . . 0 N--CA 1.481 1.079 0 N-CA-C 109.953 -0.388 . . . . 15.0 109.953 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 2.2 mt -105.25 164.88 14.2 Favored Pre-proline 0 C--N 1.32 -0.702 0 N-CA-C 109.789 -0.449 . . . . 15.0 109.789 -177.35 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 237' ' ' PRO . . . . . 0.465 ' O ' ' HD2' ' A' ' 240' ' ' TYR . 14.0 Cg_exo -69.5 166.75 26.2 Favored 'Trans proline' 0 N--CA 1.458 -0.615 0 C-N-CA 121.793 1.662 . . . . 15.0 110.221 165.706 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -69.74 142.99 53.17 Favored 'General case' 0 C--N 1.303 -1.433 0 CA-C-N 114.863 -1.062 . . . . 15.0 111.521 -173.024 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 100.15 5.83 54.27 Favored Glycine 0 N--CA 1.449 -0.485 0 CA-C-N 115.361 -0.836 . . . . 15.0 113.785 178.895 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 240' ' ' TYR . . . . . 0.649 ' CD1' ' HB2' ' A' ' 254' ' ' HIS . 71.7 m-85 -108.19 116.31 31.72 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 117.636 0.718 . . . . 15.0 111.678 -179.698 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -90.37 113.82 25.79 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.048 -0.978 . . . . 15.0 109.595 174.897 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 242' ' ' GLN . . . . . 0.645 ' HG3' ' CE1' ' A' ' 252' ' ' PHE . 39.6 tt0 -91.09 103.42 16.12 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 109.523 -0.547 . . . . 15.0 109.523 -179.771 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 243' ' ' ARG . . . . . 0.44 HH11 ' HD2' ' A' ' 243' ' ' ARG . 8.5 mtp180 -109.25 149.87 28.78 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 122.07 0.938 . . . . 15.0 112.637 -176.168 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 244' ' ' THR . . . . . 0.421 HG22 HG12 ' A' ' 250' ' ' VAL . 10.2 p -124.72 96.8 5.02 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 113.54 -1.664 . . . . 15.0 109.41 -176.257 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 245' ' ' THR . . . . . 0.703 HG23 ' HB2' ' A' ' 247' ' ' GLN . 2.7 t -89.99 150.28 22.2 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 115.861 -0.609 . . . . 15.0 111.412 -174.71 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 9.7 m -52.06 -19.21 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.315 0 CA-C-N 115.713 -0.676 . . . . 15.0 112.04 175.075 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 247' ' ' GLN . . . . . 0.703 ' HB2' HG23 ' A' ' 245' ' ' THR . 0.2 OUTLIER -49.81 -26.8 4.28 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 115.98 -0.554 . . . . 15.0 110.873 170.239 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 93.17 19.36 36.29 Favored Glycine 0 C--O 1.229 -0.188 0 CA-C-N 115.837 -0.619 . . . . 15.0 112.289 177.041 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 249' ' ' GLN . . . . . 0.476 ' NE2' ' HH2' ' A' ' 262' ' ' TRP . 0.0 OUTLIER -135.41 144.39 46.5 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.01 0.433 . . . . 15.0 110.724 -174.605 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 250' ' ' VAL . . . . . 0.421 HG12 HG22 ' A' ' 244' ' ' THR . 19.4 m -89.94 142.39 12.99 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 115.444 -0.798 . . . . 15.0 109.677 176.406 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 251' ' ' TYR . . . . . 0.543 ' HB3' ' CG ' ' B' ' 215' ' ' PRO . 6.1 p90 -148.18 142.68 26.43 Favored 'General case' 0 C--N 1.321 -0.646 0 C-N-CA 120.67 -0.412 . . . . 15.0 110.693 -179.38 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 252' ' ' PHE . . . . . 0.697 ' CE2' ' HA ' ' A' ' 264' ' ' ASP . 29.7 m-85 -98.15 119.57 37.02 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.842 -0.617 . . . . 15.0 111.869 -175.631 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 253' ' ' LEU . . . . . 0.657 HD11 ' HB3' ' B' ' 212' ' ' PRO . 2.8 mt -104.36 103.23 12.93 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 114.744 -1.116 . . . . 15.0 112.012 -177.579 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 254' ' ' HIS . . . . . 0.649 ' HB2' ' CD1' ' A' ' 240' ' ' TYR . 36.7 t-80 -113.26 89.95 3.22 Favored 'General case' 0 C--N 1.312 -1.036 0 N-CA-C 107.982 -1.118 . . . . 15.0 107.982 167.413 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 255' ' ' THR . . . . . 0.417 HG23 ' HA2' ' A' ' 258' ' ' GLY . 23.4 m -92.43 87.78 6.13 Favored 'General case' 0 N--CA 1.432 -1.355 0 C-N-CA 116.684 -2.006 . . . . 15.0 109.496 -179.328 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 64.1 tt0 -101.54 -53.43 2.99 Favored 'General case' 0 N--CA 1.439 -1.008 0 N-CA-C 106.199 -1.778 . . . . 15.0 106.199 150.592 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 257' ' ' THR . . . . . . . . . . . . . 82.6 p -96.83 -13.61 22.44 Favored 'General case' 0 CA--C 1.484 -1.561 0 CA-C-O 124.889 2.28 . . . . 15.0 111.733 -178.895 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 258' ' ' GLY . . . . . 0.417 ' HA2' HG23 ' A' ' 255' ' ' THR . . . 87.73 72.83 1.28 Allowed Glycine 1 C--N 1.241 -4.695 1 CA-C-N 108.174 -4.103 . . . . 15.0 112.703 -171.638 . . . . . . . . 4 3 . 1 . 001 nuclear nobuild full ' A' A ' 259' ' ' VAL . . . . . 0.493 ' O ' ' HA ' ' A' ' 253' ' ' LEU . 53.0 t -89.89 125.2 42.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 121.585 0.707 . . . . 15.0 112.361 176.182 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 3.3 p -132.34 101.93 5.55 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 114.091 -1.413 . . . . 15.0 107.706 167.129 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 12.3 t -132.15 150.24 52.2 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 121.188 0.518 . . . . 15.0 112.352 -169.563 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 262' ' ' TRP . . . . . 1.199 ' CZ2' ' HB2' ' B' ' 215' ' ' PRO . 77.0 m95 -78.26 -25.57 46.85 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.11 -0.95 . . . . 15.0 111.202 176.877 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 263' ' ' HIS . . . . . . . . . . . . . 6.5 p80 -89.34 131.36 35.46 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.496 -0.481 . . . . 15.0 110.212 -175.022 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 264' ' ' ASP . . . . . 1.064 ' HB3' HG12 ' A' ' 267' ' ' ILE . 19.8 t0 -56.36 125.03 64.33 Favored Pre-proline 0 C--N 1.323 -0.565 0 N-CA-C 107.669 -1.234 . . . . 15.0 107.669 170.061 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 265' ' ' PRO . . . . . 0.561 ' HD3' ' CD2' ' A' ' 252' ' ' PHE . 11.5 Cg_exo -70.54 -14.72 33.87 Favored 'Trans proline' 0 C--N 1.323 -0.766 0 C-N-CA 121.751 1.634 . . . . 15.0 112.573 -175.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 266' ' ' ARG . . . . . 0.426 ' HD3' ' HD3' ' A' ' 237' ' ' PRO . 19.3 tpt180 -76.27 -11.99 60.0 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 115.443 -0.799 . . . . 15.0 108.956 173.223 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 267' ' ' ILE . . . . . 1.064 HG12 ' HB3' ' A' ' 264' ' ' ASP . 40.3 pt . . . . . 0 C--O 1.249 1.027 0 CA-C-N 115.017 -0.992 . . . . 15.0 111.448 178.618 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 210' ' ' SER . . . . . . . . . . . . . 20.3 m . . . . . 0 N--CA 1.477 0.885 0 CA-C-O 120.635 0.255 . . . . 15.0 111.279 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 211' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -133.14 119.61 15.7 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 120.502 0.191 . . . . 15.0 110.519 -179.116 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 212' ' ' PRO . . . . . 0.657 ' HB3' HD11 ' A' ' 253' ' ' LEU . 3.9 Cg_endo -89.7 160.0 5.21 Favored 'Trans proline' 0 N--CA 1.455 -0.79 0 C-N-CA 122.707 2.271 . . . . 15.0 111.524 173.904 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -89.76 147.09 19.18 Favored Glycine 0 N--CA 1.443 -0.879 0 C-N-CA 120.338 -0.934 . . . . 15.0 112.241 -177.388 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 214' ' ' SEP . . . . . 0.453 ' HA ' ' HD3' ' B' ' 215' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 215' ' ' PRO . . . . . 1.199 ' HB2' ' CZ2' ' A' ' 262' ' ' TRP . 6.9 Cg_exo -88.04 138.51 4.19 Favored 'Trans proline' 0 C--O 1.233 0.234 0 C-N-CA 123.069 2.513 . . . . 15.0 111.082 177.471 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 216' ' ' PHE . . . . . . . . . . . . . 67.9 m-85 -90.06 115.88 27.66 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 116.203 -0.453 . . . . 15.0 110.085 -178.425 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 217' ' ' GLN . . . . . 0.687 ' HB2' ' CZ2' ' A' ' 262' ' ' TRP . 25.5 tt0 . . . . . 0 C--O 1.251 1.134 0 CA-C-O 118.442 -0.79 . . . . 15.0 109.602 179.463 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.479 1.002 0 CA-C-O 120.42 0.152 . . . . 15.0 110.848 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 61.1 mt -130.52 163.57 47.35 Favored Pre-proline 0 C--N 1.327 -0.398 0 N-CA-C 109.507 -0.553 . . . . 15.0 109.507 179.118 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 237' ' ' PRO . . . . . 0.929 ' HD3' ' HD3' ' A' ' 266' ' ' ARG . 15.2 Cg_exo -69.47 171.16 14.64 Favored 'Trans proline' 0 CA--C 1.513 -0.57 0 C-N-CA 122.055 1.837 . . . . 15.0 110.92 165.927 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -69.68 133.32 47.4 Favored 'General case' 0 C--N 1.302 -1.492 0 CA-C-N 114.415 -1.266 . . . . 15.0 112.208 -173.248 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 100.16 28.83 7.06 Favored Glycine 0 C--N 1.334 0.434 0 CA-C-N 115.16 -0.927 . . . . 15.0 114.094 174.08 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 240' ' ' TYR . . . . . 0.72 ' CD1' ' HB2' ' A' ' 254' ' ' HIS . 65.0 m-85 -117.36 123.72 47.17 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 117.963 0.881 . . . . 15.0 111.468 177.864 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 241' ' ' GLU . . . . . 0.529 ' HG3' ' HB2' ' A' ' 253' ' ' LEU . 10.6 pt-20 -119.64 119.97 35.28 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.76 -0.654 . . . . 15.0 109.595 172.807 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -90.13 109.45 20.51 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 108.775 -0.824 . . . . 15.0 108.775 178.371 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 243' ' ' ARG . . . . . 0.473 ' HB2' ' CE1' ' A' ' 251' ' ' TYR . 31.3 mtt180 -95.87 149.97 20.95 Favored 'General case' 0 CA--C 1.51 -0.574 0 CA-C-O 122.025 0.917 . . . . 15.0 112.295 -175.218 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 244' ' ' THR . . . . . . . . . . . . . 4.9 p -111.61 97.46 6.75 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-N 113.498 -1.683 . . . . 15.0 110.553 -176.553 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 245' ' ' THR . . . . . 0.701 HG23 ' HB2' ' A' ' 247' ' ' GLN . 0.9 OUTLIER -90.7 150.6 21.58 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.187 -0.915 . . . . 15.0 110.302 177.846 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 25.3 t -50.62 -18.43 0.63 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.489 0 O-C-N 123.52 0.513 . . . . 15.0 110.959 176.335 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 247' ' ' GLN . . . . . 0.701 ' HB2' HG23 ' A' ' 245' ' ' THR . 77.9 mm-40 -50.83 -29.11 10.9 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 116.038 -0.528 . . . . 15.0 111.156 171.916 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 80.94 21.41 63.29 Favored Glycine 0 N--CA 1.452 -0.27 0 N-CA-C 111.624 -0.59 . . . . 15.0 111.624 -178.43 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 249' ' ' GLN . . . . . 0.571 HE21 ' HB3' ' A' ' 247' ' ' GLN . 10.4 mt-30 -121.32 143.96 48.9 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.726 -0.472 . . . . 15.0 109.726 -175.803 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 28.8 m -89.84 133.28 32.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 N-CA-C 109.582 -0.525 . . . . 15.0 109.582 176.601 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 251' ' ' TYR . . . . . 0.592 ' CB ' ' HG2' ' B' ' 215' ' ' PRO . 2.4 p90 -140.49 130.11 24.21 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.054 0.454 . . . . 15.0 110.141 -177.12 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 252' ' ' PHE . . . . . 0.615 ' CD2' ' HA ' ' A' ' 264' ' ' ASP . 34.9 m-85 -90.01 116.49 28.09 Favored 'General case' 0 CA--C 1.513 -0.474 0 CA-C-N 115.874 -0.603 . . . . 15.0 111.857 -173.405 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 253' ' ' LEU . . . . . 0.586 HD11 ' CB ' ' B' ' 212' ' ' PRO . 12.9 mt -98.59 126.76 44.27 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-N 114.816 -1.083 . . . . 15.0 111.233 175.677 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 254' ' ' HIS . . . . . 0.72 ' HB2' ' CD1' ' A' ' 240' ' ' TYR . 33.2 t-80 -133.87 89.78 2.62 Favored 'General case' 0 C--N 1.309 -1.183 0 N-CA-C 107.633 -1.247 . . . . 15.0 107.633 167.032 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 3.3 t -94.13 87.95 5.46 Favored 'General case' 0 N--CA 1.429 -1.491 0 C-N-CA 116.334 -2.147 . . . . 15.0 110.105 -179.732 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 60.0 tt0 -101.61 -54.94 2.63 Favored 'General case' 0 N--CA 1.436 -1.137 0 CA-C-N 112.946 -1.934 . . . . 15.0 105.921 151.02 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 257' ' ' THR . . . . . . . . . . . . . 71.6 p -100.04 -13.63 18.97 Favored 'General case' 0 CA--C 1.489 -1.4 0 CA-C-N 111.989 -2.369 . . . . 15.0 112.401 -179.756 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 89.38 71.42 1.26 Allowed Glycine 1 C--N 1.243 -4.622 0 CA-C-N 108.566 -3.924 . . . . 15.0 113.59 -173.15 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 259' ' ' VAL . . . . . 0.666 ' HB ' ' HB3' ' A' ' 254' ' ' HIS . 52.6 t -90.12 129.24 41.32 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 CA-C-O 121.324 0.583 . . . . 15.0 111.564 172.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 1.4 p -143.36 108.15 4.9 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 114.539 -1.209 . . . . 15.0 108.643 169.35 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 7.4 t -149.01 150.34 32.66 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.042 0.448 . . . . 15.0 111.685 -171.616 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 262' ' ' TRP . . . . . 1.156 ' CZ2' ' HB2' ' B' ' 215' ' ' PRO . 89.8 m95 -66.89 -30.21 70.3 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.295 -0.866 . . . . 15.0 111.613 177.119 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 263' ' ' HIS . . . . . . . . . . . . . 3.1 p80 -83.85 133.34 34.75 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.55 -0.46 . . . . 15.0 110.607 -172.248 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 264' ' ' ASP . . . . . 0.87 ' HB3' HG12 ' A' ' 267' ' ' ILE . 9.5 t70 -56.9 129.87 78.44 Favored Pre-proline 0 C--N 1.323 -0.549 0 N-CA-C 108.535 -0.913 . . . . 15.0 108.535 172.766 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 265' ' ' PRO . . . . . 0.518 ' HD3' ' HA ' ' A' ' 264' ' ' ASP . 2.6 Cg_exo -76.33 -14.59 18.28 Favored 'Trans proline' 0 CA--C 1.511 -0.655 0 C-N-CA 122.297 1.998 . . . . 15.0 113.451 -174.524 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 266' ' ' ARG . . . . . 0.929 ' HD3' ' HD3' ' A' ' 237' ' ' PRO . 6.4 tpt180 -79.39 -8.72 59.3 Favored 'General case' 0 C--N 1.31 -1.149 0 CA-C-O 121.953 0.882 . . . . 15.0 108.78 175.635 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 267' ' ' ILE . . . . . 0.87 HG12 ' HB3' ' A' ' 264' ' ' ASP . 42.4 mm . . . . . 0 C--O 1.249 1.033 0 CA-C-N 113.997 -1.456 . . . . 15.0 109.809 178.755 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 210' ' ' SER . . . . . . . . . . . . . 12.5 p . . . . . 0 N--CA 1.476 0.873 0 CA-C-O 121.14 0.495 . . . . 15.0 110.74 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 211' ' ' ASP . . . . . 0.54 ' HA ' ' HD3' ' B' ' 212' ' ' PRO . 7.2 p-10 -150.3 135.38 9.86 Favored Pre-proline 0 C--N 1.325 -0.488 0 CA-C-N 115.945 -0.57 . . . . 15.0 110.672 -179.185 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 212' ' ' PRO . . . . . 0.586 ' CB ' HD11 ' A' ' 253' ' ' LEU . 1.4 Cg_endo -89.79 138.87 3.12 Favored 'Trans proline' 0 N--CA 1.458 -0.599 0 C-N-CA 123.529 2.819 . . . . 15.0 111.99 178.766 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -89.79 141.98 16.35 Favored Glycine 0 N--CA 1.444 -0.816 0 C-N-CA 120.813 -0.708 . . . . 15.0 111.561 -179.101 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 214' ' ' SEP . . . . . 0.468 ' HA ' ' HD3' ' B' ' 215' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 215' ' ' PRO . . . . . 1.156 ' HB2' ' CZ2' ' A' ' 262' ' ' TRP . 16.8 Cg_exo -88.24 147.13 6.47 Favored 'Trans proline' 0 N--CA 1.461 -0.389 0 C-N-CA 123.573 2.848 . . . . 15.0 111.88 -178.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 216' ' ' PHE . . . . . . . . . . . . . 71.0 m-85 -120.36 159.19 25.55 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.93 -0.396 . . . . 15.0 109.93 173.557 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 217' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.25 1.123 0 CA-C-O 118.869 -0.586 . . . . 15.0 110.865 -176.536 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 . . . . . 0 N--CA 1.484 1.233 0 N-CA-C 109.863 -0.421 . . . . 15.0 109.863 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 236' ' ' LEU . . . . . 0.459 HD22 ' H ' ' A' ' 236' ' ' LEU . 0.2 OUTLIER -103.31 169.53 7.3 Favored Pre-proline 0 C--N 1.321 -0.634 0 N-CA-C 109.188 -0.671 . . . . 15.0 109.188 -179.875 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 237' ' ' PRO . . . . . 0.638 ' HD3' ' HD3' ' A' ' 266' ' ' ARG . 12.9 Cg_exo -69.84 163.32 38.77 Favored 'Trans proline' 0 CA--C 1.514 -0.487 0 C-N-CA 122.022 1.815 . . . . 15.0 110.143 167.839 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 238' ' ' GLU . . . . . 0.401 ' H ' ' CD ' ' A' ' 238' ' ' GLU . 1.1 pm0 -69.81 146.14 51.6 Favored 'General case' 0 C--N 1.305 -1.365 0 CA-C-N 115.45 -0.795 . . . . 15.0 111.611 -175.456 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 239' ' ' GLY . . . . . 0.415 ' O ' ' HA ' ' A' ' 254' ' ' HIS . . . 99.96 3.54 55.84 Favored Glycine 0 N--CA 1.449 -0.48 0 CA-C-N 115.353 -0.84 . . . . 15.0 113.896 178.218 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 240' ' ' TYR . . . . . 0.765 ' CD1' ' HB2' ' A' ' 254' ' ' HIS . 83.6 m-85 -107.12 123.73 48.67 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 117.45 0.625 . . . . 15.0 110.878 178.001 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -110.12 130.71 55.49 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 109.534 -0.543 . . . . 15.0 109.534 170.442 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 242' ' ' GLN . . . . . 0.457 ' HG3' ' CE1' ' A' ' 252' ' ' PHE . 18.9 tt0 -89.92 112.04 23.3 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.253 -0.647 . . . . 15.0 109.253 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 31.9 mtp85 -105.94 145.67 31.01 Favored 'General case' 0 CA--C 1.502 -0.893 0 CA-C-O 121.957 0.884 . . . . 15.0 112.665 -177.508 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 244' ' ' THR . . . . . . . . . . . . . 48.6 m -121.74 93.33 3.97 Favored 'General case' 0 C--N 1.309 -1.157 0 CA-C-N 113.412 -1.722 . . . . 15.0 109.86 -178.8 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 245' ' ' THR . . . . . 1.059 HG23 ' HG2' ' A' ' 247' ' ' GLN . 5.2 t -89.97 150.61 22.07 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.15 -0.932 . . . . 15.0 110.484 -178.567 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 246' ' ' VAL . . . . . 0.408 ' H ' HG23 ' A' ' 246' ' ' VAL . 34.1 t -44.2 -25.7 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 N-CA-C 113.596 0.962 . . . . 15.0 113.596 -175.305 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 247' ' ' GLN . . . . . 1.059 ' HG2' HG23 ' A' ' 245' ' ' THR . 3.4 pt20 -55.1 -18.72 5.9 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 111.579 0.214 . . . . 15.0 111.579 177.649 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 87.7 26.52 29.44 Favored Glycine 0 C--N 1.334 0.472 0 C-N-CA 121.356 -0.449 . . . . 15.0 112.721 175.254 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 249' ' ' GLN . . . . . 0.489 HE21 ' CD ' ' A' ' 247' ' ' GLN . 10.7 mt-30 -138.86 140.34 38.42 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.699 -0.482 . . . . 15.0 109.699 -177.62 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 20.5 m -90.04 141.93 13.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 116.397 -0.365 . . . . 15.0 110.652 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 251' ' ' TYR . . . . . 0.743 ' HB3' ' HG2' ' B' ' 215' ' ' PRO . 18.4 p90 -142.21 140.06 32.21 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.468 -0.567 . . . . 15.0 109.468 -178.936 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 252' ' ' PHE . . . . . 0.73 ' CD2' ' HA ' ' A' ' 264' ' ' ASP . 42.4 m-85 -93.6 119.39 32.58 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.123 -0.49 . . . . 15.0 111.895 -174.708 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 253' ' ' LEU . . . . . 0.636 HD11 ' HB3' ' B' ' 212' ' ' PRO . 4.1 mt -101.46 117.05 34.15 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-N 115.225 -0.898 . . . . 15.0 111.136 179.244 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 254' ' ' HIS . . . . . 0.765 ' HB2' ' CD1' ' A' ' 240' ' ' TYR . 34.2 t-80 -130.76 90.02 2.84 Favored 'General case' 0 CA--C 1.5 -0.943 0 N-CA-C 107.916 -1.142 . . . . 15.0 107.916 169.464 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 37.1 m -92.73 87.93 6.06 Favored 'General case' 0 N--CA 1.433 -1.293 0 C-N-CA 116.735 -1.986 . . . . 15.0 110.453 -178.802 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 7.8 tt0 -101.14 -52.2 3.33 Favored 'General case' 0 N--CA 1.443 -0.809 0 N-CA-C 106.041 -1.837 . . . . 15.0 106.041 149.447 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 257' ' ' THR . . . . . . . . . . . . . 73.3 p -97.89 -13.48 21.21 Favored 'General case' 0 CA--C 1.487 -1.452 0 CA-C-O 124.779 2.228 . . . . 15.0 111.727 -179.839 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 86.28 70.83 1.31 Allowed Glycine 1 C--N 1.24 -4.772 0 CA-C-N 108.483 -3.962 . . . . 15.0 113.14 -172.665 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 259' ' ' VAL . . . . . 0.617 ' O ' HD23 ' A' ' 253' ' ' LEU . 48.0 t -89.99 125.33 42.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 N-CA-C 112.637 0.606 . . . . 15.0 112.637 177.103 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -138.07 102.19 4.62 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 107.794 -1.188 . . . . 15.0 107.794 167.217 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 12.5 t -138.02 150.35 46.88 Favored 'General case' 0 C--N 1.317 -0.812 0 C-N-CA 120.533 -0.467 . . . . 15.0 112.208 -167.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 262' ' ' TRP . . . . . 1.206 ' CZ2' ' HB2' ' B' ' 215' ' ' PRO . 80.7 m95 -71.28 -33.26 69.59 Favored 'General case' 0 N--CA 1.455 -0.195 0 CA-C-N 115.391 -0.822 . . . . 15.0 111.719 178.912 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 263' ' ' HIS . . . . . . . . . . . . . 5.0 p80 -83.48 134.68 34.84 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.511 -0.476 . . . . 15.0 110.017 -175.245 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 264' ' ' ASP . . . . . 1.001 ' HB3' HG12 ' A' ' 267' ' ' ILE . 10.8 t70 -55.87 131.9 73.17 Favored Pre-proline 0 C--N 1.323 -0.549 0 N-CA-C 108.664 -0.865 . . . . 15.0 108.664 172.615 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 265' ' ' PRO . . . . . 0.525 ' HD3' ' CD2' ' A' ' 252' ' ' PHE . 72.0 Cg_endo -75.67 -14.76 19.62 Favored 'Trans proline' 0 CA--C 1.507 -0.842 0 C-N-CA 121.456 1.437 . . . . 15.0 113.464 -172.071 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 266' ' ' ARG . . . . . 0.638 ' HD3' ' HD3' ' A' ' 237' ' ' PRO . 8.6 tpt180 -81.51 -7.43 59.58 Favored 'General case' 0 C--N 1.306 -1.283 0 N-CA-C 108.168 -1.049 . . . . 15.0 108.168 175.227 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 267' ' ' ILE . . . . . 1.001 HG12 ' HB3' ' A' ' 264' ' ' ASP . 37.5 pt . . . . . 0 C--O 1.25 1.093 0 CA-C-N 114.002 -1.454 . . . . 15.0 110.85 175.691 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 210' ' ' SER . . . . . . . . . . . . . 10.3 p . . . . . 0 N--CA 1.475 0.808 0 CA-C-O 121.014 0.435 . . . . 15.0 110.555 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 211' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -90.16 118.08 68.56 Favored Pre-proline 0 C--N 1.325 -0.489 0 CA-C-O 121.174 0.512 . . . . 15.0 111.346 -175.284 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 212' ' ' PRO . . . . . 0.636 ' HB3' HD11 ' A' ' 253' ' ' LEU . 9.2 Cg_endo -89.93 146.06 4.58 Favored 'Trans proline' 0 N--CA 1.451 -0.974 0 C-N-CA 122.816 2.344 . . . . 15.0 111.157 172.46 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -89.52 159.32 28.23 Favored Glycine 0 N--CA 1.439 -1.148 0 C-N-CA 120.099 -1.048 . . . . 15.0 111.702 -179.502 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 214' ' ' SEP . . . . . 0.636 ' HB2' HG21 ' A' ' 245' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 215' ' ' PRO . . . . . 1.206 ' HB2' ' CZ2' ' A' ' 262' ' ' TRP 0.262 16.9 Cg_exo -87.41 149.89 7.74 Favored 'Trans proline' 0 C--O 1.236 0.389 0 C-N-CA 123.248 2.632 . . . . 15.0 110.637 179.831 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 216' ' ' PHE . . . . . . . . . . . . . 99.1 m-85 -108.52 118.37 36.6 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 120.809 0.337 . . . . 15.0 110.182 -179.498 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 217' ' ' GLN . . . . . . . . . . . . . 9.4 tt0 . . . . . 0 C--O 1.246 0.91 0 CA-C-O 118.671 -0.681 . . . . 15.0 109.167 176.951 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 5.6 mp0 . . . . . 0 N--CA 1.481 1.088 0 CA-C-O 120.853 0.359 . . . . 15.0 110.454 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 5.8 mt -95.63 172.97 4.71 Favored Pre-proline 0 C--N 1.323 -0.582 0 N-CA-C 109.676 -0.49 . . . . 15.0 109.676 -179.66 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 237' ' ' PRO . . . . . 0.62 ' HD3' ' HD3' ' A' ' 266' ' ' ARG . 21.9 Cg_exo -69.37 161.16 46.97 Favored 'Trans proline' 0 C--O 1.235 0.333 0 C-N-CA 121.876 1.717 . . . . 15.0 110.398 164.466 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 238' ' ' GLU . . . . . 0.404 ' H ' ' CD ' ' A' ' 238' ' ' GLU . 1.3 pm0 -69.65 150.39 47.06 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-N 115.496 -0.774 . . . . 15.0 110.914 -175.313 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 100.24 -15.13 59.32 Favored Glycine 0 N--CA 1.447 -0.625 0 CA-C-N 115.688 -0.687 . . . . 15.0 112.599 -177.729 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 240' ' ' TYR . . . . . 0.468 ' CD1' ' HG2' ' A' ' 265' ' ' PRO . 65.9 m-85 -94.61 116.42 28.75 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.142 0.496 . . . . 15.0 110.523 177.057 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -95.3 116.93 29.43 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 115.625 -0.716 . . . . 15.0 109.123 174.843 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -90.01 97.45 11.2 Favored 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 108.993 -0.743 . . . . 15.0 108.993 178.03 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 243' ' ' ARG . . . . . 0.439 HH11 ' HD2' ' A' ' 243' ' ' ARG . 11.9 mtp180 -100.42 149.54 23.55 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 115.298 -0.865 . . . . 15.0 111.478 -179.162 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 244' ' ' THR . . . . . . . . . . . . . 22.8 m -117.64 128.7 55.18 Favored 'General case' 0 C--N 1.309 -1.172 0 CA-C-N 114.08 -1.418 . . . . 15.0 108.718 -178.629 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 245' ' ' THR . . . . . 0.422 HG22 ' O ' ' A' ' 249' ' ' GLN . 8.3 t -115.28 150.44 36.21 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 116.277 -0.42 . . . . 15.0 111.03 -174.113 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 50.8 t -57.73 -15.78 4.87 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 CA-C-N 115.795 -0.639 . . . . 15.0 111.302 179.865 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 247' ' ' GLN . . . . . . . . . . . . . 8.8 mm100 -61.46 -20.82 63.57 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 121.093 0.473 . . . . 15.0 110.65 175.553 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 90.63 36.98 6.64 Favored Glycine 0 N--CA 1.452 -0.28 0 CA-C-N 115.559 -0.746 . . . . 15.0 112.003 178.546 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 249' ' ' GLN . . . . . 0.456 ' NE2' ' HD2' ' B' ' 215' ' ' PRO . 8.0 pt20 -148.02 139.62 23.75 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.873 0.368 . . . . 15.0 111.12 -175.524 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 15.9 m -89.95 135.58 25.92 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 N-CA-C 109.395 -0.595 . . . . 15.0 109.395 172.557 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 251' ' ' TYR . . . . . 0.697 ' CD2' ' HD3' ' B' ' 215' ' ' PRO . 0.6 OUTLIER -136.81 138.36 40.77 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-O 120.95 0.405 . . . . 15.0 110.123 -179.981 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 252' ' ' PHE . . . . . 0.623 ' CE2' ' HA ' ' A' ' 264' ' ' ASP . 40.6 m-85 -89.99 118.2 29.37 Favored 'General case' 0 CA--C 1.512 -0.491 0 CA-C-O 121.229 0.537 . . . . 15.0 111.449 -173.419 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 253' ' ' LEU . . . . . 0.898 HD11 ' HB3' ' B' ' 212' ' ' PRO . 0.8 OUTLIER -110.26 106.77 16.29 Favored 'General case' 0 N--CA 1.446 -0.653 0 CA-C-N 114.714 -1.13 . . . . 15.0 111.885 -173.048 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 254' ' ' HIS . . . . . 0.417 ' HB2' ' CD1' ' A' ' 240' ' ' TYR . 26.8 t-80 -115.41 95.03 4.97 Favored 'General case' 0 C--N 1.312 -1.048 0 N-CA-C 108.298 -1.001 . . . . 15.0 108.298 170.104 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 26.3 m -94.08 88.02 5.51 Favored 'General case' 0 N--CA 1.43 -1.436 0 C-N-CA 116.985 -1.886 . . . . 15.0 110.459 -179.08 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 58.9 tt0 -101.12 -51.15 3.59 Favored 'General case' 0 N--CA 1.438 -1.033 0 N-CA-C 105.924 -1.88 . . . . 15.0 105.924 146.768 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 257' ' ' THR . . . . . . . . . . . . . 63.1 p -99.94 -13.69 19.02 Favored 'General case' 0 CA--C 1.484 -1.581 0 CA-C-O 124.735 2.207 . . . . 15.0 112.275 -178.062 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 83.09 76.18 1.14 Allowed Glycine 1 C--N 1.239 -4.851 0 CA-C-N 108.594 -3.912 . . . . 15.0 111.934 -170.225 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 259' ' ' VAL . . . . . 0.677 ' O ' ' HA ' ' A' ' 253' ' ' LEU . 54.8 t -89.35 124.47 42.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-O 121.478 0.656 . . . . 15.0 111.725 176.86 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 3.6 p -135.04 97.41 3.73 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 114.285 -1.325 . . . . 15.0 108.394 171.347 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 10.6 t -134.92 150.26 50.39 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.037 0.446 . . . . 15.0 112.018 -170.387 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 262' ' ' TRP . . . . . 1.148 ' CZ2' ' HB2' ' B' ' 215' ' ' PRO . 42.3 m95 -72.15 -31.04 65.6 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.38 -0.827 . . . . 15.0 111.844 177.341 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 263' ' ' HIS . . . . . . . . . . . . . 5.2 p80 -80.15 130.74 35.45 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 120.196 -0.602 . . . . 15.0 110.155 -174.413 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 264' ' ' ASP . . . . . 1.094 ' HB3' HG12 ' A' ' 267' ' ' ILE . 13.8 t0 -63.12 127.44 90.93 Favored Pre-proline 0 C--N 1.321 -0.64 0 N-CA-C 107.77 -1.196 . . . . 15.0 107.77 171.169 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 265' ' ' PRO . . . . . 0.468 ' HG2' ' CD1' ' A' ' 240' ' ' TYR . 15.9 Cg_exo -69.09 -14.9 39.05 Favored 'Trans proline' 0 C--N 1.323 -0.799 0 C-N-CA 121.878 1.719 . . . . 15.0 113.087 -178.118 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 266' ' ' ARG . . . . . 0.62 ' HD3' ' HD3' ' A' ' 237' ' ' PRO . 4.5 tpt180 -80.83 -6.5 58.66 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-O 121.834 0.826 . . . . 15.0 109.156 175.031 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 267' ' ' ILE . . . . . 1.094 HG12 ' HB3' ' A' ' 264' ' ' ASP . 48.2 pt . . . . . 0 C--O 1.248 0.987 0 CA-C-N 114.299 -1.318 . . . . 15.0 111.689 177.735 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 210' ' ' SER . . . . . . . . . . . . . 9.5 m . . . . . 0 N--CA 1.479 0.988 0 CA-C-O 120.759 0.314 . . . . 15.0 110.72 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 211' ' ' ASP . . . . . 0.422 ' HA ' ' HD3' ' B' ' 212' ' ' PRO . 3.0 m-20 -89.85 119.53 69.41 Favored Pre-proline 0 C--O 1.233 0.185 0 CA-C-N 116.278 -0.419 . . . . 15.0 110.319 -173.243 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 212' ' ' PRO . . . . . 0.898 ' HB3' HD11 ' A' ' 253' ' ' LEU . 1.9 Cg_endo -90.0 149.14 4.77 Favored 'Trans proline' 0 N--CA 1.458 -0.586 0 C-N-CA 123.118 2.545 . . . . 15.0 112.234 177.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -89.61 141.15 15.97 Favored Glycine 0 N--CA 1.446 -0.68 0 C-N-CA 120.925 -0.655 . . . . 15.0 112.607 -179.647 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 214' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 215' ' ' PRO . . . . . 1.148 ' HB2' ' CZ2' ' A' ' 262' ' ' TRP 0.251 16.8 Cg_exo -88.06 139.12 4.38 Favored 'Trans proline' 0 N--CA 1.475 0.428 0 C-N-CA 124.125 3.217 . . . . 15.0 112.932 -172.635 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 216' ' ' PHE . . . . . . . . . . . . . 69.7 m-85 -96.08 127.4 42.06 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.571 -0.741 . . . . 15.0 109.102 175.008 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 217' ' ' GLN . . . . . . . . . . . . . 12.3 pt20 . . . . . 0 C--O 1.247 0.952 0 CA-C-O 118.412 -0.804 . . . . 15.0 111.122 -177.68 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 . . . . . 0 N--CA 1.48 1.071 0 N-CA-C 109.843 -0.429 . . . . 15.0 109.843 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 236' ' ' LEU . . . . . 0.447 HD22 ' N ' ' A' ' 236' ' ' LEU . 1.1 mm? -114.63 168.04 8.71 Favored Pre-proline 0 C--N 1.32 -0.677 0 N-CA-C 109.765 -0.457 . . . . 15.0 109.765 -179.82 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 237' ' ' PRO . . . . . 0.458 ' HD3' ' HD3' ' A' ' 266' ' ' ARG . 16.2 Cg_exo -69.53 164.72 33.23 Favored 'Trans proline' 0 N--CA 1.459 -0.522 0 C-N-CA 121.801 1.667 . . . . 15.0 110.118 165.011 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -69.58 135.65 50.28 Favored 'General case' 0 C--N 1.303 -1.443 0 CA-C-N 115.053 -0.976 . . . . 15.0 111.361 -171.955 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 100.44 21.63 12.68 Favored Glycine 0 CA--C 1.521 0.431 0 CA-C-N 115.504 -0.771 . . . . 15.0 114.349 178.794 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 240' ' ' TYR . . . . . 0.749 ' CD1' ' HB2' ' A' ' 254' ' ' HIS . 73.7 m-85 -112.39 114.43 27.14 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 118.298 1.049 . . . . 15.0 110.798 175.307 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 37.5 mm-40 -98.2 119.44 36.86 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.686 -0.688 . . . . 15.0 109.216 175.341 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -89.93 107.52 19.16 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 108.032 -1.099 . . . . 15.0 108.032 175.909 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 6.3 mtp85 -97.25 132.38 43.06 Favored 'General case' 0 CA--C 1.496 -1.109 0 CA-C-O 122.451 1.119 . . . . 15.0 113.434 -172.774 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 244' ' ' THR . . . . . . . . . . . . . 1.3 m -100.66 89.92 4.07 Favored 'General case' 0 C--N 1.306 -1.314 0 CA-C-N 112.805 -1.998 . . . . 15.0 109.05 177.517 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 245' ' ' THR . . . . . 1.05 HG23 ' HG2' ' A' ' 247' ' ' GLN . 7.8 t -95.04 150.75 19.83 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 114.989 -1.005 . . . . 15.0 110.401 -176.653 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 61.1 t -39.69 -30.9 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 N-CA-C 113.901 1.075 . . . . 15.0 113.901 -174.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 247' ' ' GLN . . . . . 1.05 ' HG2' HG23 ' A' ' 245' ' ' THR . 3.8 pt20 -56.55 -21.14 24.34 Favored 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 111.838 0.31 . . . . 15.0 111.838 178.111 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 80.42 37.21 21.46 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 121.141 -0.552 . . . . 15.0 112.988 176.49 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 249' ' ' GLN . . . . . 0.488 ' HB2' ' OE1' ' A' ' 247' ' ' GLN . 34.3 mt-30 -135.71 149.98 49.4 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.678 -0.49 . . . . 15.0 109.678 179.633 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 15.5 m -89.83 128.23 41.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 120.934 0.397 . . . . 15.0 110.562 178.433 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 251' ' ' TYR . . . . . 0.715 ' CB ' ' HG2' ' B' ' 215' ' ' PRO . 4.0 p90 -138.69 133.19 31.98 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.006 0.431 . . . . 15.0 109.883 -178.647 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 252' ' ' PHE . . . . . 0.679 ' CD2' ' HA ' ' A' ' 264' ' ' ASP . 36.0 m-85 -89.78 118.2 29.2 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.023 -0.535 . . . . 15.0 110.88 -175.007 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 253' ' ' LEU . . . . . 0.578 HD11 ' HB3' ' B' ' 212' ' ' PRO . 0.7 OUTLIER -111.1 119.33 38.62 Favored 'General case' 0 N--CA 1.447 -0.617 0 CA-C-N 115.09 -0.959 . . . . 15.0 110.398 -177.674 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 254' ' ' HIS . . . . . 0.749 ' HB2' ' CD1' ' A' ' 240' ' ' TYR . 9.1 t-80 -133.0 101.31 5.18 Favored 'General case' 0 CA--C 1.495 -1.14 0 N-CA-C 108.956 -0.757 . . . . 15.0 108.956 173.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 3.5 t -95.89 87.66 4.69 Favored 'General case' 0 N--CA 1.432 -1.333 0 C-N-CA 116.388 -2.125 . . . . 15.0 110.617 179.74 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 44.3 tt0 -101.35 -55.96 2.42 Favored 'General case' 0 N--CA 1.441 -0.906 0 N-CA-C 105.973 -1.862 . . . . 15.0 105.973 150.807 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 257' ' ' THR . . . . . . . . . . . . . 80.4 p -99.77 -13.72 19.15 Favored 'General case' 0 CA--C 1.489 -1.383 0 CA-C-N 111.893 -2.412 . . . . 15.0 112.047 -176.275 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 89.16 70.6 1.26 Allowed Glycine 1 C--N 1.242 -4.655 0 CA-C-N 108.537 -3.938 . . . . 15.0 112.903 -171.025 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 259' ' ' VAL . . . . . 0.512 ' O ' ' HA ' ' A' ' 253' ' ' LEU . 54.6 t -90.05 127.38 42.66 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.31 0 CA-C-O 121.207 0.527 . . . . 15.0 112.251 176.861 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 2.3 p -145.68 102.15 3.64 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 114.672 -1.149 . . . . 15.0 108.416 169.686 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 5.5 t -145.48 150.12 35.9 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 115.868 -0.606 . . . . 15.0 111.781 -171.384 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 262' ' ' TRP . . . . . 1.18 ' CZ2' ' HB2' ' B' ' 215' ' ' PRO . 90.2 m95 -71.52 -23.31 61.76 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.358 -0.837 . . . . 15.0 111.199 176.535 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 263' ' ' HIS . . . . . . . . . . . . . 1.9 p80 -87.88 132.07 34.34 Favored 'General case' 0 C--O 1.234 0.266 0 C-N-CA 120.231 -0.587 . . . . 15.0 110.524 -173.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 264' ' ' ASP . . . . . 0.775 ' HB3' HG12 ' A' ' 267' ' ' ILE . 9.2 t70 -51.82 130.92 38.19 Favored Pre-proline 0 C--N 1.326 -0.439 0 CA-C-N 115.359 -0.837 . . . . 15.0 109.574 175.332 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 265' ' ' PRO . . . . . 0.519 ' HD3' ' CD2' ' A' ' 252' ' ' PHE . 71.9 Cg_endo -78.11 -14.89 14.86 Favored 'Trans proline' 0 CA--C 1.514 -0.506 0 C-N-CA 122.384 2.056 . . . . 15.0 113.644 -173.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 266' ' ' ARG . . . . . 0.458 ' HD3' ' HD3' ' A' ' 237' ' ' PRO . 7.2 tpt180 -77.08 -8.24 57.12 Favored 'General case' 0 C--N 1.311 -1.074 0 N-CA-C 107.694 -1.224 . . . . 15.0 107.694 174.546 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 267' ' ' ILE . . . . . 0.775 HG12 ' HB3' ' A' ' 264' ' ' ASP . 28.4 mm . . . . . 0 C--O 1.248 0.976 0 CA-C-N 113.537 -1.665 . . . . 15.0 109.216 174.634 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 210' ' ' SER . . . . . . . . . . . . . 14.9 m . . . . . 0 N--CA 1.477 0.889 0 CA-C-O 120.84 0.352 . . . . 15.0 110.572 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 211' ' ' ASP . . . . . 0.456 ' HA ' ' HD3' ' B' ' 212' ' ' PRO . 11.8 m-20 -89.81 130.61 42.27 Favored Pre-proline 0 C--N 1.332 -0.175 0 CA-C-N 116.449 -0.341 . . . . 15.0 110.274 -177.511 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 212' ' ' PRO . . . . . 0.578 ' HB3' HD11 ' A' ' 253' ' ' LEU . 5.0 Cg_endo -90.04 151.37 4.8 Favored 'Trans proline' 0 N--CA 1.46 -0.46 0 C-N-CA 123.483 2.788 . . . . 15.0 113.179 -175.404 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -89.95 160.21 28.41 Favored Glycine 0 N--CA 1.444 -0.796 0 CA-C-N 115.346 -0.843 . . . . 15.0 112.839 178.538 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 214' ' ' SEP . . . . . 0.673 ' HB2' HG21 ' A' ' 245' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 215' ' ' PRO . . . . . 1.18 ' HB2' ' CZ2' ' A' ' 262' ' ' TRP . 30.3 Cg_exo -87.19 146.41 7.55 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 123.172 2.581 . . . . 15.0 111.47 176.672 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 216' ' ' PHE . . . . . . . . . . . . . 87.5 m-85 -122.87 137.79 54.84 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 110.391 -0.225 . . . . 15.0 110.391 179.929 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 217' ' ' GLN . . . . . . . . . . . . . 10.6 tt0 . . . . . 0 C--O 1.248 1.017 0 O-C-N 124.339 1.025 . . . . 15.0 110.541 179.789 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.479 1.022 0 CA-C-O 120.693 0.282 . . . . 15.0 110.834 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 5.8 mt -103.89 170.37 6.22 Favored Pre-proline 0 C--N 1.325 -0.491 0 N-CA-C 108.948 -0.76 . . . . 15.0 108.948 178.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 237' ' ' PRO . . . . . 0.52 ' HD3' ' HD3' ' A' ' 266' ' ' ARG . 17.2 Cg_exo -69.31 156.96 63.01 Favored 'Trans proline' 0 N--CA 1.458 -0.563 0 C-N-CA 121.55 1.5 . . . . 15.0 109.636 162.842 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 4.6 mp0 -69.71 149.38 48.09 Favored 'General case' 0 C--N 1.31 -1.146 0 CA-C-O 121.341 0.591 . . . . 15.0 111.409 -173.325 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 100.19 -7.36 58.5 Favored Glycine 0 N--CA 1.446 -0.66 0 CA-C-N 115.173 -0.921 . . . . 15.0 113.722 179.905 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 240' ' ' TYR . . . . . 0.66 ' CD1' ' HB2' ' A' ' 254' ' ' HIS . 67.7 m-85 -91.03 113.13 25.31 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 117.535 0.667 . . . . 15.0 110.81 178.199 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 57.9 mm-40 -92.05 118.41 30.77 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 109.367 -0.605 . . . . 15.0 109.367 174.924 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 24.8 tm0? -89.94 107.75 19.3 Favored 'General case' 0 C--N 1.314 -0.963 0 N-CA-C 109.163 -0.68 . . . . 15.0 109.163 176.806 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 243' ' ' ARG . . . . . 0.429 ' HB2' ' CE1' ' A' ' 251' ' ' TYR . 17.3 mtp85 -103.47 150.03 24.27 Favored 'General case' 0 CA--C 1.512 -0.519 0 CA-C-O 122.116 0.96 . . . . 15.0 111.982 178.081 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 244' ' ' THR . . . . . . . . . . . . . 24.4 p -111.27 148.24 33.31 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-N 113.504 -1.68 . . . . 15.0 109.367 -179.064 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 245' ' ' THR . . . . . 0.463 ' OG1' ' HG2' ' A' ' 247' ' ' GLN . 6.0 t -145.26 150.11 36.09 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-O 120.641 0.258 . . . . 15.0 111.142 -175.186 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 7.7 p -50.87 -26.79 4.55 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.219 0 CA-C-N 115.541 -0.754 . . . . 15.0 111.256 177.748 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 247' ' ' GLN . . . . . 0.463 ' HG2' ' OG1' ' A' ' 245' ' ' THR . 6.8 mm-40 -53.75 -21.4 7.16 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 114.787 -1.097 . . . . 15.0 111.472 177.959 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 81.82 25.19 53.78 Favored Glycine 0 CA--C 1.509 -0.282 0 C-N-CA 121.255 -0.498 . . . . 15.0 111.871 178.146 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 249' ' ' GLN . . . . . 0.419 ' CD ' ' HH2' ' A' ' 262' ' ' TRP . 0.6 OUTLIER -130.47 138.37 50.24 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.759 -0.46 . . . . 15.0 109.759 -175.614 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 18.8 m -90.02 132.43 34.72 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 N-CA-C 109.354 -0.61 . . . . 15.0 109.354 175.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 251' ' ' TYR . . . . . 0.511 ' HB3' ' HG2' ' B' ' 215' ' ' PRO . 4.4 p90 -135.16 134.19 39.91 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.486 0.66 . . . . 15.0 111.325 -178.7 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 252' ' ' PHE . . . . . 0.731 ' CE2' ' HA ' ' A' ' 264' ' ' ASP . 37.8 m-85 -90.28 118.5 29.84 Favored 'General case' 0 CA--C 1.516 -0.335 0 CA-C-N 115.246 -0.888 . . . . 15.0 111.046 -176.654 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 253' ' ' LEU . . . . . 0.876 HD11 ' HB3' ' B' ' 212' ' ' PRO . 0.5 OUTLIER -109.9 99.21 8.37 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-N 114.942 -1.026 . . . . 15.0 111.205 -174.675 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 254' ' ' HIS . . . . . 0.66 ' HB2' ' CD1' ' A' ' 240' ' ' TYR . 36.9 t-80 -112.17 92.56 4.07 Favored 'General case' 0 CA--C 1.499 -1.018 0 N-CA-C 108.57 -0.9 . . . . 15.0 108.57 169.58 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 7.9 t -96.55 88.06 4.57 Favored 'General case' 0 N--CA 1.432 -1.331 0 C-N-CA 116.524 -2.07 . . . . 15.0 110.729 -179.076 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 49.1 tt0 -101.17 -50.39 3.8 Favored 'General case' 0 N--CA 1.441 -0.924 0 CA-C-N 113.127 -1.851 . . . . 15.0 106.42 151.601 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 257' ' ' THR . . . . . . . . . . . . . 68.7 p -97.99 -13.57 21.05 Favored 'General case' 0 CA--C 1.488 -1.431 0 CA-C-O 124.865 2.269 . . . . 15.0 111.681 -179.565 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 88.71 71.41 1.27 Allowed Glycine 1 C--N 1.241 -4.737 1 CA-C-N 108.224 -4.08 . . . . 15.0 113.109 -171.602 . . . . . . . . 3 2 . 1 . 006 nuclear nobuild full ' A' A ' 259' ' ' VAL . . . . . 0.574 ' O ' ' HA ' ' A' ' 253' ' ' LEU . 45.8 t -89.81 124.45 42.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 121.376 0.607 . . . . 15.0 111.911 174.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -136.94 92.36 2.72 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 114.541 -1.209 . . . . 15.0 108.018 167.763 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 5.0 t -129.27 150.23 50.73 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.705 -0.679 . . . . 15.0 111.966 -166.193 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 262' ' ' TRP . . . . . 1.185 ' CZ2' ' HB2' ' B' ' 215' ' ' PRO . 85.5 m95 -71.61 -50.63 29.04 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.164 -0.926 . . . . 15.0 111.691 179.337 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 263' ' ' HIS . . . . . . . . . . . . . 5.4 p80 -66.49 134.48 52.53 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.912 -0.586 . . . . 15.0 110.629 -175.527 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 264' ' ' ASP . . . . . 1.083 ' HB3' HG12 ' A' ' 267' ' ' ILE . 37.8 t0 -54.29 124.14 45.55 Favored Pre-proline 0 C--O 1.218 -0.554 0 N-CA-C 107.408 -1.33 . . . . 15.0 107.408 167.217 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 265' ' ' PRO . . . . . 0.597 ' HD3' ' CD2' ' A' ' 252' ' ' PHE . 12.6 Cg_exo -69.03 -14.67 38.84 Favored 'Trans proline' 0 C--N 1.323 -0.794 0 C-N-CA 121.788 1.659 . . . . 15.0 112.617 -176.324 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 266' ' ' ARG . . . . . 0.52 ' HD3' ' HD3' ' A' ' 237' ' ' PRO . 5.8 tpt180 -78.28 -9.86 59.41 Favored 'General case' 0 N--CA 1.439 -0.998 0 CA-C-O 121.861 0.838 . . . . 15.0 109.136 173.143 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 267' ' ' ILE . . . . . 1.083 HG12 ' HB3' ' A' ' 264' ' ' ASP . 48.2 pt . . . . . 0 C--O 1.246 0.89 0 CA-C-O 117.543 -1.218 . . . . 15.0 110.875 176.779 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 210' ' ' SER . . . . . . . . . . . . . 16.6 p . . . . . 0 N--CA 1.481 1.125 0 CA-C-O 120.859 0.361 . . . . 15.0 110.735 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' 211' ' ' ASP . . . . . 0.418 ' HA ' ' HD3' ' B' ' 212' ' ' PRO . 2.8 m-20 -89.97 115.27 63.55 Favored Pre-proline 0 C--N 1.331 -0.223 0 CA-C-N 116.4 -0.364 . . . . 15.0 110.799 -173.948 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 212' ' ' PRO . . . . . 0.876 ' HB3' HD11 ' A' ' 253' ' ' LEU . 2.6 Cg_endo -89.67 154.13 5.18 Favored 'Trans proline' 0 N--CA 1.456 -0.7 0 C-N-CA 122.752 2.301 . . . . 15.0 112.104 175.789 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -89.95 134.55 12.42 Favored Glycine 0 N--CA 1.446 -0.636 0 C-N-CA 120.554 -0.831 . . . . 15.0 112.296 179.43 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 214' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' 215' ' ' PRO . . . . . 1.185 ' HB2' ' CZ2' ' A' ' 262' ' ' TRP . 8.0 Cg_exo -87.94 147.62 6.87 Favored 'Trans proline' 0 C--O 1.235 0.333 0 C-N-CA 124.197 3.265 . . . . 15.0 112.38 -169.071 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 216' ' ' PHE . . . . . . . . . . . . . 85.1 m-85 -103.4 112.62 25.59 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 109.012 -0.736 . . . . 15.0 109.012 175.903 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 217' ' ' GLN . . . . . 0.476 ' H ' ' HG3' ' B' ' 217' ' ' GLN . 0.5 OUTLIER . . . . . 0 C--O 1.248 1.001 0 CA-C-O 118.427 -0.797 . . . . 15.0 111.635 -175.732 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 . . . . . 0 N--CA 1.48 1.06 0 N-CA-C 109.582 -0.525 . . . . 15.0 109.582 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 236' ' ' LEU . . . . . 0.441 HD22 ' N ' ' A' ' 236' ' ' LEU . 1.2 mm? -110.59 165.75 12.07 Favored Pre-proline 0 C--N 1.323 -0.584 0 CA-C-O 121.03 0.443 . . . . 15.0 110.586 -176.07 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 237' ' ' PRO . . . . . 0.548 ' HD3' ' HD3' ' A' ' 266' ' ' ARG . 21.9 Cg_exo -69.34 166.58 26.6 Favored 'Trans proline' 0 N--CA 1.46 -0.442 0 C-N-CA 122.257 1.971 . . . . 15.0 110.528 163.885 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 -69.92 147.23 50.49 Favored 'General case' 0 C--N 1.304 -1.391 0 CA-C-N 115.038 -0.983 . . . . 15.0 111.809 -176.382 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 100.25 0.93 55.8 Favored Glycine 0 CA--C 1.518 0.237 0 CA-C-N 115.348 -0.842 . . . . 15.0 113.34 179.736 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 240' ' ' TYR . . . . . 0.493 ' HD2' ' O ' ' A' ' 237' ' ' PRO . 56.5 m-85 -97.45 121.37 39.26 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.552 0.691 . . . . 15.0 111.574 -178.419 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 241' ' ' GLU . . . . . 0.745 ' HB2' ' HB2' ' A' ' 253' ' ' LEU . 7.6 mp0 -89.87 100.45 13.26 Favored 'General case' 0 N--CA 1.442 -0.833 0 CA-C-N 114.885 -1.052 . . . . 15.0 108.777 173.147 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 1.5 tm0? -89.94 113.99 25.73 Favored 'General case' 0 C--N 1.313 -1.006 0 N-CA-C 108.451 -0.944 . . . . 15.0 108.451 179.33 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 243' ' ' ARG . . . . . 0.503 ' CZ ' ' HG2' ' B' ' 212' ' ' PRO . 28.0 mtt180 -112.94 144.94 41.65 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-O 122.392 1.092 . . . . 15.0 111.926 179.511 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 244' ' ' THR . . . . . . . . . . . . . 15.8 m -120.29 92.14 3.7 Favored 'General case' 0 C--N 1.304 -1.373 0 CA-C-N 112.998 -1.91 . . . . 15.0 108.263 178.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 245' ' ' THR . . . . . 0.498 ' OG1' ' HG2' ' A' ' 247' ' ' GLN . 6.7 t -89.72 149.99 22.51 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 115.441 -0.799 . . . . 15.0 110.989 -171.882 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 23.0 t -55.2 -15.13 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 CA-C-N 115.816 -0.629 . . . . 15.0 111.349 -179.194 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 247' ' ' GLN . . . . . 0.498 ' HG2' ' OG1' ' A' ' 245' ' ' THR . 8.3 mm-40 -59.29 -15.27 14.9 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 115.895 -0.593 . . . . 15.0 111.128 176.413 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 89.51 37.4 7.02 Favored Glycine 0 C--N 1.333 0.407 0 C-N-CA 121.218 -0.515 . . . . 15.0 112.164 178.334 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 249' ' ' GLN . . . . . 0.627 ' NE2' ' HD2' ' B' ' 215' ' ' PRO . 0.8 OUTLIER -150.17 147.14 27.37 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.399 0.619 . . . . 15.0 111.515 -174.905 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 16.6 m -100.92 131.41 48.61 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.928 0 CA-C-N 114.561 -1.2 . . . . 15.0 108.386 169.189 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 251' ' ' TYR . . . . . 0.549 ' CD2' ' HD3' ' B' ' 215' ' ' PRO . 2.7 p90 -137.28 137.93 39.52 Favored 'General case' 0 C--N 1.317 -0.811 0 C-N-CA 120.558 -0.457 . . . . 15.0 110.395 -175.149 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 252' ' ' PHE . . . . . 0.738 ' CD2' ' HA ' ' A' ' 264' ' ' ASP . 40.8 m-85 -95.75 110.95 23.02 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.569 0.7 . . . . 15.0 112.329 -172.824 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 253' ' ' LEU . . . . . 0.745 ' HB2' ' HB2' ' A' ' 241' ' ' GLU . 38.9 mt -93.0 144.69 25.0 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 114.241 -1.345 . . . . 15.0 109.848 172.176 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 254' ' ' HIS . . . . . 0.56 ' HB3' ' HB ' ' A' ' 259' ' ' VAL . 40.3 t-80 -143.53 89.77 2.1 Favored 'General case' 0 C--N 1.305 -1.343 0 N-CA-C 107.31 -1.367 . . . . 15.0 107.31 164.143 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 16.3 m -91.72 87.61 6.37 Favored 'General case' 0 N--CA 1.426 -1.632 0 C-N-CA 115.655 -2.418 . . . . 15.0 110.096 -178.307 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 8.1 tt0 -101.53 -53.59 2.95 Favored 'General case' 0 N--CA 1.435 -1.193 0 CA-C-N 112.793 -2.003 . . . . 15.0 105.82 145.753 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 257' ' ' THR . . . . . . . . . . . . . 71.8 p -100.2 -13.52 18.88 Favored 'General case' 0 CA--C 1.49 -1.357 0 CA-C-O 124.727 2.203 . . . . 15.0 112.56 -176.459 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 86.07 73.24 1.28 Allowed Glycine 1 C--N 1.241 -4.747 0 CA-C-N 108.461 -3.972 . . . . 15.0 113.04 -172.529 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 259' ' ' VAL . . . . . 0.587 ' O ' ' HA ' ' A' ' 253' ' ' LEU . 74.9 t -89.71 136.76 22.89 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 CA-C-O 120.923 0.392 . . . . 15.0 112.028 174.127 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 4.0 p -145.62 100.02 3.37 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 114.822 -1.081 . . . . 15.0 108.731 168.834 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 24.3 p -132.39 150.17 52.21 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 112.216 0.45 . . . . 15.0 112.216 -172.364 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 262' ' ' TRP . . . . . 1.184 ' CZ2' ' HB2' ' B' ' 215' ' ' PRO . 71.1 m95 -72.87 -30.0 63.63 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.781 -0.645 . . . . 15.0 110.68 174.347 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 263' ' ' HIS . . . . . . . . . . . . . 3.3 p80 -77.89 129.31 35.21 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.967 0.413 . . . . 15.0 110.252 -177.666 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 264' ' ' ASP . . . . . 1.038 ' HB3' HG12 ' A' ' 267' ' ' ILE . 9.1 t0 -59.21 129.21 86.27 Favored Pre-proline 0 C--N 1.319 -0.734 0 N-CA-C 108.509 -0.923 . . . . 15.0 108.509 172.032 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 265' ' ' PRO . . . . . 0.545 ' HD3' ' CD2' ' A' ' 252' ' ' PHE . 4.4 Cg_exo -74.19 -14.65 23.18 Favored 'Trans proline' 0 CA--C 1.509 -0.729 0 C-N-CA 122.112 1.875 . . . . 15.0 113.228 -175.737 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 266' ' ' ARG . . . . . 0.548 ' HD3' ' HD3' ' A' ' 237' ' ' PRO . 2.1 tpp180 -77.41 -11.55 59.85 Favored 'General case' 0 C--N 1.31 -1.119 0 N-CA-C 108.055 -1.091 . . . . 15.0 108.055 172.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 267' ' ' ILE . . . . . 1.038 HG12 ' HB3' ' A' ' 264' ' ' ASP . 31.8 pt . . . . . 0 C--O 1.249 1.05 0 CA-C-N 114.551 -1.204 . . . . 15.0 111.0 176.886 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 210' ' ' SER . . . . . . . . . . . . . 63.0 p . . . . . 0 N--CA 1.479 1.002 0 CA-C-O 120.72 0.295 . . . . 15.0 110.841 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 211' ' ' ASP . . . . . 0.442 ' HA ' ' HD3' ' B' ' 212' ' ' PRO . 56.6 m-20 -104.49 120.62 49.94 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 120.894 0.378 . . . . 15.0 110.294 179.485 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 212' ' ' PRO . . . . . 0.52 ' CB ' HD11 ' A' ' 253' ' ' LEU . 3.4 Cg_exo -89.64 151.93 5.18 Favored 'Trans proline' 0 N--CA 1.461 -0.435 0 C-N-CA 123.88 3.054 . . . . 15.0 112.17 179.885 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -90.05 132.29 11.19 Favored Glycine 0 N--CA 1.443 -0.888 0 C-N-CA 120.74 -0.743 . . . . 15.0 111.616 178.384 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 214' ' ' SEP . . . . . 0.471 ' HA ' ' HD3' ' B' ' 215' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 215' ' ' PRO . . . . . 1.184 ' HB2' ' CZ2' ' A' ' 262' ' ' TRP . 2.7 Cg_exo -88.41 138.41 3.88 Favored 'Trans proline' 0 N--CA 1.46 -0.444 0 C-N-CA 123.988 3.125 . . . . 15.0 111.394 -177.677 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 216' ' ' PHE . . . . . . . . . . . . . 94.0 m-85 -123.36 -19.82 5.81 Favored 'General case' 0 C--N 1.322 -0.624 0 C-N-CA 120.757 -0.377 . . . . 15.0 110.997 177.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 217' ' ' GLN . . . . . . . . . . . . . 10.1 pt20 . . . . . 0 C--O 1.248 1.02 0 CA-C-O 118.37 -0.824 . . . . 15.0 109.8 177.632 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.481 1.079 0 CA-C-O 121.19 0.519 . . . . 15.0 110.323 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 236' ' ' LEU . . . . . 0.534 HD22 ' HD2' ' A' ' 265' ' ' PRO . 11.4 mt -110.75 172.84 3.25 Favored Pre-proline 0 C--N 1.323 -0.566 0 CA-C-N 115.578 -0.737 . . . . 15.0 110.161 -173.78 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 237' ' ' PRO . . . . . 0.591 ' HD3' ' HD3' ' A' ' 266' ' ' ARG . 13.0 Cg_exo -69.78 172.45 12.63 Favored 'Trans proline' 0 CA--C 1.513 -0.566 0 C-N-CA 122.21 1.94 . . . . 15.0 111.151 167.773 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 14.0 tp10 -69.41 134.57 49.16 Favored 'General case' 0 C--N 1.3 -1.549 0 CA-C-N 114.034 -1.439 . . . . 15.0 111.51 -173.474 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 100.15 9.37 48.44 Favored Glycine 0 CA--C 1.524 0.632 0 CA-C-N 115.74 -0.664 . . . . 15.0 114.31 177.013 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 240' ' ' TYR . . . . . 0.69 ' CD1' ' HB2' ' A' ' 254' ' ' HIS . 86.5 m-85 -111.41 116.88 31.67 Favored 'General case' 0 CA--C 1.517 -0.323 0 CA-C-N 118.129 0.964 . . . . 15.0 111.007 175.166 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 17.7 pt-20 -97.63 123.94 41.72 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 109.198 -0.668 . . . . 15.0 109.198 170.72 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 242' ' ' GLN . . . . . 0.564 ' HG3' ' CE1' ' A' ' 252' ' ' PHE . 1.9 tt0 -89.9 99.13 12.2 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 109.058 -0.719 . . . . 15.0 109.058 -177.841 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 84.2 mtt-85 -92.02 150.01 21.22 Favored 'General case' 0 CA--C 1.5 -0.963 0 CA-C-O 122.428 1.109 . . . . 15.0 113.184 -172.736 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 244' ' ' THR . . . . . . . . . . . . . 16.6 p -118.27 139.83 50.72 Favored 'General case' 0 C--N 1.308 -1.221 0 CA-C-N 112.567 -2.106 . . . . 15.0 109.122 174.777 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 245' ' ' THR . . . . . 1.087 HG23 ' HG2' ' A' ' 247' ' ' GLN . 3.4 t -145.02 150.46 36.93 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 116.406 -0.361 . . . . 15.0 110.124 -173.228 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 6.1 m -48.9 -22.15 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 N-CA-C 113.944 1.09 . . . . 15.0 113.944 -175.454 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 247' ' ' GLN . . . . . 1.087 ' HG2' HG23 ' A' ' 245' ' ' THR . 1.7 pt20 -58.56 -22.67 56.49 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-O 120.705 0.288 . . . . 15.0 110.851 176.539 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 91.08 30.3 11.31 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 121.276 -0.488 . . . . 15.0 112.872 177.356 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 249' ' ' GLN . . . . . 0.412 ' HB3' ' CH2' ' A' ' 262' ' ' TRP . 1.1 mp0 -137.9 143.18 40.71 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.888 0.344 . . . . 15.0 111.621 -178.118 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 29.1 m -90.16 138.39 19.54 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.129 0 CA-C-N 115.901 -0.591 . . . . 15.0 109.426 172.747 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 251' ' ' TYR . . . . . 0.686 ' HB3' ' HG2' ' B' ' 215' ' ' PRO . 32.5 p90 -144.09 136.3 26.55 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 120.853 0.358 . . . . 15.0 110.228 -175.529 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 252' ' ' PHE . . . . . 0.651 ' CD2' ' HA ' ' A' ' 264' ' ' ASP . 32.0 m-85 -89.86 119.51 30.3 Favored 'General case' 0 CA--C 1.507 -0.68 0 CA-C-N 116.043 -0.526 . . . . 15.0 111.66 -172.688 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 253' ' ' LEU . . . . . 0.8 HD11 ' HB3' ' B' ' 212' ' ' PRO . 0.4 OUTLIER -113.52 118.62 34.98 Favored 'General case' 0 N--CA 1.441 -0.919 0 CA-C-N 114.854 -1.067 . . . . 15.0 111.141 -175.727 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 254' ' ' HIS . . . . . 0.69 ' HB2' ' CD1' ' A' ' 240' ' ' TYR . 16.6 t-80 -128.07 90.28 3.06 Favored 'General case' 0 C--N 1.313 -0.992 0 N-CA-C 108.132 -1.062 . . . . 15.0 108.132 168.552 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 255' ' ' THR . . . . . 0.624 HG22 ' HA2' ' A' ' 258' ' ' GLY . 0.3 OUTLIER -89.82 87.38 6.94 Favored 'General case' 0 N--CA 1.429 -1.485 0 C-N-CA 116.462 -2.095 . . . . 15.0 109.881 178.772 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 35.9 tt0 -101.49 -56.39 2.31 Favored 'General case' 0 N--CA 1.436 -1.16 0 N-CA-C 105.884 -1.895 . . . . 15.0 105.884 150.327 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 257' ' ' THR . . . . . . . . . . . . . 63.3 p -96.65 -13.63 22.69 Favored 'General case' 0 CA--C 1.486 -1.512 0 CA-C-N 111.73 -2.486 . . . . 15.0 111.601 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 258' ' ' GLY . . . . . 0.624 ' HA2' HG22 ' A' ' 255' ' ' THR . . . 86.27 73.05 1.28 Allowed Glycine 1 C--N 1.24 -4.773 1 CA-C-N 108.3 -4.045 . . . . 15.0 113.236 -172.83 . . . . . . . . 4 3 . 1 . 008 nuclear nobuild full ' A' A ' 259' ' ' VAL . . . . . 0.619 ' O ' ' HA ' ' A' ' 253' ' ' LEU . 55.4 t -89.89 123.36 42.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-O 121.202 0.525 . . . . 15.0 112.206 173.539 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 2.5 p -134.53 92.49 2.92 Favored 'General case' 0 C--N 1.317 -0.844 0 N-CA-C 107.818 -1.179 . . . . 15.0 107.818 168.754 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 8.1 t -121.06 150.14 41.64 Favored 'General case' 0 C--N 1.314 -0.938 0 N-CA-C 112.853 0.686 . . . . 15.0 112.853 -165.251 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 262' ' ' TRP . . . . . 1.175 ' CZ2' ' HB2' ' B' ' 215' ' ' PRO . 1.9 m95 -80.94 -18.87 45.59 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 114.777 -1.102 . . . . 15.0 111.26 174.971 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 263' ' ' HIS . . . . . . . . . . . . . 4.0 p80 -100.31 133.61 44.46 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.558 -0.457 . . . . 15.0 110.106 -178.431 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 264' ' ' ASP . . . . . 0.799 ' HB3' HG12 ' A' ' 267' ' ' ILE . 9.8 t70 -55.67 132.92 71.97 Favored Pre-proline 0 C--N 1.321 -0.661 0 CA-C-N 115.908 -0.587 . . . . 15.0 109.529 175.836 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 265' ' ' PRO . . . . . 0.534 ' HD2' HD22 ' A' ' 236' ' ' LEU . 91.7 Cg_endo -80.67 -14.6 11.32 Favored 'Trans proline' 0 N--CA 1.462 -0.381 0 C-N-CA 122.42 2.08 . . . . 15.0 113.543 -176.192 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 266' ' ' ARG . . . . . 0.591 ' HD3' ' HD3' ' A' ' 237' ' ' PRO . 25.2 tpt180 -77.08 -8.52 57.61 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-O 122.269 1.033 . . . . 15.0 108.408 175.156 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 267' ' ' ILE . . . . . 0.799 HG12 ' HB3' ' A' ' 264' ' ' ASP . 43.2 mm . . . . . 0 C--O 1.249 1.052 0 CA-C-N 113.505 -1.68 . . . . 15.0 109.749 176.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 210' ' ' SER . . . . . . . . . . . . . 4.7 m . . . . . 0 N--CA 1.471 0.616 0 CA-C-O 120.792 0.33 . . . . 15.0 110.387 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' 211' ' ' ASP . . . . . 0.407 ' HA ' ' HD3' ' B' ' 212' ' ' PRO . 9.2 p-10 -150.17 131.79 7.61 Favored Pre-proline 0 C--N 1.326 -0.437 0 CA-C-N 116.262 -0.427 . . . . 15.0 110.337 -178.75 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 212' ' ' PRO . . . . . 0.8 ' HB3' HD11 ' A' ' 253' ' ' LEU . 12.3 Cg_endo -89.98 140.45 3.4 Favored 'Trans proline' 0 N--CA 1.453 -0.89 0 C-N-CA 122.995 2.463 . . . . 15.0 112.199 178.602 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -89.81 156.77 25.78 Favored Glycine 0 N--CA 1.443 -0.841 0 C-N-CA 120.548 -0.834 . . . . 15.0 111.94 178.895 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 214' ' ' SEP . . . . . 0.434 ' HA ' ' HD3' ' B' ' 215' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 215' ' ' PRO . . . . . 1.175 ' HB2' ' CZ2' ' A' ' 262' ' ' TRP . 17.6 Cg_exo -87.55 141.59 5.68 Favored 'Trans proline' 0 N--CA 1.465 -0.189 0 C-N-CA 123.904 3.069 . . . . 15.0 111.232 179.592 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 216' ' ' PHE . . . . . . . . . . . . . 93.2 m-85 -102.5 -78.37 0.54 Allowed 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 109.816 -0.439 . . . . 15.0 109.816 178.587 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 217' ' ' GLN . . . . . . . . . . . . . 8.4 pt20 . . . . . 0 C--O 1.25 1.082 0 CA-C-N 115.997 -0.547 . . . . 15.0 109.731 176.537 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.475 0.803 0 CA-C-O 120.903 0.382 . . . . 15.0 110.612 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 236' ' ' LEU . . . . . 0.431 HD22 ' N ' ' A' ' 236' ' ' LEU . 0.9 OUTLIER -112.3 170.84 4.85 Favored Pre-proline 0 C--N 1.319 -0.751 0 N-CA-C 108.828 -0.804 . . . . 15.0 108.828 175.35 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 237' ' ' PRO . . . . . 0.763 ' HD3' ' HD3' ' A' ' 266' ' ' ARG . 16.0 Cg_exo -69.24 164.54 33.64 Favored 'Trans proline' 0 CA--C 1.514 -0.524 0 C-N-CA 122.009 1.806 . . . . 15.0 110.399 167.457 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -69.92 143.65 52.65 Favored 'General case' 0 C--N 1.302 -1.465 0 CA-C-N 115.02 -0.991 . . . . 15.0 111.356 -173.695 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 239' ' ' GLY . . . . . 0.416 ' O ' ' HA ' ' A' ' 254' ' ' HIS . . . 100.16 3.9 55.48 Favored Glycine 0 N--CA 1.447 -0.628 0 CA-C-N 115.29 -0.868 . . . . 15.0 113.294 177.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 240' ' ' TYR . . . . . 0.728 ' CD1' ' HB2' ' A' ' 254' ' ' HIS . 74.7 m-85 -105.58 126.46 52.16 Favored 'General case' 0 CA--C 1.514 -0.434 0 CA-C-N 117.352 0.576 . . . . 15.0 110.874 176.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -111.71 125.23 53.75 Favored 'General case' 0 C--N 1.316 -0.871 0 N-CA-C 109.461 -0.57 . . . . 15.0 109.461 169.526 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 242' ' ' GLN . . . . . 0.486 ' HG3' ' CE1' ' A' ' 252' ' ' PHE . 7.2 tt0 -89.74 104.1 16.69 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.772 -0.649 . . . . 15.0 109.296 -178.62 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 36.0 mtt-85 -97.03 150.01 21.28 Favored 'General case' 0 CA--C 1.505 -0.771 0 CA-C-O 122.23 1.014 . . . . 15.0 112.368 -176.205 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 244' ' ' THR . . . . . . . . . . . . . 13.6 p -120.27 133.36 55.48 Favored 'General case' 0 C--N 1.308 -1.234 0 CA-C-N 113.085 -1.871 . . . . 15.0 109.506 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 245' ' ' THR . . . . . 0.557 ' OG1' ' HG2' ' A' ' 247' ' ' GLN . 4.6 t -137.4 150.23 47.51 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 116.462 -0.335 . . . . 15.0 110.911 -176.317 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 3.6 m -57.16 -15.88 3.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 115.777 -0.647 . . . . 15.0 112.117 178.694 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 247' ' ' GLN . . . . . 0.557 ' HG2' ' OG1' ' A' ' 245' ' ' THR . 6.8 mm100 -54.42 -24.04 18.35 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.123 -0.489 . . . . 15.0 110.245 172.918 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 92.9 34.12 7.01 Favored Glycine 0 C--N 1.333 0.374 0 CA-C-N 115.903 -0.589 . . . . 15.0 111.927 175.91 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 249' ' ' GLN . . . . . 0.625 HE21 ' HD2' ' B' ' 215' ' ' PRO . 0.2 OUTLIER -149.42 137.93 20.88 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.449 0.642 . . . . 15.0 111.843 -170.977 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 12.6 m -91.81 128.41 43.51 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.039 0 CA-C-N 114.527 -1.215 . . . . 15.0 109.151 171.16 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 251' ' ' TYR . . . . . 0.625 ' CB ' ' HG3' ' B' ' 215' ' ' PRO . 20.5 p90 -132.8 135.27 45.58 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 109.951 -0.389 . . . . 15.0 109.951 -178.081 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 252' ' ' PHE . . . . . 0.663 ' CD2' ' HA ' ' A' ' 264' ' ' ASP . 30.1 m-85 -90.14 121.74 32.46 Favored 'General case' 0 CA--C 1.513 -0.443 0 CA-C-O 121.224 0.535 . . . . 15.0 111.737 -174.346 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 253' ' ' LEU . . . . . 0.735 HD11 ' HB3' ' B' ' 212' ' ' PRO . 0.5 OUTLIER -109.42 116.51 31.95 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 114.783 -1.099 . . . . 15.0 111.148 -175.824 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 254' ' ' HIS . . . . . 0.728 ' HB2' ' CD1' ' A' ' 240' ' ' TYR . 26.4 t-80 -130.21 90.21 2.91 Favored 'General case' 0 CA--C 1.503 -0.859 0 N-CA-C 108.207 -1.035 . . . . 15.0 108.207 169.866 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 3.2 t -91.32 87.95 6.67 Favored 'General case' 0 N--CA 1.432 -1.374 0 C-N-CA 116.659 -2.017 . . . . 15.0 110.111 -179.424 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 48.3 tt0 -101.33 -51.26 3.53 Favored 'General case' 0 N--CA 1.44 -0.963 0 CA-C-N 113.412 -1.722 . . . . 15.0 106.422 150.712 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 257' ' ' THR . . . . . . . . . . . . . 80.9 p -98.19 -13.61 20.78 Favored 'General case' 0 CA--C 1.488 -1.43 0 CA-C-O 124.78 2.229 . . . . 15.0 111.724 178.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 87.62 73.15 1.28 Allowed Glycine 1 C--N 1.24 -4.75 1 CA-C-N 108.258 -4.065 . . . . 15.0 112.742 -170.977 . . . . . . . . 3 2 . 1 . 009 nuclear nobuild full ' A' A ' 259' ' ' VAL . . . . . 0.569 ' O ' ' HA ' ' A' ' 253' ' ' LEU . 48.7 t -89.66 125.49 42.62 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.339 0 CA-C-O 121.667 0.746 . . . . 15.0 112.18 175.846 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 1.5 p -138.23 92.39 2.64 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-N 113.763 -1.562 . . . . 15.0 107.658 167.617 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 13.2 t -124.4 150.26 45.79 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 121.386 0.612 . . . . 15.0 112.243 -167.426 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 262' ' ' TRP . . . . . 1.178 ' CZ2' ' HB2' ' B' ' 215' ' ' PRO . 40.9 m95 -75.44 -25.28 57.33 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 114.794 -1.094 . . . . 15.0 112.201 178.959 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 263' ' ' HIS . . . . . . . . . . . . . 8.1 p80 -92.9 142.26 27.5 Favored 'General case' 0 C--N 1.322 -0.608 0 C-N-CA 120.179 -0.608 . . . . 15.0 110.385 -176.043 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 264' ' ' ASP . . . . . 0.851 ' HB3' HG12 ' A' ' 267' ' ' ILE . 9.9 t0 -61.96 134.22 94.2 Favored Pre-proline 0 C--N 1.321 -0.635 0 N-CA-C 108.541 -0.911 . . . . 15.0 108.541 175.216 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 265' ' ' PRO . . . . . 0.603 ' HD3' ' CD2' ' A' ' 252' ' ' PHE . 71.6 Cg_endo -81.81 -14.46 10.01 Favored 'Trans proline' 0 N--CA 1.452 -0.969 0 C-N-CA 122.039 1.826 . . . . 15.0 113.547 -174.559 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 266' ' ' ARG . . . . . 0.763 ' HD3' ' HD3' ' A' ' 237' ' ' PRO . 17.8 tpt180 -78.87 -7.5 57.98 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-O 122.029 0.919 . . . . 15.0 108.723 174.62 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 267' ' ' ILE . . . . . 0.851 HG12 ' HB3' ' A' ' 264' ' ' ASP . 46.9 mm . . . . . 0 C--O 1.249 1.067 0 CA-C-N 113.846 -1.525 . . . . 15.0 109.663 177.063 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 210' ' ' SER . . . . . . . . . . . . . 20.0 m . . . . . 0 N--CA 1.482 1.132 0 CA-C-O 120.955 0.407 . . . . 15.0 110.969 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' 211' ' ' ASP . . . . . 0.476 ' HA ' ' HD3' ' B' ' 212' ' ' PRO . 36.3 t70 -101.58 113.82 65.76 Favored Pre-proline 0 C--N 1.325 -0.488 0 CA-C-N 116.328 -0.396 . . . . 15.0 110.244 -177.701 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 212' ' ' PRO . . . . . 0.735 ' HB3' HD11 ' A' ' 253' ' ' LEU . 6.3 Cg_endo -89.71 160.2 5.19 Favored 'Trans proline' 0 N--CA 1.456 -0.688 0 C-N-CA 123.454 2.769 . . . . 15.0 112.891 -175.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -90.08 145.5 18.2 Favored Glycine 0 N--CA 1.444 -0.813 0 CA-C-N 115.717 -0.674 . . . . 15.0 112.52 -178.151 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 214' ' ' SEP . . . . . 0.459 ' HA ' ' HD3' ' B' ' 215' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 215' ' ' PRO . . . . . 1.178 ' HB2' ' CZ2' ' A' ' 262' ' ' TRP . 6.2 Cg_exo -88.3 140.34 4.58 Favored 'Trans proline' 0 C--O 1.234 0.285 0 C-N-CA 123.424 2.749 . . . . 15.0 110.977 179.467 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 216' ' ' PHE . . . . . . . . . . . . . 92.9 m-85 -110.45 101.0 9.74 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 121.061 -0.256 . . . . 15.0 111.282 -178.838 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 217' ' ' GLN . . . . . . . . . . . . . 14.6 mm100 . . . . . 0 C--O 1.25 1.124 0 O-C-N 124.131 0.895 . . . . 15.0 112.463 174.237 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 31.9 mt-10 . . . . . 0 N--CA 1.481 1.098 0 CA-C-O 120.708 0.289 . . . . 15.0 110.276 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 4.8 mt -117.9 166.31 13.87 Favored Pre-proline 0 C--N 1.323 -0.554 0 CA-C-N 116.346 -0.388 . . . . 15.0 110.426 -175.427 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 237' ' ' PRO . . . . . 0.769 ' HD3' ' HD3' ' A' ' 266' ' ' ARG . 16.5 Cg_exo -69.37 169.6 18.04 Favored 'Trans proline' 0 CA--C 1.511 -0.672 0 C-N-CA 122.308 2.005 . . . . 15.0 110.654 165.355 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 60.0 mt-10 -69.5 137.14 52.28 Favored 'General case' 0 C--N 1.303 -1.425 0 CA-C-N 114.594 -1.185 . . . . 15.0 112.375 -172.096 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 100.54 5.76 53.69 Favored Glycine 0 N--CA 1.447 -0.582 0 CA-C-N 113.914 -1.494 . . . . 15.0 113.706 175.245 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 240' ' ' TYR . . . . . 0.703 ' CD1' ' HB2' ' A' ' 254' ' ' HIS . 83.4 m-85 -104.06 122.99 46.41 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 117.741 0.77 . . . . 15.0 110.738 175.891 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 241' ' ' GLU . . . . . 0.496 ' HG3' ' HB3' ' A' ' 253' ' ' LEU . 8.1 pt-20 -105.57 127.37 52.99 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 109.139 -0.689 . . . . 15.0 109.139 170.84 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 242' ' ' GLN . . . . . 0.641 ' HG3' ' CE1' ' A' ' 252' ' ' PHE . 9.6 tt0 -89.86 105.15 17.61 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 108.932 -0.766 . . . . 15.0 108.932 179.86 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 54.9 mtt-85 -92.39 149.28 21.51 Favored 'General case' 0 CA--C 1.506 -0.724 0 CA-C-O 122.288 1.042 . . . . 15.0 112.158 -177.074 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 244' ' ' THR . . . . . . . . . . . . . 20.4 p -126.4 89.91 3.09 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-N 113.066 -1.879 . . . . 15.0 109.101 -174.139 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 245' ' ' THR . . . . . 0.78 HG23 ' HB2' ' A' ' 247' ' ' GLN . 13.4 t -97.24 150.27 21.11 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 115.162 -0.926 . . . . 15.0 110.326 -171.106 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 26.8 t -54.41 -17.91 2.35 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 C-N-CA 122.915 0.486 . . . . 15.0 111.961 -175.069 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 247' ' ' GLN . . . . . 0.78 ' HB2' HG23 ' A' ' 245' ' ' THR . 10.4 mp0 -51.18 -22.89 2.86 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 123.25 0.62 . . . . 15.0 111.318 172.17 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 88.05 16.0 60.08 Favored Glycine 0 C--N 1.33 0.233 0 C-N-CA 121.156 -0.545 . . . . 15.0 112.06 178.23 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 249' ' ' GLN . . . . . 0.426 ' NE2' ' HH2' ' A' ' 262' ' ' TRP . 1.8 mt-30 -131.11 137.56 49.13 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 109.884 -0.413 . . . . 15.0 109.884 -176.316 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 14.4 m -89.72 134.05 29.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-N 116.358 -0.383 . . . . 15.0 110.306 177.407 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 251' ' ' TYR . . . . . 0.59 ' HB3' ' CG ' ' B' ' 215' ' ' PRO . 14.9 p90 -133.41 137.05 45.61 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.35 -0.386 . . . . 15.0 110.194 -179.698 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 252' ' ' PHE . . . . . 0.692 ' CD2' ' HA ' ' A' ' 264' ' ' ASP . 37.6 m-85 -89.88 121.74 32.28 Favored 'General case' 0 CA--C 1.512 -0.498 0 CA-C-O 121.193 0.521 . . . . 15.0 110.909 -175.8 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 253' ' ' LEU . . . . . 0.893 HD11 ' HB3' ' B' ' 212' ' ' PRO . 0.4 OUTLIER -113.16 124.75 53.28 Favored 'General case' 0 N--CA 1.445 -0.699 0 CA-C-N 114.858 -1.065 . . . . 15.0 110.756 -174.921 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 254' ' ' HIS . . . . . 0.703 ' HB2' ' CD1' ' A' ' 240' ' ' TYR . 14.5 t-80 -138.95 97.51 3.33 Favored 'General case' 0 CA--C 1.499 -1.014 0 N-CA-C 108.645 -0.872 . . . . 15.0 108.645 173.198 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 24.5 m -93.57 87.74 5.63 Favored 'General case' 0 N--CA 1.434 -1.244 0 C-N-CA 116.539 -2.064 . . . . 15.0 110.402 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 35.3 tt0 -101.29 -54.0 2.88 Favored 'General case' 0 N--CA 1.44 -0.956 0 N-CA-C 105.653 -1.981 . . . . 15.0 105.653 148.826 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 257' ' ' THR . . . . . . . . . . . . . 77.8 p -100.06 -13.61 18.96 Favored 'General case' 0 CA--C 1.485 -1.535 0 CA-C-N 112.555 -2.111 . . . . 15.0 112.223 -178.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 86.67 73.7 1.28 Allowed Glycine 1 C--N 1.239 -4.808 0 CA-C-N 108.806 -3.815 . . . . 15.0 112.753 -171.293 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 259' ' ' VAL . . . . . 0.655 ' O ' ' HA ' ' A' ' 253' ' ' LEU . 43.8 t -89.69 124.62 42.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 121.43 0.633 . . . . 15.0 112.02 176.021 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -140.15 102.14 4.31 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 114.407 -1.27 . . . . 15.0 107.915 168.345 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 12.9 t -143.31 150.35 39.07 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.9 -0.591 . . . . 15.0 111.878 -168.746 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 262' ' ' TRP . . . . . 1.208 ' CZ2' ' HB2' ' B' ' 215' ' ' PRO . 92.7 m95 -70.0 -42.57 72.87 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 115.638 -0.71 . . . . 15.0 111.492 178.286 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 263' ' ' HIS . . . . . . . . . . . . . 2.7 p80 -73.53 132.37 42.79 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.255 -0.429 . . . . 15.0 110.246 -175.868 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 264' ' ' ASP . . . . . 1.014 ' HB3' HG12 ' A' ' 267' ' ' ILE . 22.0 t0 -56.38 127.63 72.0 Favored Pre-proline 0 C--N 1.32 -0.715 0 N-CA-C 108.155 -1.054 . . . . 15.0 108.155 172.769 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 265' ' ' PRO . . . . . 0.521 ' HG2' ' CD1' ' A' ' 240' ' ' TYR . 12.1 Cg_exo -69.34 -14.52 37.56 Favored 'Trans proline' 0 C--N 1.329 -0.482 0 C-N-CA 122.27 1.98 . . . . 15.0 112.614 -177.466 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 266' ' ' ARG . . . . . 0.769 ' HD3' ' HD3' ' A' ' 237' ' ' PRO . 16.1 tpt180 -75.39 -11.62 60.08 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 108.7 -0.852 . . . . 15.0 108.7 172.91 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 267' ' ' ILE . . . . . 1.014 HG12 ' HB3' ' A' ' 264' ' ' ASP . 24.6 pt . . . . . 0 C--O 1.248 1.017 0 CA-C-N 114.625 -1.171 . . . . 15.0 111.364 178.101 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 210' ' ' SER . . . . . . . . . . . . . 40.8 m . . . . . 0 N--CA 1.479 0.99 0 CA-C-O 120.77 0.319 . . . . 15.0 111.258 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' 211' ' ' ASP . . . . . 0.422 ' HA ' ' HD3' ' B' ' 212' ' ' PRO . 10.1 p-10 -90.44 141.78 27.64 Favored Pre-proline 0 C--N 1.328 -0.363 0 N-CA-C 109.657 -0.498 . . . . 15.0 109.657 179.38 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 212' ' ' PRO . . . . . 0.893 ' HB3' HD11 ' A' ' 253' ' ' LEU . 9.5 Cg_endo -89.6 148.85 5.13 Favored 'Trans proline' 0 N--CA 1.454 -0.822 0 C-N-CA 122.733 2.289 . . . . 15.0 112.581 -177.567 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -89.88 159.89 28.24 Favored Glycine 0 N--CA 1.443 -0.87 0 C-N-CA 120.746 -0.74 . . . . 15.0 112.075 -179.386 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 214' ' ' SEP . . . . . 0.44 ' P ' HE21 ' A' ' 247' ' ' GLN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 215' ' ' PRO . . . . . 1.208 ' HB2' ' CZ2' ' A' ' 262' ' ' TRP . 7.1 Cg_exo -88.19 149.99 6.76 Favored 'Trans proline' 0 C--O 1.235 0.33 0 C-N-CA 123.417 2.745 . . . . 15.0 111.853 175.072 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 216' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -125.8 131.87 52.38 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.869 -0.419 . . . . 15.0 109.869 174.865 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 217' ' ' GLN . . . . . 0.434 ' HB3' ' NE1' ' A' ' 262' ' ' TRP . 4.0 pt20 . . . . . 0 C--O 1.247 0.96 0 CA-C-O 118.409 -0.805 . . . . 15.0 110.046 176.181 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 26.0 mt-10 . . . . . 0 N--CA 1.48 1.047 0 N-CA-C 109.682 -0.488 . . . . 15.0 109.682 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 236' ' ' LEU . . . . . 0.701 HD22 ' H ' ' A' ' 236' ' ' LEU . 0.1 OUTLIER -93.05 159.52 35.44 Favored Pre-proline 0 C--N 1.326 -0.431 0 CA-C-N 115.987 -0.551 . . . . 15.0 110.939 -170.7 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 237' ' ' PRO . . . . . 0.455 ' HD3' ' HD3' ' A' ' 266' ' ' ARG . 18.8 Cg_exo -69.65 166.21 28.21 Favored 'Trans proline' 0 CA--C 1.515 -0.455 0 C-N-CA 122.993 2.462 . . . . 15.0 110.323 164.705 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -69.7 150.02 47.41 Favored 'General case' 0 C--N 1.307 -1.278 0 CA-C-N 115.443 -0.799 . . . . 15.0 110.968 -177.207 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 100.03 -2.14 56.63 Favored Glycine 0 N--CA 1.447 -0.593 0 CA-C-N 115.508 -0.769 . . . . 15.0 113.809 179.489 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 240' ' ' TYR . . . . . 0.671 ' CD1' ' HB2' ' A' ' 254' ' ' HIS . 79.6 m-85 -104.28 115.35 30.24 Favored 'General case' 0 CA--C 1.518 -0.283 0 CA-C-N 117.688 0.744 . . . . 15.0 110.626 178.233 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 26.5 mt-10 -95.7 123.13 39.12 Favored 'General case' 0 C--N 1.317 -0.844 0 N-CA-C 109.074 -0.713 . . . . 15.0 109.074 175.015 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 23.7 tm0? -89.91 109.11 20.15 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 108.728 -0.842 . . . . 15.0 108.728 179.845 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 47.9 mtt85 -105.27 150.09 25.45 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 122.143 0.973 . . . . 15.0 112.098 -179.291 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 244' ' ' THR . . . . . . . . . . . . . 5.6 p -127.36 98.25 5.19 Favored 'General case' 0 C--N 1.31 -1.125 0 CA-C-N 113.279 -1.782 . . . . 15.0 109.309 -177.183 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 245' ' ' THR . . . . . 0.463 ' OG1' ' HG2' ' A' ' 247' ' ' GLN . 3.1 t -89.92 150.4 22.19 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 115.567 -0.742 . . . . 15.0 111.098 -174.279 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 8.4 m -50.8 -19.36 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.21 0 CA-C-N 115.413 -0.812 . . . . 15.0 112.236 177.423 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 247' ' ' GLN . . . . . 0.489 ' HB2' ' HG3' ' A' ' 249' ' ' GLN . 7.3 mm100 -55.62 -26.08 42.31 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.07 -0.514 . . . . 15.0 110.953 173.514 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 89.01 30.58 14.05 Favored Glycine 0 N--CA 1.449 -0.495 0 CA-C-N 115.943 -0.571 . . . . 15.0 111.996 179.706 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 249' ' ' GLN . . . . . 0.489 ' HG3' ' HB2' ' A' ' 247' ' ' GLN . 0.0 OUTLIER -134.76 142.09 46.64 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.642 0.258 . . . . 15.0 110.388 -177.006 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 17.9 m -89.97 134.89 27.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 115.884 -0.598 . . . . 15.0 109.825 175.373 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 251' ' ' TYR . . . . . 0.545 ' HB3' ' CG ' ' B' ' 215' ' ' PRO . 4.3 p90 -142.73 135.77 28.28 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.083 0.468 . . . . 15.0 110.448 179.493 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 252' ' ' PHE . . . . . 0.717 ' CE2' ' HA ' ' A' ' 264' ' ' ASP . 34.5 m-85 -90.27 125.55 35.54 Favored 'General case' 0 CA--C 1.511 -0.526 0 CA-C-N 115.826 -0.625 . . . . 15.0 111.126 -176.57 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 253' ' ' LEU . . . . . 1.027 HD11 ' HB3' ' B' ' 212' ' ' PRO . 0.4 OUTLIER -113.98 111.25 21.37 Favored 'General case' 0 N--CA 1.445 -0.724 0 CA-C-N 115.25 -0.886 . . . . 15.0 111.768 -174.589 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 254' ' ' HIS . . . . . 0.671 ' HB2' ' CD1' ' A' ' 240' ' ' TYR . 36.4 t-80 -122.46 90.11 3.24 Favored 'General case' 0 CA--C 1.499 -0.992 0 N-CA-C 107.981 -1.118 . . . . 15.0 107.981 166.345 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 7.3 t -96.38 88.05 4.63 Favored 'General case' 0 N--CA 1.428 -1.567 0 C-N-CA 116.599 -2.041 . . . . 15.0 110.192 -178.878 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 63.7 tt0 -101.2 -51.48 3.5 Favored 'General case' 0 N--CA 1.437 -1.081 0 CA-C-N 112.875 -1.966 . . . . 15.0 105.838 151.519 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 257' ' ' THR . . . . . . . . . . . . . 79.6 p -96.78 -13.42 22.65 Favored 'General case' 0 CA--C 1.486 -1.506 0 CA-C-O 125.034 2.35 . . . . 15.0 111.623 178.531 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 86.74 74.62 1.27 Allowed Glycine 1 C--N 1.24 -4.783 1 CA-C-N 108.222 -4.081 . . . . 15.0 112.899 -172.92 . . . . . . . . 3 2 . 1 . 011 nuclear nobuild full ' A' A ' 259' ' ' VAL . . . . . 0.587 ' O ' ' HA ' ' A' ' 253' ' ' LEU . 57.4 t -89.9 121.86 40.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-O 121.556 0.693 . . . . 15.0 112.02 172.855 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 1.3 p -135.27 103.62 5.58 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 114.042 -1.435 . . . . 15.0 107.988 169.878 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 261' ' ' THR . . . . . 0.458 ' OG1' ' HD2' ' A' ' 263' ' ' HIS . 14.3 t -143.41 150.49 39.14 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 112.977 0.732 . . . . 15.0 112.977 -168.085 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 262' ' ' TRP . . . . . 1.197 ' CZ2' ' HB2' ' B' ' 215' ' ' PRO . 89.1 m95 -71.44 -32.6 68.54 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 114.956 -1.02 . . . . 15.0 111.848 178.543 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 263' ' ' HIS . . . . . 0.458 ' HD2' ' OG1' ' A' ' 261' ' ' THR . 5.4 p80 -86.28 137.47 32.58 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.596 -0.441 . . . . 15.0 110.986 -172.241 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 264' ' ' ASP . . . . . 0.994 ' HB3' HG12 ' A' ' 267' ' ' ILE . 7.3 t0 -52.96 129.86 48.53 Favored Pre-proline 0 C--N 1.325 -0.458 0 N-CA-C 108.864 -0.791 . . . . 15.0 108.864 172.92 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 265' ' ' PRO . . . . . 0.558 ' HD2' HD12 ' A' ' 236' ' ' LEU . 67.0 Cg_endo -73.2 -14.87 25.74 Favored 'Trans proline' 0 CA--C 1.51 -0.724 0 C-N-CA 122.193 1.928 . . . . 15.0 113.64 -173.961 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 266' ' ' ARG . . . . . 0.455 ' HD3' ' HD3' ' A' ' 237' ' ' PRO . 8.4 tpt180 -83.93 -5.58 59.25 Favored 'General case' 0 C--N 1.306 -1.293 0 N-CA-C 108.254 -1.017 . . . . 15.0 108.254 174.245 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 267' ' ' ILE . . . . . 0.994 HG12 ' HB3' ' A' ' 264' ' ' ASP . 45.0 pt . . . . . 0 C--O 1.247 0.965 0 CA-C-N 114.023 -1.444 . . . . 15.0 110.728 174.667 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 210' ' ' SER . . . . . . . . . . . . . 19.3 m . . . . . 0 N--CA 1.477 0.891 0 CA-C-O 120.841 0.353 . . . . 15.0 111.038 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' B' B ' 211' ' ' ASP . . . . . 0.419 ' HA ' ' HD3' ' B' ' 212' ' ' PRO . 13.9 m-20 -110.05 115.18 55.25 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 120.76 0.314 . . . . 15.0 110.759 -178.032 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 212' ' ' PRO . . . . . 1.027 ' HB3' HD11 ' A' ' 253' ' ' LEU . 6.1 Cg_exo -89.6 141.55 3.93 Favored 'Trans proline' 0 N--CA 1.461 -0.437 0 C-N-CA 123.422 2.748 . . . . 15.0 112.851 178.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -89.98 149.07 20.15 Favored Glycine 0 N--CA 1.443 -0.866 0 CA-C-N 115.52 -0.764 . . . . 15.0 111.745 178.619 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 214' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' B' B ' 215' ' ' PRO . . . . . 1.197 ' HB2' ' CZ2' ' A' ' 262' ' ' TRP . 7.2 Cg_exo -88.4 143.39 5.45 Favored 'Trans proline' 0 C--O 1.235 0.352 0 C-N-CA 123.779 2.986 . . . . 15.0 111.459 -178.682 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 216' ' ' PHE . . . . . . . . . . . . . 84.6 m-85 -112.83 171.26 7.64 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.415 -0.357 . . . . 15.0 110.559 -179.624 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 217' ' ' GLN . . . . . . . . . . . . . 2.5 mp0 . . . . . 0 C--O 1.249 1.053 0 CA-C-O 118.402 -0.809 . . . . 15.0 109.617 179.864 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 . . . . . 0 N--CA 1.48 1.052 0 N-CA-C 110.412 -0.218 . . . . 15.0 110.412 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 236' ' ' LEU . . . . . 0.65 HD12 ' HD2' ' A' ' 265' ' ' PRO . 0.2 OUTLIER -93.54 153.6 41.28 Favored Pre-proline 0 C--N 1.323 -0.571 0 CA-C-O 121.443 0.639 . . . . 15.0 110.906 -174.522 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 237' ' ' PRO . . . . . 0.477 ' HD2' ' CE2' ' A' ' 240' ' ' TYR . 15.3 Cg_exo -69.65 173.88 10.23 Favored 'Trans proline' 0 CA--C 1.514 -0.516 0 C-N-CA 123.202 2.602 . . . . 15.0 110.672 161.675 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -69.42 143.45 53.61 Favored 'General case' 0 C--N 1.3 -1.581 0 CA-C-N 114.487 -1.233 . . . . 15.0 111.238 -177.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 100.18 8.29 50.68 Favored Glycine 0 N--CA 1.45 -0.386 0 CA-C-N 115.502 -0.772 . . . . 15.0 113.735 177.169 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 240' ' ' TYR . . . . . 0.641 ' CD1' ' HB2' ' A' ' 254' ' ' HIS . 72.2 m-85 -107.32 116.5 32.04 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 117.611 0.705 . . . . 15.0 111.346 178.826 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 241' ' ' GLU . . . . . 0.585 ' HB3' ' HB3' ' A' ' 253' ' ' LEU . 4.5 tp10 -89.84 111.58 22.65 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.156 -0.929 . . . . 15.0 108.737 174.562 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -90.06 102.72 15.43 Favored 'General case' 0 C--N 1.314 -0.943 0 N-CA-C 108.635 -0.876 . . . . 15.0 108.635 178.681 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 243' ' ' ARG . . . . . 0.437 ' HG3' ' HG3' ' A' ' 241' ' ' GLU . 51.0 mtt-85 -99.21 148.26 24.29 Favored 'General case' 0 CA--C 1.499 -0.998 0 CA-C-O 121.96 0.886 . . . . 15.0 112.185 -177.742 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 244' ' ' THR . . . . . . . . . . . . . 11.7 m -123.2 93.97 4.12 Favored 'General case' 0 C--N 1.309 -1.191 0 CA-C-N 113.505 -1.68 . . . . 15.0 110.207 -179.413 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 245' ' ' THR . . . . . 1.082 HG23 ' HG2' ' A' ' 247' ' ' GLN . 7.7 t -95.25 150.73 19.91 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.546 -0.752 . . . . 15.0 110.248 179.99 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 15.0 m -41.15 -25.27 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 N-CA-C 114.642 1.349 . . . . 15.0 114.642 -175.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 247' ' ' GLN . . . . . 1.082 ' HG2' HG23 ' A' ' 245' ' ' THR . 3.5 pt20 -54.4 -21.45 9.71 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 117.793 0.27 . . . . 15.0 111.14 177.251 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 87.76 20.64 50.07 Favored Glycine 0 C--N 1.333 0.411 0 C-N-CA 121.206 -0.521 . . . . 15.0 113.036 173.821 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 249' ' ' GLN . . . . . 0.414 HE21 ' CD ' ' A' ' 247' ' ' GLN . 18.5 mt-30 -129.98 142.71 50.6 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.586 -0.524 . . . . 15.0 109.586 -177.207 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 29.8 m -91.25 134.75 28.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-O 120.943 0.402 . . . . 15.0 110.924 179.875 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 251' ' ' TYR . . . . . 0.767 ' HB3' ' HG2' ' B' ' 215' ' ' PRO . 33.0 p90 -134.27 137.56 44.38 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.778 -0.452 . . . . 15.0 109.778 -178.005 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 252' ' ' PHE . . . . . 0.67 ' CE2' ' HA ' ' A' ' 264' ' ' ASP . 26.6 m-85 -92.01 116.58 29.05 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.218 0.533 . . . . 15.0 111.386 -174.66 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 253' ' ' LEU . . . . . 0.78 HD11 ' HB3' ' B' ' 212' ' ' PRO . 0.5 OUTLIER -106.54 96.87 6.76 Favored 'General case' 0 N--CA 1.447 -0.604 0 CA-C-N 115.063 -0.972 . . . . 15.0 111.3 -175.154 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 254' ' ' HIS . . . . . 0.641 ' HB2' ' CD1' ' A' ' 240' ' ' TYR . 33.5 t-80 -106.53 90.12 3.24 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 108.417 -0.957 . . . . 15.0 108.417 169.5 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 1.9 t -94.65 87.81 5.2 Favored 'General case' 0 N--CA 1.432 -1.342 0 C-N-CA 116.746 -1.982 . . . . 15.0 110.286 -179.698 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 57.4 tt0 -101.18 -50.2 3.86 Favored 'General case' 0 N--CA 1.441 -0.919 0 CA-C-N 112.957 -1.929 . . . . 15.0 106.25 150.876 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 257' ' ' THR . . . . . . . . . . . . . 67.0 p -98.53 -13.56 20.41 Favored 'General case' 0 CA--C 1.486 -1.503 0 CA-C-O 124.706 2.193 . . . . 15.0 111.738 178.469 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 87.07 73.57 1.28 Allowed Glycine 1 C--N 1.24 -4.803 0 CA-C-N 108.493 -3.958 . . . . 15.0 112.851 -172.3 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 259' ' ' VAL . . . . . 0.704 ' O ' ' HA ' ' A' ' 253' ' ' LEU . 52.3 t -89.92 125.3 42.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-O 121.284 0.564 . . . . 15.0 112.135 174.275 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 1.6 p -137.16 98.01 3.63 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 114.699 -1.137 . . . . 15.0 107.987 167.666 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 14.0 t -136.79 150.29 48.27 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.994 -0.548 . . . . 15.0 111.972 -168.464 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 262' ' ' TRP . . . . . 1.219 ' CZ2' ' HB2' ' B' ' 215' ' ' PRO . 83.2 m95 -71.83 -39.46 69.74 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.062 -0.972 . . . . 15.0 111.663 179.481 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 263' ' ' HIS . . . . . . . . . . . . . 5.5 p80 -77.82 137.23 38.3 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.451 -0.341 . . . . 15.0 110.48 -173.496 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 264' ' ' ASP . . . . . 1.021 ' HB3' HG12 ' A' ' 267' ' ' ILE . 27.7 t0 -57.54 124.21 66.41 Favored Pre-proline 0 C--N 1.324 -0.533 0 N-CA-C 108.024 -1.102 . . . . 15.0 108.024 169.899 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 265' ' ' PRO . . . . . 0.65 ' HD2' HD12 ' A' ' 236' ' ' LEU . 12.1 Cg_exo -69.13 -14.7 38.55 Favored 'Trans proline' 0 N--CA 1.459 -0.558 0 C-N-CA 122.236 1.957 . . . . 15.0 112.914 -175.997 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 266' ' ' ARG . . . . . 0.44 ' HD3' ' HD3' ' A' ' 237' ' ' PRO . 6.1 tpt180 -76.44 -11.64 59.92 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-O 121.99 0.9 . . . . 15.0 108.918 173.572 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 267' ' ' ILE . . . . . 1.021 HG12 ' HB3' ' A' ' 264' ' ' ASP . 36.5 pt . . . . . 0 C--O 1.246 0.904 0 CA-C-N 114.562 -1.199 . . . . 15.0 111.458 -179.364 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 210' ' ' SER . . . . . . . . . . . . . 17.7 m . . . . . 0 N--CA 1.476 0.863 0 CA-C-O 120.977 0.418 . . . . 15.0 110.327 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' B' B ' 211' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -98.97 116.83 65.05 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.136 -0.484 . . . . 15.0 110.93 -172.577 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 212' ' ' PRO . . . . . 0.78 ' HB3' HD11 ' A' ' 253' ' ' LEU . 6.6 Cg_endo -89.87 144.21 4.34 Favored 'Trans proline' 0 N--CA 1.451 -1.026 0 C-N-CA 122.851 2.367 . . . . 15.0 111.051 171.138 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -89.85 157.79 26.59 Favored Glycine 0 N--CA 1.442 -0.946 0 C-N-CA 120.192 -1.004 . . . . 15.0 111.923 -179.517 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 214' ' ' SEP . . . . . 0.759 ' HB2' HG21 ' A' ' 245' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 215' ' ' PRO . . . . . 1.219 ' HB2' ' CZ2' ' A' ' 262' ' ' TRP . 14.2 Cg_exo -87.44 144.53 6.77 Favored 'Trans proline' 0 N--CA 1.458 -0.572 0 C-N-CA 123.451 2.767 . . . . 15.0 110.839 179.71 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 216' ' ' PHE . . . . . . . . . . . . . 82.7 m-85 -116.28 146.54 42.31 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 116.357 -0.383 . . . . 15.0 110.096 179.863 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 217' ' ' GLN . . . . . . . . . . . . . 26.2 tt0 . . . . . 0 C--O 1.248 1.022 0 CA-C-O 118.816 -0.612 . . . . 15.0 110.181 -179.285 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 . . . . . 0 N--CA 1.478 0.94 0 CA-C-O 120.835 0.35 . . . . 15.0 110.106 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 236' ' ' LEU . . . . . 0.538 HD22 ' H ' ' A' ' 236' ' ' LEU . 0.6 OUTLIER -91.44 173.27 5.54 Favored Pre-proline 0 C--N 1.324 -0.519 0 CA-C-N 116.052 -0.522 . . . . 15.0 110.287 -174.52 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 237' ' ' PRO . . . . . 0.605 ' HD3' ' HD3' ' A' ' 266' ' ' ARG . 20.0 Cg_exo -69.2 170.77 15.15 Favored 'Trans proline' 0 CA--C 1.509 -0.759 0 C-N-CA 122.308 2.005 . . . . 15.0 111.258 166.81 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -69.46 139.1 53.93 Favored 'General case' 0 C--N 1.301 -1.535 0 CA-C-N 114.215 -1.357 . . . . 15.0 110.995 -171.819 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 239' ' ' GLY . . . . . 0.402 ' O ' ' HD2' ' A' ' 254' ' ' HIS . . . 100.22 -2.28 56.41 Favored Glycine 0 N--CA 1.448 -0.509 0 CA-C-N 115.621 -0.718 . . . . 15.0 113.752 179.288 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 240' ' ' TYR . . . . . 0.443 ' CD1' ' HB2' ' A' ' 254' ' ' HIS . 84.6 m-85 -97.39 116.52 29.75 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 118.087 0.943 . . . . 15.0 111.167 177.381 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 241' ' ' GLU . . . . . 0.583 ' HB2' ' HB3' ' A' ' 253' ' ' LEU . 5.6 mt-10 -89.9 111.06 21.99 Favored 'General case' 0 N--CA 1.441 -0.915 0 CA-C-N 114.297 -1.319 . . . . 15.0 109.232 177.606 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 242' ' ' GLN . . . . . 0.607 HE22 HG23 ' A' ' 244' ' ' THR . 1.0 OUTLIER -89.88 103.72 16.35 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 108.88 -0.785 . . . . 15.0 108.88 178.355 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 243' ' ' ARG . . . . . 0.43 ' CZ ' ' HG2' ' B' ' 212' ' ' PRO . 8.2 mtp180 -108.33 149.01 29.25 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.768 0.794 . . . . 15.0 112.114 -178.456 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 244' ' ' THR . . . . . 0.607 HG23 HE22 ' A' ' 242' ' ' GLN . 16.2 p -120.39 121.19 38.02 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 114.008 -1.451 . . . . 15.0 109.799 -178.035 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 245' ' ' THR . . . . . 0.521 ' OG1' ' HG2' ' A' ' 247' ' ' GLN . 4.6 t -110.66 150.55 28.85 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 116.24 -0.437 . . . . 15.0 111.013 -176.863 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 5.5 p -50.07 -24.31 1.92 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.262 0 CA-C-N 115.389 -0.823 . . . . 15.0 111.2 175.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 247' ' ' GLN . . . . . 0.521 ' HG2' ' OG1' ' A' ' 245' ' ' THR . 3.9 mm-40 -51.97 -26.84 11.46 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 115.335 -0.848 . . . . 15.0 110.823 175.42 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 104.56 9.36 35.76 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 121.098 -0.572 . . . . 15.0 113.092 174.518 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 2.1 pm0 -123.38 149.04 45.46 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 112.904 0.705 . . . . 15.0 112.904 -174.924 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 6.2 m -89.79 132.67 33.89 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.435 0 CA-C-N 114.727 -1.124 . . . . 15.0 108.367 166.69 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 251' ' ' TYR . . . . . 0.584 ' HB3' ' HG3' ' B' ' 215' ' ' PRO . 2.4 p90 -134.61 140.3 45.97 Favored 'General case' 0 C--N 1.314 -0.946 0 C-N-CA 120.538 -0.465 . . . . 15.0 110.1 179.969 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 252' ' ' PHE . . . . . 0.661 ' CD2' ' HA ' ' A' ' 264' ' ' ASP . 24.2 m-85 -90.0 111.66 22.83 Favored 'General case' 0 CA--C 1.507 -0.698 0 CA-C-O 121.854 0.835 . . . . 15.0 111.601 -174.972 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 253' ' ' LEU . . . . . 0.921 HD11 ' HB3' ' B' ' 212' ' ' PRO . 0.5 OUTLIER -99.52 140.96 32.94 Favored 'General case' 0 N--CA 1.438 -1.055 0 CA-C-N 113.696 -1.593 . . . . 15.0 109.192 178.893 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 254' ' ' HIS . . . . . 0.466 ' HB3' ' HB ' ' A' ' 259' ' ' VAL . 13.6 t-80 -149.98 93.13 1.98 Allowed 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 108.335 -0.987 . . . . 15.0 108.335 170.72 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 255' ' ' THR . . . . . 0.502 HG22 ' OE2' ' A' ' 241' ' ' GLU . 2.6 t -90.04 87.95 7.1 Favored 'General case' 0 N--CA 1.431 -1.404 0 C-N-CA 116.387 -2.125 . . . . 15.0 110.328 -179.949 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 56.3 tt0 -101.26 -54.2 2.83 Favored 'General case' 0 N--CA 1.44 -0.963 0 CA-C-N 112.761 -2.018 . . . . 15.0 105.733 148.089 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 257' ' ' THR . . . . . . . . . . . . . 71.3 p -99.94 -13.72 19.01 Favored 'General case' 0 CA--C 1.487 -1.455 0 CA-C-N 112.156 -2.293 . . . . 15.0 112.333 -178.834 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 85.71 72.0 1.3 Allowed Glycine 1 C--N 1.244 -4.546 0 CA-C-N 108.492 -3.958 . . . . 15.0 112.762 -170.986 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 259' ' ' VAL . . . . . 0.567 ' O ' ' HA ' ' A' ' 253' ' ' LEU . 85.1 t -89.75 134.56 28.53 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.426 0 CA-C-O 121.519 0.676 . . . . 15.0 112.71 178.267 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 1.7 p -144.65 105.02 4.1 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 114.388 -1.278 . . . . 15.0 108.298 168.156 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 8.8 t -141.05 150.32 42.81 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 112.333 0.494 . . . . 15.0 112.333 -170.004 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 262' ' ' TRP . . . . . 1.054 ' CZ2' ' HB2' ' B' ' 215' ' ' PRO . 6.7 m95 -68.54 -27.03 65.73 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.335 -0.848 . . . . 15.0 112.329 177.093 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 263' ' ' HIS . . . . . . . . . . . . . 5.2 p80 -85.68 132.73 34.1 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 120.137 -0.625 . . . . 15.0 111.026 -172.711 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 264' ' ' ASP . . . . . 1.015 ' HB3' HG12 ' A' ' 267' ' ' ILE . 20.5 t0 -64.84 126.4 90.94 Favored Pre-proline 0 C--N 1.319 -0.719 0 N-CA-C 108.546 -0.909 . . . . 15.0 108.546 171.597 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 265' ' ' PRO . . . . . 0.51 ' HD3' ' CD2' ' A' ' 252' ' ' PHE . 2.6 Cg_endo -80.26 -14.79 11.76 Favored 'Trans proline' 0 N--CA 1.456 -0.692 0 C-N-CA 122.642 2.228 . . . . 15.0 113.261 -177.653 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 266' ' ' ARG . . . . . 0.605 ' HD3' ' HD3' ' A' ' 237' ' ' PRO . 11.1 tpt180 -75.69 -12.79 60.26 Favored 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 108.439 -0.949 . . . . 15.0 108.439 173.581 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 267' ' ' ILE . . . . . 1.015 HG12 ' HB3' ' A' ' 264' ' ' ASP . 20.3 pt . . . . . 0 C--O 1.248 1.017 0 CA-C-N 114.324 -1.307 . . . . 15.0 110.761 178.507 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 210' ' ' SER . . . . . . . . . . . . . 19.8 m . . . . . 0 N--CA 1.475 0.786 0 CA-C-O 121.041 0.448 . . . . 15.0 110.038 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' B' B ' 211' ' ' ASP . . . . . 0.473 ' HA ' ' HD3' ' B' ' 212' ' ' PRO . 8.2 p-10 -119.51 127.01 26.67 Favored Pre-proline 0 C--N 1.324 -0.52 0 CA-C-O 121.289 0.566 . . . . 15.0 110.9 -176.244 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 212' ' ' PRO . . . . . 0.921 ' HB3' HD11 ' A' ' 253' ' ' LEU . 4.0 Cg_endo -89.72 156.4 5.14 Favored 'Trans proline' 0 N--CA 1.455 -0.743 0 C-N-CA 123.385 2.723 . . . . 15.0 112.302 179.856 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -89.87 145.52 18.29 Favored Glycine 0 N--CA 1.442 -0.961 0 C-N-CA 120.608 -0.806 . . . . 15.0 112.392 -179.177 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 214' ' ' SEP . . . . . 0.423 ' HA ' ' HD3' ' B' ' 215' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 215' ' ' PRO . . . . . 1.054 ' HB2' ' CZ2' ' A' ' 262' ' ' TRP . 3.3 Cg_exo -87.94 136.37 3.6 Favored 'Trans proline' 0 N--CA 1.461 -0.417 0 C-N-CA 123.524 2.816 . . . . 15.0 111.112 176.422 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 216' ' ' PHE . . . . . . . . . . . . . 57.9 m-85 -89.9 116.2 27.79 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.326 -0.397 . . . . 15.0 110.286 -179.15 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 217' ' ' GLN . . . . . . . . . . . . . 5.2 pm0 . . . . . 0 C--O 1.245 0.843 0 CA-C-O 118.664 -0.684 . . . . 15.0 110.443 179.751 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 . . . . . 0 N--CA 1.48 1.073 0 CA-C-O 120.94 0.4 . . . . 15.0 110.293 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 236' ' ' LEU . . . . . 0.525 HD12 ' HD2' ' A' ' 265' ' ' PRO . 1.4 mm? -106.73 169.02 7.28 Favored Pre-proline 0 C--N 1.323 -0.566 0 N-CA-C 109.162 -0.681 . . . . 15.0 109.162 178.192 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 237' ' ' PRO . . . . . 0.638 ' HD3' ' HD3' ' A' ' 266' ' ' ARG . 17.5 Cg_exo -69.37 158.06 58.86 Favored 'Trans proline' 0 N--CA 1.455 -0.771 0 C-N-CA 121.688 1.592 . . . . 15.0 108.957 160.67 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 5.2 mp0 -69.54 142.39 53.65 Favored 'General case' 0 C--N 1.303 -1.425 0 CA-C-O 121.46 0.647 . . . . 15.0 111.761 -171.217 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 100.5 7.81 50.7 Favored Glycine 0 CA--C 1.523 0.547 0 CA-C-N 114.931 -1.031 . . . . 15.0 114.017 -179.774 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 240' ' ' TYR . . . . . 0.756 ' CD1' ' HB2' ' A' ' 254' ' ' HIS . 80.9 m-85 -101.74 121.25 41.7 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 118.103 0.952 . . . . 15.0 110.721 174.845 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 241' ' ' GLU . . . . . 0.663 ' HG3' ' HB3' ' A' ' 253' ' ' LEU . 7.9 pt-20 -104.67 126.59 51.9 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 109.054 -0.721 . . . . 15.0 109.054 173.296 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -89.92 108.09 19.5 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 108.991 -0.744 . . . . 15.0 108.991 179.182 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 243' ' ' ARG . . . . . 0.559 ' HB2' ' CE1' ' A' ' 251' ' ' TYR . 9.7 mtt180 -99.44 133.43 43.76 Favored 'General case' 0 CA--C 1.502 -0.877 0 CA-C-O 122.704 1.24 . . . . 15.0 111.724 178.672 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 244' ' ' THR . . . . . . . . . . . . . 23.5 m -113.32 97.11 6.27 Favored 'General case' 0 C--N 1.301 -1.542 0 CA-C-N 112.631 -2.077 . . . . 15.0 109.067 -175.909 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 245' ' ' THR . . . . . 0.427 ' OG1' ' HG2' ' A' ' 247' ' ' GLN . 9.9 t -92.36 150.3 20.91 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 115.232 -0.894 . . . . 15.0 111.201 -172.325 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 3.5 m -54.94 -15.12 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 N-CA-C 112.882 0.697 . . . . 15.0 112.882 177.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 247' ' ' GLN . . . . . 0.427 ' HG2' ' OG1' ' A' ' 245' ' ' THR . 6.5 mm100 -58.58 -16.83 17.51 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.145 0.498 . . . . 15.0 110.63 173.414 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 88.13 37.78 7.6 Favored Glycine 0 N--CA 1.449 -0.492 0 CA-C-N 115.594 -0.73 . . . . 15.0 111.421 177.494 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 249' ' ' GLN . . . . . 0.563 ' NE2' ' HD2' ' B' ' 215' ' ' PRO . 9.0 pt20 -149.96 137.58 19.97 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.899 0.38 . . . . 15.0 111.674 -173.684 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 19.1 m -90.2 134.01 30.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 N-CA-C 109.249 -0.649 . . . . 15.0 109.249 172.235 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 251' ' ' TYR . . . . . 0.707 ' CD2' ' HD3' ' B' ' 215' ' ' PRO . 3.7 p90 -137.25 137.37 38.97 Favored 'General case' 0 C--N 1.317 -0.813 0 C-N-CA 120.427 -0.509 . . . . 15.0 110.535 179.753 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 252' ' ' PHE . . . . . 0.663 ' CD2' ' HA ' ' A' ' 264' ' ' ASP . 37.3 m-85 -89.88 118.25 29.32 Favored 'General case' 0 CA--C 1.509 -0.616 0 CA-C-O 121.5 0.667 . . . . 15.0 110.835 -173.647 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 253' ' ' LEU . . . . . 0.788 HD11 ' CB ' ' B' ' 212' ' ' PRO . 0.4 OUTLIER -110.56 118.04 35.16 Favored 'General case' 0 N--CA 1.441 -0.876 0 CA-C-N 114.337 -1.302 . . . . 15.0 110.895 -173.853 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 254' ' ' HIS . . . . . 0.756 ' HB2' ' CD1' ' A' ' 240' ' ' TYR . 17.7 t-80 -132.57 95.48 3.62 Favored 'General case' 0 CA--C 1.495 -1.159 0 N-CA-C 108.546 -0.909 . . . . 15.0 108.546 170.441 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 3.7 t -94.65 87.91 5.23 Favored 'General case' 0 N--CA 1.429 -1.486 0 C-N-CA 116.062 -2.255 . . . . 15.0 110.268 178.196 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 25.1 tt0 -101.22 -51.87 3.4 Favored 'General case' 0 N--CA 1.442 -0.859 0 N-CA-C 105.902 -1.888 . . . . 15.0 105.902 149.177 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 257' ' ' THR . . . . . . . . . . . . . 69.4 p -99.21 -13.67 19.63 Favored 'General case' 0 CA--C 1.489 -1.395 0 CA-C-O 124.958 2.313 . . . . 15.0 111.909 179.575 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 84.84 74.88 1.24 Allowed Glycine 1 C--N 1.244 -4.569 1 CA-C-N 108.352 -4.022 . . . . 15.0 112.838 -172.146 . . . . . . . . 3 2 . 1 . 014 nuclear nobuild full ' A' A ' 259' ' ' VAL . . . . . 0.55 ' O ' ' HA ' ' A' ' 253' ' ' LEU . 33.1 t -89.89 123.85 42.29 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 CA-C-O 121.316 0.579 . . . . 15.0 112.451 173.307 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 1.8 p -134.15 101.76 5.14 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 114.632 -1.167 . . . . 15.0 107.855 164.366 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 14.1 t -136.55 150.25 48.52 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 121.212 0.529 . . . . 15.0 112.273 -169.561 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 262' ' ' TRP . . . . . 1.114 ' CZ2' ' HB2' ' B' ' 215' ' ' PRO . 10.3 m95 -70.39 -37.12 74.46 Favored 'General case' 0 CA--C 1.518 -0.27 0 CA-C-N 114.967 -1.015 . . . . 15.0 111.948 179.069 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 263' ' ' HIS . . . . . . . . . . . . . 5.9 p80 -85.37 139.99 31.12 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.109 -0.496 . . . . 15.0 110.278 -174.704 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 264' ' ' ASP . . . . . 0.878 ' HB3' HG12 ' A' ' 267' ' ' ILE . 9.8 t70 -55.45 126.54 63.18 Favored Pre-proline 0 C--N 1.322 -0.604 0 N-CA-C 108.212 -1.033 . . . . 15.0 108.212 171.118 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 265' ' ' PRO . . . . . 0.525 ' HD2' HD12 ' A' ' 236' ' ' LEU . 6.2 Cg_exo -71.37 -14.61 31.15 Favored 'Trans proline' 0 N--CA 1.458 -0.581 0 C-N-CA 121.935 1.757 . . . . 15.0 112.882 -174.172 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 266' ' ' ARG . . . . . 0.638 ' HD3' ' HD3' ' A' ' 237' ' ' PRO . 6.1 tpt180 -77.24 -7.81 56.55 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-O 121.817 0.817 . . . . 15.0 108.927 175.163 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 267' ' ' ILE . . . . . 0.878 HG12 ' HB3' ' A' ' 264' ' ' ASP . 43.5 mm . . . . . 0 C--O 1.25 1.085 0 CA-C-N 114.009 -1.451 . . . . 15.0 109.646 176.511 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 210' ' ' SER . . . . . . . . . . . . . 3.9 p . . . . . 0 N--CA 1.475 0.789 0 N-CA-C 110.275 -0.268 . . . . 15.0 110.275 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' B' B ' 211' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -89.98 131.57 38.81 Favored Pre-proline 0 C--N 1.329 -0.313 0 N-CA-C 109.802 -0.444 . . . . 15.0 109.802 178.564 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 212' ' ' PRO . . . . . 0.788 ' CB ' HD11 ' A' ' 253' ' ' LEU . 60.7 Cg_endo -89.84 160.19 5.07 Favored 'Trans proline' 0 N--CA 1.45 -1.03 0 C-N-CA 122.685 2.257 . . . . 15.0 112.105 178.938 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -90.04 133.34 11.75 Favored Glycine 0 N--CA 1.442 -0.94 0 C-N-CA 120.508 -0.853 . . . . 15.0 112.251 -178.721 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 214' ' ' SEP . . . . . 0.456 ' HA ' ' HD3' ' B' ' 215' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 215' ' ' PRO . . . . . 1.114 ' HB2' ' CZ2' ' A' ' 262' ' ' TRP . 9.4 Cg_exo -87.8 124.18 1.84 Allowed 'Trans proline' 0 C--N 1.333 -0.251 0 C-N-CA 123.786 2.991 . . . . 15.0 111.779 -172.056 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 216' ' ' PHE . . . . . . . . . . . . . 94.0 m-85 -119.25 4.54 11.27 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.348 -0.842 . . . . 15.0 110.015 178.636 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 217' ' ' GLN . . . . . 0.608 ' HB2' ' CD1' ' A' ' 262' ' ' TRP . 24.9 mt-30 . . . . . 0 C--O 1.249 1.038 0 CA-C-N 115.334 -0.848 . . . . 15.0 110.661 179.532 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 . . . . . 0 N--CA 1.478 0.94 0 N-CA-C 109.465 -0.569 . . . . 15.0 109.465 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 236' ' ' LEU . . . . . 0.807 HD22 ' H ' ' A' ' 236' ' ' LEU . 0.0 OUTLIER -89.88 170.89 9.55 Favored Pre-proline 0 C--N 1.325 -0.498 0 N-CA-C 109.375 -0.602 . . . . 15.0 109.375 -176.943 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 237' ' ' PRO . . . . . 0.672 ' HD3' ' HD3' ' A' ' 266' ' ' ARG . 16.5 Cg_exo -69.6 158.83 55.77 Favored 'Trans proline' 0 N--CA 1.458 -0.61 0 C-N-CA 122.144 1.896 . . . . 15.0 109.855 166.294 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 238' ' ' GLU . . . . . 0.461 ' H ' ' CD ' ' A' ' 238' ' ' GLU . 1.5 pm0 -69.86 149.42 47.88 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-O 121.546 0.689 . . . . 15.0 111.462 -174.044 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 100.17 -8.99 59.35 Favored Glycine 0 N--CA 1.444 -0.803 0 CA-C-N 115.096 -0.956 . . . . 15.0 113.09 -178.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 240' ' ' TYR . . . . . 0.669 ' CD1' ' HB2' ' A' ' 254' ' ' HIS . 87.6 m-85 -100.32 123.81 45.01 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 117.372 0.586 . . . . 15.0 110.353 177.366 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -109.33 126.6 53.56 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 108.938 -0.764 . . . . 15.0 108.938 169.848 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -89.95 108.71 19.88 Favored 'General case' 0 C--N 1.316 -0.853 0 N-CA-C 108.363 -0.977 . . . . 15.0 108.363 177.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 13.2 mtp85 -90.6 139.07 31.05 Favored 'General case' 0 CA--C 1.5 -0.961 0 CA-C-O 122.16 0.981 . . . . 15.0 112.962 -172.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 244' ' ' THR . . . . . . . . . . . . . 28.9 p -105.5 90.9 3.55 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-N 112.919 -1.946 . . . . 15.0 109.37 178.795 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 245' ' ' THR . . . . . 1.05 HG23 ' HG2' ' A' ' 247' ' ' GLN . 9.5 t -104.01 150.7 24.01 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.661 -0.7 . . . . 15.0 110.204 -176.182 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 39.6 t -43.74 -26.81 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 N-CA-C 113.725 1.009 . . . . 15.0 113.725 -172.665 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 247' ' ' GLN . . . . . 1.05 ' HG2' HG23 ' A' ' 245' ' ' THR . 3.5 pt20 -56.06 -23.09 31.49 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-O 120.695 0.283 . . . . 15.0 111.645 177.742 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 80.52 43.05 9.57 Favored Glycine 0 C--N 1.333 0.376 0 CA-C-N 116.264 -0.425 . . . . 15.0 113.15 176.068 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 249' ' ' GLN . . . . . 0.495 HE21 ' CD ' ' A' ' 247' ' ' GLN . 32.1 mt-30 -141.85 148.77 39.35 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.908 0.354 . . . . 15.0 110.082 -178.803 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 17.2 m -89.95 114.16 27.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-O 121.144 0.497 . . . . 15.0 110.638 178.814 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 251' ' ' TYR . . . . . 0.891 ' HB2' ' HG2' ' B' ' 215' ' ' PRO . 2.4 p90 -126.43 131.91 51.6 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.565 -0.532 . . . . 15.0 109.565 -178.841 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 252' ' ' PHE . . . . . 0.553 ' CD2' ' HA ' ' A' ' 264' ' ' ASP . 50.7 m-85 -90.04 126.07 35.63 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.137 -0.483 . . . . 15.0 111.281 -175.052 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 253' ' ' LEU . . . . . 0.657 HD11 ' HB3' ' B' ' 212' ' ' PRO . 0.8 OUTLIER -118.55 121.27 39.82 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-N 115.655 -0.702 . . . . 15.0 110.776 -177.623 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 254' ' ' HIS . . . . . 0.669 ' HB2' ' CD1' ' A' ' 240' ' ' TYR . 14.6 t-80 -135.93 96.48 3.42 Favored 'General case' 0 CA--C 1.502 -0.895 0 N-CA-C 108.834 -0.802 . . . . 15.0 108.834 172.544 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 6.1 t -94.03 88.13 5.57 Favored 'General case' 0 C--N 1.311 -1.085 0 C-N-CA 116.525 -2.07 . . . . 15.0 110.797 -179.809 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 44.4 tt0 -101.23 -52.97 3.13 Favored 'General case' 0 N--CA 1.443 -0.824 0 CA-C-N 113.29 -1.777 . . . . 15.0 106.217 151.316 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 257' ' ' THR . . . . . . . . . . . . . 62.7 p -99.92 -13.45 19.14 Favored 'General case' 0 CA--C 1.488 -1.44 0 CA-C-O 124.837 2.256 . . . . 15.0 111.774 -179.279 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 87.74 72.98 1.28 Allowed Glycine 1 C--N 1.238 -4.907 1 CA-C-N 108.391 -4.004 . . . . 15.0 112.782 -169.91 . . . . . . . . 3 2 . 1 . 015 nuclear nobuild full ' A' A ' 259' ' ' VAL . . . . . 0.492 ' O ' ' HA ' ' A' ' 253' ' ' LEU . 45.1 t -90.1 127.87 42.39 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.3 0 CA-C-O 121.151 0.5 . . . . 15.0 111.576 174.309 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 260' ' ' SER . . . . . 0.489 ' HA ' ' O ' ' A' ' 252' ' ' PHE . 2.2 p -148.13 103.25 3.45 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 114.721 -1.127 . . . . 15.0 108.195 170.109 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 13.8 t -150.02 150.43 31.77 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 116.099 -0.501 . . . . 15.0 111.358 -168.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 262' ' ' TRP . . . . . 1.182 ' CZ2' ' HB2' ' B' ' 215' ' ' PRO . 92.4 m95 -69.9 -36.78 75.67 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.932 -0.576 . . . . 15.0 111.53 179.423 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 263' ' ' HIS . . . . . . . . . . . . . 2.7 p80 -75.38 129.96 38.21 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.612 -0.435 . . . . 15.0 110.605 -174.916 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 264' ' ' ASP . . . . . 1.046 ' HB3' HG12 ' A' ' 267' ' ' ILE . 67.5 t0 -59.49 124.56 76.06 Favored Pre-proline 0 C--N 1.321 -0.649 0 N-CA-C 108.609 -0.885 . . . . 15.0 108.609 172.016 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 265' ' ' PRO . . . . . 0.528 ' HG2' ' CE1' ' A' ' 240' ' ' TYR . 13.0 Cg_exo -68.83 -14.61 39.26 Favored 'Trans proline' 0 N--CA 1.456 -0.716 0 C-N-CA 121.904 1.736 . . . . 15.0 111.889 178.074 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 266' ' ' ARG . . . . . 0.672 ' HD3' ' HD3' ' A' ' 237' ' ' PRO . 22.7 tpt180 -76.73 -10.18 59.19 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 115.252 -0.885 . . . . 15.0 109.473 173.538 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 267' ' ' ILE . . . . . 1.046 HG12 ' HB3' ' A' ' 264' ' ' ASP . 40.0 pt . . . . . 0 C--O 1.25 1.096 0 CA-C-N 114.813 -1.085 . . . . 15.0 111.297 177.389 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 210' ' ' SER . . . . . . . . . . . . . 16.5 m . . . . . 0 N--CA 1.479 0.987 0 CA-C-O 120.772 0.32 . . . . 15.0 110.963 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' B' B ' 211' ' ' ASP . . . . . 0.404 ' HA ' ' HD3' ' B' ' 212' ' ' PRO . 13.5 t70 -135.34 120.64 13.82 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.536 -0.302 . . . . 15.0 110.76 -174.922 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 212' ' ' PRO . . . . . 0.657 ' HB3' HD11 ' A' ' 253' ' ' LEU . 53.9 Cg_endo -93.34 143.77 2.07 Favored 'Trans proline' 0 N--CA 1.452 -0.927 0 C-N-CA 122.837 2.358 . . . . 15.0 112.696 176.59 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -89.94 154.37 23.75 Favored Glycine 0 N--CA 1.446 -0.698 0 C-N-CA 120.406 -0.902 . . . . 15.0 111.814 179.586 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 214' ' ' SEP . . . . . 0.605 ' HB3' ' NE2' ' A' ' 247' ' ' GLN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 215' ' ' PRO . . . . . 1.182 ' HB2' ' CZ2' ' A' ' 262' ' ' TRP . 27.9 Cg_exo -88.14 151.1 6.88 Favored 'Trans proline' 0 CA--C 1.528 0.219 0 C-N-CA 123.157 2.572 . . . . 15.0 111.807 175.337 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 216' ' ' PHE . . . . . . . . . . . . . 59.0 m-85 -130.94 -46.17 1.03 Allowed 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.976 0.417 . . . . 15.0 110.654 177.902 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 217' ' ' GLN . . . . . . . . . . . . . 2.7 mp0 . . . . . 0 C--O 1.244 0.805 0 CA-C-O 118.422 -0.799 . . . . 15.0 109.727 179.074 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 . . . . . 0 N--CA 1.483 1.2 0 N-CA-C 109.583 -0.525 . . . . 15.0 109.583 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 236' ' ' LEU . . . . . 0.656 HD22 ' H ' ' A' ' 236' ' ' LEU . 0.0 OUTLIER -97.35 161.31 26.47 Favored Pre-proline 0 C--N 1.324 -0.53 0 CA-C-O 121.148 0.499 . . . . 15.0 110.177 -175.027 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 237' ' ' PRO . . . . . 0.522 ' HD3' ' HB2' ' A' ' 266' ' ' ARG . 9.0 Cg_exo -69.79 174.77 9.05 Favored 'Trans proline' 0 CA--C 1.509 -0.765 0 C-N-CA 122.845 2.363 . . . . 15.0 110.802 166.308 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -69.6 126.71 30.55 Favored 'General case' 0 C--N 1.297 -1.706 0 CA-C-N 114.132 -1.394 . . . . 15.0 111.544 -175.316 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 100.06 49.28 1.49 Allowed Glycine 0 C--N 1.333 0.37 0 CA-C-N 115.364 -0.834 . . . . 15.0 113.436 177.195 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 240' ' ' TYR . . . . . 0.646 ' CD1' ' HB2' ' A' ' 254' ' ' HIS . 74.1 m-85 -142.69 123.78 14.51 Favored 'General case' 0 CA--C 1.516 -0.345 0 CA-C-N 117.658 0.729 . . . . 15.0 111.518 176.442 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 241' ' ' GLU . . . . . 0.401 ' HB3' ' NH1' ' A' ' 243' ' ' ARG . 34.1 mm-40 -100.07 124.06 45.02 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.337 -0.847 . . . . 15.0 109.164 175.155 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 242' ' ' GLN . . . . . 0.69 ' HG3' ' CE1' ' A' ' 252' ' ' PHE . 31.7 tt0 -90.18 110.78 21.79 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.458 -0.571 . . . . 15.0 109.458 -179.82 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 243' ' ' ARG . . . . . 0.428 ' CD ' HD12 ' A' ' 253' ' ' LEU . 2.5 mpt_? -93.44 150.39 20.49 Favored 'General case' 0 CA--C 1.506 -0.739 0 CA-C-O 122.185 0.993 . . . . 15.0 113.641 -177.745 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 244' ' ' THR . . . . . . . . . . . . . 23.4 p -130.89 95.35 3.81 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 113.014 -1.903 . . . . 15.0 110.057 -176.848 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 245' ' ' THR . . . . . 0.511 ' OG1' ' HG2' ' A' ' 247' ' ' GLN . 5.5 t -93.96 150.41 20.38 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.872 -0.604 . . . . 15.0 110.044 179.672 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 3.8 p -53.37 -20.58 3.19 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 CA-C-O 121.163 0.506 . . . . 15.0 111.492 -179.244 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 247' ' ' GLN . . . . . 0.511 ' HG2' ' OG1' ' A' ' 245' ' ' THR . 31.6 mm-40 -55.12 -23.5 21.31 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.022 -0.99 . . . . 15.0 110.881 176.23 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 85.88 36.58 10.1 Favored Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 121.103 -0.57 . . . . 15.0 111.801 178.5 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 249' ' ' GLN . . . . . 0.437 ' HG2' ' HB2' ' A' ' 247' ' ' GLN . 7.3 pt20 -141.43 130.77 23.66 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.866 0.365 . . . . 15.0 110.844 -176.892 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 15.5 m -89.84 124.87 42.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 115.868 -0.605 . . . . 15.0 110.305 177.042 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 251' ' ' TYR . . . . . 0.596 ' CD2' ' HD3' ' B' ' 215' ' ' PRO . 16.4 p90 -128.95 137.24 51.27 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.812 -0.631 . . . . 15.0 109.765 -177.976 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 252' ' ' PHE . . . . . 0.69 ' CE1' ' HG3' ' A' ' 242' ' ' GLN . 29.8 m-85 -89.75 120.17 30.77 Favored 'General case' 0 CA--C 1.511 -0.535 0 CA-C-O 121.239 0.542 . . . . 15.0 112.186 -169.986 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 253' ' ' LEU . . . . . 1.004 HD11 ' HB3' ' B' ' 212' ' ' PRO . 4.6 mt -104.65 110.29 22.54 Favored 'General case' 0 N--CA 1.446 -0.627 0 CA-C-N 114.683 -1.144 . . . . 15.0 111.823 -178.308 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 254' ' ' HIS . . . . . 0.646 ' HB2' ' CD1' ' A' ' 240' ' ' TYR . 12.1 t-80 -117.89 95.65 5.01 Favored 'General case' 0 C--N 1.312 -1.042 0 N-CA-C 107.808 -1.182 . . . . 15.0 107.808 166.405 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 2.9 t -93.98 87.76 5.47 Favored 'General case' 0 N--CA 1.429 -1.507 0 C-N-CA 115.968 -2.293 . . . . 15.0 110.038 -179.115 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 51.1 tt0 -101.34 -54.55 2.75 Favored 'General case' 0 N--CA 1.441 -0.894 0 CA-C-N 113.087 -1.869 . . . . 15.0 106.068 151.208 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 257' ' ' THR . . . . . . . . . . . . . 67.2 p -99.51 -13.74 19.36 Favored 'General case' 0 CA--C 1.49 -1.365 0 CA-C-N 111.881 -2.418 . . . . 15.0 112.013 -177.183 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 87.83 71.57 1.28 Allowed Glycine 1 C--N 1.241 -4.7 1 CA-C-N 108.236 -4.074 . . . . 15.0 112.904 -171.513 . . . . . . . . 3 2 . 1 . 016 nuclear nobuild full ' A' A ' 259' ' ' VAL . . . . . 0.693 ' O ' ' HA ' ' A' ' 253' ' ' LEU . 40.6 t -89.67 124.58 42.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 121.294 0.569 . . . . 15.0 112.226 176.767 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -137.15 97.04 3.4 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 114.451 -1.25 . . . . 15.0 107.816 166.174 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 14.6 t -132.23 150.35 52.17 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.943 -0.571 . . . . 15.0 111.48 -168.45 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 262' ' ' TRP . . . . . 1.107 ' CZ2' ' HB2' ' B' ' 215' ' ' PRO . 10.7 m95 -65.57 -53.75 37.6 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.476 -0.784 . . . . 15.0 111.519 178.615 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 263' ' ' HIS . . . . . . . . . . . . . 4.4 p80 -65.3 133.43 51.41 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.242 -0.435 . . . . 15.0 110.465 -175.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 264' ' ' ASP . . . . . 0.978 ' HB3' HG12 ' A' ' 267' ' ' ILE . 24.0 t0 -53.83 128.9 55.55 Favored Pre-proline 0 C--N 1.321 -0.631 0 N-CA-C 107.833 -1.173 . . . . 15.0 107.833 169.253 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 265' ' ' PRO . . . . . 0.625 ' HD3' ' CD2' ' A' ' 252' ' ' PHE . 13.1 Cg_exo -68.98 -14.57 38.78 Favored 'Trans proline' 0 N--CA 1.458 -0.605 0 C-N-CA 122.01 1.807 . . . . 15.0 112.582 -177.483 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 266' ' ' ARG . . . . . 0.522 ' HB2' ' HD3' ' A' ' 237' ' ' PRO . 19.9 tpt180 -72.53 -14.93 61.76 Favored 'General case' 0 N--CA 1.446 -0.667 0 N-CA-C 108.611 -0.885 . . . . 15.0 108.611 170.953 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 267' ' ' ILE . . . . . 0.978 HG12 ' HB3' ' A' ' 264' ' ' ASP . 26.9 pt . . . . . 0 C--O 1.252 1.199 0 CA-C-N 114.482 -1.236 . . . . 15.0 110.438 177.748 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 210' ' ' SER . . . . . . . . . . . . . 24.4 p . . . . . 0 N--CA 1.479 1.012 0 N-CA-C 111.595 0.22 . . . . 15.0 111.595 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' B' B ' 211' ' ' ASP . . . . . 0.477 ' HA ' ' HD3' ' B' ' 212' ' ' PRO . 23.6 t70 -93.45 120.28 66.59 Favored Pre-proline 0 C--N 1.328 -0.342 0 N-CA-C 110.323 -0.251 . . . . 15.0 110.323 -179.113 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 212' ' ' PRO . . . . . 1.004 ' HB3' HD11 ' A' ' 253' ' ' LEU . 3.6 Cg_endo -89.83 147.25 4.81 Favored 'Trans proline' 0 N--CA 1.453 -0.909 0 C-N-CA 123.078 2.519 . . . . 15.0 112.595 179.714 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -89.87 148.34 19.81 Favored Glycine 0 N--CA 1.438 -1.172 0 C-N-CA 120.603 -0.808 . . . . 15.0 112.049 -179.581 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 214' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' B' B ' 215' ' ' PRO . . . . . 1.107 ' HB2' ' CZ2' ' A' ' 262' ' ' TRP . 15.6 Cg_exo -87.49 112.26 0.84 Allowed 'Trans proline' 0 C--N 1.331 -0.378 0 C-N-CA 123.53 2.82 . . . . 15.0 110.914 -178.681 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 216' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -104.26 -5.45 21.85 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.602 -0.726 . . . . 15.0 111.205 -176.294 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 217' ' ' GLN . . . . . . . . . . . . . 20.3 tt0 . . . . . 0 C--O 1.249 1.038 0 CA-C-O 118.428 -0.796 . . . . 15.0 109.513 178.575 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 . . . . . 0 N--CA 1.482 1.125 0 N-CA-C 110.307 -0.257 . . . . 15.0 110.307 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 236' ' ' LEU . . . . . 0.662 HD22 ' H ' ' A' ' 236' ' ' LEU . 0.1 OUTLIER -95.91 171.78 5.97 Favored Pre-proline 0 C--N 1.324 -0.51 0 N-CA-C 108.767 -0.827 . . . . 15.0 108.767 178.685 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 237' ' ' PRO . . . . . 0.829 ' HD3' ' HD3' ' A' ' 266' ' ' ARG . 16.8 Cg_exo -69.57 160.64 48.98 Favored 'Trans proline' 0 N--CA 1.459 -0.519 0 C-N-CA 122.077 1.851 . . . . 15.0 110.286 166.562 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -69.59 142.6 53.51 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-N 115.536 -0.756 . . . . 15.0 111.006 -174.353 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 100.37 8.77 49.16 Favored Glycine 0 CA--C 1.522 0.494 0 CA-C-N 115.807 -0.633 . . . . 15.0 113.815 179.677 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 240' ' ' TYR . . . . . 0.707 ' CD1' ' HB2' ' A' ' 254' ' ' HIS . 77.8 m-85 -109.97 110.43 21.36 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 117.465 0.632 . . . . 15.0 110.458 175.882 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 241' ' ' GLU . . . . . 0.655 ' HG3' ' HB3' ' A' ' 253' ' ' LEU . 8.0 pt-20 -90.13 115.92 27.75 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.697 0.76 . . . . 15.0 109.202 174.105 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 11.7 tm0? -90.0 109.72 20.74 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 108.805 -0.813 . . . . 15.0 108.805 -179.564 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 69.6 mtt-85 -99.14 150.18 22.3 Favored 'General case' 0 CA--C 1.504 -0.803 0 CA-C-O 122.283 1.039 . . . . 15.0 113.355 -170.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 244' ' ' THR . . . . . . . . . . . . . 3.3 p -115.67 105.4 12.71 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 112.87 -1.968 . . . . 15.0 109.725 179.184 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 245' ' ' THR . . . . . 0.94 HG23 ' HG2' ' A' ' 247' ' ' GLN . 6.1 t -116.22 150.35 37.67 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 116.036 -0.529 . . . . 15.0 110.882 -174.874 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 13.0 m -49.22 -25.22 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.313 0 N-CA-C 113.97 1.1 . . . . 15.0 113.97 -176.474 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 247' ' ' GLN . . . . . 0.94 ' HG2' HG23 ' A' ' 245' ' ' THR . 2.6 pt20 -57.75 -21.65 42.49 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-O 120.678 0.275 . . . . 15.0 111.012 178.161 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 93.62 15.41 50.06 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.925 -0.655 . . . . 15.0 113.259 174.936 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 249' ' ' GLN . . . . . 0.681 ' HB2' ' OE1' ' A' ' 247' ' ' GLN . 1.8 mp0 -123.97 147.34 47.84 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.944 0.402 . . . . 15.0 111.598 -178.689 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 31.3 m -90.13 135.71 25.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.765 -0.652 . . . . 15.0 109.89 173.235 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 251' ' ' TYR . . . . . 0.692 ' HB3' ' HG2' ' B' ' 215' ' ' PRO . 28.2 p90 -141.95 135.15 29.09 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 109.587 -0.523 . . . . 15.0 109.587 -177.038 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 252' ' ' PHE . . . . . 0.694 ' CD2' ' HA ' ' A' ' 264' ' ' ASP . 29.5 m-85 -90.13 123.39 33.93 Favored 'General case' 0 CA--C 1.51 -0.565 0 CA-C-N 115.982 -0.554 . . . . 15.0 111.593 -173.248 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 253' ' ' LEU . . . . . 0.812 HD11 ' HB3' ' B' ' 212' ' ' PRO . 0.5 OUTLIER -116.69 114.26 23.79 Favored 'General case' 0 N--CA 1.445 -0.715 0 CA-C-N 115.123 -0.944 . . . . 15.0 110.964 -176.343 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 254' ' ' HIS . . . . . 0.707 ' HB2' ' CD1' ' A' ' 240' ' ' TYR . 20.9 t-80 -124.29 95.09 4.41 Favored 'General case' 0 CA--C 1.5 -0.972 0 N-CA-C 108.48 -0.933 . . . . 15.0 108.48 169.747 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 3.0 t -94.54 88.18 5.37 Favored 'General case' 0 N--CA 1.433 -1.304 0 C-N-CA 116.33 -2.148 . . . . 15.0 110.754 179.287 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 256' ' ' GLN . . . . . 0.503 ' HB3' ' CE1' ' A' ' 254' ' ' HIS . 5.8 tt0 -101.29 -52.94 3.13 Favored 'General case' 0 N--CA 1.441 -0.906 0 N-CA-C 106.026 -1.842 . . . . 15.0 106.026 149.861 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 257' ' ' THR . . . . . . . . . . . . . 72.7 p -97.79 -13.7 21.21 Favored 'General case' 0 CA--C 1.488 -1.406 0 CA-C-O 124.634 2.159 . . . . 15.0 111.923 -179.501 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 88.7 71.04 1.27 Allowed Glycine 1 C--N 1.243 -4.598 0 CA-C-N 108.404 -3.998 . . . . 15.0 113.167 -172.933 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 259' ' ' VAL . . . . . 0.622 ' O ' ' HA ' ' A' ' 253' ' ' LEU . 57.8 t -89.83 126.06 42.74 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.289 0 CA-C-O 121.428 0.632 . . . . 15.0 112.387 175.757 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 260' ' ' SER . . . . . 0.412 ' HA ' ' O ' ' A' ' 252' ' ' PHE . 1.4 p -141.66 100.24 3.72 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 114.444 -1.253 . . . . 15.0 107.685 165.934 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 13.4 t -136.39 150.32 48.74 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.853 -0.612 . . . . 15.0 111.788 -167.376 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 262' ' ' TRP . . . . . 1.199 ' CZ2' ' HB2' ' B' ' 215' ' ' PRO . 8.9 m95 -70.7 -32.38 69.58 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.349 -0.841 . . . . 15.0 112.374 179.449 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 263' ' ' HIS . . . . . . . . . . . . . 5.0 p80 -84.63 134.67 34.37 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 120.385 -0.526 . . . . 15.0 110.388 -176.289 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 264' ' ' ASP . . . . . 1.022 ' HB3' HG12 ' A' ' 267' ' ' ILE . 43.5 t0 -56.62 124.06 60.72 Favored Pre-proline 0 C--O 1.218 -0.603 0 N-CA-C 108.56 -0.904 . . . . 15.0 108.56 169.843 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 265' ' ' PRO . . . . . 0.53 ' HD3' ' CD2' ' A' ' 252' ' ' PHE . 10.6 Cg_exo -68.93 -14.83 39.44 Favored 'Trans proline' 0 N--CA 1.46 -0.494 0 C-N-CA 122.367 2.045 . . . . 15.0 112.629 -177.55 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 266' ' ' ARG . . . . . 0.829 ' HD3' ' HD3' ' A' ' 237' ' ' PRO . 20.2 tpt180 -75.89 -11.58 60.0 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 115.483 -0.78 . . . . 15.0 109.047 173.623 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 267' ' ' ILE . . . . . 1.022 HG12 ' HB3' ' A' ' 264' ' ' ASP . 36.9 pt . . . . . 0 C--O 1.247 0.945 0 CA-C-N 114.641 -1.163 . . . . 15.0 111.253 178.899 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 210' ' ' SER . . . . . . . . . . . . . 20.4 m . . . . . 0 N--CA 1.481 1.077 0 CA-C-O 120.638 0.256 . . . . 15.0 111.229 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' B' B ' 211' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -116.95 144.32 33.27 Favored Pre-proline 0 C--O 1.235 0.319 0 N-CA-C 109.37 -0.604 . . . . 15.0 109.37 176.053 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 212' ' ' PRO . . . . . 0.812 ' HB3' HD11 ' A' ' 253' ' ' LEU . 8.4 Cg_endo -89.87 143.33 4.16 Favored 'Trans proline' 0 N--CA 1.454 -0.823 0 C-N-CA 122.819 2.346 . . . . 15.0 112.888 -176.715 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -89.77 149.98 20.82 Favored Glycine 0 N--CA 1.441 -0.976 0 CA-C-N 115.538 -0.755 . . . . 15.0 111.622 176.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 214' ' ' SEP . . . . . 0.463 ' HB3' ' NE2' ' A' ' 247' ' ' GLN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 215' ' ' PRO . . . . . 1.199 ' HB2' ' CZ2' ' A' ' 262' ' ' TRP . 12.5 Cg_exo -87.21 134.29 3.52 Favored 'Trans proline' 0 N--CA 1.464 -0.256 0 C-N-CA 123.637 2.891 . . . . 15.0 110.711 179.583 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 216' ' ' PHE . . . . . . . . . . . . . 82.5 m-85 -112.25 -28.31 7.99 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 120.399 -0.521 . . . . 15.0 111.725 -176.764 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 217' ' ' GLN . . . . . . . . . . . . . 29.5 pt20 . . . . . 0 C--O 1.247 0.934 0 N-CA-C 109.381 -0.6 . . . . 15.0 109.381 178.676 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.48 1.07 0 N-CA-C 109.914 -0.402 . . . . 15.0 109.914 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 236' ' ' LEU . . . . . 0.427 HD11 ' OD1' ' A' ' 264' ' ' ASP . 2.1 mm? -122.0 171.18 6.59 Favored Pre-proline 0 C--N 1.322 -0.614 0 CA-C-O 120.85 0.357 . . . . 15.0 110.727 -176.757 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 237' ' ' PRO . . . . . 0.563 ' HD3' ' HD3' ' A' ' 266' ' ' ARG . 15.0 Cg_exo -69.53 164.28 34.9 Favored 'Trans proline' 0 N--CA 1.456 -0.699 0 C-N-CA 121.92 1.747 . . . . 15.0 109.314 160.835 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 12.2 mm-40 -69.6 142.69 53.47 Favored 'General case' 0 C--N 1.301 -1.522 0 CA-C-N 115.166 -0.925 . . . . 15.0 113.333 -170.098 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 100.11 -1.62 56.37 Favored Glycine 0 CA--C 1.526 0.755 0 CA-C-N 114.124 -1.398 . . . . 15.0 115.166 174.103 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 240' ' ' TYR . . . . . 0.7 ' CD1' ' HB2' ' A' ' 254' ' ' HIS . 78.1 m-85 -87.9 123.46 32.67 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 118.574 1.187 . . . . 15.0 111.486 -179.449 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -96.08 114.81 26.55 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.397 -0.819 . . . . 15.0 109.214 173.332 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -90.13 99.68 12.65 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 108.823 -0.806 . . . . 15.0 108.823 176.233 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 243' ' ' ARG . . . . . 0.701 ' CZ ' ' HD2' ' B' ' 212' ' ' PRO . 34.7 mtt180 -91.28 149.86 21.57 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.531 -0.758 . . . . 15.0 111.823 179.404 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 244' ' ' THR . . . . . . . . . . . . . 6.1 m -127.2 92.05 3.44 Favored 'General case' 0 C--N 1.307 -1.267 0 CA-C-N 113.682 -1.599 . . . . 15.0 109.219 -179.407 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 245' ' ' THR . . . . . 0.438 ' OG1' ' HG2' ' A' ' 247' ' ' GLN . 5.0 t -90.0 150.59 22.05 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.204 -0.907 . . . . 15.0 110.926 -174.666 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 11.6 m -49.0 -20.23 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 CA-C-N 115.429 -0.805 . . . . 15.0 112.617 177.053 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 247' ' ' GLN . . . . . 0.565 ' HB2' ' HG3' ' A' ' 249' ' ' GLN . 6.6 mm100 -58.77 -19.51 41.4 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 116.055 -0.521 . . . . 15.0 111.128 175.307 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 85.98 26.01 35.84 Favored Glycine 0 C--N 1.332 0.357 0 C-N-CA 121.305 -0.474 . . . . 15.0 112.632 177.454 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 249' ' ' GLN . . . . . 0.565 ' HG3' ' HB2' ' A' ' 247' ' ' GLN . 0.3 OUTLIER -126.43 133.96 51.11 Favored 'General case' 0 C--N 1.326 -0.415 0 O-C-N 122.624 -0.339 . . . . 15.0 110.967 -174.493 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 3.6 m -90.01 107.23 18.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 115.768 -0.651 . . . . 15.0 109.537 173.056 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 251' ' ' TYR . . . . . 0.747 ' HB2' ' HG2' ' B' ' 215' ' ' PRO . 6.4 p90 -119.48 130.65 55.33 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.922 -0.581 . . . . 15.0 109.981 -173.399 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 252' ' ' PHE . . . . . 0.738 ' CD2' ' HA ' ' A' ' 264' ' ' ASP . 32.2 m-85 -90.03 123.09 33.62 Favored 'General case' 0 CA--C 1.506 -0.75 0 CA-C-N 116.21 -0.45 . . . . 15.0 110.832 -175.365 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 253' ' ' LEU . . . . . 0.838 HD13 ' HB2' ' B' ' 212' ' ' PRO . 1.6 tt -128.82 115.79 18.46 Favored 'General case' 0 N--CA 1.438 -1.048 0 CA-C-N 115.631 -0.713 . . . . 15.0 111.541 -175.554 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 254' ' ' HIS . . . . . 0.7 ' HB2' ' CD1' ' A' ' 240' ' ' TYR . 29.1 t-80 -124.18 92.57 3.69 Favored 'General case' 0 CA--C 1.505 -0.758 0 N-CA-C 108.723 -0.843 . . . . 15.0 108.723 174.861 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 255' ' ' THR . . . . . 0.405 ' HA ' ' HA2' ' A' ' 258' ' ' GLY . 53.0 m -94.7 88.18 5.3 Favored 'General case' 0 N--CA 1.436 -1.159 0 C-N-CA 116.66 -2.016 . . . . 15.0 110.429 179.782 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 7.1 tt0 -100.83 -50.47 3.83 Favored 'General case' 0 N--CA 1.441 -0.917 0 N-CA-C 105.848 -1.908 . . . . 15.0 105.848 151.236 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 257' ' ' THR . . . . . . . . . . . . . 60.3 p -98.46 -13.44 20.54 Favored 'General case' 0 CA--C 1.49 -1.349 0 CA-C-O 124.963 2.316 . . . . 15.0 111.795 177.598 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 258' ' ' GLY . . . . . 0.405 ' HA2' ' HA ' ' A' ' 255' ' ' THR . . . 88.52 70.8 1.27 Allowed Glycine 1 C--N 1.242 -4.665 1 CA-C-N 108.214 -4.085 . . . . 15.0 113.471 -173.405 . . . . . . . . 4 3 . 1 . 018 nuclear nobuild full ' A' A ' 259' ' ' VAL . . . . . 0.527 ' O ' ' HA ' ' A' ' 253' ' ' LEU . 76.5 t -89.8 130.42 39.13 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.58 0 CA-C-O 121.271 0.558 . . . . 15.0 111.207 173.711 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 10.1 p -150.09 96.97 2.51 Favored 'General case' 0 C--N 1.307 -1.247 0 CA-C-N 114.598 -1.183 . . . . 15.0 108.817 170.755 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 12.4 t -143.87 150.32 38.27 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.877 -0.601 . . . . 15.0 111.299 -168.377 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 262' ' ' TRP . . . . . 1.117 ' CZ2' ' HB2' ' B' ' 215' ' ' PRO . 92.9 m95 -69.07 -42.15 76.62 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.849 -0.614 . . . . 15.0 111.729 179.845 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 263' ' ' HIS . . . . . . . . . . . . . 2.6 p80 -65.22 132.32 48.8 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-O 120.896 0.379 . . . . 15.0 110.213 -176.345 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 264' ' ' ASP . . . . . 0.899 ' HB3' HG12 ' A' ' 267' ' ' ILE . 28.4 t70 -56.11 124.94 62.26 Favored Pre-proline 0 C--N 1.321 -0.665 0 N-CA-C 108.847 -0.797 . . . . 15.0 108.847 172.428 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 265' ' ' PRO . . . . . 0.672 ' HD3' ' CD2' ' A' ' 252' ' ' PHE . 4.3 Cg_exo -73.44 -14.64 25.12 Favored 'Trans proline' 0 CA--C 1.51 -0.701 0 C-N-CA 122.08 1.853 . . . . 15.0 112.224 -175.978 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 266' ' ' ARG . . . . . 0.568 ' HB3' ' OD2' ' A' ' 264' ' ' ASP . 28.1 tpt180 -72.63 -13.46 61.38 Favored 'General case' 0 C--N 1.316 -0.861 0 N-CA-C 108.542 -0.91 . . . . 15.0 108.542 171.244 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 267' ' ' ILE . . . . . 0.899 HG12 ' HB3' ' A' ' 264' ' ' ASP . 22.5 pt . . . . . 0 C--O 1.251 1.169 0 CA-C-N 114.618 -1.174 . . . . 15.0 110.645 174.667 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 210' ' ' SER . . . . . . . . . . . . . 9.6 p . . . . . 0 N--CA 1.478 0.955 0 N-CA-C 110.366 -0.235 . . . . 15.0 110.366 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' B' B ' 211' ' ' ASP . . . . . 0.485 ' HA ' ' HD3' ' B' ' 212' ' ' PRO . 20.5 t70 -150.04 128.64 6.04 Favored Pre-proline 0 C--N 1.324 -0.52 0 N-CA-C 109.673 -0.492 . . . . 15.0 109.673 177.173 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 212' ' ' PRO . . . . . 0.838 ' HB2' HD13 ' A' ' 253' ' ' LEU . 2.0 Cg_endo -89.33 141.67 4.14 Favored 'Trans proline' 0 N--CA 1.457 -0.623 0 C-N-CA 123.281 2.654 . . . . 15.0 113.734 -177.814 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -89.67 160.34 28.85 Favored Glycine 0 N--CA 1.449 -0.449 0 CA-C-N 114.796 -1.093 . . . . 15.0 113.278 -176.466 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 214' ' ' SEP . . . . . 0.482 ' HA ' ' HD3' ' B' ' 215' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 215' ' ' PRO . . . . . 1.117 ' HB2' ' CZ2' ' A' ' 262' ' ' TRP . 36.9 Cg_exo -87.36 160.09 8.22 Favored 'Trans proline' 0 C--O 1.233 0.245 0 C-N-CA 124.057 3.172 . . . . 15.0 112.078 176.125 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 216' ' ' PHE . . . . . . . . . . . . . 92.2 m-85 -117.14 122.34 43.82 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.404 -0.362 . . . . 15.0 110.416 -178.696 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 217' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 . . . . . 0 C--O 1.25 1.095 0 CA-C-O 118.504 -0.76 . . . . 15.0 110.505 -177.485 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 . . . . . 0 N--CA 1.478 0.927 0 CA-C-O 121.093 0.473 . . . . 15.0 110.668 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 236' ' ' LEU . . . . . 0.418 HD11 ' CE1' ' A' ' 252' ' ' PHE . 19.7 mt -93.62 175.76 2.88 Favored Pre-proline 0 C--N 1.321 -0.657 0 N-CA-C 108.97 -0.752 . . . . 15.0 108.97 177.663 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 237' ' ' PRO . . . . . 0.855 ' HD3' ' HD3' ' A' ' 266' ' ' ARG . 13.1 Cg_exo -69.7 163.11 39.47 Favored 'Trans proline' 0 N--CA 1.459 -0.536 0 C-N-CA 121.47 1.446 . . . . 15.0 110.247 167.289 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -69.77 140.16 53.36 Favored 'General case' 0 C--N 1.307 -1.248 0 CA-C-N 115.321 -0.854 . . . . 15.0 111.104 -174.125 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 100.29 9.34 48.02 Favored Glycine 0 N--CA 1.451 -0.36 0 CA-C-N 115.642 -0.708 . . . . 15.0 114.211 178.241 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 240' ' ' TYR . . . . . 0.769 ' CD1' ' HB2' ' A' ' 254' ' ' HIS . 85.1 m-85 -104.08 123.43 47.23 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 117.897 0.848 . . . . 15.0 110.637 174.929 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 241' ' ' GLU . . . . . 0.689 ' HG3' ' HB3' ' A' ' 253' ' ' LEU . 7.7 pt-20 -109.41 123.78 49.91 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.682 -0.69 . . . . 15.0 109.627 174.408 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 21.5 tm0? -90.01 116.07 27.77 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 108.684 -0.858 . . . . 15.0 108.684 179.021 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 63.6 mtt-85 -107.3 149.27 27.99 Favored 'General case' 0 CA--C 1.501 -0.932 0 CA-C-O 122.157 0.979 . . . . 15.0 112.579 -177.563 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 244' ' ' THR . . . . . . . . . . . . . 7.5 m -124.18 91.72 3.52 Favored 'General case' 0 C--N 1.307 -1.257 0 CA-C-N 113.288 -1.778 . . . . 15.0 110.029 179.166 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 245' ' ' THR . . . . . 1.083 HG23 ' HG2' ' A' ' 247' ' ' GLN . 8.5 t -91.28 150.67 21.22 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.572 -0.74 . . . . 15.0 109.849 177.516 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 14.9 m -41.03 -24.32 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 N-CA-C 114.968 1.47 . . . . 15.0 114.968 -175.354 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 247' ' ' GLN . . . . . 1.083 ' HG2' HG23 ' A' ' 245' ' ' THR . 3.6 pt20 -55.79 -22.48 24.64 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-O 120.752 0.31 . . . . 15.0 111.013 176.564 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 81.03 34.73 26.12 Favored Glycine 0 C--N 1.333 0.399 0 C-N-CA 121.48 -0.391 . . . . 15.0 113.182 174.196 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 249' ' ' GLN . . . . . 0.425 ' HB3' ' CZ3' ' A' ' 262' ' ' TRP . 32.5 mt-30 -136.37 146.93 47.05 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.759 -0.46 . . . . 15.0 109.759 -178.627 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 23.7 m -89.76 125.47 42.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-O 120.792 0.329 . . . . 15.0 110.989 -178.186 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 251' ' ' TYR . . . . . 0.736 ' HB3' ' HG2' ' B' ' 215' ' ' PRO . 12.8 p90 -131.79 133.16 44.43 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 109.622 -0.511 . . . . 15.0 109.622 179.679 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 252' ' ' PHE . . . . . 0.683 ' CD2' ' HA ' ' A' ' 264' ' ' ASP . 36.3 m-85 -90.05 118.68 29.78 Favored 'General case' 0 CA--C 1.512 -0.508 0 CA-C-O 121.206 0.526 . . . . 15.0 110.994 -176.786 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 253' ' ' LEU . . . . . 0.689 ' HB3' ' HG3' ' A' ' 241' ' ' GLU . 0.6 OUTLIER -106.79 122.87 47.24 Favored 'General case' 0 N--CA 1.444 -0.737 0 CA-C-N 115.082 -0.963 . . . . 15.0 110.461 -178.05 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 254' ' ' HIS . . . . . 0.769 ' HB2' ' CD1' ' A' ' 240' ' ' TYR . 29.9 t-80 -135.0 90.27 2.62 Favored 'General case' 0 C--N 1.313 -1.018 0 N-CA-C 108.081 -1.081 . . . . 15.0 108.081 172.024 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 255' ' ' THR . . . . . 0.419 ' HA ' ' HA2' ' A' ' 258' ' ' GLY . 2.8 t -91.41 87.82 6.58 Favored 'General case' 0 N--CA 1.433 -1.277 0 C-N-CA 116.411 -2.116 . . . . 15.0 110.185 -179.215 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 52.0 tt0 -101.53 -54.97 2.63 Favored 'General case' 0 N--CA 1.436 -1.135 0 CA-C-N 112.818 -1.992 . . . . 15.0 105.842 151.254 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 257' ' ' THR . . . . . . . . . . . . . 63.4 p -95.89 -13.53 23.87 Favored 'General case' 0 CA--C 1.486 -1.499 0 CA-C-N 112.214 -2.266 . . . . 15.0 111.449 179.015 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 258' ' ' GLY . . . . . 0.419 ' HA2' ' HA ' ' A' ' 255' ' ' THR . . . 86.66 70.52 1.31 Allowed Glycine 1 C--N 1.246 -4.453 1 CA-C-N 108.187 -4.097 . . . . 15.0 113.093 -172.629 . . . . . . . . 4 3 . 1 . 019 nuclear nobuild full ' A' A ' 259' ' ' VAL . . . . . 0.571 ' O ' ' HA ' ' A' ' 253' ' ' LEU . 60.6 t -89.88 129.17 41.23 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.243 0 CA-C-O 121.203 0.525 . . . . 15.0 112.227 176.674 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 1.1 p -143.49 98.83 3.32 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 114.783 -1.098 . . . . 15.0 108.228 169.475 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 9.0 t -139.52 150.31 44.95 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 116.159 -0.473 . . . . 15.0 111.819 -170.305 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 262' ' ' TRP . . . . . 1.217 ' CZ2' ' HB2' ' B' ' 215' ' ' PRO . 91.6 m95 -68.3 -30.64 69.68 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.38 -0.827 . . . . 15.0 111.707 178.587 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 263' ' ' HIS . . . . . . . . . . . . . 4.2 p80 -83.5 136.72 34.17 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 120.725 -0.39 . . . . 15.0 110.757 -172.336 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 264' ' ' ASP . . . . . 0.776 ' HB3' HG12 ' A' ' 267' ' ' ILE . 10.0 t70 -56.32 134.23 75.95 Favored Pre-proline 0 C--N 1.325 -0.469 0 CA-C-N 115.652 -0.704 . . . . 15.0 109.268 174.754 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 265' ' ' PRO . . . . . 0.603 ' HD3' ' CD2' ' A' ' 252' ' ' PHE . 88.8 Cg_endo -84.28 -14.5 6.98 Favored 'Trans proline' 0 N--CA 1.458 -0.617 0 C-N-CA 122.568 2.179 . . . . 15.0 113.995 -174.486 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 266' ' ' ARG . . . . . 0.855 ' HD3' ' HD3' ' A' ' 237' ' ' PRO . 21.8 tpt180 -80.98 -5.21 57.26 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-O 122.418 1.104 . . . . 15.0 108.505 176.265 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 267' ' ' ILE . . . . . 0.776 HG12 ' HB3' ' A' ' 264' ' ' ASP . 48.3 mm . . . . . 0 C--O 1.251 1.174 0 CA-C-N 113.153 -1.84 . . . . 15.0 109.824 176.684 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 210' ' ' SER . . . . . . . . . . . . . 5.4 p . . . . . 0 N--CA 1.474 0.765 0 CA-C-O 121.042 0.448 . . . . 15.0 110.741 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' B' B ' 211' ' ' ASP . . . . . 0.465 ' HA ' ' HD3' ' B' ' 212' ' ' PRO . 2.0 p30 -144.62 118.94 5.77 Favored Pre-proline 0 C--N 1.325 -0.496 0 CA-C-N 115.83 -0.623 . . . . 15.0 110.319 178.766 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 212' ' ' PRO . . . . . 0.689 ' HB3' HD11 ' A' ' 253' ' ' LEU . 12.6 Cg_endo -92.22 151.09 3.11 Favored 'Trans proline' 0 N--CA 1.452 -0.942 0 C-N-CA 123.587 2.858 . . . . 15.0 112.722 -179.927 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -90.38 159.03 26.99 Favored Glycine 0 N--CA 1.444 -0.771 0 C-N-CA 120.725 -0.75 . . . . 15.0 112.466 179.457 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 214' ' ' SEP . . . . . 0.763 ' HB2' HG21 ' A' ' 245' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 215' ' ' PRO . . . . . 1.217 ' HB2' ' CZ2' ' A' ' 262' ' ' TRP . 15.4 Cg_exo -87.69 132.42 2.95 Favored 'Trans proline' 0 N--CA 1.463 -0.319 0 C-N-CA 122.907 2.405 . . . . 15.0 110.148 176.882 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 216' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -113.58 83.79 1.91 Allowed 'General case' 0 C--N 1.322 -0.602 0 O-C-N 121.965 -0.46 . . . . 15.0 110.778 179.877 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 217' ' ' GLN . . . . . . . . . . . . . 26.1 mm-40 . . . . . 0 C--O 1.245 0.838 0 CA-C-N 114.933 -1.03 . . . . 15.0 110.705 179.57 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.478 0.973 0 N-CA-C 110.266 -0.272 . . . . 15.0 110.266 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 2.4 mt -121.21 170.86 6.72 Favored Pre-proline 0 C--N 1.326 -0.424 0 N-CA-C 108.918 -0.771 . . . . 15.0 108.918 178.241 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 237' ' ' PRO . . . . . 0.465 ' O ' ' HD2' ' A' ' 240' ' ' TYR . 14.8 Cg_exo -69.81 162.69 41.11 Favored 'Trans proline' 0 N--CA 1.46 -0.46 0 C-N-CA 121.657 1.571 . . . . 15.0 110.093 164.626 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 238' ' ' GLU . . . . . 0.483 ' CD ' ' H ' ' A' ' 238' ' ' GLU . 0.9 OUTLIER -69.71 148.41 49.28 Favored 'General case' 0 C--N 1.306 -1.29 0 CA-C-N 115.432 -0.804 . . . . 15.0 111.243 -175.266 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 100.28 -7.38 58.35 Favored Glycine 0 N--CA 1.45 -0.411 0 CA-C-N 115.418 -0.81 . . . . 15.0 113.275 -179.521 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 240' ' ' TYR . . . . . 0.685 ' CD1' ' HB2' ' A' ' 254' ' ' HIS . 87.8 m-85 -99.46 113.25 25.5 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 117.461 0.631 . . . . 15.0 110.47 177.351 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 241' ' ' GLU . . . . . 0.465 ' HG3' ' HB3' ' A' ' 253' ' ' LEU . 9.5 pt-20 -90.26 120.29 31.29 Favored 'General case' 0 N--CA 1.439 -0.975 0 N-CA-C 108.725 -0.843 . . . . 15.0 108.725 174.518 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? -89.86 99.1 12.18 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 108.123 -1.066 . . . . 15.0 108.123 -179.862 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 9.4 mtp180 -92.48 150.14 20.96 Favored 'General case' 0 N--CA 1.444 -0.738 0 CA-C-N 115.029 -0.987 . . . . 15.0 111.81 -175.152 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 244' ' ' THR . . . . . . . . . . . . . 4.4 p -117.54 149.92 39.82 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-N 113.733 -1.576 . . . . 15.0 110.077 -176.5 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 245' ' ' THR . . . . . 0.436 ' OG1' ' HG2' ' A' ' 247' ' ' GLN . 5.3 t -150.12 150.23 31.38 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 116.106 -0.497 . . . . 15.0 110.434 -176.003 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 19.8 t -54.82 -17.24 2.1 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 O-C-N 123.669 0.605 . . . . 15.0 111.354 179.078 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 247' ' ' GLN . . . . . 0.555 ' HB2' ' HG2' ' A' ' 249' ' ' GLN . 5.1 mm-40 -63.4 -19.25 64.52 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-O 121.006 0.431 . . . . 15.0 110.498 176.808 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 86.31 13.69 67.8 Favored Glycine 0 N--CA 1.452 -0.244 0 CA-C-N 116.013 -0.539 . . . . 15.0 112.289 176.709 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 249' ' ' GLN . . . . . 0.555 ' HG2' ' HB2' ' A' ' 247' ' ' GLN . 10.4 pt20 -114.02 135.12 54.35 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 120.927 0.394 . . . . 15.0 111.502 -174.701 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 6.0 m -90.0 120.26 38.5 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 N-CA-C 108.783 -0.821 . . . . 15.0 108.783 171.469 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 251' ' ' TYR . . . . . 0.624 ' CB ' ' HG2' ' B' ' 215' ' ' PRO . 4.3 p90 -125.75 133.04 52.2 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.863 -0.608 . . . . 15.0 109.855 -174.915 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 252' ' ' PHE . . . . . 0.613 ' CD2' ' HA ' ' A' ' 264' ' ' ASP . 24.5 m-85 -89.76 121.33 31.81 Favored 'General case' 0 CA--C 1.506 -0.728 0 CA-C-O 121.293 0.568 . . . . 15.0 111.619 -170.727 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 253' ' ' LEU . . . . . 0.57 HD11 ' CB ' ' B' ' 212' ' ' PRO . 0.6 OUTLIER -119.67 121.12 38.53 Favored 'General case' 0 N--CA 1.44 -0.944 0 CA-C-N 114.837 -1.074 . . . . 15.0 110.617 -176.017 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 254' ' ' HIS . . . . . 0.685 ' HB2' ' CD1' ' A' ' 240' ' ' TYR . 9.2 t-80 -132.33 96.59 3.9 Favored 'General case' 0 C--N 1.312 -1.065 0 N-CA-C 108.447 -0.945 . . . . 15.0 108.447 170.57 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 5.0 t -92.72 87.92 6.06 Favored 'General case' 0 N--CA 1.432 -1.369 0 C-N-CA 116.554 -2.058 . . . . 15.0 110.183 -179.509 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 256' ' ' GLN . . . . . 0.445 ' HB3' ' CE1' ' A' ' 254' ' ' HIS . 24.9 tt0 -101.36 -57.23 2.12 Favored 'General case' 0 N--CA 1.439 -0.98 0 CA-C-N 112.606 -2.088 . . . . 15.0 106.274 152.875 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 257' ' ' THR . . . . . . . . . . . . . 4.2 t -100.2 -13.56 18.86 Favored 'General case' 0 CA--C 1.488 -1.433 0 CA-C-N 111.326 -2.67 . . . . 15.0 112.085 -177.972 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 87.35 71.69 1.29 Allowed Glycine 1 C--N 1.238 -4.882 1 CA-C-N 108.136 -4.12 . . . . 15.0 112.635 -169.123 . . . . . . . . 3 2 . 1 . 020 nuclear nobuild full ' A' A ' 259' ' ' VAL . . . . . 0.567 ' O ' ' HA ' ' A' ' 253' ' ' LEU . 65.7 t -89.37 123.72 41.73 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 CA-C-O 121.667 0.746 . . . . 15.0 112.163 170.607 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 260' ' ' SER . . . . . 0.479 ' HA ' ' O ' ' A' ' 252' ' ' PHE . 2.4 p -140.85 100.57 3.87 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 113.876 -1.511 . . . . 15.0 108.442 170.706 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 261' ' ' THR . . . . . 0.4 ' OG1' ' HD2' ' A' ' 263' ' ' HIS . 8.7 t -141.75 150.51 41.86 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.18 0.514 . . . . 15.0 112.374 -168.35 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 262' ' ' TRP . . . . . 1.143 ' CZ2' ' HB2' ' B' ' 215' ' ' PRO . 29.5 m95 -71.06 -31.62 68.09 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.361 -0.836 . . . . 15.0 111.535 176.761 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 263' ' ' HIS . . . . . 0.4 ' HD2' ' OG1' ' A' ' 261' ' ' THR . 3.1 p80 -84.06 130.83 34.85 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 120.29 -0.564 . . . . 15.0 110.154 -175.737 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 264' ' ' ASP . . . . . 0.917 ' HB3' HG12 ' A' ' 267' ' ' ILE . 20.7 t0 -53.95 126.92 52.56 Favored Pre-proline 0 C--N 1.324 -0.511 0 CA-C-N 115.619 -0.719 . . . . 15.0 109.285 173.131 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 265' ' ' PRO . . . . . 0.548 ' HG2' ' CD1' ' A' ' 240' ' ' TYR . 10.9 Cg_exo -70.5 -14.96 34.24 Favored 'Trans proline' 0 N--CA 1.456 -0.709 0 C-N-CA 122.231 1.954 . . . . 15.0 112.496 -179.361 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 266' ' ' ARG . . . . . 0.462 ' HB3' ' OD2' ' A' ' 264' ' ' ASP . 26.6 tpt180 -72.38 -15.15 61.85 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-O 122.07 0.938 . . . . 15.0 108.788 171.171 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 267' ' ' ILE . . . . . 0.917 HG12 ' HB3' ' A' ' 264' ' ' ASP . 32.8 pt . . . . . 0 C--O 1.25 1.09 0 CA-C-N 114.275 -1.329 . . . . 15.0 110.936 177.117 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 210' ' ' SER . . . . . . . . . . . . . 21.0 m . . . . . 0 N--CA 1.473 0.7 0 N-CA-C 109.962 -0.384 . . . . 15.0 109.962 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' B' B ' 211' ' ' ASP . . . . . 0.431 ' HA ' ' HD3' ' B' ' 212' ' ' PRO . 6.0 p-10 -138.63 134.69 17.42 Favored Pre-proline 0 C--N 1.32 -0.694 0 CA-C-N 115.925 -0.579 . . . . 15.0 109.795 -177.684 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 212' ' ' PRO . . . . . 0.57 ' CB ' HD11 ' A' ' 253' ' ' LEU . 4.6 Cg_endo -89.7 154.78 5.15 Favored 'Trans proline' 0 N--CA 1.456 -0.711 0 C-N-CA 123.393 2.729 . . . . 15.0 112.225 -177.0 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -89.66 158.55 27.44 Favored Glycine 0 N--CA 1.442 -0.965 0 CA-C-N 115.625 -0.716 . . . . 15.0 112.587 -177.435 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 214' ' ' SEP . . . . . 0.411 ' HA ' ' HD3' ' B' ' 215' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 215' ' ' PRO . . . . . 1.143 ' HB2' ' CZ2' ' A' ' 262' ' ' TRP . 23.6 Cg_exo -87.33 148.47 7.71 Favored 'Trans proline' 0 N--CA 1.464 -0.245 0 C-N-CA 123.15 2.567 . . . . 15.0 111.62 176.207 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 216' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -114.05 -67.27 1.01 Allowed 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.132 0.491 . . . . 15.0 110.06 178.645 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 217' ' ' GLN . . . . . . . . . . . . . 28.2 pt20 . . . . . 0 C--O 1.249 1.074 0 CA-C-O 118.456 -0.783 . . . . 15.0 110.154 -179.441 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.482 1.158 0 N-CA-C 110.124 -0.324 . . . . 15.0 110.124 . . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 236' ' ' LEU . . . . . 0.443 HD11 ' OD2' ' A' ' 264' ' ' ASP . 0.9 OUTLIER -107.05 172.17 4.06 Favored Pre-proline 0 C--N 1.323 -0.549 0 CA-C-N 116.463 -0.335 . . . . 15.0 110.376 -176.889 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 237' ' ' PRO . . . . . 0.67 ' HD3' ' HD3' ' A' ' 266' ' ' ARG . 19.5 Cg_exo -69.44 170.1 16.99 Favored 'Trans proline' 0 CA--C 1.516 -0.422 0 C-N-CA 122.335 2.023 . . . . 15.0 110.838 165.577 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -69.78 140.26 53.35 Favored 'General case' 0 C--N 1.303 -1.422 0 CA-C-N 114.691 -1.14 . . . . 15.0 110.865 -176.207 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 239' ' ' GLY . . . . . 0.458 ' O ' ' HA ' ' A' ' 254' ' ' HIS . . . 100.04 11.99 41.15 Favored Glycine 0 N--CA 1.448 -0.516 0 CA-C-N 115.632 -0.713 . . . . 15.0 113.867 179.07 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 240' ' ' TYR . . . . . 0.669 ' CD1' ' HB2' ' A' ' 254' ' ' HIS . 64.2 m-85 -111.99 107.9 17.04 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 117.918 0.859 . . . . 15.0 111.579 178.13 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 13.8 mm-40 -90.15 120.81 31.64 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.021 -0.99 . . . . 15.0 109.841 176.155 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 23.4 tm0? -89.97 109.87 20.88 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 109.103 -0.703 . . . . 15.0 109.103 177.378 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 4.5 mtp180 -112.23 150.23 31.19 Favored 'General case' 0 CA--C 1.508 -0.666 0 CA-C-O 122.564 1.173 . . . . 15.0 113.494 -179.86 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 244' ' ' THR . . . . . . . . . . . . . 21.8 p -116.15 150.1 37.98 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-N 112.555 -2.111 . . . . 15.0 108.67 177.7 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 245' ' ' THR . . . . . 0.472 ' OG1' ' HG2' ' A' ' 247' ' ' GLN . 5.9 t -144.32 150.52 37.95 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 116.82 -0.173 . . . . 15.0 110.697 -175.201 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 21.6 t -52.5 -18.49 1.23 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 O-C-N 123.749 0.656 . . . . 15.0 111.589 178.261 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 247' ' ' GLN . . . . . 0.472 ' HG2' ' OG1' ' A' ' 245' ' ' THR . 4.7 mm100 -63.89 -17.15 62.91 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-O 120.893 0.378 . . . . 15.0 110.555 177.426 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 83.91 38.5 10.3 Favored Glycine 0 C--N 1.334 0.459 0 CA-C-N 116.088 -0.505 . . . . 15.0 112.571 177.275 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 249' ' ' GLN . . . . . 0.5 ' CD ' ' HH2' ' A' ' 262' ' ' TRP . 0.0 OUTLIER -146.72 147.5 31.03 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.044 0.449 . . . . 15.0 111.355 -175.194 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 13.7 m -93.92 138.45 20.44 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-N 115.1 -0.955 . . . . 15.0 109.345 173.737 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 251' ' ' TYR . . . . . 0.487 ' HB3' ' CG ' ' B' ' 215' ' ' PRO . 4.9 p90 -145.78 136.62 24.45 Favored 'General case' 0 C--N 1.32 -0.717 0 C-N-CA 120.605 -0.438 . . . . 15.0 110.419 -179.891 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 252' ' ' PHE . . . . . 0.607 ' CE2' ' HA ' ' A' ' 264' ' ' ASP . 43.9 m-85 -91.16 121.54 33.03 Favored 'General case' 0 CA--C 1.515 -0.377 0 CA-C-N 116.059 -0.519 . . . . 15.0 111.839 -174.629 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 253' ' ' LEU . . . . . 0.643 ' HA ' ' O ' ' A' ' 259' ' ' VAL . 13.7 mt -104.26 110.33 22.5 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-N 115.243 -0.89 . . . . 15.0 112.169 179.196 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 254' ' ' HIS . . . . . 0.669 ' HB2' ' CD1' ' A' ' 240' ' ' TYR . 22.7 t-80 -116.17 89.93 3.22 Favored 'General case' 0 C--N 1.311 -1.08 0 N-CA-C 107.696 -1.224 . . . . 15.0 107.696 166.099 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 37.1 m -90.86 88.03 6.89 Favored 'General case' 0 N--CA 1.43 -1.442 0 C-N-CA 116.894 -1.922 . . . . 15.0 110.097 -179.272 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 8.0 tt0 -101.04 -51.76 3.45 Favored 'General case' 0 N--CA 1.441 -0.891 0 N-CA-C 105.721 -1.955 . . . . 15.0 105.721 149.677 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 257' ' ' THR . . . . . . . . . . . . . 58.6 p -99.78 -13.69 19.15 Favored 'General case' 0 CA--C 1.485 -1.533 0 CA-C-O 124.768 2.223 . . . . 15.0 112.047 -179.435 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 85.9 75.51 1.24 Allowed Glycine 1 C--N 1.237 -4.937 0 CA-C-N 108.439 -3.982 . . . . 15.0 112.2 -169.55 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 259' ' ' VAL . . . . . 0.643 ' O ' ' HA ' ' A' ' 253' ' ' LEU . 42.9 t -89.88 123.46 42.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-O 121.395 0.617 . . . . 15.0 111.845 175.578 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 4.6 p -134.65 99.63 4.39 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 114.174 -1.376 . . . . 15.0 108.234 170.117 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 8.9 t -135.8 150.48 49.46 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 121.097 0.475 . . . . 15.0 111.841 -171.256 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 262' ' ' TRP . . . . . 1.144 ' CZ2' ' HB2' ' B' ' 215' ' ' PRO . 67.6 m95 -68.31 -33.45 74.33 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.141 -0.936 . . . . 15.0 111.345 176.595 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 263' ' ' HIS . . . . . . . . . . . . . 4.7 p80 -82.12 131.36 35.24 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 120.44 -0.504 . . . . 15.0 110.128 -172.783 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 264' ' ' ASP . . . . . 0.928 ' HB3' HG12 ' A' ' 267' ' ' ILE . 9.4 t70 -51.75 133.21 37.24 Favored Pre-proline 0 C--N 1.321 -0.635 0 N-CA-C 108.946 -0.761 . . . . 15.0 108.946 171.578 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 265' ' ' PRO . . . . . 0.457 ' HD3' ' CD2' ' A' ' 252' ' ' PHE . 36.5 Cg_endo -72.7 -14.76 27.18 Favored 'Trans proline' 0 N--CA 1.454 -0.797 0 C-N-CA 121.725 1.617 . . . . 15.0 114.294 -173.969 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 266' ' ' ARG . . . . . 0.67 ' HD3' ' HD3' ' A' ' 237' ' ' PRO . 0.1 OUTLIER -81.69 -6.65 59.22 Favored 'General case' 0 C--N 1.311 -1.107 0 N-CA-C 108.426 -0.953 . . . . 15.0 108.426 174.843 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 267' ' ' ILE . . . . . 0.928 HG12 ' HB3' ' A' ' 264' ' ' ASP . 42.1 mm . . . . . 0 C--O 1.249 1.031 0 CA-C-N 113.865 -1.516 . . . . 15.0 109.921 177.606 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 210' ' ' SER . . . . . . . . . . . . . 5.9 m . . . . . 0 N--CA 1.474 0.737 0 CA-C-O 120.873 0.368 . . . . 15.0 110.2 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' B' B ' 211' ' ' ASP . . . . . 0.437 ' HA ' ' HD3' ' B' ' 212' ' ' PRO . 30.4 t70 -150.09 129.39 6.37 Favored Pre-proline 0 C--N 1.324 -0.501 0 N-CA-C 109.504 -0.554 . . . . 15.0 109.504 -179.436 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 212' ' ' PRO . . . . . 0.591 ' CB ' HD11 ' A' ' 253' ' ' LEU . 27.3 Cg_endo -89.9 156.98 4.98 Favored 'Trans proline' 0 N--CA 1.454 -0.837 0 C-N-CA 122.601 2.2 . . . . 15.0 112.967 -176.081 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -89.89 159.98 28.3 Favored Glycine 0 N--CA 1.442 -0.942 0 CA-C-N 115.493 -0.776 . . . . 15.0 111.458 177.908 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 214' ' ' SEP . . . . . 0.417 ' HA ' ' HD3' ' B' ' 215' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 215' ' ' PRO . . . . . 1.144 ' HB2' ' CZ2' ' A' ' 262' ' ' TRP . 12.0 Cg_exo -88.0 143.29 5.81 Favored 'Trans proline' 0 C--O 1.235 0.326 0 C-N-CA 122.846 2.364 . . . . 15.0 111.731 176.833 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 216' ' ' PHE . . . . . . . . . . . . . 42.0 m-85 -111.13 -89.42 0.5 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.719 -0.673 . . . . 15.0 110.332 -178.566 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 217' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 . . . . . 0 C--O 1.248 1.006 0 CA-C-O 118.389 -0.815 . . . . 15.0 110.393 -178.591 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 . . . . . 0 N--CA 1.476 0.875 0 CA-C-O 121.087 0.47 . . . . 15.0 110.099 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 236' ' ' LEU . . . . . 0.734 HD12 ' HD2' ' A' ' 265' ' ' PRO . 0.4 OUTLIER -90.03 161.3 38.47 Favored Pre-proline 0 C--N 1.32 -0.693 0 CA-C-N 115.782 -0.644 . . . . 15.0 110.715 -171.675 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 237' ' ' PRO . . . . . 0.519 ' HD3' ' HD3' ' A' ' 266' ' ' ARG . 23.3 Cg_exo -69.32 171.0 14.75 Favored 'Trans proline' 0 CA--C 1.508 -0.783 0 C-N-CA 122.844 2.363 . . . . 15.0 110.097 162.474 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -69.42 145.1 53.1 Favored 'General case' 0 C--N 1.3 -1.553 0 CA-C-N 115.072 -0.967 . . . . 15.0 111.89 -175.845 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 100.21 10.19 45.93 Favored Glycine 0 N--CA 1.449 -0.484 0 CA-C-N 114.435 -1.257 . . . . 15.0 113.214 -179.868 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 240' ' ' TYR . . . . . 0.631 ' CD1' ' HB2' ' A' ' 254' ' ' HIS . 71.9 m-85 -116.67 123.5 47.41 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 117.235 0.518 . . . . 15.0 110.989 177.904 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -91.52 123.45 34.94 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.648 -0.705 . . . . 15.0 109.446 171.41 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 18.8 tm0? -91.4 99.86 12.74 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 108.646 -0.872 . . . . 15.0 108.646 174.513 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 68.7 mtt-85 -103.16 150.16 23.94 Favored 'General case' 0 CA--C 1.504 -0.825 0 CA-C-O 122.136 0.97 . . . . 15.0 112.087 -176.37 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 244' ' ' THR . . . . . . . . . . . . . 10.9 m -129.47 97.56 4.59 Favored 'General case' 0 C--N 1.308 -1.222 0 CA-C-N 113.28 -1.782 . . . . 15.0 109.399 -177.042 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 245' ' ' THR . . . . . 0.487 ' OG1' ' HG2' ' A' ' 247' ' ' GLN . 3.5 t -94.94 150.48 20.12 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.257 -0.883 . . . . 15.0 110.989 -175.621 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 9.9 m -50.53 -18.36 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.451 0 CA-C-N 115.615 -0.721 . . . . 15.0 112.577 176.97 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 247' ' ' GLN . . . . . 0.487 ' HG2' ' OG1' ' A' ' 245' ' ' THR . 7.3 mm100 -56.3 -21.28 23.07 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.02 -0.536 . . . . 15.0 110.682 173.182 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 89.73 11.91 63.16 Favored Glycine 0 N--CA 1.447 -0.576 0 CA-C-N 115.851 -0.613 . . . . 15.0 112.871 174.845 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 7.1 mt-30 -129.37 141.53 51.04 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 110.205 -0.294 . . . . 15.0 110.205 -176.358 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 17.1 m -89.79 135.0 27.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 116.333 -0.394 . . . . 15.0 110.109 178.235 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 251' ' ' TYR . . . . . 0.564 ' HB3' ' HG2' ' B' ' 215' ' ' PRO . 25.6 p90 -134.54 135.05 42.04 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 116.143 -0.48 . . . . 15.0 110.004 -178.437 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 252' ' ' PHE . . . . . 0.701 ' CD2' ' HA ' ' A' ' 264' ' ' ASP . 24.3 m-85 -90.22 125.72 35.58 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.31 0.576 . . . . 15.0 111.147 -175.731 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 253' ' ' LEU . . . . . 1.071 HD11 ' HB3' ' B' ' 212' ' ' PRO . 0.4 OUTLIER -113.73 109.42 18.55 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-N 114.808 -1.087 . . . . 15.0 111.858 -173.398 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 254' ' ' HIS . . . . . 0.631 ' HB2' ' CD1' ' A' ' 240' ' ' TYR . 35.2 t-80 -120.62 89.98 3.23 Favored 'General case' 0 C--N 1.314 -0.963 0 N-CA-C 108.386 -0.968 . . . . 15.0 108.386 167.785 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 8.0 t -94.94 88.03 5.15 Favored 'General case' 0 N--CA 1.433 -1.289 0 C-N-CA 116.5 -2.08 . . . . 15.0 110.998 -179.372 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 -100.76 -51.86 3.47 Favored 'General case' 0 N--CA 1.44 -0.96 0 CA-C-N 112.808 -1.996 . . . . 15.0 106.142 149.415 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 257' ' ' THR . . . . . . . . . . . . . 59.3 p -95.85 -13.23 24.17 Favored 'General case' 0 CA--C 1.487 -1.457 0 CA-C-O 125.039 2.352 . . . . 15.0 111.763 -179.21 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 84.9 73.25 1.27 Allowed Glycine 1 C--N 1.241 -4.705 1 CA-C-N 108.042 -4.163 . . . . 15.0 112.55 -172.873 . . . . . . . . 3 2 . 1 . 022 nuclear nobuild full ' A' A ' 259' ' ' VAL . . . . . 0.597 ' O ' HD23 ' A' ' 253' ' ' LEU . 66.0 t -89.86 122.59 41.38 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.411 0 CA-C-O 121.676 0.751 . . . . 15.0 111.878 176.664 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 2.2 p -134.47 100.8 4.76 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-N 113.746 -1.57 . . . . 15.0 107.295 170.42 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 9.0 t -136.26 150.32 48.89 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 112.654 0.613 . . . . 15.0 112.654 -166.413 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 262' ' ' TRP . . . . . 1.202 ' CZ2' ' HB2' ' B' ' 215' ' ' PRO . 79.9 m95 -79.02 -23.19 44.49 Favored 'General case' 0 N--CA 1.454 -0.275 0 CA-C-N 115.154 -0.93 . . . . 15.0 111.474 177.788 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 263' ' ' HIS . . . . . . . . . . . . . 5.6 p80 -92.96 134.5 35.05 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 120.271 -0.572 . . . . 15.0 110.521 -176.517 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 264' ' ' ASP . . . . . 0.965 ' HB3' HG12 ' A' ' 267' ' ' ILE . 13.7 t0 -56.99 124.1 63.34 Favored Pre-proline 0 C--N 1.321 -0.673 0 N-CA-C 108.4 -0.963 . . . . 15.0 108.4 171.049 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 265' ' ' PRO . . . . . 0.734 ' HD2' HD12 ' A' ' 236' ' ' LEU . 16.6 Cg_exo -68.39 -14.77 40.87 Favored 'Trans proline' 0 CA--C 1.514 -0.479 0 C-N-CA 122.362 2.041 . . . . 15.0 113.181 -176.45 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 266' ' ' ARG . . . . . 0.519 ' HD3' ' HD3' ' A' ' 237' ' ' PRO . 10.8 tpt180 -76.93 -10.06 59.11 Favored 'General case' 0 C--N 1.313 -1.015 0 N-CA-C 108.473 -0.936 . . . . 15.0 108.473 174.137 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 267' ' ' ILE . . . . . 0.965 HG12 ' HB3' ' A' ' 264' ' ' ASP . 27.9 pt . . . . . 0 C--O 1.251 1.175 0 CA-C-N 114.129 -1.396 . . . . 15.0 110.835 177.334 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' B' B ' 210' ' ' SER . . . . . . . . . . . . . 9.4 t . . . . . 0 N--CA 1.476 0.861 0 N-CA-C 109.141 -0.689 . . . . 15.0 109.141 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' B' B ' 211' ' ' ASP . . . . . 0.441 ' HA ' ' HD3' ' B' ' 212' ' ' PRO . 5.0 m-20 -130.58 150.17 75.57 Favored Pre-proline 0 C--N 1.321 -0.654 0 CA-C-N 116.093 -0.503 . . . . 15.0 110.711 -174.077 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 212' ' ' PRO . . . . . 1.071 ' HB3' HD11 ' A' ' 253' ' ' LEU . 5.2 Cg_endo -89.83 151.65 5.0 Favored 'Trans proline' 0 N--CA 1.453 -0.906 0 C-N-CA 123.111 2.541 . . . . 15.0 112.182 179.759 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -89.93 160.08 28.33 Favored Glycine 0 N--CA 1.442 -0.922 0 C-N-CA 120.674 -0.774 . . . . 15.0 111.643 -179.764 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' B' B ' 214' ' ' SEP . . . . . 0.435 ' HA ' ' HD3' ' B' ' 215' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' B' B ' 215' ' ' PRO . . . . . 1.202 ' HB2' ' CZ2' ' A' ' 262' ' ' TRP . 12.1 Cg_exo -88.14 138.82 4.22 Favored 'Trans proline' 0 C--O 1.235 0.37 0 C-N-CA 123.222 2.614 . . . . 15.0 111.302 178.377 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 216' ' ' PHE . . . . . . . . . . . . . 93.8 m-85 -99.88 128.12 46.0 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.97 -0.559 . . . . 15.0 110.216 -178.604 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' B' B ' 217' ' ' GLN . . . . . . . . . . . . . 18.8 mm-40 . . . . . 0 C--O 1.246 0.877 0 CA-C-O 118.506 -0.759 . . . . 15.0 110.193 177.773 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 . . . . . 0 N--CA 1.483 1.212 0 CA-C-O 121.039 0.447 . . . . 15.0 110.803 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 236' ' ' LEU . . . . . 0.465 HD12 ' HB2' ' A' ' 266' ' ' ARG . 0.4 OUTLIER -104.07 171.58 4.94 Favored Pre-proline 0 C--N 1.319 -0.732 0 N-CA-C 109.225 -0.657 . . . . 15.0 109.225 -178.878 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 237' ' ' PRO . . . . . 0.407 ' HD3' ' HD3' ' A' ' 266' ' ' ARG . 12.0 Cg_exo -69.56 164.55 33.92 Favored 'Trans proline' 0 N--CA 1.459 -0.553 0 C-N-CA 121.606 1.538 . . . . 15.0 110.689 170.802 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -69.69 150.34 47.09 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-N 114.976 -1.011 . . . . 15.0 111.707 -174.535 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 239' ' ' GLY . . . . . 0.41 ' O ' ' HA ' ' A' ' 254' ' ' HIS . . . 100.15 -7.16 58.47 Favored Glycine 0 N--CA 1.448 -0.523 0 CA-C-N 115.656 -0.702 . . . . 15.0 113.644 176.206 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 240' ' ' TYR . . . . . 0.627 ' CD1' ' HB2' ' A' ' 254' ' ' HIS . 60.0 m-85 -102.53 114.05 27.94 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 117.492 0.646 . . . . 15.0 110.628 179.125 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -94.54 131.72 39.98 Favored 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 108.924 -0.769 . . . . 15.0 108.924 171.306 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 23.0 tm0? -89.71 107.97 19.4 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 107.989 -1.115 . . . . 15.0 107.989 179.623 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 13.7 mtp180 -101.85 150.15 23.46 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-O 122.121 0.963 . . . . 15.0 112.175 -175.861 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 244' ' ' THR . . . . . . . . . . . . . 5.1 m -122.69 141.38 51.83 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-N 113.216 -1.811 . . . . 15.0 107.757 -177.798 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 245' ' ' THR . . . . . 0.631 ' CG2' ' HB3' ' A' ' 247' ' ' GLN . 3.1 t -141.96 150.34 41.29 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-O 120.878 0.371 . . . . 15.0 111.717 -169.216 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 8.8 p -55.97 -24.45 17.34 Favored 'Isoleucine or valine' 0 C--O 1.234 0.248 0 CA-C-N 115.31 -0.859 . . . . 15.0 109.886 172.49 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 247' ' ' GLN . . . . . 0.732 ' HG2' ' NE2' ' A' ' 249' ' ' GLN . 40.8 tt0 -50.46 -35.83 30.71 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 114.506 -1.224 . . . . 15.0 110.473 172.699 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 102.04 -15.29 56.76 Favored Glycine 0 C--N 1.333 0.396 0 CA-C-N 116.118 -0.492 . . . . 15.0 112.987 176.645 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 249' ' ' GLN . . . . . 0.732 ' NE2' ' HG2' ' A' ' 247' ' ' GLN . 2.3 mp0 -96.43 147.42 23.85 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 120.64 0.257 . . . . 15.0 111.3 -173.857 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 3.3 m -89.99 130.26 39.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 N-CA-C 109.617 -0.512 . . . . 15.0 109.617 174.16 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 251' ' ' TYR . . . . . 0.6 ' HB3' ' HG2' ' B' ' 215' ' ' PRO . 9.4 p90 -142.42 138.95 31.45 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.369 0.605 . . . . 15.0 111.721 -176.206 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 252' ' ' PHE . . . . . 0.62 ' CD2' ' HA ' ' A' ' 264' ' ' ASP . 43.0 m-85 -96.62 125.17 40.91 Favored 'General case' 0 CA--C 1.509 -0.607 0 CA-C-N 115.169 -0.923 . . . . 15.0 110.873 -177.265 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 253' ' ' LEU . . . . . 0.689 ' HA ' ' O ' ' A' ' 259' ' ' VAL . 0.1 OUTLIER -123.95 109.15 13.21 Favored 'General case' 0 N--CA 1.441 -0.919 0 CA-C-O 121.696 0.76 . . . . 15.0 111.979 -177.939 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 254' ' ' HIS . . . . . 0.627 ' HB2' ' CD1' ' A' ' 240' ' ' TYR . 12.4 t-80 -109.61 93.85 4.72 Favored 'General case' 0 CA--C 1.501 -0.928 0 CA-C-N 114.881 -1.054 . . . . 15.0 108.184 169.36 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 3.6 t -93.85 88.2 5.67 Favored 'General case' 0 N--CA 1.434 -1.265 0 C-N-CA 116.35 -2.14 . . . . 15.0 110.556 179.501 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 7.6 tp60 -101.21 -51.9 3.39 Favored 'General case' 0 N--CA 1.442 -0.863 0 CA-C-N 113.19 -1.823 . . . . 15.0 106.269 150.981 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 257' ' ' THR . . . . . . . . . . . . . 71.9 p -99.96 -13.67 19.01 Favored 'General case' 0 CA--C 1.487 -1.461 0 CA-C-O 124.666 2.174 . . . . 15.0 112.118 -179.501 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 88.63 73.89 1.28 Allowed Glycine 1 C--N 1.242 -4.693 0 CA-C-N 108.533 -3.94 . . . . 15.0 112.849 -171.32 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 259' ' ' VAL . . . . . 0.689 ' O ' ' HA ' ' A' ' 253' ' ' LEU . 68.7 t -89.58 126.73 42.5 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.391 0 CA-C-O 121.296 0.57 . . . . 15.0 111.583 173.219 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 2.2 p -150.01 94.13 2.11 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 114.039 -1.437 . . . . 15.0 107.72 168.886 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 9.8 t -135.03 150.29 50.27 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.516 -0.765 . . . . 15.0 111.173 -169.151 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 262' ' ' TRP . . . . . 1.161 ' CZ2' ' HB2' ' B' ' 215' ' ' PRO . 23.2 m95 -70.1 -17.51 63.22 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 113.19 0.811 . . . . 15.0 113.19 -177.194 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 263' ' ' HIS . . . . . . . . . . . . . 4.6 p80 -96.25 133.0 41.12 Favored 'General case' 0 C--N 1.323 -0.561 0 C-N-CA 120.088 -0.645 . . . . 15.0 110.01 179.961 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 264' ' ' ASP . . . . . 0.995 ' HB3' HG12 ' A' ' 267' ' ' ILE . 9.9 t0 -56.72 131.21 78.19 Favored Pre-proline 0 C--O 1.222 -0.386 0 N-CA-C 107.888 -1.153 . . . . 15.0 107.888 171.283 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 265' ' ' PRO . . . . . 0.508 ' HG2' ' CD1' ' A' ' 240' ' ' TYR . 17.0 Cg_exo -69.33 -15.05 38.42 Favored 'Trans proline' 0 C--N 1.324 -0.75 0 C-N-CA 122.092 1.861 . . . . 15.0 113.415 -176.232 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 266' ' ' ARG . . . . . 0.485 ' HD2' ' HA ' ' A' ' 266' ' ' ARG . 15.9 tpt180 -79.7 -8.02 58.96 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-O 122.037 0.922 . . . . 15.0 108.67 173.881 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 267' ' ' ILE . . . . . 0.995 HG12 ' HB3' ' A' ' 264' ' ' ASP . 33.4 pt . . . . . 0 C--O 1.248 0.984 0 CA-C-N 113.798 -1.546 . . . . 15.0 110.641 175.382 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' B' B ' 210' ' ' SER . . . . . . . . . . . . . 10.7 m . . . . . 0 N--CA 1.475 0.825 0 CA-C-O 120.883 0.373 . . . . 15.0 110.644 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' B' B ' 211' ' ' ASP . . . . . 0.507 ' HA ' ' HD3' ' B' ' 212' ' ' PRO . 25.7 t70 -140.08 122.0 9.75 Favored Pre-proline 0 N--CA 1.453 -0.286 0 CA-C-O 121.023 0.44 . . . . 15.0 111.084 -177.31 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 212' ' ' PRO . . . . . 0.6 ' HB2' HD13 ' A' ' 253' ' ' LEU . 1.2 Cg_endo -89.63 160.01 5.27 Favored 'Trans proline' 0 N--CA 1.457 -0.65 0 C-N-CA 123.774 2.983 . . . . 15.0 111.846 176.126 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -89.61 160.09 28.73 Favored Glycine 0 N--CA 1.447 -0.617 0 C-N-CA 120.809 -0.71 . . . . 15.0 112.896 -176.168 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' B' B ' 214' ' ' SEP . . . . . 0.475 ' HA ' ' HD3' ' B' ' 215' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' B' B ' 215' ' ' PRO . . . . . 1.161 ' HB2' ' CZ2' ' A' ' 262' ' ' TRP 0.291 22.2 Cg_exo -87.41 132.89 3.15 Favored 'Trans proline' 0 C--O 1.232 0.217 0 C-N-CA 123.69 2.927 . . . . 15.0 111.58 -176.448 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' B' B ' 216' ' ' PHE . . . . . . . . . . . . . 65.5 m-85 -110.52 -38.92 5.07 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 109.348 -0.612 . . . . 15.0 109.348 176.333 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' B' B ' 217' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.247 0.971 0 CA-C-N 115.412 -0.813 . . . . 15.0 109.211 176.288 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 . . . . . 0 N--CA 1.478 0.95 0 N-CA-C 109.974 -0.38 . . . . 15.0 109.974 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 236' ' ' LEU . . . . . 0.668 HD22 ' H ' ' A' ' 236' ' ' LEU . 0.1 OUTLIER -94.63 157.92 36.26 Favored Pre-proline 0 C--N 1.323 -0.554 0 CA-C-O 121.133 0.492 . . . . 15.0 110.166 -176.706 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 237' ' ' PRO . . . . . 0.557 ' HD3' ' HD3' ' A' ' 266' ' ' ARG . 15.1 Cg_exo -69.56 173.8 10.27 Favored 'Trans proline' 0 CA--C 1.507 -0.84 0 C-N-CA 122.672 2.248 . . . . 15.0 110.442 165.861 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 3.7 pm0 -69.48 142.63 53.71 Favored 'General case' 0 C--N 1.291 -1.945 0 CA-C-N 114.253 -1.339 . . . . 15.0 111.613 -173.297 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 100.17 3.36 55.68 Favored Glycine 0 CA--C 1.521 0.446 0 CA-C-N 115.233 -0.894 . . . . 15.0 113.965 177.172 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 240' ' ' TYR . . . . . 0.526 ' CD1' ' HG2' ' A' ' 265' ' ' PRO . 62.4 m-85 -111.17 125.34 53.69 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 117.856 0.828 . . . . 15.0 111.253 178.651 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 241' ' ' GLU . . . . . 0.561 ' HG3' ' HB3' ' A' ' 253' ' ' LEU . 8.6 pt-20 -108.75 123.28 48.76 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 109.199 -0.667 . . . . 15.0 109.199 170.926 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -89.81 106.55 18.54 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 109.203 -0.665 . . . . 15.0 109.203 -177.802 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 27.9 mtt-85 -98.46 148.43 23.73 Favored 'General case' 0 CA--C 1.505 -0.771 0 CA-C-O 122.123 0.963 . . . . 15.0 112.06 -177.531 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 244' ' ' THR . . . . . . . . . . . . . 25.0 p -117.26 146.06 43.54 Favored 'General case' 0 C--N 1.306 -1.285 0 CA-C-N 113.348 -1.751 . . . . 15.0 108.852 178.409 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 245' ' ' THR . . . . . 0.432 HG23 ' HB2' ' A' ' 247' ' ' GLN . 5.9 t -144.26 150.16 37.47 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 116.612 -0.267 . . . . 15.0 110.861 -172.393 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 6.4 m -53.63 -19.17 2.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.824 -0.626 . . . . 15.0 111.974 177.953 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 247' ' ' GLN . . . . . 0.432 ' HB2' HG23 ' A' ' 245' ' ' THR . 8.8 mm100 -58.68 -20.61 49.94 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.735 -0.666 . . . . 15.0 110.901 175.203 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 84.21 26.61 39.64 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 121.107 -0.568 . . . . 15.0 112.542 176.639 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 3.0 mt-30 -133.2 138.9 46.72 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 110.286 -0.264 . . . . 15.0 110.286 -173.904 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 4.4 m -89.65 122.83 41.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 N-CA-C 109.721 -0.474 . . . . 15.0 109.721 173.331 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 251' ' ' TYR . . . . . 0.759 ' HB2' ' HG2' ' B' ' 215' ' ' PRO . 2.5 p90 -129.89 134.07 47.28 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.049 0.452 . . . . 15.0 109.856 -175.792 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 252' ' ' PHE . . . . . 0.582 ' CD2' ' HA ' ' A' ' 264' ' ' ASP . 40.1 m-85 -90.05 128.11 36.21 Favored 'General case' 0 CA--C 1.512 -0.499 0 CA-C-O 121.237 0.542 . . . . 15.0 111.483 -175.185 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 253' ' ' LEU . . . . . 0.899 HD11 ' HB3' ' B' ' 212' ' ' PRO . 0.7 OUTLIER -118.66 126.27 51.56 Favored 'General case' 0 N--CA 1.446 -0.673 0 CA-C-N 115.035 -0.984 . . . . 15.0 110.78 -175.909 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 254' ' ' HIS . . . . . 0.522 ' HB3' ' HB ' ' A' ' 259' ' ' VAL . 0.2 OUTLIER -140.61 91.72 2.45 Favored 'General case' 0 C--N 1.313 -0.988 0 N-CA-C 108.595 -0.891 . . . . 15.0 108.595 173.282 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 3.1 t -103.23 87.91 3.0 Favored 'General case' 0 N--CA 1.43 -1.44 0 C-N-CA 116.796 -1.962 . . . . 15.0 111.015 -179.598 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 30.2 tp60 -101.23 -52.85 3.16 Favored 'General case' 0 N--CA 1.437 -1.099 0 CA-C-N 112.681 -2.054 . . . . 15.0 105.574 147.116 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 257' ' ' THR . . . . . . . . . . . . . 31.8 p -97.63 -13.55 21.49 Favored 'General case' 0 CA--C 1.489 -1.38 0 CA-C-O 124.89 2.281 . . . . 15.0 112.0 -177.246 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 84.73 71.37 1.32 Allowed Glycine 1 C--N 1.242 -4.676 1 CA-C-N 108.315 -4.039 . . . . 15.0 113.926 -174.575 . . . . . . . . 3 2 . 1 . 024 nuclear nobuild full ' A' A ' 259' ' ' VAL . . . . . 0.522 ' HB ' ' HB3' ' A' ' 254' ' ' HIS . 67.5 t -89.91 129.95 39.99 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 CA-C-O 121.405 0.622 . . . . 15.0 111.431 171.597 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 23.8 p -143.79 102.89 3.98 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 114.386 -1.279 . . . . 15.0 108.093 171.553 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 14.4 t -149.32 150.44 32.49 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.966 0.412 . . . . 15.0 111.747 -168.726 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 262' ' ' TRP . . . . . 1.113 ' CZ2' ' HB2' ' B' ' 215' ' ' PRO . 84.7 m95 -71.96 -37.03 70.0 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.721 -0.672 . . . . 15.0 111.282 177.724 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 263' ' ' HIS . . . . . . . . . . . . . 2.8 p80 -73.65 126.85 31.22 Favored 'General case' 0 CA--C 1.515 -0.37 0 C-N-CA 120.52 -0.472 . . . . 15.0 109.923 -174.001 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 264' ' ' ASP . . . . . 1.084 ' HB3' HG12 ' A' ' 267' ' ' ILE . 15.0 t0 -54.47 125.79 53.43 Favored Pre-proline 0 C--N 1.32 -0.699 0 N-CA-C 108.326 -0.99 . . . . 15.0 108.326 173.404 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 265' ' ' PRO . . . . . 0.526 ' HG2' ' CD1' ' A' ' 240' ' ' TYR . 14.2 Cg_exo -68.72 -14.59 39.55 Favored 'Trans proline' 0 CA--C 1.512 -0.581 0 C-N-CA 121.893 1.729 . . . . 15.0 112.667 -177.296 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 266' ' ' ARG . . . . . 0.557 ' HD3' ' HD3' ' A' ' 237' ' ' PRO . 19.8 tpt180 -76.46 -11.94 59.96 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 115.225 -0.898 . . . . 15.0 108.932 173.137 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 267' ' ' ILE . . . . . 1.084 HG12 ' HB3' ' A' ' 264' ' ' ASP . 41.8 pt . . . . . 0 C--O 1.25 1.101 0 CA-C-O 117.549 -1.215 . . . . 15.0 111.529 178.999 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' B' B ' 210' ' ' SER . . . . . . . . . . . . . 18.9 m . . . . . 0 N--CA 1.477 0.892 0 CA-C-O 120.98 0.419 . . . . 15.0 110.806 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' B' B ' 211' ' ' ASP . . . . . . . . . . . . . 11.9 p-10 -111.87 109.87 54.85 Favored Pre-proline 0 C--N 1.327 -0.38 0 CA-C-O 121.138 0.494 . . . . 15.0 110.5 -178.29 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' B' B ' 212' ' ' PRO . . . . . 0.899 ' HB3' HD11 ' A' ' 253' ' ' LEU . 6.6 Cg_endo -89.97 147.73 4.71 Favored 'Trans proline' 0 N--CA 1.453 -0.871 0 C-N-CA 122.638 2.225 . . . . 15.0 112.21 176.257 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -89.62 131.78 10.91 Favored Glycine 0 N--CA 1.442 -0.931 0 C-N-CA 120.543 -0.836 . . . . 15.0 111.598 178.286 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' B' B ' 214' ' ' SEP . . . . . 0.471 ' HA ' ' HD3' ' B' ' 215' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' B' B ' 215' ' ' PRO . . . . . 1.113 ' HB2' ' CZ2' ' A' ' 262' ' ' TRP . 16.8 Cg_exo -88.1 144.61 6.1 Favored 'Trans proline' 0 N--CA 1.453 -0.895 0 C-N-CA 123.513 2.809 . . . . 15.0 110.984 177.225 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' B' B ' 216' ' ' PHE . . . . . . . . . . . . . 99.2 m-85 -104.23 -46.25 4.47 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.523 -0.308 . . . . 15.0 110.536 -178.501 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' B' B ' 217' ' ' GLN . . . . . . . . . . . . . 9.2 tt0 . . . . . 0 C--O 1.248 0.993 0 CA-C-N 115.808 -0.633 . . . . 15.0 109.541 177.522 . . . . . . . . 0 0 . 1 stop_ save_